PubMed ID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
39792265,[Treatment of severe flares in Crohn's disease and ulcerative colitis].,2025-01-10,Schmidt C,"Medizinische Klinik II, Gastroenterologie, Hepatologie, Endokrinologie, Diabetologie und Infektiologie, Klinikum Fulda AG, Universitatsmedizin Marburg - Campus Fulda, Fulda, Deutschland.","Klinik fur Innere Medizin IV (Gastroenterologie, Hepatologie und Infektiologie), Universitatsklinikum Jena, Am Klinikum 1, 07747, Jena, Deutschland. andreas.stallmach@med.uni-jena.de."
39790480,Proenkephalin A 119-159 (penKid) and mortality in stable patients at high cardiovascular risk.,2024-01-01,Hartmann O; Lobo de Sa FD,"SphingoTec GmbH, Hennigsdorf, Germany.",Not available
39789976,"Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and Spain.",2025-01-10,Hasaligil A; Munro V; Strunz-McKendry T; Wang-Silvanto J,"Astellas Pharma Europe Ltd., Addlestone, UK.",Not available
39789734,Determination of the Bioavailability of 3 Intranasal Formulations of Azelastine Hydrochloride in Healthy Male Volunteers.,2025-01-09,Canonica GW,"Mylan Pharmaceuticals Private Limited (Now Viatris), Bengaluru, India.",Not available
39789408,Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON.,2025-01-09,Miede C; Dumistracel M; Coeck C,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.; Boehringer Ingelheim SComm., Brussels, Belgium.; mainanalytics GmbH, Sulzbach (Taunus), Germany.","Unit for Interstitial Lung Diseases, Department of Pulmonary Medicine, University Hospitals Leuven, Leuven, Belgium. wim.wuyts@uzleuven.be."
39789153,Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.,2025-01-09,Tombal B; Sandstrom P,"Bayer A/S, Copenhagen, Denmark.; Cliniques Universitaires Saint Luc, Brussels, Belgium.","Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast and Northern Ireland Cancer Centre, Belfast, UK. joe.osullivan@qub.ac.uk."
39788967,Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.,2025-01-09,Banbury B; Sherry N,"Adaptive Biotechnologies Corp, Seattle, USA.","University of California San Diego, San Diego, USA. jmayadev@health.ucsd.edu."
39788817,Deep learning model to identify and validate hypotension endotypes in surgical and critically ill patients.,2025-01-08,Jian Z; Liu X; Settels JJ; Scheeren TWL; Hatib F,"Edwards Lifesciences, Irvine, CA, USA.",Not available
39787635,Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning.,2025-01-02,Kimura K,"AOI Biosciences Inc., Tokyo, Japan.","Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan. Electronic address: da-fujimoto@hyo-med.ac.jp."
39787603,"A New Way Forward for Women's Health Research at the National Institutes of Health: A Roadmap From the National Academies of Sciences, Engineering, and Medicine's Consensus Report.",2025-01-09,Debbink MP,"Department of Obstetrics and Gynecology, Spencer Fox Eccles School of Medicine, University of Utah Health, Salt Lake City, Utah; KFF, San Francisco, California; and the Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke School of Medicine, Durham, North Carolina. All authors served on the National Academies Committee as committee members or employees of the National Academies.; the Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, and Women and Infants Hospital of Rhode Island, Providence, Rhode Island; the National Academies of Sciences, Engineering, and Medicine, and Baker Donelson, Washington, DC",Not available
39787298,Sulfilimines from a Medicinal Chemist's Perspective: Physicochemical and in Vitro Parameters Relevant for Drug Discovery.,2025-01-09,Gnamm C,"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany.",Not available
39787174,Clinical control in COPD and therapeutic implications: The EPOCONSUL audit.,2025-01-01,Fuentes Ferrer ME,"CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.",Not available
39786401,"OBI-992, a Novel TROP2-Targeted Antibody-Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models.",2024-12-30,Li WF; Chiang MF; Weng HC; Yang JJ; Wu HS; Wu SY; Chen YJ; Lu CH; Tu JS; Hsu RY; Shia CS; Huang TY; Lai MT,"OBI Pharma, Inc., Taipei, Taiwan.",Not available
39785810,Biomarkers.,2024-01-01,Snellman A; Borroni E; Quijano-Rubio C; Fauria K,"Centro de Investigacion Biomedica en Red Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigacion Biomedica en Red de Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.; Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.",Not available
39785718,Are Exposure Recommendations for QT Evaluation Being Fulfilled?,2025-01-09,Narukawa M,"Meiji Seika Pharma Co., Ltd., 2-4-16 Kyobashi, Chuo-ku, Tokyo, Japan.",Not available
39785562,Occurrence analysis of alpha-mangostin from different organs of Garcinia mangostana L.,2025-01-09,Taher M,"IKOP Pharma (IKOP Sdn. Bhd.), Jalan Sultan Ahmad Shah, Kuantan, Pahang, Malaysia.",Not available
39785474,Biomarkers.,2024-01-01,Puskas LG,"Aperus Pharma, Szeged, Hungary.",Not available
39785173,Public Health.,2024-01-01,Suarez-Calvet M; Mueggler T; Blennow K; Iranzo A,"Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.",Not available
39783852,A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled-Release Formulations Versus a Marketed Orlistat Product.,2025-01-09,Gruden S,"Empros Pharma AB, Solna, Sweden.",Not available
39783748,Developing Topics.,2024-01-01,Arbelaez MJ; Gutierrez E; Venegas M; Tangarife MA; Sanchez LT; Shahnawaz S; De Jesus WJ; Pujals KY; Grimaldi C; Rao JS; Mukunda R,"IGC Pharma, Bogota, Bogota D.C., Colombia.; IGC Pharma, Potomac, MD, USA.; Santa Cruz Behavioral, Bayamon, PR, USA.",Not available
39783700,Developing Topics.,2024-01-01,Yang T; Kollmorgen G; Wild N; Simmons C; Varda T,"Product Development Data Sciences, F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada.; Product Development Safety Risk Management, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Product Development Safety Risk Management, F. Hoffmann-La Roche Ltd, Roche China Holding, Beijing, China.; Roche Diagnostics GmbH, Penzberg, Germany.",Not available
39783694,Developing Topics.,2024-01-01,Delgado-Murillo L; Tangarife MA; Gutierrez E; Camargo F; Naranjo MP; Venegas MM; Sanchez LT; Arbelaez MJ; Shahnawaz S; Ghazaryan V; De Jesus WJ; Grimaldi C; Rao JS; Mukunda R,"IGC Pharma, Bogota, Bogota D.C., Colombia.; IGC Pharma, Potomac, MD, USA.; Santa Cruz Behavioral, Bayamon, PR, USA.",Not available
39783648,Editorial Comment.,2025-01-01,Schoenberg M,"UroGen Pharma, Princeton, New Jersey.",Not available
39783576,Developing Topics.,2024-01-01,Ge T,"Biogen, Cambridge, MA, USA.",Not available
39783522,Developing Topics.,2024-01-01,Baudler M; Bateman RJ,"F. Hoffmann-La Roche Ltd, Basel, Switzerland.; F. Hoffmann-La Roche Ltd., Pharma Development Safety Risk Management, Basel, Switzerland.",Not available
39783445,Developing Topics.,2024-01-01,Hofmann C; Wojtowicz J,"F. Hoffmann-La Roche Ltd., Pharma Development Safety Risk Management, Basel, Switzerland.",Not available
39783396,Developing Topics.,2024-01-01,Venegas M; Tangarife MA; Delgado-Murillo L; Gutierrez E; Naranjo MP; Rao JS; Shahnawaz S; Sanchez LT; Ghazaryan V; Camargo F; De Jesus WJ; Grimaldi C; Mukunda R; Arbelaez MJ,"IGC Pharma, Bogota, Bogota D.C., Colombia.; IGC Pharma, Bogota, Bogota, Colombia.; IGC Pharma, Potomac, MD, USA.; Santa Cruz Behavioral, Bayamon, PR, USA.",Not available
39783364,Developing Topics.,2024-01-01,Gutierrez E; Tangarife MA; Rao JS; Venegas M; Arbelaez MJ; Sanchez LT; De Jesus WJ; Pujals KY; Grimaldi C; Mukunda R,"IGC Pharma, Bogota, Bogota D.C., Colombia.; IGC Pharma, Potomac, MD, USA.; Santa Cruz Behavioral, Bayamon, PR, USA.",Not available
39783328,Developing Topics.,2024-01-01,Sulvaran MA; Arbelaez MJ; Gutierrez E; Tangarife MA; Rao JS; Venegas M; Sanchez LT; Shahnawaz S; De Jesus WJ; Pujals KY; Grimaldi C; Mukunda R,"IGC Pharma, Bogota, Bogota D.C., Colombia.; IGC Pharma, Potomac, MD, USA.; Santa Cruz Behavioral, Bayamon, PR, USA.",Not available
39783288,Developing Topics.,2024-01-01,Naranjo MP; Camargo F; Rao JS; Delgado-Murillo L; Venegas M; Tangarife MA; Arbelaez MJ; Gutierrez E; Sanchez LT; Shahnawaz S; Ghazaryan V; De Jesus WJ; Grimaldi C; Mukunda R,"IGC Pharma, Bogota, Bogota D.C., Colombia.; IGC Pharma, Bogota, Bogota, Colombia.; IGC Pharma, LLC, Bogota, Colombia.; IGC Pharma, Potomac, MD, USA.; Santa Cruz Behavioral, Bayamon, PR, USA.",Not available
39783265,Developing Topics.,2024-01-01,Puentes PR; Gonzalez N; Crovo D; Grimaldi B; Mukunda R,"IGC Pharma, Bogota, Bogota D.C, Colombia.; IGC Pharma, Potomac, MD, USA.",Not available
39783206,Developing Topics.,2024-01-01,Rodriguez-Soacha D; Canon A; Sanchez LT; Rao JS; Delgado-Murillo L; Venegas M; Tangarife MA; Arbelaez MJ; Gutierrez E; Shahnawaz S; Ghazaryan V; De Jesus WJ; Grimaldi C; Mukunda R,"IGC Pharma, Bogota, Bogota D.C., Colombia.; IGC Pharma, Potomac, MD, USA.; Santa Cruz Behavioral, Bayamon, PR, USA.",Not available
39782951,Alzheimer's Imaging Consortium.,2024-01-01,Falcon C; Kollmorgen G; Vanmechelen E; Perissinotti A; Molinuevo JL; Gispert JD,"ADx NeuroSciences NV, Technologiepark 94, Gent, Belgium.; Centro de Investigacion Biomedica en Red Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigacion Biomedica en Red Bioingenieria, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigacion Biomedica en Red de Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.; Lundbeck A/S, Copenhagen, Denmark.; Roche Diagnostics GmbH, Penzberg, Germany.",Not available
39782633,Drug Development.,2024-01-01,McDade E; Bateman RJ,"UCB Pharma, Braine-l'Alleud, Belgium.",Not available
39782619,Drug Development.,2024-01-01,Reda SM; Wu W; Setti SE; Berthiaume AA; Taylor RW; Johnston JL; Church KJ,"Athira Pharma, Inc., Bothell, WA, USA.",Not available
39782585,Drug Development.,2024-01-01,Reda SM; Wu W; Berthiaume AA; Setti SE; Taylor RW; Johnston JL; Church KJ,"Athira Pharma, Inc., Bothell, WA, USA.",Not available
39781818,Technology and Dementia Preconference.,2024-01-01,Schoettler M; Sommer H,"Roche Pharma AG, Grenzach-Wyhlen, Baden-Wurttemberg, Germany.",Not available
39780514,Bayesian thresholded modeling for integrating brain node and network predictors.,2024-12-31,Alanis-Lobato G,"Global Computational Biology and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str, Biberach an der Riss 88400, Germany.",Not available
39779964,Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer.,2025-01-08,Tombal B,"Cliniques Universitaires Saint-Luc, Brussels, Belgium.","Dana-Farber Cancer Institute, Boston, MA, USA. praful_ravi@dfci.harvard.edu."
39779610,"Therapeutic Potential of Microneedle Assisted Drug Delivery for Wound Healing: Current State of the Art, Challenges, and Future Perspective.",2025-01-08,Kumar M,"Jailani Shiekmydeen, Formulation R&D, Alpha Pharma Industries, KAEC, Rabigh, Saudi Arabia.",Not available
39779259,Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study.,2025-01-08,Levrat-Guillen F,"Abbott Laboratories, Maidenhead, Berkshire, UK.","The LIGHT Laboratories, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK R.Ajjan@leeds.ac.uk."
39779210,Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing.,2025-01-08,Eminizer M; Rodig SJ; Schalper KA; Szalay AS; Tetzlaff MT; Wistuba II,"AstraZeneca, Gaithersburg, Maryland, USA.; Daiichi Dankyo, Basking Ridge, New Jersey, USA.; Merck & Co, Rahway, New Jersey, USA.; SR Pathology LLC, Gaithersburg, Maryland, USA.","Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University SOM, Baltimore, Maryland, USA jtaube1@jhmi.edu."
39778975,Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis.,2025-01-08,McDonnell A; Guo X; Green J; Dalam AB; Yarur AJ,"Pfizer AG, Zurich, Switzerland.; Pfizer Inc, Cambridge, Massachusetts, USA.; Pfizer Inc, La Jolla, California, USA.; Pfizer Inc, New York, New York, USA.",Not available
39777610,Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.,2025-01-07,Serrao RT; Brown PM; Piscitelli SC; Rubenstein DS; Tallman AM,"Dermatologists of Southwest Ohio, Mason, OH, USA.; Dermavant Sciences, Inc., Morrisville, NC, USA.","Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239-3098, USA. simpsone@ohsu.edu."
39777591,Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviews.,2025-01-08,Fjallbrant H; Bailey J; McFadden S; Ritchie J,"IQVIA, Deerfield, IL, USA.; Late-stage Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.","Patient Centered Science, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA. calvin.ho@astrazeneca.com."
39777214,Patient perspectives on educational needs in scleroderma-interstitial lung disease.,2025-01-06,Savvaides TM; Di Vitantonio TA; Edgar A; Krishnan JK; Kaner RJ; Spiera R; Lakin KS,"Division of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA.; Division of Pulmonary and Critical Care, Weill Cornell Medicine, New York, NY, USA.",Not available
39777161,Management and disease burden of children and adults with severe IgE-mediated food allergy: Are adults the lost population?,2024-01-01,Bushart G; Mailaender C,"Novartis Pharma GmbH, Nuernberg, Germany.",Not available
39776360,A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab.,2025-01-08,Yamada A; Choules MP; Brightman FA; Takeshita S; Nakao S; Amino N; Nakayama T; Takeuchi M; Komatsu K; Ortega F; Mistry H; Orrell D; Chassagnole C; Bonate PL,"Astellas Pharma Inc., Northbrook, Illinois, USA.; Astellas Pharma Inc., Tokyo, Japan.; Physiomics Plc, Abingdon, UK.",Not available
39776056,"Real-World Prevalence, Incidence and Management of Systemic Lupus Erythematosus in Germany: A Retrospective Claims Data Analysis.",2025-01-08,Schulte M; Garcia TB,"Amgen GmbH, Munich, Germany.; Charite, Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin und Humboldt-Universitat zu Berlin, Berlin, Germany.","Charite, Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin und Humboldt-Universitat zu Berlin, Berlin, Germany. tobias.alexander@charite.de."
39775071,Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome project.,2025-01-07,Quatrale R,"UOC Neurologia, Fondazione Istituto G. Giglio, Contrada Pietrapollastra Snc, Cefalu, Palermo, Italy.","Neurology Unit and Multiple Sclerosis Center, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy. filippi.massimo@hsr.it."
39775043,Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial.,2025-01-07,Ren Y; Fukunaga-Kalabis M; Krepler C; Long GV,"Merck & Co. Inc., Rahway, NJ, USA.","University Hospital Zurich, Zurich, Switzerland. reinhard.dummer@usz.ch."
39775041,Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trial.,2025-01-07,Labreuche J; Touzet G; Lannoy D; Palas B; Vasseur M; Marchand F; Ollivier T; Carton L; Fisichella M,"InBrain Pharma, Lille, France.; Pharmacy CHU Lille, Lille, France.",Not available
39774900,Prevalence of urinary tract infections in women with vulvovaginal atrophy and the impact of vaginal prasterone on the rate of urinary tract infections.,2025-01-07,Moyneur E; Dea K; Dury AY,"Cosette Pharmaceuticals, Inc, Bridgewater, NJ.; Statlog Econometrics, Inc, Montreal, Quebec, Canada.",Not available
39774762,Patient-Reported Improvements in Patients with PNH Treated with Iptacopan from Two Phase 3 Studies.,2025-01-07,Bermann G; Dahlke M,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma AG, Novartis Campus, Switzerland.",Not available
39774684,"Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).",2025-01-07,Kalashnikova E; Rodriguez A; Liu MC; Aleshin A,"Natera Inc., Austin, TX, USA.",Not available
39774313,Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.,2024-12-05,Hou J; Zhang W; Xie Q; Hua R; Tang H; Morano Amado LE; Yang SS; Peng CY; Su WW; Chuang WL; Kim DJ; Avihingsanon A; Kao JH; Leerapun A; Yuen MF; Asselah T; Liang X; Bo Q; Canducci F; Catanese MT; Chen E; Cheng C; Chughlay F; Das S; Glavini K; Guerreiro N; Huang Y; Kakrana P; Kazma R; Patil A; Pavlovic V; Surujbally B; Triyatni M; Upmanyu R; Wat C; Gane E,"Enthera Pharmaceuticals, Milan (F. Canducci); F. Hoffmann-La Roche, Basel, Switzerland (F. Canducci, M.T.C., F. Chughlay, K.G., N.G., P.K., R.K., M.T.); From the Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University (J.H., X.L.), and the State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Institute of Hepatology, Nanfang Hospital (J.H.), Guangzhou, the Department of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University (W.Z.), the Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine (Q.X.), Roche Holding (Q.B., E.C.), Roche Research and Development Center (C.C., Y.H.), and Takeda APAC Biopharmaceutical Research and Development (Q.B.), Shanghai, the Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University, Changchun (R.H.), the Center of Infectious Diseases, Laboratory of Infectious and Liver Disease, Institute of Infectious Diseases, West China Hospital, Sichuan University, Chengdu (H.T.), and the Department of Medicine and State Key Laboratory of Liver Research, Queen Mary Hospital, University of Hong Kong, Hong Kong (M.-F.Y.) - all in China; Parexel International, Hyderabad, India (A.P.); Roche Products, Welwyn Garden City (S.D., V.P., B.S., R.U., C.W.), and ID Pharma Consultancy, Yelverton (C.W.) - both in the United Kingdom; Universite de Paris-Cite, Department of Hepatology, Assistance Publique-Hopitaux de Paris, Hopital Beaujon, Centre de Recherche sur l'Inflammation, INSERM Unite Mixte de Recherche 1149, Paris (T.A.); and the New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand (E.G.).; the Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, South Korea (D.J.K.); the Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital (S.-S.Y.), and the Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, China Medical University (C.-Y.P.), Taichung, the Department of Internal Medicine, Changhua Christian Hospital, Changhua (W.-W.S.), Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung (W.-L.C.), and National Taiwan University Hospital, Taipei (J.-H.K.) - all in Taiwan; the Division of Infectious Diseases, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute, Servizo Galego de Saude-Universidade de Vigo, Vigo, Spain (L.E.M.A.); the HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center and the Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok (A.A.), and the Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai (A.L.) - both in Thailand",Not available
39773824,"Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial.",2025-01-06,Carrara G; Stabile E; Boccalatte M; Russolillo E; Perrotta R,"Advice Pharma Group, Milan, Italy.; Division of Cardiology, Azienda Ospedaliera Regionale ""San Carlo"", Potenza, Italy.; Division of Cardiology, Ospedale San Giovanni Bosco, Naples, Italy.; Division of Cardiology, Ospedale Santa Maria delle Grazie, Pozzuoli, Italy.; Division of Interventional Cardiology, A.O.R.N. Sant'Anna e San Sebastiano, Caserta, Italy.",Not available
39773809,Sensory alterations and immunological changes during the chronification of postsurgical pain: a study protocol for a prospective observational cohort study.,2025-01-07,Eijkelkamp N,"Anesthesiololgy, Intensive Care and Pain Management, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.","Pain Clinic, Department of Anesthesiology, University Medical Centre Utrecht, Utrecht, The Netherlands m.e.c.vandriel-4@umcutrecht.nl."
39773805,Is longer really better? Results of a retrospective real-life cohort study evaluating the benefit of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation programme in people with COPD.,2025-01-07,Chenivesse C,"Santelys HAD, F-59120 Loos, France.","FormAction Sante, F-59840 Perenchies, France sarah.gephine@univ-lille.fr."
39773376,Risk prediction modeling for cardiorenal clinical outcomes in patients with non-diabetic CKD using US nationwide real-world data.,2025-01-07,Schuchhardt J; Bauer C; Brinker M; Kleinjung F; Vaitsiakhovich T,"Bayer AG, Berlin, Germany.; Bayer AG, Wuppertal, Germany.; MicroDiscovery GmbH, Berlin, Germany.","Medizinische Klinik Und Poliklinik 1, Schwerpunkt Nephrologie, Universitatsklinik Wurzburg, Wurzburg, Germany. wanner_c@ukw.de."
39772039,Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA).,2024-12-06,Abidi S; Elhazaz Fernandez A; Hanisch L; Karlas A; Sandig V; Jordan I,"ProBioGen AG, 13086 Berlin, Germany.; Tentamus Pharma & Med Deutschland GmbH, 76149 Karlsruhe, Germany.",Not available
39771607,Twin Screw Melt Granulation of Simvastatin: Drug Solubility and Dissolution Rate Enhancement Using Polymer Blends.,2024-12-23,Karry K,"BASF Corporation, Pharma Solutions, Tarrytown, NY 10591, USA.",Not available
39771586,"Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 85th Birthday, Recognizing His Outstanding Achievements in Advancing the Field of Dendrimers.",2024-12-17,Caminade AM,"Laboratoire de Chimie de Coordination (LCC-CNRS) 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France.",Not available
39771578,Antimicrobial Preservatives in Cyclodextrin-Containing Drug Formulations.,2024-12-16,Loftsson T,"Horus-Pharma, Departement des Operations Industrielles, 22, allee Camille-Muffat, bat. Inedi 5, 06200 Nice, France.",Not available
39771541,Buccal Absorption of Biopharmaceutics Classification System III Drugs: Formulation Approaches and Mechanistic Insights.,2024-12-06,Kirby D; Malgorzata K; Mohammed AR,"Catalent Pharma Solutions U.K. Swindon Zydis(R) Limited, Swindon SN5 8RU, UK.",Not available
39771526,Experimental Investigation of Spray Drying Breakup Regimes of a PVP-VA 64 Solution Using High-Speed Imaging.,2024-12-02,Gryczke A; Ries F,"AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen am Rhein, Germany.",Not available
39770841,"The Daunomycin: Biosynthesis, Actions, and the Search for New Solutions to Enhance Production.",2024-12-19,Benes K; Matha V,"VUAB Pharma A.S, Nemanicka 2722, 370 01 Ceske Budejovice, Czech Republic.",Not available
39770485,Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity.,2024-12-06,Silva JP; Munro R; Mullier B; Andre VM; Wolff C,"UCB Pharma, 208 Bath Road, Slough SL1 3WE, UK.; UCB Pharma, Chemin du Foriest, 1420 Braine l'Alleud, Belgium.",Not available
39770217,Intestinal Cells-on-Chip for Permeability Studies.,2024-11-30,Donkers J,"ARTIC Technologies B.V., 5612 AE Eindhoven, The Netherlands.",Not available
39769309,Indocyanine Blue (ICB) as a Functional Alternative to Indocyanine Green (ICG) for Enhanced 700 nm NIR Imaging.,2024-12-18,Frangioni JV,"Curadel Pharma, Inc., Natick, MA 01760, USA.",Not available
39768175,Discovery of Carbonic Anhydrase 9 as a Novel CLEC2 Ligand in a Cellular Interactome Screen.,2024-12-17,Hoffmann S; Berger BT; Lucas LR; Schiele F; Park JE,"Division of Biotherapeutics Discovery, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.; Division of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.; Division of High-Throughput Biology, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.",Not available
39767827,Acute Myeloid Leukemia with Normal Cytogenetics and NPM1-Mutation: Impact of Mutation Topography on Outcomes.,2024-12-23,Qin J; Cao S; Chang Y,"Acornmed Biotechnology Co., Ltd., Floor 18, Block 5, Yard 18, Kechuang 13 RD, Beijing 100176, China.",Not available
39766443,Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease.,2024-12-12,Lopez-Manzanares L; Lorenzo-Barreto P,"Fundacion Degen, 15006 A Coruna, Spain.; Grupo de Investigacion en Enfermedad de Parkinson y otros Trastornos del Movimiento, INIBIC (Instituto de Investigacion Biomedica de A Coruna), 15006 A Coruna, Spain.",Not available
39766398,Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review.,2024-11-28,Andreu H; Ochandiano I; Stoppa A; Andreazza AC; Pacchiarotti I,"Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain.",Not available
39764572,The role of patent analysis in target selection.,2025-01-08,Donovan DHO; Wang W; Sheppeck J; de Bruin G,"Oncology R&D, AstraZeneca, Cambridge, UK.; Oncology R&D, AstraZeneca, Waltham, MA, USA.; R&D, Acerta Pharma B.V., Oss, Netherlands.",Not available
39764201,"Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study.",2025-01-01,Stocker N; Corre E; Ricard L; Kaoui F; Brissot E; Dulery R; Banet A; Legrand O; Mohty M; Marjanovic Z,Service d'Hematologie Clinique et Therapie Cellulaire Hopital Saint-Antoine.,Not available
39762631,Basic Considerations for the Consistency Evaluation Based on ICH E17 Guideline.,2025-01-06,Zhu C; Zhang W,"Roche Pharma Product Development China, Shanghai, China.; Sanofi China, Beijing, China.",Not available
39762622,Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.,2025-01-06,Yoshimatsu H; Watase H; Matsuoka N,"Biometrics & Data Management, Pfizer R&D Japan G.K., Tokyo, Japan.; Pharmacokinetics, Dynamics and Metabolism, Translational Medicine and Early Development, R&D, Sanofi K.K., Tokyo, Japan.","Clinical Pharmacology, Otsuka Pharmaceutical Co., Ltd., Osaka, Japan. Sasaki.Tomohiro@otsuka.jp."
39762422,Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.,2025-01-06,Schiza A; Mancuso MR; Muller L; Yadav M; Kim L; Leveque VJP; Robert A; Darwish M; Qi T; Zhu J; Zhang J; Twomey P; Rao GK; Low DW; Petry C; Lo AA; Schartner JM; Delamarre L; Mellman I; Lower M; Muller F; Derhovanessian E; Cortini A; Manning L,"AbbVie, Inc., Santa Clara, CA, USA.; Artera, Inc., Los Altos, CA, USA.; Bluejay Therapeutics, San Mateo, CA, USA.; Genentech, Inc., South San Francisco, CA, USA.; Gilead Sciences, Foster City, CA, USA.; Seagen, Inc., Bothell, WA, USA.; Stork Therapeutics, San Francisco, CA, USA.","The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. juanita.lopez@icr.ac.uk."
39762416,A universal gene expression signature-based strategy for the high-throughput discovery of anti-inflammatory drugs.,2025-01-07,Zhang X,"Beijing CapitalBio Pharma Co., Ltd, Beijing, 102206, China.",Not available
39762124,Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study.,2025-01-06,Pham T; Flipo RM; Roux CH; Seror R,"Service de Rhumatologie, Hopital Pasteur 2, Universite Cote d'Azur, Nice, France.; Service de Rhumatologie, Hopital Roger-Salengro, Universite de Lille, Lille, France.; Service de Rhumatologie, Hopital universitaire Bicetre, Universite Paris-Saclay, Assistance Publique-Hopitaux de Par, Le Kremlin Bicetre, France.; Service de Rhumatologie, Hopital universitaire Sainte-Marguerite, Aix-Marseille Universite, Assistance Publique-Hopitaux de Marseille, Marseille, France.",Not available
39761708,Deaggregation of micronized insoluble drugs by incorporating mannitol form alpha.,2025-01-04,Tang M,"Jiangsu Litaier Pharma Ltd. Company, Nanjing 211100 PR China.",Not available
39761530,Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder.,2025-01-06,Gan-Or Z,"Roche Diagnostics GmbH, 82377 Penzberg, Germany.",Not available
39761337,"""Choosing wisely"": Intravitreal gas injection as first-line treatment for macular hole-a clinical case perspective.",2025-01-03,Gonzalez DP,"Instituto Vidaurri de Oftalmologia, Co-Director of Surgical Vitreoretinal Division, Monterrey, Nuevo Leon, Mexico.; Private retina practice",Not available
39760983,A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis.,2025-01-06,Kuo Y; Angel B; Chen X; Kallender H,"Incyte Corporation, Wilmington, DE, USA.","Henry Ford Health System, 1 Ford Pl, Detroit, MI, 48202, USA. LSTEIN1@hfhs.org."
39760525,"Adequate Failure Loads for Modified Lemaire Lateral Extra-articular Tenodesis Are Achieved With an Interference Screw, Staple, and Suture Anchor: A Biomechanical Study of Structural Properties.",2025-01-06,Tollefson LV; Shoemaker EP; Slette EL; Carlson M; LaPrade RF,"Twin Cities Orthopedics Bioengineering Lab, Eagan, Minnesota, USA.; Twin Cities Orthopedics, Edina, Minnesota, USA.",Not available
39760298,"Real-world assessment of the patient profile, clinical characteristics, treatment patterns, and outcomes associated with erythropoietic and X-linked protoporphyria.",2025-01-06,Ciepielewska M,"Mitsubishi Tanabe Pharma America, Inc., Jersey City, New Jersey, USA.",Not available
39759988,Short-term outcomes of robot-assisted versus conventional minimally invasive esophagectomy: A propensity score-matched study via a nationwide database.,2025-01-01,Nishigori T; Suda K; Yoda Y; Tanaka T; Kakeji Y; Kitagawa Y; Sakai Y; Uyama I,The Japan Society for Endoscopic Surgery Tokyo Japan.,Not available
39759449,Tenecteplase: biochemical and clot lysis activity comparisons.,2024-01-01,Bechmann J; Schmid I; Brand S; Miller F,"Boehringer Ingelheim Pharma GmbH and Co., KG, Biberach an der Riss, Germany.",Not available
39759424,Efficacy and safety of iclepertin (BI 425809) with adjunctive computerized cognitive training in patients with schizophrenia.,2025-01-01,McDonald S; Fu E; Reuteman-Fowler C,"Boehringer Ingelheim (Canada) Ltd., 5180 South Service Rd, Burlington, Ontario L7L 5Y7, Canada.; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.",Not available
39758886,Multi-tensor fixel-based metrics in tractometry: application to multiple sclerosis.,2024-01-01,Dumont M; Houde JC,"Imeka Solutions Inc., Sherbrooke, QC, Canada.",Not available
39758310,Unraveling the discrepancies between REDUCE-IT and STRENGTH trials with omega-3 fatty acids: new analytical approaches.,2024-01-01,Gan D; Huo S; Chen P,"R&D, Sirio Life Technology Co., Ltd, Shanghai, China.; R&D, Sirio Pharma Co., Ltd, Shantou, Guangdong, China.",Not available
39757731,Consensus findings of an International Workshops on Genotoxicity Testing workshop on using transcriptomic biomarkers to predict genotoxicity.,2025-01-05,Recio L,"ScitoVation, Durham, North Carolina, USA.",Not available
39756824,Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab.,2025-01-04,Jachiet M; Roque S; Belhomme N; Abisror N; Jeandel PY; Lechtman S; Grolleau C; Hadjadj J; Bouaziz JD,"Service de Dermatologie, Hopital Saint Louis, APHP, et Universite Paris Cite, Paris, France, Paris, France.; Service de Dermatologie, Hopital Saint Louis, APHP, et Universite Paris Cite, Paris, France, Paris, Ile-de-France, France.; Service de Medecine Interne et Immunologie Clinique, CHU Rennes-Faculte de Medecine de Rennes, Rennes, France, Rennes, Bretagne, France.; Service de medecine interne, APHM Hopital de la conception, Marseille, France, Marseille, France.; Sorbonne Universite, service de medecine interne, Hopital Saint-Antoine, AP-HP, Paris, France, paris, France.; Universite Cote d'Azur, CHU de Nice, Service de Medecine Interne, Hopital Archet 1, Nice, Nice, France.","Service de Medecine Interne, Centre de Reference pour les Maladies auto immunes et auto inflammatoires Systemiques Rares d'Auvergne, CHU Gabriel-Montpied, Inserm U1071, M2iSH, USC-INRA 1382, Clermont-Ferrand, France, Universite Clermont Auvergne, Clermont-Ferrand, France ltrefond@chu-clermontferrand.fr."
39756515,Proposed mechanism of cardiovascular responses for bolus injection of epinephrine from epinephrine autoinjectors.,2025-01-03,Lowenthal R,"ARS Pharmaceuticals, Inc, San Diego, CA, USA.",Not available
39756444,"Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study.",2025-01-01,Arrowsmith E; Kassalow L; Perini RF; Vickery D,"Merck & Co, Inc, Rahway, NJ, USA.; Tennessee Oncology, Chattanooga, TN, USA.","Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: toni_choueiri@dfci.harvard.edu."
39756440,Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey.,2025-01-01,Dreno B; Wainstein A,"Centro de Oncologia de Precisao - COP; Hospital Mater Dei, Belo Horizonte, Brazil.; Nantes Universite, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, Nantes, France.","Department of Dermatology, University Medical Center Schleswig-Holstein (UKSH), Kiel 24105, Germany. Electronic address: ahauschild@dermatology.uni-kiel.de."
39755818,Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers.,2025-01-04,Kim D; Chung H; Liu W; Guo X; Jameson N; de Jong PR; Yea S; Harford L; Li J; Mathews CA; Fischer K; Samatar AA; Jubb A; Bunker KD; Blackwell K; Simpkins F; Ma J,"Zentalis Pharmaceuticals, Inc., San Diego, CA, USA.",Not available
39755256,Donor Type Does Not Impact Late Graft Failure Following Reduced Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Based Graft-Versus-Host Disease Prophylaxis.,2025-01-02,Majhail NS,"Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN.",Not available
39754753,Electrocatalytic Micelle-Driven Hydrodefluorination for Accessing Unprotected Monofluorinated Indoles.,2025-01-04,Gallou F,"Novartis Pharma AG, Chemistry, SWITZERLAND.",Not available
39754720,Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells.,2025-01-03,Melo Garcia L,"Department of Medicine, Universite Laval, Quebec City, QC G1V 0A6, Canada; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Hematology-Oncology Service, CHU de Quebec - Universite Laval, Quebec City, QC G1V 0A6, Canada.",Not available
39754048,Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system.,2025-01-03,Lee JH; Gwag BJ,"GNT Pharma Co. Ltd., Yongin, Republic of Korea.",Not available
39753643,Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases.,2025-01-03,Fassbender K,"Kbo-Inn-Salzach-Klinikum Gemeinnutzige GmbH, Wasserburg Am Inn, Germany.",Not available
39753572,Radiological markers of CSF alpha-synuclein aggregation in Parkinson's disease patients.,2025-01-03,Goldstein O; Artzi M,"Biogen Inc, Cambridge, MA, USA.","Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel. amgadd@tlvmc.gov.il."
39753401,Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery: a secondary analysis of two large international studies.,2025-01-02,Villar JC,"Centro de Investigaciones, Fundacion Cardioinfantil - Instituto de Cardiologia, Bogota, Colombia; Facultad de Ciencias de la Salud, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia.","Outcomes Research Consortium, Houston, TX, USA. Electronic address: proshano@uwo.ca."
39753294,Reliability of the OMERACT Giant cell arteritis Ultrasonography Score (OGUS): results of a patient-based exercise involving experts and non-experts in vascular ultrasonography.,2025-01-02,Terslev L,"Division of Musculoskeletal and Rheumatic Disorders, Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.","Department of Internal Medicine, Clinical Division of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Tirol, Austria christina.duftner@gmx.at."
39753060,Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohort.,2024-12-21,Rotolo F; Platas A; Fonseca A; Cruz-Ramos M; Rodriguez A; Mohar A,"Biomarkers Statistics, Sanofi, Montpellier, France.; Departamento de Investigacion y de Tumores Mamarios, Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico; Departamento de Investigacion y de Tumores Mamarios, Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico.; Investigadora por Mexico del Consejo Nacional de Humanidades, Ciencias y Tecnologias (CONAHCYT), Instituto Nacional de Cancerologia, Ciudad de Mexico, Mexico.; MILC, Medicos e Investigadores en la Lucha contra el Cancer de Mama, Ciudad De Mexico, Mexico.; Unidad de Investigacion Biomedica en Cancer, Instituto Nacional de Cancerologia e Instituto de Investigaciones Biomedicas, UNAM, Ciudad de Mexico, Mexico.",Not available
39752810,Risk factors affecting quality of life in children with epilepsy and their caregivers: A secondary analysis of a cross-sectional online survey in Japan.,2025-01-02,Kumagai T; Nishiuma S; Hayashi H,"Aculys Pharma, Inc., Tokyo, Japan.; Knock on the Door, Inc., Tokyo, Japan.","Department of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan. Electronic address: sokazaki2009@gmail.com."
39752213,A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.,2025-01-01,Basuroy R; Prasad P,"Novo Nordisk A/S, Bagsvaerd, Denmark.",Not available
39752009,First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.,2025-01-03,Messina C; Incorvaia L; Kanesvaran R,"Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; SOC Oncologia PO Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy.",Not available
39749397,Long-term evaluation of rheumatoid arthritis activity with erythrocyte methotrexate-polyglutamate 3.,2025-01-01,Escal J; Poudret M; Hodin S; Neel T; Coman I; Locrelle H; Amouzougan A; Thomas T; Delavenne X; Marotte H,"CHU Saint-Etienne, Laboratoire de Pharmacologie et Toxicologie, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, Universite Jean Monnet Saint-Etienne, Saint-Etienne, France.; CHU Saint-Etienne, Service de Rhumatologie, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, Universite Jean Monnet Saint-Etienne, Saint-Etienne, France.; CHU Saint-Etienne, Service de Rhumatologie, Saint-Etienne, France.; Mines Saint-Etienne, INSERM, SAINBIOSE U1059, Universite Jean Monnet Saint-Etienne, Saint-Etienne, France.",Not available
39748849,Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment.,2024-01-01,Ito T; Tasai H; Miyagawa T,Eisai Co. Ltd. Tokyo Japan.,Not available
39748841,Relationship between physical activity and biomarkers of pathology and neuroinflammation in preclinical autosomal-dominant Alzheimer's disease.,2024-01-01,Picard G; Taylor JA,"Grupo de Neurociencias de Antioquia, Facultad de Medicina Universidad de Antioquia Medellin Colombia.",Not available
39748839,Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease.,2024-01-01,Siemers ER; Gold M; Mobius HJ,"Acumen Pharmaceuticals, Inc. Newton Massachusetts USA.; AriLex Life Sciences LLC Deerfield Illinois USA.; Athira Pharma Bothell Washington USA.",Not available
39748835,Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice.,2024-01-01,Graf A; Burnham SC; Doty EG; Moebius HJ; Montenigro P; Siemers E; Sink KM; Wildsmith KR,Acumen Pharmaceuticals Zionsville Indiana USA.; Athira Pharma Inc. Bothell Washington USA.; Eli Lilly and Company Boston Massachusetts USA.; Eli Lilly and Company Indianapolis Indiana USA.; Genentech Inc South San Francisco California USA.; Neurology Business Group Eisai Inc Nutley New Jersey USA.; Novartis Pharma AG Basel Switzerland.,Not available
39748757,Innovations in Drug Delivery Systems for Biologics: Enhancing Stability and Targeted Delivery for Next-Generation Therapeutics.,2025-01-03,S J,"Alpha Pharma Industries, KAEC 23994, Rabigh, Saudi Arabia, India.",Not available
39748726,A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers.,2025-01-01,Cheung K; Izumi Y; Johansen M; Madden T; Shimoyama S; Subach RA; Suzuki T; Wages DS; Wheeler C,"FUJIFILM Pharmaceuticals USA, Inc, Cambridge, Massachusetts, USA.",Not available
39747810,Complicated Overactive Bladder Management.,2025-01-01,Mehlman K; Wessel D,"1 Geramed Senior Care Consulting, Brunswick, Ohio.; 3 Pharma-Care Inc, Clark, New Jersey.",Not available
39747798,Chemical Probes for Investigating the Endocannabinoid System.,2025-01-03,Hanske A; Nazare M,"Leibniz-Forschungsinstitut fur Molekulare Pharmakologie FMP, Berlin, Germany.",Not available
39747684,Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial.,2025-01-02,Hagendorff A; Halle M,"Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Berlin, Germany.","Department of Cardiology, Angiology and Intensive Care Medicine, Campus Virchow Klinikum, Deutsches Herzzentrum der Charite, Berlin, Germany. frank.edelmann@dhzc-charite.de."
39747162,Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Na(v)1.6 complex in nucleus accumbens neurons.,2025-01-02,Lehmann P; Marmol Contreras YM,"Behavioral Pharma Inc., 505 Coast Blvd. South, Suite 212, La Jolla, CA, USA.",Not available
39747003,Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment.,2025-01-02,Lin L; Li J; Eum Y; Janne PA,"iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.",Not available
39746186,Hemodynamic Management guided by the Hypotension Prediction Index in Abdominal Surgery: A Multicenter Randomized Clinical Trial.,2025-01-02,Tome-Roca JL; Adell-Perez AB; Venturoli-Ojeda R; Valiente-Lourtau JM,"Althaia Xarxa Assistencial Universitaria de Manresa, Manresa, Spain.; Universidad Complutense de Madrid, Madrid, Spain.",Not available
39743396,Risk factors for complications following volar locking plate fixation of distal radial fractures.,2024-12-31,Andro C; Le Nen D; Letissier H,"Service de Chirurgie Orthopedique et Traumatologique, Hopital Clermont-Tonnerre (Hopital d'Instruction des Armees), Rue Colonel Fonferrier, Brest 29240, France.; Service de Chirurgie Orthopedique et Traumatologique, Hopital de la Cavale Blanche, Boulevard Tanguy Prigent, Brest 29200, France; Universite de Bretagne Occidentale, UBO, Brest 29200, France; Universite de Bretagne Occidentale, UBO, Brest 29200, France.",Not available
39742415,"A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps.",2025-01-01,Hernandez-Lain A; Calafell F; Vallejo-Illarramendi A; Gallano P,"CIBERNED Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), Madrid, Spain.",Not available
39741688,Adoption of Digital Therapeutics in Europe.,2024-01-01,Silva M,"Executive Management, Esperity, Brussel, Belgium.",Not available
39741587,Pharmacokinetic/pharma-codynamic study of pralurbactam (FL058) combined with meropenem in a neutropenic murine thigh infection model.,2024-01-01,Wang X; Zhang N; Gao C; Guo B,"Qilu Pharmaceutical Co., Ltd., Jinan, Shandong, China.",Not available
39741434,Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.,2025-01-01,Kirlic N; Lennard-Jones M; Atli M; Malievskaia E; Modlin NL; Peck SK; Gaillard A; Goodwin GM; Koelpin D,"Compass Pathways, London (Kirlic, Lennard-Jones, Atli, Malievskaia, Gaillard, Goodwin, Koelpin); Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Modlin); School of Medicine, University of California San Diego, San Diego (Peck).",Not available
39741294,Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study.,2024-12-31,Devaraj A,"Johns Hopkins Medicine, Baltimore, USA.","Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK. RBHILD@rbht.nhs.uk."
39740666,Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.,2024-12-30,Palm K; Lawrinson S; Low A; Sabir I; Huntsman-Labed A; Day JRS,"BioMarin (UK) Limited, Ltd., London, UK.; Otto-von-Guericke Universitat, Universitatskinderklinik, Magdeburg, Germany.","Murdoch Children's Research Institute, Royal Children's Hospital Victoria, University of Melbourne, Parkville, VIC, Australia. Electronic address: ravi.savarirayan@mcri.edu.au."
39740313,A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE).,2024-11-30,Guillot A; De Vivo R; Perrot V; Qvick B; Dutailly P,"Ipsen Pharma, Boulogne-Billancourt, France.; Ramsay Sante, Hopital prive de la Loire, Saint-Etienne, France.; ULSS Company 8 Berica, Vicenza, Italy.","Ludwig Maximilian Universitat Munchen, Klinikum Grosshadern, Munich, Germany. Electronic address: michael.staehler@med.uni-muenchen.de."
39740235,Management of Patients With Refractory Reflux-Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence-Based Consensus Statements.,2024-12-30,Gyawali CP; Sugano K,"Gastroenterology Division, Universidad de La Sabana, Chia, Cundinamarca, Colombia.; INSINC Consulting Inc., Guelph, Ontario, Canada.",Not available
39739907,Population modelling of nilotinib exposure vs. longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model.,2024-12-30,Sy SKB; Yoon DY; Darstein C; Yang Y; Kapoor S; Hoch M; Grosch K,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, Cambridge, Massachusetts, USA.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
39739876,SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance.,2024-12-31,Mazzucotelli JP,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39739635,Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systems.,2025-01-01,Rajagopal G; Krikhely A; Bessler M,"Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.; Samsara BioCapital, Palo Alto, California, USA.",Not available
39739195,Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies.,2024-12-30,Wu X; Ottery FD,"Astellas Pharma Global Development, Northbrook, IL, USA.","Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA and Sutter East Bay Medical Foundation, 2500 Milvia Street, Berkeley, CA, 94704, USA. risa.kagan@sutterhealth.org."
39738554,Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies.,2024-12-30,Ishida Y; Cotler SJ,"PhoenixBio Co., Ltd., Higashi-Hiroshima, Japan.",Not available
39737960,"A microbiota-derived metabolite, 3-phenyllactic acid, prolongs healthspan by enhancing mitochondrial function and stress resilience via SKN-1/ATFS-1 in C. elegans.",2024-12-30,Roh JH,"HEM Pharma Inc., 407, Suwon, Republic of Korea.",Not available
39737899,PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial.,2024-12-30,Jacquemont CF; Senesac JH; Bayle JH; Scripture CD,"Bellicum Pharmaceuticals, Inc., Houston, TX, USA.",Not available
39737162,"Epidemiology, patient characteristics, and treatment patterns of patients with narcolepsy in Sweden: a non-interventional study using secondary data.",2024-01-01,Crawford S,"Takeda Pharma AB, Stockholm, Sweden.",Not available
39737064,The ADHD Assessment Quality Assurance Standard for Children and Teenagers (CAAQAS).,2024-01-01,Young S; Gudjonsson G,"Independent Practice, CLC Consultancy, Dunkeld, UK.; Independent Practice, Psychology Services Limited, London, UK.",Not available
39736683,The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.,2024-12-30,Del Pozo JL; Navarro D; Rodriguez JC; Suberviola B,"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, , Madrid, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; IdiSNA: Instituto de Investigacion Sanitaria de Navarra, Pamplona, Spain.; Instituto de Investigacion Biomedica de Cadiz (INIBICA), Cadiz, Spain.","Clinical Microbiology and Infectious Diseases, Hospital Clinico Universitario San Carlos, IdISSC & IML Health Research Institutes, 28040, Madrid, Spain. fj.candel@gmail.com."
39735353,Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) Study.,2024-01-01,Maratia S; Campos Tapias I; Aceituno S,"Asociacion Espanola con la Osteoporosis y la Artrosis (AECOSAR), Madrid, Spain.; Outcomes'10, S.L.U., Castellon de la Plana, Spain.; UCB Pharma S.A., Madrid, Spain.",Not available
39735352,Awareness and Perceptions towards the Role of Systemic Inflammation and High-Sensitivity C-reactive Protein as a Biomarker in Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease: The Multinational FLAME-ASCVD Survey amongst Cardiologists.,2024-01-01,Prasad P; Zonoozi AAM,"Novo Nordisk, Copenhagen, Denmark.",Not available
39734810,Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.,2024-01-01,Iwamoto F; Ligon KL; Mrugala MM; Raizer J; Wong ET; Colman H,"Allysta Pharmaceuticals Inc., Bellevue, WA, USA.; Cytoscient LLC, Berkeley, CA, USA.; Lantern Pharma, Dallas, TX, USA.; Orbus Therapeutics Inc., Palo Alto, CA, USA.; STORM Therapeutics Ltd., Cambridge, UK.; Structure Therapeutics, San Francisco, CA, USA.",Not available
39733558,"Duration of ""Good On"" time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT(R)).",2024-12-15,Allard S; Banisadr G; Fisher S; D'Souza R,"Amneal Pharmaceuticals, LLC, 400 Crossing Boulevard, Bridgewater, NJ, USA.","University of South Florida, Tampa, FL, USA. Electronic address: rhauser@usf.edu."
39732393,Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV - A systematic review and network meta-analysis of randomized controlled trials.,2024-12-26,Kriegl L; Hoenigl M; Krause R,"BioTechMed-Graz, Graz, Austria; Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.","BioTechMed-Graz, Graz, Austria. Electronic address: stefan.hatzl@medunigraz.at."
39730386,Nitazoxanide controls virus viability through its impact on membrane bioenergetics.,2024-12-28,Hammad N; Ransy C; Pinson B; Talmasson J; Bouillaud F,"Global Virus Network, Tampa, FL, USA.; Institut Cochin, INSERM, CNRS, Universite de Paris, 75014, Paris, France.; Service Analyses Metaboliques-TBMcore, Universite Bordeaux - CNRS UAR 3427 - INSERM US005, Bordeaux, France.",Not available
39730334,Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor.,2024-12-27,Verdon G; Currinn H; Bender B; Solcan N; Schlenker O; Schutz M; Zhukov A; Sinha S; Graf S,"Nxera Pharma UK Limited (Sosei Heptares), Steinmetz Building, Granta Park, Cambridge, UK.",Not available
39730173,"Correlation of classic history, imaging and pathology with novel genetics in Birt-Hogg-Dube syndrome.",2024-12-26,Nathan SD; Aryal S; Nyquist A,"Inova Fairfax Hosp, Falls Church, Virginia, USA.","Pulmonary and Critical Care, Walter Reed National Military Medical Center, Bethesda, Maryland, USA zacharyahaynes@gmail.com."
39730128,A Training for Parents Prevents Clinically Relevant Handling Errors in the Use of Long-Term Antiseizure Medication.,2024-12-27,Schumacher PM; Hiemisch A; Kiess W; Bertsche A,"Institut fur Pharmazie, Abteilung fur Klinische Pharmazie, Universitat Leipzig Medizinische Fakultat, Leipzig, Germany.; Neuropadiatrie, Arbeitsgruppe Padiatrische Pharmazie, Universitatsmedizin Greifswald Klinik und Poliklinik fur Kinder und Jugendmedizin, Greifswald, Germany.",Not available
39730107,"Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models.",2024-12-25,Lencioni G,"Department of Biology, University of Pisa, Pisa, Italy; Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.",Not available
39729651,Value of ultrasound-assessed dactylitis in the early diagnosis of psoriatic arthritis.,2025-01-01,Criado-Alcazar A; Hoyo-Fernandez AE; Ortega-Trompeta MB; Sanchez-Barba-Izquierdo MI,"Primary Care, Centro de Salud Las Margaritas, Getafe, Madrid, Spain.; Primary Care, Centro de Salud Paseo Imperial, Madrid, Spain; Primary Care, Centro de Salud Paseo Imperial, Madrid, Spain.",Not available
39729068,Prevalence and impact of vasomotor symptoms due to menopause among women in Canada: A subgroup analysis from an international cross-sectional survey of Women with Vasomotor Symptoms Associated with Menopause (WARM Study).,2025-01-01,Bouchard C,"Clinique de Recherche en Sante des Femmes, Quebec City, Quebec, Canada.",Not available
39729067,Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy.,2025-01-01,Naftolin FN,"e-Bio Corp., New York, NY.",Not available
39727284,"The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers.",2024-12-27,Tian X; Esmaeili H; Minich D; Roessner PM; Wind S; Grempler R; Gan G; Chan TS; Mahmoudi M; Sadrolhefazi B; Muller F,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.; Staburo GmbH, Munich, Germany.",Not available
39726669,Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform.,2025-01-01,Mitratza M; de Munter L; Tran TMP; Conde-Sousa E; Drikite L,"P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven 3001, Belgium.",Not available
39726232,Severe Impact of Omeprazole Timing on pH-Sensitive Dasatinib Absorption: Unveiling Substantial Drug-Drug Interaction.,2024-12-26,Andersson P; Brisander M; Liljebris C; Jesson G,"Xspray Pharma, Solna, Sweden.",Not available
39726118,WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors.,2024-12-26,Sechidis K; Sun S; Chen Y; Baillie M; Ohlssen D; Vandemeulebroecke M; Hemmings R; Ruberg S; Bornkamp B,"Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland.; Advanced Methodology and Data Science, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.; Analytix Thinking LLC, Indiana, Indianapolis, USA.; Consilium Hemmings (UK) Ltd, Woking, UK.; Development Analytics and Statistical Innovation, UCB Farchim SA, Bulle, Switzerland.",Not available
39725778,A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer.,2024-12-27,Rajagopalan P; Wiley SE; Ghalie RG; Hochster HS,"MEI Pharma, San Diego, CA, USA.; PR Consulting, Mountain Lakes, NJ, USA.; Statbeyond Consulting, Irvine, CA, USA.","Division of Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Pb564@cinj.rutgers.edu."
39725521,Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial.,2024-12-26,Mattheus M; Bauersachs J,"Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.; INECO Neurociencias Orono, Fundacion INECO, Rosario, Argentina.",Not available
39725078,Specialist training in infectious diseases in Europe.,2024-12-24,Torti C; Miro JM,"CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Infectious Diseases, Hospital Clinic-Institut d'Investigacions Biomediques August Pi I Sunyer, University of Barcelona, Barcelona, Spain; Universita Cattolica del Sacro Cuore, Rome, Italy.","German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. Electronic address: jon.salmanton-garcia@uk-koeln.de."
39724680,"Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis.",2025-01-01,Klein T; Wohnhaas CT,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.","Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. Electronic address: denis.delic@boehringer-ingelheim.com."
39723811,Enhancing patient representation learning with inferred family pedigrees improves disease risk prediction.,2024-12-26,Arora J; Erzurumluoglu AM; Lam D; Ding Z,"CB CMDR, Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Ribeta 88400, Germany.; Human Genetics, Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Ribeta 88400, Germany.",Not available
39723797,Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post-hoc analysis of imeglimin clinical trial data.,2024-12-26,Kochi K,"Data Science, Sumitomo Pharma Co., Ltd., Tokyo, Japan.",Not available
39723106,The CSF p-tau/beta-amyloid 42 ratio correlates with brain structure and fibrillary beta-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease.,2025-01-01,Salvado G; Sanchez-Benavides G; Grau-Rivera O; Quevenco FC,"Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid 28089, Spain.",Not available
39722793,The Burden of Pain Symptoms in Individuals with Uterine Fibroids-Results from a Prospective Observational Study in the USA.,2024-01-01,Hunsche E; Rakov VG,"Sumitomo Pharma Switzerland GmbH, Basel, Switzerland.",Not available
39722400,"Efficacy and Safety of Tildrakizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis of the Scalp: Week 52 Results From a Phase 3b, Randomized, Double-Blind, Placebo-Controlled Trial.",2024-12-23,Yao SL; Nishandar T; Kopeloff I; Crane M; Gogineni R,"Sun Pharmaceutical Industries Limited, Goregaon (E), Mumbai, India.; Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.","David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: hsofen@ucla.edu."
39722117,Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis.,2024-12-26,Tashiro M,"Datack Inc., Tokyo, Japan.","Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. takahiro-takazono@nagasaki-u.ac.jp."
39721378,"Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach.",2024-12-24,Gil-Berrozpe GJ; Sanchez-Torres AM; Vieta E; Mezquida G; Forte MF; Castro J; Rodriguez N; Mas S; Bernardo M,"Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Neuroscience Institute, Barcelona, Spain.; Biomedical Network Research Centre on Mental Health (CIBERSAM), Spain; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Barcelona, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Maranon, IiSGM, Madrid, Spain; Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain; Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain.; Department of Health Sciences, Universidad Publica de Navarra, Pamplona, Spain.; Department of Medicine, Institute of Neuroscience, University of Barcelona, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Institute of Neurosciences, University of Barcelona, Barcelona, Spain; Instituto de Investigacion Sanitaria de Navarra, Pamplona, , IdiSNA, Spain; Instituto de Investigacion Sanitaria de Navarra, Pamplona, , IdiSNA, Spain.; Servicio de Psiquiatria, Hospital Universitario de Navarra, Pamplona, Spain",Not available
39720843,Transitioning From Pediatric to Adult Psychiatric Care for ADHD in Sweden: A Nationwide Study.,2025-01-01,Ahnemark E,"Takeda Pharma AB, Stockholm, Sweden.",Not available
39720753,SpeechMatch-A novel digital approach to supporting communication for neurodiverse groups.,2024-01-01,Mitchell S,Adult Learning Disability Service Leicestershire Partnership NHS Trust Leicester UK.,Not available
39718711,Comprehension of the adapted Urticaria Activity Score measure and patient guidance document: qualitative interviews with adults and adolescents with chronic spontaneous urticaria.,2024-12-24,Eseyin OR; Stefan M,"Evidera, Inc., 929 North Front Street, Wilmington, NC, 28401, USA.","Evidera, Inc., 929 North Front Street, Wilmington, NC, 28401, USA. anne.skalicky@evidera.com."
39718364,"Microarray-Based Methodology for Lipid Profiling, Enzymatic Activity, And Binding Assays in Printed Lipid Raft Membranes from Astrocytes and Neurons.",2024-12-24,Sanchez-Sanchez L; Astigarraga E; Barreda-Gomez G; Ganfornina MD,"IMG Pharma Biotech S.L, Zamudio 48170, Spain.",Not available
39718107,Large-scale prediction of biological activities with Active-IT system.,2024-01-01,Almeida VL,"Chemoinformatics Group - NEQUIM, Departamento de Quimica, Instituto de Ciencias Exatas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil; Servico de Fitoquimica e Prospeccao Farmaceutica, Fundacao Ezequiel Dias (FUNED), Belo Horizonte, Brazil.",Not available
39718074,Contrasting genetic burden for bipolar disorder: Early onset versus late onset in an older adult bipolar disorder sample.,2024-12-22,Montejo L; Sole B; Oliva V; Martinez-Aran A; Zimmermann J; Vieta E; Torrent C,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Barcelona, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Institut de Neurociencies (UBNeuro), Universitat de Barcelona (UB), Barcelona, Spain.; Fundacio Clinic per la Recerca Biomedica-Institut d'Investigacions Biomediques August Pi i Sunyer (FCRB-IDIBAPS), Barcelona, Spain; Psychiatrieverbund Oldenburger Land gGmbH, Karl-Jaspers-Klinik, Bad Zwischenahn, 26160, Germany.",Not available
39717364,Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH).,2024-01-01,Bonhomme V; Sicignano C,"EuGMS Delegate, Consultant Geriatrician and Perioperative Physician, North Bristol NHS Trust, Bristol, UK.; Laboratoire de Recherches Integratives en Neurosciences et Psychologie Cognitive, Universite Bourgogne Franche-Comte, F-25000, Besancon, France.",Not available
39716442,Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia.,2025-01-01,Bibikova E; Parsa S; Floren M; Law B; Clevenger T; Cheung J; De Jesus G; Burke K; Gulrajani M; Yamaguchi K; Do P; Dougherty B; Whitston D; Brock G; Munugalavadla V; Frigault MM; Furman RR; Covey T; Mortlock A,"Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York, USA.; Hematology, Oncology R&D, AstraZeneca, Cambridge, UK.; Hematology, Oncology R&D, AstraZeneca, South San Francisco, California, USA.; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, Massachusetts, USA.",Not available
39716331,Publisher Correction: Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trial transparency.,2024-12-23,Jordan D; Seiler W,"Consult2Deliver, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, UK.; Statisticians in the Pharmaceutical Industry, Durford Mill, Petersfield, Hampshire, GU31 5AZ, UK.",Not available
39715475,Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials.,2025-01-28,Gandhi P; Guo H; Stokes J; Nagy K; Dabruzzo B; Smith JH,"AbbVie, Budapest, Hungary.; AbbVie, Irvine, CA.; AbbVie, Madison, NJ.; AbbVie, North Chicago, IL; and.",Not available
39715469,Reply to: Accurate Determinants of Outcome in ALL.,2024-12-23,Chang TC; Chen W; Qu C; Cheng Z; Elsayed A; Pounds SB; Shago M; Rabin KR; Raetz EA; Devidas M; Cheng C; Angiolillo A; Baviskar P; Borowitz M; Burke MJ; Carroll A; Carroll WL; Chen IM; Harvey R; Heerema N; Iacobucci I; Wang JR; Jeha S; Larsen E; Mattano L; Maloney K; Pui CH; Ramirez NC; Salzer W; Willman C; Winick N; Wood B; Hunger SP; Wu G; Mullighan CG; Loh ML,"Abdelrahman Elsayed, PhD and Stanley B. Pounds, PhD, Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN; Andrew Carroll, PhD, Department of Genetics, University of Alabama at Birmingham, Birmingham, AL; Anne Angiolillo, MD, Children's National Medical Center, Washington, DC; Brent Wood, MD, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA; Charles G. Mullighan, MBBS, MD, Department of Pathology, St Jude Children's Research Hospital, Memphis, TN; Cheng Cheng, PhD, Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN; Cheryl Willman, MD, Department of Laboratory Medicine and Pathology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN; Ching-Hon Pui, MD, Department of Oncology, St Jude Children's Research Hospital, Memphis, TN; Chunxu Qu, PhD, Department of Pathology, St Jude Children's Research Hospital, Memphis, TN; Elizabeth A. Raetz, MD, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Hospital, New York, NY; Eric Larsen, MD, Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME; Gang Wu, PhD, Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN, Department of Pathology, St Jude Children's Research Hospital, Memphis, TN; I-Ming Chen, DVM and Richard Harvey, PhD, Department of Pathology, University of New Mexico, Albuquerque, NM; Ilaria Iacobucci, PhD, Department of Pathology, St Jude Children's Research Hospital, Memphis, TN; Jeremy R. Wang, PhD, Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; Karen R. Rabin, MD, PhD, Department of Pediatrics, Baylor College of Medicine, Houston, TX; Kelly Maloney, MD, Department of Pediatrics and Children's Hospital Colorado, University of Colorado, Aurora, CO; Leonard Mattano, MD, HARP Pharma Consulting, Mystic, CT; Mary Shago, PhD, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Meenakshi Devidas, PhD, Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN; Michael Borowitz, MD, Department of Pathology, Johns Hopkins University, Baltimore, MD; Michael J. Burke, MD, Division of Pediatric Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI; Naomi Winick, MD, Department of Pediatric Hematology Oncology and Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX; Nilsa C. Ramirez, MD, Institute for Genomic Medicine and Biopathology Center, Nationwide Children's Hospital, Departments of Pathology and Pediatrics, Ohio State University, Columbus, OH; Nyla Heerema, PhD, The Ohio State University, Columbus, OH; Pradyuamma Baviskar, PhD, Department of Pathology, St Jude Children's Research Hospital, Memphis, TN; Sima Jeha, MD, Department of Oncology, St Jude Children's Research Hospital, Memphis, TN; Stephen P. Hunger, MD, Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Ti-Cheng Chang, PhD, Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN; Wanda Salzer, MD, Uniformed Services University, School of Medicine, Bethesda, MD; Wenan Chen, PhD, Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN, Division of Computational Biology, Mayo Clinic, Rochester, MN; William L. Carroll, MD, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Hospital, New York, NY; Zhongshan Cheng, PhD, Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN; and Mignon L. Loh, MD, Department of Pediatrics and the Ben Towne Center for Childhood Cancer Research, Seattle Children's Hospital, University of Washington, Seattle, WA.",Not available
39714599,Association between a large change between the minimum and maximum monthly values of solar insolation and a history of suicide attempts in bipolar I disorder.,2024-12-23,Bicakci S; Fellendorf FT; Koval M,"Irccs Ospedale San Raffaele, Milan, Italy.; Universite Paris Saclay, CEA, Neurospin, 91191, Gif-Sur-Yvette, France.",Not available
39714567,A prospective study comparing highly qualified Molecular Tumor Boards with AI-powered software as a medical device.,2024-12-23,Imai M,"Genomedia Inc, 4-1-4 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.",Not available
39714546,"Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan.",2024-12-23,Ochiai K; Sugiyama Y,"Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.","Osaka Anti-Tuberculosis Association, Osaka Fukujuji Hospital, Osaka, Japan. giichiyi@me.com."
39713418,Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.,2024-12-12,Zhao N,"Current affiliation: Translational Oncology Bioinformatics, Pfizer, Bothell, WA 98021, USA.",Not available
39713242,Deep learning-based patient stratification for prognostic enrichment of clinical dementia trials.,2024-01-01,Frohlich H,"Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim 55216, Germany.",Not available
39713041,Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.,2024-01-01,Kesari S,"Lantern Pharma, Dallas, Texas, USA.",Not available
39712971,Addressing the need for genetic cancer risk assessment in Mexico: From establishment of a formal program to delivery innovation and expansion.,2024-01-01,Chavarri-Guerra Y; Rodriguez-Olivares JL; Moreno-Miron JM; Lagunas-Medina A; Penafort-Zamora JC; Arteaga-Vazquez J; Weitzel JN,"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Universidad Panamericana, Mexico City, Mexico.",Not available
39710946,SpaceHASTEN: A Structure-Based Virtual Screening Tool for Nonenumerated Virtual Chemical Libraries.,2024-12-22,Kalliokoski T; Turku A; Kasnanen H,"Orion Pharma, Orionintie 1A, 02101 Espoo, Finland.",Not available
39710898,The Safety of Recently Approved Therapeutics in Age-Related Macular Degeneration.,2025-01-01,Khanani ZA; Mojumder O; Sulahria H; Ali H; Rahimzadeh TS; Vannavong J; Gahn GM,"Sierra Eye Associates, Reno, NV.",Not available
39710253,"What is the lower limb length discrepancy after arthroplasty for proximal femoral fracture? A prospective, multicenter observational study of 590 hips.",2024-12-20,Peuchot HA; Flecher X; Pierret M; Chantelot C; Hormi-Menard M; Martz P; Pansard E; Migaud H,"CHU Dijon, Hopital Francois Mitterrand, 2 boulevard Marechal de Lattre de Tassigny, 21079 Dijon, France.; CHU Paris Ouest, Hopital Ambroise Pare, AP-HP, 9 Avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France.; Hopitaux Civils de Colmar, Service d'Orthopedie Traumatologie, Hopital Louis Pasteur, 39 Avenue de la Liberte, 68024 Colmar, France.; Institut du Mouvement et de l'appareil Locomoteur, Departement de Chirurgie Orthopedique, Universite Aix-Marseille, Hopital Sainte-Marguerite, 270 Boulevard Sainte-Marguerite, 13009 Marseille, France.; Universite de Lille, CHRU de Lille, Hopital Salengro, Service d'Orthopedie - Traumatologie, Av du Pr Emile-Laine, 59000 Lille, France.",Not available
39709737,European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024.,2025-01-17,Dreno B,"Nantes Universite, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes F-44000, France.","Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: claus.garbe@med.uni-tuebingen.de."
39709733,Predicting the past: The risks and rewards of post-hoc findings.,2024-12-21,Oliva V; Vieta E,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Spain; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Institut de Neurociencies, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain","Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain. Electronic address: violiva@recerca.clinic.cat."
39709435,"Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma.",2024-12-21,Aviles P; Sullivan H; Cuevas C,"PharmaMar S.A, Avda de los Reyes 1, Colmenar Viejo, Madrid, 28770, Spain.",Not available
39709426,"International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA.",2024-12-21,Ananth A,"Shape Therapeutics, Inc, Seattle, USA.","The Kids Research Institute Australia, Centre for Child Health Research, University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia. Jenny.Downs@thekids.org.au."
39708985,"Glepaglutide, a Long-acting Glucagon-like Peptide-2 Analog, Reduces Parenteral Support in Patients with Short Bowel Syndrome: a Phase 3, Randomized, Controlled Trial.",2024-12-19,Nielsen TSS; Berner-Hansen M,"Digestive Disease Center, Bispebjerg University Hospital, Copenhagen, Denmark.; Zealand Pharma, Denmark; Zealand Pharma, Denmark.","Department of Medical Gastroenterology and Hepatology, Rigshospitalet, Copenhagen, Denmark. Electronic address: Palle.Bekker.Jeppesen@regionh.dk."
39708914,"Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia: Results from a randomized, double-blind, placebo-controlled, phase 3, international clinical trial.",2024-12-19,Anand R; Turolla A; Sansi F; Hartman R,"Anand Pharma Consulting (APC), St. Moritz, Switzerland.; NeurWrite LLC, Morristown, NJ, USA.; Newron Pharmaceuticals SpA, Bresso, Italy.",Not available
39708905,Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions.,2024-12-19,De Sio V; Gragnano F; Capolongo A; Terracciano F; Maddaluna P; Guarnaccia N; Verde G; Cesaro A; Moscarella E,"Department of Translational Medical Sciences, University of Campania ""Luigi Vanvitelli"", Naples, Italy; Division of Cardiology, A.O.R.N. ""Sant'Anna e San Sebastiano"", Caserta, Italy.",Not available
39708636,Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study.,2024-12-13,Castiglione S; Calabresi L,"Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Universita Degli Studi di Milano, Milano, Italy.","Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Universita Degli Studi di Milano, Milano, Italy. Electronic address: chiara.pavanello@unimi.it."
39708220,"Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study.",2024-12-21,Marie S; Pasculli G; Bambury P; Lemarchant S; Kremer P,"Axoltis Pharma, Bioparc Laennec, 60 Avenue Rockefeller, 69008, Lyon, France.; InSilicoTrials Technologies, Trieste, Italy.","Axoltis Pharma, Bioparc Laennec, 60 Avenue Rockefeller, 69008, Lyon, France. ajanus@axoltis.com."
39708087,Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases.,2024-12-21,Mar F; Amador MJ; Gibson K; Margaron P; Saffar I,"F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, Inc, South San Francisco, CA, USA.; Roche Products Ltd, Welwyn Garden City, UK.",Not available
39708085,The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.,2024-12-21,Osumili B,"Eli Lilly and Company Limited, 8 Arlington Square West, Downshire Way, Bracknell, RG12, 1PU, UK.",Not available
39708032,International Multicenter Cohort Study on Beta-Blocker-Free Treatment Strategies for Catecholaminergic Polymorphic Ventricular Tachycardia Patients.,2024-11-05,van der Werf C; Bergeman AT; Peltenburg P; Kammeraad JAE; Wilde AAM,"Emma Children's Hospital, Amsterdam, the Netherlands.; Erasmus MC - Sophia Children's Hospital, Cardiovascular Institute, Department of Pediatric Cardiology, Rotterdam, the Netherlands.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart: ERN GUARD-Heart; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart: ERN GUARD-Heart.; Heart Centre, Amsterdam University Medical Centers, Department of Clinical Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, University of Amsterdam, Amsterdam, the Netherlands",Not available
39708028,Endpoint Selection in Randomized Clinical Trials for Hypertrophic Cardiomyopathy.,2024-12-07,Todiere G; Barison A,"Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.; Health Sciences Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy","Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy. Electronic address: a.aimo@santannapisa.it."
39707930,Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti-Tumour Necrosis Factor-alpha in Patients With Crohn's Disease: A Systematic Literature Review and Meta-Analysis.,2024-12-21,Brown R,"Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Madrid, Spain.",Not available
39707595,Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registry.,2024-12-20,Thill M; Ringwald K,"Agaplesion Markus Krankenhaus, Klinik fur Gynakologie und Gynakologische Onkologie, Brustzentrum, Frankfurt am Main, Germany.; Bioinformatics, iOMEDICO, Freiburg, Germany.",Not available
39707103,Pooled clinical trial analyses evaluating outcomes of HER2-low vs HER2-0 expression in patients with metastatic breast cancer following chemotherapy.,2024-12-20,Tarantino P; Ahlberg C; Qi J; Davi R,"Medidata AI, Medidata Solutions, a Dassault Systemes Company, 350 Hudson Street, New York, NY, 10014, USA.","Medidata AI, Medidata Solutions, a Dassault Systemes Company, 350 Hudson Street, New York, NY, 10014, USA. elizabeth.lamont@3ds.com."
39706882,Biologically defined neuronal synuclein disease as a tool to advance drug development.,2024-12-20,Kerchner GA; Karan R; Jennings D; Peterschmitt MJ; Brundin P,"Denali Therapeutics Inc., South San Francisco, CA, USA.; Global Drug Development, Novartis Pharma AG, Basel, Switzerland.; Neumora Therapeutics, Watertown, MA, USA.; Product Development Neurology, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; UCB Pharma, Brussels, Belgium.","Roche Pharma Research and Early Development (pRED), Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland. gennaro.pagano@roche.com."
39706868,Predicting the replicability of social and behavioural science claims in COVID-19 preprints.,2024-12-20,Duan J; Schlyfestone AR,"Central Bank of Costa Rica, San Jose, Costa Rica.; Rhizom Psychological Services LLC, Atlanta, GA, USA.","Centre for the Study of Existential Risk, University of Cambridge, Cambridge, UK. alexandru.marcoci@gmail.com."
39706645,"Paclitaxel-induced peripheral neuropathy in male rats attenuated by calmangafodipir, a superoxide dismutase mimetic.",2025-01-01,Yao K; Nagahama F,"Product Development Division, Solasia Pharma K.K., Tokyo, 105-0011, Japan.","Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, 812-8582, Japan. Electronic address: kawashiri.takehiro.650@m.kyushu-u.ac.jp."
39706551,Intraoperative goal-directed hemodynamic therapy targeting both arterial pressure and flow parameters using uncalibrated pulse contour techniques: A meta-analysis of randomized controlled trials.,2024-12-18,Ripolles-Melchor J; Fernandez-Valdes-Bango P; Navarro-Perez R; Abad-Gurumeta A,"Departamento de Anestesiologia, Hospital Universitario Clinico San Carlos, Madrid, Spain.; Departamento de Anestesiologia, Hospital Universitario Infanta Leonor, Madrid, Spain; Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.","Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anesthesiology and Critical Care, Madrid, Spain. Electronic address: ripo542@gmail.com."
39706482,The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.,2024-12-18,Alvarez O; Chai-Rees J; Croal M; Marwood L; Mistry S; Nowakowska A; Simmons H; Teoh E; Williams S; Malievskaia E,"Compass Pathfinder Ltd (a subsidiary of Compass Pathways plc), London, UK.; Parc Sanitari Sant Joan de Deu, Barcelona, Spain; Sant Joan de Deu Research Foundation, Barcelona, Spain.","Compass Pathfinder Ltd (a subsidiary of Compass Pathways plc), London, UK. Electronic address: guy.goodwin@compasspathways.com."
39706215,[A comparison of direct admissions to inpatient-equivalent home treatment with transfers from psychiatric wards].,2024-12-20,Brieger P; Klocke L; von Peter S; Timm J; Raschmann S,"Gemeinnutzige GmbH fur Psychiatrie Reutlingen (PP.rt), akademisches Lehrkrankenhaus der Universitat Tubingen, Reutlingen.; Klinik fur Psychiatrie und Psychotherapie, CCM, Charite Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin.; kbo-Isar-Amper-Klinikum Region Munchen, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universitat Munchen, Haar bei Munchen.",Not available
39705670,Amino Acid Infusion for Kidney Protection in Cardiac Surgery Patients with Chronic Kidney Disease: A Secondary Analysis of the PROTECTION Trial.,2024-12-19,Licheri M; Losiggio R,"S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I, Torino, Italy.; UOC Anestesia e Rianimazione Azienda Ospedaliero-Universitaria Sant'Andrea, Roma, Italy.",Not available
39704949,Remodeling of Individual Nucleosomes in Nucleosome Arrays.,2025-01-01,Mueller-Planitz F,"Early Stage Bioprocess Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
39704409,Neurostatus-SMARTCARE clinical trial: Enabling health care professionals to assess EDSS for decentralized trials in multiple sclerosis.,2024-12-20,Cerda-Fuertes N; Wei W; Kieseier B; Kamm CP,"Novartis Pharma AG, Basel, Switzerland.",Not available
39703904,alphaFAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues.,2024-12-12,Curtis P; Kenny CH; Panavas T,"Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.",Not available
39703112,Improved glycaemic control in people with type 2 diabetes initiating or switching to IDegAsp in a real-world setting in China.,2024-12-20,Zhong X; Shankarappa VB; Chaudhary G,"Novo Nordisk (Shanghai) Pharma Trading Co. Ltd, Shanghai, China.; Novo Nordisk Denmark A/S, Copenhagen, Denmark.; Novo Nordisk India Private Limited, Bangalore, India.",Not available
39702718,Modeling ncRNA Synergistic Regulation in Cancer.,2025-01-01,Wei X,"Beijing CapitalBio Pharma Technology Co., Ltd., Beijing, China.",Not available
39702308,Analytical and clinical performance of eight Simoa((R)) and Lumipulse((R)) assays for automated measurement of plasma p-tau181 and p-tau217.,2024-12-19,Vanbrabant J; Bastard NL; Lambrechts C; Van Loo M; Vandijck M; Stoops E; Verberk IMW,"ADx NeuroSciences NV, Ghent, Belgium.; ALZpath. Inc, Carlsbad, CA, USA.; Fujirebio Europe NV, Ghent, Belgium.","Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands. a.l.wojdala@amsterdamumc.nl."
39701919,Tackling algorithmic bias and promoting transparency in health datasets: the STANDING Together consensus recommendations.,2025-01-01,Ordish J; Cole-Lewis H; Gath J; Leung CH; Farmer LA; Mateen BA; Kumuthini J; Sapey E,"African Biobanks and Longitudinal Epidemiologic Ecosystem, Ibadan, Nigeria.; Centre for Patient Reported Outcomes Research, School of Health Sciences, College of Medical and Dental Sciences, Birmingham, UK; Google, Mountain View, CA, USA.; Hughes Hall, Cambridge, UK.; Independent Cancer Patients' Voice, London, UK; Institute of Health Informatics, University College London, London, UK; NIHR Midlands Applied Research Collaboration, Acute Care Theme, West Midlands, UK; NIHR Midlands Patient Safety Collaboration, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK; PATH, Seattle, WA, USA; PIONEER, HDR UK Health Data Hub in Acute Care, Birmingham, UK; Patient and Public Contributor, Sheffield, UK.; Roche Diagnostics, Rotkreuz, Switzerland; Tethyan Consulting, Canberra, Australia.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; University of Birmingham, Birmingham, UK; Wellcome Trust, London, UK.; patient and public contributor, Munich, Germany.",Not available
39701863,Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics.,2024-12-16,Jeromin A,"ALZPath, Inc, Carlsbad, CA, USA.",Not available
39701338,"Crystalline silica on the lung-environment interface: Impact on immunity, epithelial cells, and therapeutic perspectives for autoimmunity.",2024-12-17,Galli G; Leleu D; Depaire A; Blanco P; Contin-Bordes C; Truchetet ME,"CHRU Dijon Bourgogne, Laboratory of Clinical Chemistry, F-21000 Dijon, France.; CHU de Bordeaux, FHU ACRONIM, Centre national de reference des maladies auto-immunes et systemiques rares Est/Sud-Ouest (RESO), F-33000 Bordeaux, France; CHU de Bordeaux, Service d'Immunologie, UMR 5164, F-33000 Bordeaux, France.; CHU de Bordeaux, Service de Rhumatologie, UMR 5164, F-33000 Bordeaux, France.; MED'INN'Pharma, F-25000 Besancon, France.; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, F-33000 Bordeaux, France; Univ. Bourgogne Franche-Comte, INSERM, LNC UMR1231, LabEx LipSTIC, F-21000 Dijon, France","CHU de Bordeaux, Service de Medecine Interne, Immunologie Clinique et Maladies Infectieuses, UMR 5164, F-33000 Bordeaux, France. Electronic address: gael.galli@chu-bordeaux.fr."
39700658,European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024.,2025-01-17,Dreno B,"Nantes Universite, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, F-44000 Nantes, France.","Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: claus.garbe@med.uni-tuebingen.de."
39699934,"Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One-year outcomes from the international noninterventional CIMREAL study.",2024-12-19,Evangelia P; Hee J; Williams P; Khusru A,"HIA, Hopital Sainte Anne, Toulon, France.; UCB Pharma, Brussels, Belgium.; UCB Pharma, Madrid, Spain.; UCB Pharma, Morrisville, North Carolina, USA.",Not available
39699889,Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular Edema.,2024-12-02,Steinle NC; Stone CM; Crawford C; Dugel PU; Baldwin ME; Leitch IM,"Asheville Eye Associates, Asheville, NC, USA.; California Retina Consultants, Santa Barbara, CA, USA.; Opthea Limited, Melbourne, Victoria, Australia.; Retinal Consultants of Arizona, Phoenix, AZ, USA.; Star Retina, Burleson, TX, USA.",Not available
39699799,Experience and Care Pathway of Patients with Lung Cancer: An Online International Survey.,2024-12-19,Dallas L; Ciupek A,"ELSECARE Inc, Paris, France.","Novartis Pharma AG, Basel, Switzerland. pauline.frank09@gmail.com."
39699750,High-Titer Rheumatoid Factor is Associated with Worse Clinical Outcomes and Higher Needs for Advanced Therapies in Rheumatoid Arthritis Under Real-Life Conditions.,2024-12-19,Pereira IA; Bonfiglioli KR; Louzada-Junior P,"Universidade de Sao Paulo, Rheumatology, Ribeirao Preto, Brazil.; Universidade de Sao Paulo, Rheumatology, Sao Paulo, Brazil.; Universidade do Sul de Santa Catarina-UNISUL Santa Catarina, Rheumatology, Florianopolis, Brazil.","Hospital Universitario de Brasilia (HUB), Universidade de Brasilia (UnB), SGAN 605, Asa Norte, Brasilia, DF, 70840-901, Brazil. victordavi98@gmail.com."
39699741,Recommendations for the management of cutaneous squamous cell carcinoma: a systematic multidisciplinary Delphi consensus approach.,2024-12-19,Pardo MT; Rogado A; Berrocal Jaime A,"Fundacion ECO (Excelencia y Calidad en Oncologia), Madrid, Spain.",Not available
39698899,Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer.,2025-01-01,Lodewijk I; Nunes SP; Sanchez R; Real FX; Paramio JM,"Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.",Not available
39698038,Maternal organokines throughout pregnancy as predictors of neonatal anthropometric characteristics and adiposity.,2024-01-01,Valencia-Ortega J; Castillo-Santos A; Arceo-Cerna C; Rodriguez-Cano AM; Estrada-Gutierrez G; Camacho-Arroyo I; Solis-Paredes JM,"Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes, Mexico City, Mexico.; Seccion de Estudios de Posgrado, Escuela Superior de Medicina, Instituto Politecnico Nacional, Mexico City, Mexico.; Unidad de Investigacion en Reproduccion Humana, Instituto Nacional de Perinatologia-Facultad de Quimica, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.",Not available
39697635,Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design.,2024-01-01,Winkeljann B,"RNhale GmbH, Munchen 81371, Germany.",Not available
39697288,"Assessment of clinical benefit, cost and uptake of biosimilars versus reference biologics in immune-mediated inflammatory diseases in China.",2024-01-01,Yang Y,"BCPMdata Pharma Technology (Chengdu) Co., Ltd, Chengdu, China.",Not available
39697278,Effects of alcohol-related problems on the costs of frequent emergency department use: an economic analysis of a case-control study in Spain.,2024-01-01,Millan-Hernandez A; Vazquez M,"Red de Investigacion en Atencion Primaria de Adicciones (RIAPAd), Madrid, Spain.",Not available
39697187,Caregiver worry about COVID-19 as a predictor of social mitigation behaviours and SARS-CoV-2 infection in a 12-city U.S. surveillance study of households with children.,2025-01-01,Calatroni A; Arbes SJ Jr; Sanders J,"Rho, Inc., 2635 E NC Hwy 54, Durham, North Carolina, 27713, USA.",Not available
39696829,Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.,2025-01-01,Wynant W; Cater NB,"Global Product Development, Pfizer Inc., Groton, Connecticut, USA.; Merck & Co., Inc., Rahway, New Jersey, USA.",Not available
39696783,Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7(th) immunorad conference.,2025-01-01,Deandreis D,"INSERM U981 ""Molecular predictors and new targets in oncology"", Gustave Roussy, Villejuif, France.",Not available
39696526,Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study.,2024-12-18,Kapoor S; Cardoso AP; Nieman B; Quenet S,"Novartis Pharmaceuticals Corporation, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, SA, Australia. Tim.Hughes@sahmri.com."
39696436,Epigenome-wide association studies identify novel DNA methylation sites associated with PTSD: a meta-analysis of 23 military and civilian cohorts.,2024-12-18,Kimbrel NA,"Biogen Inc, Translational Sciences, Cambridge, MA, USA.",Not available
39696323,Lipid production from biofilms of Marinobacter atlanticus in a fixed bed bioreactor.,2024-12-19,Beasley M,"Catalent Pharma Solutions, Kansas City, MO, 64137, USA.","Center for Biomolecular Science and Engineering, US Naval Research Laboratory, Washington, DC, 20375, USA. matthew.d.yates7.civ@us.navy.mil."
39696072,Eight-fold increased COVID-19 mortality in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations: an observational study.,2024-12-18,Taylor A; Bleyer AJ Sr,"DNA Data Solutions, LLC, St. Petersburg, FL, USA.; Genespector, Prague, Czech Republic.",Not available
39695768,Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib.,2024-12-18,Leary A; Timms KM; Elks CE; Dearden S; Egile C; Lao-Sirieix P,"Institut Gustave Roussy, and GINECO, Villejuif, France.; Myriad Genetics, Salt Lake City, UT, USA.; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK.","Translational Medicine, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK. alan.barnicle@astrazeneca.com."
39695322,Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis.,2024-12-18,Solini N; Pigato G; Del Giovane C,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Dipartimento di Salute Mentale, Azienda ULSS 7 Pedemontana, Thiene, VI, Italy.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.","Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada. msolmi@toh.ca."
39695076,Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.,2024-12-18,Frenzel L; Chalopin T; Mariette C; Croizier C; Payssot A,"CHR d'Annecy, Epagny Metz-Tessy, France.; Hopital Saint Nazaire, Saint-Nazaire, France.; Hopital, Cochin, Paris, France.; Service d'Hematologie Clinique et de Therapie Cellulaire, Hopital Saint Antoine, AP-HP, Paris, France.; Universite Jean Monnet Saint-Etienne, CHU Saint-Etienne, INSERM, CIC1408, INSERM, SAINBIOSE-U1059, Service d'Hematologie Clinique et de Therapie Cellulaire, F- 42023, Saint-Etienne, France.","Sorbonne Universite, Centre de Recherche Saint-Antoine INSERM UMRs938, Paris, France. florent.malard@inserm.fr."
39694677,What is the true target population for biologics in real-life COPD or asthma-COPD overlap patients?,2024-12-18,Taille C,"Departement de Pneumologie, Service des Maladies Respiratoires, Hopital du Haut Leveque, CHU de Bordeaux, Pessac, France.","Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, CIC 1401, Universite de Bordeaux, Bordeaux, France maeva.zysman@chu-bordeaux.fr."
39694273,The Impact of Volume of Dissolution Medium for Biopredictive Dissolution/Permeation Studies of Enabling Formulations: A Comparison of Two Brands of Telmisartan / Amlodipine Tablets.,2024-12-16,Eriksen JB; Milsmann J,"Analytical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach an der Riss, 88400, Germany.; Department of Physics Chemistry and Pharmacy, University of Southern Denmark, SDU, FKF, Campusvej 52, Odense, 5230, Denmark",Not available
39694205,Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: an Open-Label Extension Study.,2024-12-16,Lucendo AJ; Santander C; Schmocker C; Halstead M; Pfurr S; Mueller R,"Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain; Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain; Dept. of Gastroenterology, Brandenburg Medical School, Ruppiner Kliniken, Neuruppin, Germany.; Dr. Falk Pharma Australia, Sydney, Australia.; Dr. Falk Pharma GmbH, Freiburg, Germany.; Instituto de Investigacion Sanitaria de Castilla-La Mancha (IDISCAM), 45071 Toledo, Spain.; Klinik fur Innere Medizin I, Sana Klinikum Lichtenberg, Berlin, Germany; Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain.","Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland. Electronic address: luc.biedermann@usz.ch."
39694077,Does needle clogging change the spatial distribution of injected drug in tissue? New insights by X-ray computed tomography.,2024-12-16,Bonaventura F; Zuern A,"Novartis Pharma AG, WSJ-204/1/100, 4002 Basel, Switzerland.; Novartis Pharmaceutical Manufacturing GmbH, Biochemiestrasse 10, 6336 Langkampfen, Austria.",Not available
39693891,Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics.,2025-01-17,Quesada S; Penault-Llorca F; Coleman RL; Rouleau E; Van Gorp T; Vergote I; Ray-Coquard I,"Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Cancer Genetics Laboratory, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.; Coordinator of Gen&Tiss GFCO, Universite Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France; Cours St Paul, Saint Paul, Reunion, France.; Department of Biology and Pathology, Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moleculaire et Strategies Theranostiques, Universite Clermont Auvergne, UMR 1240 INSERM-UCA, Clermont-Ferrand, France; Department of Cancer Genetics, University Hospital of Montpellier, Montpellier, France; Department of Medical Oncology, Institut regional du Cancer de Montpellier (ICM), Montpellier, France; Division of Gynaecological Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; Groupe d'Investigateurs Nationaux pour l'Etude des cancers de l'ovaire et du sein (GINECO), Paris, France; Medical Oncology, Centre Leon Berard and Universite Claude Bernard Lyon, Lyon, France.; Societe Francaise de Medecine Predictive et Personnalisee (SFMPP), Montpellier, France; Societe Francaise de Medecine Predictive et Personnalisee (SFMPP), Montpellier, France.; Texas Oncology, US Oncology Network, The Woodlands, TX, USA.",Not available
39693589,Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.,2024-01-01,Sudhaman S; Mahmood T; Carson C; Pajak N; Dutta P; Calhoun M; Malhotra M; ElNaggar AC; Liu MC,"Natera, Inc, Austin, TX.",Not available
39693268,Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial.,2024-12-18,Robertson K; Ge S; Lu J; Badger H; Mujais S,"Chesapeake Urology, Hanover, Maryland.; Sumitomo Pharma America, Inc, Marlborough, Massachusetts.",Not available
39692838,The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn's Disease.,2024-12-18,Su S; Durand F; Stassek L; Kawata AK,"Eli Lilly and Company, 893 S Delaware St., Indianapolis, IN, 46225, USA.; Evidera, Wilmington, NC, USA.",Not available
39692817,Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: post hoc analysis of the DELIVER trial.,2024-12-18,Rae-Espinoza H; Regnier SA; Goadsby PJ,"Clinigma, Copenhagen, Denmark.; H. Lundbeck A/S, Copenhagen, Denmark.","Headache and Pain Unit, IRCCS San Raffaele, Rome, Italy. piero.barbanti@sanraffaele.it."
39692674,Particulates in CGT guidance survey results - an ISCT process development & manufacturing committee perspective on cell and gene therapy industry knowledge awareness.,2024-10-31,Davies L; Clarke D; Werner S,"CellTherEx Consulting AB, Stockholm, Sweden; Cryoport Systems, Irvine, California, USA.; Karolinska Institutet, Stockholm, Sweden.; NextCell Pharma AB, Stockholm, Sweden; Sexton Biotechnologies, Indianapolis, Indiana, USA.",Not available
39692284,Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany.,2025-01-01,Sato R,"HTA Value & Evidence, Pfizer Inc, New York, NY, USA.",Not available
39692064,Photoreceptor-RPE loss ratio and fundus autofluorescence patterns as predictive factors for lesion progression in geographic atrophy.,2024-12-18,Ahmadzai P,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.",Not available
39691247,A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practice.,2024-01-01,Curti A; Cairoli R,"IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia ""L. & A. Seragnoli"" Bologna Italy.",Not available
39691156,Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS.,2024-01-01,Seki M; Petullo D; Bowen K; Darken PF; Duncan EA; Megally A,"AstraZeneca K.K., Osaka, Japan.; AstraZeneca, Durham, NC, USA.; AstraZeneca, Gaithersburg, MD, USA.",Not available
39690514,Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy.,2024-12-17,Zhang Y,"Sunshine Lake Pharma Co. Ltd., Dongguan, China.",Not available
39690042,Quantitative Liver Fat Assessment by Handheld Point-of-Care Ultrasound: A Technical Implementation and Pilot Study in Adults.,2024-12-16,Carrascal CA; Sanchez N,"Butterfly Network Inc., Burlington, MA, USA.","Department of Radiology, University of California San Diego, La Jolla, CA, USA. Electronic address: dtamayomurillo@health.ucsd.edu."
39688792,Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study.,2024-12-17,Fakhouri W; Ogwu S; Haladyj E; de la Torre I,"Eli Lilly and Company, Indianapolis, IN, USA.","Botnar Research Centre, Nuffield Department of Orthopaedics, Rhematology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. peter.taylor@kennedy.ox.ac.uk."
39688776,Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.,2024-12-17,Gee P; Herings RMC; Overbeek JA; Penning-van Beest FJA; Layton JB,"Bayer AG, Berlin, Germany.",Not available
39687396,Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis.,2024-01-01,White ES; Ittrich C; Diefenbach C; Selman M,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.; Instituto Nacional de Enfermedades Respiratorias ""Ismael Cosio Villegas"", Mexico City, Mexico.",Not available
39687393,Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung disease.,2024-01-01,Rekowski MJ; Yorozuya T,These authors contributed equally.,Not available
39687390,Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics.,2024-01-01,Hardin M; Soler X; Rowe PJ; Deniz Y; Sacks H; Jacob-Nara JA,"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.; Sanofi, Bridgewater, NJ, USA.; Sanofi, Cambridge, MA, USA.",Not available
39686620,"Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).",2024-12-16,Das B; Wojtowicz J; Huang Z; Bullain S; Watkin M; Lott D; Bittner T; Delmar P; Klein G; Hofmann C; Kerchner GA; Smith J; Baudler M; Fontoura P; Doody RS,"F. Hoffmann-La Roche Ltd, Basel, Switzerland.; F. Hoffmann-La Roche Ltd, Shanghai, China.; Genentech, Inc., South San Francisco, CA, USA.; Roche Products Limited, Welwyn Garden City, UK.",Not available
39684584,Understanding the Preclinical Efficacy of Antibody-Drug Conjugates.,2024-11-29,Moreno V,"START Madrid Centro Integral Oncologico Clara Campal, 28050 Madrid, Spain.",Not available
39682743,Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.,2024-12-03,Spakowicz D; Weiner GJ,"Aster Insights, Hudson, FL 34667, USA.",Not available
39682732,Alginate vs. Hyaluronic Acid as Carriers for Nucleus Pulposus Cells: A Study on Regenerative Outcomes in Disc Degeneration.,2024-11-30,Nakamura Y; Tamagawa S; Watanabe M,"TUNZ Pharma Corporation, Osaka 541-0046, Japan.",Not available
39682258,Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.,2024-12-05,Melotti B; Tronconi MC; Grosso F,"Divisione di Oncologia Medica, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Oncologia e Oncologia Dermatologica, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.; S.S. Oncologia Medica Melanomi, S.C. Oncologia Medica 1, Dipartimento di Oncologia Medica ed Ematologia, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.",Not available
39681779,Population Pharmacokinetics of Meropenem Across the Adult Lifespan.,2024-12-16,Walter EB,"The EMMES Company, LLC, Rockville, MD, USA.",Not available
39681729,"Rejoinder to the 'Letter to the Editor' on ""Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies"".",2024-12-16,Ocana J; Ring A; Shitova A,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.; Consultant, Berlin, Germany.; Gedeon Richter Plc, Budapest, Hungary.","Center for Medical Data Science of the Medical University of Vienna, 1090, Vienna, Austria. helmut.schuetz@bebac.at."
39681620,Forceps minor control of social behaviour.,2024-12-16,Stoller F; Hinds E; Ionescu T; Khatamsaz E; Marston HM,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39680866,Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report.,2025-01-06,Tannergren C; Arora S; Kotzagiorgis E; Mackie C; Sjogren E,"Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 43183, Sweden.; European Medicines Agency (EMA), Domenico Scarlattilaan 6, Amsterdam 1083 HS, The Netherlands.; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.; Pharmetheus, Uppsala 752 37, Sweden.",Not available
39680391,Comparing the Thin Plate Spline and Gaussian Interpolation Methods in Generating Hill of Visions for X-Linked Retinitis Pigmentosa Patients.,2024-12-02,Woo KM; Waheed NK,"Beacon Therapeutics, Cambridge, MA, USA.",Not available
39680314,Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.,2024-12-16,Kponee-Shovein K; Mahendran M; Song Y; Hua Q; Hilts A; Sun Y; Hirshfield KM; Mejia JA,"Analysis Group, Inc, Boston, MA, USA.; Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA.","Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA. jagadeswara.rao.earla@merck.com."
39680309,Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United Kingdom.,2024-12-16,Calvert M; Shah F,"Sick Cells, Washington, DC, USA.; Vertex Pharmaceuticals Incorporated, Boston, MA, USA.","Vertex Pharmaceuticals Incorporated, Boston, MA, USA. Jennifer_Drahos@vrtx.com."
39680127,[Post-Intensive Care Syndrome: functional impairments of critical illness survivors].,2024-12-16,Paul N,"Klinik fur Anasthesiologie und Intensivmedizin (CCM/CVK), Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland.",Not available
39680036,Modeling the Detailed Conformational Effects of the Lactosylation of Hyaluronic Acid.,2024-12-16,Elli S; Sisto T; Nizzolo S; Bertocchi L; Bianchini G; Yates EA,"Glycocore Pharma srl, Padova 35122, Italy.; Istituto di Ricerche Chimiche e Biochimiche 'G. Ronzoni', via G. Colombo 81, Milano 20133, Italy.; JoinTherapeutics srl, Padova 35122, Italy.",Not available
39678032,Long term efficacy and safety profile of dexamethasone intravitreal implant in retinal vein occlusions: a systematic review.,2024-01-01,Metrangolo C; Astarita C; Gallinaro V,"AbbVie S.r.l., Rome, Italy.; SC Oculistica, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.",Not available
39677432,Peritraumatic C-reactive protein levels predict pain outcomes following traumatic stress exposure in a sex-dependent manner.,2024-12-07,Jones CW,"The Many Brains Project, Belmont, MA, 02478, USA.",Not available
39677032,Design-related bias in studies investigating diagnostic tests for venous thromboembolic diseases: a systematic review and meta-analysis.,2024-01-01,Nagler M,"Medignition Inc., Zurich, Switzerland.",Not available
39676687,Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis.,2025-01-01,Nantes-Castillejo O; Straumann A; Biedermann L; Guagnozzi D; von Arnim U; Gouya G; Dellon ES,"Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain.; IdiSNA. Instituto de Investigacion Sanitaria de Navarra, Pamplona, Spain.; Instituto de Investigacion Sanitaria Princesa, Madrid, Spain.; Instituto de Investigacion Sanitaria de Castilla-La Mancha (IDISCAM), Toledo, Spain.",Not available
39676528,Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management.,2024-11-27,Barbet P; Taghavi K,"Universite de Paris Cite, 15 Rue de l'Ecole de Medecine, 75006 Paris, France.",Not available
39676507,JUNB O-GlcNAcylation-Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis.,2024-12-15,Haag L; Rust W; Viollet C; Strobel B; Dick A; Gantner F; Ramirez F; Thomas MJ,"C.H. Boehringer Sohn AG and Co. KG, 55218, Ingelheim, Germany.; Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach, Germany.; Global Computational Biology and Digital Science, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach, Germany.",Not available
39676148,The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients.,2024-12-16,Nakamura Y; Hirose J; Ohara K; Carter M; Meredith K; Harris J; Akerborg O,"Bayer Yakuhin Ltd, Osaka, Japan.; Wickenstones Ltd, Carlow, Ireland.",Not available
39675951,Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States.,2024-12-14,Fuldeore R; Xie B; Young C; Mucha L,"HEOR Oncology, Astellas Pharma, Inc., Northbrook, IL.; Real World Evidence and Data Science, Astellas Pharma, Inc., Northbrook, IL.","Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS. Electronic address: rchen2@kumc.edu."
39675924,Response to the Letter to the Editor by Athinarayanan.,2025-01-01,Fitch A; Jouravskaya I; Neff LM,"Eli Lilly and Company, Indianapolis, Indiana, USA.; Knownwell, Boston, Massachusetts, USA.",Not available
39675138,Changes in rates of endophthalmitis after cataract surgery over the last 23years.,2024-12-14,Sahyoun M,"Horus Pharma, Nice, France.","Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, 28, rue de Charenton, 75012 Paris, France. Electronic address: alexandrehage@gmail.com."
39674644,"In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation.",2024-01-01,Anis A; Kerema MS,"Postgraduate Pharmacist at DataClin CRO, Giza, Egypt.; Postgraduate Pharmacist at Pharco Pharmaceuticals, Alexandria, Egypt.",Not available
39674570,"Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study.",2024-12-12,Malicot KL,"Federation Francophone de Cancerologie Digestive, Dijon, France.","Sorbonne University, Hepato-gastroenterology and digestive oncology department, Pitie Salpetriere hospital, APHP, Paris, 47-83 Boulevard de l'hopital, Paris 75013, France. Electronic address: victoire.dabout@aphp.fr."
39674229,Primary care diagnostic pathways for lower gastrointestinal symptoms.,2025-01-01,Attwood D,Crohn's & Colitis UK.,"Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Electronic address: sdin@ed.ac.uk."
39674226,Rome Foundation and international neurogastroenterology and motility societies' consensus on idiopathic gastroparesis.,2025-01-01,Fernandez LMB,"Centro Medico Bustos-Fernandez, Buenos Aires, Argentina.",Not available
39674225,"Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study.",2025-01-01,Graupera I; Wedemeyer H; Gines P,"Centro de Investigacion en Red de Enfermedades Hepaticas y Digestivas (Ciberehd), Barcelona, Spain; Department of Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hannover, Germany; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Leberstiftungs-GmbH Deutschland, Hannover, Germany.; Liver Unit, Hospital Clinic of Barcelona, Barcelona, Spain",Not available
39673834,A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research.,2025-01-17,Flatz L,"Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University of Tubingen, 72076 Tubingen, Germany; Cluster of Excellence iFIT (EXC 2180) ""Image-Guided and Functionally Instructed Tumor Therapies"", Tubingen, Germany.","Cluster of Excellence iFIT (EXC 2180) ""Image-Guided and Functionally Instructed Tumor Therapies"", Tubingen, Germany. Electronic address: teresa.amaral@med.uni-tuebingen.de."
39657020,Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis.,2024-12-05,Steffensen LA; Tindberg AM; Simpson EL,"LEO Pharma A/S, Ballerup, Denmark.",Not available
39656908,Romosozumab Improves Microarchitecture as Assessed by Tissue Thickness-Adjusted Trabecular Bone Score in Postmenopausal Women with Osteoporosis.,2024-12-05,Betah D; Oates M; Timoshanko J; Wang Z,"Amgen Inc., Thousand Oaks, California, USA.; UCB Pharma, Slough, UK.",Not available
39656879,Identification and characterization of human KALRN mRNA and Kalirin protein isoforms.,2024-12-03,Hengerer B; Pinnock R,"Boehringer Ingelheim Pharma GmbH & Co. KG, 65 Birkendorfer Strasse, 88397, Biberach an der Riss, Germany.",Not available
39673713,"Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B Patients.",2025-01-01,Zhang Y; Chen Y; He Q; Chen Y; Ding Y,"Sunshine Lake Pharma Co. Ltd., Dongguan, China.",Not available
39673433,Real-World Effectiveness of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Canada.,2024-12-14,Cy A,"Cencora, Innomar Strategies Inc., Oakville, ON, Canada.",Not available
39673215,Trends and Challenges of the Modern Pathology Laboratory for Biopharmaceutical Research Excellence.,2024-12-13,Couto S; Stierstorfer B; Mohanan S; Morel C; Bangari DS; Clark E,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.; Gilead Sciences, Foster City, California, USA.; Neomorph, Inc, San Diego, California, USA.; Sanofi, Cambridge, Massachusetts, USA.",Not available
39673040,"Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration.",2024-12-14,Sylvanowicz M; Rodriguez FJ; Wong DT,"Bayer Consumer Care AG, Basel, Switzerland.; Exploristics Ltd, Belfast, Northern Ireland, UK.; Fundacion Oftalmologia Nacional, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogota, Colombia.","Department of Ophthalmology, Tel Aviv Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. anatl@tlvmc.gov.il."
39673039,"Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff.",2024-12-14,Amoaku WM; Lin X; Pearce I; Wong DT,"Bayer Consumer Care AG, Basel, Switzerland.; Exploristics Ltd, Belfast, Northern Ireland, UK.; Fundacion Oftalmologia Nacional, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogota, Colombia.; Laboratoire UMR-CNRS 5510 MATEIS, INSA, Universite Lyon 1, Villeurbanne, France.","University Eye Clinic, Department of Ophthalmology, University Hospital Leipzig, University of Leipzig, Leipzig, Germany. focke.ziemssen@medizin.uni-leipzig.de."
39672812,Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate.,2024-12-13,Liu Y; Owiredu J; Barbieri CE,"Biochemistry, Cellular, Developmental and Molecular Biology Program, Weill Cornell Medicine, New York, NY, USA.; Veracyte, Inc., South San Francisco, CA, USA.",Not available
39672591,Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial.,2024-12-12,Sharaf M; Efficace M; Lavie F,"Janssen-Cilag SpA, Imperia, Italy.; Johnson & Johnson, Middle East FZ LLC, Dubai, UAE.; The Janssen Pharmaceutical Companies of Johnson & Johnson, Paris, France.","College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK Iain.McInnes@glasgow.ac.uk."
39671752,"Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study.",2024-12-12,Oliver K; Longcor J,"Cellectar Biosciences, Florham Park, NJ, USA.","Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin (UW) School of Medicine and Public Health, Madison, WI, USA. Electronic address: jybruce@medicine.wisc.edu."
39671076,Improvement of Fatigue in Patients with Ankylosing Spondylitis Receiving Tofacitinib: Analyses of a Phase 3 Randomized Controlled Trial.,2024-12-13,Dina O; Cella D,"Inflammation and Immunology, Pfizer Inc, Oslo, Norway.; Internal Medicine, Pfizer Inc, New York, NY, USA.","Sorbonne Universite, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, Paris, France. laure.gossec@aphp.fr."
39670995,Altered X-chromosome inactivation of the TLR7/8 locus and heterogeneity of pDCs in systemic sclerosis.,2025-03-03,Ah Kioon MD; Pierides M; Truchetet ME,"Institut Cochin, Universite Paris Cite, CNRS, INSERM , Paris, France. ROR: https://ror.org/051sk4035; Institut Toulousain des Maladies Infectieuses et Inflammatoires, Universite de Toulouse, INSERM, CNRS, UPS , Toulouse, France. ROR: https://ror.org/004raaa70",Not available
39670429,Neuromuscular transmission deficits in patients with CMT and ClC-1 inhibition in CMT animal models.,2024-12-13,Gronnebaek TS; Skov M; Tankisi H; Pedersen TH; Andersen H,"NMD Pharma A/S, Aarhus, Denmark.",Not available
39668469,Population Pharmacokinetic/Pharmacodynamic and Exposure-Response Modeling Analyses of Sotatercept in Healthy Participants and Patients with Pulmonary Arterial Hypertension.,2024-12-12,Ait-Oudhia S; Jaworowicz D; Hu Z; Gaurav M; Barcomb H; Hu S; Bihorel S; Balasubrahmanyam B; Mistry B; de Oliveira Pena J; Wenning L; Gheyas F,"Acceleron Pharma, A Subsidiary of Merck & Co., Inc., Rahway, New Jersey, USA.; Cognigen division of Simulations Plus, Inc., Buffalo, New York, USA.; Merck & Co., Inc., Rahway, New Jersey, USA.",Not available
39668190,Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party.,2024-12-13,Boreland W; Maertens J; Moiseev I; Schoemans H,"EBMT Transplant Complications Working Party (TCWP), Paris, France.","Department of Hematology, University Hospitals Leuven, Leuven, Belgium. jan.brijs2@telenet.be."
39667819,Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?,2024-12-12,Rannikko A; Ganguli A; Shore ND,"Global Product Development, Pfizer, San Francisco, California.; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.; Servicio de Urologia, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.",Not available
39667814,Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model.,2025-01-03,Maier M; Guerin B,"AL-S Pharma AG, Schlieren, Zurich, Switzerland; and.",Not available
39667373,Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.,2025-01-01,Seybert C; Silva L; Bessa BS,"Champalimaud Research and Clinical Centre, Champalimaud Foundation, Lisbon, Portugal; ISPA-Instituto Universitario Ciencias Psicologicas, Sociais e da Vida, Lisbon, Portugal.; Servico de Psiquiatria da Unidade Local de Saude do Baixo Alentejo, Beja, Portugal.",Not available
39667347,scTrends: A living review of commercial single-cell and spatial 'omic technologies.,2024-12-11,Opzoomer JW; Vilas-Zornoza A; Nilges BS; Gross T; Morf J; Cudini J; Ramos-Mucci L; Mooijman D; Kashikar ND; Shalek AK,"Broad Institute of MIT and Harvard, Cambridge, MA, USA; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK; Institute for Medical Engineering and Science, Department of Chemistry and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; OMAPiX GmbH, Langenfeld, Rheinland, Germany.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.; Relation Therapeutics, London, UK; Relation Therapeutics, London, UK.; Single Cell Discoveries, Utrecht, the Netherlands.; Skyhawk Therapeutics, Basel, Switzerland.",Not available
39667100,Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer.,2025-01-01,Gava A,"Societa per l'Assistenza al Malato Oncologico Terminale Onlus (S.A.M.O.T.) Ragusa Onlus, Ragusa, Italy.",Not available
39666143,Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures.,2024-12-12,Hirman J; Asher D; Fiore D; Cady R,"Lundbeck LLC, Deerfield, IL, USA.; Pacific Northwest Statistical Consulting, Inc, Woodinville, WA, USA.; RK Consults, Ozark, MO, USA.","New England Institute for Neurology and Headache, Stamford, CT, USA. sjtepper@gmail.com."
39666070,Medical costs of treating myasthenia gravis in patients who need intravenous immunoglobulin (IVIg) - a register-based study.,2024-12-12,Bugge C; Lindberg-Schager I,"Oslo Economics, Oslo, Norway.",Not available
39666007,Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis.,2025-01-06,Faleck DM,"Vedanta Biosciences , Cambridge, MA, USA.",Not available
39665530,Pharmacological characteristics of once-weekly insulin icodec in Japanese individuals with type 1 diabetes.,2024-12-12,Nishida T,"Novo Nordisk Pharma Ltd., Tokyo, Japan.",Not available
39665415,Discovery of VU6024578/BI02982816: An mGlu(1) Positive Allosteric Modulator with Efficacy in Preclinical Antipsychotic and Cognition Models.,2024-12-26,Boutaud O; Voehringer P; Rook JM; Priepke H,"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach 88397, Germany.",Not available
39665388,Antibody-mediated degradation of 4R-tau restores mitochondrial membrane polarization in human induced pluripotent stem cell-derived neurons with the MAPT 10+16 mutation.,2024-01-01,Starkie DO; Baker T; Lightwood DJ,"Antibody Discovery and Optimization, UCB Pharma, Slough, Berkshire, UK.",Not available
39665068,High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience.,2024-01-01,Rodriguez-Otero P; Calasanz MJ; San Miguel JF,"Department of Hematology, Cancer Center Clinica Universidad de Navarra, CCUN, Centro de Investigacion Medica Aplicadas (Cima); Instituto de Investigacion Sanitaria de Navarra (IDISNA) CIBERONC Pamplona Spain.",Not available
39664231,"Efficacy and safety of prucalopride in patients with chronic idiopathic constipation stratified by age, body mass index, and renal function: a post hoc analysis of phase III and IV, randomized, placebo-controlled clinical studies.",2024-01-01,Boules M; Youssef A; Terreri B,"Takeda Pharmaceuticals USA, Inc., Cambridge, MA, USA.; Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA.",Not available
39663924,End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2).,2024-12-12,Gimpelewicz C,"Novartis Pharma, Basel, Switzerland.",Not available
39663755,Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study).,2024-01-01,Harxhi A; Kaul S; Michaud E; Juan S; Woods B; Damaraju CV,"Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, New Jersey, USA.; Johnson & Johnson Technology Solutions, Raritan, New Jersey, USA.",Not available
39663702,Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages.,2025-01-08,Tomita K; Yamashita M; Shimizu Y; Amino N,"Immuno-Oncology, Astellas Pharma Inc., Tsukuba, Japan.",Not available
39663448,Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.,2024-12-11,de Velasco G; Esteban-Villarrubia J; Sabat P; Hess D; Richly H; Hackl H; Ruschoff J; Tereshchenko A; L'Huillier P; Dutta A; Haake M; Gjorgjioska A,"Centro de Investigacion Biomedica en Red en Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain.; Discovery Life Sciences Biomarker Services, Kassel, Germany.; KinDyn Consulting, Warnham, UK.; LYO-X AG, Basel, Switzerland.; START Madrid-CIOCC, Centro Integral Oncologico Clara Campal, Madrid, Spain.; da Silva Consulting Services, Munich, Germany.","Clinica Universidad de Navarra, CIMA, IDISNA and CIBERONC, Pamplona, Spain. imelero@unav.es."
39663398,Retinal fluid quantification using a novel deep learning algorithm in patients treated with faricimab in the TRUCKEE study.,2024-12-11,Khanani I; Khanani ZA; Khan H; Gahn GM; Abbey AM; Barakat MR; Corradetti G; Sheth VS,"Erie Retinal Surgery, Erie, PA, USA.; Notal Vision, Manassas, VA, USA.; Sierra Eye Associates, Reno, NV, USA.; Southwest Eye Consultants, Durango, CO, USA.; Texas Retina Associates, Dallas, TX, USA.",Not available
39663168,Incidence and prevalence of antiphospholipid syndrome (APS) in the USA (2016-2019): a retrospective database study.,2024-12-11,Meisner P; Zaremba P; Scowcroft A,"Life Sciences, Planet Pharma, London, UK.; Real World Data Analytics Team, UCB, Warsaw, Poland.; Translational Medicine Immunology and Oncology, UCB, Slough, UK.",Not available
39662872,A novel automated chemiluminescent enzyme immunoassay for ADAMTS-13 activity enables accompanying measurements of the inhibitory autoantibodies.,2024-12-09,Konko K; Kinoshita E; Uemae S; Kobayashi K,"Hemostasis Business Development, ICH Business, Sysmex Corporation, Kobe, Japan.; Protein Technology Group, Reagent Engineering, Sysmex Corporation, Kobe, Japan.",Not available
39662705,Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta.,2024-12-09,Heil M,"Roche Molecular Diagnostics, Pleasanton, California, USA.",Not available
39662665,Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakes.,2024-12-09,Felter SP; Glowienke S; Nudelman R,"Novartis Pharma AG, Lichtstrasse 35, CH-4056, Basel, Switzerland.; Nudelman ChemTox Consulting, Rehovot, 7628422, Israel.; Procter and Gamble, Central Product Safety, 8700 Mason-Montgomery Rd, Mason, OH, USA.","Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, United Kingdom. Electronic address: david.ponting@lhasalimited.org."
39662152,Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab.,2024-11-15,Shih V; Wright P; Hepp Z; Willmon CL; Chang NN; Mucha L,"Astellas Pharma Inc., Northbrook, IL.; Pfizer Inc., Bothell, WA.","Dana-Farber Cancer Institute, Boston, MA. Electronic address: aliciak_morgans@dfci.harvard.edu."
39661913,Comparative Analysis of Generative Pre-Trained Transformer Models in Oncogene-Driven Non-Small Cell Lung Cancer: Introducing the Generative Artificial Intelligence Performance Score.,2024-01-01,Bun C,"Kirkland & Ellis, Chicago, IL.",Not available
39661618,Evaluation of the cervical liquid-based cytology sample as a microbiome resource for dual diagnosis.,2024-01-01,Jung ES; Lee S,"HEM Pharma Inc., Suwon, Gyeonggi, Republic of Korea.",Not available
39661380,"Therapeutic Effect of Evenamide, a Glutamate Inhibitor, in Patients With Treatment-Resistant Schizophrenia (TRS): Final, 1-Year Results From a Phase 2, Open-Label, Rater-Blinded, Randomized, International Clinical Trial.",2024-12-28,Anand R; Turolla A; Chinellato G; Hartman RD,"Anand Pharma Consulting AG (APC AG), St. Moritz, Switzerland.; NeurWrite LLC, Morristown, NJ, USA.; Newron Pharmaceuticals SpA, Bresso, Italy.",Not available
39660328,Evidence-based guideline: premature ovarian insufficiency().,2024-01-01,Mousa A,"Faculte de Medecine, Hopital Bicetre, Universite Paris Saclay, Le Kremlin Bicetre, France.",Not available
39659876,Bio-Interventional Cyclodialysis and Allograft Scleral Reinforcement for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients: One-Year Clinical Outcomes.,2024-01-01,Lewis J,"Cataract Philadelphia, Elkins Park, PA, USA.",Not available
39659738,On-treatment clinical remission of severe asthma with real-world longer-term biologic use.,2025-01-01,Zhou W,"ClinChoice, Inc, Fort Washington, Pa.",Not available
39659648,Hurley Staging Training for Hidradenitis Suppurativa Patients.,2024-01-01,Brooks B; Fixsen D,"HS Connect, Puyallup, WA, USA.",Not available
39659632,Identification of Physician Concerns Regarding Implementation of the Nagasaki Acute Myocardial Infarction Secondary Prevention Clinical Pathway.,2024-12-10,Yamanaka Y; Uda A; Mori K,"HEOR Group, Value and Access Division, Novartis Pharma K.K. Tokyo Japan.",Not available
39659160,"Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial.",2024-12-11,Kypriotakis G; Cinciripini PM; Green CE; Lawrence D; Anthenelli RM; Minnix JA; Beneventi D; Morris C; Karam-Hage M; Blalock JA,"Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston (Kypriotakis, Cinciripini, Minnix, Beneventi, Karam-Hage, Blalock); Department of Pediatrics, University of Texas Medical School at Houston (Green); Department of Psychiatry, University of California, San Diego, La Jolla (Anthenelli); Department of Psychiatry, University of Colorado, Aurora (Morris).; Pfizer Inc., New York (Lawrence)",Not available
39658869,International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of Nonrodent Ocular Tissues.,2024-01-01,Schafer KA; Bach U; Bartoe J; Brassard J; Farman C; Kochi M; Nolte T; Ramos M; Short B; Sorden S; Walling B; Yekkala K,"Abbvie, Irvine, California, USA.; Bayer AG, Wuppertal, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Brassard Toxicologic Pathology Consultancy, Tustin, California, USA.; Brian Short Consulting, LLC, Laguna Beach, California, USA.; Charles River Laboratories, Ashland, Ohio, USA.; Greenfield Pathology Services, Inc., Greenfield, Indiana, USA.; Horus Consulting, LLC, Spring Lake, Michigan, USA.; Johnson & Johnson Innovative Medicine, Springhouse, Pennsylvania, USA.; Labcorp, Madison, Wisconsin, USA.; Sumitomo Pharma Co., Ltd., Osaka, Japan.",Not available
39658517,Discovery of Novel Thiophene-Based Baloxavir Derivatives as Potent Cap-Dependent Endonuclease Inhibitors for Influenza Treatment.,2024-12-26,Li G,"Shenzhen AntiV Pharma Co., Ltd., Shenzhen, Guangdong 518081, China.",Not available
39657795,An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary.,2024-12-10,Berti S; Hindricks G,"Cardioangiologisches Centrum Bethanien, Agaplesion Markus Krankenhaus, Frankfurt, Germany.; Ospedale del Cuore, Fondazione CNR Regione Toscana G. Monasterio, Pisa, Italy.",Not available
39657580,Ulcerative Colitis Severity Classification and Localised Extent (UC-SCALE): An Artificial Intelligence scoring system for a spatial assessment of disease severity in Ulcerative Colitis.,2024-12-07,Machura B; Czornik J; Goslinsky J; Pitura M,"Graylight Imaging, Gliwice, Poland.",Not available
39655453,Females With Axial Spondyloarthritis Have Longer Diagnostic Delay and Higher Burden of the Disease. Results From the International Map of Axial Spondyloarthritis (IMAS).,2024-01-01,Akerkar S,"Cyprus League for People With Rheumatism (CYLPER), Nicosia, Cyprus.",Not available
39655068,Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma.,2024-01-01,Ferrando-Diez A,"CIBER en Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain.",Not available
39655038,Accelerating evidence generation: Addressing critical challenges and charting a path forward.,2024-01-01,Krofah E; Locke T; Abbasi A; Weber W; Wang T; Hernandez AF,"Food and Drug Administration, Silver Spring, MD, USA.; MITRE, Bedford, MA, USA.; Vir Biotechnology, San Francisco, CA, USA.; Wittes LLC, Washington, DC, USA.",Not available
39654831,Association of Prior Antithrombotic Drug Use with 90-Day Mortality After Intracerebral Hemorrhage.,2024-01-01,Gaist D,"Centro Espanol Investigacion Farmacoepidemiologica, Madrid, Spain.",Not available
39654701,Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.,2024-12-07,Heier JS; Liu Y; Astafurov K; Blinder KJ; Chica MA; Elman MJ; Fein JG; Hahn P; London N; Margolis T; Modi YS; Stoller GL; Wang JC; Shah AR,"Elman Retina Group P.A., Rosedale, MD, USA.; Monmouth Retina Consultants, Belleville, NJ, USA.; NJ Retina, Belleville, NJ, USA.; Northern California Retina Vitreous Associates, Mountain View, CA, USA.; Ophthalmic Consultants of Boston, Boston, MA, USA.; Ophthalmic Consultants of Long Island, Long Island, NY, USA.; Retina Associates of Kentucky, Lexington, KY, USA.; Retina Consultants San Diego, Poway, CA, USA.; Retina Consultants of Texas, San Antonio, TX, USA.; Retina Group of Washington, Washington, DC, USA.; Retinal and Ophthalmic Consultants, Northfield, NJ, USA.; Tennessee Retina, Nashville, TN, USA.",Not available
39654541,Medical Education: Considerations for a Successful Integration of Learning with and Learning about AI.,2024-01-01,Domros-Zoungrana D; Rajaeean N; Boie S; Froling E; Lenz C,"Pfizer Pharma GmbH, Berlin, Germany.",Not available
39654382,A minimal physiologically-based pharmacokinetic modeling platform to predict intratumor exposure and receptor occupancy of an anti-LAG-3 monoclonal antibody.,2024-12-09,Michelet R; Petersson K; Perez-Pitarch A; Busse D,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; qPharmetra LLC, Berlin, Germany.; qPharmetra LLC, Stockholm, Sweden.",Not available
39654366,Understanding the current provisions of support for people with an intellectual disabilities and/or autism in crisis: A mixed methods study.,2024-12-09,Staples C; Edwards S,"Expert by Experience (Independent), Coventry, UK.; Statsconsultancy Ltd., Bucks, UK.",Not available
39654063,A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer.,2024-01-01,Popa A; Kasturirangan S,"Boehringer Ingelheim Pharmaceuticals, Inc., Biotherapeutics Discovery, Ridgefield, CT, USA.; Global Computational Biology and Digital Sciences, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.",Not available
39653802,The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).,2024-12-10,Gillard P,"Breakthrough T1D (formerly JDRF), New York, NY, USA.","Department of Exercise Physiology and Metabolism (Sportsmedicine), University of Bayreuth, Bayreuth, Germany. othmar.moser@uni-bayreuth.de."
39653749,Neuroinflammation in Alzheimer disease.,2024-12-09,Stein TD,"Instituto de Neurociencias, Universidad Miguel Hernandez-Consejo Superior de Investigaciones Cientificas (UMH-CSIC), Alicante, Spain.","Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette/Belvaux, Luxembourg. michael.heneka@uni.lu."
39653319,Subretinal Gene Therapy for Treatment of Retinal and Choroidal Vascular Diseases.,2024-12-07,Khanani AM; Aziz AA; Khanani ZA; Khan H; Mojumder O; Sulahria H; Khanani I; Khan H; Gahn GM; Mishra K,"Duke University; Durham, NC, USA.; Irvine, CA, USA.; Reno, NV, USA; Reno, NV, USA.; Sierra Eye Associates; University of California, Irvine Gavin Herbert Eye Institute; University of Nevada, Reno; University of Nevada, Reno, School of Medicine","Reno, NV, USA. Electronic address: arshad.khanani@gmail.com."
39653295,Clinically relevant cell culture model of inflammatory bowel diseases for identification of new therapeutic approaches.,2025-01-25,Antoine T; Beduneau A; Chretien C; Cornu R; Bonnefoy F; Moulari B; Perruche S,"MED'INN'Pharma, F-25000 Besancon, France.; Universite de Franche-Comte, EFS, INSERM, UMR RIGHT, LabEx LipSTIC (ANR-11- LABX-0021), F-25000 Besancon, France; Universite de Franche-Comte, EFS, INSERM, UMR RIGHT, LabEx LipSTIC (ANR-11- LABX-0021), F-25000 Besancon, France.",Not available
39653044,"Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.",2025-01-01,Molfino NA; Almqvist G; Kotalik A; Hellqvist A; Golabek M; Sindhwani NS,"Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Global Development, Amgen, Thousand Oaks, CA, USA.; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA.; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Latestage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland.",Not available
39652796,"Guanidine Derivative ADS1017, a Potent Histamine H(3) Receptor Antagonist with Promising Analgesic Activity and Satisfactory Safety Profile.",2024-12-18,Calmels T,"Bioprojet-Biotech, 4rue du Chesnay Beauregard, Saint-Gregoire Cedex 35762, France.",Not available
39652349,Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer.,2024-12-02,Emir B; Russell D; Hong A; Ramaswamy K,"Pfizer Inc, New York, New York.",Not available
39652156,Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1.,2024-12-09,Kawasaki A; Sato J; Teshima T,"Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.","Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan. hidekigt@med.hokudai.ac.jp."
39652037,Evidence-based guideline: Premature Ovarian Insufficiency.,2024-12-06,Misrahi M,"Universite Paris Saclay, Faculte de Medecine, Hopital Bicetre, Le Kremlin Bicetre, France.","Queen Charlotte's and Chelsea Hospital, Imperial College London, UK. Electronic address: nickpanay@msn.com."
39651850,"Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.",2024-12-09,Gronnebaek TS; Jensen KG; Chin E; Quiroz JA; Petersen TK; Flagstad P; de Kam ML; van Esdonk MJ,"NMD Pharma A/S, Aarhus N, Denmark.",Not available
39651464,Defining methods to improve eSource site start-up practices.,2024-01-01,Cramer AE; King LS; Casteleyn P; Vattikola A,"Astellas Pharma, Northbrook, IL, USA.; Johnson & Johnson Innovative Medicine, Beerse, BE, USA.; Johnson & Johnson Innovative Medicine, Titusville, NJ, USA.; Merck & Co., Inc., Rahway, NJ, USA.",Not available
39649165,Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining.,2024-11-26,Moura IMR,Universidade de Sao Paulo.,Not available
39649038,Plain Language Summary of Publication: Does crushing vibegron 75 mg tablet affect its safety or the amount of vibegron in the body over time in healthy adults?,2024-01-01,King J; Owens-Grillo J,"Sumitomo Pharma America, Inc, Marlborough, MA, USA.",Not available
39648942,Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real-World Setting in Japan.,2024-01-01,Sugiyama N; Hoshi M; Jo JY; Hirano T,"Pfizer Japan Inc, Tokyo, Japan.; Pfizer Pharmaceuticals Korea Ltd, Seoul, South Korea.",Not available
39648195,A Retrospective Claims Data Analysis on the Burden of COVID-19-Related Hospitalization in Adults at High Risk for Severe Disease Progression in Germany.,2024-12-08,Schnaidt S; Bihrer N; Froling E; Jacob C; Kisser A,"Pfizer Pharma GmbH, Berlin, Germany.; Xcenda GmbH, Part of Cencora Inc., Lange Laube 31, 30159, Hannover, Germany.","Xcenda GmbH, Part of Cencora Inc., Lange Laube 31, 30159, Hannover, Germany. timotheus.stremel@cencora.com."
39648106,"Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase3 study with an open-label extension period in Brazil.",2024-12-07,Souza CDS; Antonio JR; Kalabic J,"AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.; Discipline of Dermatology, Faculdade Estadual de Medicina de Sao Jose do Rio Preto, Sao Jose do Rio Preto, SP, Brazil.; Division of Dermatology, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.","Department of Dermatology, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: tcestari@hcpa.edu.br."
39647958,Astragalus polysaccharide/carboxymethyl chitosan/sodium alginate based electroconductive hydrogels for diabetic wound healing and muscle function assessment.,2025-02-15,Vairo C; Lafuente EG,"Biosasun S.A., Ctra. Allo-Arroniz Km1, Navarra 31263, Spain.",Not available
39647502,International consensus statement on microbiome testing in clinical practice.,2024-12-05,Guarner F,"Centro Medico Teknon, Barcelona, Spain.",Not available
39647216,"An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study.",2025-01-17,Gandini S; Altuna SC; Girardi F,"Experimental Oncology, IRCCS IEO, Italy.; Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.; Oncomedica C.A, Caracas, Venezuela.",Not available
39645514,Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis.,2024-01-01,Navarro-Gonzalez JF; Cebrian Cuenca A; Pimentel B; Pomares Mallol E; Caudron C,"Departamento Medico, AstraZeneca, Madrid, Spain.; Departamento de Acceso al Mercado, PharmaLex Spain, Barcelona, Spain.; Facultad de Ciencias de la Salud, Universidad Pernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain.; Grupo de Atencion Primaria, Instituto Murciano de Investigacion Biosanitaria (IMIB), Murcia, Spain.; Instituto de Tecnologias Biomedicas, Universidad de La Laguna, Tenerife, Spain; Medicina Familiar y Comunitaria, Centro de Salud Cartagena Casco Antiguo, Cartagena, Murcia, Spain; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, Madrid, Spain; Unidad de Investigacion y Servicio de Nefrologia, Hospital Universitario Ntra. Sra. de Candelaria, Tenerife, Spain",Not available
39645511,"Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology.",2024-01-01,Ortiz A,"Red de Investigacion Cooperativa Orientada a Resultados en Salud b0d0 (RICORSb0d0), Madrid, Spain.; Servicio de Nefrologia e Hipertension, Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (iiS-FJD), Madrid, Spain; Universidad Autonoma de Madrid, Madrid, Spain",Not available
39645042,A genome-wide association meta-analysis links hidradenitis suppurativa to common and rare sequence variants causing disruption of the Notch and Wnt/beta-catenin signaling pathways.,2024-12-05,Stefansdottir L; Halldorsson G; Ferkingstad E; Oddsson A; Walters B; Olafsdottir TA; Rutsdottir G; Ullum H; Saemundsdottir J; Melsted P; Norddahl GL; Sulem P; Stefansson H; Holm H; Gudbjartsson D; Thorleifsson G; Jonsdottir I; Stefansson K,"Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.; Statens Serum Institut, Copenhagen, Denmark.; deCODE Genetics/Amgen, Inc, Reykjavik, Iceland; deCODE Genetics/Amgen, Inc, Reykjavik, Iceland.","Department of Immunology and Microbiology, Leo Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark. Electronic address: rune.andersen@sund.ku.dk."
39644770,"Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis.",2024-12-06,Hernandez G,"Biomedical Informatics Group, Artificial Intelligence Department, E.T.S.I. Informaticos, Universidad Politecnica de Madrid, Spain.; TriNetX, LLC, Cambridge, MA, USA",Not available
39643906,Is the use of antibiotic stewardship measures in the context of specialized outpatient palliative care sensible and feasible? An interview-based study.,2024-12-07,Schmidt J; Hitzenbichler F,"MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany.","Clinic and Polyclinic for Internal Medicine III, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. ulrich.kaiser@ukr.de."
39643843,Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.,2024-12-06,Corbo L; Morana D; Menichetti F,"Italian Group for Antimicrobial Stewardship (GISA), Pisa, Italy.; Medicina Interna MIAMA, Ospedale S. Maria della Misericordia, Perugia, Italy.; Medicina per la complessita assistenziale 1 AOU Careggi, Florence, Italy.",Not available
39643613,Immunotherapy for hormone receptorpositive HER2-negative breast cancer.,2024-12-06,Hirshfield KM; Kraynyak KA; Tryfonidis K,"Merck & Co., Inc., Rahway, NJ, USA.","Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. fatimacardoso@fundacaochampalimaud.pt."
39643074,Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results: Subretinal Gene Therapy AGTC-501 for XLRP Ph 1/2 24M Results.,2024-12-04,Anand R; Yaghy A; Scaria A; Jung J; Curtiss D; Waheed NK,"Astellas Pharma US, Inc., Northbrook, Illinois, USA; Astellas Pharma US, Inc., Northbrook, Illinois, USA.; Texas Retina Associates, Dallas, TX, USA.",Not available
39642931,Supervised Automated Kinetic Perimetry (SAKP) Using Simulated Visual Field Data - Presentation of a New Examination Technique.,2024-12-06,Zobor D,"Blickshift GmbH, Stuttgart, Deutschland.",Not available
39642873,The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.,2024-12-17,Martinon-Torres F; Aerssen J,"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Genetics, Vaccines, and Infectious Diseases Research Group (GENvip, www.genvip.eu), Instituto de Investigacion Sanitaria de Santiago, Universidad de Santiago de Compostela, Galicia, Spain; Janssen Pharmaceutica, Beerse, Belgium.; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.",Not available
39642325,Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response.,2024-01-01,Lander EM; Aushev VN; Dutta P; Ferguson J; Sharma S; Jurdi A; Liu MC,"Minnesota Oncology Hematology PA, Minneapolis, MN.; Natera, Inc, Austin, TX.",Not available
39642282,"Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study.",2024-12-01,Bogin V; Grishin SA; Egorova AN; Ponomar EG; Lavrovsky Y; Samsonov MY,"Cromos Pharma, LLC, Portland, OR.; Moscow, Russia; R-Pharm JSC, Medical Department; R-Pharm Overseas Inc, La Jolla, CA.; and.",Not available
39641779,"Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors.",2024-12-26,Palisse A; Blokhuis A; Cogswell T; Martins BS; Riemens R; Schellekens R; Battocchio G; Jansen C; Cottee MA; Sacchetto C; van Hoek-Emmelot M; Bostock M; Lucas SCC; Ahmed S; Blackwell JH; Borjesson U; Gohlke A; Hargreaves D; van Hoeven V; Kantae V; Kupcova L; Milbradt AG; Vales J; Kinzel O,"Bioscience, Oncology, R&D, Acerta B.V., A member of the AstraZeneca Group, Oss 5349 AB, The Netherlands.; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden.; Mechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.; Medicinal Chemistry, Oncology, R&D, Acerta Pharma B.V., A member of the AstraZeneca Group, Oss 5349 AB, The Netherlands.",Not available
39641738,The Coming AI Revolution in Clinical Trials.,2024-11-23,Harrington RA,"Weill Cornell Medicine, New York, New York, USA.","Stanford Center for Clinical Research, Stanford University, Stanford, California, USA. Electronic address: snehashahjain@stanford.edu."
39641724,Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction.,2024-10-30,Schampaert E,"Hopital du Sacre-Coeur de Montreal, Universite de Montreal, Montreal, Quebec, Canada.",Not available
39641537,Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer.,2025-01-01,Fabbro M; Hartman J; Booth DV,"GSK, Durham, NC 27709, USA.; GSK, Philadelphia, PA 19112, USA.; Institut Regional du Cancer de Montpellier, Montpellier, and GINECO, Paris, 34298, France.",Not available
39641521,Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onset.,2025-01-01,Callegaro S; Grassano M,"SC Neurologia 1U, AOU Citta della Salute e della Scienza di Torino, Turin, Italy.",Not available
39641354,Geographical variation in lung function: Results from the multicentric cross-sectional BOLD study.,2025-12-31,Paraguas SNM,"Instituto de Saude Ambiental, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.",Not available
39641309,Cost-utility analysis of newborn screening for spinal muscular atrophy in Japan.,2025-01-01,Uda A; Tanaka S; Toro W; Bischof M,"Novartis Gene Therapies Switzerland GmbH, Rotkreuz, Switzerland.; Novartis Gene Therapies, Inc, Bannockburn, IL, USA.; Novartis Pharma K.K, Tokyo, Japan.",Not available
39640933,"In response to: ""Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee"" by Greco et al.",2024-01-01,Miljkovic MD,"Cartesian Therapeutics, Gaithersburg, MD, USA.",Not available
39639369,Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment.,2024-12-05,Kim S; Gregory M; Mule J,"NanoString, Seattle, WA, 98109, USA.",Not available
39639015,Attenuation of skin injury by a MARCO targeting PLGA nanoparticle.,2024-12-06,Beddow S,"Cour Pharmaceutical Development Company, Northbrook, IL, USA.",Not available
39638723,Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized Study.,2024-12-04,Moser B; Xu W; Jackson K; Witcher J,"Eli Lilly and Company, Indianapolis, Indiana.","Eli Lilly and Company, Indianapolis, Indiana. Electronic address: datta_amita@lilly.com."
39638038,Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation.,2024-12-03,Sagi H; Kaneko A; Aoyagi K,"Advanced Life Science Institute, Inc., Hachioji, Tokyo, Japan.; Fujirebio Inc., Hachioji, Tokyo, Japan; Fujirebio Inc., Hachioji, Tokyo, Japan.",Not available
39637925,The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.,2024-12-06,Llorca PM; de Haan L,"Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de Sao Paulo, Avenida Doutor Arnaldo 455, CEP 01246-903 Sao Paulo, Brasil.; Nucleo de Pesquina em Saude Mental Populacional, Universidade de Sao Paulo, Avenida Doutor Arnaldo 455, CEP 01246-903 Sao Paulo, Brasil.",Not available
39637881,"Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.",2024-12-02,Genovese MC; Kwon P; Santermans E; Le Brun FO; Barron R; Masior T,"Galapagos NV, Mechelen, Belgium.; Galapagos, Basel, Switzerland.; Gilead Sciences, Foster City, CA, USA.",Not available
39636838,"Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.",2024-01-01,Diacon AH,"PHOENIX Pharma, Port Elizabeth, South Africa.",Not available
39636474,"Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administration.",2024-12-05,Becker S; Fatkenheuer G,"Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 06877, USA.; Gilead, Foster City, CA, 94404, USA.","Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA. sree.kurup@boehringer-ingelheim.com."
39635338,Association Between the Development of Sensorineural Hearing Loss and Blood NAD(+) Levels.,2024-01-01,Kanzaki S,"NOMON Co. Ltd, Kasumigaseki, Chiyoda Ku, Tokyo, Japan.",Not available
39632823,Correction: Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study.,2024-12-04,Wunder A; Weigand A,"SBGneuro Ltd, Oxford, UK.","Medical School Berlin, Berlin, Germany. marvin.meiering@medicalschool-berlin.de."
39632341,Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms.,2025-01-01,Kubota N; Moline M; Malhotra M; Pinner K; Yardley J,"Eisai Co., Ltd., Tokyo, Japan.; Eisai Inc., Nutley, New Jersey, USA.; Eisai Ltd., Hatfield, UK.",Not available
39632193,Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project.,2024-01-01,Navarro Gonzalez JF; Cebrian Cuenca A; Moreno Baron M; Segu L; Pimentel B; Pomares Mallol E; Caudron C,"Acceso al Mercado, PharmaLex Spain, Barcelona, Spain.; Asociacion para la Lucha Contra las Enfermedades Renales (ALCER), Almeria, Spain.; Grupo de Atencion Primaria del Instituto Murciano de Investigacion Biosanitaria (IMIB), Murcia, Spain.; Instituto de Tecnologias Biomedicas, Universidad de La Laguna, Tenerife, Spain; Medicina Familiar y Comunitaria, Centro de Salud Cartagena Casco Antiguo, Cartagena, Spain; Medico, AstraZeneca, Madrid, Spain.; RICORS2040 (Kidney Disease), Instituto de Salud Carlos III, Madrid, Spain; Unidad de Farmacia Clinica y Farmacoterapia, Facultad de Farmacia, Universidad de Barcelona (UB), Barcelona, Spain; Unidad de Investigacion y Servicio de Nefrologia, Hospital Universitario Nuestra Senora de Candelaria, Tenerife, Spain; Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain.",Not available
39632100,Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study.,2024-12-04,Louw S; McCloud P,"McCloud Consulting Group, Sydney, New South Wales, Australia.",Not available
39631753,Leitlinie der Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) zur Struktur- und Prozessqualitat von Hamophilie-Zentren.,2024-12-04,Eichler H; Albisetti M,"Institut fur Klinische Hamostaseologie und Transfusionsmedizin, Universitat und Universitatsklinikum des Saarlandes, Homburg/Saar, Germany.; Medizinische Poliklinik und Tagesklinik, Universitats-Kinderspital Zurich, Zurich, Switzerland.",Not available
39631193,Contemporary assessment of short- and functional 90-days outcome in old intensive care patients suffering from COVID-19.,2024-12-03,Moreno R,"Faculdade de Ciencias da Saude, Uniuversidade da Beira Interior, Covilha, Portugal.; Hospital de Sao Jose, Unidade Local de Saude Sao Jose, Centro Clinico Academico de Lisboa (CCAL), Lisboa, Portugal",Not available
39631175,The role of childhood maltreatment and mental health disorders on suicidal behaviour in adolescents.,2025-01-01,Gomez-Vallejo S; Diaz-Marsa M; Bobes-Bascaran T; Cebria AI; Crespo Facorro B; Garrido-Torres N; Jimenez-Tevino L; Lara E; Palao DJ; Perez V; Ruiz-Veguilla M; Saiz PA; Sanchez-Carro Y; de la Torre-Luque A; Vieta E; Roberto N; Grande I; Bobes J; Lazaro L; Bracco L; Corbalan F; Fares N,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Spain.; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Institut de Neurociencies, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain; Department of Child and Adolescent Psychiatry and Psychology, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Clinical and Health Psychology, Faculty of Psychology, Universitat Autonoma de Barcelona, 08193 Cerdanyola del Valles, Spain.; Department of Legal Medicine, Psychiatry and Pathology. School of Medicine, Universidad Complutense de Madrid, Madrid, Spain; Department of Legal Medicine, Psychiatry and Pathology. School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Department of Psychiatry and Forensic Medicine, Faculty of Medicine, Universitat Autonoma de Barcelona, 08193 Cerdanyola del Valles, Spain.; Department of Psychiatry, Universidad Autonoma de Madrid (UAM), Madrid, Spain.; Department of Psychology, Faculty of Psychology, Universidad Complutense de Madrid, Spain.; Department of Psychology, Universidad de Oviedo, Oviedo, Spain; Hospital Clinico San Carlos, Madrid, Spain.; Hospital Virgen del Rocio de Sevilla, Sevilla, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain; Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Instituto de Salud Mental, Hospital del Mar, Hospital del Mar Research Institute, IMIM, Barcelona, Spain.; Mental Health Service, Hospital Universitari Parc Tauli, Sabadell, Barcelona, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.; Unitat Mixta de Neurociencia Traslacional I3PT-INc-UAB, 08208 Sabadell, Barcelona, Spain",Not available
39630604,"Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers.",2024-12-26,Ding Y; Fang C; Li M; Lv X,"ChemPartner Corporation, Shanghai 201203, China.",Not available
39630427,Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.,2024-12-04,Bloomston M; Lee RT; Sundaresan TK,"City of Hope, Orange County, California.; Kaiser Permanente, San Francisco, California.; South Florida Surgical Oncology, Fort Myers.",Not available
39630385,Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry.,2024-12-04,Hajek P,"CEEOR S.R.O., Prague, Czech Republic.",Not available
39630157,Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).,2025-01-01,Brown C,"Astellas Pharma, Northbrook, IL.; National PKU Alliance, Washington, DC",Not available
39630115,Robuvit(R) supplementation reduces progression of non-alcoholic fatty liver disease in elderly subjects.,2024-12-04,Cesarone MR; Belcaro G; Cox D; Gizzi G; Pellegrini L; Scipione C; Scipione V; Coppazuccari F; Dugall M; Hu S; Orsini L; Corsi M,"Irvine3 Labs &amp; San Valentino Vascular Screening Project and IA-PSS (International Agency for Pharma-Standard Supplements) Pescara, Italy.",Not available
39630083,"Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study.",2024-12-04,Dunbar M,"Biostatistics, Alkermes, Inc, Waltham, Massachusetts.",Not available
39629079,Identifying and overcoming challenges in the EMA's qualification of novel methodologies: a two-year review.,2024-01-01,Vetter T; Ehmann F,"European Medicines Agency, Amsterdam, Netherlands.",Not available
39627568,BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-beta signaling.,2024-12-03,Ikeya M,"Takeda-CiRA Joint Program, Fujisawa, Kanagawa, Japan.","Laboratory of Skeletal Development and Regeneration, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China. chengzhu.zhao@cqmu.edu.cn."
39627502,Synthetic lethal strategies for the development of cancer therapeutics.,2025-01-01,Nardo M,"Repare Therapeutics, Inc., Montreal, Quebec, Canada.",Not available
39627164,Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS-3 Trial.,2024-01-01,Diaz I,"Novartis Pharma AG, Basel, Switzerland.",Not available
39627155,A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial.,2024-12-03,Ganslandt C; Shull JG; Bengtsson T; Ganslandt J,"Vicore Pharma, Stockholm, Sweden.",Not available
39626832,MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS.,2024-12-01,Shor N; Cohen M; Kremer S,"CRC-SEP, Neurologie Pasteur 2, CHU de Nice, Nice, France; Engineering Science, Computer Science and Imaging Laboratory (ICube), Integrative Multimodal Imaging in Healthcare, UMR 7357, University of Strasbourg-CNRS, Strasbourg, France.; Service d'imagerie 2, Hopital de Hautepierre, Hopitaux Universitaires de Strasbourg, Strasbourg, France; Service de Neuroradiologie, Hopital de la Pitie-Salpetriere, AP-HP, Paris, France.; Universite Cote d'Azur, UMR2CA (URRIS), Nice, France.","Creatis LRMN, CNRS UMR 5220, Universite Claude Bernard Lyon 1, INSERM U630, Lyon, France. Electronic address: francoise.durand-dubief@chu-lyon.fr."
39626570,"Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia.",2024-12-02,Koyanagi A,"ICREA, Pg. Lluis Companys 23, Barcelona 08010, Spain.; Research and Development Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, ISCIII, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat 08830, Barcelona, Spain","Department of Child and Adolescent Psychiatry, Charite Universitatsmedizin, Berlin, Germany. Electronic address: msolmi@toh.ca."
39626377,"OM-85 attenuates high-fat diet-induced obesity, insulin resistance, gut dysbiosis and nonalcoholic steatohepatitis in a murine model.",2024-01-01,Manuel CR; Koya J,"Meso Scale Diagnostics, Rockville, MD, USA.; Sanofi, Ridgefield, NJ, USA.",Not available
39624955,"Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis.",2025-01-01,Reyes-Leiva D; Carbayo A; Rojas-Garcia R; Querol L; Pla-Junca F; Olive M; Pujades-Rodriguez M; Cortes-Vicente E,"Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, Valencia, Spain.; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; and Institut de Recerca Sant Pau, IR-SantPau, Barcelona, Spain.",Not available
39624750,"Gender differences in melanoma awareness, diagnosis and treatment: Patient-reported data from a multicentre survey in Switzerland.",2024-01-01,Pasche N; Siegenthaler B; Dummer R; Del Prete V,Novartis Pharma Schweiz AG Risch-Rotkreuz Switzerland.,Not available
39624731,Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years.,2024-01-01,Butler K; Rosmarin D,Incyte Corporation Wilmington Delaware USA.,Not available
39624651,The Association Between Patient-Reported Disease Burden and Treatment Switching in Patients with Plaque Psoriasis Treated with Nonbiologic Systemic Therapy.,2024-01-01,Patel V; Park SH; Zhong Y; Sima AP; Zhuo J; Roberts-Toler C; Becker B; Hovland S,"Bristol Myers Squibb, Princeton, NJ, USA.; CorEvitas, LLC, Waltham, MA, USA.",Not available
39624387,Acute exacerbations in patients with progressive pulmonary fibrosis.,2024-01-01,Rohr KB,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.",Not available
39624360,Editorial: Pain Medicine Training in Latin America.,2024-01-01,Rojas-Gareca W; Carcamo-Quezada CR; Godinez Ortiz L,"Aliviar: Centro Especializado en Dolor, Santa Cruz, Bolivia.; Centro Integral Para Manejo Del Dolor. Instituto Salvadoreno de Bienestar Magisterial, San Salvador, El Salvador.; Centro Medico Villegas, Buenos Aires, Argentina.",Not available
39623757,Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry.,2024-01-01,Knapp KD; Claxton A; Munoz B; Crawford JM; Balu S; Kim Y; Schneider S; Bagel J,"LEO Pharma New Jersey, Madison, NJ, USA.; Target RWE, Durham, NC, USA.; Windsor Dermatology, East Windsor, NJ, USA.",Not available
39623527,"Effects of a novel GABA-B positive allosteric modulator, ASP8062, on alcohol cue-elicited craving and naturalistic alcohol consumption in a multisite randomized, double-blind, placebo-controlled trial.",2024-01-01,Scott C; Ransom J; Alsharif N; Ito M,"Astellas Pharma Global Development Inc., Northbrook, Illinois, USA.; Fast-Track Drugs & Biologics, LLC, Poolesville, Maryland, USA.",Not available
39622690,Associations Between Skin Microbiome and Metabolome in the Pathogenesis of Atopic Dermatitis Patients With Scalp Involvement.,2024-01-01,Suh DH; Lee S,"HEM Pharma Inc., Suwon, Korea.",Not available
39622572,"SPOON: an observational, cross-sectional study of perceptions and expectations of adults with generalised myasthenia gravis in France.",2024-12-02,Sacconi S; Richard A; Villy PE,"UCB France, Colombes, France.; Universite Cote d'Azur, Systeme nerveux peripherique et muscle, CHU Nice, Nice, Provence-Alpes-Cote d'Azur, France.",Not available
39622541,May Measurement Month 2022: results from the global blood pressure screening campaign.,2024-12-02,Schlaich M; Poulter N,"Khanda Ltd, London, UK.; Universidad Centro-Occidental Lisandro Alvarado, Barquisimeto, Venezuela.","Department of Primary Care and Public Health, Imperial College London, London, UK thomas.beaney@imperial.ac.uk."
39622410,"RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.",2024-11-30,Puri T; Chacko Varughese S; Frimodt-Moller B,"Eli Lilly Denmark A/S, Copenhagen, Denmark.; Eli Lilly and Company, Indianapolis, Indiana.; Statistics, Eli Lilly Services India Pvt. Ltd., Bengaluru, India.","Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka Japan. Electronic address: nakagawa@med.kindai.ac.jp."
39621492,The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?,2025-01-01,Fabbri C; Bloemendaal M; Menchetti M; Serretti A,"Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Institut de Neurociencies, Universitat de Barcelona (UB).; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.",Not available
39621200,Association between the COVID-19 pandemic and short-term outcomes after esophagectomy for esophageal cancer in facilities with and without board-certified esophageal surgeons: a nationwide retrospective cohort study.,2025-01-01,Kakeji Y; Watanabe M; Yasuda T; Mori M; Shirabe K,"Database Committee, The Japanese Society of Gastroenterological Surgery, Tokyo, Japan.; The Japan Esophageal Society, Tokyo, Japan.",Not available
39621161,"Incidence, treatment patterns, and mortality for patients with breast cancer during the first year of the COVID-19 pandemic: a population-based study.",2024-12-02,Freedman RA,"Grupo Oncologico Cooperativo del Sur, Neuquen, Argentina.","Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. JoseP_Leone@dfci.harvard.edu."
39618964,Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the open.,2024-11-29,Haberle S; Sundstrom M,"Drug Discovery Sciences, Bayer AG Berlin Germany.; Pfizer Medicine Design Cambridge MA 02139 USA.","Institute of Pharmaceutical Chemistry, Goethe University Frankfurt Frankfurt 60438 Germany knapp@pharmchem.uni-frankfurt.de."
39618509,Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary.,2024-01-01,Kreutz J,"Chugai Pharma Germany GmbH, Frankfurt am Main, Germany.",Not available
39618051,Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France.,2025-01-01,Lefort M; Berger E,"Service de Neurologie, CHU de Besancon, Besancon, France.; Univ Rennes, EHESP, CNRS, Inserm, Arenes-UMR 6051, RSMS (Recherche sur les Services et Management en Sante)-U 1309, Rennes, France.",Not available
39617898,Diagnostic flow analysis of tuberous sclerosis complex in Japan: a retrospective claims database study.,2024-12-01,Yamada M; Tajima T,"Division of Real-World Evidence, JMDC Inc., Tokyo, Japan.; Novartis Pharma K.K, 1-23-1 Toranomon, Minato-ku, Tokyo, 105-6333, Japan.",Not available
39617826,Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.,2025-01-01,Zinzani PL,"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli"", Bologna, Italy.",Not available
39617530,A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors.,2024-01-01,Bertulis J,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.","USC Norris (Keck School of Medicine) Comprehensive Cancer Center, Los Angeles, USA. Electronic address: lenz@usc.edu."
39617055,Qualification of mechanistic models in biopharmaceutical process development.,2024-11-29,Briskot T; Hiltmann D; Rischawy F; Studts J,"Late Stage DSP Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, an der Riss, 88397 Biberach, Germany.",Not available
39617017,"Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study.",2025-01-01,Williams LM; Ma A; Huang E; Ganpule A; Nagar SD; Sripakdeevong P; Cullingford EL; Karnik S; Dequeant ML; Patel JN; He XS; Li Z; He QA; Mendonez JH; Keegan A,"CRISPR Therapeutics, Boston, MA, USA.","Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: spiyer@mdanderson.org."
39616879,"Diversity, inclusivity and traceability of mammography datasets used in development of Artificial Intelligence technologies: a systematic review.",2024-11-26,Mateen B; Mackintosh M,"Genomics England Limited, London, UK; PATH, Seattle, Washington, United States; The Alan Turing Institute, London, UK.; University College London, Institute of Health Informatics, London, UK; Wellcome Trust, London, UK.",Not available
39616827,Sexual and emotional life among patients with hematological malignancy-Special concerns in low- and middle- income countries (LMICs).,2024-11-26,AlAsadi L,"INSERM, U1193, Hopital Universitaire Paul-Brousse, Centre Hepatobiliaire, Villejuif, France; Universite Paris-Saclay, Faculte de Medicine, Le Kremlin-Bicetre 94270, France.",Not available
39616778,Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort.,2024-11-26,Bayle-Bleuez S; Larive S; Lerolle U; Tomasini P; Missy P; Morin F; Westeel V,"APHM, Hopital Nord, Service d'Oncologie Multidisciplinaire & Innovations Therapeutiques, Marseille, France.; CH Les Chanaux, Service de Pneumologie, Macon, France.; CHU Saint-Etienne, Hopital Nord, Saint-Etienne, France.; Clinique Saint-Joseph, Service de Pneumologie, Trelaze, France.; Hopital Jean Minjoz, Pneumology, Besancon, France.; Intergroupe Francophone de Cancerologie Thoracique, Paris, France.","Centre Leon Berard, Department of Medical Oncology, Lyon, France. Electronic address: Aurelie.SWALDUZ@lyon.unicancer.fr."
39616467,Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.,2025-01-01,Higano C; Morris DS,"Madrona Oncology, Seattle, Washington, USA.; Urology Associates PC, Nashville, Tennessee, USA.",Not available
39616447,Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety.,2025-01-01,Hu W; Livingston RA,"Incyte Corporation, Wilmington, Delaware, USA.",Not available
39615889,Protocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA).,2024-11-29,Sellam J; Richette P,"CRSA Inserm UMRS_938, Sorbonne Universite, Paris, France.; Plateforme d'investigations technologiques, INSERM 1093 CAPS, Dijon, France.","Department of Rheumatology, Henri Mondor Hospital Rheumatology Service, Creteil, France florent.eymard@aphp.fr."
39615584,Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control tool.,2024-11-29,Coyne KS; Harding G,"Evidera Inc, Bethesda, Maryland.",Not available
39615412,Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trials.,2024-11-23,Dieleman EMT,"Amsterdam UMC- Location AMC, Radiation Oncology, Amsterdam, the Netherlands.","GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro), Maastricht, the Netherlands. Electronic address: janezenghaiyan@outlook.com."
39615332,Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experience.,2025-01-01,Chaput N,"Laboratoire d'Immunomonitoring en Oncologie, INSERM US23, CNRS UMS 3655, Gustave Roussy, Universite Paris-Saclay, Villejuif, Ile-de-France, France.",Not available
39614979,An Emerging Multi-mechanism and Multi-modal Approach in Interventional Glaucoma Therapy.,2024-11-30,Shultz M,"Shultz Chang Vision, Northridge, CA, USA.","Berkeley Eye Center, 1435 Hwy 6, Suite #202, Sugar Land, TX, 77478, USA. morgan.micheletti@gmail.com."
39614837,Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial.,2024-11-16,Severin T; Gimpelewicz C,"Novartis Pharma AG, Basel, Switzerland.",Not available
39614776,Association between education level and disability progression in patients with multiple sclerosis in France.,2025-01-01,Lefort M; Berger E,"Service de Neurologie, CHU de Besancon, Besancon, France.; Univ Rennes, EHESP, CNRS, Inserm, Arenes-UMR 6051, RSMS (Recherche sur les Services et Management en Sante)-U 1309, Rennes, France.",Not available
39613806,Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint.,2024-11-29,Poleur M; Goemans N; Mercuri E; Straub V; Annoussamy M; Eggenspieler D,"F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Parent Project Muscular Dystrophy, Washington, DC, USA.; Roche Products Ltd, Welwyn Garden City, UK.; Sarepta Therapeutics, Inc, Cambridge, MA, USA.; Solid Biosciences, Boston, MA, USA.","Department of Paediatrics, MDUK Oxford Neuromuscular Centre and NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. laurent.servais@paediatrics.ox.ac.uk."
39613746,Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial.,2024-11-29,Piccart M,"Novartis Pharma AG, Basel, Switzerland.",Not available
39613338,Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer.,2024-11-28,Zrafi WS; Roman G; Cournede PH; Gautheret D; Planchard D; Barlesi F; Marabelle A; Chaput-Gras N,"CDI Laboratories Inc, Baltimore, Maryland, USA.; CNRS UMR9018, Metabolic and Systemic Aspects of Oncogenesis for New Therapeutic Approaches (METSY), Villejuif, France.; Universite Paris-Saclay, Gif-sur-Yvette, France.",Not available
39613100,Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study.,2024-11-28,Garcia-Ortiz L; Diaz Moya G,"Daiichi Sankyo Espana, Madrid, Spain.; Unidad de Investigacion en Atencion Primaria de Salamanca (APISAL), Gerencia de Atencion Primaria de Salamanca, Instituto de investigacion Biomedica de Salamanca (IBSAL), Salamanca, Spain.","Atherosclerosis Unit, Department of Internal Medicine, Hospital la Paz-Carlos III, Madrid, Spain. Electronic address: josemaria.mostaza@salud.madrid.org."
39612757,Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients.,2025-01-01,Durani P; Pe Benito M; Wang P,"Bristol Myers Squibb, Princeton, NJ, USA.","Gustave Roussy and Paris-Saclay University, Villejuif-Paris Sud, France. Electronic address: caroline.robert@gustaveroussy.fr."
39612356,Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance.,2025-01-01,Novak JP; Hopper MA; Huang CC; Maurer MJ; King RL; Gandhi AK; Nowakowski G,"Informatics and Predictive Sciences, Bristol Myers Squibb, Summit, New Jersey, USA.; Translational Medicine Hematology, Bristol Myers Squibb, Summit, New Jersey, USA.",Not available
39611771,Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Week 104 results from the SUNSHINE and SUNRISE extension trial.,2024-11-29,Alarcon I; Bansal A; Gasperoni F; Martin R; Paguet B; Uhlmann L; Zouater H; Ravichandran S,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
39611655,Drug Repurposing Patent Applications July-September 2024.,2024-11-29,Mucke HAM,"H. M. Pharma Consultancy, Wien, Austria.",Not available
39611573,Safety and effectiveness of secukinumab subcutaneous injection in Japanese patients with psoriasis vulgaris and psoriatic arthritis: A post-marketing surveillance.,2025-01-01,Seko N,"Biostatistics, Novartis Pharma K.K, Tokyo, Japan.",Not available
39611152,Molecular genetics in adult-onset Still's disease: next-generation sequencing in 24 patients and literature review.,2024-01-01,Palmou-Fontana N,"Rheumatology, Complejo Asistencial de Segovia, Segovia, Spain.",Not available
39609757,The IMPACT Survey: the humanistic impact of osteogenesis imperfecta in adults.,2024-11-28,Dadzie R; Prince S,"Wickenstones Ltd, Oxford, Oxfordshire, UK.",Not available
39609618,GPR180 is a new member of the Golgi-dynamics domain seven-transmembrane helix protein family.,2024-11-28,Mitrovic SA; Winter LM; Kiechle T; Ebenhoch R; Neubauer H; Stierstorfer B; Frego L; Wolfrum C,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Boehringer Ingelheim, Ridgefield, CT, USA.",Not available
39608648,5-HT(1B) receptor activation produces rapid antidepressant-like effects in rodents.,2024-11-27,Wang L; Jagger E; Hu T; Li F; Koblan KS; Dedic N; Bristow LJ,"HD Biosciences Company Ltd., 590 Ruiqing Road, Pudong, Shanghai 201201, China.; Sumitomo Pharma America, Inc., 84 Waterford Drive, Marlborough, MA 01752, USA.; Sygnature Discovery, BioCity, Pennyfoot Street, Nottingham NG1 1GR, UK.","Sumitomo Pharma America, Inc., 84 Waterford Drive, Marlborough, MA 01752, USA. Electronic address: Erin.Clark@paragontherapeutics.com."
39607526,[Superior semicircular canal dehiscence isolation by transmastoid two-point canal plugging with preservation of the vestibulo-ocular reflex. German version].,2024-11-28,Seiwerth I; Rahne T,"Universitatsklinik und Poliklinik fur Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, Universitatsklinikum Halle (Saale), Martin-Luther-Universitat Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Deutschland.",Not available
39607084,Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live Cells.,2024-11-28,Gazzi T; Topp A,"Leibniz-Forschungsinstitut fur Molekulare Pharmakologie, Berlin, Germany.",Not available
39606455,Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.,2024-11-11,Mattano L Jr; Angiolillo A,HARP Pharma Consulting.; Servier Pharmaceuticals.,Not available
39606380,The ClinGen Syndromic Disorders Gene Curation Expert Panel: Assessing the Clinical Validity of 111 Gene-Disease Relationships.,2024-11-20,Kesari A,"Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.",Not available
39606177,Combination Low-Dose Pilocarpine/Diclofenac Sodium and Pilocarpine Alone for Presbyopia: Results of a Randomized Phase 2b Clinical Trial.,2024-01-01,Cunningham D; Smits G; Ignacio T; Gupta PK,"Dell Laser Consultants, Austin, TX, USA.; Orasis Pharmaceuticals, Ponte Vedra, FL, USA.; Triangle Eye Consultants, Raleigh, NC, USA.",Not available
39605871,Case report: Ulcerative colitis-related spondyloarthritis treated with golimumab until 27 weeks of gestation.,2024-11-26,Ikegami H,"Qol Co., Ltd, Minato-ku, Tokyo, Japan.",Not available
39605517,Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma.,2024-11-25,Broski S; Fuller MT,"EditCo Bio, Redwood City, CA.; Nura Bio, South San Francisco, CA.",Not available
39605030,Head-to-head comparison of tau PET tracers [(18)F]PI-2620 and [(18)F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.,2024-11-28,Roe-Vellve N; Bullich S; Garcia-Sanchez A; Castell-Conesa J; Roca I; Tarraga L; Stephens AW; Klein G; Marquie M,"CIBERNED, Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.; Life Molecular Imaging GmbH, Berlin, Germany.; SIMM Imagen Medica, Barcelona, Spain.",Not available
39603778,International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.,2024-11-25,Collet JP,"ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hopital Pitie-Salpetriere, Sorbonne Universite, Paris, France.","Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA. Electronic address: dominick.angiolillo@jax.ufl.edu."
39603672,Prognostic relevance of exercise pulmonary hypertension: results of the multicentre PEX-NET Clinical Research Collaboration.,2024-01-01,Avian A; Systrom D,"Universite Paris-Saclay, Inserm UMR_S 999 (HPPIT), Service de Pneumologie et Soins Intensifs Respiratoires, ERN-LUNG, Hopital Bicetre, Le Kremlin-Bicetre, France.","Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria gabor.kovacs@uniklinikum.kages.at."
39603537,"White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin.",2024-12-20,Ameri M; Burke MD; Creelman BP; Dick L; Eakins MN; Frivold C; Forster AH; Henke S; Lewis H; Mistilis JJ; Shin J; Speaker TJ; Taylor KMG; Jarrahian C,"AbbVie Inc, USA.; Americeutics Consulting, USA; Bioaxxent - Drug Delivery, Germany; Eakins & Associates, USA.; PATH, Seattle, USA.; Previously Kindeva Drug Delivery, USA.; Previously Zosano Pharma, USA.; Raphas Co. Ltd, Republic of Korea.; Stemline Therapeutics Inc, a Menarini Group Company, USA; University College London School of Pharmacy, UK; Vaxxas Pty Ltd, Australia.; previously British Pharmacopoeia Commission, UK.; previously LTS Lohmann Therapie-Systeme AG, Germany.; previously Radius Health, Inc., USA.; previously Zosano Pharma, USA.",Not available
39603430,Interaction of preservatives with contact materials during filling and storage of parenteral liquid formulations.,2025-01-01,Gottschalk P; Schleicher L; Lindner K; Presser I; Wittmann M,"Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG 88400 Biberach, Germany.",Not available
39603408,Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials.,2024-11-26,Buendia Lopez R; Folkvaljon F; Cowie MR,"Data Science, Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; HTA Statistics & Data Science, Biopharmaceuticals BBU, AstraZeneca, Barcelona, Spain.; Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.",Not available
39603386,Guidelines and guidance: what is the path forward for the ISTH?,2024-11-26,Casais P,"Hematology Department, Hospital General de Agudos ""Bernardino Rivadavia"" Buenos Aires, Argentina; Instituto de Investigaciones en Salud Publica, Universidad de Buenos Aires, Argentina.",Not available
39603063,The burden of alcohol and substance use disorders in adolescents and young adults.,2025-01-01,Diaz LA; Arab JP; Mellinger JL,"Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile; Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.; Department of Epidemiology and Biostatistics, Schulich School of Medicine, Western University, London, London, Ontario, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University & London Health Sciences Centre, London, Ontario, Canada; Observatorio Multicentrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile.","Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. Electronic address: pojsakorndan@gmail.com."
39602576,Investigation of a Highly Selective Asymmetric Synthesis Strategy for cis-2-Fluorocyclopropanecarboxylic Acid: The Key Component of Sitafloxacin.,2024-12-20,Ding D; Tan C; Wen A,"Fuan Pharmaceutical Group Chongqing Bosen Pharmaceutical Co., Ltd, Chongqing 401254, China.; Guang'an Kingday Pharma & Chem Co. Ltd, Guang'an 638400, China.",Not available
39602054,Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort.,2024-11-27,Hammerman A,"Medison Pharma Ltd, Petah Tikva, Israel.","The Helmsley Cancer Center, Shaare-Zedek Medical Center, Faculty of Medicine, The Hebrew University Jerusalem, 12 Beyth St, 9103102, Jerusalem, Israel. danielaka@szmc.org.il."
39601373,Dose-exposure-response of CARDALIS(R) (benazepril/spironolactone) on the classical and alternative arms of the renin-angiotensin-aldosterone system in healthy dogs.,2025-01-01,Guillot E; Domenig O,"Attoquant Diagnostics, Vienna, Austria.; Ceva Sante Animale, Companion Animal Franchise, Libourne, France.",Not available
39601368,Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT).,2024-11-27,Oestereich F,"Almirall AG, Wallisellen, Switzerland.",Not available
39600996,Multiple sclerosis in Colombia: A review of the literature.,2024-01-01,Castro-Castro P,"Fundacion Cardioinfantil - Instituto de Cardiologia, Bogota, Colombia.",Not available
39600794,Prevalence of mental disorders and related risk factors in refugees and asylum seekers in Campania.,2024-01-01,Bracalenti R; Schiavitelli C,"Istituto Psicoanalitico per le Ricerche Sociali (IPRS), Rome, Italy.",Not available
39600697,Oral exposure to high concentrations of polystyrene microplastics alters the intestinal environment and metabolic outcomes in mice.,2024-01-01,Sasano R,"AiSTI Science Co., Ltd., Wakayama, Japan.",Not available
39598492,Dry Amorphization of Itraconazole Using Mesoporous Silica and Twin-Screw Technology.,2024-10-25,Monsuur F; Quadflieg J,"Grace GmbH, In der Hollerhecke 1, 67547 Worms, Germany.; Sil'innov, Rue de Liege 2, 6180 Courcelles, Belgium.",Not available
39598326,L. plantarum UBLP-40 Versus the Combined Formula of L. rhamnosus UBLP-58 and B. longum UBBL-64 in Excisional Wound Healing: A Cellular Perspective.,2024-10-22,Tsetis JK,"Uni-Pharma S.A., 14564 Athens, Greece.",Not available
39598001,The Social Determinants of Health in a Cohort of Romanian Patients with Diabetic and Nondiabetic Neuropathy.,2024-11-14,Gavan NA,"Worwag Pharma Romania SRL, 21 Garii St., 400267 Cluj-Napoca, Romania.",Not available
39597998,A Narrative Review on Stress and Itch: What We Know and What We Would Like to Know.,2024-11-14,Coscarella G,"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, 00168 Rome, Italy.",Not available
39597986,Urgent Reversal of Direct Oral Anticoagulants in Critical and Life-Threatening Bleeding: A Multidisciplinary Expert Consensus.,2024-11-14,Rodrigues A; Goncalves LR; Gregorio T; Baldaia C; Santo GC; Gouveia J,"CINTESIS-Centro de Investigacao em Tecnologias e Servicos de Saude, 4200-450 Porto, Portugal.; Servico de Gastroenterologia, Unidade Local de Saude (ULS) Santa Maria, 1649-028 Lisboa, Portugal.; Servico de Imuno-Hemoterapia, Unidade Local de Saude (ULS) Santa Maria, 1649-028 Lisboa, Portugal.; Servico de Imuno-Hemoterapia, Unidade Local de Saude (ULS) Sao Joao, 4200-319 Porto, Portugal.; Servico de Medicina Intensiva, Unidade Local de Saude (ULS) Santa Maria, 1649-028 Lisboa, Portugal.; Servico de Medicina Interna e Unidade AVC, Unidade Local de Gaia e Espinho, 4434-502 Vila Nova de Gaia, Portugal.",Not available
39597872,Roxadustat Efficacy and Safety in Patients Receiving Peritoneal Dialysis: Pooled Analysis of Four Phase 3 Studies.,2024-11-08,Santos V; Khalife N; Jiletcovici A,"Astellas Pharma Europe Ltd., Addlestone KT15 2NX, UK.; Astellas Pharma, Inc., Northbrook, IL 60062, USA.",Not available
39597833,Improving Diagnosis and Management of Opioid-Induced Constipation (OIC) in Clinical Practice: An Italian Expert Opinion.,2024-11-07,Dentali F,"Dipartimento di Area Medica, Asst Sette Laghi, SC Medicina Generale, Universita dell'Insubria, 21100 Varese, Italy.",Not available
39597645,Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach.,2024-11-07,Biennier S; Fontaine M; Duquenoy A; Schwintner C; Dore J; Corvaia N,"MaaT Pharma, 69007 Lyon, France.; Universite Paris-Saclay, INRAE, MetaGenoPolis, AgroParisTech, MICALIS, 78350 Jouy-en-Josas, France.",Not available
39596506,ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.,2024-11-19,Cesano A; Warren S,"ESSA Pharma, South San Francisco, CA 94080, USA.",Not available
39596395,Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis Tools.,2024-11-17,Martin E; Zingman I; Tabet I; Bronner H; Dehghan Harati M; Heinzelmann C; Ast B; Ries R; Grundl MA; Heilker R; Humbeck L; Schuler M,"Global Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany.; Global Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany.; ScreeningHub und ValueData GmbH, 70563 Stuttgart, Germany.",Not available
39596191,Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using (1)H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids.,2024-11-12,Cannet C,"Bruker BioSpin GmbH & Co. KG, 76275 Ettlingen, Germany.",Not available
39595427,Psychometric Validation of the CLN2 Quality of Life Questionnaire in Participants with CLN2 Disease Treated with Cerliponase Alfa.,2024-11-08,Quinn J,"Debiopharm Inc., 1006 Lausanne, Switzerland.",Not available
39593749,Lifecycle DoE-The Companion for a Holistic Development Process.,2024-10-30,Kunzelmann M; Wittmann A; Presser B; Brosig P; Marhoffer PK; Haider MA; Martin J; Berger M; Wucherpfennig T,"Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstrasse 65, 88397 Biberach an der Riss, Germany.; HP BioP Operations Network Mammalian, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstrasse 65, 88397 Biberach an der Riss, Germany.",Not available
39593178,Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HF.,2024-11-26,Borow KM; Jenkins M; Rutman O; Hayes J; James CW; Rose E; Itescu S,"Global Pharma Consulting Pty, Ltd., Melbourne, VIC, Australia.; Mesoblast, Inc., New York, NY, USA.; Mesoblast, Ltd., Melbourne, VIC, Australia.",Not available
39592733,The novel BCL-2/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer.,2024-11-26,Qiu MZ,"Ascentage Pharma (Suzhou) Co, Ltd, Suzhou, 215000, China.",Not available
39592547,The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib.,2024-11-26,Watson C,"Galapagos NV, Mechelen, Belgium.","First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan. tanaka@med.uoeh-u.ac.jp."
39592491,Injectable Poly-L-Lactic Acid for Body Aesthetic Treatments: An International Consensus on Evidence Assessment and Practical Recommendations.,2024-11-26,Sarubi J; Coimbra DD; Palm M; Durairaj KK; Hexsel D; Weinberg F; Prygova I; Brasater D,", Los Angeles, CA, USA.; Advanced Plastic Surgery, Washington, DC, USA.; Art of Skin MD, Solana Beach, CA, USA.; Cosmetic Laser Dermatology, San Diego, CA, USA.; Galderma, Dallas, TX, USA.; Galderma, Princeton, NJ, USA.; Galderma, Uppsala, Sweden.; Instituto de Dermatologia Professor Rubem, David Azulay Santa Casa de Misericordia/IDPRDA, Rio de Janeiro, Brazil.","Hospital Israelita Albert Einstein, Federal University of Sao Paulo, Rua Bandeira Paulista 726, 8th Floor, Sao Paulo, SP, 04532-002, Brazil. aleshaddad@gmail.com."
39592282,Preclinical gout is common in the patient with stage 3-5 chronic kidney disease. Relevance of musculoskeletal ultrasound.,2024-01-01,Calvo-Aranda E,"Departamento de Medicina, Universidad Complutense de Madrid, Madrid, Spain; Servicio de Reumatologia, Hospital Universitario Infanta Leonor, Madrid, Spain",GEACSER: Grupo de Estudio de Artropatias Cristalinas de la Sociedad Espanola de Reumatologia. Electronic address: enrique.calvoa@salud.madrid.org.
39591609,Minimal Clinically Important Differences With the Outcomes of the App-Based Japanese Allergic Conjunctival Diseases Quality of Life Questionnaire: Cross-Sectional Observational Study.,2024-11-26,Eguchi A; Yee A; Huang T,"ENGAGE-Task Force, Tokyo, Japan.",Not available
39591253,"Comparative Assessment of the Allergenicity of Hyaluronidases from Polistes dominula (Pol d 2), Vespula vulgaris (Ves v 2), and Apis mellifera Venom (Api m 2).",2024-11-19,Dorn B; Bilo MB; Blank S,"Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale di Riposo e Cura per Anziani (INCRA), 60121 Ancona, Italy.; Spanish Network for Allergy-RETIC de Asma, Reacciones Adversas y Alergicas (ARADYAL), 28040 Madrid, Spain.; Thermo Fisher Scientific, 75450 Uppsala, Sweden.",Not available
39591134,"Proceedings of the Conference ""CMV Vaccine Development-How Close Are We?"" (27-28 September 2023).",2024-10-29,Gautam R,"Program Officer at Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, 5601 Fisher's Lane, Rockville, MD 20892, USA.",Not available
39590787,Salmon Nasal Cartilage-Derived Proteoglycans Alleviate Monosodium Iodoacetate-Induced Osteoarthritis in Rats.,2024-11-08,Wada T; Lim DS,"Daedeok Pharma Co., Ltd., Suwon-si 16226, Republic of Korea.; Nihon Pharmaceutical Co., Ltd., Tokyo 103-0012, Japan.",Not available
39590596,Considering Biomarkers of Neurodegeneration in Alzheimer's Disease: The Potential of Circulating Cell-Free DNA in Precision Neurology.,2024-11-13,Saito ER; Burns JM,"Resonant, Heber, UT 84032, USA.",Not available
39590163,Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer.,2024-11-15,Chia S,"BC Cancer-Vancouver, Vancouver, BC V5Z 4E6, Canada.",Not available
39590115,Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting.,2024-10-24,Manna M; Gelmon KA; Simmons C; Chia S,"BC Cancer-Vancouver, Vancouver, BC V5Z 4E6, Canada.; Saskatchewan Cancer Agency, Regina, SK S4W 0G3, Canada.",Not available
39589798,Health Disparities in Vasomotor Symptom Prevalence and Treatment Discontinuation in Women of Menopausal Age: A Commercial Claims Analysis.,2024-11-26,Ajmera M; Shiozawa A; Doshi R; Young C; Yeaw J; Mancuso S,"Astellas Pharma Inc., Northbrook, Illinois, USA.; IQVIA, Durham, North Carolina, USA.",Not available
39589685,Cost Savings in Chronic Pain Patients Initiating Peripheral Nerve Stimulation (PNS) with a 60-Day PNS Treatment.,2024-11-26,Epstein AJ; Crosby ND,"Gunnarsson Consulting, Jupiter, FL, USA.; Medicus Economics, Boston, MA, USA.",Not available
39589679,Brodalumab: Six-Year US Pharmacovigilance Report.,2024-11-26,Rawnsley NN,"Salix Pharmaceuticals, Bridgewater, NJ, USA.","Icahn School of Medicine at Mount Sinai, 5 East 98th Street, 5th Floor, New York, NY, 10029, USA. lebwohl@aol.com."
39589102,The Tango to Modern Collaboration and Patient-Centric Value Generation in Health Care - a real-world guide from practitioners for practitioners.,2024-12-06,Rupalla K,"Ymmunobio AG, Basel, Switzerland.",Not available
39588690,Effect of Social Isolation Due to the COVID-19 Pandemic on Cognitive Dysfunction of Patients With Alzheimer Disease: Subanalysis of Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets.,2024-01-01,Omori T; Nishiyama K; Aoki H; Nagakura N,"Teikoku Seiyaku, Higashikagawa, Japan.",Not available
39588564,Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries.,2024-11-26,Krumholz HM; Monreal M,"INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hemostase, Universite Jean-Monnet, Saint-Etienne, France.; Service de Medecine Vasculaire et Therapeutique, CHU de Saint-Etienne, Saint-Etienne, France.",Not available
39588177,Anhedonia in Major Depressive Disorder: Prevalence and Treatment Expectations and Satisfaction with Treatment Goals Among Patients and Physicians in Asia-Pacific.,2024-01-01,Vandervoort LP,"Janssen Pharmaceutical K.K., Tokyo, Japan.",Not available
39588080,Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction.,2024-01-01,Molfino NA; Martin NL; Ponnarambil SS; Martin N,"Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.; Cytel Inc., Waltham, MA, USA.; Global Development, Amgen, Thousand Oaks, CA, USA.; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.",Not available
39587782,Sequence and Configuration of a Novel Bispecific Antibody Format Impacts Its Production Using Chinese Hamster Ovary (CHO) Cells.,2025-01-01,Ellis M; Hinchliffe M; Humphreys DP; Stephens PE; Sweeney B; White J,"UCB Pharma UK, Slough, Berkshire, UK.",Not available
39587647,Network analysis of influential risk factors in adolescent suicide attempters.,2024-11-25,Bascaran TB; Canal-Rivero M; Cebria A; Crespo-Facorro B; Gomez S; Ortin F; Perez-Guerra C; Vieta E,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain.; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Servicio de Salud del Principado de Asturias (SESPA) Oviedo, Oviedo, Spain.","Department of Psychiatry, University of Oviedo, Oviedo, Spain. jenfdezfdez@gmail.com."
39587288,High genetic diversity yet weak population genetic structure in European common terns.,2024-11-25,Pavlinec Z; Tome D; Kovacs G,"Agency for Environment, Nature Conservation and Geology Mecklenburg- Vorpommern, Hiddensee Bird Ringing Scheme, Gustrow, Germany.; Kite Pharma, Hoofddorp, The Netherlands.; Secovlje Salina Nature Park, Soline Pridelava Soli d.o.o., Portoroz, Slovenia.",Not available
39587054,Decreased prefrontal glutamatergic function is associated with a reduced astrocyte-related gene expression in treatment-resistant depression.,2024-11-25,Homma S,"Teijin Pharma Ltd., Tokyo, Japan.",Not available
39586984,Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.,2024-11-26,Isobe Y,"Statistics & Decision Sciences Japan, Janssen Pharmaceutical K.K., Tokyo, Japan.",Not available
39586847,Real-world therapy and persistence of patients with neovascular age-related macular degeneration and diabetic retinopathy or diabetic macular edema: a German claims data analysis.,2024-11-25,Krieger J; Flacke JP; Beilschmidt L; Maywald U,"Cytel Inc., Potsdamer Strasse 58, 10785, Berlin, Germany.; Payers GmbH, Heilwigstrasse 34, 20249, Hamburg, Germany.; Roche Pharma AG, Emil-Barell-Strasse 1, 79639, Grenzach-Wyhlen, Germany.",Not available
39586616,"Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial.",2024-11-25,Seksik P; Plastaras L; Laharie D; Allez M; Rajca S; Goutorbe F,"CH Colmar, Colmar, France.; Gastroenterology, Hopital Ambroise-Pare Service de Nephrologie Dialyse, Boulogne-Billancourt, France.; Gastroenterology, Hopital Louis-Mourier, Colombes, France.; Gastroenterology, Hopital Saint Louis, Paris, France.; Gastroenterology, Hopital Saint-Antoine, Paris, France.; Hopital Haut-Leveque, Pessac, France.","Gastroenterology, CHU Bicetre, Le Kremlin-Bicetre, France aurelienamiot@gmail.com."
39585668,Neuropsychological Outcomes in 6-Year-Old Children of Women With Epilepsy: A Prospective Nonrandomized Clinical Trial.,2024-11-25,Matthews AG; Brown C; Robalino CP; Carmack A,"The Emmes Company, Rockville, Maryland.",Not available
39584500,Dasiglucagon in Children with Congenital Hyperinsulinism up to 1 Year of Age: Results from a Randomized Clinical Trial.,2024-11-25,Boge E; Ivkovic J; Kendall DM; Thornton PS,"Zealand Pharma A/S, Soborg 2860, Denmark.",Not available
39583647,Performance of plasma p-tau217 and NfL in an unselected memory clinic setting.,2024-01-01,Teunissen CE,ALZpath. Inc. Carlsbad California USA.,Not available
39583219,Criteria for Identifying Candidates for Systemic Psoriasis Treatment in the Real World: Application of the International Psoriasis Council Guidelines in Patients in North America.,2024-11-21,Sima A; Beeghly A; Eckmann T; Balagula E; Zhuo J; Lebwohl M,"Bristol Myers Squibb, Princeton, NJ, USA.; CorEvitas, LLC, Waltham, MA, USA.",Not available
39583218,"The FORWARD Psoriasis Registry: Patient-Reported Outcomes in a Novel Psoriasis Registry and Comparison of Traditional, Dermatologist-Led Enrollment With Web-Based Patient Enrollment.",2024-11-20,Pearson R; Schumacher R; Ogdie AR,"Advanced Dermatology and Cosmetic Surgery, Maitland, FL, USA.",Not available
39583142,GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity.,2024-01-01,Ortiz A,"RICORS2040  Madrid, Spain.",Not available
39582349,"Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial.",2025-01-01,Lucas KJ; Hennige AM,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Diabetes and Endocrinology Consultants, Morehead City, North Carolina, USA.",Not available
39582128,A three-arm clinical study to compare pharmacokinetic and pharmacodynamic similarity of the denosumab biosimilar LY06006 with reference denosumab in healthy male subjects.,2024-11-24,Sun X; Wang X; Dong Y; Tai J; Zhou M; Dou C,"Luye Pharma (USA), Ltd., Princeton, NJ, USA.; Shandong Boan Biotechnology Co., Ltd., Yantai, China.",Not available
39581908,Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Dialysis-Dependent Patients with Anaemia of Chronic Kidney Disease: A Retrospective Observational Study.,2024-11-25,Jiletcovici A; Snijder R; Leyland K; Khalife N; Ali M,"Astellas Pharma Europe B.V., Leiden, The Netherlands.; Astellas Pharma Europe Ltd, Addlestone, UK.; Astellas Pharma Global Development Inc., Northbrook, IL, USA.","Astellas Pharma Global Development Inc., Northbrook, IL, USA. christopher.atzinger@astellas.com."
39581242,Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper.,2024-11-22,Normanno N,"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) ""Dino Amadori"", Meldola, Italy.",Not available
39581202,"Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.",2024-12-14,Bragg SM; Crandall W; Durand F; Hon E; Lin Z; Lopes MU; Morris N; Protic M; Carlier H,"Eli Lilly and Company, Indianapolis, IN, USA.","Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Electronic address: marc.ferrante@uzleuven.be."
39581180,Safe and well-tolerated long-term parenteral nutrition regimen: Omega-3-fatty-acid-enriched medium chained/ long chained triglycerides emulsion.,2024-01-01,Schneider SM,"Gastroenterologie et Nutrition Clinique, CHU de Nice, Universite Cote d'Azur, Nice, France.","Surgical Oncology Clinic, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland. Electronic address: klek@poczta.onet.pl."
39580869,Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer.,2025-01-01,Duhoux FP; LeVasseur N,"BC CANCER - Vancouver, Vancouver, BC, Canada.; Cliniques universitaires Saint-Luc, Brussels, Belgium.",Not available
39580768,"Efficacy and safety of patiromer for non-dialysis and dialysis patients with hyperkalemia: the randomized, placebo-controlled and long-term study.",2024-11-24,Taniguchi Y; Ishii T,"Zeria Pharmaceutical.Co., Ltd, Tokyo, Japan.",Not available
39580227,Evaluation of extreme depyrogenation conditions on the surface hydrolytic resistance of glass containers for pharmaceutical use.,2024-11-23,Arai S; Meisner A; Otton P; Rupertus V; Zuccato D,Glass Technology Services Ltd.; Nippon Electric Glass Co.; Nipro Pharma Packaging Americas Corporation.; SCHOTT AG.; Schott AG.,massimo.guglielmi@unipd.it.
39580202,"Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 x 2 factorial design.",2024-11-23,Foulon S; Berdah JF,"Clinique Sainte Marguerite, Hyeres, France.; Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France; Oncostat U1018, Inserm, Labelled Ligue Contre le Cancer, Villejuif, France.","Amethyst Group, Paris, France. Electronic address: bossial@hotmail.com."
39580005,Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of Na(V)1.7.,2025-02-01,Chowdhury S; Hemeon I; Hasan A; Wilson MS; Bergeron P; Jia Q; Zenova AY; Grimwood ME; Gong W; Decker SM; Bichler P; Andrez JC; Focken T; Ngyuen T; Bankar G; Howard S; Chang E; Khakh K; Lin S; Dean R; Johnson JP Jr; Chang JH; Hackos DH; McKerrall SJ; Sellers B; Ortwine DF; Cohen CJ; Safina BS; Sutherlin DP; Dehnhardt CM,"Genentech Inc., 1 DNA Way, South San Francisco, CA 94080-4990, USA.; Xenon Pharmaceuticals Inc., 3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada.","Xenon Pharmaceuticals Inc., 3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada. Electronic address: ssun@xenon-pharma.com."
39579968,"Bacteriological sampling in revision surgery: When, how, and with what therapeutic impact?",2024-11-22,Senneville E; Lafon-Desmurs B; Migaud H,"Northwest Reference Center for Osteoarticular Infections (Centre de Reference pour le traitement des Infections Osteo-Articulaires Complexes Lille-Tourcoing: CRIOAC-G4), Rue Emile Laine, 59000 Lille, France; Service d'Orthopedie, Hopital Salengro, Place de Verdun, CHU Lille, F-59000 Lille, France.; Service des Maladies Infectieuses et du Voyageur, CH Dron, Rue du President Coty, 59208 Tourcoing, France.; University of Lille, Hauts de France, F-59000 Lille, France","Northwest Reference Center for Osteoarticular Infections (Centre de Reference pour le traitement des Infections Osteo-Articulaires Complexes Lille-Tourcoing: CRIOAC-G4), Rue Emile Laine, 59000 Lille, France. Electronic address: Caroline.LOIEZ@chu-lille.fr."
39579650,"Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.",2025-01-01,Akintunde G; Charles L,"Emergent Biosolutions, Inc., Gaithersburg, MD, USA.",Not available
39579593,"Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021.",2024-01-01,Toro-Huamanchumo CJ; Sookoian S; Zuluaga M; Pirola CJ,"Clinical and Molecular Hepatology, Translational Health Research Center (CENITRES), Maimonides University, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Buenos Aires, Argentina; Departament of Surgery, Universidad del Valle, Cali, Valle del Cauca, Colombia, USA.; Faculty of Health Science, Maimonides University, Buenos Aires, Argentina; Systems Biology of Complex Diseases, Centro de Investigacion Traslacional en Salud, Universidad Maimonides, Buenos Aires, Argentina.; Universidad San Ignacio de Loyola, Lima, Peru.",Not available
39579362,Biofunctionalized polymeric nanoparticles for the enhanced delivery of erlotinib in cancer therapy.,2024-11-23,Vinukonda A,"Scientist- Formulation and Process Development, Strides Pharma Inc, Chestnut Ridge, NY, USA.",Not available
39579284,Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds.,2024-11-23,Walton-Bowen K,"Allos Pharma, Cambridge, USA.","Cincinnati Children's Hospital Medical Center, Cincinnati, USA. Meredith.Nelson@cchmc.org."
39578744,Cardinality matching versus propensity score matching for addressing cluster-level residual confounding in implantable medical device and surgical epidemiology: a parametric and plasmode simulation study.,2024-11-22,Johnston S; Coplan PM; Strauss VY,"Boehringer Ingelheim Pharma GmbH and Co KG, Ingelheim, Rheinland-Pfalz, DE, Germany.; Epidemiology & Real-World Data Sciences, MedTech, Johnson & Johnson, New Brunswick, NJ, USA.",Not available
39578649,Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing's syndrome.,2024-01-01,Chen H; Moriceau S; Zhao L; Zhang S; Forveille S; Maiuri MC; Wang H,"Faculte de Medecine, Universite Paris-Saclay, Paris, France.; Institut Imagine, Platform for Neurobehavioral and Metabolism, Structure Federative de Recherche Necker, 26 INSERM US24/CNRS UAR, Paris, France.",Not available
39578497,RLS-associated MEIS transcription factors control distinct processes in human neural stem cells.,2024-11-22,Winkelmann J,"Global Computational Biology & Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.","Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany. volker.kittke@helmholtz-munich.de."
39578348,"Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials.",2024-01-01,Tilt N; Wiegratz S,"UCB, Morrisville, NC, USA.","Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA. Joseph.Merola@UTSouthwestern.edu."
39578189,Optimizing the identification of long-interval intracortical inhibition from the dorsolateral prefrontal cortex.,2025-01-01,Takano M,"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; TEIJIN PHARMA LIMITED, Tokyo, Japan.",Not available
39577923,Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study.,2024-01-01,Ma Y; Farris CM; Nguyen H,"Amprion, San Diego, CA, USA.",Not available
39577921,"Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.",2024-01-01,Littauer R; Collins J; Lucas N; Wald M; Dawson K,"Biogen, Cambridge, MA, USA.","Center for Brain & Mind Health, Departments of Neurology & Neurosurgery, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: kevin.sheth@yale.edu."
39577685,Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling.,2025-01-28,Reduzzi C,"Weill Cornell Medicine, New York, NY, USA.",Not available
39577422,Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.,2024-12-09,Quigley D,"UCSF, San Francisco, CA, USA.",Not available
39577421,Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade.,2024-12-09,Hamidi H; Senbabaoglu Y; Beig N; Roels J; Manuel C; Guan X; Koeppen H; Assaf ZJ; Nabet BY; Waddell A; Yuen K; Maund S; Giltnane JM; Schedlbauer A; Fuentes E; Cowan JD; Kadel EE 3rd; Degaonkar V; Andreev-Drakhlin A; Williams P; Carter C; Gupta S; Steinberg E; Loriot Y; Galsky MD; Mariathasan S,"Genentech, South San Francisco CA, USA.; Institut de Cancerologie Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; Mount Sinai, New York NY, USA.",Not available
39577413,Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms.,2024-12-10,Hoyos D; Di Gioacchino A; Chacon-Barahona J,"Laboratoire de Physique de l'Ecole Normale Superieure, Sorbonne Universite, Universite de Paris, Paris, France.; Tri-Institutional Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY, USA.","Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: suns3@mskcc.org."
39577179,A novel label-free biosensor for myocardial ischemia biomarker detection via CRISPR/12a.,2025-02-15,Chen L,"Pharma Technology A/S, Ashojvej 24, 4600, Koge, Denmark.",Not available
39576871,Monoclonal antibodies against jellyfish collagen.,2024-11-22,Oda M,"Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan. RINGGOLD: 608547",Not available
39576736,The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetes.,2025-01-01,Nakamura Y; Hirose J; Ohara K; Shijoh Y; Carter M; Meredith K; Harris J; Akerborg O,"Bayer Yakuhin Ltd, Osaka, Osaka, Japan.; Wickenstones Ltd, Carlow, Ireland.",Not available
39576645,Data-Driven Cutoff Selection for the Patient Health Questionnaire-9 Depression Screening Tool.,2024-11-04,Iglesias-Gonzalez M; Loureiro SR; Shinn EH,"Group Practice for Psychotherapy and Psycho-oncology, Freiburg, Germany.; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz, San Lorenzo Huipulco, Tlalpan, Mexico.; STAR-Stress, Anxiety and Resilience Consultants, Chicago, Illinois.",Not available
39575592,Planning and Implementing Master Protocol Trials in Japan: Key Considerations of the Japanese Guideline.,2024-11-22,Tokushige K,"Advanced Quantitative Sciences, Development Japan, Novartis Pharma K.K., Tokyo, Japan.",Not available
39574965,Validation of NBD-coupled taurocholic acid for intravital analysis of bile acid transport in liver and kidney of mice.,2024-01-01,Hengstler JG,"Albireo Pharma, Inc., Boston, MA 02109, USA.",Not available
39574936,Defining the Care Pathway in Patients with Psoriasis and Atopic Dermatitis.,2024-01-01,Pages-Puigdemont N; de Paz HD; Serra-Baldrich E; Riera P,"Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.; Outcomes'10 (a ProductLife Group Company), Castellon de la Plana, Spain.",Not available
39574188,Local QSAR based on quantum chemistry calculations for the stability of nitrenium ions to reduce false positive outcomes from standard QSAR systems for the mutagenicity of primary aromatic amines.,2024-11-21,Koyama N; Hitaoka S; Chikura S,"Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba-Shi, Ibaraki, 300-2635, Japan.; Teijin Pharma Limited, 4-3-2 Asahigaoka, Hino, Tokyo, 191-8512, Japan.",Not available
39574155,Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.,2024-11-21,Molnar MJ,"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.","Massachusetts General Hospital, Genetics Division Harvard Medical School Boston, Boston, MA, USA. AKARAA@mgh.harvard.edu."
39574037,"Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC.",2024-11-21,Overbeck TR; Schaefer ES,"Faculte de Medecine, Universite Paris Saclay, Kremlin Bicetre, France.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Department of Biomedical Sciences, Humanitas University, Milan, Italy. armando.santoro@cancercenter.humanitas.it."
39572927,High circulating HMGB1 indicates good prognosis in patients with advanced leiomyosarcoma under chemoimmunotherapy.,2024-12-31,Bezu L,"Equipe labellisee par La Ligue contre le cancer, Universite de Paris Cite, Sorbonne Universite, Paris, France.",Not available
39572784,Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience.,2024-01-01,Gaziano L,"European Reference Network for rare low prevalence and complex diseases of the heart: ERN GUARD-Heart, Amsterdam, the Netherlands.",Not available
39572748,Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases.,2024-11-21,Ramos R; Panova-Noeva M; van Greevenbroek M,"CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.","Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden. daniel.coral@med.lu.se."
39572620,Author Correction: Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device.,2024-11-21,Cereatti A; Koch S; Yarnall AJ; Del Din S,"CIBER Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain.; McRoberts BV, The Hague, The Netherlands.",Not available
39572513,The State of the Art of Image Guided Superficial Radiation Therapy Treatment of Non-melanoma Skin Cancer in Outpatient Dermatology Clinics in the United States and Review of the Literature.,2024-11-21,Hopkins J; Serure D; Robbins B; Osborne C; Bravo L; Lausser P,"Bare Dermatology, Dallas, TX, USA.; Hopkins Dermatology, Monroe, LA, USA.; Laserderm Dermatology, Smithtown, NY, USA.; Tru-Skin Dermatology, Austin, TX, USA.; Tru-Skin Dermatology, Hallettsville, TX, USA.","Texas A&M College of Medicine, Dallas, TX, USA. peyton.harris@tamu.edu."
39572323,Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer.,2025-01-01,Haaland B,"Pentara, Millcreek, UT, 84109.",Not available
39572211,Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.,2024-11-21,Brickman D; Turner MR,"Genetic ALS & FTD: End the Legacy, Philadelphia, Pennsylvania, USA.","Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA MBenatar@med.miami.edu."
39571587,"Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial.",2025-01-01,Roblin X,"CHU Saint-Etienne, Saint-Etienne, France.","Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, Netherlands. Electronic address: g.dhaens@amsterdamumc.nl."
39571250,Comprehensive serum biomarker analysis reveals IL-8 changes as the only predictor of the effectiveness of immune checkpoint inhibitors for patients with advanced non-small cell lung cancer.,2024-01-01,Iwasawa S; Nakagawa S,"Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.",Not available
39571058,Kidney Disease and Diabetes.,2023-01-01,Koyama AK,"Social & Scientific Systems, Inc. (A DLH Holdings Company), Silver Spring, MD",Not available
39570620,"Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial.",2024-11-21,Chen Z; Fu T; Jiang L; Wang C; Wang H; Yang D; Zhai Y,"Ascentage Pharma (Suzhou) Co Ltd, Suzhou, China.; Ascentage Pharma Group Inc., Rockville, Maryland.",Not available
39570583,First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial.,2024-11-21,May AM,"the Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.",Not available
39570518,The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic Dermatitis.,2024-01-01,Wang Z,"Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.","Sanofi, Cambridge, MA, USA. Chien-chia.Chuang@sanofi.com."
39570476,"Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective.",2024-11-21,Valle TF; Lopez-Sendon JL,"Centro Investigacion Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.",Not available
39570460,"Clinical benefits of adding olanzapine to 5-HT(3) receptor antagonist, NK(1) receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.",2025-01-01,Noda M,"Non-Profit Organizaition Sasaeau-Kai""Alpha"", 5187 KawadoCho, ChuoKu, Chiba, Chiba, 2600802, Japan.","Department of Pharmacy, Matsuyama Red Cross Hospital, 1 Bunkyo-cho, Matsuyama-shi, Ehime, 790-8524, Japan. muramichi1959@gmail.com."
39570242,5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.,2024-11-15,Horton R; Anderson JA; Zhao H,"Abbott Structural Heart, Plymouth, Minnesota, USA.; Texas Cardiac Arrhythmia, Austin, Texas, USA.","Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, Kansas, USA. Electronic address: dhanunjaya.lakkireddy@hcahealthcare.com."
39570234,Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial.,2025-01-01,Lefkowitz MP,"Novartis Pharmaceuticals, East Hanover, New Jersey, USA.","Harvard Medical School, Boston, Massachusetts, USA. Electronic address: fmccausland@bwh.harvard.edu."
39569521,Renal Proximal Tubule Cell-Specific Megalin Deletion Does Not Affect Atherosclerosis But Induces Tubulointerstitial Nephritis in Mice Fed a Western Diet.,2025-01-01,Mullick AE,"Ionis Pharmaceuticals, Carlsbad (A.E.M.).",Not available
39568894,The effect of gem-difluorination on the conformation and properties of a model macrocyclic system.,2024-12-04,Lewis RJ; Ahlqvist M,"DMPK, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden.; Medicinal Chemistry, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden.","Medicinal Chemistry, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden thomas.cogswell@acerta-pharma.com laurent.knerr@astrazeneca.com."
39568778,Exploring the genetics of airflow limitation in lung function across the lifespan - a polygenic risk score study.,2024-01-01,Bertels X; Duijts L; Brusselle G; Brumpton BM; Holloway JW,"CIBER Epidemiologia y Salud Publica (CIBERESP), Spain.; Ib-Salut, Area de Salut de Menorca, Palma, Spain.; Universitat de Barcelona, Departament de Biomedicina, Institut D'investigacions Biomediques August Pi I Sunyer (IDIBAPS), Calle Rossello 149, 08036, Barcelona, Spain.",Not available
39568469,Toward a tipping point in federated learning in healthcare and life sciences.,2024-11-08,Hagestedt I; Hales I; Boernert E; Roth HR; Hoeh MA; Rohm R; Dobson E; Prieto JT,"Apheris AI GmbH, Berlin, Germany.; F. Hoffmann-La Roche Ltd., Basel, Switzerland.; NVIDIA Corporation, Santa Clara, CA, USA.",Not available
39567893,"Correction: Forced randomization: the what, why, and how.",2024-11-20,Carter K; Kuznetsova O; Anisimov V; Krisam J,"Amgen Ltd, London, UK.; Boehringer-Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.; Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.; Merck & Co., Inc, Rahway, NJ, USA.",Not available
39567515,Accelerating Parkinson's Disease drug development with federated learning approaches.,2024-11-21,Khanna A; Cosman J; Dockendorf MF; Edgerton J; Gaetano L; Goikoetxea E; Kangarloo T; Lindemann M; Ren J,"AbbVie Pharmaceuticals, North Chicago, IL, USA.; Biogen Inc, Cambridge, MA, USA.; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Merck & Co., Inc., Rahway, NJ, USA.; Neuroscience Development, Novartis AG, Basel, Switzerland.; Takeda Pharmaceuticals, Cambridge, MA, USA.; UCB Pharmaceuticals, Leuven, Belgium.",Not available
39567211,"Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1).",2024-11-20,Boni V; Ernstoff MS; Velcheti V,"Mural Oncology, Inc, Waltham, Massachusetts, USA.; START Madrid-CIOCC, Centro Integral Oncologico Clara Campal, Madrid, Spain.","Divison of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA vaishamu@med.umich.edu."
39566963,[Economic burden of Parkinson's disease in Japan: long-term care expenditure for PD patients].,2024-12-21,Naoi I,"Data Science, Drug Development Division, Sumitomo Pharma Co., Ltd.",Not available
39566494,Employing effective recruitment and retention strategies to engage a diverse pediatric population in genomics research.,2024-12-05,Brown K; Robinson M; Williams T; Abul-Husn NS,"23andMe, Inc., Sunnyvale, CA, USA.; Bethel Gospel Assembly, New York, NY, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pediatrics, Division of Pediatric Genetic Medicine, Children's Hospital at Montefiore/Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA; Illumina, Inc., Foster City, CA, USA.; Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Midwifery Collective, Brooklyn, NY, USA.",Not available
39566464,Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer.,2024-11-19,Rey J; Weber KE; Rachakonda S; Zahm DM; Felder B; Schem C; Jackisch C; Nekljudova V,"German Breast Group (GBG) Forschungs GmbH, Neu-Isenburg, Germany.; Klinik fur Gynakologie und Geburtshilfe, Sana Klinikum Offenbach, Offenbach, Germany.; Mammazentrum Hamburg, Brustzentrum am Krankenhaus Jerusalem, Hamburg, Germany.; SRH Waldklinikum Gera GmbH, Gera, Germany.","Institute of Pathology, Philipps University Marburg, Marburg University Hospital (UKGM), and University Cancer Center Frankfurt-Marburg (UCT), Marburg, Germany. Electronic address: carsten.denkert@uni-marburg.de."
39566172,"Effects of organic acid blends on the growth performance, intestinal morphology, microbiota, and serum lipid parameters of broiler chickens.",2024-11-10,Bhat R; Datar Y; Rajora P,"Mankind Pharma Limited, 208, Okhla Phase 3 Rd, Okhla Phase III, Okhla Industrial Estate, New Delhi, Delhi 110020 India.",Not available
39565570,Quantification of normal bone and osseous metastases in castration-resistant prostate cancer using SPECT/CT with xSPECT Quant: prospective imaging sub-study of a phase 2 clinical trial investigating the combination of pembrolizumab plus radium-223 compared to radium-223 alone.,2024-11-20,Pace A,"Midstate Radiology Associates, Meriden, CT, USA.","Department of Imaging, Dana-Farber Cancer Institute, Department of Radiology Brigham and Women's Hospital, Boston, MA, 02115, USA. mrobertson@bwh.harvard.edu."
39565511,Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis.,2024-11-20,Hackl D; Brestrich G; von Eiff C,"Pfizer Pharma GmbH, Friedrichstrasse 110, 10117, Berlin, Germany.; WIG2 GmbH, Markt 8, 04109, Leipzig, Germany.","Pfizer Pharma GmbH, Friedrichstrasse 110, 10117, Berlin, Germany. katharina.schley@pfizer.com."
39565228,"Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study.",2024-11-20,Baeumer D; Melzer N; Reinhardt M,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma GmbH, Nuremberg, Germany.",Not available
39564769,Novel Amanitin-based Antibody Drug Conjugates (ATAC(R)) targeting TROP2 for the treatment of Pancreatic Cancer.,2024-11-20,Papacharisi E; Braun A; Vranic M; Pahl AM; Hechler T,"Heidelberg Pharma (Germany), Germany.; Heidelberg Pharma (Germany), Ladenburg, Germany.",Not available
39564753,EUROVISCO Consensus Guidelines for the Use of Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis Based on Patient Characteristics.,2024-11-20,Goncalves B; Migliore A,"Servico de Radiologia de Intervencao, Instituto Portugues de Oncologia-FG, Porto, Portugal.; U.O.S. of Rheumatology, Ospedale San Pietro Fatebenefratelli, Rome, Italy.",Not available
39564692,Ultrasensitive Detection of Chemokines in Clinical Samples with Graphene-Based Field-Effect Transistors.,2024-01-01,Meyerbroeker N; Purschke W; Sell S; Neumann C; Bethge L; Weimann T; Ferwerda G; Vater A; Turchanin A,"APTARION Biotech AG, 10589, Berlin, Germany.; CNM Technologies GmbH, 33609, Bielefeld, Germany.; NOXXON Pharma AG, 10589, Berlin, Germany.; Physikalisch-Technische Bundesanstalt, 38116, Braunschweig, Germany.",Not available
39564145,Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials.,2024-01-01,Krosser S,"Novaliq GmbH, Heidelberg, Germany.",Not available
39564144,Nurses' reported training needs for advanced cell therapies: a survey on behalf of the Nurses Group of the EBMT.,2024-01-01,Chabannon C,"Hospital Universitario Puerta de Hierro Majadahonda, Spain; Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia Arana. Calle Joaquin Rodrigo 2, 28222 Majadahonda, Spain.",Not available
39563684,Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease.,2024-01-01,Nagahama T; Nagai K,"JMDC Inc., Tokyo, Japan.",Not available
39563410,Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studies.,2024-11-20,Woollacott I; Chhabra A; Richardson L; Ferri Grazzi E; O'Hara J; Laffan M,"Formerly HCD Economics, Mere House, Brook St, Knutsford, UK.; Formerly Pfizer Limited, Tadworth, Surrey, UK.; HCD Economics, Mere House, Brook St, Knutsford, UK.",Not available
39563223,Investigating social orienting in children with Phelan-McDermid syndrome and 'idiopathic' autism.,2024-11-19,Cooke J; Loth E,"Centro Investigacion Biomedica en Red Salud Mental, CIBERSAM, Instituto Carlos III, Madrid, Spain.; Departamento de Psicologia Basica, Universidad Autonoma de Madrid, Madrid, Spain.",Not available
39561733,A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS).,2024-11-19,Poignant P; Cedrin Durnerin I,"EMD Serono, Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany.; Service de medecine de la reproduction et preservation de la fertilite - CECOS, Hospices Civils de Lyon, Bron, France.",Not available
39561384,"Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal Gel.",2024-12-02,Meads A; Burger B; Raju S; Louie MJ,"Urogen Pharma, Princeton, New Jersey.",Not available
39560897,Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD.,2024-11-19,Mullerova H; Price D,"AstraZeneca, Gaithersburg, MD, USA.",Not available
39560862,"Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors.",2024-11-19,Imedio ER; Miah K; Mugundu GM,"Florida Cancer Specialists, 600 N Cattlemen Rd, Suite #200, Sarasota, FL, 34232, USA.; Oncology R&D, AstraZeneca, Cambridge, UK.","Florida Cancer Specialists, 600 N Cattlemen Rd, Suite #200, Sarasota, FL, 34232, USA. mpatel@flcancer.com."
39560728,[Action algorithm: management of acute pancreatitis in acute and emergency medicine].,2024-11-19,Michels G,"Notfallzentrum, Krankenhaus der Barmherzigen Bruder Trier, Medizincampus Trier der Universitatsmedizin Mainz, Trier, Deutschland.","Klinik fur Gastroenterologie und Hepatologie, Universitatsklinikum Koln, Kerpener Str. 62, 50937, Koln, Deutschland. philipp.kasper@uk-koeln.de."
39559275,Uterine fibroids with heavy menstrual bleeding stratified by race in a commercial and Medicaid database.,2024-01-01,Lickert C,"Sumitomo Pharma America, Inc, Marlborough, MA (Lickert).",Not available
39558898,Plasma p-tau181 and GFAP reflect 7T MR-derived changes in Alzheimer's disease: A longitudinal study of structural and functional MRI and MRS.,2024-01-01,Ittermann B; Lehmann S; Cano S; Melin J; Pendrill L; Schwarz C,"Modus Outcomes Ltd, Cheltenham, UK.; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Berlin, Germany.",Not available
39558800,In Vitro Evaluation of CYP-Mediated Metabolism of Fezolinetant and Pharmacokinetic Interaction Between Fezolinetant and Fluvoxamine in Healthy Postmenopausal Smokers and Nonsmokers.,2024-11-19,Iwai M; Nielsen J; Miyagawa M; Patton M; Bonate PL; Wang X; Wojtkowski T; Sinn A,"Astellas Pharma Global Development, Inc., Northbrook, IL, USA.; Astellas Pharma, Inc., Tokyo, Japan.",Not available
39558612,Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene-related peptide monoclonal antibodies.,2024-01-01,Lalla A; Nagy K; Gandhi P,"AbbVie, Budapest, Hungary.; AbbVie, North Chicago, IL, USA. RINGGOLD: 359181",Not available
39558508,Use cases of registry-based randomized controlled trials-A review of the registries' contributions and constraints.,2024-01-01,Kubesch N; Gaitonde S; Bakker E; Birks LE; de Vries ST,"Cognizant Technology Solutions, Amsterdam, The Netherlands.; Cognizant Technology Solutions, Barcelona, Spain.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
39557820,Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors.,2024-11-18,Grinyo-Escuer A; Bort-Brusca M; Perez-Ramos S,"Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Monforte de Lemos, Madrid, 28029, Spain.",Not available
39557617,"Safety and Efficacy of Ianalumab in Patients With Sjogren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study.",2024-11-18,Mariette X; Junge G; Woznicki J; Sopala M; Avrameas A; Luo WL; Hueber W,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.; Universite Paris-Saclay, Paris, France, and Hopital Bicetre, AP-HP, Le Kremlin Bicetre, France.",Not available
39557591,Algorithm for managing infusion site adverse events caused by subcutaneous foslevodopa/foscarbidopa and other device-aided therapies for advanced Parkinson's disease.,2024-10-28,Simoes RM,"CNS - Campus Neurologico, Torres Vedras, Portugal.; Neurology Department, Hospital Beatriz Angelo, Loures, Portugal","Dermatology Center, Hospital CUF Descobertas, Lisboa, Portugal. Electronic address: pmendesbastos@gmail.com."
39557487,Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial.,2024-11-18,Wang X; Bouchard C; Wu X; Miyazaki K; Scrine L,"Astellas Pharma Europe, Addlestone, Surrey, UK.; Astellas Pharma Global Development, Northbrook, IL, USA.; Astellas Pharma, Tokyo, Japan.; Clinique de Recherche en Sante de la Femme, Quebec City, Canada.",Not available
39557179,Optimising 3D printed medications for rare diseases: In-line mass uniformity testing in direct powder extrusion 3D printing.,2025-01-05,Rial C; Bendicho-Lavilla C,"FABRX Artificial Intelligence, Carretera de Escairon, 14, Currelos, O Savinao CP 27543, Spain.; FABRX Ltd., Henwood House, Henwood, Ashford, Kent TN24 8DH, United Kingdom",Not available
39556768,Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.,2024-11-18,Ni W; Rhodes GM; Michael LF; Haupt A; Krege JH,"Eli Lilly and Company, Indianapolis, Indiana.",Not available
39556653,Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic Interventions.,2024-11-19,Humbert M,"Faculte de Medecine, Inserm UMR_S 999, HPPIT, Service de Pneumologie et Soins Intensifs Respiratoires, ERN-LUNG, Hopital Bicetre (Assistance Publique-Hopitaux de Paris), Universite Paris-Saclay, Le Kremlin-Bicetre, France (M.H.).",Not available
39556389,Amyloid-Related Imaging Abnormalities in Clinical Trials of Gantenerumab in Early Alzheimer Disease.,2024-11-18,Wojtowicz J; Klein G; Rossomanno S; Bullain S; Grundman M; Aldea R; Boada M; Doody R,"F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, South San Francisco, California.",Not available
39556242,Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial.,2024-11-18,Lystig T; Cao X; Wang K; Pecoraro ML; Tamby JF; Katz L; Sinha U; Fox JC,"BridgeBio Pharma, Inc., San Francisco, CA.",Not available
39555576,Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer.,2024-01-01,Tutrone RF,"Division of Urology, Chesapeake Urology, Towson, MD 21204, USA.",Not available
39554906,Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma.,2024-12-19,Overwijk WW; Cripe TP,"Nektar Therapeutics, San Francisco, CA 94158, USA.",Not available
39554782,Challenges and opportunities in newly diagnosed glioblastoma in the United Kingdom: A Delphi panel.,2024-01-01,Bulbeck H,"Brainstrust-The Brain Cancer People, Cowes, UK.",Not available
39554479,A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.,2024-01-01,DiMartino SJ; Mei J; Gao H; Eng S; Winslow C; Ho T; Turner KC; Hassan HE; Patel Y; Davis JD; Trinh N; Manley A; Manvelian G; Fetell M; Braunstein N; Geba GP; Dakin P,"Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Teva Pharmaceuticals, Westchester, PA, USA.",Not available
39554272,It's About Time! Timing in Epilepsy Evaluation and Treatment.,2024-04-01,Lado FA,"Neurology, Johns Hopkins Medicine, Baltimore, MD, USA.",Not available
39554150,High-throughput development and characterization of new functional nanobodies for gene regulation and epigenetic control in human cells.,2024-11-03,Thurm AR,"Present address: Pharma Technical Development, Genentech, South San Francisco, CA, 94080.",Not available
39553483,Resistance to cosmetic botulinum toxin A: A 15-patient case series across 12 sites.,2025-01-01,Kaufman J; Sterling JB; Brasileiro F; Rosenberg M,"Dr. Jean Carruthers Cosmetic, Vancouver, Canada.; Private Practice, Coral Gables, Florida.; Private Practice, Sao Paulo, Brazil.; Skin Associates of South Florida, Coral Gables, Florida.",Not available
39553134,Coexisting Medullary and Papillary Thyroid Carcinomas: A Case of Dual Neoplasia With a High Risk of Misdiagnosis.,2024-01-01,Henao Rincon MA; Aristizabal Colorado D; Vernaza Trujillo DA Sr,"Epidemiology, Fundacion Universitaria del Area Andina, Bogota, COL.; Internal Medicine, Interinstitutional Group on Internal Medicine 1 (GIMI1), Universidad Libre, Cali, COL.; Otolaryngology, Universidad de Cartagena, Cartagena, COL.",Not available
39552477,"Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension.",2024-11-18,Snipes R,"UCB, Morrisville, North Carolina, USA.",Not available
39552383,Review Article: Green Management of IBD-New Paradigms for an Eco-Friendly Approach.,2025-01-01,Di Brino E,"Alta Scuola di Economia e Management Dei Sistemi Sanitari (ALTEMS), Universita Cattolica del Sacro Cuore, Roma, Italy.",Not available
39552079,Seasonal influenza vaccines: Variability of immune responses to B lineage viruses.,2024-12-31,Vicic N; Rudin D,"Moderna, Inc., Cambridge, MA, USA.",Not available
39551616,A Model-Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology.,2024-11-17,Zhang J; Takeda K; Takeuchi M; Komatsu K; Zhu J; Yamaguchi Y,"Data Science, Astellas Pharma China, Beijing, China.; Data Science, Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.; Early Development New Technologies, Astellas Pharma Inc, Tokyo, Japan.",Not available
39551600,"Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors.",2024-11-17,Gong M; Burton J; Tu E; Durham N,"AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA.; Oncology R&D, AstraZeneca PLC, Cambridge, Cambridgeshire, UK.; Translational Medicine, Cell Therapy and Oncolytic Viruses, BioPharmaceuticals R&D, AstraZeneca R&D Gaithersburg, Gaithersburg, Maryland, USA.","UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA davard@upmc.edu."
39551590,"Immunogenicity of adalimumab reference product and adalimumab-adbm in patients with rheumatoid arthritis, Crohn's disease and chronic plaque psoriasis: a pooled analysis of the VOLTAIRE trials.",2024-11-17,McCabe D; Bender S,"Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.","Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA vibekestrand@me.com."
39551235,A workflow for accurate and consistent quantitation of host cell proteins by SWATH LC-MS/MS analysis to support process development.,2024-11-16,Kufer R; Wohlrab S; Reckermann K,"Pharma Technical Development Analytics, Roche Diagnostics GmbH, Penzberg, Germany.","Protein Analytical Chemistry, Genentech, A Member of the Roche Group, South San Francisco, CA, United States. Electronic address: guo.jia@gene.com."
39551169,"Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study.",2024-11-15,Bayes-Genis A,"Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Centro de Investigacion Biomedica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.",Not available
39551123,The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project).,2025-01-01,Richard D; Quintana M; Wuersch K; Frieauff W; Brees D; Theil D,"Novartis Pharma AG, Basel, Switzerland; Novartis Pharma AG, Basel, Switzerland.; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland.; Universite Clermont Auvergne, INSERM, U1107, NEURO-DOL, CHU Clermont-Ferrand, Laboratoire de Pharmacologie et de Toxicologie, Clermont-Ferrand, France.; Universite Clermont Auvergne, INSERM, U1240, Imagerie Moleculaire et Strategies Theranostiques, Clermont-Ferrand, France.",Not available
39550721,Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.,2025-01-01,Glasauer A; Rohwedder K; Viswanathan P; Nodari S,"Bayer AG, Berlin, Germany.",Not available
39550716,"Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.",2025-01-01,Scalise A,"Bayer AG, Pharmaceuticals R&D, Pharmacovigilance, Wuppertal, Germany.",Not available
39550630,Transportability of model-based estimands in evidence synthesis.,2024-09-30,Remiro-Azocar A,"Methods and Outreach, Novo Nordisk Pharma, Madrid, Spain.",Not available
39550530,Effect of an 18-month meditation training on cardiovascular risk in older adults: a secondary analysis of the Age-Well randomized controlled trial.,2024-11-16,Gonneaud J; Felisatti F; Palix C; Ferrand Devouge E; Chocat A; de la Sayette V; Vivien D; Lutz A,"Normandie Univ, UNICAEN, INSERM, U1237, PhIND ""Physiopathology and Imaging of Neurological Disorders"", NeuroPresage Team, Institut Blood and Brain Caen-Normandie, Cyceron, Caen, 14000, France.",Not available
39550516,ACBP/DBI neutralization for the experimental treatment of fatty liver disease.,2024-11-16,Castera L,"Grupo de Investigacion en Reumatologia (GIR), Instituto de Investigacion Biomedica de A Coruna (INIBIC), Fundacion Profesor Novoa Santos, A Coruna, Spain.","Centre de Recherche des Cordeliers, Inserm U1138, Universite de Paris, Sorbonne Universite, Equipe labellisee par la Ligue contre le cancer, Institut Universitaire de France, Paris, France. omar.motino@uva.es."
39550175,Cardiogenic shock.,2024-11-16,Combes A,"Institute of Cardiometabolism and Nutrition, Sorbonne Universite, Paris, France; Service de Medecine Intensive-Reanimation, Institut de Cardiologie, APHP Sorbonne Universite Hopital Pitie-Salpetriere, Paris, France.",Not available
39549665,A systematic approach for estimating colloidal particle adsorption model parameters.,2025-01-04,Lorenz-Cristea O; Wiebe A; Thoma J; Veelders M; Briskot T; Kluters S; Wang G; Saleh D,"DSP Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39549622,Silicone-based AC102-loaded cochlear implant coatings protect residual hearing in an animal model of cochlear implantation.,2024-01-01,Kwiatkowska M; Schlingensiepen R,"Audiocure Pharma GmbH, Berlin, Germany.",Not available
39549594,Heart rate variability wrist-wearable biomarkers identify adverse posttraumatic neuropsychiatric sequelae after traumatic stress exposure.,2024-01-01,Germine LT,"Department of Psychiatry, Harvard Medical School, Boston, MA, 02115, USA; Institute for Technology in Psychiatry, McLean Hospital, Belmont, MA, 02478, USA; The Many Brains Project, Belmont, MA, 02478, USA.","Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27559, USA. Electronic address: lauriane_guichard@med.unc.edu."
39549200,Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice Experiment.,2024-11-16,Cloutier M; Gauthier-Loiselle M; Meng Y; Libchaber B; Jiang F,"Analysis Group, Inc., 1 Angel Court, 14th Floor, London, EC2R 7HJ, UK.; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montreal, Tour Deloitte, Suite 1500, Montreal, QC, H3B 0G7, Canada.",Not available
39548059,Loss of cytoplasmic actin filaments raises nuclear actin levels to drive INO80C-dependent chromosome fragmentation.,2024-11-15,Tarashev CVD; Helliwell SB; Gasser SM,"Buhlmann Laboratories AG, Baselstrasse 55, 4124, Schonenbuch, Switzerland.; Cellvie AG, Zurich, Switzerland.; Transition Bio Inc, 250 Arsenal St, Watertown, 02472, MA, USA.",Not available
39548011,Clinical features and risk factors for colorectal gas explosion during digestive endoscopy and surgery: a systematic review.,2025-01-01,Kurihara H,"Casa di Cura Villa Montallegro, Genoa, Italy.","Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy. gianeugenio.tontini@unimi.it."
39547487,"Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP Registry.",2024-11-13,Garcia-Doval I; Descalzo-Gallego MA,"Servicio de Dermatologia, Complejo Hospitalario Universitario de Vigo, Vigo, Espana; Unidad de Investigacion, Fundacion Piel Sana AEDV, Madrid, Espana.","Servicio de Dermatologia, Hospital Universitari Germans Trias i Pujol, Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Espana. Electronic address: vicente.peris@hotmail.com."
39547253,Hypothalamic obesity: from basic mechanisms to clinical perspectives.,2025-01-01,Chowen JA; Lopez M; Tena-Sempere M,"CIBER Fisiopatologia de la Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, Spain; CIBER Fisiopatologia de la Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, Spain.; Department of Endocrinology, Hospital Infantil Universitario Nino Jesus, Instituto de Investigacion La Princesa, Madrid, Spain; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.; IMDEA-Food Institute, Madrid, Spain; Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Spain","CIBER Fisiopatologia de la Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jesus.argente@fundacionendo.org."
39547056,Calcineurin/NFAT inhibitors maintain cognition in a preclinical prevention study in an aging canine model of Alzheimer disease.,2025-01-01,Puskas LG,"Aperus Pharma, Also kikoto sor 11/D, Szeged H-6726, Hungary.",Not available
39546308,Racial and Ethnic Differences in Prostate Cancer Epidemiology Across Disease States in the VA.,2024-11-04,Kim J; Shui IM; Freedland SJ,"Merck & Co, Inc, Kenilworth, New Jersey.",Not available
39546252,"Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review.",2024-11-15,Moretti D; Chiricozzi A,"Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, Rome, Italy.; Sanofi, Milan, Italy.",Not available
39546166,The Salmonella enterica EnvE is an Outer Membrane Lipoprotein and Its Gene Expression Leads to Transcriptional Repression of the Virulence Gene msgA.,2024-01-01,Lee YH,"MThera Pharma Co., Seoul, 07793, Republic of Korea.",Not available
39546129,Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies.,2024-11-15,Papp KA; Kircik L,"Blauvelt Consulting, LLC, Lake Oswego, OR, USA.; Incyte Corporation, Wilmington, DE, USA.","Oregon Health and Science University, 3303 S. Bond Ave, Portland, OR, 97239, USA. simpsone@ohsu.edu."
39544899,"A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE study.",2024-11-07,Fagan N,"TA Inflammation Medicine, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.",Not available
39544897,"Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease.",2024-11-05,Gordon G; Steffgen J,"Eicos Sciences, San Mateo, CA, USA.; Sanofi, Cambridge, MA, USA.",Not available
39544634,Impact of nebulization versus metered-dose inhaler utilization on viral particle dispersion in patients with COVID-19.,2024-07-22,Clay C; Yates W; Lat A; Ling Ching A; Clark D; Lewin D; Chen X,"Aligos Therapeutics, Inc., South San Francisco, CA, USA.; Dermavant Sciences, Inc., Morrisville, NC, USA.; Erasca, Inc., San Diego, CA, USA.; Statistically Speaking Consulting, LLC, Venice, FL, USA.; Theravance Biopharma US, Inc., South San Francisco, CA, USA. RINGGOLD: 7406",Not available
39544355,"Preclinical development and characterisation of PP353, a formulation of linezolid for intradiscal administration.",2024-01-01,Guest S; Birchall S; Bradley A; Brindley C; Corbett D; Cummings PJ; Harris J; Wise A; Czaplewski LG,Charles River Laboratories Ltd Currie UK.; Evotec (UK) Ltd Cheshire UK.; Kinetassist Ltd. Quothquan UK.; PJC Pharma Consulting Ltd Haverhill UK.; Persica Pharmaceuticals Ltd Kent UK.,Not available
39544354,"Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose study.",2024-01-01,McHale D; Guest S; Brindley C; Cummings P; Smith S; Scott G; Ruston S; Czaplewski L,GS Drug Development Sciences Ltd East Grinsted UK.; Kinetassist Ltd Quothquan UK.; PJC Pharma Consulting Ltd Suffolk UK.; Persica Pharmaceuticals Ltd Canterbury Kent UK.; Weatherden Ltd London UK.,Not available
39544333,Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient Survey.,2024-10-14,Levit NA; Shi L; Kaplan B,"AbbVie Inc, North Chicago, IL, USA. RINGGOLD: 359181; Dermatology Physicians of Connecticut, Fairfield, CT, USA.",Not available
39543334,"Structure-activity relationship studies of ME1111, a novel antifungal agent for topical treatment of onychomycosis.",2025-01-01,Iida M; Ohyama M; Kaneda K; Tabata Y,"Meiji Seika Pharma Co. Ltd, Chuo-ku, Tokyo, Japan.","Meiji Seika Pharma Co. Ltd, Chuo-ku, Tokyo, Japan. naomi.takei@meiji.com."
39543217,Associating EEG functional networks and the effect of sleep deprivation as measured using psychomotor vigilance tests.,2024-11-14,Anderson C,"Neuronostics Limited, Engine Shed, Station Approach, Bristol, UK.","Centre for Systems Modelling and Quantitative Biomedicine, University of Birmingham, Birmingham, B15 2TT, UK. s.l.mason@bham.ac.uk."
39542508,Going astray with a smoking Traviata?,2024-01-01,Studnicka M,"Centro de Investigacion en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.","Facultat de Medicina, Universitat de les Illes Balears, Palma, Spain jbsoriano2@gmail.com."
39542473,"Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trial.",2024-11-14,Yucel A; Guo S; Pelligra CG; Shields AL; Shetty JK; Bueno LM,"Adelphi Values, Boston, Massachusetts, USA.; Bristol Myers Squibb, Madison, New Jersey, USA.; Bristol Myers Squibb, Princeton, New Jersey, USA.; Evidera, Atlanta, Georgia, USA.; Evidera, Waltham, Massachusetts, USA.","Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon ataher@aub.edu.lb."
39541997,Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium.,2024-01-01,Mauricio D,"CIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; Department of Endocrinology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.; Institut Catala de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol, Barcelona, Spain","School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: dianna.magliano@baker.edu.au."
39541621,PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trials.,2024-01-01,Arkenau HT,"Ellipses Pharma, London, UK.","Medical Oncology Unit, Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy. Electronic address: vincenzo.formica@uniroma2.it."
39541202,Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial.,2024-11-14,Luo X; Gu S; Yu W; Xu K; Zhang S; Yu J,"Shanghai Junshi Biosciences Co Ltd, Shanghai, China.; TopAlliance Biosciences Inc, Rockville, Maryland.",Not available
39541109,Patient-Reported Outcomes in RLBP1 Retinal Dystrophy: Longitudinal Assessment in a Prospective Natural History Study.,2024-11-04,Spera C; Mullins A; Deslandes JY; Su Z; Lu D,"Beijing Novartis Pharmaceuticals Corporation, Shanghai, China.; Novartis Pharma AG, Basel, Switzerland.",Not available
39541038,Correction: Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe.,2024-01-01,Hanson KA; Schaefer G; Kurosky SK; Vano-Galvan S,"Pfizer Inc, New York, NY, USA.; Pfizer Pharma GmbH, Berlin, Germany.","Adelphi Real World, Bollington, UK. peter.anderson@adelphigroup.com."
39540734,"Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.",2024-12-05,Neely M; Engelhardt M; Jones M,"Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.",Not available
39540661,"Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.",2025-01-01,Palmerini E; Sebio A,"Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz, Madrid, Spain.; Osteoncology, Bone and Soft Tissue Tumors and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.",Not available
39540398,The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring.,2024-11-14,Hinzmann R,"Equalis AB, Uppsala, Sweden.",Not available
39539991,"Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial.",2024-01-01,Nystrom A,"Crowd Pharma GmbH, Pforzheim, Germany.",Not available
39539327,Strategies for Preventing Tunnel Convergence in Multiligament Knee Injury Reconstructions.,2024-01-01,Tollefson LV; Shoemaker EP; LaPrade RF,"Twin Cities Orthopedics, Edina, MN USA. ROR: https://ror.org/01en4s460. GRID: grid.470021.0. ISNI: 0000 0004 0628 2619",Not available
39539021,A machine learning model for predicting worsening renal function using one-year time series data in patients with type 2 diabetes.,2025-01-01,Kimura K; Furukoshi M; Masuda T; Enomoto M,"Asahi Kasei Corporation, Tokyo, Japan.",Not available
39538176,"Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma.",2024-11-14,Peris K; Guneli N; Arntz R; Hauschild A,"Dermatologia, Dipartimento Di Medicina E Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, Rome, Italy.; SUN Pharmaceuticals Germany GmbH, Leverkusen, Germany.; Sun Pharmaceutical Industries B.V, Hoofddorp, Netherlands.","Universitatsklinik fur Dermatologie, Venerologie, Allergologie und Phlebologie, Johannes Wesling Klinikum, Minden, Germany. Ralf.Gutzmer@muehlenkreiskliniken.de."
39538001,Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial.,2024-11-14,Desai D; Zhu L; Abulon D,"Astellas Pharma US, Northbrook, IL, USA.; Formerly Astellas Pharma Global Development, Inc., Northbrook, IL, USA.",Not available
39537976,Psychometric evaluation of the Functional Assessment of chronic illness therapy-fatigue (FACIT-Fatigue) in adults with moderately to severely active Crohn's disease.,2024-11-13,Vadhariya A; Durand F; Stassek L; Kawata AK,"Eli Lilly and Company, Indianapolis, IN, USA.; Evidera, Wilmington, NC, USA.",Not available
39537932,NK2R control of energy expenditure and feeding to treat metabolic diseases.,2024-01-01,Urena MG; Kristensen CK,"Embark Laboratories, Copenhagen, Denmark.",Not available
39537753,Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFbeta.,2024-01-01,Oakley F,"Bioscience, Early Oncology, AstraZeneca, Cambridge, UK.",Not available
39537604,Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction.,2024-11-13,Gregersen PK; Huijbers MG; Stascheit F; Meisel A; Ripke S,"deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.",Not available
39537503,Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America.,2024-11-12,Broder MS; Chang E; Yermilov I; Campos C; Gibbs SN,"PHAR, 324 South Beverly Drive, Suite 350, Beverly Hills, California 90212, USA.","Western University, 1151 Richmond Street North, London, Ontario N6A 5B7, Canada. Electronic address: hegele@robarts.ca."
39537400,Assessing the reliability of the FricTest((R)) 4.0 for diagnosing symptomatic dermographism.,2024-01-01,Maurer M; Zampeli V; Magerl M,"Genentech Inc., 1 DNA Way, South San Francisco, California, USA.",Not available
39536691,Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.,2024-11-12,Joly F; Gropp-Meier M; Lowe ES; Pujade-Lauraine E,"ARCAGY-GINECO Universite Paris Descartes, AP-HP, Paris, France.; Arbeitsgemeinschaft Gynakologische Onkologie Studiengruppe, (AGO), Germany; Centre Francois Baclesse, Caen, France.; Global Medicines Development, Oncology, AstraZeneca, Gaithersburg, MD, USA.; Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France; Onkologie Ravensburg, Ravensburg, Germany.","Department of Medical Oncology, Wollongong Hospital, Wollongong, NSW 2500, Australia. Electronic address: katherine.francis@sydney.edu.au."
39534769,Characteristics of exacerbators in the US Bronchiectasis and NTM Research Registry: a cross-sectional study.,2024-01-01,Winthrop KL; Metersky ML,"Insmed Incorporated, Bridgewater, NJ, USA.",Not available
39534491,The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancer.,2024-01-01,Pereira Catarata MJ,"Inserm UMR 1272 ""Hypoxia and the Lung"", UFR Sante, Medecine, Biologie Humaine (SMBH), Universite Sorbonne Paris Nord (USPN), Bobigny, France.",Not available
39529946,Social Media Behavior Guidelines for Healthcare Professionals: An American Society of Pain and Neuroscience NEURON Project.,2024-01-01,Saia-Owenby C; Andriano C; Bailey-Classen A; Buchanan P; Dudas A; Lee DW; Mandell L; Rabii M,"Crimson Pain Management, Overland Park, KS, USA.; Georgia Pain Care, Stockbridge, GA, USA.; Interventional Pain and Spine, Fullerton Orthopedics, Yorba Linda, CA, USA.; MOXY Company, Covington, LA, USA.; Maya & Schnapp, Neurospine and Pain, Memphis, TN, USA.; Spanish Hills Interventional Pain Specialists, Camarillo, CA, USA.; Trinity Pain Medicine Associates, Fort Worth, TX, USA.",Not available
39526247,Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancer.,2024-01-01,Tombal B,"Cliniques Universitaires Saint-Luc, Brussels, Belgium.",Not available
39526078,Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials.,2024-01-01,Lazin K; Keating M; Goetsch M; Wu J; Loftus EV Jr,"Pfizer AG, Zurich, Switzerland.; Pfizer Inc., New York, NY, USA.; Pfizer Ltd, Sandwich, UK.; Pfizer Switzerland AG, Scharenmoosstrasse 99, 8052 Zurich, Switzerland.",Not available
39525291,Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease.,2024-01-01,Cavalli C,"Division of Gastroenterology, Fondazione IRCCS ""Casa Sollievo della Sofferenza,"" San Giovanni Rotondo, Italy.",Not available
39524435,Immunological characteristics of bronchoalveolar lavage fluid and blood across connective tissue disease-associated interstitial lung diseases.,2024-01-01,Bassler K,"Aimed Analytics GmbH, Bonn, Germany.",Not available
39524363,"A multi-market comparison of composition, formulation, and label content of CBD e-liquids.",2024-11-15,Hoeng J; Latino DARS; Schlage WK; Mazurov A; Sherwood N; McKinney WJ; Fearon IM,"Consultant in Biology, Bergisch Gladbach, Germany.; McKinney Regulatory Science Advisors, LLC, Henrico, Virginia, USA.; Rosa Serra Latino Consulting, Zug, Switzerland.; Vectura Fertin Pharma, Basel, Switzerland.; whatIF? Consulting Ltd, Harwell, UK.",Not available
39524180,"Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023.",2024-01-01,Karasawa H; Mizoguchi H; Miyano M; Moriya Y; Takakura K; Suzuki K; Tsurumaki Y; Watanabe T; Wen K; Yoneda T; Yuan TT; Nomura M,"Asahi Kasei Corporation, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo, 100-0006, Japan.; Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan.; Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan.; Chugai Pharmaceutical Co., Ltd., 5-1, Ukima 5-Chome, Kita-ku, Tokyo, 115-8543, Japan.; Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.; GenomeFrontier Therapeutics, Inc., 23F., No. 95, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, 221416, Taiwan.; MEDINET Co., Ltd., 6-1-1 Heiwajima, Ota-ku, Tokyo, 143-0006, Japan.; Novartis Pharma K.K., 1-23-1, Toranomon, Minato-ku, Tokyo, 105-6333, Japan.; TFBS Bioscience Inc., 3F., No.103, Ln. 169, Kangning St., Xizhi Dist., New Taipei City, Taiwan.; Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-Chome Fujisawa, Kanagawa, 251-8555, Japan.",Not available
39535745,Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.,2024-11-04,Avery RL; Gibiansky L; Gibiansky E; Stoilov I,"California Retina Consultants, Santa Barbara, California, USA.; Genentech, Inc., South San Francisco, California, USA.; QuantPharm LLC, North Potomac, Maryland, USA.",Not available
39535744,Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease.,2024-11-04,Gibiansky L; Gibiansky E; Gaudreault J,"JJG Pharma Consulting, Basel, Switzerland.; QuantPharm LLC, North Potomac, MD, USA.",Not available
39535661,Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.,2024-11-13,Mozaffar T; Shohet S,"Centro de Investigacion en Red en Enfermedades Raras (CIBERER), Barcelona, Spain.; Certara GmbH, Lorrach, Germany.",Not available
39534481,Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies.,2024-01-01,Lyris N; Walsh JA,"UCB, Colombes, France.",Not available
39534064,Dataset on characterisation and stability of gingival retraction cord lignocaine-adrenaline nanogel optimised using central composite design.,2024-01-01,Lestari W,"IKOP PHARMA Sdn. Bhd., 25200 Kuantan, Pahang, Malaysia.",Not available
39534017,Assessing the Fiscal Burden of Overweight and Obesity in Japan through Application of a Public Economic Framework.,2024-01-01,Copeland C; Kotsopoulos N; Ota R; Capucci S,"Global Market Access Solutions Sarl, Chardonne, Switzerland.; Novo Nordisk Pharma Ltd.; Novo Nordisk Pharma Ltd. & Novo Nordisk A/S.",Not available
39533710,Optimizing CAR-T treatment: A T(2)EVOLVE guide to raw and starting material selection.,2024-11-12,Tanaka T; Schapitz I; Ammar D; Schroeder B,"Astellas Pharma B.V., Leiden, the Netherlands.; Astellas Pharma Inc, Tokyo, Japan.; Bayer Vital GmbH, Leverkusen, Germany.; Miltenyi Biotec B.V. & Co KG, Bergisch Gladbach, Germany.","Hospital Clinic de Barcelona, Seccio d'Immunoterapia - Servei d'Immunologia, Barcelona, Spain. Electronic address: senavarro@clinic.cat."
39533349,Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study.,2024-11-12,Lagunes-Galindo I; Bu X; Wung P; Kato K; Shmagel A,"Immunology, AbbVie Inc, North Chicago, IL, USA.","Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Claudiusstr. 45, 44649, Herne, Nordrhein- Westfalen, Germany. xenofon.baraliakos@elisabethgruppe.de."
39533157,"A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib.",2025-01-01,Rubinacci M; Dai D; Rajper AW; Tecson K; Wooddell M,"Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.",Not available
39532861,Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.,2024-11-12,Kenny A; Lin BC; Gray GE; Truyers C,"Centivax, South San Francisco, CA, USA.; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.; Sanofi Vaccines R&D, Marcy l'etoile, France.; Vaccine Company Inc., South San Francisco, CA, USA.",Not available
39532835,Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial.,2024-11-12,Cope L,"Akoya Biosciences, Marlborough, USA.",Not available
39532780,Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.,2024-01-01,Nixon A; Dent JE,"Chilli Consultancy, Salisbury, UK.","SKiN Centre for Dermatology, Queen's University and Probity Medical Research, 775 Monaghan Road, Peterborough, ON, Canada. mgooderham@centrefordermatology.com."
39532540,Effectiveness of the Additional Risk Minimisation Measures for Valproate Among Healthcare Professionals and Patients: A Cross-Sectional Survey in Six European Countries.,2024-01-01,Colas S; Nishikawa T; Kaplan S; Marinier K; Lachacinski A; Kurzinger ML; Toussi M,"Epidemiology and Benefit Risk, Global R&D, Sanofi, Paris, France.; Epidemiology and Benefit Risk, Global R&D, Sanofi, Toronto, Canada.; Epidemiology, Teva Pharmaceutical Industries Ltd, Netanya, Israel.; Patient Safety & Pharmacovigilance, Sanofi, Paris, France.; Real World Solutions, IQVIA, Courbevoie, France.",Not available
39532519,Prevalence of epilepsy: a population-based cohort study in Denmark with comparison to Global Burden of Disease (GBD) prevalence estimates.,2024-11-27,Aaberg KM,"KEMRI-Wellcome Trust Collaborative Programme, Kilifi, Kenya.","Department of Clinical Medicine, Aarhus University, Aarhus, Denmark jakob@farm.au.dk."
39532310,Cure as a treatment target in rheumatoid arthritis and systemic sclerosis-achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration.,2024-11-12,Smith E,"AbbVie Inc, Cambridge, Massachusetts, USA.",Not available
39531903,"Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).",2024-11-11,Buscema J,"Gynecologic Oncology, Arizona Oncology, Tucson, AZ, USA.","National Cancer Institute-sponsored NRG Oncology, Washington University School of Medicine, St Louis, MO, USA. Electronic address: mpowell@wustl.edu."
39531538,"A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas.",2025-01-06,Mikhailova N; Elbadri R; Hajela P; Ravenstijn P; Pinto S; Garcia L; Overesch A; Pietzko K; Horwitz S,"Affimed GmbH, Mannheim, Germany.; Affimed Inc., New York, New York.; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia ""Seragnoli,"" Bologna, Italy.",Not available
39531466,Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.,2024-01-01,Almutairi AR; Almadi M,"Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.; Path Economics, LLC, Amman, Jordan.",Not available
39531096,Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.,2025-01-01,Noda M,"Non-Profit Organization Sasaeau-Kai ""Alpha"", 518-7 Kawado-Cho, Chuo-Ku, Chiba, 2600802, Japan.",Not available
39530971,"Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders.",2024-10-05,Lorente M; Pendleton M; Register A; Walker K,"Kyverna Therapeutics, Inc, Emeryville, California, USA.",Not available
39530574,Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China.,2024-01-01,Kim E; Zhang J; Li Y; Xu C; Kadeerbai H; Lee S; Gorla S,"Astellas (China) Investment co., Ltd., Beijing, China.; Astellas Pharma Inc., Northbrook, Illinois, USA.; Pfizer Inc, Bothell, Washington, USA.",Not available
39528920,Safety comparison of single-donor and pooled fecal microbiota transfer product preparation in ulcerative colitis: systematic review and meta-analysis.,2024-11-11,Levast B; Fontaine M; Dore J,"MaaT Pharma, Lyon, France.; Universite Paris-Saclay, INRAE, MetaGenoPolis, AgroParis Tech, MICALIS, Jouy-en-Josas, 78350, France.","MaaT Pharma, Lyon, France. blaperrousaz@maat-pharma.com."
39528795,Structural basis of the mechanism and inhibition of a human ceramide synthase.,2024-11-11,Tautermann CS; Traub M; Carpenter EP; Schnapp G,"Boehringer Ingelheim Pharma, GmbH & Co. KG, Biberach, Germany.","Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK. tomas.pascoa@cmd.ox.ac.uk."
39528351,Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential alpha-Synuclein PET Radioligand.,2024-11-20,Sunnemark D; Bergare J; Artelsmair M; Nordvall G; Forsberg Moren A,"AlzeCure Pharma AB, Halsovagen 7, SE-141 57 Huddinge, Sweden.; Isotope Chemistry, Drug Safety and Metabolism, AstraZeneca, Pepparedsleden 1, SE-431 83 Molndal, Sweden.; Offspring Biosciences, Sweden AB, SE-151 36 Sodertalje, Sweden.",Not available
39528343,Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression.,2024-01-01,Fernandes A; Clamp D; Asin B; Eberhardt A,"Otsuka Pharma GmbH, Frankfurt am Main, Germany.; Otsuka Pharmaceutical Development & Commercialization Inc., Rockville, MD, USA.; Otsuka Pharmaceutical Europe Ltd., Wexham, UK.",Not available
39527961,Antimicrobial resistance among refugees and asylum seekers: a global systematic review and meta-analysis.,2025-01-01,Becker T,"Pfizer Pharma, Berlin, Germany.","Pfizer, New York, NY, USA. Electronic address: elizabeth.hermsen@pfizer.com."
39527880,"Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 ""Patria"" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico.",2025-01-01,Torres M; Castro-Castrezana L; Colli-Dominguez AA; Rivera-Hernandez T; Torres-Flores A; Damian-Hernandez M; Ramirez-Martinez L; la Rosa GP; Rojas-Martinez O; Suarez-Martinez A; Peralta-Sanchez G; Carranza C; Juarez E; Zamudio-Meza H; Carreto-Binaghi LE; Viettri M; Romero-Rodriguez D; Palencia A; Reyna-Rosas E; Marquez-Garcia JE; Sarfati-Mizrahi D; Chagoya-Cortes HE; Castro-Peralta F,"CAIMED Investigacion en Salud, S. A. de C. V., CDMX, Mexico.; CEMDEC, S.A. de C.V., CDMX, Mexico.; Consultora Mextrategy, S.A.S. de C.V., CDMX, Mexico.; Investigadores por Mexico, Consejo Nacional de Humanidades, Ciencias y Tecnologias (CONAHCYT), CDMX, Mexico.; Laboratorio Avi-Mex S.A. de C.V., CDMX, Mexico.; Laboratorio BSL3 INER, ""Ismael Cosio Villegas"", CDMX, Mexico.; Laboratorio Nacional CONAHCYT de Investigacion y Diagnostico por inmunocitofluorometria INER, ""Ismael Cosio Villegas"", CDMX, Mexico.; Laboratorio de Inmunobiologia de la Tuberculosis, Instituto Nacional de Enfermedades Respiratorias (INER) ""Ismael Cosio Villegas"", CDMX, Mexico.; Oaxaca Site Management Organization (OSMO) S.C., Oaxaca, Mexico.; Posgrado en Inmunologia, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, CDMX, Mexico.; Unidad de Investigacion Medica en Inmunoquimica, UMAE Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de Mexico (CDMX), Mexico","Unidad de Investigacion Medica en Inmunoquimica, UMAE Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de Mexico (CDMX), Mexico. Electronic address: constantino.lopez@imss.gob.mx."
39527674,Discovery of Novel SIRT3 Inhibitors for the Cancer Differentiation Therapy by Structural Modification.,2024-01-01,Xu G; Li F,"Harway Pharma Co., LTD, Dongying, Shandong, China.; Weifang Synovtech New Material Technology CO., LTD, Weifang, Shandong, China.",Not available
39527466,Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.,2024-01-01,Tombal B; Kakiuchi H; Akiyama M; Kuss I; Joensuu H,"Bayer AG, Berlin, Germany.; Bayer Yakuhin, Ltd, Osaka, Japan.; Bayer Yakuhin, Ltd, Tokyo, Japan.; Division of Urology, IREC, Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium.; Orion Corporation, Espoo, Finland.",Not available
39527337,Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.,2024-11-11,Signorovitch J; Innis B; Gooch K,"Analysis Group, Inc, Boston, MA, USA.; Sarepta Therapeutics, Inc, Cambridge, MA, 02142, USA.","Sarepta Therapeutics, Inc, Cambridge, MA, 02142, USA. aklimchak@sarepta.com."
39526953,"Reactions of In Situ-Generated Difluorocarbene (:CF(2)) with Aromatic/Heteroaromatic Alcohols, Thiols, Olefins, and Alkynes under Environmentally Responsible Conditions.",2024-12-06,Gallou F; Heinz L,"Chemical & Analytical Development, Novartis Pharma AG, 4056 Basel, Switzerland.",Not available
39526612,Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta-analysis.,2024-01-01,Zhong Y; Cichewicz A; Borkowska K; Westley T; Kisa RM,"Bristol Myers Squibb, Princeton, New Jersey, USA.; Evidence Synthesis, Modeling and Communication, PPD Poland, Warsaw, Poland.; Evidera, Evidence Synthesis, Modeling and Communication, Waltham, Massachusetts, USA.; Worldwide HEOR, Bristol Myers Squibb, Princeton, New Jersey, USA.",Not available
39525480,"Does the impact of medical publications vary by disease indication and publication type? An exploration using a novel, value-based, publication metric framework: the EMPIRE Index.",2022-01-01,Rees T; Pal A,"Novartis Pharma AG, Basel, Switzerland.; Oxford PharmaGenesis, Oxford, Oxfordshire, OX13 5QJ, UK.",Not available
39523886,The three-domain impact framework for characterizing impact of patient involvement in health technology assessment.,2024-11-11,Lopez Gousset V,"VLG Consulting, Paris, France.",Not available
39523516,"Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study.",2024-01-01,Miyamoto K; Miller RM; Voors-Pette C; Oosterhaven JAF; Sato Y; Matsuda N; Kirita S; Sawa M; Arimura A,"Artemida Pharma, Ltd., Hertfordshire, UK.; Carna Biosciences, Inc., Kobe, Japan.; CarnaBio USA, Inc., South San Francisco, California, USA.; ICON plc, Groningen, The Netherlands.; QPS Netherlands BV, Groningen, The Netherlands.",Not available
39522835,Powder dosing within continuous manufacturing: A lean approach for gravimetric dosing configuration and equipment selection.,2024-12-25,Schneider P; Maus M,"Department of Pharmaceutical Technology, University of Bonn, Gerhard-Domagk-Strasse 3, 53121 Bonn, Germany.; Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany; Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany.",Not available
39522729,Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: Primary results from a randomized phase 2 study.,2024-11-09,Carruthers J; Rivers JK; Humphrey S; Pan G; Bowen B; Lee E; Brin MF,"Allergan Aesthetics, An AbbVie Company, Irvine, California; Allergan Aesthetics, An AbbVie Company, Irvine, California.; Department of Dermatology and Skin Science, University of British Columba, Vancouver, British Columbia, Canada; Department of Dermatology and Skin Science, University of British Columba, Vancouver, British Columbia, Canada.; Dr Jean Carruthers Cosmetic Surgery Inc., Vancouver, British Columbia, Canada.; Humphrey Cosmetic Dermatology, Vancouver, British Columbia, Canada.; Pacific Derm, Vancouver, British Columbia, Canada",Not available
39522654,"Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.",2024-11-08,Blauvelt A; Wei X; Wong W; Solente AC; Weber C; Adelman S; Davey S; Hurbin F; Yen K; O'Malley JT; Bernigaud C,"Blauvelt Consulting, LLC, Lake Oswego, Ore.; Sanofi, Basel, Switzerland.; Sanofi, Bridgewater, NJ.; Sanofi, Cambridge, Mass.; Sanofi, Montpellier, France.; Sanofi, Paris, France.","Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany. Electronic address: sweidinger@dermatology.uni-kiel.de."
39521282,"Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting.",2024-11-07,Westcott-Chavez A,"IFPIES, Point Pleasant, NJ.","Department of Pediatrics, Division of Pediatric Allergy and Immunology, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: Anna.nowak-wegrzyn@nyulangone.org."
39520800,Willingness and skills among students from non-health academic fields in providing efficient basic life support.,2024-01-01,Sugimoto PN; Gouvea GB; Salles IC; de Carvalho HB; Aikawa P; Azi LMTA; da Silva LFF; Macchione M; Carmona MJC,"Anesthesiology Discipline, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Sao Paulo, SP, Brazil.; Department of Pathology, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Sao Paulo, SP, Brazil.; Education, Assessment and Intervention in Cardiovascular Group, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Sao Paulo, SP, Brazil; Education, Assessment and Intervention in Cardiovascular Group, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Sao Paulo, SP, Brazil.; Federal University of Bahia, Bahia, BA, Brazil.; Institute of Biological Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Rio Grande do Sul, RS, Brazil.; Preventive Department, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), Sao Paulo, SP, Brazil.",Not available
39520771,Cost-effectiveness of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a US payer perspective.,2024-11-08,Coleman RL; Walder L; Burton M,"FIECON Ltd, London, UK.; Texas Oncology, The Woodlands, TX, USA.",Not available
39520658,"A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.",2024-11-09,Ruston L; Wilson D; Mallard N,"DJWstats Consulting, Whaley Bridge, UK.; Seda Pharmaceutical Development Services, Stockport, UK.; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK.","TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK. G.Clack@theracryf.com."
39520445,Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction: A Global Perspective.,2024-10-28,Ghadanfar M; Schweizer A; Obergfell A,"Novartis Pharma, Basel, Switzerland.",Not available
39519785,Influence of Solvent Polarity on Crocin Content and Surface Properties of Saffron (Crocus sativus L.) Extracts.,2024-10-31,Rocchi R,"Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise ""G. Caporale"", Via Campo Boario, 64100 Teramo, Italy.",Not available
39519605,Validation of a Food Frequency Questionnaire: VioScreen-Allergy.,2024-11-02,Weiss R; Fuller KNZ,"Viocare, Inc., Princeton, NJ 08542, USA.",Not available
39519232,Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.,2024-10-30,Sampei Z; Gan SW; Fukuzawa T; Tsuboi Y; Gotoh A; Ueda Y,"Chugai Pharmaceutical Co., Ltd., Yokohama 244-8602, Japan.",Not available
39519026,NIK Is a Mediator of Inflammation and Intimal Hyperplasia in Endothelial Denudation-Induced Vascular Injury.,2024-10-25,Ribagorda M; Sanchez-Diaz T; Sanz AB; Ortiz A,"Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas de la Universidad Autonoma de Madrid, 28049 Madrid, Spain.; Departamento de Farmacologia, Facultad de Medicina, Universidad Autonoma de Madrid, 28049 Madrid, Spain.; RICORS2040, 28040 Madrid, Spain.",Not available
39518760,IgA Vasculitis (Henoch-Schonlein Purpura): An Update on Treatment.,2024-11-04,Castaneda S; Floranes P; Uriarte-Ecenarro M; Valero-Martinez C; Vicente-Rabaneda EF; Gonzalez-Gay MA,"Rheumatology Division, H. Universitario La Princesa, IIS-Princesa, 28006 Madrid, Spain.",Not available
39518701,A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary.,2024-10-31,Reiber I; Rokszin G; Fabian I; Csanadi Z,"Novartis Hungary Ltd., Bartok Bela ut 43.47, 1114 Budapest, Hungary.; RxTarget Ltd., Bacso Nador u. 10. fsz. 2, 5000 Szolnok, Hungary.",Not available
39518471,"Unveiling the Impact of Moderate and Severe Atopic Dermatitis: Insights on Burden, Clinical Characteristics, and Healthcare Resource Utilization in Adult Greek Patients from the APOLO Cross-Sectional Study.",2024-10-23,Skiadas I; Nakou M; Koulias C,"Pfizer Hellas SA, 15451 Neo Psichiko, Greece.",Not available
39518447,Beyond Boundaries of a Trial: Post-Market Clinical Follow-Up of SOYA Patients.,2024-10-22,Gimeno M; Coronel P,"Scientific Depart, mentMeiji Pharma Spain, 28802 Madrid, Spain.",Not available
39517999,Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.,2024-10-22,Lugowska I; Chiarion-Sileni V; Teterycz P; Schnecko P; Jiang S; Burke T; Rutkowski P,"Alcedis GmbH, 35394 Giessen, Germany.; Instytut im. Marii Sklodowskiej-Curie, 02-781 Warsaw, Poland.; Istituto Oncologico Veneto, IOV-IRCCS, 35128 Padova, Italy.; Merck & Co., Inc., Rahway, NJ 07065, USA.",Not available
39516878,Expediting treatments in the 21st century: orphan drugs and accelerated approvals.,2024-11-08,Kennedy A,"Light Pharma Inc, Cambridge, Massachusetts, USA.","Light Pharma Inc, Cambridge, Massachusetts, USA. reuben.domike@lightpharma.com."
39516454,"Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.",2024-01-01,Kokolakis G; Soliman AM; Rubant S; Thaci D,"AbbVie Inc., North Chicago, IL, USA.; Arlington Dermatology, Rolling Meadows, IL, USA.","The Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Salford Royal NHS Foundation Trust, Irving Building, Salford, Manchester, M6 8HD, UK. richard.warren@manchester.ac.uk."
39516370,Phase 1b/2 study of the liposomal formulation of eribulin (E7389-LF) in combination with nivolumab: Results from the phase 2 esophageal cancer cohort.,2024-09-04,Hirao M; Kaname S; Matsuoka D; Otake Y; Yasuda K; Takase T; Takashima S; Semba T,"Eisai Co., Ltd., Ibaraki, Japan.; Eisai Co., Ltd., Tokyo, Japan.; NHO, Osaka, Japan.; Ono Pharmaceutical Co., Ltd., Osaka, Japan.","Kanagawa Cancer Center, Yokohama, Japan. oshimat@kcch.jp."
39516359,Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational study.,2024-10-23,Bottelli A; Lefort F; Vulsteke C,"Oncologia Medica Genito-Urinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.",Not available
39516248,Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia.,2024-07-11,Wu D; Zagrijtschuk O,"PharmaEssentia Biotech (Beijing) Limited, Beijing, China.; PharmaEssentia USA, Burlington, MA, USA.","Department of Haematology and Oncology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan. kirito@yamanashi.ac.jp."
39516087,Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With Momelotinib.,2024-10-16,Ellis C; Strouse B; Gonzalez Carreras FJ,"GSK plc, Philadelphia, PA.; GSK plc, Stevenage, UK.","Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: Claire.Harrison@gstt.nhs.uk."
39516085,Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance Study.,2024-10-10,Mohedo FH; Paolini S; Vasconcelos A; Kim I; Prebet T,"Bristol Myers Squibb, Princeton, NJ.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli,"" Bologna, Italy.; Instituto de Investigacion Biosanitaria de Granada (ibs.GRANADA)","Hematology Clinic, Azienda Ospedaliera Universitaria delle Marche, Universita Politecnica delle Marche, Ancona, Italy. Electronic address: a.poloni@univpm.it."
39516011,Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient data.,2024-11-07,Duarte C; van der Heijde D,"INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, INSERM, Sorbonne Universite, Paris, France.; Rheumatology, ULS de Coimbra EPE, Coimbra, Portugal.",Not available
39515836,Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials.,2024-12-16,Wandel S; Chen CW; Lefkowitz M; Soergel D; Gimpelewicz C,"Development, Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hannover, NJ, USA.",Not available
39515835,Dynamics of the gut microbiome in individuals at risk of rheumatoid arthritis: a cross-sectional and longitudinal observational study.,2024-11-08,Jeffery IB,"4D Pharma PLC, Cork, Ireland.","Leeds Institute of Medical Research, University of Leeds, Leeds, UK c.rooney@leeds.ac.uk."
39515409,Importance of tailored non-clinical safety testing of novel antimalarial drugs: Industry best-practice.,2024-01-01,Venishetty VK,"Pharmacokinetic Sciences, Novartis Pharma AG, Hyderabad, India.","Chemical and Preclinical Safety, Merck Healthcare KGaA, Darmstadt, Germany. Electronic address: philip.hewitt@merckgroup.com."
39515247,"Novel synthetic UV screen compounds inspired in mycosporine-like amino acids (MAAs): Antioxidant capacity, photoprotective properties and toxicity.",2024-01-01,Castro-Varela P; Vega J; Losantos R; Penin B; Lopez-Condor L; Pacheco MJ; Redoli SL; Mari-Beffa M; Abdala-Diaz R; Sampedro D,"Departamento de Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Universidad de Malaga, Malaga, Spain.; Departamento de Botanica, Facultad de Ciencias Naturales y Oceanograficas, Universidad de Concepcion, Chile.; Departamento de Quimica, Instituto de Investigacion en Quimica (IQUR), Universidad de La Rioja, Madre de Dios, 53, 26006 Logrono, La Rioja, Spain.; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), Malaga, Spain; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), Malaga, Spain.; Universidad de Malaga, Instituto Andaluz de Biotecnologia y Desarrollo Azul (IBYDA), Centro Experimental Grice Hutchinson, Lomas de San Julian, 2, 29004 Malaga, Spain; Universidad de Malaga, Instituto Andaluz de Biotecnologia y Desarrollo Azul (IBYDA), Centro Experimental Grice Hutchinson, Lomas de San Julian, 2, 29004 Malaga, Spain.","Universidad de Malaga, Instituto Andaluz de Biotecnologia y Desarrollo Azul (IBYDA), Centro Experimental Grice Hutchinson, Lomas de San Julian, 2, 29004 Malaga, Spain. Electronic address: felix_lopez@uma.es."
39513970,"Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial.",2024-11-08,Bruno BJ; Weavil JC; Ogle J; Chidambaram N; Galati JS; DelConte A; Lai JC,"Lipocine Inc., Salt Lake City, UT, USA.; Liver Specialists of Texas, Houston, TX, USA.",Not available
39513224,Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study.,2024-01-01,Yan X; Neuteboom S; Christensen JG; Chao R,"Mirati Therapeutics Inc., San Diego, CA 92121, USA.",Not available
39512431,"Disease burden among patients with Arginase 1 deficiency and their caregivers: A multinational, cross-sectional survey.",2024-01-01,Widen J; Jacobson L,Immedica Pharma AB Stockholm Sweden.,Not available
39512277,Analyzing public discourse of dementia from Spanish and English tweets: a comparative analysis with other neurological disorders.,2024-01-01,Munoz-Manchado LI; Saeidi M,"Departamento Teoria de la Senal y Comunicaciones y Sistemas Telematicos y Computacion, Escuela Tecnica Superior de Ingenieria de Telecomunicacion, Universidad Rey Juan Carlos, Fuenlabrada, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.",Not available
39512136,Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study.,2024-01-01,Jurek M; Clark A; Turner SM; Barnes CN; Achneck HE; Cosgrove GP; Lefebvre EA; Flaherty KR,"Former employee of Pliant Therapeutics, Inc., South San Francisco, CA, USA.; MedQIA LLC, Los Angeles, CA, USA.; Pliant Therapeutics, Inc., South San Francisco, CA, USA.",Not available
39511371,Eosinophils mitigate intestinal fibrosis while promoting inflammation in a chronic DSS colitis model and co-culture model with fibroblasts.,2024-11-07,Matteoli G; Breynaert C,"Cell and tissue Imaging Cluster (CIC), KU Leuven, Leuven, Belgium.",Not available
39510902,Clinical Burden and Health Care Resource Utilization Associated With Managing Sickle Cell Disease With Recurrent Vaso-occlusive Crises in England.,2024-11-06,Conner SC; Howard J; Li N,"Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.","Vertex Pharmaceuticals Incorporated, Boston, Massachusetts. Electronic address: chukaudeze1992@gmail.com."
39510780,Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohort.,2024-11-07,Martin J,"Universita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, Italy.",Not available
39510449,Early dysregulation of GSK3beta impairs mitochondrial activity in Fragile X Syndrome.,2024-01-01,Garrone B; Ombrato R; Coletta I; Prati F; Milanese C,"Angelini Pharma S.p.A., 00181 Rome, Italy.",Not available
39510141,Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.,2025-01-01,Chen E; Showalter TN; Royce TJ; Todorovic T; Huang HC; Houck SA; Yamashita R; Esteva A; Feng FY,"Artera Inc., Los Altos, CA, USA; Artera Inc., Los Altos, CA, USA.; University of California San Francisco, San Francisco, CA, USA.; University of Virginia, Charlottesville, VA, USA.",Not available
39510069,Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer.,2024-11-19,Hoyt C; Perlmutter J; Berry DA,"Akoya Biosciences, Marlborough, MA 01752, USA.; Berry Consultants, LLC, Austin, TX 78746, USA.; Gemini Group, Ann Arbor, MI 48107, USA.","Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: michael.campbell@ucsf.edu."
39509848,Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.,2024-01-01,Marouf A; Deau B,"Department of Hematology, Cochin Hospital, AP-HP, Paris, France; INSERM UMR 1163, Institut Imagine, Paris, France; Universite de Paris, France, Institut Imagine, Paris, France.","Department of Hematology, Dijon Bourgogne University Hospital and INSERM UMR 1231, Dijon, France. Electronic address: cedric.rossi@chu-dijon.fr."
39509839,Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis.,2024-01-01,Al Tabaa O; Hecquet S; Thomas M; Carves S; Combier A; Miceli-Richard C; Molto A; Fogel O; Allanore Y,"Service de rhumatologie, Hopital NOVO Site Pontoise, France.; Universite Paris Cite, Service de Rhumatologie, Hopital Cochin, AP-HP, Paris, France; Universite Paris Cite, Service de Rhumatologie, Hopital Cochin, AP-HP, Paris, France.",Not available
39509750,Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies.,2024-01-01,Hobbs BD,"Regeneron Pharmaceutical, Tarrytown, NY, USA.",Not available
39509031,Evaluation of the Biological Effect of a Nicotinamide-Containing Broad-Spectrum Sunscreen on Photodamaged Skin.,2024-01-01,Torres-Moral T; Bague J; Perez-Anker J; Orte Cano C,"Centro de Investigacion Biomedica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.",Not available
39508279,Advanced Glycation End Products (AGEs) Webinar Meeting Report.,2024-11-07,Ho CN; Ayers AT; Chalew S,"Diabetes Technology Society, Burlingame, CA, USA.; Journey Biosciences, Cleveland, OH, USA.",Not available
39508067,Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity.,2024-12-01,Davidson MH,"NewAmsterdam Pharma B.V., Naarden, The Netherlands.",Not available
39506193,GA(2)LEN ANACARE consensus statement: Potential of omalizumab in food allergy management.,2024-01-01,Bindslev-Jensen C; Szajewska H,"Institut de Recerca Sant Joan de Deu, Barcelona, Spain.; MJM Advisory, New York, New York, USA.",Not available
39506374,"Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 1: ""The What"").",2024-11-06,Gnoth MJ; de Merbel NV; Blattmann P,"Bayer, DMPK, in vivo PK and bioanalytics, Bayer AG, 42096, Wuppertal, Germany.; ICON, Bioanalytical Laboratories, 9407, TK Assen, the Netherlands.; Idorsia Pharmaceuticals Ltd, Translational Sciences, 4123, Allschwil, Switzerland.",Not available
39506372,"Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 2: ""The How"").",2024-11-06,de Merbel NV; Gnoth MJ; Blattmann P,"Bayer, DMPK, in vivo PK and bioanalytics, Bayer AG, 42096, Wuppertal, Germany.; ICON, Bioanalytical Laboratories, 9407, TK Assen, the Netherlands.; Idorsia Pharmaceuticals Ltd, Translational Sciences, 4123, Allschwil, Switzerland.",Not available
39506116,Automated real-world data integration improves cancer outcome prediction.,2024-01-01,Capelletti M; Pekala K,"Caris Life Sciences, Irving, TX, USA.",Not available
39506078,Deep functional measurements of Fragile X syndrome human neurons reveal multiparametric electrophysiological disease phenotype.,2024-11-06,Fink JJ; Delaney-Busch N; Dawes R; Nanou E; Folts C; Harikrishnan K; Hempel C; Upadhyay H; Nguyen T; Shroff H; Stoppel D; Ryan SJ; Grooms J; Berry-Kravis E; Bear MF; Williams LA; Gerber D; Bunnage M,"Q-State Biosciences, Cambridge, MA, USA.; Quiver Bioscience, Cambridge, MA, USA.; Vertex Pharmaceuticals, Boston, MA, USA.",Not available
39505437,[Not Available].,2024-01-01,Haissaguerre M; Lussey-Lepoutre C; Hadoux J,"Service d'endocrinologie, Hopital Haut-Leveque, CHU de Bordeaux, Pessac, France.; Service d'oncologie endocrinienne, Departement d'imagerie, Gustave-Roussy, F-94805 Villejuif, France.; Service de medecine nucleaire, Hopital de la Pitie-Salpetriere, Paris, France.","Inserm U 1052, CRCL. Electronic address: helene.lasolle@chu-lyon.fr."
39505413,Artificial Intelligence in Cardiovascular Clinical Trials.,2024-11-12,Mace M; Psotka MA; O'Connor CM,"Academy for HealthCare Science (AHCS), Lutterworth, United Kingdom; Acorai AB, Helsingborg, Sweden.; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA; Inova Schar Heart and Vascular, Falls Church, Virginia, USA.",Not available
39505354,Plain language summary of the pivotal study of calcium hydroxylapatite with lidocaine for improvement of jawline contour.,2024-01-01,Moradi A; Dakovic R,"Merz Pharma GmbH, Frankfurt am Main, Germany.; Moradi MD, Vista, CA, USA.",Not available
39505123,Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HF.,2025-01-01,Ward JH; Williamson KM; Sarwat S,"Novartis Pharmaceuticals Corporation, East Hanover, NJ.","Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. Electronic address: satoshi.shoji@duke.edu."
39504090,Laboratory profiles of patients hospitalized with COVID-19 pneumonia treated with tofacitinib or placebo: a post hoc analysis from the STOP-COVID trial.,2024-01-01,Deuring JJ,"Pfizer Inc., Rotterdam, The Netherlands.",Not available
39503987,A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia.,2024-11-06,Kosako M; Ikegaya M; Terada W; Kadokura T; Hill J; Gill SC; Heinloth A; Hasabou N,"Astellas Pharma Inc, Tokyo, Japan.; Astellas Pharma US, Inc., Northbrook, IL, USA.","Department of Hematology and Oncology, Aichi, Japan. msawa@wine.plala.or.jp."
39503757,Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab.,2024-11-06,Arai T,"Kyowa Kirin, Princeton, NJ, USA.",Not available
39503549,Plain language review: the safety of relugolix combination therapy for advanced prostate cancer.,2024-11-06,La Cerda J; Sieber P; Flanders SC; Gatoulis SC,"Pfizer Inc., New York, NY, USA.; Sumitomo Pharma America Inc., Cambridge, MA, USA.; Urological Associates of Lancaster, Lancaster, PA, USA.; Urology San Antonio, San Antonio, TX, USA.",Not available
39503481,In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC beta-lactamase in Klebsiella aerogenes.,2024-12-05,Lence E; Gonzalez-Bello C; Bou G,"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Departamento de Quimica Organica, Centro Singular de Investigacion en Quimica Bioloxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.",Not available
39503380,Vascular Complications After Venoarterial Extracorporeal Membrane Oxygenation Support: A CT Study.,2025-01-01,Djavidi N; Duceau B; Bahroum P; Rivoal S; Hariri G; Lancelot A; Dureau P; Abbes A; Omar E; Charfeddine A; Lebreton G; Luyt CE; Bougle A,"Departement d'Anesthesie et Reanimation, Sorbonne Universite, Assistance Publique-Hopitaux de Paris (AP-HP), Hopital La Pitie-Salpetriere, Institut de Cardiologie, Paris, France.; Service de Chirurgie Cardiaque, Sorbonne Universite, Assistance Publique-Hopitaux de Paris (AP-HP), Hopital La Pitie-Salpetriere, Institut de Cardiologie, Paris, France.; Service de Medecine Intensive-Reanimation, Sorbonne Universite, Assistance Publique-Hopitaux de Paris (AP-HP), Hopital La Pitie-Salpetriere, Institut de Cardiologie, Paris, France.",Not available
39502931,Maintenance OCS Were Used More Frequently Than Biologics in Patients with Uncontrolled GINA 4/5 Asthma in Germany in 2019.,2024-01-01,Timmermann H; Lindner R; Heck S,"GlaxoSmithKline GmbH & Co. KG, Munich, Germany.; IQVIA Commercial GmbH & Co. OHG, Frankfurt Am Main, Germany.; Schwerpunktpraxis Colonnaden, Hamburg, Germany.",Not available
39502880,The evolution of the Pharmacovigilance department in the pharmaceutical industry: results of an Italian national survey.,2024-01-01,Dellon S; Castiglione GN; Romano S; Fabrizi E; Grisoni I; Finizia G; Bonato S,"Free Lance, Pharmacovigilance Consultant, Italy.; Free Lance, Pharmacovigilance Consultant, Lissone, Italy.; Free Lance, Pharmacovigilance Consultant, Verona, Italy.; Idorsia Pharmaceuticals Italy S.r.l., Milano, Italy.; Jazz Pharmaceuticals, Villa Guardia, Italy.; Rhythm Pharmaceuticals, Roma, Italy.; Sanofi S.r.l., Milano, Italy.",Not available
39502514,Untargeted Metabolomics to Investigate the Influence of Epigenetic Modifiers on the Metabolism of Fusarium verticillioides.,2024-01-01,Groppi E; Gadea A; Monge C; Cristofoli V; Vansteelandt M; Haddad M,"UMR 152 Pharma CDev, Universite de Toulouse, IRD, UPS, Toulouse, France.",Not available
39502370,Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study.,2024-01-01,Cottone S; Ravera M,"AOUP ""Paolo Giaccone"" Palermo, Italy.",Not available
39502066,Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial.,2024-01-01,Mehran R,"Bristol Myers Squibb, Princeton, NJ (R.S.A.).",Not available
39501568,Konnektor: A Framework for Using Graph Theory to Plan Networks for Free Energy Calculations.,2024-11-25,Ries B,"Boehringer Ingelheim Pharma GmbH & Co KG, Medicinal Chemistry, Birkendorfer Str. 65, 88397 Biberach an der Riss, Germany.",Not available
39501351,Treatment satisfaction and effectiveness of Lurasidone on quality of life and functioning in adult patients with schizophrenia in the real-world Italian clinical practice: a prospective 3-month observational study.,2024-11-05,Falsetto N; Manes MA; Micillo M,"Angelini Pharma S.p.A., Roma, Italy.",Not available
39500897,"A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.",2024-11-05,Lauren I; Veerman R; Lord M; Kostakis A; Astorga-Wells J; Olsson A,"Strike Pharma AB, Uppsala, Sweden.",Not available
39500746,Scaling up production of cephalosporin C by Acremonium chrysogenum W42-I in a fermenter using submerged fermentation.,2024-11-05,Stratmann A,"W42 Industrial Biotechnology GmbH, 44227, Dortmund, Germany.",Not available
39500687,Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting.,2024-11-04,Coleman K,"Chromophobe and Oncocytic Tumor Alliance, Austin TX, USA.","Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: stephaniea_berg@dfci.harvard.edu."
39500342,Management of Adult Patients with Newly Diagnosed or Relapsed Primary Immune Thrombocytopenia in Eastern Austria.,2024-11-05,Drexel T; Neusiedler-Nicolas V,"Novartis Pharma GmbH, Vienna, Austria.",Not available
39500220,Clinical manifestations and outcomes of Tick-borne encephalitis: A systematic literature review.,2024-01-01,Schley K,"Global Access and Value, Pfizer Pharma GmbH, Berlin, Germany.","Vaccines, Antivirals, and Evidence Generation, Pfizer, UK. Electronic address: kate.halsby@pfizer.com."
39500104,On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease.,2025-01-01,Pipicella JL; Kariyawasam V; Andrews JM; Connor SJ,"Adelaide Medical School, University of Adelaide, Adelaide, Australia.; Central Adelaide Local Health Network (CALHN), Adelaide, Australia; Crohn's Colitis Cure, Sydney, New South Wales, Australia; Department of Gastroenterology and Hepatology, Liverpool Hospital, Liverpool, Australia.; Department of Gastroenterology, Blacktown & Mount Druitt Hospital, Blacktown, Australia.; Faculty of Medicine & Health, The University of New South Wales, Sydney, Australia; IBD Sydney Organisation, Sydney, Australia; Ingham Institute for Applied Medical Research, Liverpool, Australia","Faculty of Medicine & Health, The University of New South Wales, Sydney, Australia. Electronic address: neda.karimi@anu.edu.au."
39500009,Identification of late-stage tau accumulation using plasma phospho-tau217.,2024-01-01,Jeromin A,"ALZpath. Inc, Carlsbad, CA, 92008, USA.","Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, Montreal, Quebec, QC H4H 1R3, Canada. Electronic address: m.woo@uke.de."
39499532,"CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein.",2024-11-25,Beranek J; Bolotokova A; Gardiner SS; Glavatskikh M; Houliston S; Irwin JJ; Koes D; Perveen S; Puls K; Zeng H; Zhang KYJ; Zhang J,"Bayer AG, Drug Discovery Sciences, 13353 Berlin, Germany.; Bayer AG, Drug Discovery Sciences, 42096 Wuppertal, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach an der Riss, Germany.; Computational Drug Design, Merck KGaA, 64293 Darmstadt Germany.; Conscience Medicines Network, Toronto, Ontario M5G 1L7 Canada.; Galixir Technologies, 200100 Shanghai, China.; Nuvisan ICB GmBH, 89231 Neu-Ulm, Germany.; Structure and Biophysics, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, Molndal 431 50, Sweden.; Treventis Corporation, Toronto, Ontario M5T 0S8, Canada.; UCB BioSciences GmbH, 40789 Monheim am Rhein, Germany.",Not available
39497751,"Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study.",2024-01-01,Keefe D; Nassin M; Reshetnyak E,"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.",Not available
39497599,Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers.,2024-11-05,Taskar K; Mao J,"Drug Metabolism and Pharmacokinetic, GSK, Stevenage, UK.; Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California, USA.",Not available
39497460,Validation of the Chinese Maudsley three-item visual analogue scale to measure depressive symptoms in a youth population.,2024-11-05,Strawbridge R,"Nantong Central Blood Station, Jiangsu Province, Nantong, China.",Not available
39496990,"The Current State of Biotransformation Science - Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends.",2024-01-01,Coe K; Cerny MA; Moliner P; King L; Auclair A; Cancilla MT; Eno M; Yue Q; Freiberger E; Barlock B; Pusalkar S; Niehues M; Jenkins GJ,"AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA.; Bayer AG, In Vitro ADME & Isotope Chemistry, Berlin, Germany.; Blueprint Medicines, Cambridge, MA, USA.; Boehringer Ingelheim Pharmaceuticals, Inc.,Drug Metabolism and Pharmacokinetics, Ridgefield, CT, USA.; Eisai Inc., Global Drug Metabolism and Pharmacokinetics, Cambridge, MA, USA.; Gilead Sciences, Inc., Drug Metabolism Dept, Foster City, CA, USA.; J&J, Translational PKPD & Investigational Toxicology, San Diego, CA, USA.; Merck & Co., Inc., Pharmacokinetics, Dynamics, Metabolism, and Bioanalysis, Rahway, NJ, USA.; Pfizer, Inc, Groton, CT, USA.; Sanofi, Montpellier, France.; Servier Bioinnovation, LLC, DMPK, Boston, MA, USA.; UCB Biopharma, Dept. of DMPK, Slough, UK.","AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA. john.savaryn@abbvie.com."
39496965,Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.,2025-01-01,Hutchison EJ; Maher D,"QinetiQ, Cody Technology Park, Farnborough, UK.",Not available
39496422,How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.,2024-11-04,Boer J; Brand AH; O'Donnell J; Glaspool R; Lee CK; Chang TC; Cohen PA; van Gorp T; O'Toole S; Madariaga A; Piovano E; Croke J; Bookman MA,"AGO Austria, Innsbruck, Austria.; AGO Study Group, Wiesbaden, Germany.; Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, New South Wales, Australia.; Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Torino, Piemonte, Italy.; Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.; Japanese Gynecologic Oncology Group (JGOG), Tokyo, Japan.; North-Eastern German Society of Gynaecological Oncology (NOGGO eV), Berlin, Germany.; The Gynecologic Cancer InterGroup, Kingston, Ontario, Canada.; Universite Paris-Saclay, Villejuif, Ile-de-France, France.","Gynecology with Center for Oncological Surgery, Charite Universitatsmedizin Berlin, Berlin, Germany jalid.sehouli@charite.de."
39495965,Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE-1 and -2).,2025-01-01,Kloer IM,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany.",Not available
39495153,Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.,2024-11-01,Strassburg CP; Lange CM,"Centrum for Hematology and Oncology Bethanien, Frankfurt, Germany.",Not available
39494848,A systematic review and meta-analysis comparing the severity of core symptoms of attention-deficit hyperactivity disorder in females and males.,2024-11-04,Young S; Greer B,"Compass Psychology Services Ltd., Bristol, UK.; Psychology Services Ltd., London, UK.",Not available
39494454,Evaluation of the Activity of Triazoles Against Non-fumigatus Aspergillus and Cryptic Aspergillus Species Causing Invasive Infections Tested in the SENTRY Program.,2024-01-01,Pfaller MA; Rhomberg PR; Klauer A; Castanheira M,"JMI Laboratories, North Liberty, Iowa, USA.",Not available
39494423,Fostering International Knowledge Sharing and Clinical Excellence: A Partnership and Inaugural Academic Conference.,2024-01-01,Mieth Alviar K; Bonilla G; Llinas A; Rojas Lievano J,"Fundacion Santa Fe de Bogota, Bogota, Colombia.",Not available
39494247,Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy.,2024-01-01,Krishnakumar M,"Catalent Pharma Solutions, 7330 Carroll Road, San Diego, California 92121-2363 USA.",Not available
39493888,Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial.,2024-01-01,Lavie F,"Immunology, Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Horsham, PA, USA.",Not available
39493817,Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer.,2024-01-01,Bangs R,"Bladder Cancer Advocacy Network (BCAN), Bethesda, MD, USA.",Not available
39493312,"Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity.",2024-01-01,Mehran R,"Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.",Not available
39492892,"QBD approach for green synthesis of Rutin silver nanoparticles- screening for antioxidant, anticancer and anticlastogenic potential.",2024-10-30,Yadha H,"Incozen Pharma, Hyderabad, India.",Not available
39492722,Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.,2024-11-04,Wandel S; Lesogor A; Bailey K,"Novartis Pharma AG, Basel, Switzerland (S.W., A.L., K.B.).",Not available
39490969,Clinical Efficacy of Serum Antiglycopeptidolipid Core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.,2024-10-28,Ringshausen FC,"Biomedical Research in End-Stage and Obstructive Lung Disease Hannover, German Center for Lung Research, Hannover, Germany; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Frankfurt, Germany; European Reference Network on Rare and Complex Respiratory Diseases, Frankfurt, Germany.",Not available
39490602,Exploring pharmaceutical powder behavior in commercial-scale bin blending: A DEM simulation study.,2025-01-01,Gomes Lopes D; Schaefer M,"Catalent Pharma Solutions, Steinbeisstrasse 1-2, 73614 Schorndorf, Germany.",Not available
39490530,A community pharmacist intervention for people living with epilepsy.,2024-10-25,Ems D,"HEOR Specialist, UCB Pharma, Smyrna, GA.","Associate Professor, Department of Pharmacy, University of Washington School of Pharmacy, Seattle, WA. Electronic address: jbacci@uw.edu."
39490527,2024 Spanish Society of Internal Medicine (SEMI) recommendations for the management of cancer-associated venous thromboembolism.,2025-01-01,Pagan-Escribano J; Demelo-Rodriguez P,"Centro Regional de Hemodonacion, Servicio Murciano de Salud, Murcia, Spain.; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigacion Sanitaria Gregorio Maranon, Madrid, Spain; Unidad de Enfermedad Tromboembolica Venosa, Medicina Interna, Hospital General Universitario Gregorio Maranon, Madrid, Spain; Unidad de Enfermedad Tromboembolica Venosa, Medicina Interna, Hospital General Universitario Jose Maria Morales Meseguer, Murcia, Spain",Not available
39489403,Refining the Prothrombotic State in Atrial Fibrillation With Left Atrial Appendage Three-Dimensional Echocardiography.,2024-11-01,Hammoudi N,"ACTION Study Group, INSERM UMR_S 1166, and Hopital Pitie-Salpetriere, AP-HP, Sorbonne Universite, Paris, France.",Not available
39489296,Real-world experience with glucagon-like peptide 2 analogues in patients with short bowel syndrome and chronic intestinal failure: Results from an international survey in expert intestinal failure centers.,2024-01-01,Berner-Hansen M,"Digestive Disease Center K, Bispebjerg University Hospital of Copenhagen, Copenhagen, Denmark; Zealand Pharma, Copenhagen, Denmark.","Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (ChroMetA), KULeuven, Leuven, Belgium. Electronic address: tim.vanuytsel@uzleuven.be."
39487159,Over-the-counter short-acting beta(2)-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study.,2024-11-01,Barriga-Acevedo RM,"Neumonologo, CEPROSS (Centro Profesional San Salvador), Entre Rios, Argentina.",Not available
39484513,A framework for target discovery in rare cancers.,2024-11-20,Li B; Sadagopan A; Li J; Wu Y; Cui Y; Konda P; Weiss CN; Choueiri TK; Doench JG; Viswanathan SR,"Boston, MA 02215, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School; Department of Pediatric Oncology, Dana-Farber Cancer Institute",Not available
39483444,Non-acquired immunodeficiency syndrome defining malignancies in people living with haemophilia and human immunodeficiency virus after direct-acting antiviral era.,2024-10-31,Kakinuma A; Goto T; Takeda H,"Social Welfare Corporation Habataki Welfare Project, Tokyo, Japan.",Not available
39482761,Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.,2024-10-31,Truchetet ME,"Dipartimento di Medicina Interna e Specialita Mediche,  Sapienza  Universita di Roma, Rome, Italy.",Not available
39488504,"Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.",2024-11-02,Kaul I; Sawchak S; Claxton A; Sauder C; Kakar R; Zhu H; Miller AC,"Bristol Myers Squibb, Princeton, NJ, USA.; Segal Trials, Lauderhill, FL, USA.",Not available
39488494,Clinical Burden and Healthcare Resource Utilization Associated With Managing Transfusion-dependent beta-Thalassemia in England.,2024-11-01,Conner SC; Howard J; Li N,"Vertex Pharmaceuticals Incorporated, Boston, Massachusetts.","Vertex Pharmaceuticals Incorporated, Boston, Massachusetts. Electronic address: chukaudeze1992@gmail.com."
39488418,A person-centred primary care pharmacist-led osteoporosis review for optimising medicines (PHORM): a protocol for the development and co-design of a model consultation intervention.,2024-11-02,Sturrock A,"NHS Education for Scotland, Edinburgh, UK.",Not available
39488215,Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma.,2024-11-19,Hofmann MH; Gerlach D; Savarese F; Yao Z,"Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; Mechanistic Biology, Loxo Oncology at Lilly, New York, NY, USA.",Not available
39487935,Equity and Outcome Events in Hidradenitis Suppurativa: Exploring Effect Modifiers Associated with Diagnostic Delay in the Real World.,2024-01-01,Adlard N,"Novartis Pharma AG, Basel, Switzerland.",Not available
39481054,Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.,2024-10-31,Wozniak M; Zhao Y; Mihm M; Kaplan J; Gorla S,"Astellas Pharma, Inc, Northbrook, IL.",Not available
39487568,The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia.,2025-01-01,Ku G; Miller CL; Zhang M; Tatsch F; Potluri J; Schmidt X,"AbbVie, Inc, North Chicago, Illinois, USA.; Genentech, South San Francisco, California, USA.",Not available
39487373,"Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial.",2024-01-01,Fu S; Kumar S; Ottesen L; Mugundu GM; O'Connor MJ; Jones SF,"Florida Cancer Specialists, Sarasota, FL, USA.; Oncology R&D, AstraZeneca, Cambridge, UK.","Sarah Cannon Research Institute, 250 25th Avenue North, Nashville, TN, 37203, USA. Erika.Hamilton@scri.com."
39487228,Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia.,2024-01-01,Taylor J,"Division of Experimental Oncology, IRCSS Ospedale San Raffaele, Milan, Italy.",Not available
39486794,Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.,2024-01-01,Unda M,"Laboratorio Mixto de Investigacion Traslacional en Cancer de Prostata Cic bioGUNE-Basurto, IIS Biobizkaia, Basurto, Bizkaia, Spain.","Servicio de Urologia, Hospital Universitario Miguel Servet, IIS-Aragon, Zaragoza, Spain. Electronic address: dr.borque@gmail.com."
39486790,Advanced stability-indicating RP-HPLC method for the quantification of lurasidone hydrochloride in bulk and PLGA-based in situ implant formulation.,2024-10-30,Chaurasia S,"Ashland India Pvt. Ltd., Pharma R&D, Neovantage Innovation Parks, Building No. 2700, Hyderabad, Telangana 500078, India.",Not available
39486504,"Chromosomal abnormalities in oocyte donor candidates: a French survey of over 8,200 karyotypes.",2024-10-31,Puy V; Smires BB; Barberet J; Bendayan M; Blagosklonov O; Cabry-Goubet R; Clarotti MA; Chansel-Debordeaux L; Hesters L; Lattes S; Lefeuve F; Mirallie S; Oancea VG; Rives N; Sermondade N; Tachdjian G; Eustache F,"BREED, UVSQ, INRAE, ENVA, Universite Paris Saclay, Orsay, France.; CECOS Basse Normandie CAEN CHU de Caen, Caen, France.; CECOS et Biologie de la reproduction, Hopital Jean Verdier, Hopitaux Universitaires Paris Seine-Saint-Denis, AP-HP, Universite Sorbonne Paris Nord, Villetaneuse, France; CECOS et Biologie de la reproduction, Hopital Jean Verdier, Hopitaux Universitaires Paris Seine-Saint-Denis, AP-HP, Universite Sorbonne Paris Nord, Villetaneuse, France.; CECOS et laboratoire de Biologie de la Reproduction, CHU Nice, France.; INSERM U1016-Equipe ""Genomique, Epigenetique et Physiologie de la Reproduction,"" Institut Cochin, Universite Paris Descartes-Paris, Paris, France.; Institut d'Oncologie de Bordeaux - BRIC - Equipe BioGo, INSERM U1312, Universite de Bordeaux, France.; Laboratoire d'aide a la procreation-CECOS Hopital Couple-Enfant, CHU Grenoble, France.; Laboratoire de Biologie de la Reproduction - CECOS, CHU Dijon Bourgogne, France.; Medecine et Biologie de la Reproduction, CECOS de Picardie, CHU Amiens Picardie, France.; Service d'Histologie, Embryologie et Cytogenomique, Hopital Antoine Beclere, Assistance Publique - Hopitaux de Paris - Universite Paris Saclay, Orsay, France.; Service de Biologie de la Reproduction - Andrologie - CECOS, Centre Hospitalier Intercommunal de Poissy Saint Germain en Laye, France; Service de Biologie de la Reproduction-CECOS, CHU Rennes, Rennes, France.; Service de Biologie de la Reproduction-CECOS, Hopital Antoine Beclere, Assistance Publique-Hopitaux de Paris (AP-HP), Hopitaux Universitaires Paris Saclay, Clamart, France.; Service de Biologie de la Reproduction-CECOS, Hopital Tenon, Hopitaux Universitaires Est Parisien, Assistance Publique-Hopitaux de Paris, PARIS, France.; Service de Biologie et Medecine de la Reproduction, Cryobiologie. CECOS Franche-Comte, CHRU Jean Minjoz, Besancon, France.; Service de Biologie et Medecine de la Reproduction-CECOS, CHU Nantes, France.; Service de biologie de la reproduction-CECOS, CHU de Bordeaux, France; Universite Rouen Normandie, Inserm U1239, NorDIC, equipe ""Adrenal and Gonadal Pathophysiology"", CHU Rouen, Laboratoire de Biologie de la Reproduction-CECOS, Rouen, France.","INSERM U1016-Equipe ""Genomique, Epigenetique et Physiologie de la Reproduction,"" Institut Cochin, Universite Paris Descartes-Paris, Paris, France. Electronic address: vincent.puy@aphp.fr."
39486433,"Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study.",2024-01-01,Jin J; Wu S; Chen Y; Moriyama T; Inoue A; Nakajima K,"Daiichi Sankyo, Basking Ridge, NJ, USA.","Lymphoma and Chronic Lymphoproliferative Syndromes Unit, Institute of Hematology ""L. e A. Seragnoli"", University of Bologna, Bologna, Italy. Electronic address: pierluigi.zinzani@unibo.it."
39486432,"Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.",2024-01-01,Kakurai Y; Yamauchi H; Hizukuri Y; Biserna N; Tachibana M; Inoue A,"Daiichi Sankyo, Basking Ridge, NJ, USA.; Daiichi Sankyo, Tokyo, Japan.","Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: dai.maruyama@jfcr.or.jp."
39486165,"Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study.",2024-01-01,De Giorgi U; Dunshee C; Lin X; Di Santo N,"Arizona Urology Specialists, Tucson, AZ, USA.; Formerly of Pfizer Inc., Durham, NC, USA.; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.; Pfizer Inc., La Jolla, CA, USA.","Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: Arun.Azad@petermac.org."
39485624,"Burden of Current Insulin Therapy and Expectations for Future Insulin Therapy: Results from INBEING, a Web-Based Survey in Japan.",2024-01-01,Tsuboi S; Yamamoto Y,"Novo Nordisk Pharma Ltd, Tokyo, Japan.","Department of Endocrinology, Tenri Hospital, Tenri, Japan. hayasino@tenriyorozu.jp."
39485596,Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis.,2024-01-01,Kiri S; Taieb V; Slim M; Fahrbach K; Betts M; Armstrong A,"Evidera Inc, St-Laurent, Quebec, Canada.; Evidera Inc, Waltham, MA, USA.; UCB Pharma, Colombes, France.; UCB Pharma, Slough, UK.",Not available
39485000,The influence of lifestyle and environmental factors on host resilience through a homeostatic skin microbiota: An EAACI Task Force Report.,2024-01-01,Unger Z,"Departamento de Ciencias Medicas Basicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Diez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.",Not available
39484838,Amorphous solid dispersion to facilitate the delivery of poorly water-soluble drugs: recent advances on novel preparation processes and technology coupling.,2024-01-01,Gao Y,"Jiangsu Litaier Pharma Ltd, Nanjing, China.",Not available
39482555,Real-World Use of Trazodone in Older Persons in Long Term Care Setting: A Retrospective Study.,2024-01-01,Fumagalli S,"Bluecompanion Ltd, London, UK.",Not available
39481660,Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).,2025-01-01,Laws E; Dakin P; Maloney J; Lu X; Bauer D; Bansal A; Robinson LB; Abdulai RM,"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.; Sanofi, Bridgewater, NJ, USA.; Sanofi, Cambridge, MA, USA.","Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: sbhatt@uabmc.edu."
39481586,Cardiac Amyloidosis Screening and Management in Patients With Heart Failure With Preserved Ejection Fraction: An International Survey.,2025-02-01,Oerlemans MIFJ,"Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart(1), Amsterdam, The Netherlands.","Department of Hospital Therapy 2, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation. Electronic address: a.shchendrygina@gmail.com."
39481395,"Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial.",2024-01-01,Vladimirov V; Kirova B; Klinowska T,"Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Oncology Patient Safety, Oncology R&D, AstraZeneca, Cambridge, UK.; Pyatigorsky Oncology Dispensary, Pyatigorsk, Russia.","Medical Oncology Department, Vall d'Hebron University Hospital and Breast Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: moliveira@vhio.net."
39481388,Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.,2024-11-13,Mazzi B; Ferrucci PF,"Ospedale MultiMedica San Giuseppe, Milan 20132, Italy.; Ospedale San Raffaele IRCCS, Milan 20132, Italy.",Not available
39480444,"Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US.",2024-12-01,Rebeira M; MacAllister S,"Alexion Pharma Canada Corp, AstraZeneca Rare Disease, Mississauga, Ontario, Canada.; Novartis Pharma, Basel, Switzerland.",Not available
39480228,Benzodiazepines for PTSD: Poor data quality and misleading advice.,2024-10-31,Silva de Lima M,"Pulsus Pharma Consultancy Ltd., Virginia Water, UK.",Not available
39480156,In vivo efficacy of enmetazobactam combined with cefepime in a murine pneumonia model induced by OXA-48-producing Klebsiella pneumoniae.,2024-10-31,Santerre Henriksen A,"Maxel Consulting, Jyllinge, Denmark.",Not available
39480071,Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia.,2024-12-05,Hot D; MacLoughlin R,"Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Sante, Lille, France.",Not available
39479552,Evaluation of the Safety and Tolerability of Lumify Eye Illuminations Cosmetic Products.,2024-01-01,Wesley G,"Complete Eye Care, Medina, MN, USA.",Not available
39479509,"Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma Registry.",2024-01-01,Christoff GC,"BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.",Not available
39478966,Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.,2024-01-01,Nguyen MA; Weitz D; Rehberg M; Nicolas JM; Foricher Y; Schio L,"Development Science, Drug Metabolism and Pharmacokinetics, UCB Pharma, Braine-I'Alleud, Belgium.; Sanofi R&D, Drug Metabolism and Pharmacokinetics, Frankfurt am Main, Germany.; Sanofi R&D, Integrated Drug Discovery, Vitry-sur-Seine, France.; Sanofi R&D, TMED Pharmacokinetics Dynamics and Metabolism, Frankfurt am Main, Germany.; Sanofi R&D, Translational Disease Modelling, Frankfurt am Main, Germany.",Not available
39478536,Management of schizophrenia and comorbid substance use disorders: expert review and guidance.,2024-10-30,Carrera I,"Unidad Asistencial de Drogodependencias de ACLAD-Coruna/CHUAC-SERGAS, A Coruna. Departamento de Psiquiatria de la Universidad de Santiago de Compostela, A Coruna, Spain.","Psychiatry Service, University Hospital of Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain. aneyros@gobiernodecanarias.org."
39477939,Generation of binder-format-payload conjugate-matrices by antibody chain-exchange.,2024-10-31,Spranger N,"Veraxa Biotech, Heidelberg, Germany.",Not available
39477631,Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.,2024-11-05,Garcia-Pavia P; Heitner SB; Jacoby DL; Kupfer S; Malik FI; Melloni C; Meng L; Wei J,"Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.; Cytokinetics, Incorporated, South San Francisco, California, USA.; Hospital Universitario Puerta de Hierro de Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain","Oregon Health and Science University, Portland, Oregon, USA. Electronic address: masria@ohsu.edu."
39476444,"Corrigendum to ""Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations"" [Eur J Cancer 207 (2024) 114158].",2024-01-01,Oeser K; Zehaczek M; Jeratsch U,"Novartis Pharma GmbH, Nuernberg, Germany.","Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. Electronic address: anna.kron@uk-koeln.de."
39476204,"A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX.",2025-01-01,Ballesteros J,"Vivia Biotech, S.L., Madrid, Spain.",Not available
39476124,"Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.",2025-01-09,Bernasconi L,"Lonza AG, Basel, Switzerland.",Not available
39475359,Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.,2024-12-02,Rodriguez-Vida A; Vajdi A; Cristescu R; Imai K; Homet Moreno B; Matsubara N,"Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; Leningrad Regional Oncology Dispensary, Ulitsa Savushkina, Saint Petersburg, Russia.; Merck & Co., Inc., Rahway, New Jersey.",Not available
39473925,ProcCluster(R) and procaine hydrochloride inhibit the growth of Aspergillus species and exert antimicrobial properties during coinfection with influenza A viruses and A. fumigatus in vitro.,2024-01-01,Ehrhardt C,"Inflamed Pharma GmbH, Jena, Germany.",Not available
39473327,Hearing Science Accelerator: Sudden Sensorineural Hearing Loss-Executive Summary of Research Initiatives.,2024-12-01,Chandrasekhar S; Fernandez K; Hertzano R; Hoa M; Schlingensiepen R; Stewart DR,"AudioCure Pharma GmbH, Berlin, Germany.; ENT and Allergy Associates, LLP, Los Angeles, California, USA.; NIH NCI, Bethesda, Maryland, USA.; NIH NIDCD, Bethesda, Maryland, USA.",Not available
39473146,Small sample adjustment for inference without assuming orthogonality in a mixed model for repeated measures analysis.,2024-10-29,Yamaguchi Y,"Biostatistics, Data Science, Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.",Not available
39473076,Real-World Evidence of Crizanlizumab Showing Reductions in Vaso-Occlusive Crises and Opioid Usage in Sickle Cell Disease.,2025-01-01,DeBonnett L; Pasanisi A; Arcioni F; Sarp S; Soliman W,"Centro Microcitemia-UOC, Ematologia Con Trapianto, Brindisi, Italy.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.; Novartis Saudi Ltd., Riyadh, Saudi Arabia.; SC Pediatric Onco-Hematology With Bone Marrow Transplantation, Azienda Ospedaliera di Perugia, Perugia, Italy.",Not available
39472976,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,2024-10-29,Frost M; Mattson-Hoss M; Sarnoff H,"Infixion Bioscience, Inc., San Diego, CA, USA.",Not available
39472058,"Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trial.",2024-10-29,Nguyen M; Constantin A,"SAINBIOSE U1059, Inserm, Saint Etienne, France.; UMR 1027, Inserm, Universite Toulouse III Paul Sabatier, Toulouse, France.","Rheumatology Center, Toulouse University Hospital, Toulouse, France adruyssen@hotmail.com."
39471212,Evaluation of variation in preclinical electroencephalographic (EEG) spectral power across multiple laboratories and experiments: An EQIPD study.,2024-01-01,Bray J; Potschka H,"Pharmalex, Mont-Saint-Guibert, Belgium.",Not available
39470958,US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization.,2024-01-01,Parthan A; Sader SC; Balanean A,"Alexion, AstraZeneca Rare Disease, Boston, MA, USA.; FibroGen Inc., San Francisco, CA, USA.",Not available
39470879,Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis.,2024-01-01,Yang H; Du M; Chen X; Gelinas D; Brauer E; Phillips G,"Analysis Group, Inc., Boston, MA, USA.; Argenx, Inc., Boston, MA, USA.",Not available
39470878,Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.,2024-01-01,Shah P; Marco AR,"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.","University of Colorado School of Medicine, Aurora, CO, USA. boguniewiczm@njhealth.org."
39470722,BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice.,2024-01-01,Cabezas B,"Complejo Asistencial Universitario Leon, Leon, Spain.",Not available
39470436,Sub-Tenon's anesthesia in equine cataract surgery and vitrectomy: a retrospective case series (2018-2022).,2024-01-01,Stadler S,"Pferdeklinik Tillysburg, Sankt Florin, Austria.",Not available
39469838,TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab +/- platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer.,2024-01-01,Chen A,"Daiichi Sankyo Inc., Biostatics and Data Management, Basking Ridge, NJ 0792 1, USA.",Not available
39469415,Comparison of genotoxic impurities in extracted nicotine vs. synthetic nicotine.,2024-01-01,Lei X; Zeng Z; Chen J,"Porton Pharma Solutions, Chongqing, China.",Not available
39468640,Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials.,2024-10-28,Nseir S,"Cidara Therapeutics, Inc., San Diego, CA, USA.","ICU Department, CHU UCL Godinne Namur, UCL Louvain Medical School, Namur, Belgium. patrick.honore@chuuclnamur.uclouvain.be."
39468592,Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis of the phase III trial.,2024-10-28,Shimono A; Yokosawa J; Hirose K; Wang E,"Alexion Pharma GK, 3-1-1 Shibaura, Minato-ku, Tokyo, 108-0023, Japan.; Alexion, AstraZeneca Rare Disease, 121 Seaport Blvd, Boston, MA 02210, USA.","Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8521, Japan. mmatsumo@naramed-u.ac.jp."
39468073,ClC-1 Inhibition as a Mechanism for Accelerating Skeletal Muscle Recovery After Neuromuscular Block in Rats.,2024-10-28,Skals M; Broch-Lips M; Skov MB; Riisager A; Ceelen J,"NMD Pharma, Aarhus, Denmark.",Not available
39467989,The Challenge of Treating Infections Caused by Metallo-beta-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.,2024-01-01,Rodriguez-Aguirregabiria M; Martinez-Martinez L,"Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.","Hospital Universitario Virgen de las Nieves de Granada, Instituto de Investigacion Biosanitario de Granada (IBS-Granada), Granada, Spain. chidalgo72@gmail.com."
39467980,Clinical Pharmacology of Asciminib: A Review.,2024-01-01,Combes FP; Li YF; Fu Y; Sy SKB; Obourn V; Chakraborty A,"Novartis Development, Cambridge, MA, USA.; Novartis Pharmaceuticals, East Hanover, NJ, USA.","Novartis Biomedical Research, Fabrikstrasse 2, 4056, Basel, Switzerland. Matthias.hoch@novartis.com."
39466906,Comparative Analysis of 2022 Outbreak MPXV and Previous Clade II MPXV.,2024-01-01,Vidal S,"Centro de Investigaciones en Microbiologia y Biotecnologia-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.",Not available
39466701,Dietary potassium intake and its interaction with sodium intake on risk of developing cardiovascular disease in persons with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 12).,2025-01-01,Yamasaki Y,"Signpost Corporation, Osaka, Japan.",Not available
39466665,Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: A real-world data study.,2025-01-01,Lopez-Manzanares L,"Grupo de Investigacion en Enfermedad de Parkinson y otros Trastornos del Movimiento, Instituto de Investigacion Biomedica de A Coruna, A Coruna, Spain.",Not available
39466587,Safety and Tolerability of Nintedanib in Patients with Fibrosing Interstitial Lung Diseases: Post-marketing Data.,2024-01-01,Ritter I,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.","Department of Life and Health Sciences, School of Medicine, Ulster University, Northland Road, Derry-Londonderry, BT48 7JL, UK. nazia.chaudhuri@nhs.net."
39466126,A plain language summary describing changes in pain associated with uterine fibroids among women receiving relugolix combination therapy.,2024-01-01,Ferreira JA; Li Y; Hunsche E; Wagman RB,"Former employee of Myovant Sciences, Inc. Brisbane, CA, USA (now Sumitomo Pharma America).; Sumitomo Pharma America, Marlborough, MA, USA.; Sumitomo Pharma Switzerland GmbH, Basel, Switzerland.",Not available
39465888,"A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults.",2024-10-28,Peterson RD; Clark AJ; Rudemiller NP,"Helaina Inc., New York, NY, USA.; Immunologix Laboratories, Tampa, FL, USA. RINGGOLD: 482575",Not available
39465582,Evidencing the challenges of care delivery for people with intellectual disability and epilepsy in England by using the Step Together toolkit.,2024-10-28,Roy A,"Adult Learning Disability Service, Coventry and Warwickshire Partnership NHS Trust, UK.",Not available
39465550,Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011.,2025-01-01,O'Hara K; Okpara CE; Franco S; Homet Moreno B; Zolnierek J; Siefker-Radtke AO,"Eisai, Ltd, Hatfield, UK.; LUXMED Oncology, Warsaw, Poland.; Merck & Co, Inc, Rahway, New Jersey, USA.",Not available
39465429,"Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways.",2024-10-27,Shen YA; Harp C,"Genentech, Inc., 1 DNA Way, South San Francisco, CA, USA.",Not available
39465243,Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy.,2024-01-01,Du J; Tamby JF; Castano A; Siddhanti S; Katz L; Fox JC,"BridgeBio Pharma Inc, San Francisco, CA (J.D., J.-F.T., A.C., S.S., L.K., J.C.F.).",Not available
39464622,Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic Review.,2024-01-01,Solitano V; Narula N,"Alimentiv Inc., London, ON, Canada.; Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Universita Vita-Salute San Raffaele, Milan, Lombardy, Italy.",Not available
39464260,"Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making.",2024-01-01,Shivappa N; Bishop M; Chen H,"AstraZeneca, Gaithersburg, MD, USA.; AstraZeneca, Wilmington, DE, USA.",Not available
39464004,Diversity of ancestral brainstem noradrenergic neurons across species and multiple biological factors.,2024-10-16,Che A; Shea SD; Yang JH,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Integrative Biology and Physiology, UCLA, Los Angeles, CA, USA.",Not available
39462418,International congress on transposable elements (ICTE 2024) in Saint Malo: breaking down transposon waves and their impact.,2024-10-26,Gilbert C; Rebollo R; Vitte C,"Comportement et Ecologie, Universite Paris-Saclay, CNRS, IRD, UMR Evolution, Genomes, Gif-sur-Yvette, France.; INRAE, INSA Lyon, Villeurbanne, BF2I, France.; Universite Paris-Saclay, INRAE, CNRS, AgroParisTech, GQE - Le Moulon, Gif-sur-Yvette, France.","Universite Paris Cite, CNRS, Institute for Research Saint Louis (IRSL), Inserm, Paris, France. pascale.lesage@inserm.fr."
39462221,Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I study.,2025-01-01,Ikezawa H; Nomoto M; Takashima S; Uehara T; Funasaka S; Yashiro M,"Eisai Co., Ltd., Tokyo, Japan.",Not available
39462215,Evaluation of Potency and Specificity of Cryptophycin-Loaded Antibody-Drug Conjugates.,2024-10-27,Sharma P; Biyani N,"Lantern Pharma Inc., 1920 McKinney Ave, 7th Floor, Dallas 75201, TX, USA.",Not available
39461973,An integrative network-based approach to identify driving gene communities in chronic obstructive pulmonary disease.,2024-10-26,Bol V; Caselle M; Medini D,"GSK, Rixensart, Belgium.; XPE Pharma & Science, Wavre, Belgium.",Not available
39461938,The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis.,2024-10-26,Del-Ben CM,"Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.",Not available
39461553,Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry.,2024-10-24,Ringshausen FC; Rademacher J; Welte T,"Biomedical Research in End-Stage and Obstructive Lung Disease Hannover, German Center for Lung Research, Hannover, Germany; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany; European Reference Network on Rare and Complex Respiratory Diseases, Frankfurt am Main, Germany.",Not available
39461505,A phase 2a trial of brepocitinib for cicatricial alopecia.,2024-10-24,Oemar B; Mahling P; Peeva E,"Pfizer Inc, Cambridge, Massachusetts.",Not available
39461355,Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial.,2024-10-23,Okada Y; Okura I; Otsuki M; Ishida N; Iwama Y; Minamida T; Yagi Y; Kurosawa T; Zhang Y,"Arcturus Therapeutics, San Diego, CA, USA.; Meiji Seika Pharma, Tokyo, Japan.",Not available
39461299,"Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon-in-continuity: A multicenter, open-label, metabolic balance study.",2024-01-01,Bolognani F; Li C; Youssef NN; Huh S,"Ironwood Pharmaceuticals Inc, Basel, Switzerland.; Ironwood Pharmaceuticals Inc, Boston, MA, USA.",Not available
39461270,Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary.,2024-01-01,Method M; Wang Y; Coleman RL,"ImmunoGen, Inc., Waltham, MA, USA.; Texas Oncology, The Woodlands, TX, USA.","OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: kathleen-moore@ouhsc.edu."
39461193,"Vitiligo is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-matched, US-based retrospective study.",2024-01-01,Hernandez G,"TriNetX, LLC, Cambridge, MA, USA.",Not available
39460331,Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany.,2024-10-12,Halsby K; Malerczyk C; Madhava H; Moisi JC,"Pfizer Corporation Austria GmbH, 1210 Vienna, Austria.; Pfizer Ltd., Tadworth KT20 7 NY, UK.; Pfizer Pharma GmbH, 10117 Berlin, Germany.",Not available
39458626,Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route.,2024-10-04,Ferreira DC,"Aptar Pharma, 27100 Le Vaudreuil, France.",Not available
39457678,The Effectiveness of NP001 on the Long-Term Survival of Patients with Amyotrophic Lateral Sclerosis.,2024-10-16,Forrest BD; Goyal NA; Khan Z; Robinson M; Azhir A; McGrath M,"Engage Management Solutions, LLC, Hillsborough, NC 27278, USA.; Hudson Innovations, LLC, Nyack, NY 10960, USA.; Neuvivo, Inc., Palo Alto, CA 94301, USA.; Pharmaceutical Product Development, LLC, Montreal, QC H4T 1V6, Canada.",Not available
39457574,N-Pep-Zn Improves Cognitive Functions and Acute Stress Response Affected by Chronic Social Isolation in Aged Spontaneously Hypertensive Rats (SHRs).,2024-10-04,Winter S; Gulyaeva NV,"Ever Pharma, Oberburgau 3, 4866 Unterach am Attersee, Austria.",Not available
39457534,Pro-Resolving Inflammatory Effects of a Marine Oil Enriched in Specialized Pro-Resolving Mediators (SPMs) Supplement and Its Implication in Patients with Post-COVID Syndrome (PCS).,2024-09-29,Gracia Aznar A; Moreno Egea F; Gracia Banzo R; Rodriguez-Ledo P; Nerin I,"Directora de la Catedra SEMG-Estilos de Vida Unidad de Tabaquismo FMZ Prof feminine Dpto. Medicina, Psiquiatria y Dermatologia Facultad de Medicina, Universidad de Zaragoza, 50009 Zaragoza, Spain.; Sociedad Espanola de Medicos Generales y de Familia (SEMG), 28005 Madrid, Spain.; Solutex GC SL, Avenida de la Transicion Espanola 24, 28108 Alcobendas, Spain.; Solutex GC SL, Parque Empresarial Utebo, Avda. Miguel Servet n masculine 81, 50180 Utebo, Spain.",Not available
39457031,Bovine Lactoferrin Promotes Neurite Outgrowth in PC12 Cells via the TrkA Receptor.,2024-10-19,Aoki R,"NRL Pharma Inc., Kawasaki 213-0012, Kanagawa, Japan.",Not available
39456460,Exploring Angiotensin II and Oxidative Stress in Radiation-Induced Cataract Formation: Potential for Therapeutic Intervention.,2024-10-08,Dolland R; Brown SR; Dolland D,"LensCrafters, Inc., 110 Mall Circle, Suite 2001, Waldorf, MD 20603, USA.; Trocar Pharma Inc., 8101 Sandy Spring Rd., Suite 300-W9, Laurel, MD 20707, USA.",Not available
39456179,Identification of Sinapic Acid Derivatives from Petit Vert Leaves and Their Effects on Glucose Uptake in C2C12 Murine Myoblasts.,2024-10-01,Fukuda T,"Shizuoka Shin-Food Development Corp., Shizuoka 422-8064, Japan.",Not available
39455575,"The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials.",2024-10-25,Yu D; Levy J; Liu Y; Miyazaki T; Tagliaferri M; Schmitz C; Nirula A; Kotzin B; Zalevsky J,"Eli Lilly and Company, Indianapolis, IN, USA.; Levy Informatics LLC, Chapel Hill, NC, USA.; Nektar Therapeutics, San Francisco, CA, USA.; Recludix Pharma, San Diego, CA, USA, formerly affiliated with Eli Lilly and Company, Indianapolis, IN, USA.",Not available
39455313,"Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.",2024-10-24,Zabana Y; Fernandez-Clotet A; Caballol B; Calafat M; Gutierrez A; Rubin de Celix C; Brunet E; Piqueras M; Albillos A,"Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Spain.; Consorcio Sanitario Terrassa (Terrassa), Spain.; Hospital Clinic Barcelona (Barcelona), Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Spain; Hospital General Universitario Alicante Doctor Balmis (Alicante), Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL), Spain; Hospital Universitari Parc Tauli (Sabadell), Spain; Hospital Universitario Germans Trias i Pujol (Badalona), Spain; Hospital Universitario Mutua Terrassa (Terrassa), Spain; Hospital Universitario Ramon y Cajal (Madrid), Spain; Hospital Universitario de La Princesa (Madrid), Instituto de Investigacion Sanitaria Princesa (IIS-Princesa), Universidad Autonoma de Madrid (UAM), Spain; Universidad Alcala de Henares (Madrid), Spain","Universidad Alcala de Henares (Madrid), Spain. Electronic address: pacomeso@hotmail.com."
39455195,Revealing transparency gaps in publicly available COVID-19 datasets used for medical artificial intelligence development-a systematic review.,2024-01-01,Ordish J; Mateen B,"Hughes Hall, University of Cambridge, Cambridge, UK; Institute of Health Informatics, University College London, London, UK; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; PATH, Seattle, WA, USA; Roche Diagnostics, Rotkreuz, Switzerland.; Wellcome Trust, London, UK.",Not available
39455065,Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study.,2024-10-24,Rajendran V; Emery P,"ARS Rheumatica, Warsaw, Poland.; Galapagos GmbH, Basel, Switzerland.","Centre for Musculoskeletal Research, University of Manchester, Manchester, UK maya.buch@manchester.ac.uk."
39454873,Integration of a fully automated flow cytometry system with high robustness into a Screening Station.,2024-01-01,Asano H; Namatame I,"Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba-shi 305-8585, Ibaraki, Japan.; Rorze Lifescience Inc., 430-1, Kamiyokoba, Tsukuba-shi 305-0854, Ibaraki, Japan.","Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba-shi 305-8585, Ibaraki, Japan. Electronic address: Shingo.fujiyama@astellas.com."
39454576,Method of moments framework for differential expression analysis of single-cell RNA sequencing data.,2024-10-31,Kim MC; Tolopko A; Garcia-Nieto PE; Ye CJ,"Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, USA; Chan Zuckerberg Initiative, Redwood City, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA, USA; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA, USA.; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; UC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA",Not available
39454538,Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis.,2024-01-01,Ferrara R; Nuccio A,"IRCCS Ospedale San Raffaele, Department of Medical Oncology, Milan, Italy; Universita Vita-Salute San Raffaele, Milan, Italy.",Not available
39454250,Dissecting the association between long COVID and depressive symptoms in a nationally representative population from France.,2024-01-01,Pitron V; Robineau O; Steichen O,"Assistance publique-Hopitaux de Paris, AP-HP, Hopital Tenon, Service de Medecine Interne, 75020 Paris, France.; Centre du Sommeil et de la Vigilance-Pathologie Professionnelle, APHP, Hotel-Dieu, F-75004 Paris, France.; INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, UMR-S 1136, AP-HP, Paris, France.; Service Universitaire des Maladies Infectieuses, Centre Hospitalier Gustave Dron, Tourcoing, France; Sorbonne Universite, Inserm, Institut Pierre-Louis d'epidemiologie et de sante publique, iPLesp, 75012 Paris, France; Universite Paris Cite, VIFASOM (Vigilance Fatigue Sommeil et Sante Publique), F-75004 Paris, France",Not available
39454222,"Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT(4) receptors with potential interest in the treatment of Alzheimer's disease.",2024-12-15,Largilliere S; Nee G; Freret T; Legrand R; Boulouard M,"RONOMA Pharma, 31 Rue Leon Delille, F-76800, Saint Etienne du Rouvray, France.; Universite de Caen Normandie, Normandie Univ., Mobilites: Vieillissement, Pathologie, Sante (COMETE), INSERM UMR-S 1075, 14000, Caen, France.","Universite de Caen Normandie, Normandie Univ., Centre d'Etudes et de Recherche sur le Medicament de Normandie (CERMN), 14000 Caen, France. Electronic address: christophe.rochais@unicaen.fr."
39453789,Comparison of exercise training modalities and change in peak oxygen consumption in heart failure with preserved ejection fraction: a secondary analysis of the OptimEx-Clin trial.,2024-10-25,Kitzman DW,"Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Chariteplatz 1, 10117 Berlin, Germany.",Not available
39453772,Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.,2024-10-25,Perkovic V; Barratt J; Rovin B; Kashihara N; Maes B; Zhang H; Trimarchi H; Kollins D; Papachristofi O; Jacinto-Sanders S; Merkel T; Guerard N; Renfurm R; Hach T; Rizk DV,"AZ Delta, Roeselare, Belgium (B.M.); From the University of New South Wales, Sydney (V.P.); Hospital Britanico, Buenos Aires (H.T.); Kawasaki Medical School, Okayama, Japan (N.K.); Novartis Pharma, Basel, Switzerland (D.K., O.P., S.J.-S., T.M., N.G., R.R., T.H.); Ohio State University Wexner Medical Center, Columbus (B.R.); Peking University First Hospital, Beijing (H.Z.); and the University of Alabama at Birmingham, Birmingham (D.V.R.).; the Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom (J.B.)",Not available
39453596,Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis.,2024-01-01,Soliman AM; Fang S; Patel M,"AbbVie Inc., North Chicago, IL, USA.","Department of Dermatology, Keck School of Medicine, University of Southern California, 1450 San Pablo St #5400, Los Angeles, CA, 90033, USA. aprilarmstrong@post.harvard.edu."
39453357,Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial.,2024-01-01,Schueler E,"mainanalytics GmbH, Sulzbach/Taunus, Germany.","Berlin Institute of Health - Center for Regenerative Therapies, and Department of Cardiology (CVK), Deutsches Herzzentrum der Charite and German Centre for Cardiovascular Research Partner Site Berlin, Charite - Universitatsmedizin Berlin, Berlin, Germany. Electronic address: wolfram.doehner@charite.de."
39453356,Survodutide for the Treatment of Obesity: Rationale and Design of the SYNCHRONIZE Cardiovascular Outcomes Trial.,2024-01-01,Unseld A,"Boehringer Ingelheim Pharma GmbH and Co KG, Biberach/Riss, Germany.","Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA. Electronic address: mkosiborod@saint-lukes.org."
39453339,Air pollution is associated with persistent peanut allergy in the first 10 years.,2024-01-01,Mavoa S,"Environment Protection Authority Victoria, Melbourne, Australia.; Murdoch Children's Research Institute, Melbourne, Australia",Not available
39453335,Using qPCR and ddPCR to study biodistribution of cell therapy products: a multi-site evaluation.,2025-01-01,Koga Y; Yatsuda Y,"Kumamoto Laboratories, Mediford Corporation, Uto, Kumamoto, Japan.; Life Science Sales, Bio-Rad Laboratories K.K., 14th Warehouse B-Wing, Keihin Truck Terminal, Ohta-ku, Tokyo, Japan.",Not available
39453218,Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information.,2024-10-15,Kazerooni R; Gross TM; Hollander DA; Gallagher CJ,"Revance Therapeutics, Nashville, TN 37203, USA.",Not available
39453199,Continuous Treatment with IncobotulinumtoxinA Despite Presence of BoNT/A Neutralizing Antibodies: Immunological Hypothesis and a Case Report.,2024-10-01,Tay CM,"Merz Asia Pacific Pte., Ltd., Singapore 138567, Singapore.",Not available
39453196,SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication.,2024-09-29,Becker Ifantides K; Singh R; Nelson M; Battucci S; Yushmanova I; Ukah A,"AbbVie, 00144 Rome, Italy.; AbbVie, Irvine, CA 92612, USA.",Not available
39453109,"Occupational Exposures, Chronic Obstructive Pulmonary Disease and Tomographic Findings in the Spanish Population.",2024-09-24,Zock JP; Kromhout H; Garcia-Rio F; Gonzalez-Moro JR; Cosio BG,"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Servicio de Neumologia, Centro Medico Teknon, Grupo Quironsalud, 08022 Barcelona, Spain.",Not available
39452892,Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study.,2024-01-01,Feagan BG; Jamoul C; Patel H; Harris K; Taliadouros V; Oortwijn A; Peyrin-Biroulet L,"Alimentiv, Inc., London, Ontario, Canada.; Cytel, Vancouver, British Columbia, Canada.; Galapagos B.V, Leiden, Netherlands.; Galapagos NV, Mechelen, Belgium.; Galapagos S.r.l, Milan, Italy.",Not available
39450508,Mechanical Thrombectomy Access Score: A Systematic Review and Modified Delphi of Global Barriers to Endovascular Therapy.,2025-01-01,Kamel H,"Weill Cornell Medicine, New York City, NY (H.K.).",Not available
39449826,Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study.,2024-01-01,Hieke-Schulz S; Leemhuis J; Ziemssen T,"Roche Pharma AG, Grenzach-Wyhlen, Germany. RINGGOLD: 123188",Not available
39448966,"Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC.",2024-10-24,Overbeck TR; Schaefer ES,"Faculte de Medecine, Universite Paris Saclay, Kremlin Bicetre, France.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Department of Biomedical Sciences, Humanitas University, Milan, Italy. armando.santoro@cancercenter.humanitas.it."
39448862,Subclassification of obesity for precision prediction of cardiometabolic diseases.,2024-10-24,Ramos R; Panova-Noeva M; van Greevenbroek M,"CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.","Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden. daniel.coral@med.lu.se."
39448084,Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer.,2025-01-06,Schmalfeldt B; Van Gorp T,"Ciberonc, Instituto de Salud Carlos III, Madrid, Spain.; Instituto Valenciano de Oncologia, Valencia, Spain.","INCLIVA, Hospital Clinico Universitario de Valencia, Valencia, Spain japfidalgo@msn.com."
39448071,Detection of hypertension from pharyngeal images using deep learning algorithm in primary care settings in Japan.,2024-10-23,Tsugawa Y; Nakayama T,"Aillis, Inc, Tokyo, Japan.","Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan no14nec0@gmail.com."
39448029,"Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study).",2024-01-01,Vuitton L; Biron A; Pierron G; Brault Y; Assing M; Bouzidi A,"Pfizer Inc, Paris, France.; Service d'Hepato-Gastroenterologie et Oncologie Digestive, Hopital Robert Debre, Reims-Champagne-Ardennes Universite, Reims, France.; Service de Gastroenterologie, CHU de Besancon, and UMR RIGHT INSERM Universite de Franche-Comte, Besancon, France.","Service de Gastroenterologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Electronic address: david.laharie@chu-bordeaux.fr."
39447758,Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2.,2024-10-22,Dutronc Y; Durand F; Liu C; Yu G; Kolodsick J; Chiasserini C; Somani N,"Eli Lilly and Company, Indianapolis, Indiana.; Tigermed BDM Inc, Somerset, New Jersey.","Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: brett.aking@gmail.com."
39447590,International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement.,2024-01-01,Henderson G,"Gutless and Glamourous, Atlanta, GA, USA.","Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: luc@ucalgary.ca."
39447587,"Asthma symptoms, severity, and control with and without a clinical diagnosis of asthma in early adolescence in sub-Saharan Africa: a multi-country, school-based, cross-sectional study.",2024-01-01,Mkutumula E; Nkhalamba LM,"Malawi Liverpool Wellcome Programme, Blantyre, Malawi.",Not available
39447570,"Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.",2024-11-27,Zhang P,"Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK; Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK",Not available
39447537,Design of a potent and selective dual JAK1/TYK2 inhibitor.,2024-11-15,Mammoliti O; Menet C; Cottereaux C; Blanc J; De Blieck A; Coti G; Geney R; Oste L; Ostyn K; Palisse A; Quinton E; Schmitt B; Borgonovi M; Parent I; Jagerschmidt C; De Vos S; Vayssiere B; Lopez-Ramos M; Shoji K; Brys R; Amantini D; Galien R,"Galapagos NV, Generaal De Wittelaan L11, 2800 Mechelen, Belgium.; Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France.",Not available
39447096,Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.,2024-01-01,Huang HC; Esteva A; van der Wal D; DeVries S; Zhang J; Joun S; Showalter TN,"Artera, Inc, Los Altos, CA.; NRG Oncology Biospecimen Bank, San Francisco, CA.",Not available
39446565,Emerging Concepts and Success Stories in Type 1 Diabetes Research: A Road Map for a Bright Future.,2025-01-01,Mallone R; Sims E,"Institut Cochin, CNRS, INSERM, Universite Paris Cite, Paris, France.; Service de Diabetologie et Immunologie Clinique, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France.",Not available
39446087,"Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION).",2025-01-01,Louie MJ; Raju S; Burger B; Meads A; Schoenberg M,"UroGen Pharma, Princeton, New Jersey.",Not available
39445912,Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis.,2024-11-01,Diaz LA; Mortuza R; Dunn W; Bataller R,"Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.; Maple Statistical Consulting, Ottawa, Ontario, Canada.",Not available
39445673,Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?,2024-01-01,Thouvenot E; Berger T,"icometrix, Leuven, Belgium.",Not available
39445581,Improved quality control of allergen products: Assessing the molecular allergen composition by mass spectrometry.,2024-01-01,Augustin S; Wald M,"Allergopharma GmbH & Co, Reinbek, Germany.",Not available
39445554,Nonlinear mixed-effects modeling as a method for causal inference to predict exposures under desired within-subject dose titration schemes.,2025-01-01,Bartels C; Scauda M; Coello N; Dumortier T; Bornkamp B,"Novartis Pharma AG, Basel, Switzerland.",Not available
39445319,Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis.,2024-01-01,Mathew J; Ferro T,"Drs. Mathew and Ferro are with Sun Pharmaceutical Industries, Inc. in Princeton, New Jersey.",Not available
39444707,Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium.,2024-01-01,Nouhaud E,"Hopital Prive du Confluent, Nantes, France.",Not available
39444703,Multiple sclerosis: emerging epidemiological trends and redefining the clinical course.,2024-01-01,Ruet A; Scalfari A,"Magendie, INSERM U 1215, Universite de Bordeaux, 30776, Bordeaux Cedex, France.",Not available
39444426,"BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer.",2024-01-01,Schalm SS; Conti C; Millet YA; Woessner R; Zhang Z; Tavera-Mendoza LE; Stevison F; Albayya F; Dineen TA; Hsieh J; Zalutskaya A,"Blueprint Medicines Corporation, Cambridge, MA, USA.",Not available
39444224,Potential and challenges of clinical high-dimensional flow cytometry: A call to action.,2024-01-01,Liechti T; Schroeder A; Gonneau C; Green C,"Labcorp, Geneva, Switzerland.; Translational Medicine, Genentech, San Francisco, California, USA.; Translational Science, Ozette, Seattle, Washington, USA.",Not available
39443403,"Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015-2019).",2024-01-01,Broughton E; de Figueiredo Valente MLN; Jiang L; Fernandez M,"Pfizer Inc., New York, NY, USA.; Pfizer Inc., Sao Paulo, Brazil.",Not available
39443015,Platelet FcgammaRIIa as a Marker of Cardiovascular Risk After Myocardial Infarction.,2024-10-29,DiBattiste PM,"Prolocor, Philadelphia, Pennsylvania, USA.","Department of Medicine, Cardiovascular Research Institute, University of Vermont, Burlington, Vermont, USA. Electronic address: david.schneider@med.uvm.edu."
39442769,An evaluation of six techniques for measuring porosity of ribbons produced by roller compaction.,2024-12-25,Martinez L; Palanisamy A; Gururajan B,"Novartis Pharma AG, Novartis Campus,Basel, 4056, Switzerland; Novartis Pharma AG, Novartis Campus,Basel, 4056, Switzerland.; School of Engineering, University of Edinburgh, Edinburgh, EH8 9YL, United Kingdom.",Not available
39442694,Dehydrin Client Proteins Identified Using Phage Display Affinity Selected Libraries Processed With Paired-End Phage Sequencing.,2024-01-01,Hao G; Afroza B,"Catalent Pharma Solution, Baltimore, Maryland, USA.; Department of Horticulture, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, Kentucky, USA; Department of Plant and Soil Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, Kentucky, USA; Division of Vegetable Science, SKUAST- Kashmir, Srinagar, Kashmir, India.; Seed Biology Program, University of Kentucky, Lexington, Kentucky, USA",Not available
39442371,"Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER study.",2024-01-01,Li Y; Estrem ST; Nguyen B; Bacchion F; Ismail-Khan R,"Eli Lilly and Company, Indianapolis, IN, USA.",Not available
39442037,Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.,2024-01-01,Yeh WZ; Van Der Walt A; Skibina OG; Kalincik T; Alroughani R; Kermode AG; Fabis-Pedrini MJ; Carroll WM; Lechner-Scott J; Boz C; Ozakbas S; Buzzard K; Habek M; John NA; Prat A; Girard M; Duquette P; Baghbanian SM; Hodgkinson S; Van Pesch V; Laureys G; Willekens B; Prevost J; Foschi M; De Gans K; Horakova D; Havrdova EK; Karabudak R; Patti F; Mccombe PA; Maimone D; Altintas A; Ampapa R; Spitaleri D; Gerlach OHH; Sa MJ; Hughes S; Gouider R; Mrabet S; Macdonell RA; Turkoglu R; Cartechini E; Al-Asmi A; Soysal A; Oh J; Muros-Le Rouzic E; Guye S; Pasquarelli N; Butzkueven H; Jokubaitis VG,"Amiri Hospital (R.A.), Sharq, Kuwait; Austin Health (R.A.M.), Melbourne, Australia; Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.S.), Avellino, Italy; Azienda Sanitaria Unica Regionale Marche - AV3 (E.C.), Macerata, Italy; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey; CHUM and Universite de Montreal (A.P., M.G., P.D.), Canada; CORe (T.K.), Department of Medicine, University of Melbourne, Australia; CSSS Saint-Jerome (J.P.), Saint-Jerome, Canada; Centre for Molecular Medicine and Innovative Therapeutics (A.G.K., M.J.F.-P.), Murdoch University, Perth; Centro Hospitalar Universitario de Sao Joao (M.J.S.); Centro Sclerosi Multipla (D.M.), UOC Neurologia, Azienda Ospedaliera per l'Emergenza Cannizzaro, Catania, Italy; Charles University in Prague and General University Hospital (D.H., E.K.H.), Prague, Czech Republic; Cliniques Universitaires Saint-Luc (V.V.P.), Brussels; Department of Biotechnological and Applied Clinical Sciences (M.F.), University of L'Aquila, Italy; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania; Department of Medicine (N.A.J.), School of Clinical Sciences, Monash University, Melbourne, Australia; Department of Neurology (B.W.), Antwerp University Hospital, Edegem; Department of Neurology (O.G.S., K.B.), Box Hill Hospital; Department of Neurology (R.G., S.M.), Research laboratory LR18SP03, Clinical investigation Center Neurosciences and Mental Health, Razi Hospital; Department of Neurology (W.Z.Y., A.V.D.W., O.G.S., H.B., V.G.J.), Alfred Health, Melbourne; Department of Neuroscience (M.F.), Neurology Unit-MS Center, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy; Department of Neurosciences (O.G.S., K.B.), Eastern Health Clinical School, Monash University, Box Hill; Faculty of Health Sciences (M.J.S.), University Fernando Pessoa, Porto, Portugal; Faculty of Medicine of Tunis (R.G., S.M.), University of Tunis El Manar, Tunis, Tunisia; From the Department of Neuroscience (W.Z.Y., A.V.D.W., H.B., V.G.J.), School of Translational Medicine, Monash University; Groene Hart Ziekenhuis (K.D.G.), Gouda, Netherlands; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Hunter New England Health (J.L.-S.), John Hunter Hospital, New South Wales, Australia; Izmir University of Economics (S.O.), Medical Point Hospital, Izmir, Turkey; Karadeniz Technical University (C.B.), Medical Faculty, Trabzon; Koc University (A.A.), Istanbul, Turkey; Monash Health (N.A.J.); Nemocnice Jihlava (Radek Ampapa), Jihlava, Czech Republic; Neuroimmunology Centre (T.K.), Department of Neurology, Royal Melbourne Hospital; Neurology Department (S.M.B.), Faculty of Medicine, Mazandaran University of Medical Sciences, Iran; Perron Institute for Neurological and Translational Science (A.G.K., M.J.F.-P., W.M.C.), University of Western Australia, Nedlands; Royal Brisbane and Women's Hospital (P.A.M.), Australia; Royal Victoria Hospital (Stella Hughes), Belfast, United Kingdom; School for Mental Health and Neuroscience (O.H.H.G.), Maastricht University, The Netherlands; Sir Charles Gairdner Hospital (A.G.K., W.M.C.), QEIIMC, Nedlands; St. Michael's Hospital (J.O.), Toronto, Canada; Sultan Qaboos University (A.A.-A.), Al-Khodh, Oman; Translational Neurosciences Research Group (B.W.), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; UOS Sclerosi Multipla (F.P.), AOU Policlinico ""G Rodloico-San Marco"", University of Catania, Italy; Universitary Hospital Ghent (G.L.); Universite Catholique de Louvain (V.V.P.); University Hospital Center Zagreb (M.H.); University of New South Wales (Suzanne Hodgkinson), Sydney, Australia; University of Newcastle (J.L.-S.), Newcastle; University of Queensland (P.A.M.), Brisbane; University of Zagreb (M.H.), School of Medicine, Croatia; Yeditepe University Kosuyolu Hospital (R.K.), Neurological Sciences, Istanbul, Turkey; Zuyderland Medical Center (O.H.H.G.), Sittard-Geleen; and F. Hoffmann-La Roche Ltd (E.M.-L.R., S.G., N.P.), Basel, Switzerland.",Not available
39441986,Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment.,2024-11-14,Yelland T; Hole AJ; Alam B,"Evotec (U.K.) Ltd, 95 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, U.K.",Not available
39441580,Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks.,2024-12-01,Zheng M; Yamamoto-Hanada K; Teixeira HD; Irvine AD,"AbbVie Inc, North Chicago, Illinois.",Not available
39441116,Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS.,2024-10-23,Stampfli M,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.",Not available
39440991,"ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.",2024-11-01,Fares J; Wehbe M; Palfi A; Hechler T; Pahl A; Azim HA Jr; Lhospice F; Preville X; Olive D,"Emergence Therapeutics SA, A Wholly Owned Subsidiary of Eli Lilly and Company, Marseille, France.; Heidelberg Pharma AG, Ladenburg, Germany.",Not available
39440683,Reply: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.,2025-01-01,Owens-Grillo J; Thomas E,"Sumitomo Pharma America, Inc, Marlborough, Massachusetts.",Not available
39440608,The use of surrogate matrices in bioanalytical preclinical safety testing using chromatographic methods: a recommendation from the European Bioanalysis forum.,2024-01-01,Goodwin L; Gnoth MJ; Mascher D; Faber J; Huber P; Greco A; Eggers LF; Sury M; van de Merbel N,"A&M Labor fur Analytik und Metabolismusforschung Service GmbH, 50126, Bergheim, Germany.; Aptuit (Verona) Srl, an Evotec Company, ADMET and Bioanalytical Sciences, 37135, Verona, Italy.; Bayer, DMPK, in vivo PK and bioanalytics, Bayer AG, Wuppertal, 42096, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, DMPK GER/Bioanalysis, 88397Biberach, Germany.; Celerion Switzerland AG, Bioanalytical Services, 8320, Fehraltorf, Switzerland.; ICON, Bioanalytical Laboratories, 9407 TK, Assen, the Netherlands.; Labcorp, Bioanalytical Services, Harrogate, HG3 1PY, UK.; Nuvisan GmbH, Bioanalysis, 89231, Neu-Ulm, Germany.; pharm-analyt Labor GmbH, Bioanalytical Services, 2500, Baden, Austria.",Not available
39440304,Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's disease.,2024-01-01,Cash DM,"Instituto de Investigaciones Neurologicas FLENI, Buenos Aires, Argentina.",Not available
39439530,Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial.,2024-01-01,Bhatt DL,"Instituto Dante Pazzanese de Cardiologia, Sao Paulo, 04012-180, Brazil.",Not available
39439325,[Shortened antimicrobial therapy duration].,2024-01-01,Dinh A,"Service des maladies infectieuses, hopital Raymond-Poincare-Ambroise-Pare, Garches, AP-HP, universite Versailles-Saint-Quentin-Paris-Saclay, Garches, France.",Not available
39438660,A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.,2024-01-01,Filer A; Travis S; Uhlig HH; Dendrou CA; Buckley CD,"Celsius Therapeutics, Cambridge, MA, USA.",Not available
39438587,"Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalities.",2025-01-01,Kuroda J,"Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.",Not available
39438322,Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial.,2024-01-01,Levato L,"SOC. Ematologia AOU ""R. Dulbecco"", Catanzaro, Italy.","Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy. f.efficace@gimema.it."
39438068,How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes.,2024-12-02,Cecere SC; Moore KN; Gomez-Garcia EM,"BC Cancer - Vancouver, Vancouver, British Columbia, Canada.; Division of Gynecologic Oncology, UZ Leuven, Leuven, Belgium.; Grupo Espanol de Investigacion en Cancer Ginecologico (GEICO), Madrid, Spain.",Not available
39438067,Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up).,2024-12-23,Wu X; Han Y; Levy G; Altman K; Calimlim B; Eyerich K,"AbbVie, Inc., North Chicago, IL, USA.",Not available
39437991,[Use of long-acting triple therapy for chronic obstructive pulmonary disease (COPD) in practice: The ELETHON physicians' survey].,2024-10-22,Beeh KM,"Institut fur Atemwegsforschung GmbH, insaf, Taunusstein, Deutschland.",Not available
39437778,EGFR-directed antibodies promote HER2 ADC internalization and efficacy.,2024-11-19,Ghafourian N; Thyparambil S,"mProbe Inc, Rockville, MD, USA.",Not available
39437511,Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.,2024-01-01,De Rose F; Cancian M; Cinquini M; Cariello A; Cretella E; Criscitiello C; De Giorgi U; Carmen De Santis M; Donati S; Dri A; Foglietta J; Gianni L; Giordani S; Malorni L; Mantoan C; Miglietta F; Tralongo P; Curigliano G,"Dipartimento di Oncologia Medica - Centro di Riferimento Oncologico (CRO) - IRCCS Aviano, Pordenone, Universita degli Studi di Udine, Italy.; Dipartimento di Oncologia ed Emato-Oncologia, Universita di Milano, Milano, Italy.; Dirigente delle Professioni Sanitarie - Ospedale Fracastoro - San Bonifacio, Azienda Ulss9 Scaligera, Verona, Italy.; General Practitioner, Coordinatore MGI De Gironcoli, Conegliano, Treviso, Italy; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola FC, Italy.; Istituto Europeo di Oncologia, IRCCS, Milano, Italy; Laboratorio di metodologia delle revisioni sistematiche e produzione di linee guida, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.; National Executive Council of the Italian Society of General Medicine (S.I.M.G.), Florence, Italy.; Oncologia Medica 2, IRCCS Istituto Oncologico Veneto, DiSCOG Universita degli Studi di Padova, Padova, Italy.; Oncologia Medica e Traslazionale, Ospedale Santa Maria di Terni, Italy.; Oncologia Medica, Ospedale di Bolzano, Italy.; Oncologia Ospedale Versilia, Camaiore, Lucca, Italy.; Oncologia Territoriale - AUSL, Bologna, Italy.; Oncologia di Ravenna-AUSL Romagna, Ravenna, Italy.; Radiation Oncology Fondazione I.R.C.C.S. Istituto Nazionale Tumori di Milano, Italy.; Radiation Oncology, APSS, Trento, Italy.; S.O.S. Ricerca Traslazionale, S.O.C. Oncologia Medica, Nuovo Ospedale di Prato Santo Stefano, Azienda USL Toscana Centro, Prato, Italy.; Struttura Complessa di Oncologia, Dipartimento di Oncologia, Ospedale Umberto I Siracusa, Italy.; Sviluppo Nuovi farmaci per le terapie innovative, Istituto Europeo di Oncologia (IEO) IRCCS, Universita degli studi di Milano, Milano, Italy.; UO Operativa di Oncologia-Ospedale Infermi, Rimini, Italy.","Medical Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy. Electronic address: stefania.gori@sacroccuore.it."
39437010,First-in-Human Dose-Escalation Study of the First-in-Class PDE3A-SLFN12 Complex Inducer BAY 2666605 in Patients with Advanced Solid Tumors Coexpressing SLFN12 and PDE3A.,2024-12-16,Papadopoulos KP; Genvresse I; Garrido MF; Wilkinson G; Kneip C,"Bayer AG, Leverkusen, Germany.; Bayer Consumer Care AG, Pharmaceuticals, Basel, Switzerland.; START San Antonio, San Antonio, Texas.",Not available
39436314,Substance use and help seeking as coping behaviors among parents and unpaid caregivers of adults in the United States during the COVID-19 pandemic.,2024-01-01,Matjasko JL,"ARCHANGELS, Boston, MA, USA.",Not available
39435271,Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT.,2024-01-01,Mody K,"Biostatistics, Eisai Inc., Nutley, NJ, USA.",Not available
39435268,Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study.,2024-01-01,Barnes G; Abdrashitov R; Li S,"BeiGene USA, Emeryville, CA, USA.; BeiGene USA, Fulton, MD, USA.; Statistics and Data Science, BeiGene USA, Ridgefield Park, NJ, USA.",Not available
39434631,Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial.,2024-10-22,Anstrom KJ; Armstrong PW,"Bayer Pharma AG, Basel, Switzerland.; Merck & Co Inc, Kenilworth, New Jersey, USA.",Not available
39432738,Efficacy and safety of the oral JAK3/TEC family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase 2b/3 and long-term phase 3 clinical studies in alopecia areata.,2024-10-21,Soung J; Wolk R; Woodworth D; Lejeune A,"Pfizer Inc, Groton, CT, USA.; Pfizer Pharma GmbH, Berlin, Germany.; Southern California Dermatology, Santa Ana, CA, USA.",Not available
39432420,Insights into Molecular Interactions and Biological Effect of Natural Stilbenoids at the TRPA1 Ion Channel.,2024-10-21,Koivisto AP,"Pain Therapy Area, R&D, Orion Pharma, Tengstrominkatu 8, Turku, 20360, Finland.",Not available
39432308,Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial.,2024-10-01,Defiore-Hyrmer J; Shadwick A,"Recovery Ohio, Columbus.; State of Ohio Board of Pharmacy, Columbus.",Not available
39432188,Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study.,2024-01-01,Koch M; Baufeld C; Weiss C,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma GmbH, Nuremberg, Germany.","Headache Center Frankfurt, Frankfurt, Germany. c.gaul@kopfschmerz-frankfurt.de."
39432104,Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsis.,2024-01-01,Scicluna BP,"Computational Biology, Novo Nordisk, Oxford, UK.","Baillie Gifford Pandemic Science Hub, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK. j.k.baillie@ed.ac.uk."
39430616,Multivariable models of outcomes with [(177)Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial.,2024-01-01,Wong CC; Zhang Z; Wilke C; Mirante O,"Advanced Accelerator Applications, A Novartis Company, Geneva, Switzerland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA.",Not available
39429811,Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease.,2024-01-01,Willis-Parker M; Grundman M; Assman B,"F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Global R&D Partners, LLC, San Diego, CA, USA.; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine; Minority Engagement Core, Atlanta, GA, USA.",Not available
39429145,Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.,2024-12-10,Desai AS; Lefkowitz MP; Martinez F,"Novartis Pharmaceuticals, East Hanover, NJ (L.-M.C., J.G., M.P.L.).",Not available
39428614,Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms.,2024-01-01,Yoshida K,"Data Science, Sumitomo Pharma Co., Ltd, Tokyo, Japan.",Not available
39428453,Development and Validation of a Patient-Reported Outcome Measure of the Impact of Chronic Hand Eczema on Health-Related Quality of Life: the Hand Eczema Impact Scale (HEIS).,2024-01-01,Larsen LS; Balita-Crisostomo CL; Mathiasen NN; Thoning H,"LEO Pharma A/S, Ballerup, Denmark.",Not available
39428402,Collagen Type VII (COL7A1) as a Longevity Mediator in Caenorhabditis elegans: Anti-Aging Effects on Healthspan Extension and Skin Collagen Synthesis.,2024-11-01,Kim H; Seo WY; Lee E; Cho D,"ABIOTECH Co., Ltd., Suwon 16675, Republic of Korea.; GENINUS Inc., Seoul 05836, Republic of Korea.; HEM pharma, Suwon 16229, Republic of Korea.",Not available
39428126,Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer.,2024-10-20,Perea F; Megias D; Munoz-Viana R; Garrido F; Aptsiauri N; Ruiz-Cabello F,"Departamento de Bioquimica, Biologia Molecular e Inmunologia III. Instituto de Investigacion Biosanitaria de Granada (Ibs. GRANADA), Universidad de Granada Facultad de Medicina, Granada, Andalucia, Spain.; Unidad de Bioinformatica, Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain.; Unidad de Microscopia Optica Avanzada, Instituto de Salud Carlos III, Majadahonda, Spain.",Not available
39427441,First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study.,2024-01-01,Thakur M,"Pfizer, Sandwich, UK.",Not available
39427187,CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD.,2024-10-19,Rony F; Charretier R; Galkin D; Benfeitas R,"Chiesi Pharma AB, Stockholm, Sweden.; Chiesi SAS, Bois Colombes, France.; Chiesi USA, Inc, Cary, NC, USA.","Chiesi Farmaceutici SpA, Parma, Italy. m.govoni@chiesi.com."
39426944,Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States: Real-world asciminib treatment outcomes in CML-CP.,2024-09-26,Wei D; Latremouille-Viau D; Rossi C; Damon A; Ferreira G; Guerin A; Jadhav K,"Analysis Group, Inc, Montreal, Canada.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ.","Medical College of Wisconsin, Milwaukee, WI. Electronic address: eatallah@mcw.edu."
39426936,Cellular and immunotherapies for myelodysplastic syndromes.,2024-01-01,Stubbins RJ; Cherniawsky H,"Division of Hematology, Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, BC, Canada.; Leukemia/BMT Program of BC, BC Cancer, Vancouver V5Z 1M9, BC, Canada","Division of Hematology, Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, BC, Canada. Electronic address: ryan.stubbins1@bccancer.bc.ca."
39426664,Natriuretic Peptides For Diagnosing Heart Stress: Taking Action Now.,2024-01-01,Bayes-Genis A,"Autonomous University of Barcelona, Barcelona, Spain; Cardiology Department, Hospital Germans Trias i Pujol, Badalona, Spain; Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.",Not available
39426660,"Predictive, integrative, and regulatory aspects of AI-driven computational toxicology - Highlights of the German Pharm-Tox Summit (GPTS) 2024.",2024-01-01,Amann S; Babayan N; Hofmaier T,"Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit GmbH, Spargelfeldstrasse 191, Wien 1220, Austria.; Toxlicon GmbH, Obwaldener Zeile 23, Berlin 12205, Germany.; Toxometris.ai Inc., USA.","Toxlicon GmbH, Obwaldener Zeile 23, Berlin 12205, Germany. Electronic address: hassmann@toxlicon.com."
39426393,"Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study.",2024-01-01,Mangal B; Lowe S; Cunningham T,"Amryt Pharmaceuticals, Dublin, Ireland.; Solara Consulting, North Vancouver, BC, Canada.","Universitat Rovira i Virgili, Vascular Medicine and Metabolism Unit, Sant Joan University Hospital, CIBERDEM, Reus, Spain. Electronic address: luis.masana@urv.cat."
39426360,Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis.,2024-11-15,Qi CZ; Phillips G; Gelinas D; Brauer E; Mantegazza R,"Associazione Italiana Miastenia e Malattie Immunodegenerative, Milan, Italy.; Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy; argenx, Boston, MA, USA.","Services in Health Economics, Brussels, Belgium. Electronic address: sd@she-consulting.be."
39425271,Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials.,2024-01-01,Kastelein JJP; Ditmarsch M; Hsieh A; Johnson J; Curcio D; Kling D; Davidson MH,"NewAmsterdam Pharma B.V, Naarden, The Netherlands.",Not available
39425188,MAVS signaling shapes microglia responses to neurotropic virus infection.,2024-10-18,Costa B,"Genentech, South San Francisco, CA, USA.",Not available
39424802,Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salience.,2024-10-18,Bertuca A; Golia M; Nicoletta R,"Centro di Salute Mentale di Lamezia Terme (CZ), Dipartimento di Salute Mentale di Catanzaro, Catanzaro, Italia.",Not available
39424619,Comparative transcriptomic analysis validates iPSC derived in-vitro progressive fibrosis model as a screening tool for drug discovery and development in systemic sclerosis.,2024-10-18,Bretschneider T,"Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39424560,"Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.",2024-01-01,Corcia P; Zurek G,"Centre de Reference Maladie Rare (CRMR) SLA et les Autres Maladies du Neurone Moteur (FILSLAN), Tours, France; Faculte de Medecine, INSERM U1253, ""iBrain Imaging Brain and Neuropsychiatry"" Universite Francois-Rabelais de Tours, Tours, France.; MVZ Medizinisches Labor Bremen GmbH, Bremen, Germany.",Not available
39424405,The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study.,2024-10-18,van Vollenhoven RF,"UCB Pharma Ltd, Slough, UK.",Not available
39424404,"Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47.",2024-10-18,Jaworski J; Zielinska A; Dudek A; Kim S; Bae Y; Yang G; Jung Y; Hong J,"Celltrion, Inc, Incheon, Republic of Korea.; Centrum Medyczne Amed, Warsaw, Poland.; Klinika Reuma Park, Warsaw, Poland.; MICS Centrum Medyczne, Warsaw, Poland.","Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria josef.smolen@meduniwien.ac.at."
39424378,"VAL-1221 for the treatment of patients with Lafora disease: study protocol for a single-arm, open-label clinical trial.",2024-10-18,Michelucci R,"Parasail LLC, Quincy, Massachusetts, USA.",Not available
39423930,Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial.,2024-10-17,Sinclair R; Wolk R; Zwillich SH; Tran H; Wajsbrot D,"Pfizer Inc, Groton, Connecticut.; Pfizer Inc, New York, New York.; Sinclair Dermatology, Melbourne, Victoria, Australia.",Not available
39423875,Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial.,2024-01-01,Meng X; Xin Q; Meng W,"Sinovac Biotech, Beijing, China.",Not available
39423606,Metabolomic analysis reveals the potential of fucosylated chondroitin sulfate from sea cucumber in modulating metabolic homeostasis.,2025-01-01,Yao Y,"Suzhou Ronnsi Pharma Co., Ltd, Suzhou, Jiangsu 215125, China.",Not available
39423118,"Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial.",2024-12-01,Ly TT,"Insulet Corporation, Acton, MA.",Not available
39422912,Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.,2024-10-01,Thicklin F; Garcia Del Sol IT,"ACTIV-6 Stakeholder Advisory Committee, Pittsburgh, Pennsylvania.; Weill Cornell Medicine, New York, New York.",Not available
39422767,Enzalutamide versus abiraterone acetate in the development of new-onset or worsening type 2 diabetes mellitus in patients with metastatic castration-resistant prostate cancer: EVADE study.,2024-10-18,Snjider R; Chilelli A; Pranzo A; Martins K; Rozario N,"Astellas Pharma Europe Ltd., Surrey, UK.",Not available
39422602,"Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09).",2025-01-01,Kim J,"Bioinformatics, Geninus Inc., Seoul, South Korea.",Not available
39422598,"First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies.",2024-12-16,Papadopoulos KP; Jankovic V; Paccaly A; Masinde S; Mani J; Lowy I; Gullo G; Sims T; Kroog G,"Regeneron Pharmaceuticals, Inc., Tarrytown, New York.; START San Antonio, San Antonio, Texas.",Not available
39422118,Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.,2024-10-18,Cabalu TD; de Zwart L; Dowty ME; Boulu L; Fu Q; Leblanc AF; Liang G; Pilla Reddy V; Rehmel J,"DMPK, Janssen Pharmaceutica NV, A Johnson & Johnson Company, Beerse, Belgium.; DMPK, Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc., Rahway, New Jersey, USA.; DMPK, Vertex Pharmaceuticals, Boston, Massachusetts, USA.; Global PKPD/Pharmacometrics, Eli Lilly and Company, Bracknell, UK and Indianapolis, Indiana, USA.; Modeling and Simulation, Translational Medicine and Early Development, Sanofi, Montpellier, France.; Modeling and Simulation, Vertex Pharmaceuticals, Boston, Massachusetts, USA.; Pharmacokinetics Dynamics and Metabolism, Pfizer Inc, Cambridge, Massachusetts, USA.; Quantitative, Translational & ADME Sciences, Development Science, AbbVie, North Chicago, Illinois, USA.",Not available
39422109,Assessment of cell-binding capacity of shed rAAV particles after gene therapy vector administration: implications for environmental risk and hygiene recommendations.,2024-01-01,Fleischmann T,"Biotransformation and Environmental Sciences, Pfizer Pharma GmbH, Berlin, Germany.",Not available
39421431,Chronic kidney disease-associated pruritus and quality of life with difelikefalin treatment: a post hoc analysis of phase 3 data using the Skindex-10 questionnaire.,2024-01-01,Menzaghi F; Wen W,"Cara Therapeutics Inc., Stamford, CT, USA.",Not available
39421231,Inflammationbased prognostic markers in patients with advanced or recurrent gastric cancer treated with nivolumab: Tokushukai REAlworld Data project 02 (TREAD 02).,2024-01-01,Shiragami M; Fujimura Y; Hayashi M; Shinozaki N,"Development Division, Tokushukai Information System Inc., Osaka 530-0001, Japan.; deCult Co., Ltd., Hatsukaichi, Hiroshima 739-0413, Japan.",Not available
39420177,MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates.,2024-10-17,Contreras V; Naninck T; Kahlaoui N; Gallouet AS; Langlois S; Burban E; Joly C; Gros W; Dereuddre-Bosquet N; Morin J; Le Grand R,"Universite Paris-Saclay, Inserm, CEA, Immunologie des maladies virales, auto-immunes, hematologiques et bacteriennes (IMVA-HB/IDMIT/UMR1184), 92265, Fontenay-aux-Roses & Kremlin Bicetre, France.","Department of Infectious Disease Immunology, Statens Serum Institut, Artillerivej 5, 2300, Copenhagen, Denmark. jow@ssi.dk."
39419848,"First-in-human study of dosimetry, safety and efficacy for [(177)Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases.",2024-10-18,Alexoff D; Ploessl K,"Five Eleven Pharma Inc, 3700 Market St., Philadelphia, PA, 19104, USA.",Not available
39419642,Evaluation of induced pluripotent stem cell differentiation into neural progenitor cell using Raman spectra derived from extracellular vesicles in culture supernatants.,2025-01-01,Sekiya S; Yoshida K; Kishino A; Kimura T,"Regenerative and Cellular Medicine Office, Sumitomo Pharma Co., Ltd., Tokyo Nihonbashi Tower, 2-7-1 Nihonbashi, Tokyo 103-6012, Japan.",Not available
39419118,Sleep disorders in younger and middle-older age adults with newly diagnosed type 2 diabetes mellitus: A retrospective cohort study in >1million individuals.,2024-01-01,Ibarburu GH; Drebert Z,"TriNetX LLC, Cambridge, MA, USA.","Diabetes Research Centre, College of Life Sciences, University of Leicester, UK. Electronic address: jjh18@leicester.ac.uk."
39419054,"Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.",2024-10-19,Gallardo D; Colombo N; Alamilla-Garcia G,"Instituto Nacional de Cancerlogia, Mexico City, Mexico.; Istituto Europeo di Oncologia, Milan, Italy.","University College Hospital NHS Trust, London, UK. Electronic address: mary.mccormack2@nhs.net."
39418694,Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.,2024-01-01,Kempf W,"Department of Dermatology, University Hospital Zurich, CH-8091 Zurich, Switzerland.; Kempf und Pfaltz Histologische Diagnostik, Affolternstrasse 56, CH-8050 Zurich, Switzerland","University Cancer Center (UCT) Frankfurt-Marburg, Marburg, Frankfurt, Germany. Electronic address: khaled.elsayad@uk-gm.de."
39418644,Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy.,2024-12-24,Wang Q; Faderl S; Chakravarthy D; Menno D; Cheung RS,"Jazz Pharmaceuticals, Palo Alto, CA.; Jazz Pharmaceuticals, Philadelphia, PA.",Not available
39418598,The seventh blind test of crystal structure prediction: structure ranking methods.,2024-12-01,Bellucci MA; Bis JA; Carino S; Darden T; DiPasquale A; Greenwell C; Jain V; Lubach JW; Muddana HS; Sekharan S; Skillman AG; Tarczynski F; Woollam GR,"Catalent Pharma Solutions, 160 Pharma Drive, Morrisville, NC 27560, USA.; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.; Novartis Pharma AG, Basel 4002, Switzerland.; OpenEye Scientific Software, 9 Bisbee Court, Santa Fe, NM 87508, USA.; XtalPi Inc, 245 Main Street, Cambridge, MA 02142, USA.",Not available
39418382,Description and functional validation of human enteroendocrine cell sensors.,2024-10-18,van Es JH; Clevers H,"Single Cell Discoveries BV, 3584 BW Utrecht, Netherlands.",Not available
39418184,MASLD: What We Have Learned and Where We Need to Go-A Call to Action.,2024-01-01,Hosseini Shabanan S; Martins VF; Wolfson T; Weeks JT; Ceriani L; Behling C; Chernyak V; El Kaffas A; Borhani AA; Han A; Wang K; Fowler KJ; Sirlin CB,"Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, Va (A.H.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (V.C.); Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Ill (A.A.B.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (A.E.K.); From the Department of Radiology, UC San Diego Altman Clinical and Translational Research Institute Liver Imaging Group, University of California San Diego, 9452 Medical Center Dr, La Jolla, CA 92037 (S.H.S., V.F.M., T.W., J.T.W., L.C., K.J.F., C.B.S.); Pacific Rim Pathology, San Diego, Calif (C.B.); and Department of Radiology, University of California San Francisco, Calif (K.W.).",Not available
39417943,Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.,2024-01-01,Noda M,"Non-Profit Organization Sasaeau-Kai ""Alpha"", 518-7 Kawado-Cho, Chuo-Ku, Chiba, Chiba, 2600802, Japan.",Not available
39415924,"Routine hemostasis profile in steady state sickle cell disease adult patients compared to laboratory values, between phenotypes and during pregnancy: A retrospective, descriptive study.",2024-01-01,Affo C; Dumont B,"Service de Medecine Interne Hopital Louis Mourier, AP-HP Colombes France.",Not available
39415923,Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy.,2024-01-01,Flinn IW; Cohen JB; Sizelove R; Tsai DE; Jurczak W,"Eli Lilly and Company Indianapolis Indiana USA.; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia ""Seragnoli"" Bologna Italy.; Tennessee Oncology and OneOncology Nashville Tennessee USA.",Not available
39415900,"A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma.",2024-01-01,Stumpp MT; Suter C; Dawson KM; Zitt C; Legenne P; Stavropoulou V; Fey MF; Leupin N,Molecular Partners AG Zurich-Schlieren Switzerland.,Not available
39415562,Prognostic factors and overall survival among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland study.,2024-10-16,Roebuck N,"GSK, Brentford, Middlesex, UK; ImmunoGen, Inc.",Not available
39415381,Prognostic Impact of Admission Time in Infarct-Related Cardiogenic Shock: An ECLS-SHOCK Substudy.,2024-10-14,Voigt I,"Contilia Elisabeth-Krankenhaus, Essen, Germany.",Not available
39415344,"Evaluation of an oral small-molecule glucagon-like peptide-1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose-ranging, phase 2, randomized, placebo-controlled study.",2025-01-01,Zmuda W,"Medicome Sp. Z O.O., Oswiecim, Poland.",Not available
39415149,The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.,2024-10-16,Hielscher C,"ClinSol GmbH & Co KG, Wurzburg, Germany.",Not available
39414986,PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement.,2024-01-01,Nicol G; Lessie E; Prensky Z; Valenta I,"LB Pharmaceuticals Inc., New York, NY, USA.; Mark S. Hixon Consulting LLC, San Diego, CA, USA.","Mallinckrodt Institute of Radiology, and Department of Radiology, Washington University in Saint Louis, St. Louis, MO, USA. dfwong@wustl.edu."
39414726,Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe.,2024-01-01,Hanson KA; Schaefer G; Kurosky SK; Vano-Galvan S,"Pfizer Inc, New York, NY, USA.; Pfizer Pharma GmbH, Berlin, Germany.","Adelphi Real World, Bollington, UK. peter.anderson@adelphigroup.com."
39414325,"First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments.",2024-10-15,Lillie T; Stacey A; Thomas M,"Akamis Bio Ltd, Abingdon, UK.","Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA anaing@mdanderson.org."
39413884,"Adjunctive cariprazine for the treatment of major depressive disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.",2025-01-15,Reda I; Kerolous M,"AbbVie, Florham Park, NJ, USA.","Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA. Electronic address: nntman@gmail.com."
39412947,Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors.,2025-01-02,Ngo C; Eychenne T; Bordelet L; Song F; Bouyakoub R; Romo-Morales A; Schwob E; Zimmermann A; Faron M; Postel-Vinay S,"Organoid Core Facility, Gustave Roussy, Villejuif, France.; Sarcoma Committee, Gustave Roussy, Villejuif, France.; Universite Paris-Saclay, Universite Paris-Sud XI, Faculte de Medicine, Le Kremlin Bicetre, France.; Viroxis SAS Biotech, Gustave Roussy, Villejuif, France.",Not available
39412702,"First-in-human study of D6-[(18)F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [(18)F]FP-(+)-DTBZ (AV-133).",2024-10-16,Alexoff D; Zhu L,"Five Eleven Pharma Inc.,, Philadelphia, PA, 19104, USA.",Not available
39412212,Cost-effectiveness of cell-based influenza vaccine in France.,2024-01-01,Burlet N,"Vifor Pharma, Paris, France.",Not available
39412014,[Definitions and epidemiology of varicose vein disease].,2024-01-01,Josnin M,"Service de phlebologie interventionnelle, clinique Saint-Charles, La Roche-sur-Yon, France. Societe francaise de phlebologie.",Not available
39411574,Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications.,2024-01-01,Marjenberg Z; Marshall J,"Maverex Ltd, Newcastle Upon Tyne, UK.",Not available
39411532,"Discovery of BAY 2666605, a Molecular Glue for PDE3A and SLFN12.",2024-10-10,Ellermann M; Kopitz C; Lange M; Denner K; Lienau P; Kaulfuss S; Goldoni S,"Bayer AG, Berlin 13353, Germany.; Bayer AG, Wuppertal 42096, Germany.",Not available
39411524,"Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer.",2024-10-10,Zhang C; Tu P; Jia X; Xia Y; Lu B; Yang F; Wang S; Jin L,"Changchun Genescience Pharma, 88 Hongmei Road, Xuhui District, Shanghai 200233, China.",Not available
39411234,Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin Cohort.,2024-01-01,Chiricozzi A,"Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Universita Cattolica Del Sacro Cuore, Rome, Italy.",Not available
39411131,Revising cancer incidence in a Central European country: a Hungarian nationwide study between 2011-2019 based on a health insurance fund database.,2024-01-01,Kiss Z; Polgar C; Kenessey I; Wittmann I; Moldvay J; Galffy G; Tamasi L; Muller V,"MSD Pharma Hungary Ltd, Budapest, Hungary.; RxTarget Ltd., Szolnok, Hungary.",Not available
39411071,Analysis of criteria for choosing drug treatment strategies in allergic rhinitis.,2024-01-01,Grzegorzewski D; Pawliczak R,"Aurovitas Pharma Poland Ltd., Warsaw, Poland.; Quality Audit House Ltd., Lodz, Poland.",Not available
39410752,Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates.,2024-10-24,Watanabe T; Arashida N; Fujii T; Shikida N; Ito K; Shimbo K; Seki T; Iwai Y; Hirama R; Hatada N; Nakayama A,"Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan.",Not available
39410544,Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study.,2024-09-26,Bahur B; Barberio B,"ProciseDx Inc., 9449 Carroll Park Drive, San Diego, CA 92121, USA.",Not available
39410538,In Vivo Reflectance Confocal Microscopy Applied to Acral Melanocytic Lesions: A Systematic Review of the Literature.,2024-09-25,Cappilli S; Michelini S; Salvi M; Peris K,"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, 00168 Rome, Italy.",Not available
39410042,Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series.,2024-10-09,Kryukov K; Ying H; Shen JP; Zhao D,"BostonGene Corporation, 100 Beaver St, Waltham, MA 02453, USA.",Not available
39408932,Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs.,2024-10-01,Alejo T; Toro-Cordova A; Fernandez L; Rivero A; Stoian AM; Perez L; Navarro V; Martinez-Olivan J; de Miguel D,"CerTest Biotec S.L., 50840 San Mateo de Gallego, Spain.",Not available
39408593,Using Spectral Flow Cytometry for CAR T-Cell Clinical Trials: Game Changing Technologies Enabling Novel Therapies.,2024-09-24,Beadnell TC; Jasti S; Wang R,"Eurofins Pharma Bioanalytical Services, St. Charles, MO 63304, USA.; Eurofins Viracor Biopharma, Lenexa, KS 66219, USA.",Not available
39408262,Effect of Isoflavone on Muscle Atrophy in Ovariectomized Mice.,2024-09-28,Sasano R,"AiSTI SCIENCE Co., Ltd., Wakayama 640-0033, Japan.",Not available
39406916,Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors.,2024-01-01,Utro F,"Ascension St. Vincent's Birmingham, Birmingham, AL, USA.",Not available
39406585,Results of the AMIC(R) method in patients operated on for an osteochondral lesion of the talar dome (OLTD) at a mean follow-up of 34 months. A retrospective multicenter study.,2024-10-14,Peras M; Bilichtin E; Choufani C; Caubere A; Barbier O,"Service de Chirurgie Orthopedique et Traumatologique, Hopital d'Instruction des Armees Sainte-Anne, 2 Boulevard Sainte-Anne, 83000, Toulon, France; Service de Chirurgie Orthopedique et Traumatologique, Hopital d'Instruction des Armees Sainte-Anne, 2 Boulevard Sainte-Anne, 83000, Toulon, France.","IULS-University Institute for Locomotion and Sports, Pasteur 2 Hospital, Unite de Recherche Clinique Cote d'Azur (UR2CA), Hopital Pasteur II, 30, voie Romaine, 06000 Nice, France. Electronic address: matthieu.peras@gmail.com."
39405196,The seventh blind test of crystal structure prediction: structure generation methods.,2024-12-01,Bellucci MA; Bis JA; Carino S; Couch R; Darden T; DiPasquale A; Greenwell C; Jain V; Lubach JW; Muddana HS; Tarczynski F; Woollam GR,"Catalent Pharma Solutions, 160 Pharma Drive, Morrisville, NC 27560, USA.; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.; Novartis Pharma AG, Basel 4002, Switzerland.; OpenEye Scientific Software, 9 Bisbee Court, Santa Fe, NM 87508, USA.; XtalPi Inc., 245 Main Street, Cambridge, MA 02142, USA.",Not available
39405058,"Sex Differences in Frequency, Severity, and Distribution of Cerebral Microbleeds.",2024-10-01,Barbato C,"GHU-Paris Psychiatrie et Neurosciences, Service de Neuroradiologie, Hopital Sainte Anne, Paris, France.",Not available
39405017,"Authors' Reply to Wang et al., ""Comment on 'Efficacy and Safety of Brodalumab, an Antiinterleukin17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16Week Results of a Randomized Clinical Trial'"".",2024-01-01,Kikuta N,"Kyowa Kirin Co., Ltd., 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.",Not available
39404139,Pharmacokinetics and Safety of a Novel Extended-Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder.,2024-10-15,Walling DP; Dong Y; Fu F,"CenExel - CNS, Garden Grove, CA, USA.; Luye Pharma (USA), Ltd., Princeton, NJ, USA.",Not available
39403959,Social support and (complex) posttraumatic stress symptom severity: does gender matter?,2024-01-01,Mossie TB; Luond A,"Facultad de Medicina ""San Fernando"", Universidad Nacional Mayor de San Marcos, Lima, Peru.; Hopitaux de Saint-Maurice, Saint-Maurice, France.",Not available
39403626,Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study.,2024-01-01,Peguero J; Bajaj P,"Oncology Consultants, Houston, Texas.; Tasman Oncology, Southport, Queensland, Australia.",Not available
39403449,Validation of a holistic composite outcome measure for the evaluation of chronic pain interventions.,2024-01-01,Mullin CM; Leitner A,"North American Science Associates, Minneapolis, MN, USA.; Spanish Hills Interventional Pain Specialists, Camarillo, CA, USA.",Not available
39403308,Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy.,2024-01-01,Donnarumma G,"Dipartimento di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, Rome, Italy.",Not available
39402834,Firth-Type Penalized Methods of the Modified Poisson and Least-Squares Regression Analyses for Binary Outcomes.,2024-01-01,Noma H,"Data Science, Astellas Pharma Inc., Tokyo, Japan.",Not available
39402675,"Comprehensive biomarker and modeling approach to support dose finding for BI 836880, a VEGF/Ang-2 inhibitor.",2024-10-14,Keller S; Kunz U; Schmid U; He M; Luedtke D; Niessen HG; Oum'hamed Z; Pleiner S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.",Not available
39402603,Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials.,2024-10-14,Ho HT; Chen GJ; Wu YE; Hao JY; Liang CW; Hu OY,"Sinew Pharma Inc. Rm C516, Building C, No.99, Lane 130, Sec. 1, Academia Rd., Nangang Dist, Taipei City, 11571, Taiwan.",Not available
39402301,Long-term safety profile of sutimlimab in adult Japanese patients with cold agglutinin disease.,2024-01-01,Nishimi M; Kawaguchi O; Tahara S,"Sanofi K.K, Tokyo, Japan.","Department of Hematology, Saitama Medical University Hospital, 38 Morohongo Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan. miyakawa@saitama-med.ac.jp."
39402057,Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.,2024-10-14,Micol JB,"INSERM U1287, Gustave Roussy, Universite Paris-Saclay, Villejuif, France.","Department of Pharmacology, Caen-Normandy University Hospital, Caen, France. morice-pm@chu-caen.fr."
39402015,Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study.,2024-10-14,Wunder A; Weigand A,"SBGneuro Ltd, Oxford, UK.","Medical School Berlin, Berlin, Germany. marvin.meiering@medicalschool-berlin.de."
39401861,Evidence for a lipofibroblast-to- Cthrc1 + myofibroblast reversible switch during the development and resolution of lung fibrosis in young mice.,2024-11-21,Vasquez-Pacheco E; Gautier-Isola M; Chu X; Marega M,"Equal contribution.; Universite Cote d'Azur, UMR CNRS 7275 Inserm 1323, IPMC, FHU-OncoAge, IHU RespiERA, , Valbonne, France.",Not available
39401856,Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomics.,2024-01-01,Sterk PJ,"Biosci Consulting, Maasmechelen, Belgium.",Not available
39401854,Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis.,2025-01-01,Drager LF; Ip MSM; Phillips CL,"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.; Unidades de Hipertensao, Instituto do Coracao (InCor) e Disciplina de Nefrologia, Universidade de Sao Paulo, Sao Paulo, Brazil.","Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Milan, Italy m.pengo@auxologico.it."
39401853,Skewed adaptive immune responses are involved in alpha-1 antitrypsin deficiency emphysema.,2025-01-01,Barjaktarevic I,"Pulmonary and Critical Care Medicine, UCLA, Los Angeles, CA, USA.",Not available
39400461,"Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial.",2024-01-01,Frangou E; Love S,"Freeline Therapeutics, King's Court, Stevenage, UK.; Translational Medicine, UCB Pharma, Slough, UK.",Not available
39400386,Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival.,2025-01-01,Kiladjian JJ; Buckley S; Roman-Torres K,"Hopital Saint-Louis, Universite Paris Cite, Paris, France.; Sobi Inc., Waltham, Massachusetts, USA.",Not available
39399920,SARS-CoV-2 infection and the risk of depressive symptoms: a retrospective longitudinal study from the population-based CONSTANCES cohort.,2024-10-14,Carrat F; Touvier M; Gouraud C; Ouazana Vedrines C; Lemogne C,"Departement de sante publique, AP-HP, Hopital Saint-Antoine, Paris, France.; Sorbonne Universite, Inserm, Institut Pierre-Louis d'Epidemiologie et de Sante Publique, Paris, France.; Universite Paris Cite, VIFASOM (Vigilance Fatigue Sommeil et Sante Publique), Paris, France.; Universite Paris-Saclay, UVSQ, INSERM, CESP U1018, Gustave Roussy, Villejuif, France.",Not available
39399157,Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (>/=90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or Cemiplimab.,2024-01-01,McIntyre DA; Pouliot JF; Altan M,"Regeneron Pharmaceuticals, Tarrytown, New York.",Not available
39398317,Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study.,2024-01-01,Carr WW,"Allergy & Asthma Associates of Southern California, Mission Viejo, CA, USA.",Not available
39397239,Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary.,2024-01-01,Verhagen LAW; Marotte H,"Nordic Pharma B.V., Siriusdreef 41, 2132 WT, Hoofddorp, The Netherlands.; Universite Jean Monnet, Service de Rhumatologie, CHU Saint-Etienne, Mines Saint-Etienne, INSERM U1059, Saint-Etienne, France.","Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Windmill Road, Oxford, OX3 7LD, UK. peter.taylor@kennedy.ox.ac.uk."
39396828,"Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI-75 and HECSI-90 as within-patient responder definitions.",2025-01-01,Thoning H; Larsen LS; Lehmann L,"LEO Pharma A/S, Ballerup, Denmark.",Not available
39396529,"Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial.",2024-01-01,Grimmer K; Kemble G; Bruno Martins E; McCulloch W; O'Farrell M; Tsai WW,"Sagimet Biosciences, San Mateo, CA, USA.","MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, CA, USA. Electronic address: roloomba@health.ucsd.edu."
39395775,Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults.,2024-01-01,Dworaczyk DA,"Bryn Pharma, LLC, Lebanon, NJ.","Section of Allergy and Immunology, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Denver, Colo. Electronic address: Matthew.Greenhawt@childrenscolorado.org."
39395438,Sex and gender in inflammatory bowel disease outcomes and research.,2024-01-01,Johansson M; Carlsson A; Svavarsdottir E,"Crohn's og Colitis Ulcerosa Samtokin, Reykjavik, Iceland.; Mage-tarmforbundet, Nes, Norway.; Tarm-uro-och stomiforbundet ILCO, Stockholm, Sweden.","Molecular Diagnostics and Clinical Research Unit, Department of Internal Medicine, University Hospital of Southern Denmark, Aabenraa, Denmark. Electronic address: va@rsyd.dk."
39395411,A tumor cornification and immune-infiltration-based scheme for anti-PD-1 plus chemotherapy response in advanced squamous cell lung carcinoma.,2024-10-11,Sun J; Peng B; Zhou H,"Innovent Biologics, Inc., Suzhou, Jiangsu 215123, China.",Not available
39387766,Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials.,2025-01-01,Lefkowitz M,"Novartis, East Hanover, New Jersey, USA.",Not available
39387517,Multidomain Protein-Urea Interactions: Differences in Binding Behavior Lead to Different Destabilization Tendencies for Monoclonal Antibodies.,2024-10-24,Burkert O; Mizaikoff B,"Boehringer Ingelheim Pharma GmbH & Co. KG, Analytical Development Biologicals, Biberach D-88397, Germany.",Not available
39387200,Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study.,2024-10-10,Rhys-Williams W; Lees JP; Dane A; Love WG; Gonzalez Moreno J; Martina Y; Barker D,"Danestat Consulting Ltd., Macclesfield, UK.; Destiny Pharma plc, Brighton, UK.; Formerly at Destiny Pharma plc, Brighton, UK.",Not available
39395231,Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.,2024-01-01,Ardeshir C,"Roche Products Ltd, Welwyn Garden City, UK.",Not available
39394969,Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023.,2025-01-01,Carrascosa-Carrillo JM,"Servicio de Dermatologia, Complejo Asistencial Universitario de Leon (CAULE), Leon, Spain.",Not available
39394450,Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.,2024-01-01,Wei B,"Chimerix, Durham, NC, 27713, USA.","Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. cchattop@mdanderson.org."
39394179,Review of the current ongoing clinical trials exploring the possible anti-anxiety effects of cannabidiol.,2024-10-12,Bhuller R; Hoeng J,"Vectura Fertin Pharma Switzerland SA, Avenue de Rhodanie 50, Lausanne, 1007, Switzerland.",Not available
39394034,A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol.,2024-09-20,Farago AF,"Novartis Pharmaceuticals, Cambridge, MA, USA.",Not available
39393925,Implementation of an Occupational Sun Safety Intervention: A Comparison of Two Scalability Strategies.,2025-01-01,Buller DB,"From the Klein Buendel, Inc., Golden, Colorado (D.B.B., M.K.B., J.B., A.K., I.A., N.C.); Kaiser Permanente Center for Health Research, Portland, Oregon (R.M.); University of Alabama, Birmingham, Alabama (G.R.C.); and Colorado State University in Ft Collins, Colorado (K.L.H.).",Not available
39393881,Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line.,2024-01-01,Zhao L; Liu P; Kepp O; Kroemer G,"Equipe Labellisee Par La Ligue Contre Le Cancer, Universite de Paris, Sorbonne Universite, Centre de Recherche des Cordeliers, Institut Universitaire de France, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy, Universite Paris Saclay, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy, Universite Paris Saclay, Villejuif, France.; Pole de Biologie, Hopital europeen Georges Pompidou, AP-HP, Paris, France.",Not available
39393712,"Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics.",2024-01-01,Winkeljann B,"Center for NanoScience (CeNS), Ludwig-Maximilians-Universitat Munchen, Munchen 80799, Germany; Comprehensive Pneumology Center Munich (CPC-M), Helmholtz Munich, German Center for Lung Research (DZL), 81377 Munich, Germany; Department of Pharmacy, Ludwig-Maximilians-Universitat Munich, Butenandtstrasse 5-13, Haus B, 81377 Munchen, Germany; Pharmaceutical Engineering and Technology Research Scientists (PETRS).; RNhale GmbH, Munchen 81371, Germany",Not available
39393564,A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines.,2025-01-01,Rojubally A; Wolf B,"Bayer AG, Germany, Berlin.; Franklin Pharmaceutical Consulting, Morrisville, NC, USA.",Not available
39393368,"Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.",2024-01-01,Marchetti M; Travaglino E; List AF; Roboz GJ; Steensma DP; Sanz G; Iastrebner M,"Ajax Therapeutics, Cambridge, MA, USA.; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.; IRCCS Polilcinico San Matteo, Pavia, Italy.; Instituto de Salud Carlos III, Valencia, Spain.; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA.; Precision BioSciences, Durham, NC, USA.; Sanatorio Sagrado Corazon, Buenos Aires, Argentina.",Not available
39393045,Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.,2024-01-01,Foley JF; Defer G; Ryerson LZ; Cohen JA; Arnold DL; Butzkueven H; Cutter GR; Giovannoni G; Killestein J; Wiendl H; Li K; Dsilva L; Toukam M; Ferber K; Sohn J; Engelman H; Lasky T,"Biogen (K.L., L.D., M.T., K.F., J.S., T.L.), Cambridge, MA; Blizard Institute (G.G.), Barts and The London School of Medicine and Dentistry; Department of Neurology (G.D.), Centre Hospitalier Universitaire de Caen, France; Department of Neurology (J.K.), Amsterdam University Medical Centers, Vrije Universiteit, Netherlands; Department of Neurology with Institute of Translational Neurology (H.W.), University of Munster, Germany; Department of Neuroscience (H.B.), Central Clinical School, Monash University, Melbourne, Victoria, Australia; From the Rocky Mountain MS Clinic (J.F.F.), Salt Lake City, UT; Hackensack Meridian Medical Group - Neurology (L.Z.R.), Jersey Shore University Medical Center, Neptune City, NJ; Mellen MS Center (J.A.C.), Neurological Institute, Cleveland Clinic, OH; Montreal Neurological Institute (D.L.A.), McGill University; NeuroRx Research (D.L.A.), Montreal, Quebec, Canada; Queen Mary University of London (G.G.), United Kingdom; University of Alabama at Birmingham (G.R.C.), School of Public Health; and Ashfield MedComms (H.E.), Middletown, CT.",Not available
39392718,"Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort study.",2024-01-01,Toro J; Gaitan J; Comme-Debroth R; Baez JPM; Gulec B; Uygunoglu U; Tutuncu M; Oliveira EML; Zaidan PPT,"Dipartimento Di Neuroscienze, Universita Cattolica del Sacro Cuore, Rome, Italy.; Fundacion Santa Fe de Bogota, Bogota, Colombia.; Universidad El Bosque, Bogota, Colombia.; Universidad de los Andes, Bogota, Colombia.",Not available
39392382,Correction: The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.,2024-10-11,Chardes T,"Millegen SA, Labege, F-31670, France.",Not available
39392339,Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.,2024-11-01,Iwasawa S; Nakagawa S,"Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.",Not available
39391955,Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework.,2024-01-01,Peyrin-Biroulet L,"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy.",Not available
39390311,Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations.,2024-01-01,Feliciano J; Lewing B; Mohanty M; Lauterio M; Fucile S; Tkacz J,"Inovalon, 4321 Collington Rd, Bowie, MD, 20716, USA.; Insmed Incorporated, 700 US-206, Bridgewater, NJ, 08807, USA.",Not available
39390205,Recommendations for a standardized publication protocol for a QSP model.,2024-01-01,Weddell J; Yamada A,"Early Development, New Technology, Astellas Pharma Inc, Northbrook, IL, USA.; Early Development, New Technology, Astellas Pharma Inc, Tokyo, Japan.",Not available
39389783,Excitation-contraction coupling inhibitors potentiate the actions of botulinum neurotoxin type A at the neuromuscular junction.,2025-01-01,Machicoane M; Onillon P,"Fastox Pharma SA, Lausanne, Switzerland.",Not available
39389585,A systematic assessment of robustness in CNS safety pharmacology.,2025-01-01,Ahuis TP; Arias W; Dressler U; Kela J; Kerker K; Kuosmanen T; Lorenz H; Pennington AT; Schauerte H; Torturo C; Virtanen S; Ramboz S,"AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Orion Corporation, Turku, Finland.; PsychoGenics, Inc., Paramus, New Jersey, USA.",Not available
39389561,Consensus Statement on the Outcome of the European Herbal Health Products Summit - Which Way Forward?,2024-01-01,Roether B; Symma N,"Dr. Willmar Schwabe GmbH & Co.KG, Karlsruhe, Germany.; G. Pohl-Boskamp GmbH & Co.KG, Hohenlockstedt, Germany.",Not available
39389093,Aggregation-induced emissive copper nanoclusters with peroxidase-like activity for colorimetric detection of cholesterol.,2024-10-10,Wang W,"Nhwa Pharma. Corporation, No.18, Yangshan Road, Economic Development Zone, Xuzhou, 221000, CHINA.",Not available
39389075,12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine.,2024-01-01,Oda Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Chivukula P; Zhang Y,"Arcturus Therapeutics, San Diego, CA, USA.; Meiji Seika Pharma, Chuo-ku, Tokyo, Japan.",Not available
39388913,Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial.,2024-01-01,Pardo Gonzalez de Quevedo JI; Diz Morales MP; Palomo Alameda L; Duce Tello S; Gonzalez Bejar M; Rosado Martin J,"Centro Medico Oporto S.L.P, Plaza San Vicente de Paul 2, Madrid, Spain.; Centro Medico Somosaguas, Camino de las Huertas numero 6, Pozuelo de Alarcon, Madrid, Spain.; Centro de Salud Aravaca, Calle Riaza, 5, 28023 Madrid, Spain.; Centro de Salud Orcasitas, Calle de Cestona 3, Madrid, Spain.; Centro de Salud Reina Victoria, Av. de la Reina Victoria 21, Madrid, Spain.; Centro medico Fuengirola, Calle San Rafael 3, Malaga, Spain.",Not available
39388904,Discovery of new pyrazole-4-carboxamide analogues as potential anticancer agents targeting dual aurora kinase A and B.,2024-12-15,Lalwani T; Dalasaniya M,"Piramal Pharma Limited, Plot No. 18, Pharmaceutical Special Economic Zone, Village-Matoda, Taluka- Sanand, Ahmedabad, Gujarat, 382213, India.",Not available
39387949,Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA).,2024-01-01,de Pouvourville G; Nevoret C,"UCB Pharma, 420, Rue d'Estienne d'Orves-Immeuble Defense Ouest, La Defense, 92700, Colombes, France.; Universite Paris-Saclay, UVSQ, INSERM U1179, Versailles, France.",Not available
39388397,"Optimization of individualized faricimab dosing for patients with diabetic macular edema: Protocol for the SWAN open-label, single-arm clinical trial.",2024-01-01,Iwasaki K; Tsujimura J,"Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.",Not available
39386211,Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.,2024-01-01,Aktas M; Apel M; Assenmacher M; Burger I; Richter A; Altefrohne P; Schubert C,"Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany.; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.",Not available
39385035,CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.,2024-01-01,Palmer R; Jahchan N; Juan JM; Min C; Yu Y; Pan X; Rizvi NA; Hellmann MD; Huang A; Winslow MM; Winters IP; Papadimitrakopoulou VA; Cascone T,"AstraZeneca, Gaithersburg, MD, USA.; D2G Oncology, Mountain View, CA, USA.; Pfizer, New York, NY, USA.; Pionyr Immunotherapeutics, South San Francisco, CA, USA.; Synthekine, Menlo Park, CA, USA.; Tango Therapeutics, Boston, MA, USA.","Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. fskoulidis@mdanderson.org."
39384685,Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.,2024-01-01,Bernardeau C,"Clinique Francois Chenieux, Limoges, France.",Not available
39384092,High efficacy of red light photodynamic therapy with 10 % aminolevulinic acid gel irrespective of the extent of keratinocyte atypia in actinic keratosis - exploratory post-hoc analysis of three pivotal phase III trials.,2024-01-01,Reinhold U,"MVZ Dermatologisches Zentrum Bonn GmbH, Bonn, Germany.","MVZ Corius DermPathBonn GmbH, Heinz-Werner-Seifert-Institute of Dermatopathology Bonn, Germany. Electronic address: Erhard.Bierhoff@Dermpath-Bonn.de."
39384067,"Design of a phase 3, randomized, double-blind, placebo-controlled, 48-week study to evaluate the efficacy and safety of cendakimab in adult and adolescent patients with eosinophilic esophagitis.",2024-01-01,Zhang S; de Oliveira CHMC; Patel V; Oh YS,"Bristol Myers Squibb, Princeton, NJ, USA.","Bristol Myers Squibb, Princeton, NJ, USA. Electronic address: christina.charriez@bms.com."
39383972,Esophageal transit of solid oral dosage forms - impact of different surface materials characterized in vitro and in vivo by MRI in healthy volunteers.,2024-12-01,Hummler H; Page S; Stillhart C,"Center of Drug Absorption and Transport, Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, 17487 Greifswald, Germany.; Pharma Technical Development, F. Hoffmann-La Roche Ltd, Grenzacherstr. 124, 4070 Basel, Switzerland; Pharma Technical Development, F. Hoffmann-La Roche Ltd, Grenzacherstr. 124, 4070 Basel, Switzerland.",Not available
39383939,The paradigm shift in drug development for atopic dermatitis: Addressing the variables of the equation leading to disease modification.,2024-10-09,Bieber T,"Christine Kuhne-Center for Allergy Research and Education, Medicine Campus Davos, Davos, Switzerland; Davos Biosciences, Medicine Campus Davos, Davos, Switzerland; Department of Dermatology, University Hospital, Zurich, Switzerland","Bieber Dermatology Consulting, Bonn, Germany. Electronic address: Thomas.bieber@medizincampus-davos.ch."
39383862,Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer.,2024-12-12,Danaher P; Schurman N; Hudson BM; North K; Church SE; Kim TK; Cui Y; Kim Y,"NanoString Technologies, Seattle, WA 98109, USA.",Not available
39382891,Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease.,2024-10-09,Salling Olesen M,"LEO Pharma, Ballerup, Denmark.",Not available
39382872,Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study.,2024-10-01,Huckfeldt RM; Kay C,"Massachusetts Eye and Ear, Boston, MA, USA.; Vitreoretinal Associates, Gainesville, FL, USA.",Not available
39382718,First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE048.,2024-01-01,Gumuscu B; Lerman N,"Merck & Co., Inc, 126 E. Lincoln Avenue, Rahway, NJ, 07033, USA.",Not available
39382153,Multi-Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy.,2024-01-01,Li F,"Harway Pharma Co., Ltd., Dongying, 254753, China.",Not available
39381863,"A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.",2025-01-01,Sakov A,"DataSights Ltd, Haifa, Israel.",Not available
39381624,Time to ACT-UP: Update on precautionary allergen labelling (PAL).,2024-01-01,Hossny E; Fierro V,"Brooke-Taylor & Co Pty Ltd, Milawa, Victoria, Australia.; RICORS de Enfermedades Inflamatorias (ISCIII), Madrid, Spain.",Not available
39380845,Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.,2024-01-01,Lopez C; Nadeu F; Grau M; Bosch-Schips J; Radke J; Ishaque N; Alcoceba M; Tapia G; Luizaga L; Garcia-Sancho AM; Siebert R; Climent F,Centro de Investigacion Biomedica en Red de Cancer (CIBERONC) Madrid Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) Barcelona Spain.,Not available
39380841,Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.,2024-01-01,Asnagli H; Beer P; Parker A,Step Pharma Saint-Genis-Pouilly France.,Not available
39380430,"Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population-based registry study.",2024-01-01,Lindberg-Schager I; Pitsi D; Tsitlakidis E; Vesikansa A,"Significance Consulting, Thessaloniki, Greece.; UCB Pharma, Brussels, Belgium.; UCB Pharma, Copenhagen, Denmark.; UCB Pharma, Stockholm, Sweden.",Not available
39380259,Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a hidden Markov model.,2024-01-01,Lennon-Chrimes S; Ito H; Miya K,"Chugai Pharmaceutical Co., Tokyo, Japan.; Roche Products Ltd, Welwyn, UK.",Not available
39379960,Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER(+) breast cancer.,2024-10-08,Uleer C; Foerster F; Jackisch C; Hanson S; Kreuzeder J; Guderian G,"Dpt. of Obstetrics and Gynecology, Sana Klinikum Offenbach, Offenbach, Germany.; Gynecologic Group Practice, Hildesheim, Germany.; Novartis Pharma GmbH, Nuernberg, Germany.; Poliklinik GmbH Chemnitz, Chemnitz, Germany.","Institute for Sport and Sport Science, Division of Performance and Health (Sports Medicine), TU Dortmund University, Dortmund, Germany. philipp.zimmer@tu-dortmund.de."
39379875,Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies.,2024-10-08,Ait-Tihyaty M; Gandhi K; Zierhut ML; Salvo-Halloran EM; Ramirez AO; Vuong V; Singh S; Hutton B,"Certara USA, Inc., Radnor, PA, USA.; EVERSANA, Value & Evidence Services, Burlington, ON, Canada.; Janssen Pharmaceuticals, Titusville, NJ, USA.; Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA.",Not available
39379810,"Forced randomization: the what, why, and how.",2024-10-08,Carter K; Kuznetsova O; Anisimov V; Krisam J,"Amgen Ltd., London, UK.; Boehringer-Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.; Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.; Merck & Co., Inc., Rahway, NJ, USA.",Not available
39379782,Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial.,2025-01-01,Sambe T; Ozaki T; Schiavon G,"Oncology R&D, AstraZeneca, Cambridge, UK.; Oncology R&D, AstraZeneca, Osaka, Japan.","National Hospital Organization (NHO) Kyushu Cancer Center, Fukuoka, Japan. erikotokunaga.nkcc@gmail.com."
39379705,Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.,2024-01-01,Reyes A; Ribba B; Simuni T; Doody R; Kerchner GA; Brundin P; Marek K,"Excelya Germany GmbH, Freiburg, Germany.; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech USA Inc., San Francisco, CA, USA.; Roche Diagnostics GmbH, Penzberg, Germany.","Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland. gennaro.pagano@roche.com."
39379403,Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy.,2024-10-08,Tansey M; Previtera ML; Crozier RA; Magnus L,"NS Pharma, Inc., Paramus, NJ, USA.",Not available
39378061,Vimseltinib versus a placebo in patients with tenosynovial giant cell tumor: a plain language summary of the MOTION phase 3 trial.,2024-01-01,Stern S,"Patient & patient advocate, TGCT Support & the Life Raft Group, Wayne, NJ, USA.",Not available
39377880,"Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study.",2024-01-01,Spada F; Das D; Krepler C; Grebennik D; Chiarion-Sileni V,"Istituto Europeo di Oncologia (IEO) IRCCS, Via Giuseppe Ripamonti, 435, Milan, Italy.; Istituto Oncologico Veneto IOV-IRCCS, Via Gattamelata, 64, Padua, Italy.; Merck & Co., Inc., 126 E. Lincoln Ave, Rahway, NJ, USA.","Universite Lille, CHRU Lille, 42 Rue Paul Duez, Lille, France. laurent.mortier@chru-lille.fr."
39377810,Pharmacokinetic analysis and simplified uptake measures for tumour lesion [(18)F]F-AraG PET imaging in patients with non-small cell lung cancer.,2024-10-08,Boellaard R,"CellSight Technologies Incorporated, San Francisco, CA, USA.","Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands. j.e.wijngaarden@amsterdamumc.nl."
39377773,"A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.",2024-12-02,Yuen E; Rodrik-Outmezguine V; Ciruelos E,"Eli Lilly and Company, Indianapolis, Indiana.",Not available
39377522,"Estimated incidence of symptomatic Lyme borreliosis cases in five southern coastal counties in Norway, 2022.",2024-01-01,Molden T; Pilz A; Brestrich G; Stark JH,"Pfizer AS, Lysaker, Norway.; Pfizer Vaccines, Pfizer Pharma GmbH, Berlin, Germany.; Vaccines, Antivirals, and Evidence Generation, Pfizer Biopharma Group, Cambridge, Massachusetts, USA.; Vaccines, Pfizer Corporation Austria, Vienna, Austria.",Not available
39377364,Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study.,2024-10-08,Causse C; Lecomte JM; Schwartz JC,"Bioprojet Pharma, Paris, France.",Not available
39376498,Automated remote speech-based testing of individuals with cognitive decline: Bayesian agreement of transcription accuracy.,2024-01-01,Konig A,ki:elements GmbH Saarbrucken Germany.,Not available
39376239,Recent advances of CRISPR-based genome editing for enhancing staple crops.,2024-01-01,Chen L,"Pharma Technology A/S, Koge, Denmark.",Not available
39376010,Efficacy and Safety of TransCon PTH in Adults with Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.,2024-10-08,Kohlmeier L; Pihl S; An X; Smith AR; Lai B; Ukena J; Sibley CT; Shu AD,"Ascendis Pharma A/S, Hellerup, Denmark.; Ascendis Pharma Inc, Palo Alto, CA, USA.; Endocrinology and Spokane Osteoporosis, Spokane, WA, USA.",Not available
39375888,Drug Development Considerations for Additives to Organ Preservation Solutions.,2024-10-08,O'Brien Laramy M; Robinson J; Venkatramani CJ; Horn S; Son YJ,"Pharma Technical Development Project and Portfolio Development, South San Francisco, CA.; Pharma Technical Regulatory, Genentech, Inc., South San Francisco, CA.; Pharma Technical Regulatory-Device and Combination Products, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., South San Francisco, CA.",Not available
39375687,A hybrid framework with large language models for rare disease phenotyping.,2024-10-08,Dai C; Ali W; Scordis P; Wu H,"UCB Pharma UK, Slough, UK.","Institute of Health Informatics, University College London, London, UK. jinge.wu.20@ucl.ac.uk."
39375428,Generation of human-pig chimeric renal organoids using iPSC technology.,2024-10-08,Shimada K; Kuroda T; Ikeda A; Inoue M,"Sumitomo Pharma Co. Ltd., Osaka, Japan.","Sumitomo Pharma Co. Ltd., Osaka, Japan. koki.fujimori@sumitomo-pharma.co.jp."
39375356,Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN.,2024-10-07,Gruber O,"CIBERSAM, Centro Investigacion Biomedica en Red Salud Mental, Madrid, Spain.","Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands. I.E.Slot-3@umcutrecht.nl."
39375281,Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History.,2024-01-01,Sturm D; Li Q; Ren H; Eichenfield LF,"Incyte Corporation, Wilmington, DE, USA.","Oregon Medical Research Center, Portland, OR, USA. blauveltconsults@gmail.com."
39375241,Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques.,2024-01-01,Conti DS; Bielski E,"Nanopharm Ltd, an Aptar Pharma Company, Wales, UK.","Pharmaceutical Surface Science Research Group, Department of Pharmacy & Pharmacology, University of Bath, Bath, UK. goncalo.farias01@aptar.com."
39375222,Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3/Machado-Joseph disease.,2024-01-01,Lima M; Monckton DG,"Faculdade de Ciencias e Tecnologia, Universidade dos Acores, Ponta Delgada, 9500-321, Portugal.; Unidade Multidisciplinar de Investigacao Biomedica, Instituto de Ciencias Biomedicas Abel Salazar, Universidade do Porto, Porto, Portugal.",Not available
39375168,"GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer.",2025-01-06,Lustgarten S; Youssoufian H,"Verastem, Needham, Massachusetts, USA.","Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA grishamr@mskcc.org."
39374655,In vitro activity of cefepime-enmetazobactam on carbapenem-resistant gram negatives.,2024-10-05,Bonnin RA; Santerre Henriksen A; Quevedo J; Dortet L,"ADVANZ Pharma, France.; Associated French National Reference Center for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicetre, France.; Bacteriology-Hygiene Unit, Bicetre Hospital, Assistance Publique-Hopitaux de Paris, Le Kremlin-Bicetre, France; Maxel Consulting ApS, Jyllinge, Denmark.; Team ""Resist"" UMR1184 ""Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB)"", INSERM, Universite Paris-Saclay, CEA, LabEx LERMIT, Le Kremlin-Bicetre, France",Not available
39374446,Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation.,2024-09-23,Agarwal H; Eitel I,"Fondazione Toscana ""G. Monasterio,"" Massa, Italy.",Not available
39373939,Severe bleeding events among critically ill patients with haematological malignancies.,2024-10-07,Vigneron C; Charpentier J; Jamme M,"Service de Medecine Intensive-Reanimation, Hopital Cochin, Assistance Publique - Hopitaux de Paris, 27 rue du Faubourg Saint Jacques, Paris, 75014, France.",Not available
39373938,Pharmacometrics-Enhanced Bayesian Borrowing for Pediatric Extrapolation - A Case Study of the DINAMO Trial.,2025-01-01,Neubacher D; Perez-Pitarch A; Tartakovsky I; Marquard J; Laffel LM,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, 06877, USA.; Global Biostatistics & Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397, Biberach, Germany.; Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.","Global Biostatistics & Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397, Biberach, Germany. martin_oliver.sailer@boehringer-ingelheim.com."
39373843,Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.,2024-01-01,Strom S,"Satsuma Pharmaceuticals, Inc., 4819 Emperor Blvd, Suite 340, Durham, NC, 27703, USA.",Not available
39373311,"A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesity.",2025-01-01,Beetz N; Schmid B,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
39373062,"Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.",2024-01-01,Liao S; Beasley KN,"Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA.",Not available
39372878,A Unified Approach to Facial Contours and Volume Correction: The Role of the Cheek and the Chin.,2024-01-01,Montes JR; Bertossi D,"Humphrey Cosmetic Dermatology, Vancouver, B.C.; JRM Eyes & Facial Rejuvenation, San Juan, Puerto Rico.",Not available
39372098,Review: Risk Stratification of Patients With Ulcerative Colitis for Treatment With Tofacitinib.,2024-01-01,Yndestad A,"Pfizer Inc., Oslo, Norway.",Not available
39371627,Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension.,2024-01-01,Yan J; Xu WJ; Sun JC; Li JF; Liu ZC; Wang Q; Zhou XN,"Shenzhen Salubris Pharmaceuticals Co, Ltd, Shenzhen, Guangdong, China.",Not available
39370939,The epithelial barrier theory and its associated diseases.,2024-01-01,Kreienbuhl A; Akdis M,"APC Microbiome Ireland, Cork, Ireland.; Obstetrician and Gynecologist, Nisantasi, Istanbul, Turkey.",Not available
39370595,Environmentally Controlled Microfluidic System Enabling Immune Cell Flow and Activation in an Endothelialised Skin-On-Chip.,2024-01-01,Fassini D; Kodolanyi J; Gibbs S,"Cherry Biotech SAS, 14 Rue De La Beaune, Batiment A, 2eme Etage, Montreuil, 93100, France.",Not available
39370480,"Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective.",2024-10-07,Valle TF; Lopez-Sendon JL,"Centro Investigacion Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.",Not available
39369689,Validation of a Dermatoscopy-Based Algorithm for the Diagnosis of Acral Melanoma.,2024-01-01,Di Stefani A,"Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, Rome, Italy.",Not available
39369609,Real-world comparative effectiveness of sotorasib versus docetaxel in second line and beyond among patients with advanced non-small cell lung cancer (NSCLC).,2024-01-01,Spira A,"Virginia Cancer Specialists, 8503 Arlington Blvd Suite 400, Fairfax, VA 22031, USA.",Not available
39369312,The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.,2024-01-01,Misra S; Tran NK; Rutledge K; Ho CN; Ayers AT; Adler A; Ahn DT; Ejskjaer N; Hoang T; Joshi SR,"Children's Mercy Kansas City, Kansas City, MO, USA.; Diabetes Technology Society, Burlingame, CA, USA.; Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York, NY, USA.; Kinexum, Harpers Ferry, WV, USA.; Krouwer Consulting, Sherborn, MA, USA.; QuesGen, Burlingame, CA, USA.; Science Consulting in Diabetes GmbH, Dusseldorf, Germany.",Not available
39369310,High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy.,2024-10-06,Stauss TG; Scowcroft JA; Jaasma MJ; Edgar DR; White JL; Nairizi A; Patterson DG; Galan V; Bundschu RH; DiBenedetto DJ; Israel AF; Chang P; Caraway DL,"AES Compass Orlando, Orlando, FL, USA.; Advanced Pain Management, Greenfield, WI, USA.; Boston PainCare, Waltham, MA, USA.; Coastal Orthopedics and Sports Medicine, Bradenton, FL, USA.; Commexus Ltd, Stirling, UK.; Nevada Advanced Pain Specialists, Reno, NV, USA.; Nevro Corporation, Redwood City, CA, USA.; Pain Care, Stockbridge, GA, USA.; Pain Management Associates, Lee's Summit, MO, USA.",Not available
39368841,"Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.",2024-10-05,Kiykim E; Ingalls K; Smith N,"Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul, Turkiye.; PTC Therapeutics, Warren, NJ, USA.","German Center for Child and Adolescent Health (DZKJ), Hamburg, Germany. Electronic address: muntau@uke.de."
39368778,"Sex matters: Differences in prodromes, clinical and neuropsychological features in individuals with a first episode mania or psychosis.",2025-01-15,Palacios-Garran R; Amoretti S; Serra-Navarro M; Torrent C; Garriga M; Fares-Otero NE; Sague-Vilavella M; Madero S; Forte MF; Montejo L; Pacchiarotti I; Garcia-Rizo C; Verdolini N,"Barcelona Clinic Schizophrenia Unit, Hospital Clinic de Barcelona, Departament de Medicina, Institut de Neurociencies (UBNeuro), Universitat de Barcelona (UB), FCRB-IDIBAPS), CIBERSAM-ISCIII, Barcelona, Spain; Barcelona Clinic Schizophrenia Unit, Hospital Clinic de Barcelona, Departament de Medicina, Institut de Neurociencies (UBNeuro), Universitat de Barcelona (UB), FCRB-IDIBAPS), CIBERSAM-ISCIII, Barcelona, Spain.; Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience (UB Neuro), Department of Medicine, Facultat de Medicina i Ciencies de la Salut, University of Barcelona, Fundacio Clinic per la Recerca Biomedica-Institut d'Investigacions Biomediques August Pi I Sunyer (FCRB-IDIBAPS), CIBERSAM-ISCIII, Barcelona, Catalonia, Spain; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Universitat de Barcelona (UB), Barcelona, Spain; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.; Hospital Universitario Jerez de la Frontera, University of Cadiz, Cadiz, Spain.; Local Health Unit Umbria 1, Department of Mental Health, Mental Health Center of Perugia, Perugia, Italy.; Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), CIBERSAM-ISCIII, Barcelona, Catalonia, Spain",Not available
39368488,Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1.,2024-01-01,Goldenberg R,"LMC Diabetes & Endocrinology, Concord, ON, Canada.","Behavioral Diabetes Institute, San Diego, CA, USA. Electronic address: whp@behavioraldiabetes.org."
39368474,Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitis.,2024-10-04,Solitano V; Wang Z; Hogan M; Zou G; Cornfield LJ; Feagan BG; Jairath V; Ma C,"Alimentiv, Inc., London, ON, Canada; Alimentiv, Inc., London, ON, Canada.; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada; Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Universita Vita-Salute San Raffaele, Milan, Italy.; Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada",Not available
39366717,Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA.,2024-10-04,Tan X; Dhopeshwarkar N; Bohn R; Dea K,"Bohn Epidemiology LLC, Boston, Massachusetts, USA.; Novo Nordisk Inc, Plainsboro, New Jersey, USA.; Statlog Econometrics, Montreal, Quebec, Canada.; TriNetX LLC, Cambridge, Massachusetts, USA.",Not available
39366209,Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.,2024-01-01,Lebbe C,"APHP Hospital St-Louis, Dermatology Department, DMU ICARE, Paris, France; Universite de Paris Cite, 45 Rue des Saint-Peres, Paris, France.",Not available
39367654,Physiologically based pharmacokinetic modelling to predict potential drug-drug interactions of dersimelagon (MT-7117).,2024-10-04,Ogasawara A; Kojima K; Murata Y; Shimizu H,"Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.",Not available
39366959,Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk.,2024-10-04,Ji SG; Sendamarai AK; Devineni P; Timens W,"Booz Allen Hamilton, McLean, VA, USA.; BridgeBio Pharma, Palo Alto, CA, USA.",Not available
39366934,The genomic and transcriptomic landscape of metastastic urothelial cancer.,2024-10-04,Lavaud P; Nicotra C; Ngocamus M; Neuzillet Y; Besse B; Bieche I,"INSERM 981, Universite Paris-Saclay, Gustave Roussy, Villejuif, France.","Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr."
39365820,Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned.,2024-10-08,Parab V; Pinheiro EM; Morris N; He L; Vigeant SM,"Discovery Oncology Merck & Co., Inc., Boston, MA 02115.; Pharmacokinetics, Merck & Co., Inc., Boston, MA 02115.; Pharmacokinetics, Merck & Co., Inc., South San Francisco, CA 94080.; Quantitative Biosciences, Merck & Co., Inc., Boston, MA 02115.",Not available
39365365,"Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain.",2024-10-04,Strunz-McKendry T; Upadhyay A; Ortiz Nunez A; Gonzalez Portela J,"Astellas Pharma Europe Ltd, Addlestone, Surrey, UK.","Medical Oncology Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (IdISSC), CIBERONC, Calle del Prof Martin Lagos, S/N, 28040, Madrid, Spain. javierpuente.hcsc@gmail.com."
39363329,Efficacy and safety of olezarsen in lowering apolipoprotein C-III and triglycerides in healthy Japanese Americans.,2024-10-03,Karwatowska-Prokopczuk E; Lesogor A; Yan JH; Hoenlinger A; Margolskee A; Li L,"Ionis Pharmaceuticals, Carlsbad, CA, USA.; Novartis Pharma AG, Basel, Switzerland.",Not available
39363320,Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development.,2024-10-04,Beshiri K; Facchinetti F; Hollebecque A; Aldea M; Gazzah A; Planchard D; Pata-Merci N; Ngo-Camus M; Braye F; Jules-Clement G; Olaussen KA; Andre F; Barlesi F; Ponce S; Soria JC; Besse B,"Bioinformatics Core Facility, Gustave Roussy, Universite Paris-Saclay, CNRS UMS 3655, Inserm US23, Villejuif, France.; Departement de Medecine Oncologique, Gustave Roussy, Villejuif, France.; Universite Paris-Saclay, CESP, InsermVillejuif, France.; Universite Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.",Not available
39363115,A Bayesian analysis of heart rate variability changes over acute episodes of bipolar disorder.,2024-10-03,Valenzuela-Pascual C; Pacchiarotti I,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.","School of Informatics, University of Edinburgh, Edinburgh, UK. filippo.corponi@ed.ac.uk."
39362843,Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards.,2024-10-03,Chocholouskova M; Dickens AM; Fedorova M; Gallart-Ayala H; Meikle PJ; Ramanathan A; Saigusa D; Schock TB; Tomiyasu N,"Avanti Polar Lipids, Alabaster, AL, USA.; Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Godoy Cruz 2390, C1425FQD, Ciudad de Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Departamento de Desarrollo Analitico y Control de Procesos, Instituto Nacional de Tecnologia Industrial, Av. General Paz 5445, B1650WAB, Buenos Aires, Argentina.; LipidALL Technologies, Changzhou, 213000, Jiangshu, China.; Metabolomics Core Facility-MetCore, Universidad de los Andes, Bogota, 111711, Colombia.; Universite Paris-Saclay, CEA, INRAE, Departement Medicaments et Technologies pour la Sante (DMTS), MetaboHUB, F-91191, Gif sur Yvette, France.",Not available
39362263,The tyranny of non-inferiority trials.,2024-01-01,Goldstein DA; Ratain MJ; Saltz LB; Strohbehn GW,"Clalit Health Services, Tel Aviv, Israel; Davidoff Cancer Center, Rabin Medical Center, Israel; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.; Division of Oncology and Lung Precision Oncology Program, University of Michigan Division of Hematology/Oncology, Rogel Cancer Center, Institute for Health Policy and Innovation, and Center for Global Health Equity, Ann Arbor, MI, USA.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Optimal Cancer Care Alliance, Ann Arbor, MI, USA; Veterans Affairs Center for Clinical Management Research, Charles S Kettles VA Medical Center, Ann Arbor, MI, USA","Optimal Cancer Care Alliance, Ann Arbor, MI, USA. Electronic address: ian.tannock@uhn.ca."
39362249,"Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial.",2024-01-01,Reguart N; Robeva A; Carbini M; Le Mouhaer S; Yovine A; Boran A; Bossen C; Yang Y,"Global Drug Development, Novartis Pharma S.A.S, Rueil Malmaison, France.; Global Drug Development, Novartis Services, East Hanover, New Jersey, USA.; Medical Oncology Department, Hospital Clinic i Provincial de Barcelona, Barcelona, Spain; Oncology DU Global Drug Development, Novartis Pharma, Basel, Switzerland.; Oncology Global Drug Development, Novartis Pharmaceuticals, East Hanover, NJ, USA.; Translational Genomics and Targeted Therapeutics in Solid Tumours, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.","Department of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de."
39362248,"Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.",2024-01-01,Papayannidis C; Nie K; Mitra A; Ahsan JM; Tabachri M; Soifer HS; Corum D; Leoni M; Dale S,"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli"", Bologna, Italy.; Kura Oncology, Inc, San Diego, CA, USA.","Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: eunice.wang@roswellpark.org."
39361315,Characteristics of a Large Database of Healthy Eyes From Optometry Practices: Implications for a Real-World Reference Database.,2024-10-01,Lee C,"UPMC, Pittsburgh, PA, USA.",Not available
39361311,Assessment of Antitachycardia Pacing in Primary Prevention Patients: The APPRAISE ATP Randomized Clinical Trial.,2024-11-26,Wold N; Stein KM,"Boston Scientific Corporation, Saint Paul, Minnesota.",Not available
39361234,Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study.,2024-01-01,Shimada F; Tajima T; Stefanelli T; Teshima T,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma K.K, Tokyo, Japan.",Not available
39361233,Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.,2024-01-01,Kawase H,"PharmaEssentia Corporation USA, 35 Corporate Drive, Suite 325, Burlington, MA, 01803, USA.","Department of Hematology and Oncology, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan. kirito@yamanashi.ac.jp."
39361081,European Society of Intensive Care Medicine guidelines on end of life and palliative care in the intensive care unit.,2024-01-01,Umbrello M; Zegers M,"Faculdade de Ciencias da Saude, Universidade da Beira Interior, Covilha, Portugal.; Universidad Catolica de Valencia San Vicente Martir, Valencia, Spain.","Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. j.kesecioglu@umcutrecht.nl."
39361025,Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.,2024-10-03,Galsgaard ED; Hald A; Zosel F,"Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.",Not available
39360947,Identification of a Novel Transasparaginase Activity of Bacillus subtilis (bTG) for Sequence-Specific Bioconjugation.,2024-10-03,Flamme M; Gohring R; Mann G,"Chemical and Analytical Development, Novartis Pharma AG, 4056-CH Basel, Switzerland.",Not available
39360943,Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050.,2024-01-01,Linke R; Tang Y; Tan W,"Pfizer, San Diego, CA 92121, USA.; SFJ Pharmaceuticals Inc., Pleasanton, CA 94588, USA.",Not available
39358667,"A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis.",2024-01-01,Espaillat R; Rettig T; Wu T; Shi L; Kaldas MI; Dilley DM; Sinvhal R; Nduaka C,"AbbVie Inc., North Chicago, IL, USA.","Weill Cornell Medicine, 211 East 80 St, New York, NY, 10075, USA. drandrewalexis@gmail.com."
39358601,MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.,2024-01-01,Kanu N,"Centro Ciencia & Vida, Fundacion Ciencia & Vida, Santiago, Chile.",Not available
39357994,Performance analysis of a deep-learning algorithm to detect the presence of inflammation in MRI of sacroiliac joints in patients with axial spondyloarthritis.,2024-10-02,Tselenti E; Aouad T; Lopez-Medina C; Hoepken B; de Peyrecave N; Dougados M,"UCB Pharma, Brussels, Belgium.; UCB Pharma, Monheim am Rhein, Germany.; UCB Pharma, Slough, UK.; Universite Paris-Saclay, CentraleSupelec, Inria, Gif-sur-Yvette, France.","Department of Electrical Engineering (ESAT), Center for Processing Speech and Images, KU Leuven, Leuven, Belgium joeri.nicolaes@ucb.com."
39357146,"Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, double blind, randomized, placebo-controlled, phase IIa study.",2024-10-02,Abbate A; Van Tassell B; Bogin V; Markley R; Pevzner DV; Cremer PC; Privalov DV; Taylor A; Grishin SA; Egorova AN; Ponomar EG; Lavrovsky Y; Samsonov MY,"City Clinical Hospital No. 51 of Moscow Healthcare Department""; Cleveland Clinic; Cleveland, USA.; Cromos Pharma, LLC; La Jolla, CA, USA.; Moscow, Russia.; National Medical Research Center for Cardiology"" of the Ministry of Healthcare of the Russian Federation; Portland, OR, USA.; R-Pharm JSC, Medical Department; R-Pharm Overseas Inc; Richmond, USA.; University of Virginia; Virginia Commonwealth University; Virginia, USA.",Not available
39353876,Epidemiology and clinical outcomes of vasomotor symptoms among perimenopausal women and women aged 65 years or older in the US: a systematic review.,2024-10-01,Ajmera M; O'Sullivan F; Shiozawa A; Lozano-Ortega G; Badillo E; Venkataraman M; Mancuso S,"Astellas Pharma, Inc, Northbrook, Illinois, USA.; Broadstreet HEOR, Vancouver, Canada.",Not available
39353286,"DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China.",2024-01-01,Fan X; Wang H; Ge L,"Fosun Pharma, Beijing, China.",Not available
39353178,Inhaled Analgesia in Dermatologic Settings: A Comprehensive Overview of Methoxyflurane.,2024-01-01,Yadav G,"Beacon Dermatology, Calgary, AB, Canada.",Not available
39353164,Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy.,2025-01-10,Ferron G,"Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.",Not available
39353163,"Efficacy and Safety of Roxadustat for Anemia in Patients Receiving Chemotherapy for Nonmyeloid Malignancies: A Randomized, Open-Label, Active-Controlled Phase III Study.",2025-01-10,Lee T; Eisner MD,"FibroGen, Inc, San Francisco, CA.",Not available
39356530,Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.,2024-12-01,Zirakashvili T; Klein L,"Weill Cornell Medicine, New Yok, New York.",Not available
39356310,"A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.",2024-10-02,Zinzani PL,"Istituto di Ematologia ""Seragnoli"", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.",Not available
39356043,Treatment with brivaracetam has no apparent long-term effects on body weight in pediatric patients with epilepsy.,2024-01-01,Floricel FI; Dickson N; Fleyshman S; Reichel C; Elshoff JP,"UCB Pharma, Monheim am Rhein, Germany.; UCB Pharma, Morrisville, North Carolina, USA.",Not available
39355923,Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis.,2024-11-12,Vukadinovic D; Lauder L,"Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Universitat des Saarlandes, Homburg, Germany (D.V., L.L., M.B., F.M.).",Not available
39355729,Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab.,2024-01-01,Falco GM; D'Amore A; De Simone C,Dermatologia Dipartimento di Medicina e Chirurgia Traslazionale Universita Cattolica del Sacro Cuore Rome Italy.,Not available
39355551,Corrigendum: Treatment sequence after initiating biologic therapy for patients with rheumatoid arthritis in Korea: a nationwide retrospective cohort study.,2024-10-01,Kim S; Stoelzel M,"Astellas Pharma Europe B.V., Leiden, The Netherlands.; Astellas Pharma Singapore Pte. Ltd, Singapore, Singapore.",Not available
39354317,Rapid Lipid Mediator Profiling by Convergence Chromatography-MS/MS.,2025-01-01,Metzler G; King RC; Fernandez-Metzler C; Das A; Davis TG; Bajrami B; Bretschneider T,"Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Immunology and Respiratory Disease, Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.; PharmaCadence Analytical Services, LLC, Hatfield, PA, USA.",Not available
39354306,Prostaglandin Metabolites Analysis in Urine by LC-MS/MS.,2025-01-01,Metzler G; Day LA; King RC; Fernandez-Metzler C; Das A; Davis TG; Bajrami B; Bretschneider T,"Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Immunology and Respiratory Disease, Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.; PharmaCadence Analytical Services, LLC, Hatfield, PA, USA.",Not available
39354179,Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2(EV) Study.,2024-01-01,Kucharz J; Monteiro FSM; Gupta S; Santoni M,"Escuela de Medicina, Universidad Panamericana, Mexico City, Mexico.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; U.O. Oncologia, Ospedale di Civitanova Marche, Civitanova Marche, Italy.; UOC Oncologia Territoriale Ausl Latina, Aprilia, Italy.","Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, alej Svobody 80, 30460, Pilsen, Czech Republic. fialao@fnplzen.cz."
39352339,Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.,2024-11-05,Jacoby DL; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A,"Cytokinetics, Incorporated, South San Francisco, California, USA.","Lahey Hospital and Medical Center, Burlington, Massachusetts, USA. Electronic address: martin.maron@lahey.org."
39351771,Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential?,2024-12-09,Ellingson BM,"IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy.",Not available
39351585,Impact of Demographics and Insurance Coverage on Schizophrenia Treatment and Healthcare Resource Utilization Within an Integrated Healthcare System.,2024-01-01,Healey BE; McLin R; Sacks NC,"PRECISIONheor, Boston, MA, USA.",Not available
39351386,Associations between respiratory pathogens and lung function in primary ciliary dyskinesia: cross-sectional analysis from the PROVALF-PCD cohort.,2024-01-01,Constant C,"Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer, Florence, Italy.",Not available
39351380,Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT.,2024-01-01,Wollin L; Coeck C; Vinisko R; Patel N,"Boehringer Ingelheim Pharma GmbH & Co, KG, Biberach an der Riss, Germany.; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.; Boehringer Ingelheim SComm, Brussels, Belgium.",Not available
39351379,1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.,2024-01-01,Harrison EM; Kerr S,These authors contributed equally.,Not available
39351327,"Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro Model of Intestinal Epithelial Barrier Dysfunction.",2024-01-01,Bulferi G; De Togni H; Lanza R; Consolo P,"Schwabe Pharma Italia Srl, Egna (BZ), Italy.",Not available
39349764,AI-driven antibody design with generative diffusion models: current insights and future directions.,2024-09-30,Shan H,"Cascade Pharma, Shanghai, 201318, China.",Not available
39349504,The dimensional structure of the Positive and Negative Syndrome Scale in first-episode schizophrenia spectrum disorders: an Exploratory Graph Analysis from the OPTiMiSE trial.,2024-09-30,Garcia-Portilla MP; Fernandez-Egea E; Gonzalez-Blanco L,"Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Instituto de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain.; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.",Not available
39349477,Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study.,2024-09-30,Figg WD,"Virginia Cancer Specialists, Fairfax, VA, USA.",Not available
39349249,Intrahepatic Exhausted Antiviral Immunity in an Immunocompetent Mouse Model of Chronic Hepatitis B.,2025-01-01,Fukushima A,"Vaccines, Sumitomo Pharma Co., Ltd., Osaka, Japan.",Not available
39349183,"The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study.",2025-01-01,Chen Z; Bansal A; Prescilla R; Wang Z; Marco AR,"Regeneron Pharmaceuticals Inc., Tarrytown, New York.; Sanofi, Cambridge, Massachusetts.; Sanofi, Madrid, Spain.","Division of Dermatology, Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois. Electronic address: apaller@northwestern.edu."
39348844,[Survey on the use of nasal tamponades in sinunasal surgery].,2024-01-01,Sommer F,"EWIG NORD Rechtsanwalte PartmbB, Bonn.",Not available
39348843,"[Sinunasal surgery as outpatient procedure with special consideration of nasal packing - Position paper of the German Society of Otorhinolaryngology, Head and Neck Surgery, the working group Rhinology/Rhinosurgery (ARHIN) of the German Society of Otorhinolaryngology, Head and Neck Surgery and German Professional Association of Otorhinolaryngologists].",2024-01-01,Sommer F,"EWIG NORD Rechtsanwalte PartmbB, Bonn.",Not available
39348199,POLR3B is associated with a developmental and epileptic encephalopathy with myoclonic-atonic seizures and ataxia.,2024-01-01,Ashrafian H; Keren B; Smith-Hicks C,"UCB Pharma, Braine l'Alleud, Belgium.; UCB Pharma, Slough, UK.",Not available
39348118,Calibrating Observational Health Record Data Against a Randomized Trial.,2024-09-03,Ovbiosa OE; Pinheiro S; Pace N; Bruno A; Lunacsek O; Chen J; San Francisco B; Sangli C; Natanzon Y; Chan KA; Dhopeshwarkar N,"AbbVie, North Chicago, Illinois.; Bayer Pharmaceuticals, Philadelphia, Pennsylvania.; Bayer Pharmaceuticals, Whippany, New Jersey.; ConcertAI, Cambridge, Massachusetts.; Tempus, Chicago, Illinois.; TriNetX, Cambridge, Massachusetts.",Not available
39347953,Acacetin is a Promising Drug Candidate for Cardiovascular Diseases.,2024-01-01,Dong MQ,"Nanjing Amazigh Pharma Limited, Nanjing, Jiangsu 210032, P. R. China.",Not available
39347921,Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone.,2024-09-30,Cipriano A; Kapil RP; He E; Shet M; Harris SC,"Imbrium Therapeutics L.P., a subsidiary of Purdue Pharma L.P., Stamford, CT, USA.",Not available
39345902,Artificial intelligence: A new tool in the pathologist's armamentarium for the diagnosis of IBD.,2024-01-01,Cannarozzi AL; Latiano A; Bossa F; Di Brina AL; Biscaglia G; Perri F; Palmieri O,"Division of Gastroenterology, Fondazione IRCCS - Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.",Not available
39345862,"Exploratory study of associations between monetary reward anticipation brain responses and mu-opioid signalling in alcohol dependence, gambling disorder and healthy controls.",2024-01-01,Nutt DJ,"Perspectum Ltd, Oxford, UK.",Not available
39345527,Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans.,2024-09-19,Ludin A; Stirtz GL; Tal A; Nirmal AJ; Besson N; Jones SM; Manos M; Barrera I; Afeyan AB; Sefton J; McCall WD; van Konijnenburg DPH; Cole HL; Cordova M; Deng L; Rajadhyaksha M; Quake SR; Awad MM; Chen F; Sorger PK; Hodi FS; Rodig SJ; Zon LI,"Boston, MA, USA.; Cambridge, MA, USA.; Department of Systems Biology, Harvard Medical School; Dermatology Service, Memorial Sloan Kettering Cancer Center; Harvard Center for Biological Imaging, Department of Molecular and Cellular Biology, Harvard University; Harvard Stem Cell and Regenerative Biology Department, Harvard University; Ludwig Center at Harvard; New York, NY, USA.|.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute; These authors contributed equally.",Not available
39344833,"Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials.",2024-01-01,Nishida T; Yamamoto Y,"Novo Nordisk Pharma Ltd, Tokyo, Japan.",Not available
39344281,"Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study.",2024-09-29,Zack J,"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.",Not available
39343868,A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in Japan.,2024-01-01,Kamei K; Abraham L,"Global Access & Value, Pfizer R&D UK Ltd., Surrey, UK.; Japan Access & Value, Pfizer Japan Inc., Shinjuku Bunka Quint Building, 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan.",Not available
39343822,TRPC4/5 inhibitors: Phase I results and proof of concept studies.,2024-09-29,Fuertig R; Dwyer JB; Sharma VM,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.","Medical School Berlin, Rudesheimer Str., 5014197, Berlin, Germany. simone.grimm@medicalschool-berlin.de."
39343173,CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity.,2024-09-27,Calatroni A; Lussier S; David G,"Rho Inc, Durham, NC.",Not available
39343145,A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.,2024-01-01,Ritzel R; Bonnemaire M,"Division of Endocrinology, Diabetes and Angiology, Klinikum Schwabing and Klinikum Bogenhausen, Stadtisches Klinikum Munchen GmbH, Munich, Germany.; Sanofi, Paris, France.","Trilium Health Partners & Unity Health, Toronto, Canada. Electronic address: Alice.Cheng@unityhealth.to."
39342655,Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF.,2024-01-01,Martinez FA; Kolkhof P; Viswanathan P; Lage A; Rohwedder K; Mueller K,"Bayer AG, Berlin, Germany (P.K., P.V., A.L., K.R., K.M.).; Universidad Nacional de Cordoba, Argentina (F.A.M.).",Not available
39342544,Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings.,2024-01-01,Hatanaka S; Tsuji Y; Higashi K,"Pharmacovigilance Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.","Department of Hematology, Faculty of Medicine, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki, 305-8575, Japan. n-obara@md.tsukuba.ac.jp."
39342463,"Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma.",2025-01-01,Moon J,"Bristol Myers Squibb, Princeton, New Jersey, USA.",Not available
39341700,Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients.,2024-09-03,Assaf I; Bregni G; Anthoine G; Aparicio T; Artru P; Puleo F; Hendlisz A,"Service d'Oncologie Digestive, Hopital Chirec Delta, Brussels, Belgium.; Service d'Oncologie Digestive, Universite libre de Bruxelles (ULB), Hopital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium.; Service de Gastroenterologie et Cancerologie Digestive, Hopital Saint Louis, Paris, France.; Service de Gastroenterologie et Oncologie Digestive, Hopital Prive Jean Mermoz, Lyon, France.",Not available
39341170,Scaling laws for nanoparticles - Online shape heterogeneity analysis by size exclusion chromatography coupled with multi-angle light scattering.,2024-11-08,Levy ES; Zang N; Goyon A; Chang D; Cebrero A; Tang Y; Pellett JD,"Pharma Technical Development, Genentech, Inc., South San Francisco, CA 94080, USA.; Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., South San Francisco, CA 94080, USA.","Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: tang.shijia@gene.com."
39341044,Towards a consensus roadmap for a new diagnostic framework for mental disorders.,2025-01-01,Etkin A,"Alto Neuroscience Inc, Los Altos, CA, USA; Stanford University, Stanford, CA, USA.","Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, the Netherlands. Electronic address: m.j.h.kas@rug.nl."
39340847,In vitro antioxidant and protective effects of the extract of Broussonetia papyrifera leaves on imiquimod-induced skin lesions in psoriasis-like mice.,2024-01-01,De-Quan X,"Henan Xiangshi Yaofang BEN CAO PHARMA Co., Ltd., PR China.",Not available
39340697,Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.,2024-01-01,Vanhooteghem O; Williams P; Shimizu S; Heidbrede T; Warren RB,"Clinique Sainte-Elisabeth, Place Louise Godin 15, 5000, Namur, Belgium.; UCB Pharma, Brussels, Belgium.; UCB Pharma, Madrid, Spain.; UCB Pharma, Morrisville, NC, USA.","Dermatology Practice Dr. Bernhard Korge, Oberstrasse 75-77, 52349, Duren, Germany. hautarzt@dr-korge.de."
39340493,Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis.,2024-01-01,Budden J,"CSL Vifor, Redwood City, California, USA.","Heart Research Institute, Sydney, New South Wales, Australia. Electronic address: ajscoats@aol.com."
39340359,Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.,2024-01-01,Ocampo A; Cuklina J; Graham G; Mousseau MC; Gardiner S; Kieseier BC; Arnold DL; Nichols TE,"Novartis Ireland Ltd, Dublin, Ireland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals, East Hanover, NJ, USA.",Not available
39340061,Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.,2024-09-09,Burian APN,"Centro de Referencias para Imunobiologicos Especiais (CRIE), Secretaria de Saude do Estado do Espirito Santo, Vitoria 29050-360, ES, Brazil.",Not available
39340047,Phase I Clinical Study of the Subunit Betulin-Adjuvanted Tetravalent Candidate Influenza Vaccine TetraFluBet.,2024-09-05,Krasilnikov I; Tcymbarevich I; Krasheninnikova A; Sukhova M; Ivanov A; Mironov A,"CJSC Biotechnology Developments, 119136 Moscow, Russia.; CRO ""CTR-Pharma"", 119311 Moscow, Russia.",Not available
39339754,Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review.,2024-09-18,Samaniego-Vaesken ML; Morais-Moreno C; Carretero-Krug A; Puga AM; Montero-Bravo AM; Partearroyo T; Gregorio VM,"Grupo USP-CEU de Excelencia ""Nutricion para la vida (Nutrition for Life)"", Ref: E02/0720, Departamento de Ciencias Farmaceuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanizacion Monteprincipe, 28660 Boadilla del Monte, Spain.; Instituto Universitario CEU Alimentacion y Sociedad, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanizacion Monteprincipe, 28660 Boadilla del Monte, Spain.",Not available
39339736,Effectiveness of High-Protein Energy-Dense Oral Supplements on Patients with Malnutrition Using Morphofunctional Assessment with AI-Assisted Muscle Ultrasonography: A Real-World One-Arm Study.,2024-09-17,Godoy EJ; Gonzalez Gutierrez J,"DAWAKO Medtech S.L., Parc Cientific de la Universitat de Valencia, Calle del Catedratic Agustin Escardino Benlloch, 9, 46980 Paterna, Spain.",Not available
39339171,"Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an H. erinaceus-Based Nutraceutical Add-on Multi-Compound: The ""HERICIUM-UC"" Two-Arm Multicentre Retrospective Study.",2024-08-28,Pellegrino R,"SC Gastroenterologia, ARNAS Brotzu, Piazzale A. Ricchi, 09047 Cagliari, Italy.",Not available
39339164,Imaging-Based Drug Penetration Profiling in an Excised Sheep Cornea Model.,2024-08-26,Manuelli A; Guerin C,"Horus Pharma, 22, Allee Camille Muffat, Inedi 5, 06200 Nice, France.",Not available
39338561,Diagnostic Benefit of Molecular Imaging in Patients Undergoing Heart Valve Surgery for Infective Endocarditis.,2024-09-13,Sartori E; Sima ST; Moter A,"Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Chariteplatz 1, 10117 Berlin, Germany.",Not available
39338442,Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO(2) Requirements.,2024-08-26,Barnett-Griness O; Piconi S; Saffoury A; Sobroza de Mello R; Garcia Rincon CI; Roberto Hoffmann Filho C; Blewaska P; Campbell E; Bibliowicz A; Fathi R; Anderson P; Raday G; Klein M; Fehrmann C; Eagle G; Ben-Yair VK; Levitt ML,"Azienda Ospedaliera SS, 15121 Alessandria, Italy.; Bioforum Ltd., Ness Ziona 7403636, Israel.; CEEF Solutions Beaconsfield, Pointe-Claire, QC H9S 4L7, Canada.; Centro Medico Imbanaco de Cali, Valle del Cauca 760042, Colombia.; Centrum Onkologii w Lodzi, Oddzial COVID-19, 93-510 Lodz, Poland.; G.E.T. Pharma Consulting, LLC, Lumberville, PA 18933, USA.; Ospedale A. Manzoni, 23900 Lecco, Italy.; Ospedale Amedeo di Savoia, 10149 Torino, Italy.; Ospedale Luigi Sacco, 20157 Milan, Italy.; RedHill Biopharma Ltd., Tel-Aviv 6473921, Israel.",Not available
39336855,Integrative Treatment Approaches with Mind-Body Therapies in the Management of Atopic Dermatitis.,2024-09-11,Canchy L; Tempark T,"Doctorclaudia, Inc., Los Angeles, CA 90291, USA.; La Roche-Posay Laboratoire Dermatologique, 92300 Levallois-Perret, France.",Not available
39335613,Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn's Disease.,2024-09-14,Takacs B; Pal S; Gacser A,"Delta Bio 2000 Ltd., H-6726 Szeged, Hungary.",Not available
39334461,Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in Canada.,2024-09-27,Wadhwa A; El-Zoeiby A,"Takeda Canada Inc., Toronto, ON, Canada.",Not available
39334382,NX210c drug candidate peptide strengthens mouse and human blood-brain barriers.,2024-09-27,Rebergue N; Fewell G; Janigro D; Godfrin Y,"Axoltis Pharma, 60 avenue Rockefeller, Lyon, 69008, France.; Flocel Inc., Cleveland, OH, 44103, USA.; SynVivo, Huntsville, AL, 35806, USA.",Not available
39334237,Characterization and angiogenic potential of CD146(+) endometrial stem cells.,2024-09-27,Marsale T,"PCI Pharma Services, 23 commerce Dr, Bedford, NH, 03110, USA.",Not available
39334086,Blood-based DNA methylation and exposure risk scores predict PTSD with high accuracy in military and civilian cohorts.,2024-09-27,Koen N,"Biogen Inc., Translational Sciences, Cambridge, MA, USA.",Not available
39333906,Modelling cell type-specific lncRNA regulatory network in autism with Cycle.,2024-09-27,Zhang M,"Beijing CapitalBio Pharma Technology Co.,Ltd., Beijing, China.",Not available
39333763,Heme deficiency in skeletal muscle exacerbates sarcopenia and impairs autophagy by reducing AMPK signaling.,2024-09-27,Nakajima M; Tanaka T; Takagi M; Nakajima O,"KIYAN PHARMA Co., Ltd., Tokyo, Japan.; SBI Pharmaceuticals Co., Ltd., Tokyo, Japan.",Not available
39333167,"Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.",2024-09-27,Dam T; Pagano G; Concha-Marambio L; Kieburtz K; Tolosa E,"Amprion Inc., San Diego, CA, USA.; Biogen, Boston, MA, USA.; Denali Therapeutics Inc., South San Francisco, CA, USA.; F. Hoffmann-La Roche Ltd., Basel, Switzerland.",Not available
39333121,"Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial.",2024-09-27,Zheng Q; Ning J; Zhu Z; Guo M; Bu Y; Li Y; Jones CL; Fenaux M; Junaidi MK; Xu S; Pan H,"Aidea Pharma, No. 69, Xinganquan Road West, Hanjiang District, Yangzhou, Jiangsu, China.; Hangzhou Sciwind Biosciences, 400 Fucheng Rd, Rm 901 9F Bldg 2, Qiantang District, Hangzhou, Zhejiang, China.; Sciwind Biosciences, 3001 Bishop Drive, Suite 300, San Ramon, CA, 94583, USA.","Department of Endocrinology, Endocrine and Metabolic Disease Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. zhudalong@nju.edu.cn."
39332391,Monitoring of Pseudomonas aeruginosa mutational resistome dynamics using an enrichment panel for direct sequencing of clinical samples.,2024-01-01,Oteo-Iglesias J,"Laboratorio de Referencia en Resistencia a Antibioticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiologia, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.",Not available
39332148,Lung function decline in people with serious mental illness: A call to action.,2024-01-01,Otero-Ferrer JL; Vieta E; Sarramea F,"Biostatech, Advice, Training and Innovation in Biostatistics (Ltd.), Santiago de Compostela, Spain.; Bipolar and Depressive Disorders Unit, Hospital Clinic, 170 Villarroel st., 08036 Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Medicine, School of Medicine & Health Sciences, University of Barcelona (UB), 143 Casanova st., 08036 Barcelona, Catalonia, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), 170 Villarroel st., 08036 Barcelona, Catalonia, Spain; Institute of Neurosciences (UBNeuro), Barcelona, Catalonia, Spain; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Avenida Menendez Pidal, 14004 Cordoba, Spain; Reina Sofia University Hospital, Avenida Menendez Pidal 7, 14004 Cordoba, Spain; University of Cordoba, Departament of Morphological and Sociosanitary Science, Cordoba, Spain",Not available
39332146,Psychiatric first-aid kit: A review of EMA's critical medicines list.,2024-01-01,Vieta E; Ilzarbe L,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, c. Villarroel, 170, 08036, Barcelona, Spain; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Institut de Neurociencies (UBNeuro), Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036, Barcelona, Spain.","Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: evieta@clinic.cat."
39332145,The polarity index of cariprazine.,2024-01-01,Popovic D; Vieta E,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Spain; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain.; Institut de Neurociencies (UBNeuro), Casanova 143, Barcelona, Spain",Not available
39331323,"Letter to the Editor regarding Response to ""Letter to Editor: ""Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19"".",2024-01-01,Uehara T,"Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.",Not available
39331079,IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis.,2025-01-01,Hodson E,"Cochrane Kidney and Transplant, Westmead, Australia.","Laboratory of Nephrology, Bambino Gesu Children's Hospital, IRCCS, Piazza S. Onofrio 4 00165, Rome, Italy. marina.vivarelli@opbg.net."
39330850,Use of Botulinum Toxin in Upper-Limb Tremor: Systematic Review and Perspectives.,2024-09-13,Motavasseli D; Gracies JM; Baude M,"Assistance Publique Hopitaux de Paris, Service de Reeducation Neurolocomotrice, Hopitaux Universitaires Henri Mondor, F-94010 Creteil, France.",Not available
39329732,Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine.,2024-09-14,Iacomino N; Tarasco MC; Ronchi J,"Neurology 4-Neuroimmunology and Neuromuscolar Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.",Not available
39328126,"Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study.",2024-01-01,Cross N; Hoepken B,"UCB Pharma, Morrisville, North Carolina, USA.; UCB Pharma, Slough, UK.",Not available
39328096,"Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.",2024-01-01,Sinclair R; Peeva E; Banerjee A; Cox LA; Wajsbrot D; Kerkmann U; Law E; Wolk R; Schaefer G,"Pfizer Inc, Cambridge, Massachusetts, USA.; Pfizer Inc, Groton, Connecticut, USA.; Pfizer Inc, New York, New York, USA.; Pfizer Pharma GmbH, Berlin, Germany.; Sinclair Dermatology, Melbourne, Victoria, Australia.",Not available
39327996,"Impact of Estetrol Combined with Drospirenone on Blood Coagulation and Fibrinolysis in Patients with Endometriosis: A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study.",2024-01-01,Foidart JM,"Estetra SRL, Mithra Pharmaceuticals, Liege, Belgium.",Not available
39327792,"Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK(2) receptors, in infants with colic.",2024-09-26,Jonsson S; Bouchene S; Mazzei P,"Pharmetheus AB, Uppsala, Sweden.; UCB Pharma, Braine l'Alleud, Belgium.",Not available
39327581,Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases.,2024-09-26,Bold T; Regler A; Strathmeyer S; Wittmann J; Heelemann S,"Lifespin GmbH, Am BioPark 13, 93050, Regensburg, Germany.","Department of Neurology, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat Zu Berlin, Chariteplatz 1, 10117, Berlin, Germany. carolin.otto@charite.de."
39327531,Identification and characterization of human GDF15 knockouts.,2024-01-01,Carrion AM; Tsunoyama K; Shuldiner AR; Rodriguez-Flores JL; Rasheed A,"Astellas Pharma Inc., Ibaraki, Japan.; Tango Therapeutics, Boston, MA, USA.; Yarrow Biotechnology, New York, NY, USA.","Biomedical Research at Novartis, Boston, MA, USA. allan.gurtan@novartis.com."
39327219,Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria.,2025-01-01,Sasajima T; Fujishige A; Ichishita R; Tomimatsu N; Burciu A; Severin T,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma K.K., Tokyo, Japan.",Not available
39326921,"Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies.",2024-01-01,Roseti SL; Hunter G,"Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.",Not available
39326494,Tocilizumab in combination with standard of care in patients with severe COVID-19 pneumonia: Efficacy and safety from a phase 3 clinical trial in Japan.,2024-09-24,Shiokawa R; Ozaki R; Kawabata N,"Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.","Division of Infectious Diseases, Department of Medicine, St. Luke's International Hospital, Tokyo, Japan. Electronic address: morinob@luke.ac.jp."
39326268,Enhanced stability and reduced irritation of 4-n-butylresorcinol via nanoemulsion formulation: Implications for skin pigmentation treatment.,2024-12-05,Liu J; Li Z,"Bode Intelligent Manufacturing (Guangzhou) Biotechnology Co., Ltd. Guangzhou, Guangdong, 510000, China.; Jining Huanju Pharma Co., Ltd, Jining, Shandong, 272000, China.",Not available
39325356,"Clinical and economic inpatient burden of respiratory syncytial virus (RSV) infections in children < 2 years of age in Germany, 2014-2019: a retrospective health claims analysis.",2024-09-26,Bayer L; Riedel J; Melnik S; Brestrich G; von Eiff C,"Gesundheitsforen Leipzig GmbH, Leipzig, Germany.; Pfizer Pharma GmbH, Berlin, Germany.","Pfizer Pharma GmbH, Berlin, Germany. caroline.lade@pfizer.com."
39325020,Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.,2024-01-01,Li J; Jamil S; Paccaly A; Seebach F; Lowy I; Mathias M; Fury MG,"Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.",Not available
39324963,Long-term real-world data of ustekinumab in ulcerative colitis: the Stockholm Ustekinumab Study (STOCUSTE).,2024-12-01,Wennerstrom C; Lordal M,Janssen Cilag AB.,Not available
39324726,Summary of quality of life in the ASCENT phase 3 clinical trial for people with metastatic triple-negative breast cancer.,2024-01-01,Phan S; Shi L; Spears PA,"Evidera PPD, Bethesda, MD, USA.; Gilead Sciences, Inc., Foster City, CA, USA.",Not available
39324510,Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease.,2024-01-01,Llibre-Guerra J,"Grupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.",Not available
39324405,Neuroprogression happens.,2024-09-26,Vieta E,"Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain.",Not available
39323431,"A novel self-rating instrument designed for long-term, app-based monitoring of ADHD symptoms: A mixed-methods development and validation study.",2024-01-01,Johansson M,"Takeda Pharma AB, Stockholm, Sweden. RINGGOLD: 385874",Not available
39322961,Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON).,2024-09-25,Schlegel E; Jaeger K; Ortler S; Leist L,"Novartis Pharma GmbH, Nurnberg, Deutschland.; Zentrum fur Neurologisch-Psychiatrische Studien, ZNS GmbH, Siegen, Deutschland.","Schmerzklinik Kiel, Migrane und Kopfschmerzzentrum, Kiel, Deutschland. hg@schmerzklinik.de."
39322711,Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial.,2024-01-01,Dinh MH; Kilavuz N; Soong D; Mark T; Sacchi M; Lugtenburg PJ,"AbbVie, North Chicago, IL, USA.; City of Hope, Duarte, CA, USA.; Genmab, Copenhagen, Denmark.; Genmab, Plainsboro, NJ, USA.","Assistance Publique & Hopitaux de Paris (APHP), Hopital Saint-Louis, Hemato-oncologie, Universite de Paris, Paris, France. catherine.thieblemont@aphp.fr."
39322709,LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma - 2-year follow-up (final analysis).,2024-01-01,Roccia T; Koskinen S; Haddad I; Strulev V; Buyze J; Filho OC,"Janssen Global Services, Raritan, NJ, USA.; Janssen Pharmaceutica NV, Beerse, Belgium.; Janssen-Cilag, Espoo, Finland.; Janssen-Cilag, Issy-les-Moulineaux, France.; Legend Biotech USA Inc, Somerset, NJ, USA.","Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBASL), Centro de Investigacion del Cancer (IBMCC-USAL,CSIC), Salamanca, Spain. mvmateos@usal.es."
39322609,"Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.",2024-12-02,Heitz F; Wimberger P,"Gyncology and Obstetrics, Technische Universitat Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany.; Gynecology and Gynocologic Oncology, Kliniken Essen-Mitte, Essen, Germany.","OB/GYN, Hochtaunus Kliniken gGmbH, Bad Homburg vor der Hohe, Germany dominik.denschlag@hochtaunus-kliniken.de."
39322323,Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia.,2024-10-01,Bahit C; Budden J,"CSL Vifor, Redwood City, California, USA.; INECO Neurociencias Orono, Rosario, Santa Fe, Argentina.","Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: bpitt@med.umich.edu."
39322098,An efficient regioconvergent synthesis of 3-aza-obeticholic acid.,2024-01-01,Weymouth-Wilson A,"ICE Pharma, 68 Weld Street, RD2, Palmerston North 4472, New Zealand.",Not available
39321989,Basic Requirements and Framework Conditions of Real-World Data (RWD) on Herbal Medicinal Products.,2024-01-01,Holzle SS; Reineke T; Symma N,"Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany.; Pharma Deutschland e. V., Bonn, Germany.",Not available
39321115,A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States.,2024-01-01,Lu M; Terasawa E; Ayyagari R; Du S; Pi S; Westermeyer B; Terreri B; Boules M; Moshiree B,"Analysis Group, Inc., Boston, MA.; Analysis Group, Inc., New York City, NY.; Now with Ironwood Pharmaceuticals, Boston, MA.; Takeda Pharmaceuticals USA, Inc., Lexington, MA.",Not available
39320884,Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study.,2024-11-01,Spinner J,"Pontificia Universidad Catolica de Chile, Santiago, Chile.",Not available
39320583,Guselkumab in Biologic-Naive Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials.,2024-01-01,Vasilchenkov D; Sharaf M; Deodhar A,"Janssen-Cilag, Issy-Les-Moulineaux, France.; Johnson & Johnson LLC, Moscow, Russian Federation.","Department of Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health, and University of Washington, 601 Broadway, Ste 600, Seattle, WA, 98122, USA. pmease@philipmease.com."
39320326,Drug Repurposing Patent Applications: April-June 2024.,2024-01-01,Mucke HAM,"H. M. Pharma Consultancy, Wien, Austria.",Not available
39320292,Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF.,2024-10-29,Lefkowitz MP,"Novartis, East Hanover, New Jersey, USA.",Not available
39320017,Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies.,2024-01-01,Ricart J; Caputo A,"Amgen Inc., Cambridge, Massachusetts, USA.; Global Business Solutions, Neuroscience, Novartis Ireland Ltd, Dublin, Ireland.",Not available
39319513,Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.,2024-12-01,Nehal US; Schaecher KL,"Patient advocate and LITE study stakeholder committee member, Atlanta, Georgia.; Patient advocate and LITE study stakeholder committee member, Melbourne, Florida.",Not available
39319469,"Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.",2024-11-26,Solar-Yohay S; Garito T; Kocun M,"Novartis Pharma AG, Basel, Switzerland (T.G.).; Novartis Pharmaceuticals Corporation, East Hanover, NJ (S.S.-Y., M.K.).",Not available
39319267,"Association of inflammatory cytokines with lung function, chronic lung diseases, and COVID-19.",2024-10-18,Jalkanen S,"Fimlab Laboratories, Tampere, Finland.",Not available
39319046,"AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.",2024-01-01,Nivens MC; Djandji M; Soler X; Liu Y; Kosloski MP; Xu CR; Amin N; Staudinger H; Lederer DJ; Abdulai RM,"Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Sanofi, Amsterdam, Netherlands.; Sanofi, Bridgewater, NJ, USA.; Sanofi, Cambridge, MA, USA.; Sanofi, Chilly-Mazarin, France.",Not available
39318788,"Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial.",2024-01-01,Burkert J,"Fakultni Nemocnice v Motole, Prague, Czech Republic.",Not available
39318699,"Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC).",2024-01-01,Neubeck L,"Late CVRM, Biopharmaceuticals R&D, Astrazeneca, Boston MA, USA.",Not available
39317850,"Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects.",2024-01-01,Song H; Li X; Zhou M; Xie J; Deng K,"Shandong Boan Biotechnology Co. Ltd, Luye Life Sciences Group, Beijing, China.",Not available
39317418,Clinical information on imaging referrals for suspected or known axial spondyloarthritis: recommendations from the Assessment of Spondyloarthritis International Society (ASAS).,2024-11-14,Baraliakos X,"Rheumatology, Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina.","Department of Radiology, Freie Universitat Berlin, Berlin, Germany torsten.diekhoff@charite.de."
39317417,"EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.",2024-11-14,Minoia F,"Universita Campus Bio-Medico di Roma Facolta Dipartimentale di Medicina e Chirurgia, Roma, Italy.","Rheumatology, CEREMAIA Reference Center (ERN RITA) , Sorbonne Universite - AP-HP, Pitie-Salpetriere Hospital, Paris, France bruno.fautrel@aphp.fr."
39317414,Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease.,2024-11-14,De Matteis A; De Benedetti F; Carmona L,"Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy.; Instituto de Salud Musculoesqueletica (INMUSC), Madrid, Spain.",Not available
39316932,Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients.,2024-01-01,Andre T,"Sorbonne Universite, Hopital Saint Antoine, Assistance Publique Hopitaux de Paris, France; Unite Mixte de Recherche Scientifique 938, and SIRIC CURAMUS, Paris, France.","Tel-Aviv University, Tel-Aviv, Israel. Electronic address: Ofer.margalit@sheba.health.gov.il."
39316411,A framework for translating tauopathy therapeutics: Drug discovery to clinical trials.,2024-01-01,Beher D; Diaz K; Ewen C; Gonzalez MI; Hoffman BJ; Rabinovici GD; Kim DY; May PC; Rommel A,"ADvantage Neuroscience Consulting LLC, Fort Wayne, Indiana, USA.; Asceneuron, Lausanne, Switzerland.; Berry Consultants, Austin, Texas, USA.; Biogen, Cambridge, Massachusetts, USA.; CurePSP, New York, New York, USA.; Denali Therapeutics, South San Francisco, California, USA.; Drug Discovery and Development Consultants, Cambridge, UK.; Origami Therapeutics, San Diego, California, USA.; UCB Pharma, Slough, UK.",Not available
39316358,Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.,2024-01-01,Palazzo G; Potenza C,"Dipartimento di Scienze e Biotecnologie Medico-Chirurgiche, Facolta di Farmacia e Medicina, Sapienza Universita di Roma - Polo Pontino, 00185, Latina, Italy.; Ospedale Distrettuale di Tinchi, Azienda Sanitaria di Matera, 75015, Pisticci, Italy.",Not available
39316357,Comprehensive Codified Algorithms to Identify the Underestimated Burden of Hidradenitis Suppurativa in the United States.,2024-01-01,Geissbuhler Y; Darcy J 2nd; Foley S; Gaffney A; McConnon A; Richardson C,"Novartis Ireland Ltd, Dublin, Ireland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, US.","Department of Dermatology and Academic Wound Healing, Division of Infection and Immunity, Cardiff University, Cardiff, UK. ingramjr@cardiff.ac.uk."
39316284,Safety of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: Pooled Analysis of Three Phase 3 Randomized Trials.,2024-01-01,Morte A; Vaque A; Cebrecos J; Sust M; Gimenez-Arnau JM,"ESTEVE Pharmaceuticals S.A., Barcelona, Spain.","Department of Anesthesiology, Sidney Kimmel Medical College, Thomas Jefferson University, 111 South Eleventh Street, Suite 8290, Philadelphia, PA, 19107, USA. Eugene.Viscusi@jefferson.edu."
39314957,"Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts.",2024-09-10,Dam T; Pagano G; Concha-Marambio L; Kieburtz K; Tolosa E,"Amprion Inc., San Diego, CA, USA.; Biogen, Boston, MA, USA.; Denali Therapeutics Inc., South San Francisco, CA, USA.; F. Hoffmann-La Roche Ltd., Basel, Switzerland.",Not available
39313594,Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial.,2024-01-01,Murphy DA; Pu J; Saffari H; Zhang X; Hamilton P; Xie T,"Pfizer, La Jolla, CA, USA.; Pfizer, New York, NY, USA.; Pfizer, South San Francisco, CA, USA.","University of Texas MD Anderson Cancer Center, Houston, TX, USA. SKopetz@mdanderson.org."
39313500,Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.,2024-09-23,Ozogul E; Pol M; Frigola G; Balague O; Royo R; Buhler MM; Carras S; Valmary-Degano S; Raffeld M; Jaffe ES; Puente XS; Lopez C; Campo E,"Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006, Oviedo, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.",Not available
39313395,"Beneficial Effects of a Formulated Supplement of Ascidiacea (Halocynthia-roretzi)-derived Plasmalogen and Tuna-derived Elastin on Memory Function in Elderly Japanese Subjects; A Randomized, Double-blind, Placebo-controlled Study.",2024-10-01,Katsumata M; Kurono M; Matahira Y,"Hagoromo Foods Corporation.; Sunsho Pharmaceutical Co., Ltd.",Not available
39313328,"Absorption, Distribution, Metabolism, and Excretion of Icenticaftor (QBW251) in Healthy Male Volunteers at Steady State and In Vitro Phenotyping of Major Metabolites.",2024-11-15,Huth F; Eggimann F; Hackling M; Leuthold LA; Meissner A; Bebrevska L,"Novartis Pharma AG, Basel, Switzerland (U.G., F.H., F.E., L.A.L., A.M., L.B.) and Novartis Pharmaceuticals Corporation, East Hanover, New Jersey (M.H.).","Novartis Pharma AG, Basel, Switzerland (U.G., F.H., F.E., L.A.L., A.M., L.B.) and Novartis Pharmaceuticals Corporation, East Hanover, New Jersey (M.H.) ulrike.glaenzel@novartis.com."
39313302,Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies.,2024-09-23,Gladman DD,"UCB, Morrisville, North Carolina, USA.","Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio, USA husnie@ccf.org."
39313297,Dynamic changes in TP53 mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas.,2024-11-04,Marzac C; Rouleau E; Leary A,"Inivata Ltd, Cambridge, UK.; Universite Paris-Saclay, Gif-sur-Yvette, France.","Medical Oncology Department, Institut Gustave-Roussy, Villejuif, Ile-de-France, France kfourym@ipc.unicancer.fr."
39313275,In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: Utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fraction.,2024-01-01,Shinozaki M; Iwata K; Kaneko N,"Aetas Pharma Co., Ltd, 1-7 Kanda-Ogawamachi, Chiyoda-ku, Tokyo, 101-0052, Japan; Aetas Pharma Co., Ltd, 1-7 Kanda-Ogawamachi, Chiyoda-ku, Tokyo, 101-0052, Japan.; Department of Medicine, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, 321-0293, Japan.; Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan",Not available
39313274,Effect of antiemetics on zolbetuximab-induced gastric injury and emesis in ferrets.,2024-01-01,Haggerty G; Nakazawa T,"Immuno-Oncology, Astellas Pharma, Inc., Tsukuba, Ibaraki, Japan.; Translational Science & Development Toxicology - Applied Safety, Astellas Pharma US, Inc., Northbrook, IL, USA.","Research Program Management - Applied Research Management, Applied Research & Operations, Astellas Pharma, Inc., Tsukuba, Ibaraki, Japan. Electronic address: fumitaka.kinugasa@astellas.com."
39313156,"Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials.",2025-01-01,Solovieff N; Su F; Chia S; Joshi M; Chakravartty A; Lteif A; Taran T,"British Columbia Cancer Agency, Vancouver, Canada.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, Cambridge.; Novartis Pharmaceuticals Corporation, East Hanover.","Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. Electronic address: Carlos.Arteaga@UTSouthwestern.edu."
39312922,Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation.,2024-01-01,Alasadi L; Linke A; Chalandon Y,"EBMT Patient Advocacy Committee, EBMT Executive Office, Barcelona, Spain.; Faculte de Medicine, Universite Paris-Saclay, Paris, France.; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Hopitaux Universitaires de Geneve, Departement d'Oncologie, Service d'Hematologie, Geneva, Switzerland; INSERM, U1193, Hopital Universitaire Paul-Brousse, Paris, France","INSERM, Unite Mixte de Recherche 938, Paris, France. Electronic address: dr.tameem.soliman@gmail.com."
39312920,"Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial.",2024-01-01,Bernardi S; Santarone S; Carella AM; Martino M; Alati C; Beltrami G; Curti A; Giaccone L; Leoni A; Garuffo L,"Centro Trapianti Midollo Osseo, Azienda Sanitaria Locale di Pescara, Pescara, Italy.; Centro Unico Trapianti, Division of Hematology, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.; Centro di Ricerca Emato-Oncologica AIL, ASST Spedali Civili di Brescia, Brescia, Italy; Centro di Ricerca Emato-Oncologica AIL, ASST Spedali Civili di Brescia, Brescia, Italy.; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seragnoli, Bologna, Italy.; IRCCS Ospedale Casa Sollievo della Sofferenza, Foggia, Italy.; National Center for Gene Therapy and Drug based on RNA Technology, Padova, Italy.; UO Ematologia e Terapie Cellulari, IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy.; Univesity of Torino, AOU Citta Della Salute E Della Scienza Di Torino, Torino, Italy.","Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy. Electronic address: domenico.russo@unibs.it."
39312412,Use of the Novel Site-Directed Enzyme Enhancement Therapy (SEE-Tx) Drug Discovery Platform to Identify Pharmacological Chaperones for Glutaric Acidemia Type 1.,2024-10-10,Goebel I; Martinell M; Barril X; Cubero E; Gersting SW,"Gain Therapeutics Sucursal en Espana, Parc Cientific de Barcelona, Barcelona 08028, Spain.; Minoryx Therapeutics S.L., Tecno Campus Mataro-Maresme, Mataro, Barcelona 08302, Spain.; Pharmaceutical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss 88397, Germany.","University Children's Research, UCR@Kinder-UKE, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany."
39311947,"Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.",2024-01-01,Xu D; Saville MW,"OBI Pharma USA, Inc, San Diego, CA, USA.","Department of Investigational Cancer Therapeutics, Katherine Russell Dixie Distinguished Endowed Professor, The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. atsimber@mdanderson.org."
39311372,FAMS-A Targeted Fatty Acid Mass Spectrometry Method for Monitoring Free Fatty Acids from Polysorbate Hydrolysis.,2024-09-07,Bathke A; Hoelterhoff S; Wendler J; Yuk IH; Bell CH,"Pharma Technical Development, F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070 Basel, Switzerland.; Pharma Technical Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.",Not available
39310726,Economic Evaluation of a Novel Treatment of Attention-Deficit/Hyperactivity Disorder in US Motor Vehicle Drivers.,2024-01-01,Potenziano J; Fam DS,"Tris Pharma, Inc., South Brunswick, New Jersey, USA.",Not available
39310372,World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XI - Milk supplement/replacement formulas for infants and toddlers with CMA - Systematic review.,2024-01-01,Galli E; Papadopoulos NG,"Clinique Marcel Sembat, Ramsay Group, Boulogne-Billancourt, France.; Evidence Prime Inc., Krakow, Poland.",Not available
39309750,Comparison of blended e-learning and face-to-face-only education for resuscitation training in German schools - A cluster randomized-controlled prospective study.,2024-01-01,Bottiger BW,"L2R GmbH, Cliev 4, 51515 Kuerten, Germany.",Not available
39309723,Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study.,2024-01-01,Bossi P,"Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.",Not available
39309477,Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?,2024-01-01,Raut P; Cameron B,"Genentech Inc., South San Francisco, CA, USA.",Not available
39308778,"More or less ""modest"" versus significant excess mortality due to COVID-19 deaths in Europe.",2024-01-01,Lumbreras S; Fernandez E,"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.",Not available
39308371,Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.,2024-12-10,Abraham WT,"V-Wave Ltd, Caesarea, Israel (N.L.E.).",Not available
39308141,The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.,2024-11-01,Seitz RS; Nielsen TJ; Russo S; Schweitzer BL; Ross DT; Greil R; Mariani G; Pusztai L; Bianchini G,"Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-CCCIT; IEO, Istituto Europeo di Oncologia IRCCS, Milan, Italy.; Oncocyte Corp., Irvine, California.; and Cancer Cluster Salzburg, Salzburg, Austria.",Not available
39308116,Stakeholders' Perspectives on Current Issues in Data Monitoring Committees.,2024-01-01,May E; Mutze T,"Analytics, Novartis Pharma AG, Basel, Switzerland.; ICON PLC, Reading, UK.",Not available
39308047,Dodecafluoropentane emulsion as an oxygen therapeutic.,2024-01-01,Johnson JLH; Unger E,"NuvOx Pharma, Tucson, AZ, USA.",Not available
39308028,Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study.,2024-01-01,Miller K,"AstraZeneca, South San Francisco, California, USA.",Not available
39307151,"Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.",2024-01-01,Le Bolay C; Shen Loo L; Tenenbaum N,"EMD Serono, an affiliate of Merck KGaA, Billerica, MA, USA.; Merck Sante, an affiliate of Merck KGaA, Lyon, France.","Department of Neurology, Centre d'Esclerosi Multiple de Catalunya, Hospital Universitario Vall d'Hebron, Barcelona, Spain. Electronic address: xavier.montalban@cem-cat.org."
39307144,"Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial.",2024-01-01,Parsley E; Marmon T; Kamau-Kelley W; Jones R; Grewal R; Wring S; Palacios M; Naik H; Denning J; Lazarus HM,"Bellerophon Therapeutics, Warren, NJ, USA.; Marmon Biostatistics, Seattle, WA, USA.; Sumitomo Pharma America (formerly Enzyvant), Morrisville, NC, USA.; Sumitovant Biopharma, Boston, MA, USA.",Not available
39306923,Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.,2024-01-01,Gerstner G; Morris S; Kaul M; Cuchelkar V; Danner BJ; Nabet BY,"Computational Sciences, Genentech, South San Francisco, CA, USA.; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, South San Francisco, CA, USA.; Illinois Cancer Care, Peoria, IL, USA.; Oncology Product Development Safety, Genentech Inc, South San Francisco, CA, USA.; Product Development Oncology-Hematology, Genentech, South San Francisco, CA, USA.","Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de."
39306350,Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial.,2024-09-20,McKenna BS; Evins AE; Anthenelli RM,"Global Biometrics and Data Management, Pfizer Inc, New York, New York, USA.; Global Product Development, Pfizer Inc, New York, New York, USA.; Internal Medicine, Pfizer Inc, New York, New York, USA.",Not available
39306343,Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study.,2024-09-20,Ng KJ; Ngantcha M; Chandran V; Kennedy D; Holzkamper T; Gullick N; de la Torre I; McGonagle DG,"Eli Lilly and Company, Indianapolis, Indiana, USA.; Internal Medicine II, Rheumatology, Schlosspark-Klinik GmbH, Berlin, Germany.",Not available
39306036,"Visualisation and quantification of subcutaneous injections of different volumes, viscosities and injection rates: An ex-vivo micro-CT study.",2024-01-01,Willekens W; Fehervary H,"Biomechanics Section, Mechanical Engineering Department, KU Leuven, Leuven, Belgium.; FIBER, KU Leuven Core Facility for Biomechanical Experimentation, Leuven, Belgium; FIBER, KU Leuven Core Facility for Biomechanical Experimentation, Leuven, Belgium.","Crux Product Design, Bristol, UK. Electronic address: joel.gresham@cruxproductdesign.com."
39305737,Standardized emergency protocols to improve the management of patients with suspected or confirmed inherited metabolic disorders (IMDs): An initiative of the French IMDs Healthcare Network for Rare Diseases.,2024-01-01,Schiff M; Benoist JF; Oualha M,"Centre de reference des maladies hereditaires du metabolisme, Hopital Universitaire Necker-Enfants Malades, Assistance Publique-Hopitaux de Paris (AP-HP), Institut Imagine, Universite Paris Cite, 75015 Paris, France; Filiere nationale de sante maladies rares G2M-Maladies Hereditaires du Metabolisme, France; INSERM UMR1163, Institut Imagine, Paris, France.; Laboratoire de biochimie metabolique, Hopital Universitaire Necker-Enfants Malades, Assistance Publique-Hopitaux de Paris (AP-HP), Universite Paris-Saclay, Paris, France.; MetabERN: European Reference Network for Rare Hereditary Metabolic Disorders, France; Service de reanimation et surveillance continue medico-chirurgicales pediatriques, Hopital Universitaire Necker-Enfants Malades, Assistance Publique-Hopitaux de Paris (AP-HP), Universite Paris Cite, 75015 Paris, France.",Not available
39305432,What's New After NICE Acne Guidelines.,2024-01-01,Gupta G,"Edinburgh Royal Infirmary, Edinburgh, Scotland, UK.","Skin Research Centre, University of York, Heslington Road, York, YO10 5DD, UK. alison.layton1@nhs.net."
39305190,"Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023.",2025-01-01,Guerra M; Alouani E; Hueso T; Ouali K; Hollebecque A; Bahleda R; Gazzah A; Baldini C; Postel-Vinay S; De Botton S; Ribrag V,"Departement des Innovations Therapeutiques et des Essais Precoces (DITEP), Gustave Roussy, Villejuif, France.; Universite Paris-Saclay, Villejuif, France.",Not available
39305160,Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.,2024-01-01,Mohnike K; Leiva-Gea A; Rowell R,"BioMarin Pharmaceutical Inc., Novato, CA.; Hospital Universitario Virgen de la Victoria, Malaga, Spain.; Instituto de Investigacion Biomedica de Malaga-Plataforma Bionand, Malaga, Andalucia, Spain; Otto-von-Guericke Universitat, Universitatskinderklinik, Magdeburg, Germany.","Murdoch Children's Research Institute, Royal Children's Hospital Victoria, University of Melbourne, Parkville, Victoria, Australia. Electronic address: ravi.savarirayan@mcri.edu.au."
39305107,Imatinib dose reduction after major molecular response in chronic-phase chronic myeloid leukemia.,2025-01-01,Guo Y; Qin Y,"TargetingOne Corporation, Beijing, China.",Not available
39304546,Management of complications in patients with an ileostomy: an umbrella review of systematic reviews for the EndOTrial Consortium.,2024-09-21,Vuyyuru SK; Singh S; Van Koughnett JA,"Alimentiv Inc, London, ON, Canada.; Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Universita Vita-Salute San Raffaele, Milan, Italy.",Not available
39304061,"HDAC5 controls a hypothalamic STAT5b-TH axis, the sympathetic activation of ATP-consuming futile cycles and adult-onset obesity in male mice.",2024-01-01,Gutierrez-Aguilar R; Mellor J,"Chronos Therapeutics, Oxford, UK.; Department of Biochemistry, University of Oxford, Oxford, UK; Division de Investigacion, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico; Laboratorio de Investigacion en Enfermedades Metabolicas, Obesidad y Diabetes, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico.",Not available
39303668,Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer.,2024-01-01,Macagno M; Quara V; Mellano A; Borghi F; Corti G; Marchio C; Sapino A; Bartolini A; Fenocchio E; Di Nicolantonio F,"Department of Medical Sciences, University of Torino, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy.; Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS, Candiolo, Torino, Italy; Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS, Candiolo, Torino, Italy.",Not available
39303400,Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation.,2024-01-01,Giannopoulou C; Stollenwerk B; Obiozor CC; Wang Y,"Amgen (Europe) GmbH, Rotkreuz, Switzerland.; Amgen Inc., Thousand Oaks, CA, USA.","Oncology Hematology Care (OHC)/SCRI Research, Cincinnati, OH, USA. Electronic address: david.waterhouse1@usoncology.com."
39301474,Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel.,2024-01-01,Benedan L; Bauleo S; Brusa P; Marozio L; Sangermani R,"Fondazione Onda, Osservatorio nazionale sulla salute della donna e di genere ETS, Milan, Italy.; Medicina Generale, Casa della Salute di Zola Predosa, AUSL, Bologna, Italy.; SC Neurologia PO Levante, Ospedale San Paolo, ASL 2 Savonese, Savona, Italy.; SC Oncologia, ASST Santi Paolo e Carlo, Milan, Italy.; Universita Lumsa Roma, Rome, Italy.",Not available
39301469,Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings.,2023-01-01,Webster D,"Sage Bionetworks, Seattle, WA, USA.",Not available
39301213,"Analyzing the Benefits and Costs of the Safe Step Act on Patients, Physicians, and Insurers.",2024-01-01,Greene E,"Amwins Rx, North Kingstown, RI, USA.",Not available
39300641,Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negative.,2024-01-01,Fleischhacker WW,"Division of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria; Weill Cornell Medicine, New York, NY, USA.","Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, Netherlands. Electronic address: j.j.luykx@amsterdamumc.nl."
39297964,Exploring the reliability and validity of clinically-relevant outcome measures for chemotherapy-induced peripheral neuropathy.,2024-09-19,Shah D,"Delaware/Christiana Care NCORP, Newark, DE, 19713, USA.","University of Michigan School of Nursing, 400 North Ingalls St, Office 2350, Ann Arbor, MI, 48109, USA. rjknoerl@med.umich.edu."
39303200,"Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.",2025-01-10,Gross-Goupil M; Nair SG; Spiridigliozzi J; Lee CW; van Kooten Losio M; Grunwald V,"BC Cancer, Vancouver, BC, Canada.; Bradford Hill, Santiago, Chile.; Bristol Myers Squibb, Princeton, NJ.",Not available
39302692,"Relationship between activity and sleep, as measured through a wearable accelerometer, and appropriate cardioverter defibrillator interventions: a prospective SafeHeart substudy.",2024-10-03,Langford J,"Activinsights Ltd., Kimbolton, UK.",Not available
39302614,Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors.,2024-01-01,Lai C; Zhang D; Gary D; Huynh D,"Gilead Sciences, Inc., Foster City, CA, USA.","Department of General Internal Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. ynaito@east.ncc.go.jp."
39302603,The Epidemiology of Biliary Tract Cancer and Associated Prevalence of MDM2 Amplification: A Targeted Literature Review.,2024-01-01,Vilu HL; Knight JF; Ueno M,"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.; Evidera Ltd, London, UK.","Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA. jdkratz@medicine.wisc.edu."
39300596,"Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study.",2024-09-19,Whelan S; Dumortier T; Zhu X; Martin R; Pricop L,"Novartis Ireland Ltd, Dublin, Ireland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.",Not available
39300513,"Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 Study.",2024-09-19,Kapur K; Rohrer S; Richards HB,"Novartis Pharma AG, Basel, Switzerland.",Not available
39300150,Label-free ghost cytometry for manufacturing of cell therapy products.,2024-09-19,Takahashi S; Yamaguchi H,"Astellas Pharma, Inc., 5-2-3 Tokodai, Tsukuba-shi, Ibaraki, 300-2698, Japan.",Not available
39300090,Sequential immunization with chimeric hemagglutinin DeltaNS1 attenuated influenza vaccines induces broad humoral and cellular immunity.,2024-09-16,Jangra S; Gertje HP; Tseng AE,"CSL Seqirus, 225 Wyman Street, Waltham, MA, 02451, USA.; Vivaldi Biosciences Inc., Fort Collins, CO, 80523, USA.",Not available
39299943,An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries.,2024-09-19,Leon G; Carbonel C; Rampuria A,"Price Governance and Negotiations, Value and Access and Commercial Development, Novartis Pharma AG, Basel, Switzerland.",Not available
39299734,Timing of oral anticoagulation in atrial fibrillation patients after acute ischaemic stroke and outcome after 3 months: results of the multicentre Berlin Atrial Fibrillation Registry.,2024-09-18,Kauert A; Voelzke E,"Evangelisches Krankenhaus Konigin Elisabeth Herzberge gGmbH, Berlin, Germany.; Schlosspark-Klinik GmbH, Berlin, Germany.",Not available
39298919,Raman laser intensity and sample clarification on biochemical monitoring over Zika-VLP upstream stages.,2024-11-12,da Silva Cavalcante PE; Publio Rabello J; Leme J; Aragao Tejo Dias V; Correia Barrence FA; de Oliveira Guardalini LG; Consoni Bernardino T; Almeida S; Tonso A; Attie Calil Jorge S,"Grupo de Espectroscopia. Astro34. Rua Belem, 106 - Jardim Vista Alegre, Embu das Artes - SP, CEP: 06807-340, Sao Paulo, SP-Brazil.; Laboratorio de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, CEP 05503-900, Sao Paulo, SP, Brazil.; Laboratorio de Celulas Animais, Departamento de Engenharia Quimica, Escola Politecnica, Universidade de Sao Paulo, Av. Prof. Luciano Gualberto, Travessa do Politecnico, 380, 05508-010, Sao Paulo, SP, Brazil.; Laboratorio de Engenharia de Bioprocessos. Escola de Artes, Ciencias e Humanidades (EACH), Universidade de Sao Paulo, Rua Arlindo Bettio, 1000, CEP 03828-000, Sao Paulo, SP, Brazil.",Not available
39298738,Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.,2025-01-10,Reddy V; McNamara K; Spross J; Haeuber E; Vusirikala M; Nahar A; Desai A; Giralt S,"Actinium Pharmaceuticals, New York, NY.; Loxo Oncology at Lilly, Stamford, CT.; Statistical Consultant to Actinium Pharmaceuticals, New York, NY.",Not available
39297248,Mathematical model of the relationship between pH holding time and erosive esophagitis healing rates.,2025-01-01,Lahu G; Facius A,"thinkQ2 AG, Baar, Switzerland.",Not available
39297137,The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development.,2024-01-01,Hsieh A; Dicklin MR,"NewAmsterdam Pharma, Naarden, the Netherlands.",Not available
39297052,"Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study.",2024-01-01,Boehnlein M; Greve B; Woltering F,"UCB Pharma, Monheim am Rhein, Germany.",Not available
39296887,Tourette syndrome research highlights from 2023.,2024-01-01,Hartmann A; Czernecki V; Delorme C,"Hopital de la Pitie-Salpetriere, Assistance Publique - Hopitaux de Paris, Paris, Ile-de-France, 75013, France.",Not available
39296620,"Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.",2024-01-01,Cascinu S,"SC Oncologia-Ematologia PO San Martino Oristano, Oristano, Italy.",Not available
39296339,"Limited Impact of Cannabidiol on Health-related Quality of Life of People With Long-term Controlled HIV: A Double-blind, Randomized, Controlled Trial.",2024-01-01,de Dieuleveult B; Prazuck T,"IPIC, Laboratoire Interdisciplinaire pour l'Innovation et la Recherche en Sante d'Orleans (LI(2)RSO), Universite d'Orleans, Orleans, France.; Little Green Pharma, West Perth, Western Australia, Australia.",Not available
39295945,"Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease.",2024-01-01,Bagrov AY,"Padakonn Pharma, Narva, Estonia.",Not available
39295888,Lichenoid drug reaction to technicium-99: a case report and review of the literature.,2024-01-01,Cachia A,"Kossard Dermatopathologists, Sydney, Australia.",Not available
39295563,Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer Therapy.,2025-01-01,Hua F; Burke J,"Certara Predictive Technology, Certara, Concord, Massachusetts, USA.",Not available
39295215,Buffer system improves the removal of host cell protein impurities in monoclonal antibody purification.,2024-01-01,Lakatos D; Idler M; Stibitzky S; Amann J; Schuschkewitz J; Krayl D; Liebau J; Grosch JH; Arango Gutierrez E; Kluters S,"Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Development Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
39294891,The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review.,2024-09-18,Prokocimer P; Humphries AC; Elnawasany O; Muresan B,"Astellas Pharma Global Development Inc., Northbrook, Illinois, USA.; Astellas Pharma, Addlestone, UK.; Formerly employed with Astellas Pharma DMCC, Dubai, UAE.",Not available
39294551,Physics-informed neural networks for biopharmaceutical cultivation processes: Consideration of varying process parameter settings.,2025-01-01,Adebar N; Arnold S; Herrera LM; Emenike VN; Wucherpfennig T,"Boehringer Ingelheim Pharma GmbH & Co. KG, Bioprocess Development Biologicals, Biberach (Riss), Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Development NCE, Ingelheim (Rhein), Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Global Innovation & Alliance Management, Biberach (Riss), Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, HP BioP Launch and Innovation, Ingelheim (Rhein), Germany.",Not available
39294533,Quantitation of mitral regurgitation using positron emission tomography.,2024-09-18,Kero T,"MedTrace Pharma A/S, Horsholm, Denmark.","Molecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Jonathan.sigfridsson@uu.se."
39294392,Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study.,2024-09-19,Liczenczias E; Chang P,"Novartis Pharma GmbH, Nuremberg, Germany.",Not available
39294194,"Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols.",2024-09-18,Le Roux-Bourdieu M; Tentillier N; Sethi P; Font L; An J; Sage J; Seredenina T; Carlyle BC; Adolfsson O; Sadri-Vakili G,"AC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.; Boehringer Ingelheim Vetmedica, St Joseph, MO, 64503, USA.; Dipartimento di Medicina Trasfusionale Giuliano-Isontina, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy.; Eisai US, 35 Cambridgepark Drive, Cambridge, MA, 02140, USA.","AC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland. ruth.luthi-carter@acimmune.com."
39294048,Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naive Prostate Cancer.,2024-01-01,Proudfoot JA; Davicioni E,"Veracyte, Inc, San Diego, CA, USA.","Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA. Electronic address: abweiner@mednet.ucla.edu."
39294041,The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab.,2024-01-01,Poetzl J; Schwebig A; Sekhar S; Krivtsova N; Renner O,"Hexal AG (a Sandoz company), Holzkirchen, Germany.","Hexal AG (a Sandoz company), Holzkirchen, Germany. Electronic address: barbara.vogg@sandoz.com."
39293780,Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control.,2024-01-01,Yee LD; Komm BS,"City of Hope, Duarte, CA, USA.; Komm Pharma Consulting, LLC, USA.","University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. Electronic address: cfabian@kumc.edu."
39293681,Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic Solution.,2025-01-01,Evans D; Withers B; Lazar A; Coleman D; Patel R; Jaber R; Sooch M; Brigell M,"Evans Eyecare, Nanticoke, Pennsylvania.; Ocuphire Pharma, Inc., Farmington Hills, Michigan.",Not available
39293462,"(177)Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial.",2024-09-28,Chi KN; Crosby M; Kpamegan E; Ghebremariam S; Kreisl TN; Wilke C; Lehnhoff K,"BC Cancer, Vancouver, BC, Canada.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; Veterans Prostate Cancer Awareness, San Diego, CA, USA.","Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: morrism@mskcc.org."
39293083,Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma.,2024-11-26,Hacohen-Kleiman G; Huo Y; Zhang Y; Renard C,"Gilead Sciences, Inc, Foster City, CA.",Not available
39292443,"Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.",2024-11-01,Draelos ZD; Papp KA; Prajapati VH,"Dermatology Consulting Services, High Point, North Carolina.; Physicians Skin Care PLLC, Louisville, Kentucky.; Skin Sciences PLLC, Louisville, Kentucky.",Not available
39291709,Systematic literature review of the humanistic and economic burden of focal epilepsy and primary generalized tonic-clonic seizures in adults.,2024-01-01,Boccaletti S; Nixon A; Di Dato G,"Angelini Pharma, Rome, Italy.; Chilli Consultancy, Salisbury, UK.",Not available
39291304,Ternary structure of Plasmodium vivaxN-myristoyltransferase with myristoyl-CoA and inhibitor IMP-0001173.,2024-10-01,Dranow DM,"UCB BioSciences, Bainbridge Island, WA 98110, USA.",Not available
39290813,Is It Time for Population-Based Screening for Transthyretin Cardiac Amyloidosis?,2024-01-01,McDonald DM,"Program for the Care and Study of the Aging Heart, Weill Cornell Medicine, New York, New York, USA.",Not available
39290806,Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis.,2024-01-01,Nascimento BR; Mosser JF,"Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Evidence Generation, Novartis Pharma AG, Basel, Switzerland.",Not available
39290716,"Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.",2024-01-01,Scarfo L; Minga E; Al-Shemari S; Marquet J,"IRCCS Ospedale San Raffaele Milan Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche Universita Cattolica del Sacro Cuore Rome Italy.; Universita Vita-Salute San Raffaele Milan Italy.",Not available
39290307,Prediction of medical admissions after psychiatric inpatient hospitalization in bipolar disorder: a retrospective cohort study.,2024-01-01,Dughiero E; Nunez NA,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.",Not available
39289919,Frequency of weight and body composition increases in advanced non-small cell lung cancer patients during first line therapy.,2024-01-01,Cobain S; Collins S,"Global Biometrics and Data Management, Pfizer R&D UK Ltd, Sandwich, UK.",Not available
39289739,fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.,2024-09-17,Fielhauer K; McCoy B,"Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria.",Not available
39289684,International expert opinion on the considerations for combining vosoritide and limb surgery: a modified delphi study.,2024-09-17,Vilenskii V; Huser AJ,"Fundacion Cardio infantil Facultad de Medicina, Bogota, Colombia.; Universitatsklinikum Munster, Universitatsklinikum Munster, Albert-Schweitzer-Campus 1, Gebaude A1, Anfahrtsadresse: Albert-Schweitzer-Strasse 33, 48149, Munster, Germany.",Not available
39289391,Structural basis of CDNF interaction with the UPR regulator GRP78.,2024-09-18,Volkova M; Jonasson K; Maatta JAE; Mamidi S; Kulesskaya N; Evenas J; Johnsson RE; Svergun D; Bhattacharjee A,"BIOSAXS GmbH, DE-22607, Hamburg, Germany.; Herantis Pharma Plc, FI-02600, Espoo, Finland.; Red Glead Discovery AB, Medicon Village SE-223 81, Lund, Sweden.",Not available
39289358,Claustrum and dorsal endopiriform cortex complex cell-identity is determined by Nurr1 and regulates hallucinogenic-like states in mice.,2024-09-18,Ionescu T; Le Merre P,"CNSDR, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.","Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. ioannis.mantas@ki.se."
39289313,Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1).,2024-01-01,Poprach A; Mollica V; Porta C,"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.",Not available
39289170,The Challenges of Measuring Socioeconomic Inequality in Pharmacoepidemiology Studies.,2024-09-17,Prener C; Schley K; Miles A; Willis S,"Pfizer Pharma GmbH, Berlin, Germany.; Pfizer, Inc., Cambridge, MA.; Pfizer, Inc., New York, NY.",Not available
39289139,CF Ferrets exposed to in utero ivacaftor do not develop lens abnormalities.,2024-09-16,Han S,"Han Diagnostics, LLC., Arvada, CO USA.","National Jewish Health, Departments of Internal Medicine and Pediatrics Denver, CO, USA. Electronic address: taylorcousarj@njhealth.org."
39289123,Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round Table.,2024-01-01,Soronen J,"Scientific Communication and Strategy, Daiichi-Sankyo Europe GmbH, Munich, Germany (Dr Soronen).","Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland (Dr Mach). Electronic address: Francois.Mach@hcuge.ch."
39288779,"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.",2024-10-05,Leiva M; Acevedo A; Sehouli J; Petru E; Liu P; Yamada K; Toker S; Keefe SM,"AGO-Austria, Innsbruck, Austria.; Department of Gynecology, Charite Universitaetsmedizin, Berlin, Germany; Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria; Merck & Co, Rahway, NJ, USA.; North-Eastern German Society of Gynecological Oncology, Berlin, Germany.; Oncocentro, Valparaiso, Chile.; Oncologia Medica, Instituto Peruano de Oncologia y Radioterapia, Lima, Peru.","Gynaecology Oncology Unit, Humanitas San Pio X, Milan, Italy. Electronic address: domenica.lorusso@hunimed.eu."
39288737,Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial.,2024-01-01,Grebennik D; Kreplere C,"Merck & Co., Inc., Rahway, NJ, USA.","Princess Maxima Center and University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: alexander.eggermont@prinsesmaximacentrum.nl."
39288341,Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia.,2024-10-08,Lorenzini L; Maranzano A; Ingala S; Collij LE; Tranfa M; Blennow K; Di Perri C; Foley C; Fox NC; Frisoni GB; Haller S; Martinez-Lage P; Mollison D; O'Brien J; Payoux P; Ritchie C; Scheltens P; Schwarz AJ; Sudre CH; Tijms BM; Verde F; Ticozzi N; Silani V; Visser PJ; Waldman A; Wolz R; Chetelat G; Ewers M; Wink AM; Mutsaerts H; Gispert JD; Wardlaw JM; Barkhof F,"Alzheimer Center Amsterdam (P.S., B.M.T., P.J.V.), Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc; Alzheimer Center Limburg (P.J.V.), Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, 6229 GS, Maastricht University, The Netherlands; Amsterdam Neuroscience (L.L., S.I., L.E.C., A.M.W., H.M.), Brain Imaging, Amsterdam, The Netherlands; Amsterdam Neuroscience (P.S., B.M.T., P.J.V.), Neurodegeneration, Amsterdam, The Netherlands; Barcelonabetaeta Brain Research Center (BBRC) (J.D.G.), Pasqual Maragall Foundation; CIBER Bioingenieria (J.D.G.), Biomateriales y Nanomedicina (CIBER-BBN), Madrid; CIMC - Centre d'Imagerie Medicale de Cornavin (S.H.), Place de Cornavin 18, Geneve, Switzerland; Centre for Clinical Brain Sciences (D.M., A.W., J.M.W.), The University of Edinburgh; Centro de Investigacion y Terapias Avanzadas (P.M.-L.), Neurologia, CITA-Alzheimer Foundation, San Sebastian, Spain; Cerebriu A/S (S.I.), Copenhagen, Denmark; Clinical Memory Research Unit (L.E.C.), Department of Clinical Sciences, Lund University, Malmo, Sweden; Clinical Neurochemistry Laboratory (K.B.), Sahlgrenska University Hospital, Molndal, Sweden; Dementia Research Centre (N.C.F.), UCL Queen Square Institute of Neurology; Department of Advanced Biomedical Sciences (M.T.), University ""Federico II,"" Naples, Italy; Department of Medical Physics and Biomedical Engineering (C.H.S.), Centre for Medical Image Computing (CMIC), University College London (UCL); Department of Medicine (A.W.), Imperial College London; Department of Neurology and Laboratory of Neuroscience (A.M., F.V., N.T., V.S.), IRCCS Istituto Auxologico Italiano, Milan, Italy; Department of Nuclear Medicine (P.P.), Toulouse University Hospital; Department of Pathophysiology and Transplantation (F.V., N.T., V.S.), ""Dino Ferrari"" Center, Universita degli Studi di Milano, Milan, Italy; Department of Psychiatry (J.O.B.), School of Clinical Medicine, CB2 0SP, University of Cambridge, United Kingdom; Department of Psychiatry and Neurochemistry (K.B., C.H.S.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburgn; Department of Radiology (S.H.), Beijing Tiantan Hospital, Capital Medical University, P. R. China; Department of Radiology (S.I.), Copenhagen University Hospital Rigshospitalet; Department of Surgical Sciences (S.H.), Radiology, Uppsala University, Sweden; Division of Neurogeriatrics (P.J.V.), Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Edinburgh Dementia Prevention (C.R.), Centre for Clinical Brain Sciences, Outpatient Department 2, Western General Hospital, University of Edinburgh Brain Health Scotland (C.R.), Edinburgh, United Kingdom; From the Department of Radiology and Nuclear Medicine (L.L., S.I., L.E.C., M.T., A.M.W., F.B.), Amsterdam University Medical Centre, Vrije Universiteit; GE HealthCare (C.F.), Amersham; German Center for Neurodegenerative Diseases (DZNE) (M.E.), Munich, Germany; Ghent Institute for Functional and Metabolic Imaging (GIfMI) (H.M.), Ghent University, Belgium; IMIM (Hospital del Mar Medical Research Institute) (J.D.G.); IXICO (R.W.), EC1A 9PN, London, United Kingdom; Laboratory Alzheimer's Neuroimaging and Epidemiology (G.B.F.), IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; MRC Unit for Lifelong Health & Ageing at UCL (C.H.S.), University College London; Neuroradiology Department (C.D.P.), University Hospital of Coventry and Warwickshire (UHCW), Coventry; School of Biomedical Engineering and Imaging Sciences (C.H.S.), King's College London, United Kingdom; Takeda Pharmaceuticals Ltd. (A.J.S.), Cambridge, MA; ToNIC (P.P.), Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France; UK Dementia Research Institute Centre at the University of Edinburgh (J.M.W.); UK Dementia Research Institute at University College London (N.C.F.), United Kingdom; Universitat Pompeu Fabra (J.D.G.), Barcelona, Spain; University Hospitals and University of Geneva (G.B.F.); and Institutes of Neurology and Healthcare Engineering (F.B.), University College London, United Kingdom.","Universite de Normandie (G.C.), Unicaen, Inserm, U1237, PhIND ""Physiopathology and Imaging of Neurological Disorders"", institut Blood-and-Brain @ Caen-Normandie, Cyceron, Caen, France"
39288302,Oxadiazolines as Photoreleasable Labels for Drug Target Identification.,2024-10-02,Flamme M,"Chemical and Analytical Development, Novartis Development, Novartis Pharma AG, Basel 4056, Switzerland.",Not available
39288032,Drug-drug interactions of icenticaftor (QBW251) with a 5-probe cytochrome P450 cocktail and oral contraceptives.,2024-01-01,Huth F; Glaenzel U; Drollmann A; Weis W; Zack J; Bebrevska L,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
39287897,"Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE Study.",2024-01-01,Qiu C; van Hoogstraten H,"Sanofi, Bridgewater, NJ, USA.","Altoona Centre for Clinical Research, 175 Meadowbrook Lane, Duncansville, PA, 16635-8445, USA. ajkivitz@yahoo.com."
39287821,"A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.",2024-11-15,Arnold SM; Nosaki K; Zha J; Li R; Robinson RR; Hingorani P; Jeng EE; Furqan M,"AbbVie, Inc., North Chicago, Illinois.; Highlands Oncology Group, Fayetteville, Arkansas.; NEXT Oncology, San Antonio, Texas.",Not available
39287781,Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review.,2024-01-01,Hughes O; Dabruzzo B; Manack Adams A; Diamond M,"AbbVie, North Chicago, IL, USA.; ICON Plc, Blue Bell, PA, USA.; Neuroscience Group, Neenah, WI, USA.","The Los Angeles Headache Center, Los Angeles, CA, USA. ablumenfeldmd@gmail.com."
39287765,Factors Influencing Treatment Preference in Patients with Diabetic Macular Edema: A Study Using Conjoint Analysis.,2024-01-01,Tanabe K,"Novartis Pharma K.K, 1-23-1 Toranomon, Minato-Ku, Tokyo, 105-6333, Japan.","Department of Ophthalmology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. takaoh@shinshu-u.ac.jp."
39286886,The impact of COVID-19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database.,2024-01-01,Iwagami M; Adachi T; Masaki K; Miyagawa A; Okumura Y; Huang T; Morooka Y; Nakao S,"ENGAGE-Task Force, Tokyo, Japan.",Not available
39286575,Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD study.,2024-01-01,Wirth W; Knight C,"Chondrometrics GmbH, Freilassing, Germany.",Not available
39286058,"Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC.",2024-01-01,Crosby J; Guo S; Xia S; Yu R; Newman KB,"Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA.",Not available
39286057,"RLS-0071, a novel anti-inflammatory agent, significantly reduced inflammatory biomarkers in a randomised human evaluation of mechanisms and safety study.",2024-01-01,Hair P,"Children's Specialty Group, Norfolk, VA, USA.",Not available
39285138,Measuring and Demonstrating the Value of Patient Engagement Across the Medicines Lifecycle: A Patient Engagement Impact Measurement Framework.,2025-01-01,Oehrlein EM; Lobban TCA; Boutin M,"Applied Patient Experience, Washington, DC, USA.; Arrhythmia Alliance, Winchester, UK.; Novartis Pharma AG, Basel, Switzerland.","Novartis Pharma AG, Basel, Switzerland. fraubeyzaklein@gmail.com."
39285121,Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis.,2024-01-01,Szilagyi B,"UCB, Colombes, France.","Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. m.augustin@uke.de."
39284960,Propensity score matching.,2024-01-01,Kurz CF,"Novartis Pharma GmbH, Munich, Germany.",Not available
39284545,Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study.,2024-09-14,Ohishi T; Iimori T; Kitamura T,"Novartis Pharma K.K., Tokyo, Japan.","School of Medicine and Graduate School, International University of Health and Welfare, Okawa, Japan. Electronic address: tsutsui.hiroyuki.691@m.kyushu-u.ac.jp."
39284422,Optimization of a Twin screw melt granulation process for fixed dose combination immediate release Tablets: Differential amorphization of one drug and crystalline continuance in the other.,2024-11-15,Johnson L; Karry K,"BASF Corporation, Pharma Solutions, Tarrytown, NY 10591.",Not available
39284329,Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study.,2024-10-05,Bourlon MT; Chehrazi-Raffle A; Braendle E,"Aveo Oncology, Boston, MA, USA.; City of Hope, Los Angeles, CA, USA.; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.","Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: toni_choueiri@dfci.harvard.edu."
39283700,"Characteristics of motion signal profiles of tonic-clonic, tonic, hyperkinetic, and motor seizures extracted from nocturnal video recordings.",2024-01-01,Kertesz C; Peltola J,"Neuro Event Labs, Tampere, Finland.",Not available
39283627,"Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.",2024-09-16,Yang Y; Paiva da Silva Lima G,"Amgen Inc, Thousand Oaks, California.",Not available
39283600,A Widespread Radical-Mediated Glycolysis Pathway.,2024-09-25,Robinson RC,"Meining Pharma Inc., 2-401-1, Bldg 8, Huiying Industrial Park, No. 86 West Zhonghuan Road, Tianjin Pilot Free Trade Zone, Tianjin 300308, China.",Not available
39283416,Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry.,2024-01-01,McLean RR; Beaty SW; Sima AP; Low R; Stark JL; McClung L; Bagel J,"CorEvitas, LLC, Waltham, MA, USA.; UCB, Inc., Smyrna, GA, USA.","Oregon Medical Research Center, 9495 SW Locust Street, Suite G, Portland, OR, 97223, USA. blauveltconsults@gmail.com."
39283415,Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry.,2024-01-01,Sima AP; Beaty SW; Low R; Gomez B; Gurrola M,"CorEvitas, LLC, Waltham, MA, USA.; UCB, Inc., Smyrna, GA, USA.",Not available
39282934,Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.,2024-09-26,Lonardi S; Nakajima T; Matsangou M; Cao Y; Li R; Moran D; Pophale R; Oh M; Ranganath R,"Astellas Pharma Global Development, Northbrook, IL.; Istituto Oncologico Veneto IRCCS, Padua, Italy.",Not available
39282750,Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational study.,2024-09-16,Riccardi C,"L'altrastatistica S.r.l., for GB Pharma Services & Consulting S.r.l, Rome, Italy.",Not available
39282663,Alectinib Versus Crizotinib in Asian Patients With Treatment-Naive Advanced ALK-Positive NSCLC: Five-Year Update From the Phase 3 ALESIA Study.,2024-01-01,Hilton M,"Product Development Data Sciences, F. Hoffmann-La Roche Ltd., Basel, Switzerland.",Not available
39281971,"Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.",2024-01-01,Saenko DV; Ursol GM; Davis C; Kowalski K; Michelon E; Pavlov D; Hirohashi T,"Astellas Pharma, Northbrook, IL, USA.; Klinika UZI 4D, LLC, Pyatigorsk, Russia.; Pfizer Inc, New York, NY, USA.; Pfizer Inc, San Diego, CA, USA.; Private Enterprise Private Manufacturing Company Acinus, Kropyvnytskyi, Ukraine.",Not available
39281848,Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn's Disease: A Real-World Global Study.,2024-01-01,Streit P; Gurses G; Hunter Gibble T,"Global New Product Planning, Eli Lilly and Company, Vernier, Switzerland.; Reimbursement Access, Eli Lilly and Company, Istanbul, Turkey.; Value, Evidence and Outcomes, Eli Lilly and Company, Indianapolis, USA.",Not available
39281665,[Not Available].,2024-01-01,Di Rienzo P; Del Vecchio L,"Astellas Pharma SpA, Via Don Luigi Sturzo 43, Milano - Italy.; U.O. Nefrologia e Dialisi, ASST Lariana, Via Ravona 20, 22042 San Fermo Della Battaglia (Como) - Italy.",Not available
39281357,Optimizing paediatric specialist referrals for short stature in an era of multiple growth hormone indications.,2024-01-01,Saoudi Z,"Novo Nordisk Canada, Mississauga, Ontario, Canada.",Not available
39279781,Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.,2024-01-01,Passos J,"Instituto Portugues Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.",Not available
39279689,A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg.,2024-09-16,Biskupska-Bodova K; Regidor PA,"Aetas, Private Gynecology Practice, Turcianske Teplice, Slovakia.; Chemo Group, Exeltis Pharma, Madrid, Spain.",Not available
39279647,Impact of baseline characteristics on the efficacy of once-weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China.,2024-01-01,Shen Z; Hu P; Liu W,"Novo Nordisk (Shanghai) Pharma Trading Co., Ltd, Shanghai, China.",Not available
39279631,"Adult indication 13-valent pneumococcal conjugate vaccine clinical development overview: formulation, safety, immunogenicity (dosing and sequence), coadministration, and efficacy.",2024-01-01,Paradiso PR,"Paradiso Biologics Consulting, LLC, Newtown Square, PA, USA.",Not available
39279580,Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial.,2024-12-20,Pereira de Santana Gomes AJ; Nevalaita L; Kuss I,"Bayer AG, Berlin, Germany.; Liga Norte Riograndense Contra O Cancer, Natal, Brazil.; Orion Corporation, Orion Pharma, Espoo, Finland.",Not available
39279472,Development of in vitro biopharmaceutics tools for predicting the bioavailability of subcutaneously injected monoclonal antibodies and oligonucleotides.,2024-01-01,Campagna V; Sanchez-Felix MV; Forbes B; Vllasaliu D,"Currently with Halozyme Therapeutics, San Diego, CA, USA.; Formerly with Novartis Pharma AG, Basel, Switzerland.; Formerly with Novartis Pharma AG, Cambridge, USA.; Novartis Pharma AG, Basel, Switzerland.",Not available
39279181,Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products.,2024-01-01,Green P; Schneider A; Lange J,"Chesapeake Pharma LLC, Weehawken, NJ, USA.; Delivery Systems, Ypsomed AG, Burgdorf, Switzerland.",Not available
39278651,Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan.,2024-12-01,Wakasugi N; Hashida T; Uno S,"Astellas Pharma Inc., Tokyo.",kuwanam@nms.ac.jp.
39278599,Risk-Based Qualification of Cellular Starting Material Collection Sites: Tools to Determine Scope of Manufacturer Audits and Reduce Duplicative Efforts.,2024-01-01,Myers J; Hlucky T; Walters V; Anderson C; Contractor K,"Independent Contractor, Dallas, Texas.; Kite Pharma/Gilead, Los Angeles, California.; Vertex Pharmaceuticals, Boston, Massachusetts.","Arsenal Biosciences, South San Francisco, California. Electronic address: Pholman@ArsenalBio.com."
39278389,"Prevalence Estimates and Genetic Diversity for Autosomal Dominant Retinitis Pigmentosa Due to RHO, c.68C>A (p.P23H) Variant.",2024-01-01,Jayagopal A,"Ocuphire Pharma (A.J.), Farmington Hills, Michigan, USA.; Opus Genetics (A.J.), Durham, North Carolina, USA",Not available
39277916,Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study.,2024-01-01,Gounant V; Odier L; Missy P; Morin F; Westeel V,"Hopital Nord-Ouest de Villefranche-sur-Saone, Gleize, France.; Intergroupe Francophone de Cancerologie Thoracique, Paris, France.; Service d'Oncologie Thoracique Hopital Bichat, AP-HP, Paris, France.; Service de Pneumologie, Hopital Jean Minjoz, Besancon, France.",Not available
39277672,Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.,2024-01-01,DeMichele A,"The Gemini Group, Ann Arbor, MI, USA.",Not available
39277671,Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.,2024-01-01,Shatsky RA,"The Gemini Group, Ann Arbor, MI, USA.",Not available
39277636,Ensembling U-Nets for microaneurysm segmentation in optical coherence tomography angiography in patients with diabetic retinopathy.,2024-09-14,Schottenhamml J; Ploner SB; Maier A,"Pattern Recognition Lab, Friedrich-Alexander-Universitat Erlangen-Nurnberg, 91058, Erlangen , Germany.","Pattern Recognition Lab, Friedrich-Alexander-Universitat Erlangen-Nurnberg, 91058, Erlangen , Germany. Lennart.Husvogt@fau.de."
39277507,Recombinant human thioredoxin ameliorates imiquimod-induced psoriasis-like dermatitis in mice.,2024-01-01,Tian H,"Department of Basic Medicine, Medical College, Shaoxing University, Shaoxing, China.; Redox Bioscience Inc, Kyoto, Japan",Not available
39276184,"Ten Recommendations for Accelerating Hypertension and Diabetes Control to Reduce Stroke, Heart, and Renal Disease with the Aim to Save Lives in Cameroon Through Partnerships and Collaborations.",2024-01-01,Choukem SP; Nganou CN,"Fondation Coeur et vie, Douala, Cameroon.; Portefeuille Rein et Sante, Douala, Cameroon.","Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon. aitdzudie@yahoo.com."
39276176,A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors.,2024-01-01,Huang M; Chen LC,"Merck & Co., Inc., Rahway, NJ, USA.","START Midwest, Grand Rapids, MI, USA. nehal.lakhani@startmidwest.com."
39275959,"Innovative UPLC technique for concurrent quantification of etofenamate and benzyl nicotinate in the presence of methylparaben and benzyl alcohol in their topical cream: Greens, white, and Six Sigma methodologies.",2024-01-01,Mahmoud OA; Mohamed MA,"Hikma Pharmaceutical Company, Beni-Suef, 62511, Egypt.; Penta Pharma Egypt, Ismailia, Egypt.",Not available
39275547,Wearable Sensor-Based Assessments for Remotely Screening Early-Stage Parkinson's Disease.,2024-08-30,Best A,"Takeda Pharmaceuticals, Cambridge, MA 02142, USA.",Not available
39275225,Longitudinal Dietary Intake Data in Patients with Phenylketonuria from Europe: The Impact of Age and Phenylketonuria Severity.,2024-08-31,Ashmore C; Belanger-Quintana A,"Centro de Genetica Medica, Unidade Local de Saude de Santo Antonio, E.P.E. (ULSSA), 4099-028 Porto, Portugal.; Centro de Referencia na area de Doencas Hereditarias do Metabolismo, Unidade Local de Saude de Santo Antonio, E.P.E. (ULSSA), 4099-001 Porto, Portugal.",Not available
39275183,Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis.,2024-08-27,Shalaurova I; Otvos JD,"LabCorp Diagnostics, Morrisville, NC 27560, USA.",Not available
39274425,Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease.,2024-09-02,Galluccio G; Rubegni P; Calabrese L,"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, 00168 Rome, Italy.",Not available
39274360,Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis-The OPTIMISE Study.,2024-08-30,Ugur A; Clark B; Wiatr M,"Ferring Pharmaceuticals A/S, 2770 Kastrup, Denmark.; Osrodek Badan Klinicznych CLINSANTE S.C. Ewa Galczak-Nowak Malgorzata Trzaska, Chalubinskiego, 85-004 Bydgoszcz, Poland.",Not available
39274208,Automated Speech Analysis in Bipolar Disorder: The CALIBER Study Protocol and Preliminary Results.,2024-08-23,Mishra S,"Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.",Not available
39273524,Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway.,2024-09-04,Monroy-Garcia A,"Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, Mexico City 04510, Mexico.",Not available
39273294,A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.,2024-08-28,White A; Vowinckel J; Bailey M; Beeler K; Cesano A; Warren S,"Biognosys AG, 8952 Schlieren, Switzerland.; NanoString Technologies, Seattle, WA 98109, USA.",Not available
39271668,Template-dependent DNA ligation for the synthesis of modified oligonucleotides.,2024-09-13,Hanlon S; Bisagni S; Puntener K,"Pharmaceutical Division, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland.",Not available
39270835,[Role of cranioplasty in the management of decompressive craniectomies: Study of the Adolphe de Rothschild Foundation Hospital cohort over 7 years].,2025-01-01,Nicolaos G; Judel C; Dupont C,"Service de pharmacie, hopital Fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France.","Service de pharmacie, hopital Fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France. Electronic address: zohra.gachouch@gmail.com."
39270817,Comparison of Results from Two Commercially Available In-House Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit and TruSight Oncology 500 Assay.,2024-01-01,Adams HP; Hertel K; Fuhlbruck F; Thomas M; Sorensen H; Schlecht U; De Vos M,"F. Hoffmann-La Roche AG, Basel, Switzerland.; Helios MVZ Pathologie Erfurt GmbH, Erfurt, Germany.; Roche Diagnostics Solutions, Inc., Santa Clara, California.; Roche Diagnostics Solutions, Rotkreuz, Switzerland.; Signature Diagnostics GmbH, Potsdam, Germany.",Not available
39270816,The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus.,2024-01-01,Sookoian S; Bermudez-Silva FJ,"Clinical Unit of Endocrinology and Nutrition, University Regional Hospital of Malaga, Malaga, Spain; Clinical and Molecular Hepatology, Translational Health Research Center (CENITRES), Maimonides University, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Buenos Aires, Argentina; Faculty of Health Science, Maimonides University, Buenos Aires, Argentina.; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain; The Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain.",Not available
39270686,Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial.,2024-09-21,Vijayanagaram V; Katz ML; Carr MC; Chang AM,"Eli Lilly and Company, Bengaluru, India.; Eli Lilly and Company, Indianapolis, IN, USA.","Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Electronic address: richard.bergenstal@parknicollet.com."
39270619,Fatigue Management in Advanced Prostate Cancer: Real-World Insights From Qualitative Interviews With Patients.,2024-01-01,El-Chaar N; Elsouda D; Hong A,"Astellas Pharma Inc., Northbrook, IL.","Durham VA Health Care System, Durham, NC. Electronic address: Stephen.freedland@cshs.org."
39269178,"NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.",2024-12-02,Horan JC; Tangpeerachaikul A; Mente S; Sun Y; Kohl NE; Porter JR; Shair MD; Zhu VW; Pelish HE,"Kohl Consulting, Wellesley, Massachusetts.; Nuvalent, Inc., Cambridge, Massachusetts.",Not available
39269033,Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis.,2024-10-01,Lafeuille P; Socolov A; Diamond SS; Aptekar J,"Medidata, a Dassault Systemes Company, New York, New York.",Not available
39268761,3D printed personalized therapies for pediatric patients affected by adrenal insufficiency.,2024-01-01,Alvarez-Lorenzo C; Goyanes A,"FABRX Artificial Intelligence, Carretera de Escairon, 14, Currelos (O Savinao), Spain.; FABRX Ltd., Henwood House, Henwood, Ashford, Kent, UK.",Not available
39268198,Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm(2) of the face or scalp in patients with actinic keratosis: A phase 3 study.,2024-01-01,Jarell A; Falques M; Kiyasova V; Padulles L; Blauvelt A,"Almirall, Sant Feliu de Llobregat, Spain.; Sanova Dermatology, Austin, Texas.",Not available
39267142,TwinF interface inhibitor FP802 prevents retinal ganglion cell loss in a mouse model of amyotrophic lateral sclerosis.,2024-09-12,Williams SK,"FundaMental Pharma GmbH, 69120, Heidelberg, Germany.",Not available
39267130,Meta-analysis of bone mineral density in adults with phenylketonuria.,2024-09-12,Clague GE; Rose S; Whitehall KB; Ahring KK; Pessoa ALS; Muntau AC,"BioMarin Pharmaceutical Inc, Novato, CA, USA.; HCD Economics, Knutsford, UK.; Met Ed Consultants, Boulder, CO, USA.","NOVA Medical School/Faculdade de Ciencias Medicas (NMS/FCM), Universidade NOVA de Lisboa, Lisboa, Portugal. rochajc@nms.unl.pt."
39267100,"SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirements.",2024-09-12,Wang V; Clancy J; Marchetti M,"EURORDIS-Rare Diseases Europe, Patient Engagement and Therapeutic Development Director, Paris, France.; Medicine Evaluation Committee, Brussels, Belgium.; UBC Late Stage Ltd, London, UK.",Not available
39266764,Five latent factors underlie response to immunotherapy.,2024-01-01,Carles J; Gomez-Rey M,"Centro de Investigacion Biomedica en Red en Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.",Not available
39266656,Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation.,2024-09-12,Li AW; Lu J; Walker Q; Martinez R; Hiraragi H; Boldajipour BA; Sundar P; Potluri S; Lee G; Ali OA,"Awaken Capital, 250 S. Northwest Highway Suite 330, Park Ridge, IL, 60068, USA.; Kite Pharma, 344 Lakeside Drive, Foster City, CA, 94404, USA.; Lyell Immunopharma, 201 Haskins Way, South San Francisco, CA, 94080, USA.",Not available
39266535,Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.,2024-09-12,Schmid P,"Merck & Co., Inc., Rahway, NJ, USA.","Seoul National University Hospital, Seoul National University College of Medicine, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. moisa@snu.ac.kr."
39266308,Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis.,2024-09-12,de Vries IJM; Broere F,"Trajectum Pharma B.V, Utrecht, The Netherlands.","Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands a.j.stoppelenburg@umcutrecht.nl."
39266215,Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy.,2024-09-12,Mardis E,"Nektar Therapeutics, San Francisco, California, USA.",Not available
39265913,Low von Willebrand factor-unraveling an enigma wrapped in a conundrum.,2024-01-01,Baker RI,"Irish-Australian Blood Collaborative (IABC) Network; Western Australia Centre for Thrombosis and Haemostasis, Perth Blood Institute, Murdoch University, Perth, Western Australia, Australia.",Irish-Australian Blood Collaborative (IABC) Network. Electronic address: jamesodonnell@rcsi.ie.
39265745,Multimodal convolutional neural network-based algorithm for real-time detection and differentiation of malignant and inflammatory biliary strictures in cholangioscopy: a proof-of-concept study (with video).,2024-09-13,Ziegler J; Rozema M; Reuther S,"Unetiq GmbH, Munchen, Germany.",Not available
39265579,The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis.,2024-09-11,Blanch S,"Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.; Medica Scientia Innovation Research (MEDSIR) - Oncoclinicas&Co, Jersey City, NJ, USA",Not available
39264730,A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors.,2024-01-01,Carneiro BA,"Oncology Biometrics, AstraZeneca, Gaithersburg, MD 20878,USA.",Not available
39264607,"Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival.",2024-11-01,Goldstein D,"Syntropy Technologies LLC, Cambridge, Massachusetts.",Not available
39264599,Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.,2024-10-01,Barve A,"Viatris Inc, Canonsburg, Pennsylvania.",Not available
39263699,Highlights of the 15th Japan Bioanalysis Forum Symposium.,2024-01-01,Hara H; Uchiyama H; Nagaya H; Nakazawa T; Okamoto H,"R&D Division, Daiichi Sankyo Co., Ltd., Shinagawa-ku, Tokyo, Japan.; R&D Division, Towa Pharmaceutical Co., Ltd., Settsu, Osaka, Japan.; RW Bioanalysis Consulting, Bottmingen, Switzerland.; Synplogen Co., Ltd., Kobe, Hyogo, Japan.",Not available
39263674,Development and validation of a mortality risk prediction model for chronic obstructive pulmonary disease: a cross-sectional study using probabilistic graphical modelling.,2024-01-01,Ryu MH; Sciurba FC,"Joint CMU-Pitt PhD Program in Computational Biology, Pittsburgh, PA, USA.",Not available
39263264,The Use of GLP-1 Agonists in the Management of Cutaneous Disease.,2024-01-01,Lal K,"Dr. Lal is with Affiliated Dermatology in Scottsdale, Arizona, and Northwell Dermatology in Lake Success, New York.",Not available
39263262,Is Acne the Same Around the World?,2024-01-01,Kerob D; Demessant A,"Drs. Kerob and Demessant are with La Roche-Posay Laboratoire Dermatological Beauty in Paris, France.",Not available
39262640,Influenza Vaccination and Cardiovascular Events in Japanese Patients With Heart Failure- Findings From the PARALLEL-HF Trial.,2024-09-10,Ohishi T; Ito C,Novartis Pharma K.K. Tokyo Japan.,Not available
39262288,"Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers.",2024-01-01,Schaible J; Goeldner RG; Yamamura N,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Nippon Boehringer Ingelheim Co., Ltd., Kobe, Japan.",Not available
39262214,International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine.,2024-01-01,Pozo-Rosich P,"Instituto de Investigacion Medica Mercedes y Martin Ferreyra (INIMEC), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Universidad Nacional de Cordoba, Cordoba, Argentina.",Not available
39262145,Notalgia Paresthetica Dermatologist Report of Symptom Burden and Treatment: Results from a Physician Survey.,2024-09-11,Mohawk JA; So S; Shah N; Munera C; Punzalan JC; Argudo R,"AplusA Bell Falla, Newark, NJ, USA.; Cara Therapeutics, Stamford, CT, USA.",Not available
39261602,The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.,2024-01-01,Shanafelt T; Rossi D,"Division of Experimental Oncology, IRCCS, Ospedale San Raffaele, Milan, Italy.; Universita Vita-Salute San Raffaele, Milan, Italy.",Not available
39261601,Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.,2024-01-01,Xu X; Angiolillo AL; Brown P; Mattano LA; Winter SS,"Bristol Myers Squibb, Princeton, NJ, USA.; Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN, USA.; Children's Oncology Group, Monrovia, CA, USA.; HARP Pharma Consulting, Mystic, CT, USA.; Servier Pharmaceuticals, Boston, MA, USA.","Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. rheingold@chop.edu."
39261598,Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments.,2024-09-12,Donini M,"Pharma Technical Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany.",Not available
39261446,Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials.,2024-01-01,Han C; Gladman DD,"Janssen Global Services, LLC, Immunology, Malvern, PA, USA.; Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Immunology, Horsham, PA, USA.","Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA. jrcurtis@uabmc.edu."
39261236,Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial.,2024-09-10,Boysen G; Martins K; Iwata K; Gourgioti G; Serikoff A,"Astellas Pharma Europe Ltd, Addlestone, UK.; Astellas Pharma USA, Northbrook, IL, USA.",Not available
39260929,Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF.,2024-09-17,Davies M,"Lexicon Pharmaceuticals Inc, The Woodlands, Texas, USA.",Not available
39260223,Dyslipidemias in multiple sclerosis.,2024-01-01,Shalaurova I,"LabCorp Diagnostics, Morrisville, NC, USA.",Not available
39259701,Running the enrollment numbers on ophthalmic clinical trials in the United States.,2024-08-01,Pucker AD; Derthick N,"Lexitas Pharma Services, Durham, North Carolina.",Not available
39259562,"Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules.",2024-12-03,Gollner A; Rudolph D; Weyer-Czernilofsky U; Baumgartinger R; Jung P; Weinstabl H; Ramharter J; Grempler R; Quant J; Rinnenthal J; Perez Pitarch A; Golubovic B; Gerlach D; Bader G; Wetzel K; Otto S; Mandl C; Boehmelt G; McConnell DB; Kraut N; Sini P,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.; Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria.",Not available
39259426,Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities.,2024-01-01,Rajaeean N; Hinrichsmeyer KS; Domros-Zoungrana D; Urban JN; Lenz C,"Pfizer Pharma GmbH, Friedrichstrasse 110, 10117, Berlin, Germany.","Pfizer Pharma GmbH, Friedrichstrasse 110, 10117, Berlin, Germany. emma.froeling@pfizer.com."
39258976,Narrative review of value frameworks in urothelial carcinoma and positioning of enfortumab vedotin.,2024-01-01,Ortiz Nunez A; Gonzalez Portela J,"HEOR Established Markets, Astellas Pharma Europe, Madrid, Spain.",Not available
39257456,Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race.,2024-01-01,Khilfeh I; Rossi C; Muser E; Morrison L; Hilts A; Diaz L; Lefebvre P; Pilon D,"Analysis Group, Inc., Montreal, QC, Canada.; Janssen Scientific Affairs, LLC, Horsham, PA, USA.",Not available
39257278,"Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.",2024-01-01,Zaliaduonyte D; Saad AM,"CIBERCV, A Coruna, Spain.; Universidad de A Coruna (UDC), A Coruna, Spain.",Not available
39256350,Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial.,2024-09-10,Watters C,"Novartis Pharmaceuticals Corporation, Cambridge, MA, USA.","Department of Clinical Neuroscience, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. anders.kvanta@ki.se."
39256193,Pharmacokinetics and Bioequivalence of a Generic Ticagrelor 90-mg Formulation Versus the Innovator Product in Healthy White Subjects Under Fasting Conditions.,2025-01-01,Ghita A; Iordachescu A; Chirila M,"3S-Pharmacological Consultation & Res. SRL, Bucharest, Romania.; Medochemie Ltd, Cyprus.",Not available
39255991,"MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study.",2024-01-01,Bortman G; Patel MJ; La Rosa C; Fu W; Loureiro MJ,"Merck & Co., Inc., Rahway, NJ, USA.; Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina.","Universite Paris-Saclay, Faculte de Medecine, Inserm UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, Hopital Bicetre (Assistance Publique - Hopitaux de Paris), Le Kremlin-Bicetre, France marc.humbert@aphp.fr."
39255990,"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study.",2025-01-01,Chotirmall SH; Armstrong AW; Eickholz P,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.","Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, UK j.chalmers@dundee.ac.uk."
39255442,Survey of patient experience and management of vasomotor symptoms due to menopause from the PatientsLikeMe community.,2024-11-01,Shiozawa A; Schild AL; Singh D; Mancuso SA,"Astellas Pharma Inc., Northbrook, IL.; PatientsLikeMe LLC, Boston, MA.",Not available
39254621,Maximal Analgesic Effect Attained by the Use of Objective Neurophysiological Measurements With Closed-Loop Spinal Cord Stimulation.,2024-01-01,Falowski SM; Calodney AK; Buchanan P,"Neurosurgical Associates of Lancaster, Lancaster, PA, USA.; Precision Spine Care, Tyler, TX, USA.; Spanish Hills Interventional Pain Specialists, Camarillo, CA, USA.","Neurosurgical Services, Clinical Research, Anesthesia Pain Care Consultants, Tamarac, FL, USA. Electronic address: rml199@northwestern.edu."
39254458,Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease.,2024-01-01,Pierce TT; Ozturk A; Sherlock SP; Moura Cunha G; Wang X; Li Q; Hunt D; Middleton MS; Martin M; Corey KE; Edenbaum H; Shankar SS; Heymann H; Kamphaus TN; Calle RA; Covarrubias Y; Loomba R; Obuchowski NA; Sanyal AJ; Sirlin CB; Fowler KJ; Samir AE,"BioAge Labs, Richmond, Calif (S.S.S.); Department of Medicine, Division of Gastroenterology, NAFLD Research Center, University of California at San Diego, La Jolla, Calif (R.L.); Department of Radiology, Liver Imaging Group, University of California San Diego, La Jolla, Calif (M.S.M., Y.C., C.B.S., K.J.F.); Department of Radiology, University of Washington, Seattle, Wash (G.M.C.); Department of Ultrasound, Shenzhen University General Hospital, Shenzhen, China (Q.L.); Foundation for the National Institutes of Health, North Bethesda, Md (H.H., T.N.K.); From the Center for Ultrasound Research and Translation, Massachusetts General Hospital, 55 Fruit St, White Bldg, Rm 270, Boston, MA 02114 (T.T.P., A.O., X.W., Q.L., D.H., M.M., H.E., A.E.S.); Harvard Medical School, Boston, Mass (T.T.P., A.O., Q.L., A.E.S.); MGH Fatty Liver Program, Gastrointestinal Unit, Massachusetts General Hospital, Boston, Mass (K.E.C.); Pfizer, Cambridge, Mass (S.P.S.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); Regeneron Pharmaceuticals, Tarrytown, NY (R.A.C.); and Department of Internal Medicine, Division of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University Medical Center, Richmond, Va (A.J.S.).",Not available
39254310,"Perspectives of Japanese patients on psoriatic disease burden: Results from ""Psoriasis and Beyond,"" the Global Psoriatic Disease Survey.",2024-01-01,Itakura A; Kawamura T; Frade S,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma K.K, Tokyo, Japan.",Not available
39252867,"Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension.",2024-01-01,Keller LH,"KJC Statistics Ireland Limited, Dublin, Ireland.",Not available
39252866,Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.,2024-01-01,Evering TH; Margolis D,"Brii Biosciences, Durham, NC, USA.; Weill Cornell Medicine, New York, NY, USA.",Not available
39252657,"Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism.",2024-09-10,Chidambaram N; King S,"Antares Pharma Inc, Ewing, New Jersey, USA.; Lipocine, Inc., Salt Lake City, Utah, USA.",Not available
39251785,PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research.,2024-09-09,Steinbeisser C; Nicoletti R; Zong J; Tafreshiha A; Snijder R; Horgan D,"ARTTIC Innovation GmbH, Munich, Germany.; Astellas Pharma, Inc, Northbrook, IL, USA.; Collaborate Project Management, Munich, Germany.; Universita Vita-Salute San Raffaele, Milan, Italy.","Transforming cancer OUtcomes through Research (TOUR), King's College London, London, UK. ailbhe.lawlor@kcl.ac.uk."
39251349,"Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.",2024-01-01,Okamoto A,"Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.",Not available
39251025,"Response to Reynolds et al's ""Guidelines of care for the management of acne vulgaris"".",2025-01-01,Zaenglein A; Callender V; Schlosser B; Graber E; Keri J; Weiss J,"American Acne and Rosacea Society (AARS) Board of Directors, Montclair, New Jersey.","American Acne and Rosacea Society (AARS) Board of Directors, Montclair, New Jersey. Electronic address: info@acneandrosacea.org."
39250923,Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials.,2024-01-01,Gasparyan SB,"Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.",Not available
39249591,"Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).",2024-09-09,Casillas M; Ding Y; Yang FE; Pierce E,"Eli Lilly and Company, Indianapolis, IN, USA.","Oregon Health & Science University, Portland, OR, USA. simpsone@ohsu.edu."
39248292,Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis.,2024-09-09,Montmayeur S,"Eli Lilly and Company, Indianapolis, IN, USA.",Not available
39248039,Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology.,2024-01-01,Chng E; Brees D; Ren Y; Tai D,"Histoindex Pte. Ltd., Singapore, Singapore.; Novartis Pharma AG, Basel, Switzerland.",Not available
39247520,Peanut-specific IgG subclasses as biomarkers of peanut allergy in LEAP study participants.,2024-01-01,Huffaker M,"Immune Tolerance Network, Bethesda, MD, USA.",Not available
39246289,Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndrome.,2024-01-01,Landes-Chateau C; Mondot L; Cohen M; Lebrun-Frenay C,"Universite Cote d'Azur, UMR2CA (URRIS), Nice, France.",Not available
39245969,Decoding the mannose receptor-mAb interaction: the importance of high-mannose N-glycans and glycan-pairing.,2024-01-01,Baumeister J; Ebert S; Higel F,"Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
39245555,Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism Interventions.,2024-01-01,Dubois-Silva A,"Hospital at Home and Palliative Care Department, Complexo Hospitalario Universitario de A Coruna (CHUAC), A Coruna, Spain.; Universidade da Coruna (UDC), A Coruna, Spain; Venous Thromboembolism Unit, Department of Internal Medicine, Complexo Hospitalario Universitario de A Coruna (CHUAC), A Coruna, Spain",Not available
39245360,"A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.",2025-01-01,Basset-Seguin N; Booth J; Yoo SY; Seebach F; Lowy I; Fury MG,"Hopital Saint-Louis, Paris, France.; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.","Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: brett.hughes@health.qld.gov.au."
39244862,In silico assessments of the small molecular boron agents to pave the way for artificial intelligence-based boron neutron capture therapy.,2024-12-05,Zhang Y,"Sunshine Lake Pharma Co. Ltd., Dongguan, 523871, China.",Not available
39244017,Impact of thrombophilia on venous thromboembolism management.,2024-01-01,Zuily S,"FCRIN INNOVTE network, Saint-Etienne, France; Inserm, UMR 1116 DCAC, F-54000 Nancy, France.; Vascular Medicine Division, Universite de Lorraine, CHRU-Nancy, Rare Vascular and Systemic Autoimmune Diseases Regional Referral Center, France","FCRIN INNOVTE network, Saint-Etienne, France. Electronic address: jemmerich@ghpsj.fr."
39244016,A tribute to Guy Meyer.,2024-01-01,Girard P,"Departement de Pneumologie, InstitutMutualiste Montsouris, Paris, France.; FCRIN INNOVTE network, Saint-Etienne, France","FCRININNOVTE network, Saint-Etienne, France. Electronic address: francis.couturaud@chu-brest.fr."
39243945,Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes From the Phase 3 POSEIDON Trial.,2024-09-05,Araujo LH,"Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil.","Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch."
39243797,State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus.,2024-09-04,Dore J,"Universite Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.; Universite Paris-Saclay, INRAE, MGP Metagenopolis, Jouy-en-Josas, France",Not available
39243430,Optimization of anti-TIM3 chimeric antigen receptor with CD8alpha spacer and TNFR-based costimulation for enhanced efficacy in AML therapy.,2024-01-01,Rad SAH,"Kite Pharma Inc, Santa Monica, California, USA.",Not available
39242519,Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance.,2024-09-06,Zhao L; Nogueira-Recalde U; Joseph A; Messaoudene M; Ben Ahmed T; Piaggio E; Zitvogel L; Delaloge S,"Equipe Labellisee Par la Ligue Contre le Cancer, Inserm U1015, Gustave Roussy, Villejuif, France.; Faculte de Medecine, Universite de Paris Saclay, Kremlin Bicetre, Paris, France.; Growth Factors, Nutrients and Cancer Group, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncologicas, CNIO, Madrid, 28029, Spain.; Grupo de Investigacion en Reumatologia (GIR), Instituto de Investigacion Biomedica de A Coruna (INIBIC), Fundacion Profesor Novoa Santos, A Coruna, Spain.",Not available
39242435,Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic Therapy.,2024-01-01,Bentink S; Hesslinger C; Leonard TB; Schlange T; Todd JL,"Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.; Staburo GmbH, Munich, Germany.","Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany. julia.soellner@boehringer-ingelheim.com."
39242335,Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy.,2024-01-01,Boehmerle W; Huehnchen P,"Berlin Institute of Health at Charite, Universitatsmedizin Berlin, Anna-Louisa-Karsch Strasse 2, 10178 Berlin, Germany; Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Klinik und Hochschulambulanz fur Neurologie, Chariteplatz 1, 10117 Berlin, Germany; Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, NeuroCure Cluster of Excellence, Chariteplatz 1, 10117 Berlin, Germany; Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, NeuroCure Cluster of Excellence, Chariteplatz 1, 10117 Berlin, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany.",Not available
39242198,Intermediate HTT CAG repeats worsen disease severity in amyotrophic lateral sclerosis.,2024-12-16,Dewan R,"Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Torino, Piemonte, Italy.","Department of Neurosciences Rita Levi Montalcini, University of Turin, Torino, Piemonte, Italy maurizio.grassano@unito.it."
39242112,Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease.,2024-09-05,Alves M,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.","Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan kuwanam@nms.ac.jp."
39241795,Best buy interventions to address the burden of steatotic liver disease.,2024-01-01,Diaz LA,"Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.","Barcelona Institute for Global Health, Hospital Clinic, University of Barcelona, Barcelona, Spain. Electronic address: jeffrey.lazarus@isglobal.org."
39241319,Preferences of US adolescents and parents for vaccination against invasive meningococcal disease.,2024-11-14,Hauber B; Cappelleri JC; Coulter J,"Pfizer, Groton, CT, USA.; Pfizer, New York, NY, USA.","Pfizer Pharma GmbH, Berlin, Germany. Electronic address: katharina.schley@pfizer.com."
39240729,Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication.,2024-09-01,Levijoki JM,"Orion Pharma, Espoo, Finland.",Not available
39240335,Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting.,2024-10-07,Mary H; Robinot R; Bscheider M; Chakrabarti LA,"Biomaterials and Microfluidics Core Facility, Institut Pasteur, Universite de Paris Cite , Paris, France. ROR: https://ror.org/0495fxg12; Emulate Inc , Boston, USA. ROR: https://ror.org/011n0hq04",Not available
39240040,Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trial.,2024-01-01,Severin T; Gimpelewicz C,"Novartis Pharma, Basel, Switzerland.",Not available
39239871,How pharma can amplify product value with implementation science.,2024-01-01,Olson MS,"Olson Strategies GmbH, Allschwil, 4123, Switzerland.",Not available
39238143,Excess Healthcare Costs and Resource Utilisation of Lyme Borreliosis in Germany: A Propensity Score-Matched Cohort Study.,2025-01-01,Brestrich G; Stark JH; Pilz A,"Pfizer Corporation GmbH, Vienna, Austria.; Pfizer Pharma GmbH, Berlin, Germany.; Vaccines, Antivirals, and Evidence Generation, Pfizer Biopharma Group, Cambridge, Massachusetts, USA.",Not available
39238048,"Incidence of symptomatic Borrelia burgdorferi sensu lato infection in Romania, 2018-2023.",2024-09-05,Purdel V,"Hologic, Inc, Marlborough, MA 01752, USA.","Vaccines and Antivirals Medical Affairs, Pfizer US Commercial Division, 500 Arcola Road, Collegeville, PA, 19426, USA. Frederick.J.Angulo@pfizer.com."
39238042,Reliability of the assessment of the clinical dementia rating scale from the analysis of medical records in comparison with the reference method.,2024-09-05,Krolak-Salmon P,"PhIND ""Physiopathology and Imaging of Neurological Disorders"", Neuropresage Team, Normandie Univ, UNICAEN, INSERM, U1237, Cyceron, Caen, 14000, France.","Clinical and Research Memory Center of Lyon, Lyon Institute For Aging, Charpennes Hospital, Hospices Civils de Lyon, Lyon, France. virginie.dauphinot@chu-lyon.fr."
39237835,Predictors of Disease Activity After Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration Using Real-World Data from the PROOF Study.,2024-01-01,Chae JE,"LSK Global Pharma Services, Seoul, Korea.",Not available
39237634,Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.,2024-01-01,Yuan M; Sakatani T; Kadokura T; Takeuchi M; Kosako M; Ma X; Hasabou N,"Astellas China Investment Co, Ltd., Beijing, China.; Astellas Pharma, Inc., Northbrook, IL, USA.; Astellas Pharma, Inc., Tokyo, Japan.","State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. wangjx@ihcams.ac.cn."
39237611,Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.,2024-09-05,Alegria-Carrasco E,"Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM), Madrid, Spain.",Not available
39237321,Long-term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan(R) Adult Maternal Paediatric European Registry multinational observational study.,2025-01-01,Kucuksayrac E,"BioMarin Europe Ltd., London, UK.",Not available
39236955,Formulating a TMEM176B blocker in chitosan nanoparticles uncouples its paradoxical roles in innate and adaptive antitumoral immunity.,2024-01-01,Castro A; Cebrian I; Mombru AW,"Centro NanoMat, Instituto Polo Tecnologico de Pando, Facultad de Quimica, UdelaR, Camino Aparicio Saravia s/n, 9100 Pando, Canelones, Uruguay.; Facultad de Ciencias Medicas, Instituto de Histologia y Embriologia de Mendoza (IHEM)-CONICET/Universidad Nacional de Cuyo, Mendoza, Argentina.",Not available
39236850,"Manufacture, characterization, and elucidation of drug release mechanisms of etonogestrel implants based on ethylene vinyl acetate.",2025-01-01,Listro T,"Sever Pharma Solutions, Putnam, CT, USA.",Not available
39235858,A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use.,2024-09-05,Martinot MP; Papadopoulos Orfanos D,"NeuroSpin, CEA, Universite Paris-Saclay, Gif-sur-Yvette, France.; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany.",Not available
39235686,Laxative Properties of Microencapsulated Oleic Acid Delivered to the Distal Small Intestine in Patients with Constipation after Bariatric Surgery or Treatment with Glucagon-Like- Peptide 1 Analogues.,2024-01-01,le Roux CW,"AnaBio Technologies Ltd, Carrigtwohill, Cork, T45 RW24, Ireland.",Not available
39235051,Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO).,2024-09-05,Haustrup N; Konicek BW; Kadziola Z; Nunez M; Brnabic A; Schuster C,"Department of Dermatology, Medical University of Vienna, Vienna, Austria; Eli Lilly and Company, Indianapolis, USA.","University of California, Los Angeles, CA, USA. aprilarmstrong@post.harvard.edu."
39234802,Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis.,2024-01-01,Calabresi PA,"QMENTA, Boston, MA, USA.",Not available
39234619,Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patients.,2024-01-01,McDonnell D,"Alkermes Pharma Ireland Limited, Dublin, Ireland.",Not available
39234243,An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies.,2024-01-01,Dejardin D; Wolbers M,"Data Sciences, Product Development, F. Hoffmann-La Roche AG, Basel, Switzerland.",Not available
39233903,"Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.",2024-01-01,Cattaneo C,"UVSQ, Universite Paris-Saclay, UFR Sante Simone Veil, Inserm, CESP Villejuif France.",Not available
39233587,Missense and loss-of-function variants at GWAS loci in familial Alzheimer's disease.,2024-01-01,Mejia DR; Medrano M; Lantigua RA,"Los Centros de Diagnostico y Medicina Avanzada y de Conferencias Medicas y Telemedicina, CEDIMAT, Arturo Logrono, Plaza de la Salud, Dr. Juan Manuel Taveras Rodriguez, C. Pepillo Salcedo esq, Santo Domingo, Dominican Republic.; Pontificia Universidad Catolica Madre y Maestra (PUCMM), Autopista Duarte Km 1 1/2, Santiago de los Caballeros, Dominican Republic.; Universidad Pedro Henriquez Urena, Av. John F. Kennedy Km. 7-1/2 Santo Domingo 1423, Santo Domingo, Dominican Republic.",Not available
39233497,"Development, evaluation of critical method variables and stability assessment using a Box-Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone.",2024-01-01,Jeedimalla N; Dongala T,"Agilent Technologies, Wilmington, Delaware, USA.; Laurus Generics, Inc., Berkeley Heights, New Jersey, USA.",Not available
39233241,Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.,2024-12-15,Di Lorenzo G,"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; IRCCS Fondazione Santa Lucia, Rome, Italy.",Not available
39232634,"Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome.",2024-09-10,Du W; Diaz R; Scemama M; Manvelian G; Pordy R; Fazio S; Geba GP,"Estudios Cardiologicos Latinoamerica, Instituto Cardiovascular de Rosario, Rosario, Argentina.; Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.; Sanofi, Chilly-Mazarin, France.","Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. Electronic address: dzahger@bgu.ac.il."
39232630,Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?,2024-09-10,Zeller C,"Boehringer Ingelheim Pharma, Ingelheim, Germany.","Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: john.gregson@lshtm.ac.uk."
39232179,A protein risk score for all-cause and respiratory-specific mortality in non-Hispanic white and African American individuals who smoke.,2024-09-04,Manichaikul A,"Regeneron Pharmaceuticals, Tarrytown, NY, 10591, USA.","Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Ave, Boston, MA, 02115, USA. remol@channing.harvard.edu."
39232033,Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research.,2024-09-04,Dartee W,"Novartis Pharma AG, Basel, Switzerland.","Novartis Pharmaceuticals Corporation, Cambridge, MA, USA. gul.erdemli@novartis.com."
39231907,Current Approaches to Design Space Development and Regulatory Applications for Drug Products: Findings from the IQ Utilization of Design Space for Filings Working Group Survey.,2024-01-01,Osei-Yeboah F; Pauli-Bruns A; Chen B; Manceva S; Wade JB; Yin S; Desai D; Dirat O; Stauffer F,"Biologics Drug Product Development, Sanofi, Frankfurt, Germany.; Biologics Drug Product Development, Teva Branded Pharmaceuticals, West Chester, PA, USA.; Drug Product Development, BMS, New Brunswick, NJ, USA.; Global Regulatory Sciences - CMC Advisory Office, Pfizer, Sandwich, UK.; Pharmaceutical Development, Biogen, Cambridge, MA, USA.; Product Development Science & Technology, Abbvie, North Chicago, IL, USA.; Technical Services/Manufacturing Science, Eli Lilly and Company, Indianapolis, IN, USA.; UCB Pharma, Brussels, Belgium.","Synthetic Molecule Design and Development, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. miesleje@lilly.com."
39231546,Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis.,2024-09-03,Kim M; Kumke T; Tham R; Rudwaleit M,"UCB Pharma, Monheim am Rhein, Germany.; UCB Pharma, Smyrna, Georgia, USA.","Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany baraliakos@me.com."
39231389,Risk Stratification in Older Intensively Treated Patients With AML.,2024-01-01,Freeman SD,"Cliniques Universitaires Saint-Luc, Brussels, Belgium.",Not available
39230885,Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.,2024-11-01,Veselka J; Jacoby DL; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A,"Cytokinetics, Incorporated, South San Francisco, California.; JV Cardiology, Prague, Czech Republic.",Not available
39230829,"Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19.",2024-01-01,Patel DR; Macpherson L; Bohm M; Upadhyaya H; Deveau C; Nirula A; Klekotka P; Williams M,"Eli Lilly and Company, 893 S Delaware St, Indianapolis, IN, 46220, USA.",Not available
39230682,"Societal costs and quality of life associated with arginase 1 deficiency in a European setting - a multinational, cross-sectional survey.",2024-01-01,Widen J; Rudebeck M,"Immedica Pharma AB, Stockholm, Sweden.",Not available
39230674,Diagnosis and management of eosinophilic esophagitis and esophageal food impaction in adults : A position paper issued by the Austrian Society of Gastroenterology and Hepatology (OGGH).,2024-01-01,Madl C,"Division of Gastroenterology and Hepatology, Krankenanstalt Rudolfstiftung, Krankenanstaltenverbund Wien (KAV), Vienna, Austria.","Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, University Hospital Graz, Auenbruggerplatz 15, 8036, Graz, Austria. hansjoerg.schlager@medunigraz.at."
39230545,ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.,2024-11-26,Duffy D; Bahit MC; Anschuetz G; Girgis IG; Harrington RA,"CSL Behring, King of Prussia, Pennsylvania, USA.; INECO Neurociencias Rosario, Rosario, Argentina.; Weill Cornell Medicine, New York, New York, USA.","Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: charlesmichaelgibson@gmail.com."
39229786,"The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations.",2024-01-01,Jones RL; Sprott K; Cox P; Sherman ML; Ruiz-Soto R; Heinrich MC,"Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA.; Weill Cornell Medicine, New York, NY 10065, USA.",Not available
39229634,Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer.,2024-01-01,Lux MP,"Klinik fur Gynakologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, Frauenklinik St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Kliniken Salzkotten + Paderborn, Paderborn, Germany.",Not available
39229561,Impact of SARS-CoV-2 infection on short-term postoperative outcomes after gastroenterological cancer surgery using data from a nationwide database in Japan.,2024-01-01,Kakeji Y; Mori M,"Database Committee, The Japanese Society of Gastroenterological Surgery Minato-ku Tokyo Japan.",Not available
39229557,"Impact of the COVID-19 pandemic on short-term outcomes after pancreaticoduodenectomy for pancreatic cancer: A retrospective study from the Japanese National Clinical Database, 2018-2021.",2024-01-01,Kakeji Y; Ueno H,"Database Committee, The Japanese Society of Gastroenterological Surgery Tokyo Japan.",Not available
39229539,Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: A systematic literature review.,2024-08-30,Smoyer KE; Rossulek MI; Revkin JH; Groarke JD; Tarasenko LC; Kosiborod MN,"Envision Pharma Group, London, UK.; Envision Pharma Group, Philadelphia, PA, USA.; Pfizer Inc, Cambridge, MA, USA.; Pfizer Inc, New York, NY, USA.",Not available
39229287,High Rates of Nonsusceptibility to Common Oral Antibiotics in Streptococcus pneumoniae Clinical Isolates From the United States (2019-2021).,2024-01-01,Deshpande LM; Huband MD; Charbon S; Castanheira M; Mendes RE,"Element Iowa City (JMI Laboratories), North Liberty, Iowa, USA.",Not available
39229199,In vivo Antibody Painting for Next Generation Weight Loss Drugs.,2024-08-23,Rondon A,"Present address: Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.",Not available
39229002,Tissue determinants of the human T cell receptor repertoire.,2024-08-19,Thakur C,"Medical Scientist Training Program, Washington University School of Medicine; St. Louis, 63110, USA.",Not available
39228973,Change in pulse pressure and cardiovascular outcomes after percutaneous coronary intervention: The CLIDAS study.,2024-01-01,Iwai T; Fujita H,"Development Bank of Japan Inc., 1-9-6 Otemachi, Chiyoda-ku, Tokyo 100-8178, Japan.; Precision Inc., 4-2-5 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.",Not available
39228749,Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides: A call for action.,2024-01-01,Fitch A; Younglove C,"Diplomate of American Board of Obesity Medicine, Knownwell, 15 Oak St Suite 3, Needham, MA, 02492, USA.; Heartland Weight Loss, 14205 Metcalf Avenue, Overland Park, KS, 66223, USA.",Not available
39228740,The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.,2024-08-22,Zhang B; Luo Y; Jeromin A; Vandijck M; Bastard NL; Kolb H; Triana-Baltzer G; Wohlstadter J; Malyavantham K; Khare M; Jethwa A; Stoeckl L; Gobom J; Kac PR; Gonzalez-Ortiz F; Montoliu-Gaya L,"ALZpath Inc., Carlsbad, CA, USA.; Alamar Biosciences, Inc., Fremont, CA, USA.; MagQu Co., Ltd., New Taipei City 112, Taiwan.; Meso Scale Diagnostics, LLC., Rockville, Maryland, USA.; Quanterix Corp, Billerica, MA, USA.; Roche Diagnostics GmbH, Penzberg, Germany.",Not available
39228093,Therapeutic inertia in obesity management among people living with obesity from the perspective of general/family practitioners in Canada: A mixed-methods study.,2025-01-01,Lavji R; Belloum A; Ng G,"IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada.; Novo Nordisk Canada Inc., Mississauga, Ontario, Canada.",Not available
39228016,Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers.,2024-01-01,Fu L; Jiang L; Wang C; Minto I; Zhai Y,"Ascentage Pharma Group Inc, Rockville, Maryland, USA.",Not available
39227642,Induction and maintenance of mucosal healing in Crohn's disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS).,2024-09-03,von Arnim U; Ochsenkuhn T; Stein J; Lugering A,"DGD Kliniken Frankfurt Sachsenhausen, Abteilung Gastroenterologie/Ernahrungsmedizin, Frankfurt am Main, Germany.; Isarklinikum, Klinik fur Gastroenterologie, Hepatologie und Gastroenterologische Onkologie, Munchen, Germany.; MVZ Portal 10, Zentrum fur Leber-, Magen- und Darmerkrankungen, Munster, Germany.; Universitatsklinikum Magdeburg, Universitatsklinik fur Gastroenterologie, Hepatologie und Infektiologie, Magdeburg, Germany.","Medizinische Klinik m.S. Hepatologie und Gastroenterologie, Charite-Universitatsmedizin Berlin, Berlin, Germany. daniel.baumgart@charite.de."
39227409,Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors.,2024-01-01,Xiu J; Ribeiro JR; Nicolaides T; Zhang J; Poorman KA; Oberley MJ; Sledge GW Jr; Spetzler D,"Caris Life Sciences, Irving, TX, USA.; Caris Life Sciences, Phoenix, AZ, USA.",Not available
39227343,Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities.,2024-09-03,Kristoforus T; Lanz HL; Joore J; Vulto P; Villenave R,"3MIMETAS BV, Oegstgeest, The Netherlands.; 4MIMETAS US, Inc., Gaithersburg, Maryland, USA",Not available
39227284,Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+).,2024-01-01,Noukens J,"Curare Consulting, Liempde, the Netherlands.","Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: howardj@neurology.unc.edu."
39227075,Worsening dyspnoea as a predictor of progression of pulmonary fibrosis.,2024-01-01,Stansen W,"Boehringer Ingelheim GmbH & Co. KG, Ingelheim am Rhein, Germany.","Department of Respiratory Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands m.wijsenbeek-lourens@erasmusmc.nl."
39227073,Effect of sotatercept on circulating proteomics in pulmonary arterial hypertension.,2024-01-01,Savale L; Boucly A; Montani D; Park DH; Humbert M,"Universite Paris-Saclay, Hypertension Pulmonaire: Physiopathology and Innovation Therapeutique, HPPIT, Faculte de Medecine, Le Kremlin-Bicetre, France.",Not available
39227008,Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort.,2024-01-01,Stein K; Wissniowski TT,"Practice of Hepatology Magdeburg, Magdeburg, Germany.; Zentrum Innere Medizin II, Klinikum Chemnitz gGmbH, Chemnitz, Germany.",Not available
39226466,Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice.,2024-11-26,De Cristofaro R; Di Minno G,"Dipartimento di Medicina Traslazionale e di Precisione, Sapienza Universita di Roma, Rome, Italy.",Not available
39226398,Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.,2024-11-01,Facchinetti F; Loriot Y; Vasseur D; Bahleda R; Combarel D; Italiano A; Smolenschi C; Scoazec JY; Hollebecque A,"Departement de Medecine Oncologique, Gustave Roussy, Villejuif, France.; Service de Pharmacocinetique, Faculte de Pharmacie, Universite Paris-Saclay, Orsay, France.; Universite Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Universite Paris-Saclay, Inserm, CESP, Villejuif, France.",Not available
39226214,Characteristics and outcomes of heart failure in Japan: A hospital-based administrative database analysis.,2024-01-01,Okuyama N,"Mebix, Inc., Tokyo, Japan.",Not available
39226073,Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan.,2024-01-01,Saika T; Ikeda S,"KAKEHASHI Inc., Tokyo, Japan.; Patient Engagement Business Commercial Intelligence, KAKEHASHI Inc., Tokyo, Japan.",Not available
39225713,Overview of 37 Tear Substitutes in Europe Based on Various Physicochemical Parameters.,2024-01-01,Manuelli A; Chauchat L; Legall M; Rebika H; Sahyoun M; Guerin C,"Laboratoires Horus Pharma, 22 Allee Camille Muffat, 06200, Nice, France.","Laboratoires Horus Pharma, 22 Allee Camille Muffat, 06200, Nice, France. adrien.paschier@horus-pharma.com."
39225512,Meeting report of the 5th European Biotransformation Workshop.,2024-01-01,Isin EM,"DMPK, Translational Medicine, Servier, Paris-Saclay, France.",Not available
39225433,The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.,2024-01-01,Ashby S; Hallab A,"Charite-Universitatsmedizin Berlin, Corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Berlin, Germany.; SUDEP Action, Wantage, UK.",Not available
39225211,"Myrtleciclib, a CDK4/6/9 Inhibitor for the Treatment of Aggressive Cancers.",2024-09-02,De Forni D; Poddesu B; Cugia G; Lagace L; Chafouleas J; Lori F,"Sonnet Pharma Consulting Inc., 912 Rue Lajeunesse, Ste-Therese QC J7E 4X8, Canada.; ViroStatics srl Sassari Italy.; ViroStatics srl, Viale Umberto I 46, 07100 Sassari, Italy.",Not available
39225059,Epidemiology of paediatric chronic heart failure in Germany-A population-based analysis.,2024-01-01,Klebs S; Hackl D,"Novartis Pharma GmbH, Nuremberg, Germany.; WIG2 GmbH, Leipzig, Germany.",Not available
39224799,Satisfaction with videoconferencing support for levodopa-carbidopa intestinal gel: An observational study.,2024-01-01,Slawek J,"AbbVie Inc., North Chicago, IL, USA. RINGGOLD: 359181",Not available
39224774,"Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study.",2024-01-01,Klingmann I,"Pharmaplex Bv, Wezembeek-Oppem, Belgium.",Not available
39224770,Do sex and gender aspects influence non-adherence to secondary prevention measures after myocardial infarction?,2024-01-01,Moreno G; Cerro EPD,"Centro de Investigacion Biomedica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Departamento de Enfermeria, Facultad de Enfermeria, Fisioterapia y Podologia, Universidad Complutense de Madrid (UCM), Madrid, Spain.",Not available
39224484,Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies.,2024-01-01,Fischer R; Furlong P; Penrod M; Miller D; Laverty CG; Lowes LP,"Cureduchenne, Newport Beach, CA, USA.; Duchenne Family Assistance Program, Detroit, MI, USA.; Parent Project Muscular Dystrophy, Washington, DC, USA.; Team Joseph, West Bloomfield, MI, USA.",Not available
39223967,P-doped carbon dot nano-probe for inner filter effect-based determination of sarecycline in pharmaceutical dosage form and human plasma.,2024-01-01,Yassin MG,"Zeta Pharma for Pharmaceutical Industries, Sadat City, Egypt.",Not available
39222899,"Cardiac Surgical Bleeding, Transfusion, and Quality Metrics: Joint Consensus Statement by the Enhanced Recovery After Surgery Cardiac Society and Society for the Advancement of Patient Blood Management.",2024-08-31,Ozawa S,"Department of Anesthesiology, Critical Care and Hyperbaric Medicine, TeamHealth, Englewood Hospital, Englewood, New Jersey; Society for the Advancement of Patient Blood Management (SABM), Englewood, New Jersey.",Not available
39222700,Intravenous alteplase versus tenecteplase in patients with acute posterior circulation strokes: A secondary analysis from the AcT randomized controlled trial.,2024-01-01,Cimflova P,"Department of Radiology, University of Calgary, Calgary, Canada; Universitatsinstitut fur Diagnostische und Interventionelle Neuroradiologie, Universitatsspital Bern, Rosenbuhlgasse 25, Bern 3010, Switzerland","Department of Clinical Neurosciences, University of Calgary, Calgary, Canada. Electronic address: petracimflova@gmail.com."
39222436,Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis.,2024-11-01,Lauwerys B; Tilt N; Ufuktepe B; Xavier RM,"UCB Pharma, Brussels, Belgium.; UCB Pharma, Istanbul, Turkey.; UCB Pharma, Madrid, Spain.; UCB Pharma, Slough, UK.",Not available
39222408,B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity.,2024-01-01,Smith MA; Gunsior M; Mittereder N; Rees WA; Cimbora D; Cree BAC,"Horizon Therapeutics (now Amgen Inc., Thousand Oaks, California, USA), Gaithersburg, Maryland, USA.",Not available
39222070,Diagnosed and undiagnosed cough-related stress urinary incontinence in women with refractory or unexplained chronic cough: Its impact on general health status and quality of life.,2024-01-01,Gonzalez-Barcala FJ,"Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Universidad de Santiago de Compostela (USC), Santiago de Compostela, Spain.; Grupo de Investigacion Traslacional en Enfermedades de las Vias Aereas (TRIAD), Santiago de Compostela, Spain; Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain",Not available
39222035,"Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.",2024-11-19,Beygui F; Da Costa A,"Departement de Cardiologie, CHU de la Cote de Nacre, Caen, France (F.B.).; Service de Cardiologie, CHU de Saint-Etienne, Hopital Nord, Universite Jean-Monnet, France (A.D.C.).",Not available
39221845,"Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects.",2024-08-21,De Lago E; Gazzi T; Gertsch J; Haider A; He Y; Heitman LH; Romero J,"Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Instituto Ramon y Cajal de Investigacion Sanitaria (IRYCIS), Madrid, Spain.; Instituto Universitario de Investigacion en Neuroquimica, Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain.; Leibniz-Forschungsinstitut fur Molekulare Pharmakologie FMP, Campus Berlin-Buch, 13125 Berlin, Germany.",Not available
39219320,Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases.,2024-01-01,Menshykau D; Sidhu J; Shaughnessy L; Lledo-Garcia R; Dua P; Teil M; Khandelwal A,"UCB Australia Pty Ltd, Malvern, Victoria, Australia.; UCB BioSciences Inc, Raleigh, North Carolina, USA.; UCB Biopharma SRL, Brussels, Belgium.; UCB Biosciences GmbH, Monheim am Rhein, Germany.; UCB Pharma, Slough, UK.",Not available
39217574,Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2.,2024-12-10,Zamorano JL,"CIBERCV, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Cardiology, Hospital Universitario Ramon y Cajal, Madrid, Spain",Not available
39217569,Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.,2024-11-05,Butzner M; Jacoby DL; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A,"Cytokinetics, Incorporated, South San Francisco, California, USA.","Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA. Electronic address: csherrod@saint-lukes.org."
39217567,Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.,2024-10-22,Nunez J,"Centro de Investigacion Biomedica en Red Cardiovascular, Valencia, Spain.; Hospital Clinico Universitario de Valencia, Instituto de Investigacion Sanitaria, Universidad de Valencia, Valencia, Spain","Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: ssolomon@bwh.harvard.edu."
39217563,Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy.,2024-11-05,Jacoby DL; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A,"Cytokinetics, South San Francisco, California, USA.","Oregon Health and Science University, Portland, Oregon, USA. Electronic address: masria@ohsu.edu."
39217559,The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT Trial.,2024-10-22,Schiele F,"Universite de Franche-Comte, SINERGIES, Besancon, France.","TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: bscirica@bwh.harvard.edu."
39217556,Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy.,2024-11-05,Jacoby DL; Heitner SB; Kupfer S; Meng L; Wohltman A; Malik FI,"Cytokinetics, Incorporated, South San Francisco, California, USA.","Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: shegde@bwh.harvard.edu."
39217551,Temporal Trends in Takotsubo Syndrome: Results From the International Takotsubo Registry.,2024-09-24,Chen S; Ebrahimi R; Gili S; Ukena C; Bianco M; Bohm M,"Cardioangiologisches Centrum Bethanien (CCB), Kardiologie, Medizinische Klinik III, Agaplesion Markus Krankenhaus, Akademisches Lehrkrankenhaus der Goethe-Universitat Frankfurt am Main, Frankfurt am Main, Germany; Cardioangiologisches Centrum Bethanien (CCB), Kardiologie, Medizinische Klinik III, Agaplesion Markus Krankenhaus, Akademisches Lehrkrankenhaus der Goethe-Universitat Frankfurt am Main, Frankfurt am Main, Germany.; Centro cardiologico Monzino, IRCCS, Milan, Italy.; Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Turin, Italy.; Heart Clinic Pratteln, Zentrum fur Kardiologie, Pratteln, Switzerland.; Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg/Saar, Germany.",Not available
39217550,Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure: A Validation Cohort of the EMPEROR Program.,2024-11-12,Gonzalez Maldonado S; Panova-Noeva M; Saadati M,"Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; Center for Thrombosis and Haemostasis, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.; Elderbrook Solutions GmbH, on behalf of Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany.","Imperial College London, London, United Kingdom. Electronic address: milton.packer@baylorhealth.edu."
39217260,Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases.,2024-01-01,Fitzpatrick S; Leal S; Brunck L; Hasanbasic Z; Chu KW; Reed K; Sivaprasad S,"Bayer Consumer Care AG, Basel, Switzerland.; Bayer Inc., Mississauga, Ontario, Canada.; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.",Not available
39217154,Structural basis for CCR6 modulation by allosteric antagonists.,2024-08-31,Wasilko DJ; Gerstenberger BS; Farley KA; Schnute ME; Unwalla RJ; Victorino J; Sahasrabudhe PV; Vincent F; Frisbie RK; Dermenci A; Flick A; Choi C; Chinigo G; Mousseau JJ; Trujillo JI; Nuhant P; Mondal P; Lombardo V; Hogan BJ; Segala E; Rappas M; Cooke RM; Berstein G; Wu H,"Discovery Sciences, Medicine Design, Pfizer Inc., Groton, CT, USA.; Medicine Design, Pfizer Inc., Cambridge, MA, USA.; Medicine Design, Pfizer Inc., Groton, CT, USA.; Nxera Pharma UK Limited, Steinmetz Building, Granta Park, Great Abington, Cambridge, UK.",Not available
39216175,BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer.,2024-01-01,Lonardi S,"Istituto Oncologico Veneto, IRCCS, Padua, Italy.",Not available
39215949,Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies.,2024-01-01,Gossec L; Heinrichs A; Bajracharya R; Shende V; Coarse J; Coates LC,"Sorbonne Universite, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, Paris, France.; UCB Biosciences GmbH, Monheim, Germany.; UCB Pharma, Morrisville, NC, USA.; UCB Pharma, Slough, UK.","Department of Rheumatology, Providence-Swedish Medical Center and University of Washington, Seattle, WA, USA. pmease@philipmease.com."
39215767,"Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST).",2024-01-01,Mahboub B; Abreu G; Dos Santos D; Queiroz J; Raimondi A; Noibi S; Levy G; Bavbek S,"Fundacion Neumologica de Colombia, Bogota, Colombia.; GSK, Bogota, Colombia.; GSK, Jeddah, Saudi Arabia.; Real-World Evidence Matrix Team, Emerging Markets, Value Evidence & Outcomes, GSK, Rio de Janeiro, Brazil.; Servicios de Salud Ips Suramericana SAS, Medellin, Antioquia, Colombia.",Not available
39215755,"Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence.",2024-01-01,Cannarozzi AL; Latiano A; Bossa F; Guerra M; Brina ALD; Biscaglia G; Tavano F; Carparelli S; Perri F; Palmieri O,"Division of Gastroenterology and Endoscopy, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.",Not available
39213145,Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review.,2024-01-01,Hur P,"Pfizer Inc, New York City, NY.",Not available
39214920,Interleukin-1alpha inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.,2024-08-30,Pawlikowski J,"Janssen Scientific Affairs, LLC, Horsham, PA, 19044, USA.","Oregon Health & Science University, South Waterfront, 3303 S. Bond Ave, Portland, OR, 97239, USA. simpsone@ohsu.edu."
39214801,Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.,2024-01-01,Horrow J; Li D,"Bristol Myers Squibb, Princeton, NJ.",Not available
39214650,"Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment.",2024-08-30,Hubbard C; Zizlsperger N; Fitzgerald D; Kutok JL; Ilaria R Jr; Peluso S,"Infinity Pharmaceuticals, Cambridge, Massachusetts, USA.","Infinity Pharmaceuticals, Cambridge, Massachusetts, USA brendaoconnell5@gmail.com."
39214158,Diagnostic and therapeutic practice for Heart Failure with preserved ejection fraction around the world: An international survey.,2024-01-01,Tejero A,"Centro medico ISSEM, Mexico.","University of Antioquia, Pontificia bolivarina University, CardioVID clinic, Medellin, Colombia. Electronic address: clarais@hotmail.com."
39214113,Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.,2024-01-01,Bookman MA,"Kaiser Permanente Northern California, San Francisco, CA, USA.","Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: c.l.creutzberg@lumc.nl."
39214106,"Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial.",2024-01-01,Dalenc F; Gomez HL; Fulford M; Andrews H; Wadsworth I; D'Cruz C,"Departamento de Oncologia Medica, Instituto Nacional de Enfermedades Neoplasicas (INEN) and Universidad Ricardo Palma, Lima, Peru.; Oncology R&D, AstraZeneca, Cambridge, UK; Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Oncology R&D, AstraZeneca, Waltham, MA, USA.; Oncology R&D, AstraZeneca, Warsaw, Poland.; Oncopole Claudius Regaud, Institut Universitaire du Cancer-Toulouse, Toulouse, France.; PHASTAR, London, UK.","Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: moliveira@vhio.net."
39214078,Load Distribution After Serial Resection of the Posterior Horn of the Lateral Meniscus and Subsequent Meniscal Allograft Transplant: A Biomechanical Study.,2024-01-01,Ambra LF; Mestriner AB; Mameri ES; Gomoll AH,"Departamento de Ortopedia e Traumatologia, Escola Paulista de Medicina (EPM - UNIFESP), Sao Paulo, Brazil.; Instituto Brasil de Tecnologia da Saude (IBTS), Rio de Janeiro, Brazil.",Not available
39213421,Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial.,2024-11-26,Hacohen-Kleiman G; Huo Y; Su-Feher L; Renard C,"Gilead Sciences, Inc, Foster City, CA.",Not available
39213129,Where Are Patients' Voices in Chronic Kidney Disease?,2024-11-01,Macari S,Kansas.,Not available
39213084,First Biodistribution Study of [68Ga]Ga-NOTA-Insulin Following Intranasal Administration in Adult Vervet Monkeys.,2024-01-01,Cazzola C; Gandhi R; Suman J,"Aptar Pharma, Le Vaudreuil, France.; Aptar Pharmaceuticals, Congers, NY, USA.",Not available
39212270,Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial.,2024-09-24,Danguy des Deserts M; Girardot T,"Hopital Saint Philibert-Groupement des Hopitaux de l'Institut Catholique de Lille, Lille, France.; Universite de Bordeaux, CNRS, Inserm, Immuno ConcEpT, UMR 5164, Bordeaux, France.",Not available
39212197,A surge in endogenous spermidine is essential for rapamycin-induced autophagy and longevity.,2024-01-01,Daskalaki I; Tavernarakis N; Madeo F,"BioTechMed-Graz, Graz, Austria.",Not available
39210913,Polypharmacy and Guideline-Directed Medical Therapy Initiation Among Adults Hospitalized With Heart Failure.,2024-01-01,Musse M,"Program for the Care and Study of the Aging Heart, Weill Cornell Medicine, New York, New York, USA.",Not available
39209782,Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study.,2024-08-29,Santoro A; Szpakowski S; Gutzwiller S; Pastore A,"Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia IRCCS, Milan, Italy.; Larkspur Biosciences, Washington, District of Columbia, USA.; Novartis Pharma AG, Basel, Switzerland.","Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan cclin1@ntu.edu.tw."
39209474,Pathology and pathobiology of pulmonary hypertension: current insights and future directions.,2024-01-01,Guignabert C,"Universite Paris-Saclay, Hypertension Pulmonaire: Physiopathology and Innovation Therapeutique, HPPIT, Faculte de Medecine, Le Kremlin-Bicetre, France.",Not available
39209470,The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona.,2024-01-01,McLaughlin VV,"Universite Paris-Saclay, Faculte de Medecine, Inserm UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, Hopital Bicetre (Assistance Publique - Hopitaux de Paris), ERN-LUNG, Le Kremlin-Bicetre, France.","Universite Paris-Saclay, Faculte de Medecine, Inserm UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, Hopital Bicetre (Assistance Publique - Hopitaux de Paris), ERN-LUNG, Le Kremlin-Bicetre, France marc.humbert@aphp.fr."
39209369,Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis.,2024-08-28,Kumke T; Bauer L; de Peyrecave N; Kim M; Van den Bosch F,"UCB Pharma, Atlanta, Georgia, USA.; UCB Pharma, Brussels, Belgium.; UCB Pharma, Monheim, Germany.; UCB Pharma, Slough, UK.","University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany MARTIN.RUDWALEIT@KLINIKUMBIELEFELD.DE."
39208985,A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement.,2024-01-01,Pan A; Zhan T; Drogaris L; Douglas K; St John G; Espaillat R,"AbbVie, Inc., North Chicago, Illinois.","Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: lebwohl@aol.com."
39208496,Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: Findings from the REALISE study.,2024-01-01,Caetano C; Janssenswillen C; Moeller C; Schoof N,"Bayer AG, Berlin, Germany.; Bayer Consumer Care, Basel, Switzerland.","University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, United States. Electronic address: Sheryl.Kingsberg@UHhospitals.org."
39207667,Real-World Data on Brodalumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: An Observational Study from the Czech Republic BIOREP Registry.,2024-01-01,Turkova B; Dolezal T; Apol ED,"LEO Pharma A/S, Ballerup, Denmark.; Value Outcomes, Prague, Czech Republic.","Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic. martina.kojanova@vfn.cz."
39207468,[Androgen deprivation as initial and backbone therapy for prostate carcinoma cancer : A retrospective data analysis from urological practices in Germany].,2024-01-01,Cornelius F; Fernandez Milano A,"IQVIA Commercial GmbH & Co. OHG, Frankfurt am Main, Deutschland.; TumorScout GmbH, Berlin, Deutschland.",Not available
39207314,"Author language and communication preferences, and familiarity with global publication guidelines, for English-language industry-sponsored publications in Asia-Pacific: insights from a cross-sectional survey.",2024-01-01,Carruthers A; Chung H,"Envision Pharma Group, Sydney, Australia.; Oxford PharmaGenesis, Melbourne, Australia.",Not available
39206792,Clopidogrel Versus Aspirin as Monotherapy Following Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Receiving a Drug-Eluting Stent: A Systematic Literature Review and Meta-Analysis.,2024-01-01,Stipek W; Khan I,"Sanofi, Bridgewater, New Jersey, USA.",Not available
39206549,Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial.,2024-12-03,Silvain J,"Sorbonne Universite, ACTION Study Group, INSERM UMRS1166, Institut de Cardiologie Hopital Pitie-Salpetriere (AP-HP), Paris, France (J.S.).",Not available
39206547,Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.,2024-01-01,O'Connor CM,"Bayer AG, Wuppertal, Germany (L.R.).",Not available
39206370,ProcCluster((R)) and procaine hydrochloride inhibit the replication of influenza A virus in vitro.,2024-01-01,Engert B,"inflamed pharma GmbH, Jena, Germany.",Not available
39205651,Population pharmacokinetics of oral fosfomycin calcium in healthy women.,2024-11-04,Alarcia-Lacalle A; Del Pozo-Rodriguez A; Cabero M; Rodriguez-Gascon A,"Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, Vitoria-Gasteiz 01009, Spain.",Not available
39205396,"Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysis.",2024-08-28,Kleophas W,"MVZ DaVita Rhein-Ruhr GmbH, Duesseldorf, Germany.",Not available
39204421,Recent Review on Biological Barriers and Host-Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies.,2024-08-16,Salave S,"Formulation R&D, Alpha Pharma, KAEC, Rabigh 23994, Saudi Arabia.",Not available
39204347,Hydrogen Bonding in Amorphous Indomethacin.,2024-07-29,Byrn SR,"Improved Pharma, West Lafayette, IN 47906, USA.",Not available
39204102,Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer's Disease.,2024-07-28,Forsell P; Nilsson B; Nordvall G; Segerdahl M,"AlzeCure Pharma AB, Halsovagen 7, 141 57 Huddinge, Sweden.",Not available
39204076,"Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374.",2024-08-12,Groth M; Winkelmann VE,"Novartis Pharma GmbH, 90429 Nuremberg, Germany.",Not available
39204043,Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac.,2024-08-15,Diaz-Dinamarca DA; Cardenas-Caceres S; Muena NA; Diaz P; Barra G; Puentes R; Escobar DF; Diaz-Samirin M; Santis-Alay NT; Canales C; Diaz J; Garcia-Escorza HE; Vasquez AE,"Departamento Agencia Nacional de Dispositivos Medicos, Innovacion y Desarrollo, Instituto de Salud Publica de Chile, Santiago 7780050, Chile.; Instituto de Salud Publica de Chile, Santiago 7780050, Chile.; Laboratorio de Virologia Molecular, Centro Ciencia & Vida, Fundacion Ciencia & Vida, Santiago 8581151, Chile.; Subdepartamento Innovacion y Desarrollo, Departamento Agencia Nacional de Dispositivos Medicos, Innovacion y Desarrollo, Instituto de Salud Publica de Chile, Santiago 7780050, Chile.",Not available
39203967,Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results.,2024-07-25,Arana-Arri E; Molto J; Boreika R; Natalini Martinez S,"Centro de Investigacion Biomedica en Red-Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Unidad de Coordinacion Cientifica, Biocruces Bizkaia, Osakidetza, 48903 Barakaldo, Spain.",Not available
39203805,Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis.,2024-08-13,Subotic A; Verstockt B,"NovelYeast bv, Bio-Incubator BIO4, Gaston Geenslaan 3, Leuven-Heverlee, 3001 Leuven, Belgium.",Not available
39202308,"Line-Field Confocal Optical Coherence Tomography: A New Skin Imaging Technique Reproducing a ""Virtual Biopsy"" with Evolving Clinical Applications in Dermatology.",2024-08-21,Cappilli S; Di Stefani A; Pellegrino L; Ricci C; Verzi AE,"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, 00168 Rome, Italy.",Not available
39202045,RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists.,2024-08-12,Barberi S,"Registro Italiano Allergen Immunotherapy (RIAIT), Via San Gregorio 12, 20124 Milan, Italy.",Not available
39201581,Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease.,2024-08-15,Bagrov AY,"Padakonn Pharma, Puskini 9, 20309 Narva, Estonia.",Not available
39198468,A qualitative exploration of the patient journey in axial spondyloarthritis towards a people-centered understanding.,2024-08-28,Welcker M,"Medizinisches Versorgungszentrum fur Rheumatologie Dr. M. Welcker GmbH, Planegg, Germany.",Not available
39198374,Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding.,2025-01-01,Farrar M; Hepp Z; Mucha L,"Astellas Pharma, Inc, Northbrook, IL, USA.; Pfizer Inc, Bothell, WA, USA.",Not available
39197814,Phosphodiesterase 4 is overexpressed in human keloids and its inhibition reduces fibroblast activation and skin fibrosis.,2024-10-01,Tenor H,"Topadur Pharma AG, Schlieren, Switzerland.","Pharmacy Unit, University General Hospital Consortium of Valencia, Spain. Electronic address: javier.milara-paya@uv.es."
39197535,TAAR1 and 5-HT(1B) receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid.,2024-01-01,Wang L; Clark EA; Hanratty L; Koblan KS; Foley A,"Berand Neuropharmacology, Ltd., Dublin, Ireland.; Sumitomo Pharma America, Inc., Marlborough, MA, USA.",Not available
39197510,Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate to Severe COPD.,2024-08-27,Rheault T; Rickard K,"Verona Pharma plc, Raleigh, NC.",Not available
39197499,Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: A population-based analysis.,2024-01-01,Soliman AM; Li C; Patel M; Unigwe I,"AbbVie Inc, North Chicago, Illinois.","Central Connecticut Dermatology, Cromwell, Connecticut. Electronic address: brucestrober30@me.com."
39197436,Effects of a pH-Regulating Emollient Cream in Mild Atopic Dermatitis Patients with Moderate Localized Lesions.,2024-01-01,Ng SP; Laing S,"Hyphens Pharma Pte Ltd, Singapore, Singapore.; SGS proderm GmbH, Schenefeld, Germany.",Not available
39197425,Rationale and Design of PURE: A Randomized Controlled Trial to Evaluate Peritoneal Ultrafiltration with PolyCore in Refractory Congestive Heart Failure.,2024-01-01,Pacileo G,"UOSD ""Scompenso Cardiaco"", Ospedale Monaldi AOS Dei Colli, Naples, Italy.",Not available
39197381,Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough.,2024-01-01,Domingo C; Davila I; Arismendi E; Gonzalez-Barcala FJ,"Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERES), Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, Pabellon 11. Planta 0, 28029, Madrid, Spain; Departamento de Medicina Respiratoria, Hospital Universitario de Santiago de Compostela, Rua da Choupana, A Coruna, S/n, 15706, Santiago de Compostela, Spain.; Departamento de Medicina, Universidad de Santiago de Compostela, Rua de San Francisco, A Coruna, s/n, 15782, Santiago de Compostela, Spain; Departamento de Medicina, Universitat Autonoma de Barcelona, Placa Civica, Bellaterra, 08193, Barcelona, Spain.; Facultad de Medicina, Universidad de Salamanca, C. Alfonso X El Sabio, S/n, 37007, Salamanca, Spain.; Grupo de Investigacion Traslacional en Enfermedades de Las Vias Aereas (TRIAD), Santiago de Compostela, Spain; IDIBAPS, Universitat de Barcelona, Gran Via de Les Corts Catalanes, 585, 08007, Barcelona, Spain.; Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Hospital Clinico, Edificio D, 1(a) Planta. Travesia da Choupana S/N, 15706, Santiago de Compostela, Spain; Servicio de Alergia, Hospital Universitario de Salamanca, Departamento de Ciencias Biomedicas y del Diagnostico, P. degrees  de San Vicente, 182, 37007, Salamanca, Spain; Servicio de Neumologia, Corporacio Sanitaria Parc Tauli, Parc Tauli, 1, Sabadell, 08208, Barcelona, Spain; Servicio de Neumologia, Hospital Clinic de Barcelona, C. de Villarroel, 170, L'Eixample, 08036, Barcelona, Spain",Not available
39197119,Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.,2024-01-01,Chen TC,"Genentech, Inc, South San Francisco, CA.",Not available
39195817,Effects of Synbiotic Administration on Gut Microbiome and Fecal Bile Acids in Dogs with Chronic Hepatobiliary Disease: A Randomized Case-Control Study.,2024-08-10,Bruni N; Olivero D,"Analysis Lab. BSA Scilvet, Via A. D'Aosta 7, 20129 Milan, Italy.; Candioli Pharma, Via Manzoni 2, 10092 Beinasco, Italy.",Not available
39195716,Bioelectroremediation of a Real Industrial Wastewater: The Role of Electroactive Biofilm and Planktonic Cells through Enzymatic Activities.,2024-08-20,Diaz LKC; Berna A; Boltes K,"Departamento de Quimica Analitica Quimica Fisica e Ingenieria Quimica, Campus Cientifico Tecnologico, Universidad de Alcala, Ctra. A-II km 33.6, 28871 Alcala de Henares, Madrid, Spain.; IMDEA Water, Avda. Punto Com, 2, 28805 Alcala de Henares, Madrid, Spain.",Not available
39193899,Blood-based multivariate methylation risk score for cognitive impairment and dementia.,2024-01-01,Lleo A,"Neuroscience Therapeutic Area, GlaxoSmithKline R&D, Stevenage, Hertfordshire, UK.",Not available
39193893,Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study.,2024-01-01,de Roeck E,"Neuroscience Therapeutic Area, GlaxoSmithKline R&D, Stevenage, Hertfordshire, UK.",Not available
39193419,Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?,2024-01-01,Trzaskoma B; Holden M,"Genentech, Inc., South San Francisco, CA, USA.",Not available
39193150,"Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO).",2024-01-01,Smith J; Gelfand JM,"Product Development Neuroscience, F. Hoffmann-La Roche Ltd., Basel, Switzerland.",Not available
39191170,Clinical and neuroradiological spectrum of biallelic variants in NOTCH3.,2024-01-01,Iruzubieta P; Ragno M; Zifarelli G; Bauer P,"CENTOGENE GmbH, Am Strande 7, 18055, Rostock, Germany.; CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carlos III (CIBER-CIBERNED-ISCIII), 28029, Madrid, Spain.; Department of Neurogenetics, UCL Institute of Neurology London Queen Square and National Hospital for Neurology and Neurosurgery, University College London, London, United Kingdom; Department of Neurology, Donostia University Hospital, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain; Pianeta Salute, Viale Assisi, 88, 63084, Villa Pigna, Ascoli Piceno, Italy.",Not available
39191129,Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls.,2024-01-01,Klein H; Horan WP,"Karuna Therapeutics, Boston, MA, USA.; WCG Endpoint Solutions, Cary, NC, USA.",Not available
39190688,Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system.,2024-01-01,Chang PS; Chen YC; Hua WK; Hsu JC; Tsai JC; Huang YW; Kao YH; Wu PH; Yang WC; Shen CN; Wen KK; Wu SC,"GenomeFrontier Therapeutics TW Co., Ltd., Taipei City, Taiwan (R.O.C.).; OBI Pharma, Inc., Taipei, Taiwan (R.O.C.).",Not available
39190534,Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.,2024-10-07,Wong P; Bucktrout S; Ibrahim R; Santulli-Marotto S,"Bristol Myers Squibb , New York, NY, USA. ROR: https://ror.org/00gtmwv55; Natera Inc. , Austin, TX, USA. ROR: https://ror.org/02anzyy56; Personalis Inc. , Fremont, CA, USA. ROR: https://ror.org/0303drj82",Not available
39190308,Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.,2024-08-01,Constantinovici N; Hlebec V,"Bayer Consumer Care AG, Basel, Switzerland.",Not available
39190241,Improving oxygenation in severe ARDS treated with VV-ECMO: comparative efficacy of moderate hypothermia and landiolol in a swine ARDS model.,2024-08-27,Kimmoun A; Levy B,"Universite de Lorraine, Ecole de Chirurgie, Nancy, France.",Not available
39189087,Comparison of the Effectiveness of Baloxavir and Oseltamivir in Outpatients With Influenza B.,2024-01-01,Mukae H,"Global Development Division, Shionogi & Co., Ltd., Tokyo, Japan.",Not available
39188969,A statistical-physics approach for codon usage optimisation.,2024-01-01,Adame-Perez S; Lampaya V; Larraga A; Alejo T; Martinez-Olivan J; Broset E; Bruscolini P,"Certest Pharma, Certest Biotec S.L, Poligono Industrial Rio Gallego II, Calle J, 1, San Mateo de Gallego, 50840, Spain.",Not available
39188872,Safety of intraoperative autologous plasma incubation of corneal grafts for reducing endothelial cell loss: a pilot study.,2024-01-01,Mercado C; Lopez-Rojas C; De La Sen-Corcuera B; Sabater AL,"Escuela Superior de Oftalmologia, Instituto Barraquer de America, Bogota, Colombia.",Not available
39188767,Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort.,2024-01-01,Hasegawa T; Praga M; Fernandez-Fernandez B,"Instituto de Investigacion 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.; RICORS2040 Madrid, Spain.",Not available
39187787,Monitoring the VDPV2 outbreak in Egypt during 2020-2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus.,2024-08-26,Shabana MR; Zaghloul AY; El Shaarawy TH,"WHO Regional Reference lab for Diagnosis of Poliovirus and Enteroviruses, VACSERA Dokki, Giza, Cairo, Egypt.",Not available
39187656,Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).,2024-01-01,Bandello F; Shanamugam M,"Illinois Retina Associates, Chicago, IL, USA.; Sierra Eye Associates, Reno, NV, USA.","Lotus Eye Hospital and Institute, Avinashi Road, Coimbatore, TN, India. drashish79@hotmail.com."
39187558,Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study.,2024-08-27,Grande E,"Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.","Medical Oncology Unit, Azienda Ospedaliero Universitaria Consorziale Policlinico Di Bari, Piazza Giulio Cesare 11, 70124, Bari, Italy. rizzo.mimma@gmail.com."
39186707,TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy.,2024-10-10,Loriot Y; Vance M; Zhou H; Grivas P,"Gilead Sciences, Inc, Parsippany, NJ.; Institut de Cancerologie Gustave Roussy, Universite Paris-Saclay, Villejuif, France.",Not available
39186452,"Treatment satisfaction, unmet needs, and new treatment expectations for vasomotor symptoms due to menopause: women's and physicians' opinions.",2024-09-01,Shiozawa A; Kim J; Wang Y; Yang H; Mancuso S,"Analysis Group, Inc., Boston, MA.; Astellas Pharma, Inc., Northbrook, IL.",Not available
39185917,Population screening for cirrhosis.,2024-09-01,Gines P,"Centro de Investigacion En Red de Enfermedades Hepaticas y Digestivas, Spain.",Not available
39184229,Optimization of wet granulation process for manufacturing Rivaroxban generic immediate-release tablets using PBPK modeling and simulations.,2024-01-01,Tanisha; Kannaiyan DC,"R&D, Alpha Pharma (Formerly Julphar Saudi Arabia), King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia.",Not available
39183946,The design of a sample rapid magnetic resonance imaging (MRI) acquisition protocol supporting assessment of multiple articular tissues and pathologies in knee osteoarthritis.,2024-01-01,Chaudhari AS,"Chondrometrics GmbH, Freilassing, Germany.",Not available
39183442,PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells.,2024-01-01,Fundel-Clemens K; Laemmle B,"Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
39183245,Removal of ceftriaxone and cefotaxime antibiotics from industrial wastewater via complexation with Cu(II).,2024-01-01,Galal MS,"Upper Egypt Pharmaceuticals (UP Pharma), Industrial Zone, Arab Al-Awamer, Assiut, Egypt.",Not available
39182825,Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction Trial.,2024-09-07,Blaustein RO,"Merck & Co., Inc., Whippany, New Jersey.",Not available
39182756,Preventative and curative treatment of venous thromboembolic disease in cancer patients.,2024-01-01,Bertoletti L; Girard P; Laporte S; Mahe I,"Departement de Pneumologie, Institut Mutualiste Montsouris, Paris, France; F-CRIN INNOVTE Network, Saint-Etienne, France. Electronic address: https://twitter.com/https://twitter.com/Philipp29279657.; INSERM UMR_S1140, Innovations Therapeutiques en Hemostase, Laboratoire de Chirurgie experimentale, Fondation Alain Carpentier, Paris, France. Electronic address: https://twitter.com/https://twitter.com/Isabellemahe1.; INSERM, CIC-1408, CHU Saint-Etienne, Hopital Nord, Saint-Etienne, France; SAINBIOSE U1059, Universite Jean Monnet, INSERM, Saint-Etienne, France; SAINBIOSE U1059, Universite Jean Monnet, INSERM, Saint-Etienne, France. Electronic address: https://twitter.com/https://twitter.com/LaurentBertole1.; Service de Medecine Vasculaire et Therapeutique, CHU Saint-Etienne, Hopital Nord, Saint-Etienne, France; Unite de Recherche Clinique, Innovation, Pharmacologie, CHU Saint-Etienne, Hopital Nord, Saint-Etienne, France. Electronic address: https://twitter.com/https://twitter.com/SilvyLaporte.","Department of Medicine, The Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Canada. Electronic address: mcarrier@toh.ca."
39181883,Applications of OPM-MEG for translational neuroscience: a perspective.,2024-08-24,Kuhn AA,"Physikalisch-Technische Bundesanstalt, Berlin, Germany.","Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat Berlin, and Berlin Institute of Health, Department of Child and Adolescent Psychiatry, 13353, Berlin, Germany. marion.brickwedde@charite.de."
39181163,Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus Aureus infections: In vitro and in vivo efficacy of a novel antibiotic.,2024-01-01,Gross B; Schubert S,"Max von Pettenkofer-Institut Munich fur Hygiene und Medizinische Mikrobiologie, Elisabeth-Winterhalter-Weg 6, 81377 Munich, DE, Germany.",Not available
39181153,X-linked hypophosphataemia.,2024-08-31,Kamenicky P; Linglart A,"Service d'Endocrinologie et du Diabete de l'Enfant, Hopital Bicetre, Assistance Publique-Hopitaux de Paris, Le Kremlin-Bicetre, France.; Universite Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Le Kremlin-Bicetre, France","Centre de Reference des Maladies du Metabolisme du Calcium et du Phosphate, Service d'Endocrinologie et des Maladies de la Reproduction, Hopital Bicetre, Assistance Publique-Hopitaux de Paris, Le Kremlin-Bicetre, France. Electronic address: peter.kamenicky@universite-paris-saclay.fr."
39180694,Improving hidradenitis suppurativa management: consensus statements from physicians and patients' perspectives.,2024-08-24,Nappi F; Pappagallo G,"AISI-Associazione Italiana Sostegno Idrosadenite, Viterbo, Italy.","Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Pace, 9, 20122, Milan, Italy. angelo.marzano@unimi.it."
39180217,The performance of AlphaMissense to identify genes influencing disease.,2024-10-10,Richards JB,"5 Prime Sciences Inc, Montreal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; Department of Human Genetics, McGill University, Montreal, QC, Canada; Department of Medicine, McGill University, Montreal, QC, Canada; Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada",Not available
39180054,User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study.,2024-08-23,Grehl T; Munch C,"Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany.","Department of Neurology, Center for ALS and Other Motor Neuron Disorders, Charite - Universitatsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. susanne.spittel@charite.de."
39179948,Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.,2024-01-01,Abe M; Hojo S; Nakanishi T,"Eisai Co., Ltd., Tokyo, Japan.","Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kizutsu@ncc.go.jp."
39179257,Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis.,2024-08-22,Miyazaki Y; Kawanishi M; Yamasaki H,"Taisho Pharmaceutical Co Ltd, Toshima-ku, Tokyo, Japan.",Not available
39179180,"Discovery of BI-9787, a potent zwitterionic ketohexokinase inhibitor with oral bioavailability.",2024-11-01,Heine N; Weber A; Pautsch A; Gottschling D; Bauer M; Ebenhoch R; Magarkar A; Nosse B,"Boehringer Ingelheim International GmbH, Business Development & Licensing, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Global Medicinal Chemistry, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany; Boehringer Ingelheim Pharma GmbH & Co. KG, Global Medicinal Chemistry, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany.",Not available
39178993,Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis.,2025-01-01,Chen Z; Zahn J; Rodriguez Marco A,"Regeneron Pharmaceuticals Inc, Tarrytown, NY.; Sanofi, Madrid, Spain.","Department of Dermatology, University of Rochester Medical Center, Rochester, NY. Electronic address: lisa_beck@urmc.rochester.edu."
39177967,"Targeted Therapies, Novel Antibodies, and Immunotherapies in Advanced Non-Small Cell Lung Cancer: Clinical Evidence and Drug Approval Patterns.",2024-11-01,Hartmann M; Shah I,"EMD Serono, Billerica, Massachusetts.; Ecc-Oncology, Trier, Germany.",Not available
39177931,SGLT2 inhibition improves PI3Kalpha inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials.,2024-01-01,Reyes-Cosmelli F; Airoldi M; Fein L; Ghaznawi F; Pantoja K; Schnell C; Akdere M; Chia S,"Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Turin, Italy.; BC Cancer, Vancouver, BC, Canada.; Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile.; Instituto de Oncologia de Rosario, Santa Fe, Argentina.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Hospital Universitario Virgen del Rocio de Sevilla, Seville, Spain. ruizsabater@gmail.com."
39177870,"Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis.",2024-01-01,Liu Y; Teneralli RE,"Janssen Global Services, LLC, Horsham/Malvern, 200 Great Valley Pkwy, Malvern, PA, USA.",Not available
39177285,"ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.",2024-09-01,Sommerhalder D; Tolcher AW; Ueno NT; Xu R; Wang J; Barkund SR; Zhou H; Pankov A; Kong W; Jahchan NS; Jackson EL; Sun JD; Junttila MR; Multani PS; Daemen A; Chow Maneval E; Munster PN,"NEXT Oncology, San Antonio, Texas.; ORIC Pharmaceuticals, South San Francisco, California.",Not available
39176980,Italian report on RARE epilepsies (i-RARE): A consensus on multidisciplinarity.,2024-01-01,Macari F; di Bonaventura C; Balestrini S; Pruna D,"Alleanza Epilessie Rare e Complesse, Italy.; Associazione Famiglie LGS Italia, Correggio, Italy.; Associazione Sclerosi Tuberosa, Rome, Italy.; Epag ERN EpiCare, Verona, Italy.",Not available
39176173,Construction of a T (m)-value prediction model and molecular dynamics study of AmNA-containing gapmer antisense oligonucleotide.,2024-09-10,Kasahara Y,"Mitsubishi Tanabe Pharma Corporation, Yokohama 227-0033, Japan.",Not available
39175454,The Disease Burdens of Self-diagnosed Hidradenitis Suppurativa Patients in Japan: A Cross-sectional Web-based Survey.,2024-08-23,Okazaki M; Morita K,"AbbVie GK, Tokyo, Japan.","Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan. hayama.koremasa@nihon-u.ac.jp."
39175365,Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study.,2024-01-01,Fanning KM; Lipton RB,"AbbVie, North Chicago, IL, USA.",Not available
39175217,"Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers.",2024-01-01,Diefenbach C; Eleftheraki A,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39174806,Mass Balance in Pharmaceutical Stress Testing: A Review of Principles and Practical Applications.,2024-08-22,Coelho R; Foti C; Huang Z; Ultramari M; Baertschi SW,"Analytical Development and Operations, Gilead Sciences Inc., Foster City, California, USA.; Baertschi Consulting LLC, Carmel, Indiana, USA.; Drug Product Development, Bristol-Myers Squibb Co., New Brunswick, New Jersey, USA.; Regulatory Affairs, Eurofarma Laboratorios SA, Itapevi, Sao Paulo, Brazil.; Spektra Solucoes Cientifico-Regulatorias Ltda, Sao Paulo, Brazil.","Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Astrazeneca, Boston, 35 Gatehouse Dr., Waltham, Massachusetts, 02451, USA. stacey.marden@astrazeneca.com."
39174284,"Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.",2024-11-21,Moiseenko A; Davies JC; Gill DR; Hyde SC; Alton EWFW,"Boehringer Ingelheim Pharma GmbH, Biberach an der Riss, Germany.; ProtaGene CGT (former GeneWerk GmbH), Heidelberg, Germany.",Not available
39173604,The Lived Experience of Patients with Chronic Kidney Disease: Insights From DISCOVER CKD.,2024-01-01,Linder A,"Calibrations Counseling & Consultation, Akron, Ohio, USA.",Not available
39173598,"Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial.",2024-01-01,Villoria A,"Corporacion sanitaria Parc Tauli, Sabadell, Spain.",Not available
39173102,Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases.,2024-09-24,Schoenmakers DH; van den Berg S; Timmers L; Adang LA; Baumer T; Bosch A; van de Casteele M; Datema MR; Dekker H; Donnelly C; Driessens MHE; Graessner H; Greger V; Haddad T; Hoglinger GU; van den Hout H; Jonker C; Langeveld M; Lambert LJ; Neacy E; Nieuwland M; Klockgether T; van der Knaap MS; Papadopoulou A; Plueschke K; van Rijn S; Rosenberg N; Saunier-Vivar EF; Dos Santos Vieira B; Hollak CEM; Goettsch WG; Wolf NI,"Amsterdam Leukodystrophy Center (D.H.S., M.S.v.d.K., N.I.W.), Amsterdam Neuroscience, Cellular & Molecular Mechanisms; CHDI Management, Inc. (E.N.), the company that manages the scientific activities of CHDI Foundation, Inc., New York, NY; Canadian Agency for Drugs and Health Technology Technologies Agendcy in Health (CADTH) (L.J.L.), Ottawa, Ontario, Canada; Centre for Rare Disease (H.G.), University Hospital Tubingen, Germany; Centre of Rare Diseases (T.B.), University Hospital Schleswig Holstein, Lubeck, Germany; Department of Endocrinology and Metabolism (M.L.), Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, University of Amsterdam, the Netherlands; Department of Endocrinology and Metabolism (S.v.d.B., A.B., M.R.D., N.R., C.E.M.H.), Amsterdam UMC location University of Amsterdam; Department of Integrative Neurophysiology (M.S.v.d.K.), Center for Neurogenomics and Cognitive Research, Vrije Universiteit, Amsterdam, the Netherlands; Department of Neurology (G.U.H.), LMU University Hospital, Ludwig-Maximilians-Universitat (LMU), Munich; Department of Neurology (T.K.), University of Bonn, Germany; Department of Pediatrics (H.v.d.H.), Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Sophia Children's Hospital, Rotterdam; Division of Child Neurology (L.A.A.), Children's Hospital of Philadelphia, PA; Division of Metabolic Diseases (A.B.), Department of Pediatrics, Emma Childrens' Hospital, Amsterdam UMC location University of Amsterdam, the Netherlands; European Commission (A.P.), Joint Research Centre (JRC), Ispra, Italy; European Leukodystrophies Association (E.F.S.-V.), Paris, France; European Medicines Agency (C.J., K.P.), Amsterdam; From the Department of Child Neurology (D.H.S., M.S.v.d.K., N.I.W.), Emma's Children's Hospital, Amsterdam UMC location Vrije Universiteit; German Center for Neurodegenerative Diseases e.V. (DZNE) (G.U.H., T.K.), Munich; Institute for Medical Genetics and Applied Genomics (H.G.), University of Tubingen; Institute of Systems Motor Science (T.B.), CBBM, Universitat of Lubeck; International Niemann-Pick Disease Registry (C.D.), Washington, Tyne & Wear, United Kingdom; Medical BioSciences Department (B.d.S.V.), Radboud University Medical Center, Nijmegen; Medicine for Society (D.H.S., S.v.d.B., N.R., C.E.M.H.), Platform at Amsterdam UMC location University of Amsterdam; Medicines Evaluation Board (C.J.), Utrecht; Munich Cluster for Systems Neurology (SyNergy) (G.U.H.), Germany; National Health Care Institute (M.N., W.G.G.), Diemen, the Netherlands; National Health Care Institute (Zorginstituut Nederland) (L.T.), Diemen, the Netherlands; National Health Care Institute RIZIV-INAMI (M.v.d.C.), Brussels, Belgium; Orphanet (T.H.), INSERM US14 Rare Disease Platform, Paris, France; Patient Advocate Organization 'Vereniging HCHWA-d' (HCHWA-D Association) (S.v.R.), the Netherlands; United for Metabolic Diseases (UMD) (H.D.), Amsterdam, the Netherlands; VKS (H.D.), Dutch Patient Organization for Metabolic Diseases, Zwolle; VSOP-Patient Alliance for Rare and Genetic Diseases (M.H.E.D.), Soest, the Netherlands; Yaya foundation for 4H Leukodystrophy (V.G.), Minneapolis, MN; and WHO Collaborating Centre for Pharmaceutical Policy and Regulation (W.G.G.), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, the Netherlands.",Not available
39173098,"Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase InhibitorResistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.",2024-01-01,de Marinis F; de la Mora Jimenez E; Luo Y; Chirovsky D; Pietanza MC; Bhagwati N,"Instituto Jalisciense de Cancerologia, Guadalajara, Mexico.; Istituto Europeo di Oncologia, IRCCS, Milan, Italy.; Merck & Co, Inc, Rahway, NJ.",Not available
39172981,COVID-19 vaccination during therapy in relation to COVID-19 death in CLL.,2024-10-22,Miller K,"Oncology R&D, AstraZeneca, South San Francisco, CA.",Not available
39172446,Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.,2024-08-22,Haberland C; Haseli Mashhadi N; Mellinger U; Parke S; Seitz C; Zuurman L,"Bayer AG, Berlin, Germany.; Bayer AG, Wuppertal, Germany.; Bayer CC AG, Basel, Switzerland.",Not available
39172167,Artificial intelligence-assisted volume isotropic simultaneous interleaved bright- and black-blood examination for brain metastases.,2024-08-22,Obara M,"Philips Japan Ltd., 2-13-37, Konan, Minato-ku, Tokyo, 108-8507, Japan.","Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. kikuchi.kazufumi.953@m.kyushu-u.ac.jp."
39171394,Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial.,2024-01-01,Ruschitzka F,"Universite Paris Cite, Inserm MASCOT, APHP, France (A.M.).",Not available
39169899,Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas.,2024-01-01,Adhikary S; Schweitzer C; Astrow SH; Bot A,"Capstan Therapeutics, San Diego, CA.; Chimeric Therapeutics, Carlton South, Vic., Australia.; Kite, A Gilead Company, Santa Monica, CA.",Not available
39169619,Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients.,2024-10-10,Hosoki K,"Department of Pediatrics, Hokkaido University Hospital, Sapporo 060-8648, Japan; DigitalX, Astellas Pharma, 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.",Not available
39169516,Survey on the knowledge and practices in anorexia of aging diagnosis and management in Japan.,2024-01-01,Wakabayashi H,"Society on Sarcopenia, Cachexia and Wasting Disorders, Lausanne, Switzerland.",Not available
39169098,Beta-adrenergic agonism protects mitochondrial metabolism in the pancreatectomised rat heart.,2024-08-21,Fosgerau K,"Ascendis Pharma A/S, Hellerup, Denmark.","Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK. rosstlindsay@gmail.com."
39168978,A class I PI3K signalling network regulates primary cilia disassembly in normal physiology and disease.,2024-08-21,Foukas LC; McDonald NQ; Vanhaesebroeck B,"Centro de Investigacion Biomedica En Red de Cancer (CIBERONC), 28029, Madrid, Spain.","Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK. s.conduit@ucl.ac.uk."
39168901,Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer.,2024-01-01,Spira A; Yan X; Neuteboom S; Chao R,"Mirati Therapeutics Inc., San Diego, CA, USA.; Virginia Cancer Specialists, Fairfax, VA, USA.",Not available
39168590,Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study.,2024-08-21,Labalette P; Bodaghi B,"CHRU Lille Pole Specialites Medicochirurgicales, Lille, France.; Hopital Universitaire Pitie Salpetriere, Paris, France.",Not available
39168375,Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice.,2024-01-01,Koh C; Heller T,"Liver Diseases Branch, NIDDK, NIH, USA.",Not available
39168166,"Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis.",2024-11-15,Grande I,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, (UB), c. Casanova, 143, 08036 Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain; Institute of Neurosciences (UBNeuro), Barcelona, Spain","Brain and Cognition Discovery Foundation, Toronto, Canada. Electronic address: hanny.le@mail.utoronto.ca."
39168093,HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES.,2024-08-20,Wozniak M; Zohren F; Sugg J; Haas GP,"Astellas Pharma Inc., Northbrook, IL, USA.; Pfizer Inc., San Diego, CA, USA.","Desai Sethi Urology Institute and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: nimasharifi@miami.edu."
39168020,"Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.",2024-01-01,Bodro M; Cantisan S; Carratala J; Caston JJ; Cordero E; Farinas MC; Fernandez-Ruiz M; Fortun J; Len O; Lopez-Medrano F; Marcos MA; Martin-Davila P; Monforte V; Munoz P; Navarro D; Perez AB; Redondo N; Rodriguez-Goncer I; San-Juan R; Sanchez-Cespedes J; Valerio M; Vidal E; Aguado JM,"CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Departament of Medicine, Faculty of Medicine, Universidad de Sevilla, Spain.; Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Maranon, Instituto de Investigacion Sanitario Gregorio Maranon, Departamento de Medicina, Universidad Complutense, Madrid, Spain.; Department of Clinical Microbiology, Hospital Clinic, University of Barcelona, ISGlobal Barcelona Institute for Global Health, Barcelona, Spain.; Department of Infectious Diseases, Bellvitge University Hospital-IDIBELL, University of Barcelona, Spain.; Department of Infectious Diseases, Hospital Clinic-IDIBAPS, University of Barcelona, Spain.; Department of Infectious Diseases, Hospital Universitario Marques de Valdecilla-IDIVAL, Universidad de Cantabria, Santander, Spain.; Department of Infectious Diseases, Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron University Hospital, Barcelona, Spain.; Lung Transplant Program, Department of Pulmonology, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Department of Microbiology School of Medicine, University of Valencia, Spain.; Microbiology Unit, Hospital Universitario Reina Sofia-Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain.; Service of Infectious Diseases, Ramon y Cajal University Hospital, IRYCIS, Madrid, Spain.; Service of Infectious Diseases, Reina Sofia University Hospital. Maimonides Institute for Biomedical Research (IMIBIC), University of Cordoba, Cordoba, Spain; Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocio University Hospital, Junta de Andalucia, CSIC, Universidad de Sevilla, Sevilla, Spain; Unit of Infectious Diseases, Microbiology and Parasitology, Instituto de Biomedicina de Sevilla (IBiS), Virgen del Rocio University Hospital, Junta de Andalucia, CSIC, Universidad de Sevilla, Sevilla, Spain.; Unit of Infectious Diseases, University Hospital ""12 de Octubre"", Instituto de Investigacion Hospital ""12 de Octubre"" (i+12), School of Medicine, Universidad Complutense, Madrid, Spain.",Not available
39167622,A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies.,2024-11-01,Desai P; Flinn I,"Tennessee Oncology, Nashville, Tennessee.; Weill Cornell Medicine, New York, New York.",Not available
39167621,KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.,2024-10-15,Santagata S; Trotta AM; D'Alterio C; Napolitano M; Rea G; Di Napoli M; Portella L; Ierano C; Guardascione G; Coppola E; Feroce F; Chiodini P; Pignata S,"Microenvironment Molecular Targets, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.; Uro-Gynecological Oncology, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.",Not available
39167601,Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity.,2024-08-27,Honda H,"KOTAI Biotechnologies, Inc., Osaka 565-0871, Japan.",Not available
39167366,Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial.,2024-10-01,Zhang X; Franchimont N; Gangolli EA; Srivastava B,"Nimbus Discovery Inc, Boston, Massachusetts.",Not available
39167348,Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance.,2024-01-01,Takenaka R; Kobayashi M; Ito A; Sakai M,"AbbVie GK, Tokyo, Japan.","Department of Hematology, Kansai Medical University Hospital, 2-3-1 Shinmachi, Hirakata City, Osaka, Japan. itot@hirakata.kmu.ac.jp."
39167332,Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis.,2024-01-01,Hauber B; Hong A; Hunsche E; Maculaitis MC,"Oracle Life Sciences, Austin, TX, USA.; Pfizer Inc., New York, NY, USA.; Sumitomo Pharma Switzerland GmbH, Basel, Switzerland.",Not available
39166972,Deep Learning-based Unsupervised Domain Adaptation via a Unified Model for Prostate Lesion Detection Using Multisite Biparametric MRI Datasets.,2024-01-01,Li H; Liu H; von Busch H; Grimm R; Huisman H; Tong A; Winkel D; Penzkofer T; Shabunin I; Choi MH; Yang Q; Szolar D; Shea S; Coakley F; Harisinghani M; Oguz I; Comaniciu D; Kamen A; Lou B,"Charite, Universitatsmedizin Berlin, Berlin, Germany (T.P.); Department of Diagnostic Radiology, Oregon Health and Science University School of Medicine, Portland, Ore (F.C.); Department of Radiology, Changhai Hospital of Shanghai, Shanghai, China (Q.Y.); Department of Radiology, Loyola University Medical Center, Maywood, Ill (S.S.); Diagnostic Imaging, Siemens Healthineers, Erlangen, Bavaria, Germany (H.v.B., R.G.); Diagnostikum Graz Sud-West, Graz, Austria (D.S.); Eunpyeong St. Mary's Hospital, Catholic University of Korea, Seoul, Republic of Korea (M.H.C.); From Digital Technology and Innovation, Siemens Healthineers, 755 College Rd E, Princeton, NJ 08540 (H. Li, H. Liu, D.C., A.K., B.L.); New York University, New York, NY (A.T.); Patero Clinic, Moscow, Russia (I.S.); Radboud University Medical Center, Nijmegen, the Netherlands (H.H.); Universitatsspital Basel, Basel, Switzerland (D.W.); Vanderbilt University, Nashville, Tenn (H. Li, H. Liu, I.O.); and Massachusetts General Hospital, Boston, Mass (M.H.).",Not available
39166791,CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease.,2024-01-01,Lizama BN; Williams C; North HA; Pandey K; Di Caro V,"Cognition Therapeutics, Pittsburgh, Pennsylvania, USA.; Emtherapro Inc, Systems Biology, Atlanta, Georgia, USA.",Not available
39166460,Testing for similarity of multivariate mixed outcomes using generalized joint regression models with application to efficacy-toxicity responses.,2024-07-01,Mollenhoff K,"Statistical Methodology, Novartis Pharma AG, Basel, 4056, Switzerland.",Not available
39165367,Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies.,2024-01-01,Gupta PK; Toyos M; Higgins D,"Lusk Eye Specialists, Shreveport, LA, USA.; Triangle Eye Consultants, Raleigh, NC, USA.; Virginia Eye Consultants, Norfolk, VA, USA.",Not available
39164995,Plasma monomeric ApoA1 and high-density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapy.,2024-01-01,Niesor EJ; Perez A; Bordat C,"Hartis Pharma SA, Nyon, Switzerland.",Not available
39164816,Genomic correlates of the response to first-line PD-1 blockade plus chemotherapy in patients with advanced non-small-cell lung cancer.,2024-08-21,Yang Y; Zhang J; Sun H; Zhang H,"Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu 214104, China.",Not available
39164557,Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.,2024-01-01,Fonseca MM; Castilla-Fernandez G; Holenz J; Rocha JF; Rascol O,"BIAL - Portela and Ca S.A., Coronado, Portugal.; BIAL - R&D Investments, S.A., Coronado, Portugal.","IMM - Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. jferreira@medicina.ulisboa.pt."
39164292,"Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.",2024-08-20,Castro M; Farooqui N; Lugogo NL; Brown R; Li T,"Allergy Partners of Fishers, Indianapolis, IN, USA.; Incyte Corporation, Newark, DE, USA.; Teva Branded Pharmaceutical Products R&D Inc., West Chester, PA, USA.; Teva Pharmaceutical Industries Ltd, Tel Aviv, Israel.; Teva Pharmaceuticals Europe B.V., Amsterdam, Netherlands.","General Practitioner, London, UK. bigcatdoc@gmail.com."
39164067,Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial.,2024-10-21,Wang R; Brunori M; Klyachkin Y; Deignan C; Mease PJ,"Amgen Inc, Thousand Oaks, California, USA.","INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, Sorbonne Universite, Paris, France laure.gossec@aphp.fr."
39163787,New functional dissociations between prefrontal and parietal cortex during task switching: A combined fMRI and TMS study.,2024-01-01,Viejo-Sobera R; Redolar-Ripoll D; Munoz Marron E,"Brain360 Neuroscience Institute, Barcelona, Spain.; Cognitive NeuroLab, Universitat Oberta de Catalunya, Barcelona, Spain; Cognitive NeuroLab, Universitat Oberta de Catalunya, Barcelona, Spain.","Department of Experimental Psychology, Complutense University of Madrid, Spain. Electronic address: japerian@ucm.es."
39163735,Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates.,2024-09-02,Woollam GR,"Novartis Pharma AG, Postfach, Basel 4002, Switzerland.",Not available
39163550,An evaluation of the best practices and barriers for the Nagasaki acute myocardial infarction secondary prevention clinical pathway.,2024-01-01,Yamanaka Y; Uda A; Mori K,"HEOR Group, Value and Access Division, Novartis Pharma K.K, Tokyo, Japan.",Not available
39163092,Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer.,2025-01-06,Lanickova T; Kasikova L; Vosahlikova S; Angelidou A; Pasulka J; Griebler H; Drozenova J; Vankerckhoven A; Laco J,"Sotio Biotech, Prague, Czech Republic.",Not available
39162764,Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Cross-Sectional Survey of Dermatologists Within the Asia-Pacific Region.,2024-01-01,Liao HF,"Pfizer Ltd, Taipei, Taiwan.",Not available
39162634,Quantitative (68)Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following (177)Lu-PSMA-617 (VISION Trial).,2024-01-01,Kuo PH; Morris MJ; Hesterman J; Kendi AT; Rahbar K; Wei XX; Fang B; Adra N; Garje R; Michalski JM; Chi K; de Bono J; Fizazi K; Krause B; Sartor O; Tagawa ST; Ghebremariam S; Brackman M; Wong CC; Catafau AM; Benson T; Armstrong AJ; Herrmann K,"Astera Cancer Care, East Brunswick, NJ (B.F.); British Columbia Cancer Agency, Vancouver, British Columbia, Canada (K.C.); Dana-Farber Cancer Institute, Boston, Mass (X.X.W.); Department of Nuclear Medicine, University Hospital Munster, Munster, Germany (K.R.); Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC (A.J.A.); From the University of Arizona, Tucson, Ariz (P.H.K.); Gustave Roussy Institute, University of Paris-Saclay, Villejuif, France (K.F.); Indiana University Simon Comprehensive Cancer Center, Indianapolis, Ind (N.A.); Invicro, Needham, Mass (J.H.); Mayo Clinic, Rochester, Minn (A.T.K., O.S.); Memorial Sloan-Kettering Cancer Center, New York, NY (M.J.M.); Miami Cancer Institute, Baptist Health South Florida, Miami, Fla (R.G.); Novartis Pharmaceuticals, Cambridge, Mass (C.C.W.); Novartis Pharmaceuticals, East Hanover, NJ (S.G.); Novartis Pharmaceuticals, Geneva, Switzerland (A.M.C.); Novartis Pharmaceuticals, Indianapolis, Ind (M.B.); Novartis Pharmaceuticals, St. George, Utah (T.B.); Rostock University Medical Center, Rostock, Germany (B.K.); The Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom (J.d.B.); Washington University, St. Louis, Mo (J.M.M.); Weill Cornell Medicine, New York, NY (S.T.T.); West German Cancer Center, Munster and Essen, Germany (K.R.); and University Hospital Essen and German Cancer Consortium, Hufelandstr. 55, 45147 Essen, Germany (K.H.).",Not available
39162434,"CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.",2024-09-17,Genin H; Gallois-Montbrun S; Sams A; Rosenberg AR; Dubuisson J; Terrier B; Bomsel M; Ganor Y,"Epoqe Pharma, Copenhagen, Denmark.; Service of Virology, AP-HP Hopital Cochin, Paris, France.; Universite Paris Cite, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.",Not available
39162127,Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancer.,2024-01-01,Xie B; Young C; Ramaswamy K; El-Chaar N; Gao W; Yang H; Wang Y; Mucha L,"Analysis Group, Boston, Massachusetts, USA.; Astellas Pharma Inc., Northbrook, Illinois, USA.; Pfizer Inc., New York, New York, USA.",Not available
39161543,"Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial.",2024-01-01,Westin JR,"BostonGene, Waltham, MA, USA.",Not available
39160886,Antiviral Efficacy Testing of a Rechargeable Textile.,2024-08-19,Izadjoo M; Carhart K; Marcel V; Izadjoo S; Swicegood F; Merritt C; Clarke G,"Integrated Pharma Services, Rockville, MD 20850, USA.; UMF Corporation, Skokie, IL 60076, USA.",Not available
39160592,Inclusion of fibrinoid necrosis increases the accuracy of synovial tissue assessment in predicting response to methotrexate: analysis of the UCLouvain Brussels ERA Cohort.,2024-08-19,Natalucci F; Sokolova T; de Bellefon LM; Nzeusseu A; Galant C; Lauwerys B,"Cliniques Universitaires Saint-Luc - Universite catholique de Louvain (UCLouvain), Institut de Recherche Experimentale et Clinique (IREC), Rheumatology, Brussels, Belgium.",Not available
39160517,Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group.,2024-08-19,McElvaney NG,"Conresp, Loerzweiler, Germany.","Pneumology Department, Health Care Provider of the European Reference Network On Rare Respiratory Diseases (ERN LUNG), Hospital Universitari Vall d'Hebron/Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. marcm@separ.es."
39160255,Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.,2024-01-01,Orloff G; Niesvizky R; Donnelly A; Zaugg B; Toone M; McBride K,"InStat Services, Chatham, NJ, USA.; Precision for Medicine, Flemington, NJ, USA.; Virginia Cancer Specialists, Fairfax, VA, USA.; Weill Cornell Medicine, New York City, NY, USA.",Not available
39160089,'Gout was like the boss'. A qualitative study exploring the impact of gout on employment.,2024-08-19,Horne A,"EAP Encants, Institut Catala de la Salut, Barcelona, Catalunya, Spain.","Faculty of Medical and Health Sciences, Department of Medicine, The University of Auckland, Auckland, New Zealand cesardiaztorne@gmail.com."
39160000,Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users.,2024-01-01,Potz O; Damkier P,"Signatope GmbH, Reutlingen, Germany.",Not available
39159997,"Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study.",2024-10-21,Roth DA,"Biostatistics, GSK, Stevenage, UK.","Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA caranow@northwell.edu."
39159648,"Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial.",2024-01-01,Muller L,"Oncological Practice UnterEms, Leer, Germany.",Not available
39159624,Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.,2024-01-01,Metra M,"CSL Vifor, Redwood City, California, USA.",Not available
39158910,Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors.,2024-08-01,Camargo MC,"Centro de Investigacion Biomedica en Red Cancer, Valencia, Spain.",Not available
39158893,Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.,2024-10-01,Thome C; Kerschbaumer J,"Brain Implant Therapeutics (BIT) Pharma GmbH, Graz, Austria.",Not available
39158833,Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A.,2024-01-01,Kitagawa T; Takemura K; Miyaguchi Y; Nogami K,"Takeda Pharmaceutical Company Limited, Osaka, Japan.; Takeda Pharmaceutical Company Limited, Tokyo, Japan.","Department of Hematology, Niigata University Medical and Dental Hospital, Niigata, Japan. y-seki@med.niigata-u.ac.jp."
39158295,Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis.,2024-10-08,Tavakkol A,"Moberg Pharma AB, Bromma, Sweden.",Not available
39158261,"A Randomized, Parallel, Open-Label, Single-Dose and Multiple-Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China.",2024-08-19,Ditmarsch M; Kastelein JJP; Kling D; Hsieh A; Wuerdeman E; Davidson MH,"NewAmsterdam Pharma, Naarden, The Netherlands.",Not available
39157876,"Oxygen release from hemoglobin has limited effects on mitochondrial respiration measured from red blood cells. Reply to the Comment on ""Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress"".",2025-01-01,Esperti S; Roussel D,"Erytech Pharma, 69008 Lyon, France.; Laboratoire d'Ecologie des Hydrosystemes Naturels et Anthropises, CNRS UMR 5023 Universite Claude Bernard Lyon 1, Universite de Lyon, Lyon, France.; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, 79015 Paris, France; Laboratoire interuniversitaire de Biologie de la Motricite (LIBM) EA7424, Team << Vascular Biology and Red Blood Cell >> Universite Claude Bernard Lyon 1, Universite de Lyon, Lyon, France","Department of Biology, University of Turku, Turku, Finland. antoine.stier@iphc.cnrs.fr."
39157625,Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis.,2024-01-01,Hamer-Maansson JE; Yu J; Kalafut T; Braunstein E; Passamonti F,Incyte Corporation Wilmington Delaware USA.,Not available
39157330,Functional properties of starch cultivars of two Andean grains grown in Bolivia: Amaranth (Amaranthus caudatus) and canihua (Chenopodium pallidicaule).,2024-08-15,Merida-Lopez J; Rojas CC,"Centro de Alimentos y Productos Naturales, Universidad Mayor de San Simon, Cochabamba, Bolivia.",Not available
39157284,Metabolic Fingerprinting of Serum and Seminal Plasma of Testicular Cancer Patients Using Raman Spectroscopy: A Pilot Study.,2024-01-01,Ghods R,"LogixX Pharma, Theale, Berkshire, UK.",Not available
39155805,"SP-101, A Novel Adeno-Associated Virus Gene Therapy for the Treatment of Cystic Fibrosis, Mediates Functional Correction of Primary Human Airway Epithelia From Donors with Cystic Fibrosis.",2024-01-01,Excoffon KJDA; Lin S; Narayan PKL; Sitaraman S; Jimah AM; Fallon TT; James ML; Glatfelter MR; Limberis MP; Smith MD; Guffanti G; Kolbeck R,"Spirovant Sciences, Inc., Philadelphia, Pennsylvania, USA.; Sumitomo Pharma America, New York, New York, USA.",Not available
39155359,Pexidartinib Upfront in a Case of Tenosynovial Giant Cell Tumor: Proof of Concept for a Treatment Paradigm Shift.,2024-01-01,Peta G,"IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.","Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, 40136, Bologna, Italy. emanuela.palmerini@ior.it."
39154736,Biowaiver monograph for immediate-release solid oral dosage forms: Raltegravir potassium.,2024-01-01,Abrahamsson B; Parr A; Shah VP,"Bioceutics LCC, Raleigh-Durham, NC, USA.; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.; Pharmaceutical Consultant, North Potomac, MD, USA.","Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan. Electronic address: kambayashi@rs.tus.ac.jp."
39154302,Presurgical Use of Cenobamate for Adult and Pediatric Patients Referred for Epilepsy Surgery: Expert Panel Recommendations.,2024-01-01,Ferrari L,"SK Life Science, Inc., Paramus, NJ, USA.","Sutter Pacific Epilepsy Program, California Pacific Medical Center, 1100 Van Ness Ave, 6th floor, San Francisco, CA, 94109, USA. laxerkd@sutterhealth.org."
39153251,"Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: Unravelling complementary effects on acute myocardial infarction and metabolic syndrome.",2024-01-01,Tseti I,"Uni-Pharma S.A., Athens, Greece.",Not available
39153094,A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamide.,2024-01-01,Morita S; Kobayashi T,"Astellas Pharma Inc, 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, 103-8411, Japan.","Department of Urology, Japanese Red Cross Otsu Hospital, 1 Chome-1-35 Nagara, Otsu, Shiga, 520-0046, Japan. unity.tashiro@gmail.com."
39153060,Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial.,2024-01-01,Gorecki P; Gramiccia T; Jazra M; Buyze J; Conrad C,"Janssen-Cilag BV, Breda, The Netherlands.; Janssen-Cilag GmbH, Neuss, Germany.; Janssen-Cilag Ltd, High Wycombe, UK.; Janssen-Cilag SpA, Milan, Italy.; Janssen-Cilag, Paris, France.","Department of Dermatology, IIB Sant Pau, Hospital de Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain. LPuig@santpau.cat."
39153059,Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.,2024-01-01,Blauvelt A; Kaplan B; Koetse W; Ashley DG; Lippe R; Sinvhal R,"AbbVie Inc., North Chicago, IL, USA.; Blauvelt Consulting, LLC, Lake Oswego, OR, USA.","Department of Dermatology, Medical College of Wisconsin, 8701 Watertown Plank RD, TBRC C2010, Milwaukee, WI, 53226-3522, USA. gordon.kenneth@att.net."
39152986,Rapid Uptitration of Guideline-Directed Medical Therapies in Acute Heart Failure With and Without Atrial Fibrillation.,2024-01-01,Davison B; Gayat E; Mebazaa A; Cotter G,"Department of Anesthesiology and Critical Care and Burn Unit, Saint-Louis and Lariboisiere Hospitals, University Hospital Federation PROMICE (PRecision medicine for cOMprehensIve care of Critically ill patieEnts), Departments Medico-Universitaires Parabol, Assistance Public - Hopitaux de Paris, Paris, France.; Heart Initiative, Durham, North Carolina, USA; Momentum Research Inc, Durham, North Carolina, USA; Universite Paris Cite, INSERM UMR-S 942 (MASCOT), Paris, France.; Universite Paris Cite, INSERM UMR-S 942(MASCOT [Cardiovascular MArkers in Stressed COndiTions]), Paris, France.; Universite Paris Cite, INSERM UMR-S 942(MASCOT), Paris, France",Not available
39152532,"First-in-human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor.",2024-01-01,Tortorici MA; van Iersel MT; van Lier JJ; Djedjos S; Slingsby BT; Rodman DM,"ICON, Groningen, The Netherlands.; Mineralys Therapeutics, Radnor, Pennsylvania, USA.",Not available
39152181,Classification of melanocytic lesions using direct illumination multispectral imaging.,2024-08-16,Muhleisen B,"FotoFinder Systems GmbH, Bad Birnbach, Germany.",Not available
39152028,"Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.",2024-01-01,Thye D,"Quince Therapeutics, South San Francisco, CA, USA.",Not available
39151887,"Global burden of metabolic diseases, 1990-2021.",2024-01-01,Toro-Huamanchumo CJ; Sookoian S,"Clinical and Molecular Hepatology, Translational Health Research Center (CENITRES), Maimonides University, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Buenos Aires, Argentina; Faculty of Health Science, Maimonides University, Buenos Aires, Argentina; Nutrition and Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Western Australia, Australia.; OBEMET Center for Obesity and Metabolic Health, Lima, Peru; Universidad San Ignacio de Loyola, Lima, Peru",Not available
39151425,Long-distance microbial mechanisms impacting cancer immunosurveillance.,2024-09-10,Zitvogel L; Fidelle M,"Gustave Roussy Cancer Campus, Villejuif, France; Institut National de la Sante Et de la Recherche Medicale (INSERM) UMR 1015, ClinicObiome, Equipe Labellisee-Ligue Nationale contre le Cancer, Villejuif, France; Universite Paris-Saclay, Ile-de-France, France; Universite Paris-Saclay, Ile-de-France, France.","Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France. Electronic address: laurence.zitvogel@gustaveroussy.fr."
39151421,Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.,2024-08-15,Nick A; Coleman R,"Texas Oncology, Houston, TX, USA.","Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jahow@mdanderson.org."
39151277,Enrichment using speech latencies improves treatment effect size in a clinical trial of bipolar depression.,2024-01-01,Siegel JS; Szabo ST; Tomioka S; Opler M; Kirkpatrick B; Hopkins S,"Psychiatric Research Institute, University of Arkansas for Medical Sciences.; Quantic Innovation, Inc; Sumitomo Pharmaceuticals Inc; Sumitomo Pharmaceuticals Inc.; WCG, Inc.; Washington University in St. Louis, Department of Psychiatry.",Not available
39150711,Suvorexant for Reduction of Delirium in Older Adults After Hospitalization: A Randomized Clinical Trial.,2024-08-01,Takahashi K; Sato A; Shirakawa M; Herring WJ; Arano I,"MDS K.K. (Merck Sharp & Dohme LLC, a subsidiary of Merck & Co Inc), Tokyo Japan.; Merck & Co Inc, Rahway, New Jersey.",Not available
39150292,Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials.,2024-01-01,Murata R; Yamane S,"Japan Tobacco Inc., Tokyo, Japan.",Not available
39149980,Patterns of migraine medication use in Norway: A nationwide registry-based observational study.,2024-01-01,Oteiza F; Dueland AN; Bugge C; Saether EM; Stovner LJ,"Oslo Economics, Oslo, Norway.; Sandvika Nevrosenter, Oslo, Norway.",Not available
39149535,Comparative omics directed gene discovery and rewiring for normal temperature-adaptive red pigment synthesis by polar psychrotrophic fungus Geomyces sp. WNF-15A.,2024-01-01,Liu H; Zhou X,"China Resources Angde Biotech Pharma Co., Ltd., 78 E-jiao Street, Liaocheng, China.; China Resources Biopharmaceutical Co., Ltd., 1301-84 Sightseeing Road, Shenzhen, China.",Not available
39149468,Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial.,2024-08-05,Boissel N; Jacobs K,Mersana Therapeutics.; aphp hopital saint louis paris.,Not available
39149090,Long-term outcomes of patients with IgA nephropathy in the German CKD cohort.,2024-01-01,Mercer A; Seikrit C,"JAMCO Pharma Consulting, Stockholm, Sweden.; Travere Therapeutics, San Diego, CA, USA.",Not available
39148958,The Role of Coenzyme Q10 in Skin Aging and Opportunities for Topical Intervention: A Review.,2024-01-01,Lain ET; Agrawal N; Ruvolo E,"Dr. Lain is with Sanova Dermatology in Austin, Texas.; Messrs. Agrawal and Ruvolo are with Beiersdorf, Inc, IC in Florham Park, New Jersey.",Not available
39148579,American Society of Retina Specialists Artificial Intelligence Task Force Report.,2024-01-01,Kim JE; Modi Y,"Genentech/Roche, South San Francisco, CA, USA.; Retina Specialists of Michigan, Grand Rapids, MI, USA.",Not available
39148560,Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema.,2024-01-01,Kasper J,"Alimera Sciences, Alpharetta, GA, USA.",Not available
39148430,A growth-differentiation factor 15 receptor agonist in randomized placebo-controlled trials in healthy or obese persons.,2024-08-16,Kagan MR; Kompa J,"Novartis Pharmaceuticals Corporation, East Hanover, NJ  USA.",Not available
39147916,Autophagy in cancer resistance: New combinatorial strategy for cancer therapy.,2024-01-01,Bestion E,"Genoscience Pharma, Marseille, France.",Not available
39147519,Food-grade emulsion gels and oleogels prepared by all-natural dual nanofibril system from citrus fiber and glycyrrhizic acid.,2024-01-01,Fang S,"Sirio Pharma Co. Ltd., Shantou 515041, China.",Not available
39147409,Association of airway inflammation and smoking status with IL-33 level in sputum of patients with asthma or COPD.,2024-01-01,Pedersen F; Groth EE,Authors contributed equally to this work.,Not available
39147328,Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators of the glucagon subfamily of GPCRs.,2024-01-01,Ebenhoch R; Nar H; Weichert D,"Boehringer-Ingelheim Pharma, GmbH & Co KG, 88400 Biberach an der Riss, Germany.",Not available
39147327,IL-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma.,2024-01-01,Bick F; Bigirimana R; Vieira J; Blanchetot C,"Cancer Research Institute Ghent, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Laboratory of Immunoregulation and Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent, Belgium; argenx BV, Zwijnaarde, Belgium; argenx BV, Zwijnaarde, Belgium.",Not available
39147132,Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma.,2024-01-01,Walter A,"Service d'Hepatologie, Hopital Avicenne, Hopitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hopitaux de Paris, 125, rue de Stalingrad, 93000 Bobigny, France.","Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. Electronic address: sternlouisa@gmail.com."
39146951,"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.",2024-01-01,Grebennik D; Krepler C,"Merck, Rahway, NJ, USA.","European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. Electronic address: emanuel.buhrer@bluewin.ch."
39146931,Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling.,2024-09-05,Belfakir SB; Ross GMS; Lomonte B,"Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark; Instituto Clodomiro Picado, Facultad de Microbiologia, Universidad de Costa Rica, San Jose, Costa Rica.; VenomAid Diagnostics ApS, Lyngby, Denmark.",Not available
39146750,[Positioning therapy for intensive care patients].,2024-01-01,Hermes C; Schaller SJ,"Pflege und Management, Hochschule fur Angewandte Wissenschaften Hamburg, Hamburg, Deutschland.; Universitatsinstitut fur Pflegewissenschaft und -praxis, Paracelsus Medizinische Privatuniversitat, Salzburg, Osterreich.",Not available
39146670,"Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials.",2024-01-01,Oh M; Ganguli A; Chang L; Rhoten S; Bhattacharya P; Matsangou M; Park JW; Pophale R; Ranganath R,"Astellas Pharma Global Development, Inc., Northbrook. Electronic address: https://twitter.com/AstellasUS.; IQVIA, San Francisco, USA.",Not available
39145781,"A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis.",2024-01-01,Shimoda K,"PharmaEssentia USA, Burlington, MA, USA.","Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, 10021, USA. gfa2001@med.cornell.edu."
39145700,Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial.,2024-01-01,Lakdawala NK; Sinagra G; Ripoll-Vera T; Afshar K,"Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Centro de Investigacion en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Madrid, Spain.; Universidad Francisco de Vitoria (UFV), Madrid, Spain.",Not available
39144837,Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).,2024-01-01,Franke A,"GastroZentrum Netzer AG, Lindenhofspital, Bern, Switzerland.",Not available
39144585,The feasibility and effectiveness of remote cognitive training on cognitive function and work performance in workers.,2024-01-01,Masuda M,"Smart OHW Co., Ltd., Tokyo, Japan.",Not available
39144032,Effects of oral contrast agent on the viscoelastic properties of the terminal ileum investigated using magnetic resonance elastography.,2024-08-01,Neumann GM,"iPATH.Berlin-Immunopathology for Experimental Models, Core Facility, Charite - Universitatsmedizin Berlin, Berlin, Germany.",Not available
39143443,The effectiveness of coronary computed tomography angiography and functional testing for the diagnosis of obstructive coronary artery disease: results from the individual patient data Collaborative Meta-Analysis of Cardiac CT (COME-CCT).,2024-08-14,Andreini D; Pontone G,"Centro Cardiologico Monzino, IRCCS, Milan, Italy.",Not available
39143312,"Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases.",2024-01-01,Potluri R; Agarwal E; Cappelleri JC; Ling YL,"Pfizer Inc, Groton, CT, USA.; Pfizer Inc, New York, NY, USA.; Putnam Associates, New York, NY, USA.","Swedish Medical Center/Providence St Joseph Health and University of Washington, Seattle, WA, USA. pmease@philipmease.com."
39143103,Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids.,2024-08-14,Saugy D; Homicsko K; Lutolf MP,"DOPPL, Lausanne, Switzerland.; Molecular Partners AG, Zurich, Switzerland.; SUN bioscience, Lausanne, Switzerland.",Not available
39143082,Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer.,2024-08-14,Bonadio RC; de Sousa IM; Bines J; Ferreira RDP; Rosa DD; de Souza ZS; de Araujo JAP; Dos Anjos CH; Ferrari A; Cangussu R; Hoff PM; Barroso-Sousa R,"Grupo Brasileiro de Estudos em Cancer de Mama (GBECAM), Sao Paulo, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Recife, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, Brazil.",Not available
39142926,"Pharmacokinetics, Safety, Tolerability, and Exploratory Efficacy of Upadacitinib in Children with Severe Atopic Dermatitis.",2024-01-01,Raymundo EM; Hao S; Unnebrink K; Levy GF; Teixeira HD; Chu AD,"Data and Statistical Sciences, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.; Discovery and Exploratory Statistics, AbbVie, North Chicago, IL, USA.; Immunology Development, AbbVie, North Chicago, IL, USA.; Pharmacovigilance and Patient Safety, AbbVie, North Chicago, IL, USA.",Not available
39142727,Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay.,2024-08-20,Storvold GL; Broughton MN,"SpinChip Diagnostics, Oslo, Norway.","GREAT Network, Rome, Italy. Electronic address: luca.koechlin@usb.ch."
39142718,"Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab.",2024-08-13,Chandana S; Lakhani N; Enstrom A; LeBlanc H; Schmalz J; Thomas H; Chisamore MJ; Peng SL; Naumovski A,"Adaptive Biotechnologies Corp, Seattle, Washington, USA.; Alpine Immune Sciences Inc, Seattle, Washington, USA.; Merck & Co Inc, Rahway, New Jersey, USA.; START Midwest, Grand Rapids, Michigan, USA.","Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA ludi.cavalcante@gmail.com."
39142152,Oral formulations for highly lipophilic drugs: Impact of surface decoration on the efficacy of self-emulsifying drug delivery systems.,2025-01-01,Sandmeier M; Hoeng J; Skov Jensen S; Nykjaer Nikolajsen G; Ziegler Bruun H; Ricci F,"Department of Pharmaceutical Technology, University of Innsbruck, Institute of Pharmacy, Center for Chemistry and Biomedicine, 6020, Innsbruck, Austria; Fertin Pharma A/S, Dandyvej 19, 7100 Vejle, Denmark.; Thiomatrix Forschungs- und Beratungs GmbH, Trientlgasse 65, 6020 Innsbruck, Austria.; Vectura Fertin Pharma, Avenue de Rhodanie 50, 1007 Lausanne, Switzerland.",Not available
39141816,Targeting Tumor-Associated Macrophages with the Immune-Activating Nanomedicine for Achieving Strong Antitumor Activity with Rapid Clearance from the Body.,2024-08-27,Ban H,"Oncology, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan.",Not available
39141577,Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC.,2025-01-01,Peguero JA; Eggleton SP,"Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany.; Oncology Consultants, Houston, Texas, USA.",Not available
39141519,Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research.,2024-09-20,Bellina M; Fiore S; Bernet A; Mehlen P,"Apoptosis, Cancer and Development Laboratory - Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancerologie de Lyon (CRCL), INSERM U1052-CNRS UMR5286, Universite de Lyon, Universite Claude Bernard Lyon1, Centre Leon Berard, 69008 Lyon, France; Netris Pharma, 69008 Lyon. France.",Not available
39141364,Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial.,2024-10-01,Yu G; Liu C; Somani N; Ball S; Mesinkovska NA,"Eli Lilly and Company, Indianapolis, Indiana.; Tigermed-BDM Inc, Somerset, New Jersey.",Not available
39141064,Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.,2024-01-01,Witzel S,"Ambulanzpartner Soziotechnologie GmbH, 13353, Berlin, Germany.","Department of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany. maximilian.wiesenfarth@rku.de."
39140604,Dose escalation and associated economic outcomes in patients with psoriasis treated with biologics: a retrospective analysis of German health claims data.,2024-11-22,Soliman AM; Manz KC; Weber V; Mocek A; Hoer A; Richter SG,"AbbVie Inc, North Chicago, IL, USA.; IGES Institut GmbH, Berlin, Germany.",Not available
39138846,Principles for Defining Estimands in Clinical Trials-A Proposal.,2024-08-13,Mutze T; Englert S,"Statistical Methodology, Novartis Pharma AG, Basel, Switzerland.; Statistical Modeling and Methodology, Janssen-Cilag GmbH, Johnson & Johnson Company, Neuss, Germany.",Not available
39138765,"Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability.",2024-08-13,Zhuang K; Zhang J,"Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd., 866 Moganshan Road, Hangzhou, 310011, China.; Pharma Solutions, BASF Corp., 500 White Plains Rd, Tarrytown, NY, 10591, USA.",Not available
39138652,"Rasmussen's encephalitis: structural, functional, and clinical correlates of contralesional epileptiform activity.",2024-01-01,Weber B,"Amsterdam Neuroscience, Brain Imaging Amsterdam, Amsterdam, The Netherlands.",Not available
39138575,"Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States.",2024-08-13,Murray S; Del Fiacco R; Muehlenbein CE; Lazure P,"AXDEV Group Inc, Brossard, QC, Canada.; Eli Lilly and Company, Florence, Toscana, Italy.; Eli Lilly and Company, Indianapolis, IN, USA.","AXDEV Group Inc, Brossard, QC, Canada. peloquins@axdevgroup.com."
39137914,Interleukin-1 receptor-associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll-like receptors 4 and 7/8 in murine and human lungs.,2024-01-01,Kreideweiss S; Grundl MA; Bouyssou T; Thamm S; Kreuz S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39137882,RIPK3 and caspase-8 interpret cytokine signals to regulate ILC3 survival in the gut.,2024-01-01,Vivier E,"APHM, Marseille-Immunopole, University Hospital of Timone, Marseille, France.; Aix-Marseille University, Centre of National Scientific Research (CNRS), National Insititute of Health and Medical Research (INSERM), Centre of Immunology at Marseille-Luminy (CIML), Marseille, France; Innate Pharma, Marseille, France",Not available
39137558,Evaluating speech latencies during structured psychiatric interviews as an automated objective measure of psychomotor slowing.,2024-01-01,Opler M; Kirkpatrick B; Milanovic S; Piacentino D; Szabo ST; Tomioka S; Ogirala A; Koblan KS; Siegel JS; Hopkins S,"Psychiatric Research Institute, University of Arkansas for Medical Sciences, USA.; Quantic Innovation, Inc, USA; Sumitomo Pharmaceuticals Inc, USA; Sumitomo Pharmaceuticals Inc, USA.; WCG, Inc, USA.; Washington University in St. Louis, Department of Psychiatry, USA.","Quantic Innovation, Inc, USA. Electronic address: acohen@lsu.edu."
39137353,Classification of Cannabis Strains Based on their Chemical Fingerprint-A Broad Analysis of Chemovars in the German Market.,2024-08-13,Herwig N; Utgenannt S; Nickl F; Mobius P; Nowak L; Schulz O; Fischer M,"Schurer Pharma & Kosmetik GmbH, Leipzig, Germany.",Not available
39137167,Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).,2024-01-01,Nguyen C; Boutron I; Daste C; Berenbaum F,"INSERM UMR-S 1124, Toxicite Environnementale, Cibles Therapeutiques, Signalisation Cellulaire et Biomarqueurs (T3S), Campus Saint-Germain-des-Pres, Paris, France.; Universite Paris Cite, Faculte de Sante, UFR de Medecine, Paris, France.",Not available
39136801,Measuring treatment impacts on symptoms in adults with hypoparathyroidism: findings from the PaTHway trial.,2024-08-13,Pfeiffer KM; Beck JF; Smith A,"Ascendis Pharma, Inc., 1000 Page Mill Road, Palo Alto, CA, 94304, USA.; The Brod Group, 219 Julia Ave., Mill Valley, CA, 94941, USA.","The Brod Group, 219 Julia Ave., Mill Valley, CA, 94941, USA. mbrod@thebrodgroup.net."
39136550,Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies.,2024-10-15,North K; Richardson ET 3rd; DiLullo M,"NanoString Technologies, Inc., Seattle, Washington.",Not available
39135381,A comprehensive guide for secondary structure and tertiary structure determination in peptides and proteins by circular dichroism spectrometer.,2025-01-01,Vashi A; Subbappa PK,"Flamma USA LLC, Malvern, PA, USA.; Slayback Pharma LLC, Princeton, NJ, USA.",Not available
39135125,Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.,2024-08-12,Rose S; Clague GE; Oshinbolu S,"BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA.; Met Ed Consultants, Boulder, CO, USA.","BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA, 94949, USA. Kaleigh.Whitehall@bmrn.com."
39133921,Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine.,2024-11-21,Li X; Ku G; Liu Z; Sun Y; Potluri J; Dail M; Chyla B,"AbbVie Inc, North Chicago, IL.; Genentech Inc, South San Francisco, CA.",Not available
39133774,"Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).",2024-08-13,Bogin V; Lavrovsky Y,"Cromos Pharma, LLC, Portland, OR (V.B.).; R-Pharm Overseas Inc, La Jolla, CA (Y.L.).",Not available
39133752,The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.,2024-01-01,Gronchi A,"Fondazione IRCCS Istituto Nazionale Tumori, Sarcoma Surgery, Milan, Italy.",Not available
39133438,The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) scale in patients with axial spondyloarthritis: psychometric properties and clinically meaningful thresholds for interpretation.,2024-08-12,de la Loge C; Guo S; Ellis A; Fleurinck C; Massow U,"Evidera, Waltham, MA, USA.; PCOM Analytics, Avallon, France.; UCB Pharma, Brussels, Belgium.; UCB Pharma, Monheim, Germany.; UCB Pharma, Raleigh, NC, USA.","Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. axSpAFacit-Fatigue@costellomedical.com."
39133376,Real-Life Study on the Efficacy and Tolerance of a Preservative-Free Surfactant-Free Latanoprost Eye Drop in Patients with Glaucoma.,2024-01-01,Guerin C; Rebika H; Collignon N,"Laboratoires Horus Pharma, 22 Allee Camille Muffat, 06200, Nice, France.","Laboratoires Horus Pharma, 22 Allee Camille Muffat, 06200, Nice, France. laure.chauchat@horus-pharma.com."
39133176,International Headache Society global practice recommendations for the acute pharmacological treatment of migraine.,2024-01-01,Peres M; Pozo-Rosich P,"Instituto de Investigacion Medica Mercedes y Martin Ferreyra (INIMEC), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Universidad Nacional de Cordoba, Cordoba, Argentina.",Not available
39133115,Multimorbidities in COPD are Associated With Increased Exacerbations and Health Care Resource Utilization in Real-World Patients from a U.S. Database.,2024-09-27,Karcher H; Schoenberger M,"Novartis Pharma AG, Basel, Switzerland.",Not available
39132915,"Erenumab versus topiramate: migraine-related disability, impact and health-related quality of life.",2024-01-01,Hentschke C,"Novartis Pharma GmbH, Nuremberg, Germany.",Not available
39132891,A proof-of-concept rat toxicity study highlights the potential utility and challenges of virtual control groups.,2024-01-01,Andaya R; Sullivan R; Pourmohamad T; Maliver P; Laing S; Hasselgren C; Dybdal N; Adedeji AO,"Data and Statistical Sciences, Genentech Inc., South San Francisco, CA, USA.; Safety Assessment, Genentech Inc., South San Francisco, CA, USA.",Not available
39132840,"Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project.",2024-01-01,Kobayashi I,"New England Biolabs, Ipswich, MA, USA.",Not available
39132334,R(2)-CHA(2)DS(2)-VASc Score for Cardiovascular Event Prediction After Bioprosthetic Valve Replacement- Subanalysis From the BPV-AF Registry.,2024-08-09,Nawada R,"Division of Cardiology, Hirakata Kohsai Hospial Osaka Japan.",Not available
39132186,Identification of Fast Progressors Among Patients With Nonalcoholic Steatohepatitis Using Machine Learning.,2024-01-01,Balp MM; Tietz A; Pedrosa MC,"Novartis Pharma AG, Basel, Switzerland.",Not available
39131742,Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease.,2024-01-01,Hendrix S; Nicodemus-Johnson J; Knowlton N; Yeramian PD; Leslie K,"Amylyx Pharmaceuticals, Inc. Cambridge Massachusetts USA.; Pentara Corporation Millcreek Utah USA.",Not available
39131693,Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder - A Discrete Choice Experiment.,2024-01-01,Schein J; Cloutier M; Gauthier-Loiselle M; Catillon M; Meng Y; Libchaber B; Jiang F,"Analysis Group, Inc, London, UK.; Analysis Group, Inc, Montreal, QC, Canada.; Analysis Group, Inc, New York, NY, USA.; Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA.",Not available
39131604,"Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive, and cognitive symptoms in schizophrenia and of dual psychosis.",2024-01-01,Lago Garcia L; Diaz-Marsa M; Martin-Carrasco M,"CSM Corredoria, Oviedo, Spain.; Departamento de Ciencias Morfologicas y Sociosanitarias, Universidad de Cordoba, Cordoba, Spain.; Instituto Maimonides de Investigacion Biomedica de Cordoba, Cordoba, Spain.",Not available
39131200,Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators.,2024-01-01,Koutsokera A,"SYNLAB Genetics, Lausanne, Switzerland.",Not available
39129675,Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.,2024-01-01,Garcia-Donas J; Prat-Vidal C; Palomero J,"Banc de Sang i Teixits (BST), Barcelona, Spain.; Centro Integral Oncologico Clara Campal (HM CIOCC), Madrid, Spain.",Not available
39129595,Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing.,2024-01-01,Fathollahi S; Dickhoff BHJ; Frijlink HW,"Innovation & Technical Solutions, DFE Pharma, Goch, Germany.",Not available
39129317,Targeting adenocarcinoma and enzalutamideresistant prostate cancer using the novel antiandrogen inhibitor ADA308.,2024-01-01,Koistinaho M; Muona A,"Aranda Pharma Ltd., 70210 Kuopio, Finland.",Not available
39127720,Signaling by a bacterial phytochrome histidine kinase involves a conformational cascade reorganizing the dimeric photoreceptor.,2024-08-10,Basore K; Mickles AJ,"Bayer Crop Sciences, Chesterfield, MO, USA.",Not available
39126596,"Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons.",2024-01-01,Tran J; Remple V; Levy G; Sanchez Gonzalez Y; Panaccione R,"AbbVie Inc., North Chicago, IL, USA.","Department Internal Medicine III, Division Gastroenterology & Hepatology, Medical University Vienna, Wahringer Gurtel 18-20, 1090, Vienna, Austria. walter.reinisch@meduniwien.ac.at."
39126010,A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets.,2024-08-02,Puig L,"Institut de Recerca Sant Pau (IR Sant Pau), Sant Quinti 77-79, 08041 Barcelona, Spain.",Not available
39125917,Assessment of Tie2-Rejuvenated Nucleus Pulposus Cell Transplants from Young and Old Patient Sources Demonstrates That Age Still Matters.,2024-07-30,Munesada D,"TUNZ Pharma Corporation, Osaka 541-0046, Japan.",Not available
39125870,The Role of Viruses in the Pathogenesis of Immune-Mediated Gastro-Intestinal Diseases.,2024-07-30,Bernardi F; D'Amico F; Zilli A; Parigi TL; Massimino L; Allocca M; Danese S; Furfaro F,"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.",Not available
39125646,High-Throughput Determination of Infectious Virus Titers by Kinetic Measurement of Infection-Induced Changes in Cell Morphology.,2024-07-24,Kunzelmann M,"Boehringer Ingelheim Pharma GmbH & Co. KG, Development Biologicals, 88397 Biberach an der Riss, Germany.",Not available
39125405,"Cosmeceuticals: A Review of Clinical Studies Claiming to Contain Specific, Well-Characterized Strains of Probiotics or Postbiotics.",2024-08-02,Theodorou M; Tsetis JK,"Uni-Pharma S.A., 14564 Athens, Greece.",Not available
39124737,EMPATHY Life in Psoriasis: Embracing Patients' Well-Being in Their Journey of Moderate-to-Severe Psoriasis.,2024-07-30,Megna M,"UOC Dermatology, IRCCS INRCA, 60124 Ancona, Italy.",Not available
39123435,Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma-Systematic Literature Review of Clinical and Real-World Evidence.,2024-07-30,Godhania E; Ritchie A; Crichton K,"Pfizer Ltd., Walton Oaks, Tadworth KT20 7NS, UK.",Not available
39123076,Chronic stress deficits in reward behaviour co-occur with low nucleus accumbens dopamine activity during reward anticipation specifically.,2024-08-09,Hengerer B,"Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39123054,Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.,2024-01-01,Xu Z; Casillas M; Pierce E; Agell H; Stander S,"CIMS Global LLC, Somerset, NJ, USA.; Eli Lilly and Company, Indianapolis, IN, USA.","George Washington University School of Medicine, Washington, DC, USA. jonathanisilverberg@gmail.com."
39122202,The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials.,2024-01-01,Becker G; Felten R,"Departement Universitaire de Pharmacologie, Addictologie, Toxicologie et Therapeutique (DUPATT), Universite de Strasbourg, Strasbourg, France; Departement Universitaire de Pharmacologie, Addictologie, Toxicologie et Therapeutique (DUPATT), Universite de Strasbourg, Strasbourg, France.; Pole Pharmacie-Pharmacologie, Hopitaux Universitaires de Strasbourg, F-67000 Strasbourg, France; Service de Rhumatologie, Centre National de Reference des Maladies Auto-immunes et Systemiques Rares (RESO), Hopitaux Universitaires de Strasbourg, F-67000 Strasbourg, France",Not available
39121923,"Development, optimization and ex-vivo evaluation of a transdermal formulation containing trazodone.",2024-10-01,Marchitto L; Ragni L; Russo V; Tommasi G,"Angelini Pharma S.p.A., Via Vecchia del Pinocchio, 22, Ancona 60131, Italy.",Not available
39121846,Guidelines for minimal information on cellular senescence experimentation in vivo.,2024-08-08,Carlos Acosta J; Rodier F,"Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh EH4 2XR, UK; Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Montreal, QC, Canada; Institut du cancer de Montreal, Montreal, QC, Canada; Instituto de Biomedicina y Biotecnologia de Cantabria, IBBTEC (CSIC, Universidad de Cantabria), C/ Albert Einstein 22, 39011 Santander, Spain.; Universite de Montreal, Departement de radiologie, radio-oncologie et medicine nucleaire, Montreal, QC, Canada.","Austrian Cluster for Tissue Regeneration, Vienna, Austria. Electronic address: mikolaj.ogrodnik@lbg.ac.at."
39121717,Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators.,2024-01-01,Koyanagi A,"ICREA, Pg. Lluis Companys 23, Barcelona 08010, Spain.; Research and Development Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, ISCIII, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain","SCIENCES Lab, Department of Psychiatry, University of Ottawa, Ottawa, Canada. Electronic address: msolmi@toh.ca."
39121442,Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.,2024-10-10,Pui CH,"HARP Pharma Consulting, Mystic, CT.",Not available
39121212,Spatial transcriptomic characterization of pathologic niches in IPF.,2024-08-09,Santacruz D,"Boehringer Ingelheim Pharma GmbH & Co. KG, Global Computational Biology and Digital Sciences, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany.",Not available
39121107,The aperiodic exponent of neural activity varies with vigilance state in mice and men.,2024-01-01,Kas MJH,"Biomedica en Red de Salud Mental, CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain.",Not available
39120865,Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity.,2024-01-01,Anderson SG; Payne EH; Turdalieva S,"The Emmes Company, LLC, Rockville, MD, USA.",Not available
39120849,Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.,2024-01-01,Lyris N; Willems D; Taieb V; Eells J,"UCB Pharma, Brussels, Belgium.; UCB Pharma, Colombes, France.; UCB Pharma, Slough, UK.","Swedish Medical Center/Providence St. Joseph Health and University of Washington, 601 Broadway, Seattle, WA, 98122, USA. pmease@phillipmease.com."
39120848,Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.,2024-01-01,Lyris N; Taieb V; Eells J,"UCB Pharma, Colombes, France.; UCB Pharma, Slough, UK.","Swedish Medical Center/Providence St. Joseph Health and University of Washington, 601 Broadway, Seattle, WA, 98122, USA. pmease@phillipmease.com."
39120847,Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA.,2024-01-01,McCabe D,"Biostatistics, Alnylam Pharmaceuticals, Inc, Cambridge, MA, USA.","Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. vstrand@stanford.edu."
39120747,Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology.,2024-01-01,Schmidt-Hegemann NS,"PET committee of the German Society of Nuclear Medicine, (DGN), Germany.","Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. simone.wegen@uk-koeln.de."
39120742,Metabolically healthy obesity in adults with X-linked hypophosphatemia.,2024-08-05,Rocher L; Trabado S; Garnier A,"Universite Paris-Saclay, BIOMAPS, UMR1281, AP-HP, Hopital Antoine Beclere, Service de Radiologie, 92140 Clamart, France.; Universite Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hopital Bicetre, Laboratoire de Genetique Moleculaire, Pharmacogenetique et Hormonologie, 94275 Le Kremlin Bicetre Cedex, France.",Not available
39120740,Recommendations for the optimal use of bone forming agents in osteoporosis.,2024-08-09,Burlet N; Cooper C,"EUPATI Fellow, Holiday, FL, USA.; Patient Partner, Holiday, FL, USA.","Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Via del Vespro 141, 90127, Palermo, Italy. nicola.veronese@unipa.it."
39120583,"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Muscarinic M(3) Receptor-Positive Allosteric Modulator ASP8302 Following Single and Multiple Ascending Oral Doses in Healthy Volunteers.",2024-01-01,Takusagawa S; Treijtel N; Saito M; Michon I; Miyatake D; Osaki F; Guro S; Aarden-Bakker M; Kuroishi K; van Till JWO; Groenendaal-van de Meent D; de Vries M,"Astellas Pharma Europe B.V., Leiden, The Netherlands.; Astellas Pharma Inc., Tokyo, Japan.; Mitobridge Inc., Cambridge, MA, USA.",Not available
39120220,"Treatment of Superficial Vein Thrombosis: Recent Advances, Unmet Needs and Future Directions.",2024-07-31,Di Micco P,"AFO Medica, UOC Medicina Interna, P.O. Santa Maria delle Grazie, ASL Napoli 2 nord, 80076 Pozzuoli, Italy.",Not available
39120125,Detection of residual pluripotent stem cells in cell therapy products utilizing droplet digital PCR: an international multisite evaluation study.,2024-10-10,Bando K; Watanabe T; Fujimori K; Harada K; Terai O,"Sumitomo Pharma Co., Ltd., Kobe, Japan.; Takeda Pharmaceutical Company Limited, Fujisawa, Japan.",Not available
39119894,Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring.,2024-01-01,Poythress JC; Takeda K; Liu J,"Data Science, Astellas Pharma Global Development, Inc, Northbrook, Illinois, USA.",Not available
39119660,Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum.,2024-01-01,Golob M; Nelson R; Bloem K; Butsel BV; Champion L; Dang M; Galeva D; Lai CH; Roch T; Stevenson L; Widmaier H,"BioAgilytix Laboratories, 22339, Hamburg, Germany.; Celerion Switzerland AG, Bioanalytical Services, 8320, Fehraltorf, Switzerland.; CheckImmune GmbH, Soluble Factors, 13353, Berlin, Germany.; Immunologix Laboratories, Tampa, FL 33634, USA.; Labcorp Early Drug Development Laboratories Limited, Immunology & Immunotoxicology, PE28 4HS, Alconbury, Huntingdon, UK.; Nuvisan GmbH, Bioanalysis, 89231, Neu-Ulm, Germany.; Regeneron Pharmaceuticals, Bioanalytical Sciences, Tarrytown NY 10591, USA.; Sanofi, Drug Metabolism & Pharmacokinetics, 9052, Zwijnaarde, Belgium.; Sanquin Diagnostic Services, R&D Antibodies & Immunogenicity, 1066 CX, Amsterdam, The Netherlands.",Not available
39118456,Broad versus narrow research questions in evidence synthesis: A parallel to (and plea for) estimands.,2024-01-01,Remiro-Azocar A,"Methods and Outreach, Novo Nordisk Pharma, Madrid, Spain.",Not available
39118394,"Respiratory syncytial virus immunization patterns in Germany, 2015-2020.",2024-12-31,Soudani S,"Competence Network for Congenital Heart Defects, Deutsches Herzzentrum Berlin, Berlin, Germany.",Not available
39118366,Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR(9)) measure of suicidal risk.,2024-01-01,Mayes TL,"Curbstone Consultant LLC, Dallas, TX, USA.",Not available
39118245,"Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies.",2024-08-08,Inoue Y,"Data Management & Biometry, Nxera Pharma Japan Co., Ltd, Tokyo, Japan.",Not available
39117997,Regression without regrets -initial data analysis is a prerequisite for multivariable regression.,2024-08-08,Baillie M,"Novartis Pharma AG, Basel, Switzerland.","Center for Medical Data Science, Institute of Clinical Biometrics, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria. georg.heinze@meduniwien.ac.at."
39117797,Spermidine is essential for fasting-mediated autophagy and longevity.,2024-01-01,Bergmann M; Enzenhofer S; Gschiel V; Cerrato G; McCormick MA,"BioTechMed Graz, Graz, Austria.",Not available
39117670,Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913).,2024-08-08,Sevilla I,"Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain.",Not available
39117168,"Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals.",2024-01-01,Reid K; Brouta F; Beilmann M; Young G; Beattie KA; Valentin JP; Shaid S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach, Germany.; European Federation of Pharmaceutical Industries and Associates, Leopold Plaza Building, Rue Du Trone 108, B-1050. Brussels, Belgium.; GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK. UK.; UCB Biopharma SRL, Chemin Du Foriest, B-1420, Braine-l'Alleud, Belgium.","GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK. UK. Electronic address: Andrew.harrell@btinternet.com."
39116902,"Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial.",2024-01-01,Van den Eynde M; Barrios D; Yan Q; Kamio T; Kobayashi K; Boran A; Koga M; Allard JD,"Daiichi Sankyo, Basking Ridge, NJ, USA.; Daiichi Sankyo, Tokyo, Japan.; Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.","Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: kpraghav@mdanderson.org."
39115868,Planned Dental Extractions After Radiation Therapy.,2024-10-01,Petersen CM; Baldwin C; Milas ZL,"Southeast Radiation Oncology Group, PA, Charlotte, North Carolina.",Not available
39115567,Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement.,2024-01-01,Fuhmann DY,"Fenix Nephrology, Sao Paulo, Brazil.","Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital of Munster, Albert-Schweitzer Campus 1, Building A1, 48149, Munster, Germany. zarbock@uni-muenster.de."
39115134,[Not Available].,2024-01-01,Lynggaard H; Mutze T; Rehal S,"GlaxoSmithKline plc, Brentford, UK.; Novartis Pharma AG, Basel, Switzerland.; Novo Nordisk A/S, Bagsvaerd, Denmark.",Not available
39114870,A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer.,2024-01-01,Ducreux M; Boyken L; Garfin P,"Jazz Pharmaceuticals, Palo Alto, CA, USA.; Universite Paris-Saclay, Gustave Roussy, Villejuif, France.; Zymeworks Inc., Vancouver, BC, Canada.",Not available
39114809,Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States.,2024-01-01,Ruddy J,"Patient Advocacy, Ardelyx, Inc., Waltham, MA, USA.",Not available
39114764,A Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116.,2024-01-01,Mody K,"Biostatistics Oncology, Eisai Inc., Nutley, NJ, USA.",Not available
39114762,Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study.,2024-01-01,Take R; Yamada K; Asakawa T; Nakagawa Y,"Chugai Pharmaceutical Ltd, Tokyo, Japan.",Not available
39114542,Bioavailability of dronedarone tablets administered with or without food in healthy participants.,2024-01-01,McKindley DS; Rashkin J; Ollier C,"Cardiovascular, Sanofi, Bridgewater, NJ, USA.; Sanofi R&D, Montpellier, France.",Not available
39114536,Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial.,2024-01-01,Chamelian L,"Departement de Gestion, d'evaluation et de politique de sante, Ecole de sante publique, Universite de Montreal, Montreal, QC, Canada.",Not available
39114304,Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives.,2024-01-01,Breccia M; Palandri F,"Dipartimento di Medicina Traslazionale e di Precisione, Sapienza Universita, Roma, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seragnoli, Bologna, Italy.",Not available
39114302,Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer.,2024-01-01,Alzeeb G; Tortorelli C; Brun M; Chalus L; Pinteur B; Bravetti P,"Brenus-Pharma, Lyon, France.",Not available
39114271,GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.,2024-01-01,de la Rosa G; Pascual Vicente T; Gonzalez Grande R; Bilbao I; Oton E; Espinosa MD; Blanco Fernandez G; Amador Navarrete A; Rodriguez Soler M,"Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Monforte de Lemos 3-5, 28029, Madrid, Spain.",Not available
39113238,Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies.,2024-01-01,Sant'Anna-Silva ACB; Botton T; Bzioueche H; Blot L; Mazure NM; Rocchi S; Tulic MK,"Universite Cote d'Azur, INSERM U1065, C3M, Nice, France.",Not available
39112438,Model-based comparisons of post-treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union.,2024-01-01,Zhu R; Schoemaker R; Gautier A; Tian X; Sim CH; Omachi TA; Joshi A; Jin J; Owen R,"Genentech, Inc., South San Francisco, California, USA.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; Occams, Occams Cooperatie U.A., Amstelveen, Netherlands.",Not available
39111953,Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF Trial.,2024-01-01,Echeverria LE; Demacq C; Chiang LM; Bahit MC; Ferrari A; Gimpelewicz C,"Division of Cardiology, Fundacion Cardiovascular de Colombia, Floridablanca, Colombia.; INECO Neurociencias Orono, Rosario, Argentina.; Novartis Pharma AG, Basel, Switzerland.",Not available
39111209,Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer.,2024-01-01,Antoni L; Capone C; Van Sanden S,"Janssen Pharmaceutica NV, Beerse, Antwerp, Belgium.","Department of Medical Oncology, Institut Bergonie, Bordeaux, France. Electronic address: g.roubaud@bordeaux.unicancer.fr."
39110948,[Association between induced abortion and depression: A systematic review and meta-analysis].,2024-01-08,Montoya-Gambini NJS; Apaza-Garcia JJ; Munares-Garcia OF,"Universidad Cientifica del Sur, Facultad de Ciencias de la Salud ""Fernando Cabieses Molina"", Carrera de Medicina Humana. Lima, Peru.",Not available
39110310,"A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor.",2024-01-01,Milligan J; Barlow S,"AbbVie Inc., 1 N. Waukegan Road, North Chicago, IL, 60064, USA.",Not available
39110227,Kidney transplantation in children and adolescents with C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis: a real-world study within the CERTAIN research network.,2024-01-01,Webb NJA; Meier M,"Novartis Pharma AG, Basel, Switzerland.","Heidelberg University, Medical Faculty, Department of Pediatrics I, University Children's Hospital Heidelberg, Im Neuenheimer Feld 430, Heidelberg, 69120, Germany. Christian.Patry@med.uni-heidelberg.de."
39110203,"Effect of midostaurin on the pharmacokinetics of P-gp, BCRP, and CYP2D6 substrates: assessing potential drug-drug interactions in healthy participants : Brief title: Drug-drug interaction of midostaurin.",2024-01-01,Gu H; Rahmanzadeh G; Chiparus O; Menssen HD,"Novartis Pharma AG, Basel, CH-4002, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Novartis Pharma AG, Basel, CH-4002, Switzerland. romain.sechaud@novartis.com."
39110143,Momelotinib versus ruxolitinib in JAK inhibitor-naive patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial.,2024-01-01,Kosugi H,"Sierra Oncology, Inc., San Mateo, USA.","Hematology, Diabetes, and Endocrinology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan. kshimoda@med.miyazaki-u.ac.jp."
39110139,More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis.,2024-01-01,Platt AM; Silverberg JI,"AbbVie Inc., North Chicago, IL, USA.","Blauvelt Consulting LLC, Lake Oswego, OR, USA. blauveltconsults@gmail.com."
39109988,Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time-to-event endpoints.,2024-10-15,Kormaksson M; Lange MR; Demanse D; Duan J; Xie Q; Carbini M; Bossen C; Guettner A; Maniero A,"Analytics, Development, Novartis Pharma AG, Basel, Switzerland.; Analytics, Development, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
39109268,"Correlation of brain tissue volume loss with inflammatory biomarkers IL1beta, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population.",2024-01-01,Kim ST,"JN Pharma, Seongnam-si, Republic of Korea.",Not available
39108476,Portable UV-C Device to Treat High Flow of Infectious Aerosols Generated during Clinical Respiratory Care.,2024-07-26,Paredes J,Independent Consultant.,Not available
39108321,The PI3Kdelta inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study.,2024-01-01,Sungala N; Sheehy O; Odera M; Miao L; Gold DP; Ghalie RG; Zinzani PL,"Cliniques Universitaires Saint-Luc Bruxelles Belgium.; Istituto Scientifico Romagnolo per lo Studio et la Cura dei Tumori Meldola Italy.; Kyowa Kirin Co. Ltd. Tokyo Japan.; MEI Pharma San Diego California USA.; Present address: City of Hope, Duarte California USA.",Not available
39108108,Eco-friendly Approaches to Chromene Derivatives: A Comprehensive Review of Green Synthesis Strategies.,2024-08-06,Bhimani B,"Piramal Pharma Limited, Pharmaceutical Special Economic Zone, Ahmedabad, 382213, India.",Not available
39107697,Setting the international research agenda for sarcomas with patients and carers: results of phase II of the Sarcoma Patient Advocacy Global Network (SPAGN) priority setting partnership.,2024-08-06,Schuster K; Bickley S; Wartenberg M; Gonzato O; Kasper B; Pilgermann K; Wilson R; Steeghs N; Husson O,"Fondazione Paola Gonzato-Rete Sarcoma ETS, Rome, Italy.; Policy and Support, Sarcoma UK, 17/18 Angel Gate City Road, London, UK.; Sarcoma Patient Advocacy Global Network (SPAGN), Untergasse 36, D-61200, Wolfersheim, Germany.",Not available
39107131,"Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.",2024-08-06,Richardet M; Delord JP; Pacius M; Duong Q; Huang N; Doshi P; Baden J; Di Nicola M,"Bristol Myers Squibb, Princeton, New Jersey, USA.; Fundacion Richardet Longo, Instituto Oncologico de Cordoba, Cordoba, Argentina.; Universite Paris-Saclay and Institut GustaveRoussy, Villejuif, France.",Not available
39106936,Evaluation of cervical spinal cord atrophy using a modified SIENA approach.,2024-01-01,Luchetti L; Gentile G,"Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy; Siena Imaging S.r.l., Siena, Italy.",Not available
39106582,Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episode.,2024-01-01,Jorda-Baleri T; Garriga M; Mezquida G; Martinez-Aran A; Garcia-Rizo C; Gonzalez-Pinto A; Vieta E; Bernardo M; Amoretti S,"BIOARABA Health Research Institute, OSI Araba, University Hospital, University of the Basque Country, Vitoria, Spain; Barcelona Clinic Schizophrenia Unit, Hospital Clinic de Barcelona; Biomedical Network Research Centre on Mental Health (CIBERSAM), Spain; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona; CIBERSAM, ISCIII, Barcelona, Catalonia, Spain; CIBERSAM, ISCIII, Barcelona, Catalonia, Spain.; CIBERSAM, ISCIII, Barcelona, Spain; CIBERSAM, ISCIII, Barcelona, Spain.; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Departament de Medicina, Institut de Neurociencies (UBNeuro), Universitat de Barcelona (UB); Department of Psychiatry, Hospital Universitari Vall d'Hebron; Group of Psychiatry, Mental Health and Addictions, Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS); Section of Psychiatry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; Serra-Hunter Fellow, Department of Basic Clinal Practice, Pharmacology Unit, University of Barcelona.; Universitat Autonoma de Barcelona, Barcelona, Spain.",Not available
39106541,"A randomized, double-blind, placebo-controlled trial to evaluate the effect of nabiximols oromucosal spray on clinical measures of spasticity in patients with multiple sclerosis.",2024-01-01,Checketts D; Sahr N; Berwaerts J; Alexander JK; Skobieranda F,"Jazz Pharmaceuticals Inc., Carlsbad, CA, USA.; Jazz Pharmaceuticals UK Ltd, London, UK.","Cleveland Clinic Neurological Institute, Cleveland, OH, USA. Electronic address: BETHOUF@ccf.org."
39106167,Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials.,2024-01-01,Jairath V,"i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto, Porto, Portugal.",Not available
39106081,A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.,2024-10-15,Wang Y; Bielska AA,"AstraZeneca, Waltham, Massachusetts.",Not available
39106052,Effect of ensifentrine on dyspnea in patients with moderate-to-severe chronic obstructive pulmonary disease: pooled analysis of the ENHANCE trials.,2024-01-01,Reyner D; Bengtsson T; Rickard K; Singh D,"Verona Pharma plc, Raleigh, NC, USA.",Not available
39105878,"Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.",2024-08-06,Ramon J; Corral E; Calvo E,"START Madrid-CIOCC, Centro Integral Oncologico Clara Campal, Madrid, Spain.","Sourasky Medical Center, Tel-Aviv university, Tel-Aviv, Israel. ravitg@tlvmc.gov.il."
39105626,Economic burden of respiratory syncytial virus in adults in Germany - a health claims analysis between 2015 and 2018.,2024-01-01,Huebbe B; Mocek A; Manz KC; Bayer LJ; Schiffner-Rohe J; von Eiff C; Lade C,"IGES Institut GmbH, Berlin, Germany.; Pfizer Pharma GmbH, Berlin, Germany.",Not available
39105131,"Air travel in patients suffering from pulmonary hypertension-A prospective, multicentre study.",2024-01-01,Barnikel M; Ulrich S; Gall H,"Klinik III fur Innere Medizin Herzzentrum der Universitat zu Koln Cologne Germany.; Klinik fur Innere Medizin V, Pneumologie Universitatsklinikum des Saarlandes Homburg Germany.",Not available
39104956,Development and initial validation of a disease-specific instrument to measure health-related quality of life in hypersensitivity pneumonitis.,2024-01-01,Aronson KI; Varadarajan J; Krishnan JK; Kaner RJ; Safford MM,"Division of Pulmonary and Critical Care, Weill Cornell Medicine, New York, NY, USA.",Not available
39104653,Abrocitinib may improve itch and quality of life in patients with itch-dominant atopic dermatitis.,2024-01-01,Guler E,Pfizer Inc. Istanbul Turkey.,Not available
39104410,Cytokine profile of anti-spike CD4(+)T cells predicts humoral and CD8(+)T cell responses after anti-SARS-CoV-2 mRNA vaccination.,2024-08-16,Lebeaux D,"Universite de Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.",Not available
39104319,"Adiponectin suppresses stiffness-dependent, profibrotic activation of lung fibroblasts.",2024-10-01,Skronska-Wasek W; Schoenberger T; Quast K; El Kasmi KC,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
39104082,Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study.,2024-11-18,Nesnas J; Randall R; Czachorowski M,"Pfizer Ltd, Walton Oaks, Walton on the Hill, Tadworth, Surrey, UK.",Not available
39103901,Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.,2024-08-05,Duncan EA; Bowen K; Megally A; Patel M,"Formerly of AstraZeneca, Durham, NC, USA.; Late RIA Biometrics, AstraZeneca, Gaithersburg, MD, USA.; Late RIA, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Late RIA, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.","Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan. smuro@naramed-u.ac.jp."
39103848,BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.,2024-08-05,Barker HE,"Clovis Oncology Inc., San Francisco, CA, USA.",Not available
39103673,Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia-Pacific Region: A Cross-sectional Survey.,2024-01-01,Liao HF,"Pfizer Ltd, Taipei, Taiwan.",Not available
39103508,Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.,2024-08-05,Lozac'hmeur A; Danek T; Yang Q; Rosasco MG; Welch JS; Go WY; Ng EW; Mardiros A,"A2 Biotherapeutics, Agoura Hills, CA, USA.; Tempus AI Inc., Chicago, IL, USA.",Not available
39103338,"Correction to ""The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3'-UTR and promoting Rag1 mRNA expression"".",2024-08-05,Daniel C,"Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
39103243,"Stability Development, Optimization and Evaluation of Gastro-Retentive Microspheres of Antidiabetic Agent by Full Factorial Design.",2024-08-06,Janjanam KC,"Director R&D, Epic Pharma LLC, 227-15N Conduit Ave, Laurelton, New York, USA.",Not available
39102832,"Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.",2024-01-01,Galli F; Marme F; Piovano E; Tasca G; Tognon G; Lissoni AA; Petrella M; Laudani ME; Rulli E; Uggeri S,"AOU Citta della Salute e della Scienza di Torino - Presidio Sant'Anna, Torino, Italy.; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.; Obstetrics and Gynecology, Section Gynecologic Oncology, Universitaetsklinikum Mannheim Medizinische Fakultaet, Mannheim, Germany.; SOD Oncologia Medica Ginecologica, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.; UO Ostetricia-Ginecologia ASST Spedali Civili, Universita degli Studi-Brescia, Brescia, Italy.; UOC Oncologia 2 IRCCS Istituto Oncologico Veneto - Padova, Padova, Italy.; UOS Oncologia Ginecologica Medica, Universita degli Studi di Milano Bicocca, IRCCS San Gerardo dei Tintori - Monza, Monza, Italy.",Not available
39102822,Calciprotein particle counts associate with vascular remodelling in chronic kidney disease.,2024-12-04,Smith ER,"Calciscon AG, Biel, Switzerland.",Not available
39101698,New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials.,2024-08-05,Passera A; Muscianisi E; Demanse D; Wei X; Uhlmann L; Vandemeulebroecke M; Ravichandran S,"Novartis Gene Therapies, Bannockburn, Illinois, USA.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma Shanghai, Shanghai, China.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
39101618,The European Bioanalysis Forum recommendation on establishing appropriate drug tolerance levels in antidrug antibody assays.,2024-01-01,Champion L; Dyer D; Carlsen MF; Geary L; Golob M; Goodman J; Revell H; Rieger M; Venema F,"BioAgilytix Laboratories, Hamburg, 22339, Germany.; Bioanalytical Services, Celerion, Lincoln, NE 68502, USA.; Celerion Switzerland AG, Bioanalytical Services, Fehraltorf, 8320, Switzerland.; LEO Pharma, Bioanalysis & Pharmacokinetics, Ballerup, 2750, Denmark.; Labcorp, Immunochemistry Method Development, Harrogate, HG3 1PY, UK.; Nuvisan GmbH, Bioanalysis, Neu-Ulm, 89231, Germany.; Resolian Bioanalytics, Immunoassay Bioanalysis, Fordham, CB7 5WW, UK.; Sanofi, Drug Metabolism & Pharmacokinetics, Zwijnaarde, 9052, Belgium.",Not available
39101487,A European Bioanalysis Forum recommendation for requiring a context-of-use statement for successful development and validation of biomarker assays.,2024-01-01,Blattmann P; Gulati P; Goodman J; Golob M; Nelson R,"BioAgilytix Laboratories, 22339Hamburg, Germany.; Bioanalytical Services, Celerion, Lincoln, NE 68502, USA.; F. Hoffmann La Roche Ltd Bioanalysis & Biomarkers Chapter, Pharmaceutical Sciences, 4070Basel, Switzerland.; Idorsia Pharmaceuticals Ltd, Translational Sciences, 4123Allschwil, Switzerland.; Nuvisan GmbH, Bioanalysis, 89231, Neu-Ulm, Germany.",Not available
39101472,In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programme.,2024-11-11,Granjeon-Noriot S; Bechet E; Boissel JP; Courcelles E; Diatchenko A; Kahoul R; Peyronnet E; Porte S; Wang Y,"Novadiscovery, Lyon, France.",Not available
39101340,"A European Consensus on the Consistent Use of the Term ""Keratinocyte Cancer"".",2024-08-05,Philipp-Dormston WG; Basset-Seguin N; Szeimies RM,"Hautzentrum Koln (Cologne Dermatology), Koln, Germany; Hopital Saint-Louis, Paris, France; Klinikum Vest GmbH, Knappschaftskrankenhaus Recklinghausen, Germany.; Universite de Paris, Paris, France.","Faculty of Health, University Witten-Herdecke, Witten, Germany. mail@hautzentrum.com."
39100430,Physician and Patient Preferences for Treatment of Anemia Associated with Chronic Kidney Disease in Japan: A Survey Including Best-Worst Scaling.,2024-01-01,Mishina S; Ito Y; Lee T,"Astellas Pharma Inc, Tokyo, Japan.",Not available
39099093,Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to >/=60 Years of Age.,2024-10-15,Nunez SA; Toursarkissian N,"Infectologia, Centro Medico Maffei, Buenos Aires, Argentina.; Praxis Dr. Med. Nicole Toursarkissian, Berlin, Germany.",Not available
39098867,Impact of twice-daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis.,2024-01-01,Kurosu S; Inagaki K; Iwayama KI,"EA Pharma Co., Ltd., Tokyo, Japan.; Kissei Pharmaceutical Co., Ltd., Tokyo, Japan.",Not available
39098798,The role of registries in hematological disorders.,2024-01-01,Ciceri F; Frutos C; Garderet L; Nair G,"Blutspende SRK Schweiz AG, UK.; Instituto de Prevision Social, Asuncion, Paraguay.; Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy.; Sorbonne Universite, Service d'Hematologie et Therapie Cellulaire, HopitalPitie Salpetriere, AP-HP, Paris, France.",Not available
39098761,A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depression.,2024-01-01,Tomioka S; Szabo ST; Koblan KS,"Sumitomo Pharma America, Marlborough, MA, USA.","Sumitomo Pharma America, Marlborough, MA, USA. Electronic address: seth.hopkins@otsuka-us.com."
39098043,Validation of a new protocol for a zebrafish MEFL (malformation or embryo-fetal lethality) test method that conforms to the ICH S5 (R3) guideline.,2024-01-01,Aoki Y; Hayashi M; Sugimoto W; Fujiwara M,"Drug Development Laboratories, Maruho Co., Ltd.; Ideation & Creation Group, Discovery Accelerator, Astellas Pharma Inc.; M-Odyssey LLC.",Not available
39097500,"Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab +/- ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study.",2024-01-01,Leidig T; Bauer H,"CROLLL GmbH, Woernitzstrasse 115A, 90449 Nuremberg, Germany.; Staburo GmbH, Aschauer Strasse 26a, 81549 Munich, Germany.",Not available
39097413,"Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2).",2024-08-03,Moser J; Grewal JS; Enstrom A; Blanchfield L; Chisamore MJ; Peng SL; Naumovski A,"Alpine Immune Sciences Inc, Seattle, Washington, USA.; Franciscan Physician Network with Franciscan Alliance, Lafayette, Indiana, USA.; Nucleus Network Ltd, Melbourne, Victoria, Australia.; START Midwest, Grand Rapids, Michigan, USA.; START, San Antonio, Texas, USA.","UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA davard@upmc.edu."
39097219,Comparative analysis of FDA approvals by top 20 pharma companies (2014-2023).,2024-01-01,Hinder M; Hartl D,"Fresenius University of Applied Sciences, Moritzstr. 17a, D-65185 Wiesbaden, Germany.; Granite Bio, Aeschenvorstadt 36, CH-4051 Basel, Switzerland.; Novartis, Development, Patient Safety, Forum 1, CH-4002 Basel, Switzerland; University of Tubingen, Hoppe-Seyler-Strasse 1, D-72076 Tubingen, Germany","University of St. Gallen, Institute of Technology Management, Dufourstrasse 40a, CH-9000 St. Gallen, Switzerland. Electronic address: alexander.schuhmacher@thi.de."
39097214,Extended survival of 9- and 10-gene-edited pig heart xenografts with ischemia minimization and CD154 costimulation blockade-based immunosuppression.,2024-01-01,Burdorf L; Ayares DL; Eyestone W; Sardana P; Kuravi K; Sorrells L; Lederman S,"Center for Transplantation Sciences and Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Revivicor, Inc., Blacksburg, Virginia.; Tonix Pharma LLC, Chatham, New Jersey.",Not available
39096929,"Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjogren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.",2024-08-10,Sopala M; Montecchi-Palmer M; Luo WL; Scheurer C,"Novartis Pharma, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.",Not available
39095951,The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review.,2024-01-01,Smoyer KE,"Envision Pharma Group, Fairfield, Connecticut, USA.",Not available
39095878,Predictors of continuation for asenapine from real-world data in patients with schizophrenia.,2024-08-02,Hiraoka S; Iwama Y; Matsui D,"Meiji Seika Pharma Co., Ltd., Tokyo, Japan.","Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan. takekity@takii.kmu.ac.jp."
39095866,Frontline use of rituximab may prevent ADAMTS13 inhibitor boosting during caplacizumab treatment in patients with iTTP: post hoc analysis of a phase 2/3 study in Japan.,2024-08-02,Hashimoto Y; Nishimi M; Tsukamoto M; Tahara S,"Sanofi K.K, Tokyo, Japan.",Not available
39095295,Final Analysis of a Noninterventional Study on Cabozantinib in Patients With Advanced Renal Cell Carcinoma After Prior Checkpoint Inhibitor Therapy of the German Interdisciplinary Working Group on Renal Tumors (IAG-N).,2024-01-01,Mohammad-Reza R; Anne F; Christoph M; Disorn S,"Institut fur Klinische Krebsforschung IKF GmbH, Krankenhaus Nordwest GmbH, Frankfurt, Germany.; Krankenhaus Nordwest gGmbH, Institut fur Klinisch-Onkologische Forschung (IKF), Frankfurt, Germany.; MVZ West GmbH Wurselen, Wurselen, Germany.; Medizinische Klinik m.S. Hamatologie, Onkologie und Tumorimmunologie, Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, Berlin, Deutschland.","Westdeutsches Tumorzentrum Essen, Klinik fur Urologie, Universitatsklinikum Essen (AoR), Essen, Germany. Electronic address: viktor.gruenwald@uk-essen.de."
39094577,In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAF(V600E) lung adenocarcinoma.,2024-08-20,San Jose S; de Hita S,"Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; Centro de Investigacion del Cancer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain.; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France","Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium. Electronic address: mjnokin@uliege.be."
39093560,Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-Analysis.,2024-08-01,Shi Q,"Solid Tumor Oncology, Weill Cornell Medicine, New York, New York.",Not available
39093262,Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials.,2024-07-05,Conde LG; Han J,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corp, East Hanover, NJ, USA.","Division of Preventive Cardiology and the Department of Cardiology, Mayo Clinic, Rochester, MN, USA. Electronic address: wright.scott@mayo.edu."
39092426,Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation.,2024-01-01,Milnes JT; van der Heyden MAG,"Acesion Pharma, Copenhagen, Denmark.",Not available
39091595,"Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL.",2024-01-01,Tatsuno M; Mitsudomi T,"Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.",Not available
39090513,Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants.,2024-01-01,Ranade SV; Cantrell RA; Singh S; Gazzard G,"Envision Value & Access, Battersea, London, UK.; Genentech, Inc., a Member of the Roche Group, South San Francisco, CA, USA.","Pepose Vision Institute, Chesterfield, MO, USA. nancy.holekamp@roche.com."
39089584,The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas.,2024-01-01,Woods A; Poradosu E,"Nuvectis Pharma Inc, Fort Lee, New Jersey, USA.",Not available
39089363,Analytical considerations for characterization of generic peptide product: A regulatory insight.,2024-01-01,Subbappa PK,"Slayback Pharma LLC, Princeton, NJ, 08540, USA.","Bhagwant University, Sikar Road, Ajmer, Rajasthan, India. Electronic address: gentleakhilesh@gmail.com."
39089344,Enhancing cellular affinity for skin disorders: Electrospun polyurethane/collagen nanofiber mats coated with phytoceramides.,2024-09-30,Shoueir KR,"ICPEES, Institut de Chimie et Procede pour l'Energie, l'Environnement et la Sante, CNRS, UMR 7515, Universite de Strasbourg, 25 rue Becquerel, 67087 Strasbourg Cedex 2, France",Not available
39089305,"Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial.",2024-01-01,Wislez M; Mazieres J; Berghoff K,"CHU de Toulouse, Universite Paul Sabatier, Toulouse, France.; Global Patient Safety, Merck, Darmstadt, Germany.; Service de Pneumologie, Hopital Cochin, Assistance Publique-Hopitaux de Paris, Paris, France; Universite Paris Cite, Paris, France.","Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: wuyilong@gdph.org.cn."
39088302,Human gut microbiota-reactive DP8alpha Tregs prevent acute graft-versus-host disease in a CD73-dependent manner.,2024-08-01,Godefroy E; Verdon M; Pedron A; Peterlin P; Vibet MA; Le Bourgeois A; Jotereau F,"Maat Pharma, Lyon, France.; Nantes Universite, Univ Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT,UMR 1302, F-44000 Nantes, France.",Not available
39088193,Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program.,2024-01-01,Checketts D; Sahebkar F,"Jazz Pharmaceuticals, Inc, Cambridge, UK.; Jazz Pharmaceuticals, Inc, Carlsbad, California, USA.",Not available
39088126,Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search.,2024-01-01,Leonardi C,"Central Dermatology, St. Louis, MO, USA.","Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. LPuig@santpau.cat."
39088098,Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV.,2024-08-01,Lagrou K; Lass-Florl C,"Dipartimento Scienze Biomediche per la Salute, Universita degli Studi di Milano, Milan, Italy.; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en sante, environnement et travail), UMR_S 1085, 35000, Rennes, France.",Not available
39087959,"Elacestrant in ER+, HER2- Metastatic Breast Cancer with ESR1-Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups.",2024-10-01,Bidard FC,"Institut Curie, Paris and Saint Cloud, France.",Not available
39087264,Recent Advances Addressing the Challenges of Precision Dosing.,2024-01-01,Peck RW,"InsightRx, San Francisco, California, USA.",Not available
39087208,"Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.",2024-01-01,Luis Sanchez-Menoyo J; Oh J; Spitaleri D; L Brown JW,"Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.; CISSS de Chaudiere-Appalache, Sainte-Marie, QC, Canada.; CSSS de Saint-Jerome, Saint-Jerome, QC, Canada.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.",Not available
39087202,Health Equity Considerations for Children With Type 1 Diabetes Who Utilize Insulin Cost-Sharing Cap Programs.,2024-01-01,DeWitt K; Bergmann KR,"Pediatric Emergency Medicine, Children's Minnesota, Minneapolis, USA.",Not available
39086989,Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis.,2024-01-01,Zhuleku E; Wirth D; Nissinen R; Bravata I; Ziavra D; Duva A; Lee J; Mueller S; Wilke T,"Cytel Inc., Potsdamer Str. 58, Berlin 10785, Germany.; Institut Fur Pharmakookonomie Und Arzneimittellogistik e.V., Wismar, Germany.; Janssen-Cilag A/S Denmark, Birkerod, Denmark.; Janssen-Cilag GmbH, Neuss, Germany.; Janssen-Cilag Ltd, High Wycombe, UK.; Janssen-Cilag Oy, Espoo, Finland.; Janssen-Cilag S.A.C.I., Pefki, Greece.; Janssen-Cilag S.P.A., Milan, Italy.",Not available
39086881,Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study).,2024-01-01,Sharma S; Ensor J; Jurdi A; Liu MC,"Natera, Inc., Austin, Texas, USA.",Not available
39086306,Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical study.,2024-08-01,Solanes A; Radua J,"Department of Medicine, School of Medicine and Health Sciences, University of Barcelona, Spain; Early Psychosis: Interventions & Clinical Detection (EPIC) Laboratory, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK; Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Institute of Neurosciences (UBNeuro), University of Barcelona, Spain; and Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.; and Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.",Not available
39085939,Structural modification of 2-phenylquinoline-4-carboxylic acid containing SIRT3 inhibitors for the cancer differentiation therapy.,2024-01-01,Xu G; Li F,"Harway Pharma Co., LTD., Dongying, Shandong, China.; Weifang Synovtech New Material Technology Co., LTD., Weifang, Shandong, China.",Not available
39085584,"ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dube syndrome.",2024-01-01,Genuardi M; Richard S; Rajan N,"Dipartimento di Scienze della Vita e Sanita Pubblica, Universita Cattolica del Sacro Cuore, Rome, Italy.; French NCI (INCa) network for rare cancers in adults PREDIR, AP-HP, Hopital Bicetre, Le Kremlin-Bicetre, France.; Instytut Gruzlicy Chorob Pluc, Warsaw, Poland.","Aarhus University Hospital, Aarhus, Denmark. marianne.geilswijk@auh.rm.dk."
39085532,An Advanced Twin-Screw Granulation Technology: The use of Non-Volatile Solvents with High Solubilizing Capacity.,2024-07-31,Ross S; Mithu MSH,"Custom Pharma Services, Conway St, Brighton and Hove, Hove, BN3 3LW, UK.",Not available
39085209,Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice.,2024-07-31,Huchet C; Lafoux A; Mir O; Chretien F,"CESP, MOODS Team, Inserm, Faculte de Pharmacie, Universite Paris-Saclay, Chatenay-Malabry, France.; Sarcoma Group, Gustave Roussy, Villejuif, France.; Therassay Platform, Capacites, Universite de Nantes, IRS 2 Nantes Biotech, Nantes, France.",Not available
39085075,Anti-atrial Fibrillatory and Cardiorenal Protective Effects of the Combination of Valsartan and Cilnidipine in Dahl Salt-Sensitive Rats.,2024-01-01,Harada E; Sugino K; Takahara A,"Ajinomoto Co., Inc.; EA Pharma Co., Ltd. (Formerly Ajinomoto Pharmaceuticals Co., Ltd.).",Not available
39084859,Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers.,2024-01-01,Lou J; Zhu J,"Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd, Hangzhou, China.; Zhejiang Aotuokang Pharmaceutical Group Inc. Co., Jinhua, Zhejiang, China.",Not available
39084827,A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.,2024-08-06,Mathews K; Ullery S; Eapen ZJ; Kumar UN,"Element Science, Inc, San Francisco, California, USA.; NAMSA, Minneapolis, Minnesota, USA.",Not available
39084786,Cell Painting unravels insecticidal modes of action on Spodoptera frugiperda insect cells.,2024-01-01,Leggio B; Konig T; Gnutt D,"R&D Disease Control, Bayer SAS, Crop Science Division, Lyon, France.; R&D Image-based Screening Systems, Bayer AG, Pharma Division, Wuppertal, Germany.",Not available
39084344,Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies.,2024-01-01,Emmanuelle G,"Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Sorbonne Universite, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, Paris, France.",Not available
39084186,From discovery to innovation in animal health: Maturing emerging technologies for industrial development.,2024-01-01,Charlier J; Cloherty AP; Hofer M,"BioLizard NV, Foreestelaan 88, 9000, Ghent, Belgium.; Kreavet BV, Hendrik Mertensstraat 17, 9150, Kruibeke, Belgium.; Stonehaven Cozmix Group AG, Schlossmuhlestrasse 9, 8500, Frauenfeld, Switzerland.",Not available
39083724,Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer.,2024-10-10,Patel J; Mekan S; Wu T; Lin KW; Kuo P,"Gilead Sciences, Inc, Foster City, CA.",Not available
39083288,Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical Trial.,2024-09-01,Taut FJH; Kohler K; Chen Y; Sendecki J; Leung MWL; Wegner S; Personke Y; Gomez M; Kruger N; Tabori S; Schakel K,"Janssen Global Services LLC, Horsham, Pennsylvania.; Janssen R&D, LLC, San Diego, California.; Janssen-Cilag GmbH, Neuss, Germany.; Taut Science and Service GmbH, Konstanz, Germany.",Not available
39083282,Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata.,2024-09-01,Soliman AM; Li C; Grada A,"AbbVie Inc, North Chicago, Illinois.",Not available
39083197,Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study).,2024-01-01,Fernandes CC; Remenova T,"Global Epidemiology, Actelion Pharmaceuticals Ltd, a Johnson & Johnson Company, Allschwil, Switzerland.; Statistics and Decision Sciences, Janssen-Cilag S.p.A, a Johnson & Johnson Company, Milan, Italy.","Department of Pulmonology, Kreisklinik Bad Reichenhall, Riedelstrasse 5, 83435, Bad Reichenhall, Germany. Tobias.Lange@kliniken-sob.de."
39083163,Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors.,2024-01-01,Zhao R; Shiff NJ; Morrison L; Yu LH; Schwartzbein S; Lefebvre P; Pilon D; Chakravarty SD; Mease P,"Analysis Group, Inc., Montreal, QC, Canada.; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, US.","University of Utah School of Medicine, 50 North Medical Drive, Salt Lake City, UT, 84132, US. Jessica.Walsh@hsc.utah.edu."
39083132,Interpretation of results of PCR and B-D-glucan for the diagnosis of Pneumocystis Jirovecii Pneumonia in immunocompromised adults with acute respiratory failure.,2024-07-31,Bauer P,"Centro de Investigacion Biomedica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Barcelona, Spain.",Not available
39082680,A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.,2024-07-02,Sheridan T; Davis-Dusenbery BN; Robinson PN; Chuang JH,"Velsera, Charlestown, Massachusetts.",Not available
39082340,"Molecular Regulation of Bone Turnover in Juvenile Idiopathic Arthritis: Animal Models, Cellular Features and TNFalpha.",2024-07-10,Ray S,"ExesaLibero Pharma, Morgantown, WV 26505, USA.",Not available
39082063,iPREDICT: proof-of-concept study to develop a predictive model of changes in asthma control.,2024-01-01,Zavod M; Dutta B; Hagger L,"AstraZeneca, Gaithersburg, MD, USA.; AstraZeneca, Wilmington, DE, USA.",Not available
39081993,Remote data collection speech analysis in people at risk for Alzheimer's disease dementia: usability and acceptability results.,2023-01-01,Jenkins N; Mallick E; Pullen H; Welstead M; Troger J,"CoBTek (Cognition-Behaviour-Technology) Lab, Universite Cote d'Azur, Nice, France.; ki:elements GmbH, Saarbrucken, Germany.",Not available
39081781,The Efficacy of a Home-Based Functional Skills Training Program for Older Adults With and Without a Cognitive Impairment.,2024-01-01,Czaja SJ; Kallestrup P,"Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York, New York, USA.; i-Function Inc., Miami, Florida, USA.",Not available
39081766,Outcomes of Early Versus Delayed Anemia Treatment in Nondialysis-Dependent CKD.,2024-01-01,Kawai K; Ishii M; Kokado Y; Horikawa T,"Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.",Not available
39081306,"Confounding and Negative Control Methods in Observational Study of SARS-CoV-2 Vaccine Effectiveness: A Nationwide, Population-Based Danish Health Registry Study.",2024-01-01,Ullum H; Sorensen HT,"Statens Serum Institut, Copenhagen, 2300, Denmark.",Not available
39081053,Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.,2024-01-01,Ovejero-Benito MC; Martinez-Lopez A,"Departamento de Ciencias Farmaceuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU, CEU Universities Madrid, Madrid, Spain.; Grupo de Investigacion en Dermatologia (GRIDER), Universidad de Oviedo, Oviedo, Spain.",Not available
39080474,Author Correction: Multifunctional effects of Lactobacillus sakei HEM 224 on the gastrointestinal tract and airway inflammation.,2024-07-30,Oh H; Ji Y; Holzapfel WH,"HEM Pharma Inc., Pohang, Gyeongbuk, 37554, Republic of Korea.",Not available
39080281,GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer.,2024-07-30,Wachsmann G; Jackisch C; Rey J,"Elisabeth Krankenhaus Kassel, Kassel, Germany.; Frauenklinik, Kreiskliniken Boblingen gGmbH, Boblingen, Germany.; Sana Klinikum Offenbach, Offenbach, Germany.",Not available
39080267,Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson's disease.,2024-07-31,Smets B,"Neuroscience Data Science, Janssen Pharmaceutica NV, Beerse, Belgium.","Population Analytics & Insights, AI/ML, Data Science & Digital Health, Janssen Research & Development, LLC, Spring House, PA, USA. adoostpa@its.jnj.com."
39080222,A Novel Formulation of Ketorolac Tromethamine (NTM-001) in Continuous Infusion in Adults with and without Renal Impairment: A Randomized Controlled Pharmacologic Study.,2024-01-01,Batra A; Schmidt WK,"Neumentum, Inc, Summit, NJ, USA.; NorthStar Consulting, LLC, Davis, CA, USA.","Neumentum, Inc, Summit, NJ, USA. jpjmd@msn.com."
39080153,Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.,2024-01-01,Becker B; Zhong Y; Kisa RM; Banerjee S,"Bristol Myers Squibb, 3401 Princeton Pike, Princeton, NJ, 08648, USA.",Not available
39080094,Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD.,2024-07-30,Barnum S; Jaeger J; Shao L; Ozturk ZE; Korotzer A,"CognitionMetrics, LLC, Stamford, CT, 06903, USA.; Regeneron Pharmaceuticals Inc., Tarrytown, NY, 410591-6717, USA.; Sanofi, Cambridge, MA, 02142, USA.","Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. apaller@nm.org."
39079892,Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study.,2024-07-30,Schwartz H; Zanlonghi X,"Cell and Gene Therapies, Ophthalmology, Astellas Pharma US, Northbrook, Illinois, USA.; Shri Bhagwan Mahavir Vitreoretinal services, Sankara Nethralaya, Chennai, Tamil Nadu, India.",Not available
39078584,Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis.,2024-01-01,Crowell MM; Silverberg JI,"Medicus Economics LLC, Boston, MA, USA.",Not available
39078120,Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study.,2024-07-30,Kezic S; Ropke MA,"LEO Pharma A/S, Ballerup, Denmark.",Not available
39077906,Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials.,2024-01-01,Kosloski MP; Harel S; Kamal MA; Goulaouic H; Xu CR; Avetisova E; Davis JD; Nivens MC; Shabbir A; Radin A,"Formerly Regeneron Pharmaceuticals Inc., Basking Ridge, New Jersy, USA.; Formerly Regeneron Pharmaceuticals, Tarrytown, New York, USA.; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Sanofi, Bridgewater, New Jersey, USA.; Sanofi, Chilly-Mazarin, France.",Not available
39077886,Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies.,2024-01-01,Coarse J,"UCB Pharma, Morrisville, North Carolina.",Not available
39077157,"Diabetes-specific formula with standard of care improves glycemic control, body composition, and cardiometabolic risk factors in overweight and obese adults with type 2 diabetes: results from a randomized controlled trial.",2024-01-01,Berde Y,"Biostatistics and Statistical Programming, Cognizant Technology Solutions, Mumbai, India.",Not available
39076989,Centralized care model for hereditary angioedema overcomes geographical barriers.,2024-01-01,Blain H,"Alberta Precision Laboratories, Edmonton, AB, Canada.",Not available
39076975,Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis.,2024-01-01,Marchesoni A,"Rheumatology, Humanitas San Pio X, Milan, Italy.",Not available
39076530,Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis.,2024-01-01,Kirchgassler KU; Maher TM,"F. Hoffmann-La Roche, Ltd., Basel, Switzerland.",Not available
39076522,Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis.,2024-01-01,Luijten D; Ghanima W,L.A. Cimini and D. Luijten contributed equally and share first authorship.,Not available
39076473,Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease.,2024-01-01,Mackinnon ES,"Amgen Canada Inc., ON L5N 0A4, Canada.",Not available
39076333,"Wide Spectrum of Bradyarrhythmias and Supraventricular Tachyarrhythmias in Sportsmen: Run Forrest, Run?!",2024-01-01,Mizia-Stec K,"Abbott Electrophysiology, 02-676 Warsaw, Poland.",Not available
39076250,Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURE.,2024-01-01,Muller A; Fontana M,"Actelion Pharmaceuticals Ltd, a Johnson & Johnson Company, Global Epidemiology Allschwil Switzerland.; Janssen-Cilag S.p.A, a Johnson & Johnson Company, Statistics and Decision Sciences Milan Italy.",Not available
39076204,Assessment of corneal nerve regeneration after axotomy in a compartmentalized microfluidic chip model with automated 3D high resolution live-imaging.,2024-01-01,Reaux-Le Goazigo A,"Hopital Ambroise Pare, APHP, Universite Versailles-Saint-Quentin-en-Yvelines, Boulogne-Billancourt, France.",Not available
39075620,Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial.,2024-07-29,Walter PM; Singhal A; Bu X; Li Y; Penn SK; Camp HS; Aelion J,"AbbVie Inc, North Chicago, IL, USA.; Aprillus Asistencia e Investigacion, Buenos Aires, Argentina.; Instituto Guatemalteco de Seguridad Social, Ciudad de Guatemala, Guatemala.","Amsterdam University Medical Centers, Amsterdam, Netherlands. r.vanvollenhoven@amsterdamumc.nl."
39075460,Facilitating the use of the target product profile in academic research: a systematic review.,2024-07-29,Teipel S; Gardiol A,"AriLex Life Sciences LLC, 780 Elysian Way, Deerfield, IL, 60015, USA.; IDEA Pharma, London, UK.",Not available
39075233,Engineering Toxoplasma gondii secretion systems for intracellular delivery of multiple large therapeutic proteins to neurons.,2024-01-01,Koshy AA; Sheiner L; Rechavi O,"Epeius Pharma, Ness Ziona, Israel.","Department of Neurobiology, Biochemistry and Biophysics, Wise Faculty of Life Sciences and Sagol School for Neuroscience, Tel Aviv University, Tel Aviv, Israel. shaharbr@mit.edu."
39074992,"Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",2024-08-01,Carbonell J; Meng Y; Strom SP,"Centro Cardioneuro Oftalmologico y Trasplante, Santo Domingo 10306, Republica Dominicana.; Fulgent Genetics, Temple City, CA 91780, USA.; Illumina Inc., San Diego, CA 92122, USA.",Not available
39074480,"Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial.",2024-01-01,Fiehler J; Dorn F; Flottmann F; Gellissen S; Hopf-Jensen S; Muller-Hulsbeck S; Papanagiotou P; Pham M,"DIAKO Krankenhaus, Institut fur Diagnostische und Interventionelle Radiologie und Neuroradiologie, Flensburg, Germany.; Department of Radiology, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Klinik fur Diagnostische und Interventionelle Neuroradiologie, Klinikum Bremen Mitte, Bremen, Germany; Klinik fur Diagnostische und Interventionelle Neuroradiologie, Universitatsklinikum Bonn, Bonn, Germany.; Universitatsklinikum Hamburg-Eppendorf, Klinik und Poliklinik fur Neuroradiologische Diagnostik und Intervention, Hamburg, Germany; Universitatsklinikum Hamburg-Eppendorf, Klinik und Poliklinik fur Neuroradiologische Diagnostik und Intervention, Hamburg, Germany.; Universitatsklinikum Wurzburg, Institut fur Diagnostische und Interventionelle Neuroradiologie, Wurzburg, Germany.; eppdata, Hamburg, Germany.","Klinik und Poliklinik fur Neurologie, Kopf, und Neurozentrum, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany. Electronic address: thomalla@uke.de."
39074035,"Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross-sectional imaging in a tertiary care setting.",2024-01-01,Aruljothy A; Alkhattabi M,"Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy.; Universita Vita-Salute San Raffaele, Milan, Italy.",Not available
39074033,Inulin: a multifaceted ingredient in pharmaceutical sciences.,2024-01-01,Rudrangi SRS; Rudrangi S,"Head of Product Development and Commercialisation, (Kent Pharma UK Limited), Ashford, UK.; Pharmacist, Lifecare Pharmacy of Austin, Bexar, TX, USA.",Not available
39073834,Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial.,2024-09-01,Pereira PAB,"Laaperi Statistical Consulting, Helsinki, Finland.",Not available
39073799,Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial.,2024-01-01,Chen CI; Ivanescu C; Harnett J; Mastey V; Reaney M; Daskalopoulou C; LaFontaine PR; Konidaris G; Bury D; Yoo SY; Mohan K; Coates E; Bowler T; Fury MG,"IQVIA, Durham, NC 27703, USA.; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.; Sanofi, Cambridge, MA 02142, USA.",Not available
39073610,Treatment patterns and outcomes in patients with nonmetastatic castration-resistant prostate cancer in the United States.,2024-01-01,Hong A; Diessner B; Young C; Bunner SH; Xie B; Ramaswamy K; Chastek B; El Chaar N,"Astellas Pharma Inc., Northbrook, IL USA.; Optum, Eden Prairie, MN USA.; Pfizer Inc., New York, NYUSA.",Not available
39073397,C5 inhibitor avacincaptad pegol treatment for geographic atrophy: A comprehensive review.,2024-01-01,Loewenstein A,"Sierra Eye Associates, Reno, NV 89502, USA.",Not available
39073291,Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's disease.,2024-01-01,Raket LL,"Eli Lilly and Company, Indianapolis, Indiana, USA.",Not available
39072356,"VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancer.",2024-01-01,Liu Y; Anderson S,"Biostatistics, Pfizer Inc., San Diego, CA 92121, USA.; Translational Oncology, Pfizer, Inc., San Diego, CA 92121, USA.",Not available
39072306,The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy.,2024-01-01,Garcia MJ,"F. Hoffmann-La Roche AG, 4070 Basel, Switzerland.",Not available
39072034,Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.,2024-07-21,Churchman M; Dalton WS,"Aster Insights, Hudson, FL 34667, USA.",Not available
39072012,Epigenome-wide association studies identify novel DNA methylation sites associated with PTSD: A meta-analysis of 23 military and civilian cohorts.,2024-07-15,Kimbrel NA,"Biogen Inc., Translational Sciences, Cambridge, MA, US.",Not available
39071859,"Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes.",2024-01-01,Vespa E; Barchi A,"Gastroenterology and Digestive Endoscopy, IRCCS Ospedale San Raffaele, Milan, 20132, Italy.",Not available
39071145,"Cost of overweight, obesity, and related complications in Switzerland 2021.",2024-01-01,Pollak T,"Novo Nordisk Pharma AG, Zurich, Switzerland.",Not available
39070175,Optimising antibiotic exposure by customising the duration of treatment for respiratory tract infections based on patient needs in primary care.,2024-01-01,Frimodt-Moller N,"CIBER de Enfermedades Infecciosas, Madrid, Spain.",Not available
39069503,From chromosomal aberrations to mutations in individual genes - the significance of genetic studies of chorions after miscarriage in the search for causes of miscarriages.,2024-01-01,Matuszewska KE; Piechota M; Staniek-Lacna K; Kochalska N; Milanowska K; Bialek-Proscinska A; Hirschfeld AS; Wisniewska M; Latos-Bielenska A,"Diagnostyka GENESIS sp. z o.o, Poznan, Poland.",Not available
39069265,Impact of wrinkles on the dermatoscopic pattern of solar lentigines: A longitudinal clinical study.,2024-01-01,Passeron T,"Universite Cote d'Azur, Centre Hospitalier Universitaire de Nice, Service de Dermatologie, Nice, France; Universite Cote d'Azur, INSERM U1065, C3M, Nice, France.","L'Oreal Research & Innovation, Aulnay-sous-Bois, France. Electronic address: romain.dedormael@loreal.com."
39068669,Plasma Phosphorylated Tau 217 and Abeta42/40 to Predict Early Brain Abeta Accumulation in People Without Cognitive Impairment.,2024-09-01,Morris JC,"C 2 N Diagnostics, St Louis, Missouri.",Not available
39068545,Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.,2024-10-15,Hansson O,"C2N Diagnostics LLC, St Louis, Missouri.",Not available
39068098,"Treatment Switches, Patterns, and Outcomes in Adult and Pediatric Patients Undergoing Kidney Transplantation Between 2000 and 2019: A Retrospective United States Claims Database Study.",2024-01-01,Gharbi H; Aubrun E; Kuessner D; Barcelos G; Prieto L,"Novartis Pharma AG, Basel, Switzerland; Novartis Pharma AG, Basel, Switzerland.; Pfizer AG, Zurich, Switzerland.","Novartis Pharma AG, Basel, Switzerland. Electronic address: yvonne.geissbuehler@novartis.com."
39067504,"PET myocardial perfusion imaging: Trends, challenges, and opportunities.",2024-01-01,Harms HJ,"MedTrace Pharma A/S, Horsholm, Denmark.",Not available
39067461,"Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.",2024-08-03,Havlickova B; Cheong SY; Fleuranceau Morel P,"Biometrics, Galderma Laboratories, Dallas, TX, USA.; Klinika GHC Praha, Prague, Czech Republic.; Pharmacovigilance Risk Management, Galderma Laboratories, Dallas, TX, USA.",Not available
39066978,"Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels.",2024-01-01,Maloney J; Bauer D; Radin A; Makhija M,"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.; Sanofi, Bridgewater, NJ, USA.","Institute of Allergology, Charite-Universitatsmedizin Berlin, Corporate Member of Free University of Berlin and Humboldt-University of Berlin, Hindenburgdamm 27, 12203, Berlin, Germany. marcus.maurer@charite.de."
39066962,"Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study.",2024-01-01,Onofrei A; O'Brien J; Margolin Z; Barr C; Mizuno Y; Agarwal E; Sugiyama N,"CorEvitas, LLC, Waltham, MA, USA.; Pfizer Japan Inc, Tokyo, Japan.; Pfizer, Inc, New York, NY, USA.","The First Department of Internal Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi, Kitakyushu, 807-8555, Japan. tanaka@med.uoeh-u.ac.jp."
39066373,Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates.,2024-07-02,Sharma B; Bekerman E; Truong H; Lee J; Gamez-Guerrero M; Boopathy A; Mital R; Huang KB; Ahmadi-Erber S; Wimmer R; Schulha S; Lauterbach H; Orlinger K; Suthram S; Lewis MG; Blair W; Makadzange T; Geleziunas R; Murry JP; Schmidt S,"Bioqual, Inc., Rockville, MD 20850, USA.; Gilead Sciences, Inc., Foster City, CA 94404, USA.; Hookipa Pharma Inc., New York, NY 10018, USA.",Not available
39065753,Risk-Based Approach for Defining Retest Dates for Active Pharmaceutical Ingredients and Excipients.,2024-07-07,Akanji O,"Katchey Laboratories, 26, Adeniyi, Adeniyi Jones Ave, Ogba, Ikeja 101233, Nigeria.",Not available
39065156,Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT.,2024-07-09,Belotti T; Masetti R; Viale P,"Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.",Not available
39064736,gammadelta+ T-Cells Is a Useful Biomarker for the Differential Diagnosis between Celiac Disease and Non-Celiac Gluten Sensitivity in Patients under Gluten Free Diet.,2024-07-17,Carrasco A; Vidal J; Ferrer C; Tebe C,"Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.",Not available
39064181,Using Deep Learning to Distinguish Highly Malignant Uveal Melanoma from Benign Choroidal Nevi.,2024-07-16,Marquardt P; Haas V; Biniaminov N; Biniaminov S,"HS Analysis GmbH, 76131 Karlsruhe, Germany.",Not available
39063344,In Vivo Glycemic Response of Fruit-Based Mango (Mangifera indica) and Pineapple (Ananas comosus) Bars in In Vitro and In Silico Enzyme Inhibitory Effects Studies.,2024-07-17,Perez-Beltran YE; Wall-Medrano A; Valencia Estrada MA; Sanchez-Burgos JA; Blancas-Benitez FJ; Sayago-Ayerdi SG,"Instituto de Ciencias Biomedicas, Universidad Autonoma de Ciudad Juarez, Chihuahua 32310, Mexico.; Laboratorio Integral de Investigacion en Alimentos, Tecnologico Nacional de Mexico/Instituto Tecnologico de Tepic, Nayarit 63175, Mexico.",Not available
39062538,Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis.,2024-07-10,Weinstock-Guttman B,"Octave Bioscience, Menlo Park, CA 94025, USA.",Not available
39061651,Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease.,2024-07-13,Farrag K,"Innere Medizin, DGD Kliniken Sachsenhausen, Schulstrasse 31, 60594 Frankfurt am Main, Germany.",Not available
39061410,Verbal Learning and Memory Deficits across Neurological and Neuropsychiatric Disorders: Insights from an ENIGMA Mega Analysis.,2024-06-29,Babikian T; Brosch K; Dalrymple-Alford JC; Goltermann J; Lee J; McDonald CR; Melzer TR; Dennis EL,"Centro Investigacion Biomedica en Red Salud Mental (CIBERSAM), 28029 Madrid, Spain.; Institut d'Investiacio Sanitaria Pere Virgili-CERCA, Universitat Rovira i Virgili, 43007 Tarragona, Spain.; VISN 6 MIRECC, Durham VA, Durham, NC 27705, USA.",Not available
39061326,What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study.,2024-07-12,Dinh A; Courjon J,"Service des Maladies Infectieuses et Tropicales, Hopital Raymond-Poincare, 92380 Garches, France.; Service des Maladies Infectieuses et Tropicales, Universite Cote d'Azur, CHU Nice, 06200 Nice, France.",Not available
39061293,"Investigating the Bactericidal Activity of an Ocular Solution Containing EDTA, Tris, and Polysorbate 80 and Its Impact on the In Vitro Efficacy of Neomycin Sulfate against Staphylococcus aureus: A Preliminary Study.",2024-06-30,Amiriantz S; Hoummady S; Roudeix S; Philippon T,"Domes Pharma, ZA Champ Lamet, 3 Rue Andre Citroen, 63430 Pont-du-Chateau, France.; Groupe Icare, Biopole Limagne, 6 Rue Emile Duclaux, 63360 Saint Beauzire, France.",Not available
39061215,Baseline Association between Healthy Eating Index-2015 and Health-Related Quality of Life in Breast Cancer Patients Enrolled in a Randomized Trial.,2024-07-18,Messina F; Ferrau F; Montesarchio V; Libra M,"Ospedale Evangelico Betania, 80147 Naples, Italy.; Ospedale San Vincenzo, 98039 Taormina, Italy.; UOC Oncologia, AORN dei Colli (Monaldi-Cotugno-CTO), 80131 Naples, Italy.",Not available
39061175,Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer.,2024-07-14,Conteduca V; Duran I; Palma-Mendez J; De Giorgi U; Gonzalez-Billalabeitia E,"Departamento de Ingenieria de la Informacion y las Comunicaciones, Universidad de Murcia, 30100 Murcia, Spain.; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) ""Dino Amadori"", 47014 Meldola, Italy.; Instituto Valenciano de Oncologia, 46009 Valencia, Spain.",Not available
39061107,"Identification of profiles associated with conversions between the Alzheimer's disease stages, using a machine learning approach.",2024-07-26,Civet A,"Roche France S.A.S, Boulogne Billancourt, France.","Clinical and Research Memory Centre, Lyon Institute For Aging, Charpennes Hospital, Hospices Civils de Lyon, 27 rue Gabriel Peri, Villeurbanne, Lyon, 69100, France. virginie.dauphinot@chu-lyon.fr."
39060633,In vivo monitoring of active subretinal fibrosis in mice using collagen hybridizing peptides.,2024-01-01,Foxton RH,"3Helix, Salt Lake City, UT, USA.",Not available
39060472,Recommendations for Development and Validation of a Fit-For-Purpose Biomarker Assays Using Western Blotting; An-AAPS Sponsored Initiative to Harmonize Industry Practices.,2024-07-25,Harman J; Honrine K; Lavelle A; Valentin MA; Mathews J,"Automation Group, PPD, Richmond, VA, USA.; Biomarker Services, Pharmaceutical Product Development (PPD) Laboratories, Richmond, VA, USA.; Immunochemistry R&D, PPD, Richmond, VA, USA.; Ionis Pharmaceuticals, Carlsbad, CA, USA.; Novartis Pharma AG, Basel, Switzerland.","BioMedical Research, Novartis, 250 Massachusetts Avenue, Room 6A148, Cambridge, MA, 02139, USA. arvind.kinhikar@novartis.com."
39060244,A preoperative dose of the pyridoindole AC102 improves the recovery of residual hearing in a gerbil animal model of cochlear implantation.,2024-07-26,Bera S; Kwiatkowska M; Schlingensiepen R; Rommelspacher H,"AudioCure Pharma GmbH, Berlin, Germany.",Not available
39060023,Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma.,2024-07-25,van de Donk NWCJ,"Cellectis SA, Paris, France.",Not available
39060019,Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.,2024-07-25,Regan MM,"Bristol Myers Squibb, Princeton, New Jersey, USA.",Not available
39059484,Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION.,2024-01-01,Tsatsaris V,"Maternite Port-Royal, FHU PREMA, Assistance Publique Hopitaux de Paris, Hopital Cochin, Paris, France.; Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPe, Centre for Epidemiology and Statistics Sorbonne Paris Cite (CRESS), INSERM, Paris, France","Universite Paris Est, Creteil, France. Electronic address: gregory.lailler@santepubliquefrance.fr."
39059407,"Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study.",2024-01-01,Pattee GL; Jafar-Nejad P; Rigo F; Lin L; Ferguson TA; Gotter AL; Graham D; Monine M; Inra J; Sinks S; Eraly S; Garafalo S; Fradette S,"Biogen, Cambridge, MA, USA.; Bryan Physicians Network, Lincoln, NE, USA; Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.; Ionis Pharmaceuticals, Carlsbad, CA, USA.","UMC Utrecht Brain Center, Department of Neurology, UMC Utrecht, Utrecht, Netherlands. Electronic address: l.h.vandenBerg@umcutrecht.nl."
39059384,International consensus on fasting terminology.,2024-08-06,Madeo F,"BioTechMed Graz, Graz, Austria; Field of Excellence BioHealth, University of Graz, Graz, Austria.; Institute of Molecular Biosciences, University of Graz, Graz, Austria","Charite Competence Center for Traditional and Integrative Medicine (CCCTIM), Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin and Berlin Institute of Health, Berlin, Germany. Electronic address: daniela.koppold@charite.de."
39059248,Prevalence of prominent and predominant negative symptoms across different criteria for negative symptom severity and minimal positive symptoms: A comparison of different criteria.,2024-01-01,Davidson M; Saoud JB; Kuchibhatla R,"Minerva Neurosciences, Waltham, MA, USA.","University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: PHarvey@miami.edu."
39059184,Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.,2024-01-01,Theuser AK; Hofmann NM; Bohm S; Schmatloch S; Jackisch C; Belleville E,"ClinSol GmbH & Co KG., Wurzburg, Germany.; Elisabeth Krankenhaus Kassel, Kassel, Germany.; Frauenklinik Sana Klinikum, Offenbach, Germany.; Institut fur Frauengesundheit GmbH, Erlangen, Germany.","Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Germany. Electronic address: peter.fasching@uk-erlangen.de."
39059108,Treatment utilization and non-drug interventions for vasomotor symptoms in breast cancer survivors taking endocrine therapy: Real-world findings from the United States and Europe.,2024-01-01,Caetano C; Janssenswillen C; Moeller C; Schoof N,"Bayer AG, Mullerstr. 178, 13342 Berlin, Germany.; Bayer Consumer Care, Peter Merian-Strasse 84, 4052 Basel, Switzerland.","University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, 11100 Euclid Ave, Cleveland, OH 44106, United States. Electronic address: Sheryl.Kingsberg@UHhospitals.org."
39059062,Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials.,2024-01-01,Pan W; Tian X; Men L; Wang H; Liang E; Wang C; Yang D; Zhai Y,"Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China; Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China.; Ascentage Pharma Group Inc., Rockville, USA.; Department of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.",Not available
39058951,CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma.,2024-09-24,Zinzani PL; Kim WS; Kriachok I; Morcos PN; Buvaylo V,"Bayer AG, Berlin, Germany.; Bayer SA, Sao Paulo, Brazil.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli,"" Bologna, Italy.; Oncology Dispensary No. 2, Sochi, Russia.; Sociedad de Investigaciones Medicas Ltda, Temuco, Chile.",Not available
39058741,nf-core/airrflow: An adaptive immune receptor repertoire analysis workflow employing the Immcantation framework.,2024-01-01,Meng H; Polster M,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; oNKo-Innate Pty Ltd, Melbourne, Victoria, Australia.",Not available
39058452,Modeling of Parkinson's Disease Progression and Implications for Detection of Disease Modification in Treatment Trials.,2024-01-01,Monnet A; Nikolcheva T,"Roche Product Development, F. Hoffmann La Roche Ltd., Basel, Switzerland.",Not available
39058451,Risk Factors for Postoperative Delirium Severity After Deep Brain Stimulation Surgery in Parkinson's Disease.,2024-01-01,Franke C,"Physikalisch-Technische Bundesanstalt, Berlin, Germany.",Not available
39058425,Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial.,2024-10-01,Bradley D; Wongchenko MJ; Reilly SJ,"Biostatistics, Genentech, Inc., South San Francisco, California.; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.; Product Development Safety, F. Hoffmann-La Roche Ltd., Basel, Switzerland.",Not available
39058022,"First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults.",2024-09-04,Lecot J; Zhang J,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
39058003,Adhesion of Bacteroides vulgatus and Fusobacterium varium to the Colonic Mucosa of Healthy Beagles.,2024-07-16,Huhtinen M; Sclivagnotis YS; Lyhs U,"Orion Corporation, Orion Pharma, R&D, Orionintie 1A, 02200 Espoo, Finland.",Not available
39055646,Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study.,2024-01-01,Sullivan ST,Global Product Development Pfizer Inc. Cambridge Massachusetts USA.,Not available
39054491,Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study.,2024-07-25,Peer A; Balar AV; de Wit R,"Incyte Corporation, Wilmington, Delaware, USA.; Odessa Regional Oncological Dispensary, Odessa, Ukraine.","Vita-Salute San Raffaele University Milan, Milan, Italy. necchi.andrea@hsr.it."
39054485,Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study.,2024-07-25,Munteanu M; Kataria R; Jia C; Powles T,"Incyte Corporation, Wilmington, DE, USA.; Merck & Co., Inc., Rahway, NJ, USA.","Department of Medical Oncology, Trakya University, 22030, Edirne, Turkey. irfancicin@trakya.edu.tr."
39054476,"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study.",2024-07-25,Hussein M,"Florida Cancer Specialists, Tavares, FL, USA.","Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan. tokitou_takaaki@kurume-u.ac.jp."
39054467,"Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.",2024-07-25,Hong RL; Leopold L; Munteanu M; Ge JY; Swaby RF; Hughes BGM,"CHU de Quebec - Hotel-Dieu de Quebec, 11 Cote du Palais, Quebec City, QC, G1R 2J6, Canada.; Incyte Corporation, Wilmington, DE, 19803, USA.; Instituto Portugues de Oncologia de Coimbra Francisco Gentil EPE, Avenida Bissaya Barreto 98, Coimbra, 3000-075, Portugal.; Merck & Co., Inc., P.O. Box 2000, 126 East Lincoln Ave., Rahway, NJ, 07065, USA.","Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seoul, 03722, Republic of Korea. cbc1971@yuhs.ac."
39054363,Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients.,2024-07-25,Valkadinov I,"Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany.","Division of Neurodegenerative Disorders, Neurological University Clinic Mannheim, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany. jochen.weishaupt@medma.uni-heidelberg.de."
39054258,Underrecognition of migraine-related stigmatizing attitudes and social burden: Results of the OVERCOME Japan study.,2024-01-01,Zagar AJ,"Real World and Access Analytics, Eli Lilly and Company, Indianapolis, Indiana, USA.",Not available
39054088,Asthma: effect of excess short-acting beta(2)-agonist (SABA) inhaler prescriptions on healthcare resource utilisation.,2024-01-01,Antalffy T,"Smart Respiratory Ltd, London.",Not available
39054040,I love you with all my lungs: a viewpoint on communicating effectively and positively about lung health.,2024-01-01,Celli BR; Jenkins CR,"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.; Departamento de Organizacion Industrial, Escuela Tecnica Superior de Ingenieria (ICAI), Universidad Pontificia Comillas - IIT, Madrid, Spain.","Servicio de Neumologia, Hospital Universitario de la Princesa, Madrid, Spain jbsoriano2@gmail.com."
39053945,Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers.,2024-07-24,Yamaguchi Y; Ishida T; Takubo R; Ogami C; Sekiya M; Nakagawa Y; Kuboki Y,"Chugai Pharmaceutical Co Ltd, Chuo-ku, Tokyo, Japan.","Department of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan nbryamam@ncc.go.jp."
39053904,Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.,2024-01-01,Chouchana M; Pinel S; Colboc H; Buard G; Lilamand M,"Faculte de pharmacie de Paris, Universite de Paris Cite, Paris, France.; Service Pharmacie, Assistance Publique des Hopitaux de Paris, Hopital Lariboisiere-Fernand Widal, Paris, France.; Sorbonne Universite, Hopital Rothschild, Service de Geriatrie - Plaies et Cicatrisation, Paris, France.; Universite Paris Cite Inserm UMRS-1144, Optimisation Therapeutique en Neuropsychopharmacologie, Paris, France.",Not available
39053620,"Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world.",2024-01-01,Madhavan S; Natarajan K; Corbo M; True JM,"Pfizer, 66 Hudson Boulevard, New York, NY 10018, USA.","Pfizer, 66 Hudson Boulevard, New York, NY 10018, USA. Electronic address: charles.jones@pfizer.com."
39053611,"Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1).",2024-01-01,Zirwas M; Hamilton C; Cassella J,"DOCS Dermatology, Columbus, Ohio.; Sun Pharmaceutical Industries, Inc., Lexington, Massachusetts.","Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: brett.king@yale.edu."
39052972,15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).,2024-01-01,Materin MA; Char DH; Wells JR; Gao A,"Associated Retina Consultants, Royal Oak, MI.; Colorado Retina Associates, Denver, CO.; Retina Consultants of Texas, Houston, TX.; Retina Consultants, Hartford, CT.",Not available
39052958,"Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.",2024-09-10,Tsai KY; Yom SS,"Natera, Inc, Austin, TX.",Not available
39052668,"Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.",2024-01-01,De Brouwer E; Soysal A; Iuliano G; van der Walt A; McGuigan C,"Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.; Azienda Sanitaria Unica Regionale Marche - AV3, Macerata, Italy.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; ESAT-STADIUS, KU Leuven, Belgium.; Universidade Metropolitana de Santos, Santos, Brazil.",Not available
39052242,Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure: A Nonrandomized Controlled Trial.,2024-09-01,Vugmeyster Y; Zhang S; Bajars M,"EMD Serono, Billerica, Massachusetts.; Now with Theseus Pharmaceuticals, Cambridge, Massachusetts.",Not available
39052075,[Interdisciplinary centers for autoimmune diseases in Germany].,2024-01-01,Keysser G; Sunderkotter C,"Arbeitsbereich Rheumatologie, Universitatsklinik und Poliklinik fur Innere Medizin II (Nephrologie, Rheumatologie, Endokrinologie/Diabetologie), Universitatsklinikum Halle (Saale), Halle, Deutschland.; Universitatsklinik und Poliklinik fur Dermatologie und Venerologie, Universitatsklinikum Halle (Saale), Halle, Deutschland.","Abteilung fur Allergologie und Immunologie, Klinik fur Dermatologie, Venerologie und Allergologie, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117, Berlin, Deutschland. margitta.worm@charite.de."
39052039,"United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use.",2024-01-01,Parthan A; Sader SC; Balanean A; Howard JF Jr,"Alexion, AstraZeneca Rare Disease, Boston, MA, USA.; FibroGen Inc., San Francisco, CA, USA.; Hematology-Oncology Associates of CNY, East Syracuse, NY, USA.",Not available
39051124,Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform.,2024-01-01,Kamel H,"Division of Neurocritical Care, Weill Cornell Medicine, New York, NY (H.K.).",Not available
39051027,Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET.,2024-01-01,di Molfetta G; Zetterberg H; Ashton NJ,"ADx NeuroSciences NV, 9052 Ghent, Belgium.",Not available
39051019,Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial.,2024-01-01,Lu F; Park KH,"Sankara Nethralaya, Chennai, India.; Santen Pharmaceuticals, Inc, Emeryville, CA, USA.",Not available
39050811,Why Liver Cancer Hits Home: Bridging Healthcare Disparities in the Asian American and Pacific Islander Community.,2024-01-01,Cheng S; Tan R; Chi ZH,"Genentech, South San Francisco, CA, USA.",Not available
39050806,Relationships Between Success Factors in Daily Disposable Multifocal Contact Lenses.,2024-01-01,Vega J; Orsborn G,"CooperVision Incorporated, San Ramon, CA, USA.",Not available
39050757,Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily.,2024-01-01,Barenz F; Pommereau A; Zuschlag Y; Stanka J; Batoulis H; Bender E; Reinhardt J; Ehrmann A; Licher T,"Lead Identification and Characterization, Bayer Pharmaceuticals, Wuppertal, Germany.; Novartis Pharma AG, Basel, Switzerland.; Sanofi, Integrated Drug Discovery, Industriepark Hoechst, Frankfurt am Main, Hessen, Germany.",Not available
39050138,Nighttime eating during pregnancy and infant adiposity at 6 months of life.,2024-01-01,Rodriguez-Cano AM; Medel-Canchola B; Gonzalez-Ludlow I; Rodriguez-Hernandez C; Reyes-Munoz E; Schiffman-Selechnik E; Perichart-Perera O,"Gynecological and Perinatal Endocrinology Coordination, Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes, Mexico City, Mexico.; Nutrition and Bioprogramming Coordination, Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes, Mexico City, Mexico.; Private Consultant, Mexico City, Mexico.",Not available
39050030,Healthcare Resource Utilisation of Severe Uncontrolled T2low and Non-T2low Asthma in Finland During 2018-2021.,2024-01-01,Aakko J; Kaijala S; Lassenius MI,"Medaffcon Oy, Espoo, Finland.",Not available
39049734,Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article.,2024-01-01,Del Rio Espinola A; Jadlowsky JK; Schambach A,"GentiBio Inc., Cambridge, Massachusetts, USA.; Merck & Co., Inc., Boston, Massachusetts, USA.; ProtaGene CGT, Heidelberg, Germany.",Not available
39049083,"The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products.",2024-07-24,Hindocha C; Bagul M,"GW Pharmaceuticals (Part of Jazz Pharmaceuticals), Cambridge, UK.","Science of Health Department, Magna Grecia University, Catanzaro, Italy. erusso@unicz.it."
39048822,Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.,2024-01-01,Schumacher TN; Sheehan KCF; Colonna M; Allison JP; Murphy KM; Artyomov MN,"Asher Biotherapeutics, South San Francisco, CA, USA.; Natera Inc., Austin, TX, USA.; Oncovir Inc., Washington, DC, USA.",Not available
39048638,COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.,2024-01-01,Cooper ZA; Kumar R,"AstraZeneca, Gaithersburg, MD, USA.",Not available
39048611,Gnao1 is a molecular switch that regulates the Rho signaling pathway in differentiating neurons.,2024-07-24,Ohga S,"Shionogi Pharma Co., Ltd., Settsu, Osaka, Japan.",Not available
39046767,Ruxolitinib for pediatric patients with treatment-naive and steroid-refractory acute graft-versus-host disease: the REACH4 study.,2024-11-14,Cleary G; Rosko C; Li X; St Pierre A; Prahallad A,"Novartis Ireland Limited, Dublin, Ireland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ.",Not available
39046635,Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri((R))) Dosing: NOVA Phase IIIb Extension Study (Part 2).,2024-01-01,Domingo-Horne R; Toukam M; Maghzi AH; Lasky T,"Biogen, Cambridge, MA, USA.","Department of Neurology with Institute of Translational Neurology, University of Munster, Albert-Schweitzer-Campus 1, Building A1, 48149, Munster, Germany. heinz.wiendl@ukmuenster.de."
39046464,"Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.",2024-01-01,Brenner GB; Gemmink A; Coronel R,"Pharmahungary Group, 6722, Szeged, Hungary.; Pole of Pharmacology and Therapeutics, Institut de Recherche Experimentale et Clinique (IREC) and Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain (UCLouvain), Brussels, Belgium.",Not available
39046031,Large-scale analysis of structural brain asymmetries during neurodevelopment: Associations with age and sex in 4265 children and adolescents.,2024-08-01,O'Gorman Tuura RL; Jackowski A; Ortiz AE; Pariente JC; Zugman A,"Centro de Investigacion Biomedica en Red Salud Mental (CIBERSAM), Barcelona, Spain.; Instituto Ame Sua Mente, Sao Paulo, Brazil.; Instituto Nacional de siquiatria do Desenvolvimento (INPD), Sao Paulo, Brazil.; Swedish Collegium for Advanced Study (SCAS), Uppsala, Sweden.",Not available
39045914,Early intervention and cumulative life course impairment in psoriasis: a review.,2024-11-22,D'Amico D; Levi A; Di Fino S; Zucchi B,"AbbVie Srl, Campoverde di Aprilia, Lazio, Italy.; UO di Dermatologia - P.O. 'A. Pugliese' - Azienda Ospedaliero Universitaria 'Renato Dulbecco', Catanzaro, Italy.",Not available
39045440,Validation of the Spanish Childhood Trauma Questionnaire-Short Form in adolescents with suicide attempts.,2024-01-01,Martinez-Cao C; Sanchez-Fernandez-Quejo A; Andreo-Jover J; Ayad-Ahmed W; Diaz-Marsa M; Garrido-Torres N; Gomez S; Palao DJ; Zorrilla I; Perez V,"CIBER de Salud Mental, Instituto de Salud Carlos III, Madrid, Spain.; Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain.; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.",Not available
39044480,Stenopool: A Comprehensive Platform for Consolidating Diabetes Device Data.,2024-07-23,Jensen MT; Norgaard K,"Line Systems ApS, Copenhagen, Denmark.",Not available
39044426,A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders.,2024-10-02,McBlane F; Lion M; Mindur JE,"Novartis Pharma AG, Basel, Switzerland.; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA.",Not available
39043978,Tips and tricks in tremor treatment.,2024-01-01,Paus S,"Parkinson-Klinik Ortenau, GmbH & Co KG, Kreuzbergstrasse 12-16, 77709, Wolfach, Germany.","Department of Neurology, Neurologische Klinik und Poliklinik mit Friedrich Baur Institut, Ludwig-Maximilians University, Campus Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany. franziska.hopfner@med.uni-muenchen.de."
39043076,Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND).,2024-01-01,Makino M,"NTT Data Corp., Res. & Dev. Headquarters, Tokyo, Japan.",Not available
39042770,"Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study.",2024-08-01,Santos V; Larson TJ; Takeuchi M; Wang X,"Astellas Pharma Global Development Inc, Northbrook, IL.",Not available
39042425,Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial.,2024-07-23,Tascilar K; von der Decken CB,"AGEIS, Universite Grenoble Alpes, Grenoble, France.",Not available
39042318,How Digital Solutions Might Provide a World of New Opportunities for Holistic and Empathic Support of Patients with Hidradenitis Suppurativa.,2024-01-01,Boucher A; Peters M,"Novartis Pharma AG, Lichtstrasse 35, 4056, Basel, Switzerland.",Not available
39041585,One-Pot Synthesis of Glutathione Trisulfide from Oxidized Glutathione.,2024-08-02,Tomonaga S; Nuno T; Ishimaru H; Isobe T; Ohshima E; Kitagaki S,"Kyowa Pharma Chemical Co., Ltd., Chokeiji, Takaoka 933-8511, Toyama, Japan.",Not available
39041385,Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum.,2024-09-26,Badshah C; Boeckh M; Komatsu T; Westman G,"Centro de Investigacion Biomedica en Red Enfermedades Infecciosas, Valencia, Spain.; Division of Infectious Diseases, Johns Hopkins, Baltimore, Maryland, USA.; Merck & Co, Inc., Rahway, New Jersey, USA.; Takeda Pharmaceuticals Inc., Cambridge, Massachusetts, USA.",Not available
39041200,STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer.,2024-01-01,Smith R; Hecht JR,"Exelixis, Inc.Alameda, CA, USA.",Not available
39040895,Biologic drugs in hidradenitis suppurativa: what does the GP have to know? A narrative review.,2024-01-01,Thomas N; Alarcon I,"Novartis Pharma AG, Basel, Switzerland.",Not available
39040590,Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial.,2024-01-01,Song JW; Diefenbach C; Stowasser S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Instituto Nacional de Enfermedades Respiratorias ""Ismael Cosio Villegas"", Mexico City, Mexico.",Not available
39040578,Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics.,2024-01-01,Mange K; Teper A; Fernandez C; Conroy D,"Insmed Incorporated, Bridgewater, NJ, USA.",Not available
39040538,A systematic review of the epidemiology of pediatric autoimmune encephalitis: disease burden and clinical decision-making.,2024-01-01,Tennigkeit F,"UCB Biosciences, Monheim, Germany.",Not available
39040515,Process intensification of pharmaceutical powder blending at commercial throughputs by utilizing semi-continuous mini-blending.,2024-01-01,Jaspers M; Tegel F; Roelofs TP; Starsich F; Meir B; Dickhoff BHJ,"DFE Pharma, Klever Strasse 187, 47568 Goch, Germany.; Gericke AG, Althardstrasse 120, CH-8105 Regensdorf, Switzerland.",Not available
39039666,Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma.,2024-01-01,Pinto A; Ferreri AJM; Gritti G,"Dipartimento di Medicina Traslazionale, Universita del Piemonte Orientale SCDU Ematologia, AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.; Ematologia Oncologica, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Naples, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli"", Bologna, Italy.",Not available
39039635,Population Pharmacokinetic Modeling and Exposure-Response Analysis for the Antibody-Drug Conjugate Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Carcinoma.,2024-01-01,Zuo P; Bonate P; Garg A; Matsangou M; Tang M,"Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA.; Astellas Pharma, Inc., Northbrook, Illinois, USA.; Pfizer Inc., South San Francisco, California, USA.",Not available
39039386,Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison.,2024-01-01,Filomeno R,"Novo Nordisk Pharma Ltd., Tokyo, Japan.",Not available
39039282,Genome-wide association meta-analysis identifies five loci associated with postpartum hemorrhage.,2024-01-01,Stefansdottir L; Rohde PD; Wu X,"Methods and Analysis, Statistics Denmark, Copenhagen, Denmark.; deCODE genetics/Amgen, Reykjavik, Iceland.",Not available
39039153,New epilepsy therapies in development.,2024-01-01,Kaminski RM,"Angelini Pharma, Rome, Italy.","Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA. kleinp@epilepsydc.com."
39039102,A novel digital tool for detection and monitoring of amyotrophic lateral sclerosis motor impairment and progression via keystroke dynamics.,2024-07-22,Acien A; Scheier Z; Iwasaki S; Pascarella M; Johnson SA; Arroyo-Gallego T; Berry JD,"Area 2 AI Corporation, 245 Main St, Cambridge, MA, 02142, USA.; Mitsubishi Tanabe Pharma America, Inc, Jersey City, NJ, USA.; Mitsubishi Tanabe Pharma Corporation, Osaka, Osaka, Japan.; ProKidney Corporation, Winston-Salem, NC, USA.",Not available
39038918,Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases.,2024-07-22,Ghosh CC; Liu Y; Ballarin A; LaPorte J; Morrissey M; Fraser K; Perati S; Cox BF; Guha P; Katz SC,"Trisalus Life Sciences, Westminster, Colorado, USA.",Not available
39038917,First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors.,2024-07-22,Grund-Groschke S; Aslan K; Satelli A; Marisetty A; Satam S; Kalra M; Hukelmann J; Kursunel MA; Pozo K; Acs A; Backert L; Baumeister M; Bunk S; Wagner C; Schoor O; Mohamed AS; Mayer-Mokler A; Hilf N; Krishna D; Walter S; Tsimberidou AM,"Immatics Biotechnologies GmbH, Tuebingen, Germany.; Immatics US, Inc, Houston, Texas, USA.","Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany Martin.Wermke@uniklinikum-dresden.de."
39038915,"Disability and long-term breathlessness: a cross-sectional, population study.",2024-07-22,Johnson M,"service de pneumologie departement R3S, Hopital Pitie-Salpetriere, Paris, Ile-de-France, France.","Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia slavica.kochovska@uow.edu.au."
39038545,Understanding the role of swirling flow in dry powder inhalers: Implications for design considerations and pulmonary delivery.,2024-01-01,Shi K; Dong J; Ma Y,"Particle Technology Research Centre, Department of Chemical and Biochemical Engineering, University of Western Ontario, London, Ontario N6A 5B9, Canada; Suzhou Inhal Pharma Co., Ltd, 502-Bldf A SIP, 108 Yuxin Road, Suzhou 215125, China.",Not available
39038479,"Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial.",2024-01-01,Li J; Zhang J; Pilot R; Pozharskaya V; Keeperman KL; Rose S; Prebet T; Lai Y; Paolini S; Cluzeau T; Fenaux P,"Bristol Myers Squibb, Princeton, NJ, USA.; Departement d'Hematologie Clinique, Universite Cote d'Azur, CHU Nice, Nice, France.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli"", Bologna, Italy.; Service d'Hematologie Seniors, Hopital Saint-Louis, Universite Paris 7, Paris, France.","Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.edu."
39038457,Prevalence and prognostic role of thoracic lymphadenopathy in Covid-19.,2024-07-22,Penzkofer T,"Diagnostic and Interventional Radiology, Universitatsklinikum Leipzig, Germany.",Not available
39038086,Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.,2024-07-23,Storey RF,"ACTION Group, Institut de Cardiologie, Hopital Pitie-Salpetriere, Assistance Publique-Hopitaux de Paris, Sorbonne Universite, France (G.M.).",Not available
39037824,Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin Studies.,2024-09-01,Block GA; Menzaghi F; Wen W,"Cara Therapeutics, Stamford, Connecticut.; US Renal Care, Inc., Denver, Colorado.",Not available
39037800,Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.,2024-09-17,Kalabic J; Chen S; Cheng L; Shu L; Duan WR; Pivorunas V; Sanchez Gonzalez Y; D'Cunha R; Neimark E; Wallace K; Atreya R,"AbbVie Deutschland GmbH and Co KG, Ludwigshafen, Germany.; AbbVie Inc, North Chicago, Illinois.",Not available
39037596,Pulmonary embolism as an incidental finding in [(15)O]H(2)O PET/CT myocardial perfusion imaging.,2024-01-01,Gormsen LC,"Medtrace Pharma A/S, Horsholm, Denmark.","Department of Nuclear Medicine & PET-Centre, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, 8200, Denmark. julnag@rm.dk."
39037564,High-intensity care for GDMT titration.,2024-01-01,Ponikowski P; Mebazaa A,"Heart Initiative, Durham, NC, USA.; Universite Paris Cite, INSERM UMR-S 942(MASCOT), Paris, France.","Institute of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Borowska 213, Poland. jan.biegus@umw.edu.pl."
39037536,Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy.,2024-01-01,Guittar J; Mitra A; Driessen T; Schwind R; Stein MM; Kaneva K; Hyun SW; Liu Y; Dugan AJ; Vibat CRT; Sangli C; Freaney J; Rivers Z; Lo C; Sasser K; Nimeiri H,"Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA.",Not available
39037383,"Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality.",2024-08-01,Osuna-Gomez R,"CIBER-BBN, Centro de Investigacion Biomedica en Red de Bioingenieria, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.",Not available
39037192,Effect of Mediterranean diet or mindfulness-based stress reduction during pregnancy on placental volume and perfusion: A subanalysis of the IMPACT BCN randomized clinical trial.,2024-01-01,Denaro E; Casas I; Pozo OJ; Estruch R; Gratacos E; Crispi F,"Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Institut de Recerca Sant Joan de Deu, Esplugues de Llobregat, Spain.; Instituto de Investigacion Sanitaria Aragon (IISAragon), Red de Salud Materno Infantil y del Desarrollo (SAMID), RETICS, Instituto de Salud Carlos III (ISCIII), Subdireccion General de Evaluacion y Fomento de la Investigacion y Fondo Europeo de Desarrollo Regional (FEDER), Zaragoza, Spain.",Not available
39036442,"Regulatory systems and requirements for clinical trials of AAV-based gene therapies - Perspectives from six Asian countries or regions: Report from the 6th Asia Partnership Conference of Regenerative Medicine - April 20, 2023.",2024-01-01,Mizoguchi H; Zhang AJ; Komuro M; Cheun WK; Chiu CW,"Astellas Pharma Inc., Regulatory Affairs, 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan.; Help Therapeutics Co. Ltd., 568 Longmian Avenue, Jiangning District, Nanjing, PR China.; Novartis Asia Pacific Pharmaceuticals Pte Ltd., Regulatory & Development Policy, Regulatory Affairs, Singapore.; Sanofi K.K., Regulatory Affairs, Tokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, 163-1488, Japan.; TFBS Bioscience Inc., 3F., No.103, Ln. 169, Kangning St., Xizhi Dist., New Taipei City, Taiwan.",Not available
39036087,Human induced pluripotent stem cells-derived liver organoids grown on a Biomimesys(R) hyaluronic acid-based hydroscaffold as a new model for studying human lipoprotein metabolism.,2024-01-01,Caillaud A; Bray L; Patitucci M; Delpouve G; Le May C; Maubon N; Si-Tayeb K,"CRNH-Ouest Mass Spectrometry Core Facility Nantes France.; HCS Pharma Lille France.; Inserm, UMR 1188 Diabete Atherothrombose Therapies Reunion Ocean Indien (DeTROI) Universite de La Reunion Saint-Denis de La Reunion France.",Not available
39034992,Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.,2024-01-01,Pipitone S; Fratino L; Nole F,"SS Oncologia Medica Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; SSD Oncologia Medica, Azienda Sanitaria Locale (ASL) Sulcis, Cagliari, Italy.; UOC Oncologia, AULSS 6 Euganea, Ospedale di Camposampiero, Padova, Italy.",Not available
39034968,Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial.,2024-01-01,Carcereny E; Martini JF; Wang E; De Beukelaer S,"Institut Catala d'Oncologia de Badalona, Servicio de Oncologia Medica, Badalona, Spain.; Pfizer, San Diego, California.; Present address: IDEAYA Biosciences, South San Francisco, California.",Not available
39034668,Functional Neurological Disorders Among Patients With Tremor.,2024-07-22,Baizabal-Carvallo JF; Alonso-Juarez M; Jankovic J,"Department of Sciences and Engineering, University of Guanajuato, Campus Leon, Leon, Mexico (Baizabal-Carvallo); Instituto Politecnico Nacional, Mexico City, Mexico (Alonso-Juarez).; Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston (Baizabal-Carvallo, Jankovic)",Not available
39034363,"Impact of trazodone once-a-day on quality of life and functional recovery in adults with major depressive disorder: A prospective, observational study.",2024-01-01,Margolis MK; Fallone R,"Evidera-PPD, Bethesda, Maryland, USA.",Not available
39034203,Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib.,2024-01-01,Treskes P; Buckley S; Roman-Torres K,"IQVIA CSMS Germany GmbH, Mannheim, Germany.; Sobi Inc., Waltham, MA.","Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: n.gagelmann@uke.de."
39033924,Effect of Brolucizumab and Aflibercept on the Maximum Thickness of Pigment Epithelial Detachments and Sub-Retinal Pigment Epithelium Fluid in HAWK and HARRIER.,2025-01-01,Kempf AS; Saffar I; Gedif K,"Novartis Pharma AG, Basel, Switzerland.","Reno School of Medicine, University of Nevada, Reno, Nevada. Electronic address: arshad.khanani@gmail.com."
39033770,"Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study.",2024-01-01,Abada PB; Ho C; McNeely SC; Marella N; Nguyen B; Wang C; Ruppert AS; Nair B; Liu H; Tsai DE; Ghia P,"Eli Lilly, Indianapolis, IN, USA.; Loxo Oncology, Indianapolis, IN, USA.; Universita Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.","The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: wwierda@mdanderson.org."
39033766,"Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.",2024-08-03,Baranowski K; Korn S; Kurvits M; Plohberger U; Strange Vest N,"LEO Pharma, Ballerup, Denmark.","Innovaderm Research, Montreal, QC, Canada. Electronic address: rbissonnette@innovaderm.com."
39033692,A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion-mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study.,2024-01-01,Schioppa CA; Diels J; Rodrigues BH; Rahhali N; Sermon J; Ghilotti F,"Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B-2340, Belgium.; Janssen-Cilag NV, Turnhoutseweg 30, Beerse B-2340, Belgium.; Janssen-Cilag SpA, Via Michelangelo Buonarroti, 23, Cologno Monzese 20093, Italy.; Janssen-Cilag, 1 rue Camille Desmoulins, Issy-les-Moulineaux 92130, France.; Janssen-Cilag, Lagoas Park, Edificio 9, Porto Salvo 2740-262, Portugal.","Institut Curie, Institut du Thorax Curie-Montsouris, 42 Bd Jourdan, Paris 75014, France. Electronic address: nicolas.girard2@curie.fr."
39033284,Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems.,2024-07-20,Kumar S; Schwartz RE; Cohn K,"NASHNET, 29 Broadway, Floor 26, New York, NY, 10003, USA.; Weill Cornell Medicine, 1305 York Avenue, 4 Floor, New York, NY, 10021, USA.",Not available
39033013,Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration.,2024-08-01,Viola F,"Macula, Vitreous and Retina Associates of Costa Rica, San Jose, Costa Rica.","Faculty of Medical and Health Sciences, Ophthalmology Division, Tel Aviv University, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel dinahzur@gmail.com dinagz@tlvmc.gov.il."
39032943,Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee.,2024-07-20,Warren S; Barrett JC; Garnett-Benson C; Topp B,"Bristol Myers Squibb, Princeton, New Jersey, USA.; Gilead Sciences, Seattle, Washington, USA.; Merck and Co, Rahway, New Jersey, USA.; Precede Biosciences, Boston, Massachusetts, USA.",Not available
39032397,Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease after first-line chemotherapy: An ad hoc subgroup analysis of PRIMA/ENGOT-OV26/GOG-3012.,2024-01-01,York W; Malinowska IA,"GSK, Philadelphia, PA, USA.","Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: mitchell.kamrava@cshs.org."
39031963,Health-related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial.,2024-01-01,Inocencio TJ; Lewis KD; Ivanescu C; Fury MG; Chen CI; Quek RGW,"IQVIA, Durham, North Carolina, USA.; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.",Not available
39031889,Best of both worlds: An expansion of the state of the art pK(a) model with data from three industrial partners.,2024-01-01,Fraczkiewicz R; Quoc Nguyen H; Wu N,"Genentech Inc., Discovery Chemistry, 1 DNA Way, South San Francisco, CA 94080, USA.; Simulations Plus, Inc., 42505 10th Street West, Lancaster, CA 93534, USA.",Not available
39031849,Physiologically-based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co-administered with ritonavir.,2024-01-01,Peng Y; Liu X; Zhang Y; Zhao X; Liu Z,"Sunshine Lake Pharma Co., Ltd, Dongguan, China.",Not available
39030997,Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignancies.,2024-01-01,Kumar P; Sumi H; Hizukuri Y; Hong Y; Patel P; Seki T; Duan T; Lesegretain A,"Daiichi Sankyo Co., Tokyo, Japan.; Daiichi Sankyo Inc., Basking Ridge, New Jersey, USA.",Not available
39030931,Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors.,2025-01-01,Fera T; Moore MR; Turck CJ; Fanikos J,"Mass General Brigham, Boston, MA, USA. RINGGOLD: 1813; Project Consultant, Greater Pittsburgh Area, PA, USA.; Scientia Perpetuam, LLC, Greater Chicago Area, IL, USA.; ScientiaCME, Inc., Los Angeles, CA, USA.",Not available
39030751,Statistical considerations when estimating time-saving treatment effects in Alzheimer's disease clinical trials.,2024-01-01,Mangal B; Liao Y; Llibre-Guerra JJ; Bateman RJ,"F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Neogene Therapeutics, Inc., Santa Monica, California, USA.; Solara Consulting Corp., North Vancouver, British Columbia, Canada.; Tenaya Therapeutics, South San Francisco, California, USA.",Not available
39030735,Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies.,2024-01-01,Polega S; Lothe A,"UCB, Colombes, France.; UCB, Smyrna, Georgia, USA.",Not available
39029295,Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC.,2024-01-01,Girard N; Snyder W; Tran Q; Kormany W; Houk B; Mehta B,"Amgen Inc., Thousand Oaks, CA, USA.; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France; UVSQ, Paris Saclay, Versailles, France.","Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria. Electronic address: maximilian.hochmair@gesundheitsverbund.at."
39029076,Multimodal imaging analysis of autosomal recessive bestrophinopathy: Case series.,2024-07-19,Hayashi T; Kameya S,"Topcon Corporation, Itabashi, Tokyo, Japan.",Not available
39028876,Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.,2024-10-24,Lozenski K; Langston A; Horan JT; Watkins B; Gomez-Caminero A; Pasquini MC,"Bristol Myers Squibb, Princeton, NJ.; Cytel Inc, Waltham, MA.",Not available
39028412,A Randomised Controlled Trial of SFX-01 After Subarachnoid Haemorrhage - The SAS Study.,2024-07-19,Howat D; Franklin S,"Evgen Pharma, Nether Alderley, UK.",Not available
39028259,DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms.,2024-01-01,Wu CH,"Uni-Pharma Co-Ltd, Taipei, Taiwan.",Not available
39028130,Adverse Effects of Nicotine on Human Sperm Nuclear Proteins.,2024-07-11,Tofighi Niaki M,"LogixX Pharma Ltd., Theale, Berkshire, UK.",Not available
39026628,Effect of Qualifying Atherosclerotic Cardiovascular Disease Diagnosis Proximity on Cardiovascular Risk and Benefit of Empagliflozin in the EMPA-REG OUTCOME Trial.,2024-01-01,Udell JA,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.",Not available
39026098,"Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis ""Nutra NMA SCZ"".",2025-01-01,Correll CU,"Fondation FondaMental Fondation de Cooperation Scientifique en Sante Mentale, Universite Paris Est, Creteil, France.","Department of Neuroscience, Reproductive Sciences, and Dentistry, Section of Psychiatry, University School of Medicine Federico II, Naples, Italy. dott.fornaro@gmail.com."
39025756,Completeness of revascularization by FFR(CT) in stable angina: Association to adverse cardiovascular outcomes.,2024-01-01,Rogers C; Mullen S,"HeartFlow Inc., Mountain View, CA, USA.","Department of Cardiology, University Hospital of Southern Denmark, Esbjerg, Denmark. Electronic address: kristian.taekker.madsen2@rsyd.dk."
39025748,Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials.,2024-01-01,Liu VYT; Royce TJ,"Artera Inc., Los Altos, CA, USA.","University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA. Electronic address: daniel.spratt@uhhospitals.org."
39025478,Pd-Catalyzed C(sp(2))-H/C(sp(2))-H Coupling of Limonene.,2024-08-02,Gallou F,"Novartis Pharma AG, CH-4057 Basel, Switzerland.",Not available
39025065,"Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study.",2024-10-11,An D; Bishop KM,"Acadia Pharmaceuticals, Inc., San Diego, CA, USA.",Not available
39024860,Monitoring and integrated care coordination of patients with alpha-mannosidosis: A global Delphi consensus study.,2024-01-01,Garcia-Ortiz JE,"Division of Genetics, Centro de Investigacion Biomedica de Occidente (CIBO) del Instituto Mexicano de Seguro Social (IMSS), Guadalajara, Mexico.","Reference Centre for Inherited Metabolic Diseases (CERLYMM), Hospices Civils of Lyon (HCL), Lyon, France. Electronic address: nathalie.guffon-fouilhoux@chu-lyon.fr."
39024856,Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition.,2024-01-01,Saoud JB; Davidson M; Kuchibhatla R; Luthringer R,"Department of Basic and Clinical Sciences, Psychiatry, University of Nicosia Medical School, 2414, Nicosia, Cyprus.; Minerva Neurosciences, Inc., Burlington, MA, USA; Minerva Neurosciences, Inc., Burlington, MA, USA.; Pharmaceutical Product Development Associates, LLC, Groton, MA, USA.",Not available
39023568,"Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.",2024-07-18,Sloan A,"Ronald N. Shore Dermatology, Rockville, MD, USA.",Not available
39023287,PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer.,2024-01-01,Gopinathan A,"Grupo Brasileiro de Oncologia Toracica, Porto Alegre, Brazil.",Not available
39023227,Evaluation of romosozumab's effects on bone marrow adiposity in postmenopausal osteoporotic women: results from the FRAME bone biopsy sub-study.,2024-09-02,Libanati C,"UCB Pharma, Brussels, Belgium.",Not available
39022387,The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.,2024-01-01,Stepanova M,"Departamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.",Not available
39022351,Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice.,2024-07-12,Gargiulo M,"Miuli Pharma S.r.l., via Circumvallazione, Nola 310 80035, Italy.",Not available
39022226,Clinical validation of fully automated laminar knee cartilage transverse relaxation time (T2) analysis in anterior cruciate ligament (ACL)-injured knees- on behalf of the osteoarthritis (OA)-Bio consortium.,2024-07-01,Eckstein F; Berenbaum F; Duda GN,"Chondrometrics GmbH, Freilassing, Germany.",Not available
39020362,Long-term safety and effectiveness of lurasidone in adolescents and young adults with schizophrenia: pooled post hoc analyses of two 12-month extension studies.,2024-07-18,Calisti F; Mao Y; Goldman R,"Angelini Pharma S.P.A, Viale Amelia, 70, 00181, Rome, Italy.; Former Employee of Sumitomo Pharma America, Inc, 84 Waterford Drive, Marlborough, MA 01752, USA.; Sumitomo Pharma America, Inc, 84 Waterford Drive, Marlborough, MA, 01752, USA.",Not available
39020361,Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies.,2024-07-18,Popp J; Peyratout G,"Fundacion CITA-Alzheimer Fundazioa, San Sebastian, Spain.","Department of Psychiatry and Neuropsychology, Alzheimer Centrum Limburg, School for Mental Health and Neuroscience, Maastricht University, P.O. Box 616, Maastricht, 6200 MD, The Netherlands. a.delvenne@maastrichtuniversity.nl."
39020051,"Development of a first-in-class antibody and a specific assay for alpha-1,6-fucosylated prostate-specific antigen.",2024-07-17,Hillringhaus L; Hojer C; Muranyi A; Schraeml M; Tabares G,"Roche Diagnostics GmbH, Nonnenwald, Penzberg, Germany.; Roche Diagnostics Solutions, Tucson, AZ, USA.",Not available
39019993,Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgery.,2024-07-17,Hakamada K,"NOMON Co. Ltd., Kasumigaseki, Chiyoda-Ku, Tokyo, Japan.",Not available
39019698,Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer.,2024-01-01,Baurain JF; Fabbro M; Braicu EI; Prendergast E; Taylor A; Kheibarshekan L; Zhang ZY; Jewell RC; Gupta D,"Certara Inc., Princeton, NJ, USA.; Charite-Universitatsmedizin and Arbeitsgemeinschaft Gynakologische Onkologie (AGO), Berlin, Germany.; Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium.; GSK, Cambridge, MA, USA.; GSK, Durham, NC, USA.; Institut du Cancer de Montpellier, Montpellier, France, and Groupe d'Investigateurs Nationaux pour les Etudes des Cancers de l'Ovaire (GINECO).; Minnesota Oncology, Minneapolis, MN, USA.","present affiliation, The GOG Foundation, Inc., and Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA. Electronic address: bmonk@gog.org."
39019527,"Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF.",2024-07-23,Mebazaa A; Davison B; Cotter G; Cohen-Solal A; Deniau B; Gayat E,"Department of Anesthesiology and Critical Care and Burn Unit, Saint-Louis and Lariboisiere Hospitals, FHU PROMICE, DMU Parabol, APHP Nord, Paris, France.; Department of Cardiology, APHP Nord, Lariboisiere University Hospital, Paris, France.; Heart Initiative, Durham, North Carolina, USA.; Momentum Research Inc, Durham, North Carolina, USA; Universite Paris Cite, INSERM UMR-S 942(MASCOT), Paris, France","Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. Electronic address: janbiegus@gmail.com."
39019200,Assessment of corrected JT-peak (JTpc) and Tpeak-to-Tend (TpTec) as proarrhythmia biomarkers in non-human primates: Outcome from a HESI consortium.,2024-01-01,Boulay E; Authier S; Bartko T; Leishman D; Li D; Nichols JV; Rossman EI; Valentin JP; Walisser J; Troncy E; Wisialowski TA,"Charles River Laboratories, Laval, Quebec, Canada; Eli Lilly and Company, Indianapolis, IN, USA.; GREPAQ (Groupe de recherche en pharmacologie animale du Quebec), Universite de Montreal, St-Hyacinthe, Quebec, Canada.; GSK, King of Prussia, PA, USA.; Labcorp Early Development Laboratories Inc, Madison, WI, USA.; Pfizer, Inc, Groton, CT, USA.; UCB Biopharma SPRL, Brussels, Belgium.",Not available
39018512,Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses.,2024-08-13,Williams MJ; Amezcua L; Cohan SL; Cohen JA; Delgado SR; Hua LH; Lucassen EB; Piccolo RS; Koulouris CR; Stankiewicz J,"Cleveland Clinic Lou Ruvo Center for Brain Health (L.H.H.), Las Vegas, NV; Cleveland Clinic Mellen Center (J.A.C.) OH; Department of Neurology (S.R.D.), University of Miami Miller School of Medicine, FL; From the Joi Life Wellness MS Center (M.J.W.), Atlanta, GA; Novartis Pharmaceuticals Corporation (E.B.L., R.S.P., J.S.), East Hanover, NJ; Providence Multiple Sclerosis Center (S.L.C.), Providence Brain and Spine Institute, Portland, OR; University of Southern California (L.A.), Los Angeles; and Envision Pharma, Inc. (C.R.K.), Horsham, United Kingdom.",Not available
39018073,Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia: An Open-Label Extension Study of a Randomized Clinical Trial.,2024-07-01,Sun L; Sajatovic M,"Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, New Jersey.",Not available
39018038,Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.,2024-08-01,Machkova M; Zhang P; Linaberry M; Li J; Zhang S; Franchin G; Charles ED; De Oliveira CHMC,"Bristol Myers Squibb, Princeton, New Jersey.; CCR Czech Prague, Prague, Czech Republic.",Not available
39018020,The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study.,2024-12-23,Nagra R,"Pfizer Ltd, Tadworth, UK.",Not available
39017907,Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry.,2024-01-01,Sugiyama N; Yamanaka H,"Biometrics and Data Management, Pfizer R&D Japan, Tokyo, Japan.; Inflammation & Immunology, Pfizer Japan Inc, Tokyo, Japan.","Department of Rheumatology, Sanno Hospital, 8-10-16 Akasaka, Minato-ku, Tokyo, 107-0052, Japan. mharigai@iuhw.ac.jp."
39016335,Viral and non-viral episodes of wheezing in early life and the development of asthma and respiratory phenotypes among urban children.,2024-01-01,Calatroni A; Jackson DJ; Bacharier LB,"GSK, Philadelphia, Pennsylvania, USA.; Thermo Fisher Scientific, Wilmington, North Carolina, USA.",Not available
39016187,How debunking biases in research and development decisions could lead to more equitable healthcare?,2024-01-01,Weber B; Visser SAG,"Lansdale, Pennsylvania, USA.; NovoNordisk, Copenhagen, Denmark.",Not available
39016172,Public health management of pertussis in adults: Practical challenges and future strategies.,2024-12-31,Sampson K; Sobczyk E,"AMDA - The Society for Post-Acute and Long-Term Care Medicine, Columbia, SC, USA.; Immunisation Coalition, Melbourne, Australia.",Not available
39015768,Cognitive function in severe progressive multiple sclerosis.,2024-01-01,Wicks TR; Benedict RHB,"The Boston Home, Dorchester, MA 02124, USA.",Not available
39015407,Suppression of toxic transgene expression by optimized artificial miRNAs increases AAV vector yields in HEK-293 cells.,2024-09-12,Blahetek G; Mayer C; Strobel B,"Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany.",Not available
39014996,Quality of life from childhood to adulthood: Perspectives from adult patients with pediatric-onset intestinal failure.,2024-01-01,Ladner A,"The Gutsy Perspective, Huntsville, Alabama, USA.",Not available
39014498,The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.,2024-07-16,van Enst A,"Nederlandse Vereniging Voor Dermatologie en Venereologie, NVDV, Utrecht, the Netherlands.","Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, Amsterdam Public Health, Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands. e.knops@amsterdamumc.nl."
39014486,High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia.,2024-07-17,Jansz N,"UCB Pharma, Smyrna, GA, USA.",Not available
39014480,Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium.,2024-07-17,Miederer M,"Institut fur Radiopharmazie, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstrasse 400, D-01328, Dresden, Germany.",Not available
39014446,BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study.,2024-07-16,Pearson ER; Dawed AY,"IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.; Lilly Deutschland GmbH, Bad Homburg, Germany.",Not available
39014160,Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy.,2024-07-16,Rudin CM,"Informatics Systems, Memorial Sloan Kettering Cancer, New York, NY, USA.","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. arielle.elkrief@umontreal.ca."
39013870,Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial.,2024-07-16,Savoye AM; Derbel O; Martinez A; Martinez M; Collard O,"GINECO and Clinique Pasteur, Toulouse, France.; GINECO and Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, France.; GINECO and Institut Jean Godinot, Reims, France.; GINECO and Institut de Cancerologie de la Loire, Saint-Priest-en-Jarez, France.; GINECO and Institut de Cancerologie, Hopital Prive Jean Mermoz, Lyon, France.","Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Leon Berard, University Claude Bernard, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr."
39013654,"Study protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone.",2024-07-16,Tudor IC; Moraitis AG,"Corcept Therapeutics Incorporated, Menlo Park, California, USA.",Not available
39013265,Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy.,2024-01-01,Braicu EI; York W; Malinowska IA,"Charite Universitatsmedizin and Arbeitsgemeinschaft Gynakologische Onkologie (AGO), Berlin, Germany.; GSK, Philadelphia, PA, USA.; GSK, Waltham, MA, USA.","Integrated Cancer Center, AZ Maria Middelares, Ghent, and Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium. Electronic address: christof.vulsteke@mijnziekenhuis.be."
39013243,Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study.,2024-01-01,Clougher D; Forte MF; Mezquida G; Sanchez-Torres AM; Serra-Navarro M; Penades R; Martinez-Aran A; Ramos-Quiroga JA; Bernardo M; Amoretti S,"BIOARABA, Department Psychiatry. Hospital Universitario de Alava. CIBERSAM. University of the Basque Country, Vitoria, Spain.; Barcelona Clinic Schizophrenia Unit, Hospital Clinic de Barcelona; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona; CIBERSAM, ISCIII, Barcelona, Spain; CIBERSAM, ISCIII, Barcelona, Spain.; Departament de Medicina, Institut de Neurociencies (UBNeuro), Universitat de Barcelona (UB); Departamento de Ciencias de la Salud, Universidad Publica de Navarra (UPNA), Campus de Arrosadia, 31006, Pamplona, Espana.; Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain; Fundacio Clinic-Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS); Group of Psychiatry, Mental Health and Addictions, Valld'Hebron Research Institute (VHIR); Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS); Navarra Institute of Health Research (IdiSNA), Pamplona, Spain Department of Health Sciences, Universidad Publica de Navarra, Pamplona, Spain; Psychiatric Genetics Unit, Valld'Hebron Research Institute (VHIR); Serra-Hunter Fellow, Department of Basic Clinal Practice, Pharmacology Unit, University of Barcelona.",Not available
39012413,Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease.,2024-01-01,Shupo F; Wayi-Wayi G; Zibelnik N,"EUSA Pharma (UK), Hemel Hempstead, UK.",Not available
39012406,Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance.,2024-01-01,Tsumuraya T; Yamashita K,"Drug Safety Division, Chugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, 103-8324, Japan.","Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4 Chome-1-1 Ogawahigashicho, Kodaira, Tokyo, 187-8551, Japan. yamamura@ncnp.go.jp."
39012325,A Modern Curriculum for Training Scientists in Model-Informed Drug Development: Progress Report on FDA Grant to Train Regulatory Scientists.,2024-01-01,Rayner C; Tannenbaum S; Kern S,"Astellas Pharma, Northbrook, Illinois, USA.; CP+ Associates GmbH, Basel, Switzerland.; Certara, Princeton, New Jersey, USA.",Not available
39011068,iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease Control.,2024-01-01,Zavod M; Hagger L,"Content Strategy & Experience Design, Digital Global Commercial, AstraZeneca, Gaithersburg, MD, USA.; User Experience, AstraZeneca, Wilmington, DE, USA.",Not available
39009804,The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis.,2024-01-01,Piruzeli MLB; Pierce E; Garcia Gil E; Jarell AD,"Eli Lilly and Company, Indianapolis, IN, USA.","Southern California Dermatology, 1125 E 17th St., Santa Ana, CA, 92701, USA. doctorsoung@gmail.com."
39009409,Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis.,2024-01-01,Emson C,"Translational Medicine, Horizon Therapeutics (now Amgen, Inc.), Rockville, MD, USA.",Not available
39009229,"Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study.",2024-01-01,Wu J; Ardeleanu M; Ozturk ZE,"Regeneron Pharmaceuticals Inc., Tarrytown, New York.; Sanofi, Bridgewater, New Jersey.; Sanofi, Cambridge, Massachusetts.","Department of Dermatology, Medicine and Rheumatology, UT Southwestern Medical Center, Dallas, Texas. Electronic address: joseph.merola@gmail.com."
39009041,Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical Assays.,2024-07-25,Gerstberger T; Berger H; Buttner FH; Gmachl M; Kessler D; Koegl M; Lucas S; Martin LJ; Mayer M; McConnell DB; Mitzner S; Scholz G; Treu M; Wolkerstorfer B; Zahn S; Zak KM; Jaeger PA; Ettmayer P,"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, D-88397 Biberach, Germany.; Boehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, A-1121 Vienna, Austria.",Not available
39008826,Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial.,2024-09-01,Carton I; Chevalier N; Guivarc'h-Leveque A,"Reproductive Medicine, Clinique Mutualiste La Sagesse, Rennes, France.; Reproductive Medicine, Clinique Saint Roch, Montpellier, France.",Not available
39008225,Bridging the Gap: Comparing Patient-Clinician Views on Treatment Goals and Communication in the Management of Atopic Dermatitis Within the Asia-Pacific Region.,2024-01-01,Liao HF,"Pfizer Ltd, Taipei, Taiwan.",Not available
39008191,Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials.,2024-07-15,Rodriguez D,"Evidera, Seattle, WA, USA.","Evidera, Ivry-sur-Seine, France. carla.dias-barbosa@evidera.com."
39008024,Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports.,2024-01-01,Levy G; Ali M; Lacerda AP; Wegrzyn L; Palac H; Scialli AR,"AbbVie, Inc., Chicago, IL, USA.; Scialli Consulting LLC, Washington, DC, USA.","Division of Gastroenterology and Hepatology, University of California San Francisco, 1701 Divisadero Street #120, San Francisco, CA, 94010, USA. Uma.mahadevan@ucsf.edu."
39007560,Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps.,2024-08-07,Alm RA; Melchiorri D; Arias CA; Cameron AM,"AMR Solutions, Boston, Massachusetts, USA.; Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, Boston, Massachusetts, USA.; WHO Consultants to the WHO AMR Division, Geneva, Switzerland.",Not available
39007525,"Consensus panel recommendations for the optimization of EPIDIOLEX(R) treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.",2024-01-01,Wechsler RT,"Consultants in Epilepsy and Neurology, Boise, Idaho, USA.",Not available
39007449,Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age.,2024-01-01,Yoshisue H; Homma Y; Ito C; Ebisawa M,"JMDC Co. Ltd, Tokyo, Japan.; Novartis Pharma K.K., Tokyo, Japan.",Not available
39007062,Real-life efficacy of immunotherapy for Sezary syndrome: a multicenter observational cohort study.,2024-01-01,Beylot-Barry M; Pham-Ledard A; Moins-Teisserenc H; Boulinguez S,"INSERM U976, Institut de Recherche Saint-Louis, Paris, France.",Not available
39006917,Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).,2024-01-01,Laws E; Nivens MC; Maloney J; Shi G; Bansal A; Dubost-Brama A,"Regeneron Pharmaceuticals Inc, Tarrytown, New York.; Sanofi, Bridgewater, New Jersey.; Sanofi, Gentilly, France.",Not available
39006526,"Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.",2024-01-01,Bakker A; Blakeley JO; Azizi AA; Legius E,"AstraZeneca Oncology R&D, Cambridge, UK.; Berry Consultants, Abingdon, UK.; Biostatistics & Pharmacometrics, Novartis Pharma AG, Basel, Switzerland.; Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt Universitat zu Berlin, Berlin, Germany.",Not available
39006447,"Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling.",2024-07-05,Lehto K; Deckert J,"23andMe, Sunnyvale, CA, USA.",Not available
39006439,Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomas.,2024-07-05,Ewalt MD,"Genmab, Princeton, NJ.",Not available
39005761,"Screening, Synthesis, and Characterization of a More Rapidly Dissolving Celecoxib Crystal Form.",2024-07-09,Lusi M,"Custom Pharma Services, Brighton and Hove, East Sussex BN3 3LW, U.K.",Not available
39004647,"SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study.",2024-07-15,Jiao Z; Zhao K; Song K; Li Y; Shi W,"Geneplus-Beijing, Co., Ltd., Beijing, 102206, China.; Jiangsu Hengrui Pharmaceuticals, Co., Ltd., Shanghai, 200120, China.",Not available
39004550,"Real-life data on biliary tract cancers in France: The nested Amber study from the French ACABi GERCOR PRONOBIL retro-prospective, observational cohort.",2025-01-01,Boileau C; Ducroux A; Neuzillet C,"Association pour l'etude des Cancers et Affections des voies Biliaires (ACABi), France; AstraZeneca France, Courbevoie, France.; Department of Medical Oncology, Gastrointestinal Oncology, Institut Curie, Universite Versailles Saint-Quentin-Universite Paris-Saclay, Saint-Cloud, France; GERCOR, Paris, France.","GERCOR, Paris, France. Electronic address: matthieu.delaye@curie.fr."
39004432,Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis.,2024-07-14,Panni T; Bolce R; Liu-Leage S; Janos B; Nissen MJ,"Arthritis Associates, San Antonio, Texas, USA.; Eli Lilly and Company, Indianapolis, Indiana, USA.","Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands sofiaramiro@gmail.com."
39004117,Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1.,2024-07-14,Farag A; Bachelez H; Leparc G; Delic D; Lang B; Thoma C,"Boehringer Ingelheim Pharma, Biberach, Germany.; INSERM Unite 1163, Imagine Institute of Genetic Diseases, Universite Paris Cite, Paris, France.; Service de Dermatologie, Assistance Publique-Hopitaux de Paris Hopital Saint-Louis, Paris, France",Not available
39003801,Cognitive reserve and cognition in mood disorders: A systematic review and meta-analysis.,2024-01-01,Camprodon-Boadas P; De Prisco M; Sugranyes G; Clougher D; Baeza I; Torrent C; Castro-Fornieles J; Tosetti Y; Vieta E; de la Serna E; Amoretti S,"BIOARABA, Department of Psychiatry. Hospital Universitario de Alava. University of the Basque Country, Vitoria, Spain.; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Barcelona, Spain; Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, Barcelona, Spain.; Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM; Centro de Investigacion Biomedica en Red de Salud Mental, CIBERSAM.; Department of Child and Adolescent Psychiatry and Psychology, 2021SGR01319, Institute of Neuroscience, Hospital Clinic de Barcelona, Barcelona, Spain; Department of Medicine, Institute of Neuroscience, University of Barcelona, Spain.; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Group of Psychiatry, Mental Health and Addictions, Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Fundacio de Recerca Clinic Barcelona-Institut d Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","Department of Medicine, Institute of Neuroscience, University of Barcelona, Spain. Electronic address: camprodon@recerca.clinic.cat."
39003659,Prevalence of Tendon Rupture and Tendinopathies Among Patients with Atherosclerotic Cardiovascular Disease Derived From United States Administrative Claims Data.,2024-01-01,Grady-Benson JC; Edwards A; Thompson PD,"Esperion Therapeutics Inc., Ann Arbor, MI, USA.; Orthopedic Associates of Hartford PC, Hartford, CT, USA.","Esperion Therapeutics Inc., Ann Arbor, MI, USA. kristin.mariek@gmail.com."
39003387,"Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial.",2024-07-13,Russo E,"CReDO Science, Vashon, WA, USA.","Department of Psychology, Washington State University, PO Box 644820, Pullman, WA, 99164-4820, USA. carrie.cuttler@wsu.edu."
39003185,MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC.,2024-01-01,Girard N,"Institut du Thorax Curie Montsouris, Institut Curie, Paris, France, and UVSQ, Paris Saclay, Versailles, France.","Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de."
39003108,Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer.,2024-01-01,Hong A; Hanson S,"Oncology, Pfizer Inc., New York, NY.; US Value & Evidence Oncology, Pfizer Inc., New York, NY.","Department of Urology, Brigham and Women's Hospital, Boston, MA. Electronic address: mpreston@bwh.harvard.edu."
39002879,"Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study.",2024-01-01,Foidart JM,"Department of Obstetrics and Gynecology, University of Liege, Liege, Belgium.; Estetra SRL, Mithra Pharmaceuticals, Liege, Belgium","Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan. Electronic address: tasuku@med.tottori-u.ac.jp."
39002836,Effective treatment of actinic keratosis on the hands with red light photodynamic therapy using BF-200 ALA.,2024-01-01,Ulrich M; Reinhold U; Schaning R; Zeuner MT; Pospiech N; Dirschka T,"Biofrontera Bioscience GmbH, Leverkusen, Germany.; Biofrontera Discovery GmbH, Leverkusen, Germany.; CMB Collegium Medicum Berlin GmbH, Berlin, Germany.; CentroDerm GmbH, Wuppertal, Germany; MVZ Dermatologisches Zentrum Bonn GmbH, Bonn, Germany.",Not available
39002755,Validation of the number of pulses required for TMS-EEG in the prefrontal cortex considering test feasibility.,2024-08-30,Takano M,"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Teijin Pharma Ltd., Tokyo, Japan.","Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Electronic address: yoshi-tms@keio.jp."
39002551,"Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study.",2024-01-01,Dias Matos MGA; Stefanelli T; Rosko C; St Pierre A; Burock K; Smith Y; Sinclair K,"GRAACC, Sao Paulo, Brazil.; Novartis Ireland Limited, Dublin, Ireland.; Novartis Pharma, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Department of Pediatric Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesu Children's Hospital, Catholic University of the Sacred Heart, Rome, Italy. Electronic address: franco.locatelli@opbg.net."
39002448,beta-lactam resistant phenotypes reported by VITEK(R)2 advanced expert system(TM) (AES) compared to whole genome sequencing in Enterobacterales from North and Latin America.,2024-01-01,Shortridge D; Rhomberg P; Castanheira M,"JMI Laboratories, North Liberty, IA 52317 USA.","bioMerieux, St Louis, USA. Electronic address: cecilia.carvalhaes@biomerieux.com."
39002401,"British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.",2024-01-01,Buckley L,"Beverley Counselling & Psychotherapy, 114 Holme Church Lane, Beverley, East Yorkshire HU17 0PY, UK.",Not available
39002360,A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumors.,2024-01-01,Men L; Wang H; Liang E; Wang C; Yang D; Zhai Y,"Ascentage Pharma (Suzhou) Co., Ltd, Suzhou, China; Ascentage Pharma (Suzhou) Co., Ltd, Suzhou, China.; Ascentage Pharma Group Inc., Rockville, USA; Ascentage Pharma Group Inc., Rockville, USA.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.","Melanoma and Sarcoma Medical Oncology Unit, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou. Electronic address: zhangxing@sysucc.org.cn."
39002348,Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population.,2024-01-01,Oneda E; Spinelli GP,"Dipartimento di Oncologia medica, Fondazione Poliambulanza, Brescia, Italy.; UOC Oncologia Territoriale, Polo Pontino, La Sapienza Universita Di Roma, Latina, Italy.",Not available
39002281,Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.,2024-01-01,Borner M; Giordano M,"ASST-Lariana, Como, Italy.; Division of Oncology (Oncocare), Klinik Engeried, Lindenhofgruppe, Bern, Switzerland.",Not available
39002122,"A double-blind, placebo-controlled, randomized multiple dose phase 1b trial of a CDK4/6 inhibitor, TCK-276, in patients with active rheumatoid arthritis.",2024-07-13,Tsuruda K,"Teijin America, Inc., Sausalito, CA, USA.",Not available
39002092,Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.,2024-01-01,Ding Y; Yang FE; Bardolet L; Stander S,"Eli Lilly and Company, Indianapolis, IN, USA.","University of Miami Miller School of Medicine, Miami, USA. yosipog@gmail.com."
39001744,Management of Iron Deficiency in Heart Failure: Practical Considerations and Implementation of Evidence-Based Iron Supplementation.,2024-01-01,Fida N,"Houston Methodist, Houston, Texas, USA.","West Virginia University School of Pharmacy, Morgantown, West Virginia, USA. Electronic address: kazuhiko.kido0322@gmail.com."
39001743,Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory.,2024-01-01,Psotka MA; Carson PE; Saville BR; O'Connor C,"Adaptix Trials LLC, Austin, Texas, USA.; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.; Inova Schar Heart and Vascular, Falls Church, Virginia, USA; Inova Schar Heart and Vascular, Falls Church, Virginia, USA.; Retired, Rehoboth Beach, Delaware, USA.","Inova Schar Heart and Vascular, Falls Church, Virginia, USA. Electronic address: Vanessa.blumer@inova.org."
39001701,A multi-omics approach to overeating and inactivity-induced muscle atrophy in db/db mice.,2024-01-01,Fukui M,"AiSTI Science Co., Ltd., Wakayama, Japan.",Not available
39001476,Incident Cancer Risk of Patients with Prevalent Type 2 Diabetes Mellitus in Hungary (Part 2).,2024-06-29,Abonyi-Toth Z; Suto G; Kiss Z,"RxTarget Ltd., 5000 Szolnok, Hungary.",Not available
39000465,Intestinal Epithelial Co-Culture Sensitivity to Pro-Inflammatory Stimuli and Polyphenols Is Medium-Independent.,2024-07-04,Haddad MJ; Zuluaga-Arango J; Mathieu H; Barbezier N; Anton PM,"HCS Pharma, 59120 Loos, France.; Transformations et Agroressources, ULR 7519, Institut Polytechnique UniLaSalle, Universite d'Artois, 60000 Beauvais, France.",Not available
39000225,GBA1-Associated Parkinson's Disease Is a Distinct Entity.,2024-06-28,Skrahin A; Skrahina V; Lukas J,"Agyany Pharma Ltd., 9695614 Jerusalem, Israel.; Rare Disease Consulting RCV GmbH, Leibnizstrasse 58, 10629 Berlin, Germany.",Not available
38999918,Citrullus mucosospermus Extract Reduces Weight Gain in Mice Fed a High-Fat Diet.,2024-07-08,Lee KW,"Natural Products Convergence R&D Division, Kwangdong Pharma. Co., Ltd., Seoul 08381, Republic of Korea.",Not available
38999825,The Effects of Dietary Intervention and Macrophage-Activating Factor Supplementation on Cognitive Function in Elderly Users of Outpatient Rehabilitation.,2024-06-28,Yamakage H,"Satista Co., Ltd., 77-1, Minamiochiai, Makishimama-cho, Uji 611-0041, Kyoto, Japan.",Not available
38999811,Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?,2024-06-28,Ashmore C; Belanger-Quintana A,"Centro de Genetica Medica, Unidade Local de Saude de Santo Antonio, E.P.E. (ULSSA), 4099-028 Porto, Portugal.; Centro de Referencia na area de Doencas Hereditarias do Metabolismo, Unidade Local de Saude de Santo Antonio, E.P.E. (ULSSA), 4099-001 Porto, Portugal.",Not available
38999525,Incidence and Causes of Tubal Occlusion in Infertility: A Retrospective Cohort Study.,2024-07-06,Ott J,"Parryscope and Positive Steps Fertility, Madison, MS 39110, USA.",Not available
38999507,Facing Life in Old Age: Exploring Resilience in Older Adults with Bipolar Disorder.,2024-07-05,Retuerto M; Martin S; Bort M; Martinez-Aran A; Torrent C,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain.",Not available
38999429,"Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study.",2024-06-30,Mugheddu C; Burlando M; Atzori L,"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, 00168 Rome, Italy.",Not available
38998738,Exploring Disulfiram's Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy.,2024-06-30,Tolaymat I,"GMPriority Pharma Ltd., Priors Way, Coggeshall CO6 1TW, UK.",Not available
38996924,Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.,2025-01-01,Giudicelli H; Allaire M; Massoumi H,"AP-HP Sorbonne Universite, Hopital Universitaire Pitie-Salpetriere, Service d'Hepato-gastroenterologie, Paris, France; AP-HP Sorbonne Universite, Hopital Universitaire Pitie-Salpetriere, Service d'Hepato-gastroenterologie, Paris, France.; Division of Hepatology, Northwell 261 East 78th Street, Floor 4, New York, NY 10075, USA.; INSERM UMR 1138, Centre de recherche des Cordeliers, 75006 Paris, France.",Not available
38996765,Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants.,2024-01-01,Christophersen P,"Saniona A/S, Ballerup, Denmark.",Not available
38996211,The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1.,2024-09-26,Zhu S; Emsley J; Jilma B,"Band Therapeutics, Lexington, MA.; Irish-Australian Blood Collaborative Network, Dublin, Ireland.",Not available
38995938,Reverse causation bias: A simulation study comparing first- and second-line treatments with an overlap of symptoms between treatment indication and studied outcome.,2024-01-01,Oland CB; Ranch LS; Skaaby T; Delvin T; Jakobsen HB; Pipper CB,"Biostatistics and Pharmacoepidemiology, LEO Pharma A/S, Ballerup, Denmark.",Not available
38995601,"Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study.",2024-01-01,Capra Marzani F; Cattelan A; Serino FS; Bassetti M,"AOU SS Antonio, Biagio e Cesare Arrigo di Alessandria, Alessandria, Italy.; SC Malattie Infettive e Tropicali, Ospedale San Paolo Savona, Savona, Italy.; Universita Vita-Salute San Raffaele, Milan, Italy.","Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. danieleroberto.giacobbe@unige.it."
38995504,Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies.,2024-01-01,Sturm D; Wang M; Eichenfield LF,"Incyte Corporation, Wilmington, DE, USA.","Oregon Health & Science University, 3303 S. Bond Ave, Portland, OR, 97239, USA. simpsone@ohsu.edu."
38995311,CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib.,2024-09-13,Bauer TM; Tait C; Matin B; Narasimhan S; Sharma MG; Ruiz-Soto R; Sherman ML,"Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts.; Tennessee Oncology, Nashville, Tennessee.",Not available
38995291,HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II Trial.,2024-09-13,Gion M; Villagrasa P,"Institut D'Investigacions Biomediques August Pi i Sunyer Barcelona, Barcelona, Spain.",Not available
38995268,Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors.,2024-09-03,Choi Y; Dharia NV; Jun T; Chang J; Royer-Joo S; Yau KK; Assaf ZJ; Aimi J,"Genentech, Inc., South San Francisco, California.; Hoffmann-La Roche Limited, Mississauga, Canada.",Not available
38994272,NeuroToolKit Data Hackathon: advancing data collaboration in Alzheimer's disease.,2024-01-01,Suarez-Calvet M,"Centro de Investigacion Biomedica en Red Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.",Not available
38993854,Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy.,2023-01-01,Elsasser A; Nashan B,"Immunology, Novartis Pharma GmbH, Nurnberg, Germany.",Not available
38993773,Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease-an analysis from transplant centers across Europe.,2024-01-01,Moritz Middeke J,"Novartis Pharmaceuticals AG, Basel, Switzerland.",Not available
38993741,Frameshift Mutations in Leukemia-Associated Genes Correlate With Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for De Novo Acute Myeloid Leukemia.,2024-01-01,Makarenko V; Chen B,"Bristol Myers Squibb Company, Cambridge, MA, USA.; Commonwealth Pathology Partners, P.C., Salem, MA, USA.",Not available
38993535,Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer.,2024-01-01,DeGraff DJ; Milowsky MI; Black PC,"Convergent Genomics, San Francisco, CA, USA.; Emmes Company, Rockville, MD, USA.; Patient Advocate, Baltimore, MD, USA.",Not available
38993392,"Association between echocardiographic features, troponin levels, and survival time in hospitalized COVID-19 patients with cardiovascular events.",2024-01-01,Huang EC,"Biometrics and Data Science, Fosun Pharma, Beijing 100026, China.",Not available
38993184,Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer.,2023-01-01,Sachse K; Smith AB,"Bladder Cancer Advocacy Network, Bethesda, MD, USA.",Not available
38992789,"Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged >/=75 years (EU-COVAT-1-AGED Part B).",2024-01-01,Molto J,"CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Fundacio Lluita Contra les Infeccions, Infectious Diseases Department, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain",Not available
38992713,Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial.,2024-07-11,Vedin O,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.",Not available
38992182,Author Correction: A novel antibiotic class targeting the lipopolysaccharide transporter.,2024-01-01,Bissantz C; Leyn S,"Discovery Microbiology, Aptuit (Verona) Srl, an Evotec Company, Verona, Italy.; Independent consultant, Cambridge, Great Britain.",Not available
38991584,Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials.,2024-01-01,Liu CC; Sabatine MS; Wiviott SD,"Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Merck, Rahway, NJ, USA.; TIMI Study Group, Boston, MA, USA",Not available
38991538,De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome.,2024-01-01,Fica SM; Baralle D,"Institut des Maladies Rares, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.; Service de Neurologie Pediatrique, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.",Not available
38991123,Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma.,2024-09-10,Saunders A; Bendris N; Mackey J; Leoni M,"Kura Oncology Inc, Boston, MA.",Not available
38991060,Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.,2024-07-12,Jenkins RW; Yates KB,"Servier Pharmaceuticals LLC, Boston, MA, USA.; Universite Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France.",Not available
38990855,Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB(1)R).,2024-07-25,Mach L; Omran A; Radetzki S; Gazzi T; Mostinski Y; Wasinska-Kalwa M; de Molnier F; van der Horst C; Hua T,"Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.",Not available
38990487,ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation.,2024-01-01,Scalfaro E; Angehrn Z; Banhazi J,"IQVIA AG, Basel, Switzerland.; Novartis Pharma AG, Basel, Switzerland.",Not available
38990441,"A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma.",2024-01-01,Park JH; Igarashi K,"OncoTherapy Science, Inc., Kawasaki, Kanagawa, Japan.; Project Management, Shionogi & Co., Ltd., Osaka, Japan.",Not available
38990433,Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2.,2024-01-01,Ellis C; Patel B; Strouse B,"GSK plc, Philadelphia, PA, USA.","Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, UK. claire.harrison@gstt.nhs.uk."
38990393,"Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer's agents: design, synthesis and biological evaluation.",2024-07-11,Yadav MR,"Piramal Pharma Solution, Ahmedabad, Gujarat, India.",Not available
38989947,Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson's disease.,2025-04-01,Kulesskaya N,"Herantis Pharma Plc, Espoo, Finland.",Not available
38989688,Biotransformation research advances - 2023 year in review.,2024-01-01,Dhaware D; Johnson KM; Maw H,"DMPK and Safety Sciences, Orion Pharma, Espoo, Finland.; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.; Drug Metabolism and Pharmacokinetics, Inotiv, MD Heights, MO, USA.",Not available
38989280,Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort.,2024-01-01,Mercer A; Bechtel-Walz W,"JAMCO Pharma Consulting, Enskede, Sweden.; Travere Therapeutics , Inc., San Diego, CA, USA.",Not available
38989130,Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report.,2024-01-01,Sharma S; Gautam A,"Mankind Pharma Ltd, New Delhi, India.",Not available
38988686,Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations.,2024-01-01,Woodle ES,"Veloxis Pharmaceuticals, Inc, Cary, NC.",Not available
38988416,"Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.",2024-01-01,Matthews DC; Andrews RD; Lukic AS; Koenig LN; Zhong K,"ADM Diagnostics, Inc. Northbrook Illinois USA.; CNS Innovations LLC Henderson Nevada USA.",Not available
38988207,"House dust mite immunotherapy: A real-world, prescription data-based analysis.",2024-01-01,Mosges R,"ClinCompetence Cologne GmbH, Cologne, Germany.",Not available
38987228,"Efficacy and safety of eculizumab in Guillain-Barre syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial.",2024-01-01,Ishida H; Kasuya T; Kupperman E; Lin Q; Frick G,"Alexion Pharma GK, Tokyo, Japan.; AstraZeneca Rare Disease, Alexion, Boston, USA.",Not available
38986791,"Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus.",2024-01-01,Whittenhall ME; King CS; Kingrey JF,"Brown Medicine, Providence, RI, USA.; Inova Schar Heart and Vascular, Annandale, VA, USA.; Integris Baptist NZTI, Oklahoma City, OK, USA.",Not available
38986667,Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.,2024-07-16,Perfetti R; Urbinati A,"Applied Therapeutics, New York, New York, USA.",Not available
38986421,Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer.,2024-01-01,Barlesi F; Djentuh LO; Smith N; Jary A; Belli R; Glaser S; Zou M; Giovannini M,"Aix Marseille University, CNRS, INSERM, CRCM, APHM, CEPCM CLIP, Marseille, France; Medical Oncology department, Gustave Roussy, Villejuif, France; Novartis Pharma AG, Basel, Switzerland.; Novartis Services Inc., East Hanover, NJ, USA.; Universite Paris Saclay, Faculte de Medecine, Kremlin Bicetre, Gustave Roussy, Villejuif, France.","Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain. Electronic address: efelip@vhio.net."
38986265,Amygdala and hippocampal substructure volumes and their association with improvement in mood symptoms in patients with mood disorders undergoing electroconvulsive therapy.,2024-01-01,Craciun S; Ketterer-Sykes EB,"DIS Copenhagen, Copenhagen, Denmark; Dickinson College, Carlisle, PA, USA.; Skidmore College, Saratoga Springs, New York, USA.","Neurocogntion and Emotion in Affective Disorders (NEAD) Centre, Psychiatric Centre Copenhagen, and Department of Psychology, University of Copenhagen, Copenhagen, Denmark. Electronic address: julian.macoveanu@regionh.dk."
38986210,"Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies.",2024-01-01,Papadopoulos KP; Tian C; Silverman IM,"Incyte Corporation, Wilmington.; START San Antonio, San Antonio.","Department of Hematology and Oncology, Aga Khan University, Nairobi, Kenya. Electronic address: mansoor.saleh@aku.edu."
38985486,Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.,2024-08-01,Coleman A; Xiao J; Dingman R; Xu C; Avetisova E; Dubost-Brama A; Shabbir A,"Regeneron Pharmaceuticals Inc, Dublin, Ireland.; Regeneron Pharmaceuticals Inc, Tarrytown, New York.; Sanofi, Bridgewater, New Jersey.; Sanofi, Chilly-Mazarin, France.",Not available
38985461,Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial.,2024-09-01,Chen CZL; Unverdorben M,"Daiichi Sankyo Pharma Development, Edison, New Jersey.",Not available
38985331,Stereoselective Synthesis of Baloxavir Marboxil Using Diastereoselective Cyclization and Photoredox Decarboxylation of l-Serine.,2024-07-19,Okamoto K; Hakogi T; Majima S,"Technology Development Division, Shionogi Pharma & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan.",Not available
38985302,CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.,2024-10-22,Fein JA,"Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY.",Not available
38985247,Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis.,2024-01-01,Downie B; Han L; Hawtin R; Hertz A,"Gilead Sciences, Inc., Foster City, CA, 94404, USA.","Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. peter.taylor@kennedy.ox.ac.uk."
38984665,Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations.,2024-01-01,Maier M; Zeh N; Dehghani A; Felix MN; Heinzelmann D; Lindner B; Schmidt M; Studts J; Schulz P; Reisinger B; Otte K; Franzreb M,"Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
38983832,Multisite studies for optimization of a highly efficient culture assay used for in vitro detection of residual undifferentiated human pluripotent stem cells intermingled in cell therapy products.,2024-01-01,Morishita A; Hata S,"Ig-M Co. Ltd, Hyogo, Japan.",Not available
38983688,Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors.,2024-01-01,Nekkal SM; Lelli A,"Baxalta Innovations GmbH, a Takeda company, Vienna, Austria.; CHU Isaad Hassani, Beni Messous, Algiers, Algeria.",Not available
38982771,Enhanced stabilisation and reduced fibril forming potential of an amyloidogenic light chain using a variable heavy domain to mimic the homodimer complex.,2024-01-01,Galmiche C; Scott-Tucker A; Kennedy J; Crabbe T,"UCB Pharma, Slough, UK.",Not available
38982261,Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group.,2024-01-01,Kiladjian JJ,"Hopital Saint-Louis, Universite Paris Cite, Inserm CIC-1427, Paris, France.",Not available
38982051,Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.,2024-07-09,McDaniel L; Abbott C; Chen RO; Boyle SM,"Personalis, Inc., Menlo Park, CA, USA.",Not available
38981329,Highly sensitive two-dimensional ion chromatography mass spectrometry method for nitrite determination in hydroxypropyl methylcellulose.,2024-09-15,Zhu K; Kerry M; Serr B; Mintert M; Pursch M,"DDP Specialty Products Germany GmbH & Co. KG, August-Wolff-Str. 13, Walsrode 29699, Germany.; Dow Deutschland Anlagen GmbH, Analytical Science, Wiesbaden 65201, Germany.; Pharma Solutions, IFF, Midland, MI 48640, USA; Pharma Solutions, IFF, Midland, MI 48640, USA.","Department of Chemical Engineering, Vrije Universititeit Brussel, Pleinlaan 2, Brussel 1050, Belgium. Electronic address: koudi.zhu@iff.com."
38981188,Whole phenotype of patients with systemic sclerosis and sicca manifestations: Comparison with sicca manifestations from other causes.,2024-01-01,Belhomme N; Lescoat A,"Department of Internal Medicine, CHU Rennes, University of Rennes 1, Rennes, France; Universite de Rennes, CHU Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Sante, Environnement et Travail) - UMR_S 1085, Rennes, France.","Universite de Rennes, CHU Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Sante, Environnement et Travail) - UMR_S 1085, Rennes, France. Electronic address: francois.zimmermann@chu-rennes.fr."
38981146,Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method.,2024-08-16,Purves RW,"Canadian Food Inspection Agency, Saskatoon, Saskatchewan S7N 2R3, Canada.; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada",Not available
38980735,Retrospective text and qualitative analyses of patient experience and management of vasomotor symptoms due to menopause: voices from the PatientsLikeMe community.,2024-09-01,Shiozawa A; Schild AL; Singh D; Mancuso SA,"Astellas Pharma, Inc, Northbrook, IL.; PatientsLikeMe LLC, Boston, MA.",Not available
38980272,Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.,2024-01-01,Kosiborod MN,"Elderbrook Solutions GmbH, Sky Tower, Borsigstr. 4, D-74321 Bietigheim-Bissingen, Germany on behalf of Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach, Germany.",Not available
38979893,Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer.,2024-01-01,Egorov A; Nishijima S; Nakatani S; Nishiyama Y; Sugihara M,"Daiichi Sankyo Inc., Basking Ridge, New Jersey, USA.; Daiichi Sankyo, Co., Ltd., Tokyo, Japan.",Not available
38979696,Systematic review: effectiveness and safety of switching between originator infliximab and biosimilar infliximab in patients with inflammatory bowel disease.,2024-01-01,Singh S,"Value and Access, Curo, Envision Pharma Group, London, UK.",Not available
38979279,A broadly-neutralizing antibody against Ebolavirus glycoprotein that potentiates the breadth and neutralization potency of other antibodies.,2024-06-25,Parekh D,"UCB Pharma, 208 Bath Road, Slough, SL1 3WE, UK.",Not available
38978809,Clinical meaningfulness and psychometric robustness of the MG Symptoms PRO scales in clinical trials in adults with myasthenia gravis.,2024-01-01,Regnault A; Creel K; Morel T,"Modus Outcomes, A Division of THREAD, Lyon, France.; UCB Pharma, Brussels, Belgium.",Not available
38978633,Behavioral comorbidities treatment by fecal microbiota transplantation in canine epilepsy: a pilot study of a novel therapeutic approach.,2024-01-01,Busch-Hahn K,"Tierarztpraxis Dr A. Bathen-Nothen, Cologne, Germany.",Not available
38978555,Maternal use of snus as smokeless tobacco in pregnancy and infant lung function.,2024-01-01,Granum B; Hedlin G,Shared second authorship.,Not available
38978130,Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort study.,2024-07-08,Cloutier M; Gauthier-Loiselle M; Chen K; Chan D; Guerin A,"Analysis Group, Inc., 1190 avenue des Canadiens-de-Montreal, Tour Deloitte, Suite 1500, Montreal, QC, H3B 0G7, Canada.",Not available
38977707,Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.,2024-07-08,Cortoos A; Patel S; Lin TS,"Janssen Scientific Affairs, LLC, Horsham, PA, USA.","Icahn School of Medicine at Mount Sinai, New York, NY, USA. ajai.chari@ucsf.edu."
38977682,Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.,2024-07-08,Shah N,"Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA.",Not available
38977635,A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy.,2024-01-01,Ross R,"Labor Berlin, Charite Vivantes GmbH, Berlin, Germany.",Not available
38977276,Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials.,2024-11-14,Marten A; Massow U; de Peyrecave N; Vaux T; White K; Deodhar A,"UCB Pharma, Brussels, Belgium.; UCB Pharma, Monheim am Rhein, Germany.; UCB Pharma, Slough, UK.","Genomics England, London, UK matt.brown@genomicsengland.co.uk."
38976997,Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study.,2024-01-01,Martin-Broto J; Gutierrez A,"Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz, Madrid, Spain.; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital, Madrid, Spain; Medical Oncology Department, Hospital General de Villalba, Madrid, Spain",Not available
38976983,[Not Available].,2024-01-01,Schattenberg JM,"Klinik fur Innere Medizin II des Universitatsklinikums des Saarlandes, Homburg, Deutschland.",Not available
38976982,[Need for improvement in the care of patients with Clostridioides difficile infections (CDI) - expert opinion in international comparison].,2024-01-01,von Muller L; Wahler S,"Christopherus Kliniken Coesfeld, Coesfeld, Germany.; St. Bernward GmbH, Hamburg, Germany.",Not available
38976649,"Assessing the interplay between off-target promiscuity, cytotoxicity, and tolerability in rodents to improve the safety profile of novel anti-malarial plasmepsin X inhibitors.",2024-10-01,Gerets HHJ; Delaunois A; Cardenas A; Class R; Fleurance R; de Haro T; Rosseels ML; Valentin JP,"UCB Biopharma SRL, 1420 Braine-l'Alleud, Belgium.",Not available
38976647,Deconvoluting and derisking QRS complex widening to improve cardiac safety profile of novel plasmepsin X antimalarials.,2024-10-01,Delaunois A; Cardenas A; de Haro T; Gerets HHJ; Gryshkova V; Hebeisen S; Korlowski C; Valentin JP,"B'SYS GmbH, 4108 Witterswil, Switzerland.; UCB Biopharma SRL, 1420 Braine-l'Alleud, Belgium.",Not available
38976584,[XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (II)].,2024-07-16,Fernandez O; Montalban X; Prieto JM; Romero-Pinel L,"Instituto de Investigacion Biomedica de Malaga. IBIMA, Malaga, Espana.; Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Espana.; Universidad Catolica San Antonio, Murcia, Espana.; Universidad de Malaga, Malaga, Espana.",Not available
38976169,A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs.,2024-01-01,Bessette L; Florica B; Naik L; Fournier PA; Girard T; Liazoghli D,"AbbVie Corporation, Saint-Laurent, QC, Canada.; Brandusa Florica Medicine Professional Corporation, Mississauga, ON, Canada.; Dr. Latha Naik Medicine Professional Corporation, Saskatoon, SK, Canada.; Groupe de Recherche en Maladies Osseuses Inc., Quebec City, QC, Canada.",Not available
38975874,Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.,2024-11-01,Aguirre AJ,"Amgen Inc., Thousand Oaks, California.",Not available
38973127,Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.,2024-01-01,Parasrampuria DA; Chiney M; Liao MZ; Chang SS,"Astellas Pharma Global Development, Inc, Chicago, IL, USA.; Genentech, South San Francisco, CA, USA.; Gilead, Parsippany, NJ, USA.; Merck & Co., Inc., Upper Gwynedd, Pennsylvania, USA.",Not available
38972608,Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung disease.,2024-01-01,Taniya S,"Revorf. Co., Ltd., Tokyo, Japan.",Not available
38972603,Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial.,2024-01-01,Fukushi A; Imamura T; Sakaguchi H; Sonoyama T; Ichihashi G; Tsuge Y,"Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.",Not available
38972393,Factors Affecting Implant Length in Primary Inflatable Penile Prosthesis Placement.,2024-01-01,Perito P; Suarez-Sarmiento A Jr,"Perito Urology, Coral Gables, FL.","Department of Urology, University of California, Irvine, Orange, CA. Electronic address: jakeam1@hs.uci.edu."
38972349,Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia: An Observational Study.,2024-01-01,Schondorf I,SAPERCO GmbH.,Not available
38972109,Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting.,2024-01-01,Bertoletti L; Hascoet S,"Departement of Medecine Vasculaire et Therapeutique, Universite Jean Monnet Saint-Etienne, CHU Saint-Etienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, CIC 1408, Saint-Etienne, France.; Hopital Marie Lannelongue, Faculte de Medecine, Paris-Saclay, Universite Paris-Saclay, Le Plessis Robinson, France.; University of Paris-Saclay, School of Medicine, le Kremlin-Bicetre, France",Not available
38971950,PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers.,2024-01-01,Willis J; Shemesh CS; Xiao J; Lin KK; Guan Y; Ray-Coquard I; Mileshkin L,"Clovis Oncology, San Francisco, CA, USA.; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Product Development Oncology, Genentech Inc., South San Francisco, CA, USA.; Product Development Safety, Roche Products Ltd, Welwyn Garden City, UK.; Translational Medicine, Genentech Inc., South San Francisco, CA, USA.","University College London Cancer Institute, London, UK. rebecca.kristeleit@gstt.nhs.uk."
38971201,beta-Lactoglobulin-based amorphous solid dispersions: A graphical review on the state-of-the-art.,2024-01-01,Zhuo X; Jasiukenaite I,"Zerion Pharma A/S, Fruebjergvej 3, 2100 Copenhagen, Denmark.",Not available
38971175,"Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.",2024-07-27,Ferdinandus J; Schneider G; Greil R; Kreissl S; Kaul H; von Tresckow B; Borchmann S; Behringer K; Fuchs M; Diehl V,"3rd Medical Department, Paracelcus Medical University, Salzburg, Austria; Arbeitsgemeinschaft Medikamentose Tumortherapie, Salzburg, Austria.; Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University Hospital, Dusseldorf, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Department of Haematology, University Hospital, University Duisburg-Essen, Essen, Germany.; Faculty of Medicine, University of Cologne, Cologne, Germany; German Hodgkin Study Group, Cologne, Germany; German Hodgkin Study Group, Cologne, Germany.; Ordensklinikum Linz Elisabethinen, Linz, Austria.; Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria","German Hodgkin Study Group, Cologne, Germany. Electronic address: peter.borchmann@uk-koeln.de."
38970891,Emergency management of pediatric epileptic seizures in non-hospital settings in Japan.,2024-01-01,Hayashi H,"Knock on the Door, Inc., Tokyo, Japan.","Department of Pediatric Neurology, Osaka City General Hospital, Osaka, Japan. Electronic address: sokazaki2009@gmail.com."
38970614,Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group.,2024-01-01,Solomon JN; Mack A; Durand N; Cameau E; Dianat N; Hunter A; Oh S; Schoen B; Marsh M; Bravery C; Sumen C; Clarke D,"BioCytics Inc, Huntersville, NC, USA.; Cellvec Pte. Ltd. 100 Pasir Panjang, #04-01/02, Singapore 118518 Singapore.; Charles River Laboratories Cell Solutions, Inc. 8500 Balboa Blvd. Suite 230 Northridge, CA 91320, USA.; Consulting on Advanced Biologicals Ltd, London, UK.; Cytiva, Pall Life Sciences 24-26 avenue de Winchester, CS5005, 78100 St. Germain-en-Laye, France.; Dark Horse Consulting, Denver, CO, USA.; MaxCyte, Inc., Rockville, MD, USA.; Minaris Regenerative Medicine, Allendale, NJ, USA.; Orange County Bio, Aliso Viejo, CA, USA.; STEMCELL Technologies Inc, Vancouver, Canada.; Sartorius Stedim, Aubagne, France.",Not available
38970586,Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2.,2024-01-01,Cotter G; Davison BA; Gimpelewicz C,"Inserm U 942 (Cardiovascular Markers in Stress Conditions), Hopital Lariboisiere, Paris, France.; Momentum Research, Inc, Durham, North Carolina, USA; Novartis Pharma AG, Basel, Switzerland.",Not available
38970536,Drug survival of biologics in patients with psoriasis: real-world evidence for Greece during the period 2016-2020.,2024-11-22,Ravanidis S; Gounelas G; Stefanou G,"ECONCARE, Athens, Greece.",Not available
38970274,Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample.,2024-01-01,Zetterberg H; Johnson SC,"ALZpath, Inc., Carlsbad, California, USA.",Not available
38970256,"Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.",2024-01-01,Arkenau HT; Chang V; Zhang W; Barve M,"BeiGene (Beijing) Co., Ltd, Beijing, China.; BeiGene, USA Inc, Ridgefield Park, New Jersey, USA.; BeiGene, USA Inc, San Mateo, California, USA.; START Midwest, Grand Rapids, Michigan, USA.",Not available
38970214,A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.,2024-01-01,Torri Clerici V,"Centro ad Alta Specializzazione per la diagnosi e la cura della sclerosi multipla, Ospedale Generale di zona Valduce, Como, Italy.",Not available
38969959,A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata.,2024-01-01,Wolk R; Schaefer G; Gong Y; Sisson M; Posner HB,"Pfizer Inc, Groton, Connecticut, USA.; Pfizer Inc, New York, New York, USA.; Pfizer Pharma GmbH, Berlin, Germany.",Not available
38968827,Pleural lung sliding quantification using a speckle tracking technology: A feasibility study on 30 healthy volunteers.,2024-01-01,Resseguier N; Postzich M; Muller L,"CEReSS-Health Services and Quality of Research, Aix-Marseille University, Marseille, France.; Service d'Epidemiologie et d'Economie de la Sante, AP-HM, Marseille, France, Aix-Marseille Universite; Service d'Epidemiologie et d'Economie de la Sante, AP-HM, Marseille, France, Aix-Marseille Universite.; Service de Reanimation et Surveillance Continue, Pole Anesthesie Reanimation Douleur Urgences, CHU Nimes Caremeau, Montpellier, France.","Service d'anesthesie Reanimation, Hopital Nord, Marseille, France, Aix-Marseille Universite. Electronic address: gary.duclos@ap-hm.fr."
38968805,Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI study.,2024-01-01,Tortelli A,"Etablissement Public de Sante Maison Blanche, GHU Psychiatrie Neurosciences Paris, INSERM U-955, Paris, France.","Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Meibergdreef 5, 1105 AZ Amsterdam, the Netherlands. Electronic address: c.b.heuschen@amsterdamumc.nl."
38968139,Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial.,2024-08-27,Cairoli R; Storti G; Luppi M; Ingrosso C; Albano F; Mule A,"ASST Grande Ospedale Metropolitano Niguarda-Milano; Azienda Ospedaliero-Universitaria Arcispedale Sant'Anna, Ferrara, Italy.; Fondazione IRCCS Casa Sollievo della Sofferenza, UO di Ematologia, San Giovanni Rotondo, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli,"" Bologna, Italy.; IRCCS Istituto Romagnolo per lo Studio dei Tumori ""Dino Amadori,"" Meldola, Italy.; Ospedale S. Maria della Misericordia, Perugia, Italy.; Universita degli Studi di Milano-Bicocca, Milan, Italy.",Not available
38968138,A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.,2024-10-17,Jackson C; Marcondes AM; Miklos D; Mackall C,"Division of Hematology/Oncology, UT Southwestern, Dallas, TX.; Nektar Therapeutics, San Francisco, CA.",Not available
38968122,Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.,2024-07-09,Wadosky KM,"Astrazeneca Oncology R&D, New York, NY 10016.",Not available
38967550,Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding.,2024-09-03,Gutierrez J; Sardegna MS,"Patient advocate, Castle Pines, Colorado.; Patient advocate, Laguna Hills, California.",Not available
38966556,"Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King's College, London and the GMDP Academy, New York.",2024-01-01,Jones S; Morgan D; Thakker K,"Genovax Pharma, Milan, Italy.; PharmaTrain Federation, Brussels, Belgium.",Not available
38965814,Key steps and barriers in the journey of patients with epilepsy through the National Healthcare System in Spain: The EPIPASS qualitative study.,2024-01-01,Aledo-Serrano A,"Angelini Pharma, Barcelona, Spain.",Not available
38965370,Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study.,2024-01-01,Barbus M,"CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.",Not available
38965205,Epigenetic signals associated with delirium replicated across four independent cohorts.,2024-07-04,Toda H,"Sumitomo Pharma Co, Ltd, Osaka, Osaka, Japan.",Not available
38964362,Measures to prevent and treat Nipah virus disease: research priorities for 2024-29.,2024-01-01,Fay PC; Hart PJ; Golding JP; Roth C,"UK Foreign, Commonwealth and Development Office, London, UK.; Wellcome Trust, London, UK.","Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA. Electronic address: kamoore@umn.edu."
38963177,Intranasal administration of DSM 32444 Bacillus subtilis spores: safety and tolerability.,2024-01-01,Ho YT; Nguyen LH,"Huro Biotech JSC, Lot A1-8, VL3 Road, Vinh Loc 2 Industrial Park, Long Hiep Commune, Ben Luc District, Long An Province, Vietnam.",Not available
38963129,Bioactivation and reactivity research advances - 2023 year in review.,2024-01-01,Chatzopoulou M; Dhaware D; Johnson KM; Rowley JA,"DMPK and Safety Sciences, Orion Pharma, Espoo, Finland.; Drug Metabolism and Pharmacokinetics, Inotiv, Maryland Heights, MO, USA.; Translational Science, UCB Biopharma UK, Slough, UK.",Not available
38962750,Serum and CSF metabolomics analysis shows Mediterranean Ketogenic Diet mitigates risk factors of Alzheimer's disease.,2024-01-01,Schweickart A,"Tri-Institutional Program in Computational Biology & Medicine, Weill Cornell Medicine, New York, NY USA. ROR: https://ror.org/02r109517. GRID: grid.471410.7. ISNI: 0000 0001 2179 7643",Not available
38962523,"Impact of Catheter-Drawn Blood Cultures on Patient Management: A Multicenter, Retrospective Cohort Study.",2024-01-01,Del Pozo JL; Mermel LA,"Division of Infectious Diseases, Instituto de Investigacion Sanitaria de Navarra, Pamplona, Spain.",Not available
38961808,Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology.,2024-01-01,Klunk WE; Barkhof F,"Life Molecular Imaging GmbH, Berlin, Germany.",Not available
38961436,Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers.,2024-07-03,de la Espriella R; Fu X,"Centro de Investigacion Biomedica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.",Not available
38961431,The impact of regional disparities on the availability of meningococcal vaccines in the US.,2024-07-03,Jodar E; Willis SJ; Prener CG,"Pfizer Inc, Cambridge, MA, USA.; Pfizer Inc, New York, NY, USA.","Pfizer Pharma GmbH, Berlin, Germany. katharina.schley@pfizer.com."
38961306,Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.,2024-01-01,Baltgalvis KA; Lamb KN; Symons KT; Wu CC; Hoffman MA; Snead AN; Song X; Glaza T; Kikuchi S; Green JC; Rogness DC; Lam B; Rodriguez-Aguirre ME; Woody DR; Eissler CL; Rodiles S; Negron SM; Bernard SM; Tran E; Pollock J; Tabatabaei A; Contreras V; Williams HN; Pastuszka MK; Sigler JJ; Burgess LE; Abraham RT; Weinstein DS; Simon GM; Patricelli MP,"Odyssey Therapeutics, San Diego, CA, USA.; Vividion Therapeutics, San Diego, CA, USA.",Not available
38960812,Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study.,2024-01-01,Diaz R; McGinniss J; Pordy R; Garon G,"Estudios Cardiologicos Latino America, Instituto Cardiovascular de Rosario, Rosario, Argentina (Dr Diaz).; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA (Dr McGinniss, Pordy).; Sanofi, Montreal, Canada (Ms Garon).","Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, UK (Dr Bittner). Electronic address: vbittner@uab.edu."
38960586,Measurement properties of the Inclusion Body Myositis Functional Rating Scale.,2024-07-11,Guldberg C,"Orphazyme Aps, Copenhagen, Denmark.",Not available
38960514,Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review.,2024-07-09,Edelmann F,"Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt Universitat zu Berlin, Berlin, Germany; Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charite - Medical Heart Center of Charite and German Heart Institute Berlin, Berlin, Germany; German Centre for Cardiovascular Research, Partner Site Berlin, Berlin, Germany.","Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, USA. Electronic address: rth2@columbia.edu."
38960508,Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.,2024-07-09,Sasiela WJ; Haddad T; Li N,"Esperion Therapeutics, Inc, Ann Arbor Michigan, USA.; Virginia Heart, Falls Church, Virginia, USA.","Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: lincofa@ccf.org."
38960321,Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry.,2024-01-01,Jun G,"Novartis Pharma K.K., Tokyo, Japan.","Department of Hematology and Oncology, Kyoto University, Kyoto, Japan. Electronic address: jkanda16@kuhp.kyoto-u.ac.jp."
38959744,Overview of acute seizure management in US nursing homes.,2024-01-01,Eads P,"UCB Pharmaceuticals, Smyrna, GA, USA.","Department of Neurological Science, Rush University Medical Center, Chicago, IL, USA. Electronic address: rebecca_odwyer@rush.edu."
38959712,Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial.,2024-01-01,Aimetti A; Busse G,"Marinus Pharmaceuticals, Inc, USA.","Curtin School of Allied Health, Curtin University, Perth, Australia. Electronic address: Jenny.Downs@telethonkids.org.au."
38959578,Glycocalyx shedding patterns identifies antipsychotic-naive patients with first-episode psychosis.,2024-01-01,DellaValle B; Bogehave H; Mogensen PB; Goth CK; Jorgensen ML; Hempel C,"Copenhagen Center for Translational Research, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Denmark; DTU Health, Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.; Department of Endocrinology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark; GLX Analytix ApS, Copenhagen, Denmark; GLX Analytix ApS, Copenhagen, Denmark.","Copenhagen Research Centre for Mental Health and VIRTU Research Group, Mental Health Centre Copenhagen, Denmark. Electronic address: Helle.Gade.Andersen.02@regionh.dk."
38959068,Transglutaminase 2 knockout mice are protected from bleomycin-induced lung fibrosis with preserved lung function and reduced metabolic derangements.,2024-01-01,Narrow W; Haak J,"UCB Pharma SA, Slough, Berkshire, UK.",Not available
38958901,SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023).,2024-01-01,Climent Duran MA,"Instituto Valenciano de Oncologia, Valencia, Spain.","Hospital General Universitario Gregorio Maranon, Madrid, Spain. jarranza.oncomed@gmail.com."
38958840,Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.,2024-01-01,Sehinovych I; McNeill C,"Sarepta Therapeutics Inc., 215 First St, Cambridge, MA, 02142, USA.","Sarepta Therapeutics Inc., 215 First St, Cambridge, MA, 02142, USA. JIff@Sarepta.com."
38958627,Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee.,2024-01-01,Madrid M; Lakshmipathy U; Zhang X; Wall DM; Ting A; Smith N; Kawamata S; Moore JC; Makovoz B,"Aspen Neuroscience Inc., San Diego, USA.; BRL C&GT consulting, LLC., Cleveland, USA.; Cell Therapies Pty Ltd, Melbourne, Australia; Cell Therapies Pty Ltd, Melbourne, Australia.; Cellino Biotech, Cambridge, USA.; Cyto-Facto Inc., Kobe, Japan; Peter MacCallum Cancer Centre, Melbourne Australia; Pharma Services, Thermo Fisher Scientific, Carlsbad, USA.; Sampled, New York City, USA.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.",Not available
38958260,Off-label use of dalbavancin in children: a case series.,2024-08-01,Fumado V; Fortuny C,"CIBER de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain.",Not available
38958156,Force Field X: A computational microscope to study genetic variation and organic crystals using theory and experiment.,2024-07-07,Fenn TD,"Analytical Development, LEXEO Therapeutics, New York, New York 10010, USA.",Not available
38957632,Translation and validation of patient-oriented eczema measure in the Greek language.,2024-06-14,Stefanou G; Kontodimas S; Sfaelos K,"Biostatistics and Programming, ECONCARE, Athens.; LEO Pharma Hellas, Athens.",Not available
38957012,"Large-scale international study on scalp seborrheic dermatitis: Prevalence, demographics, healthcare trends and quality of life.",2024-07-02,Baissac C,"Dermocosmetics Care & Personal Care, Pierre Fabre, Toulouse, France.",Not available
38956909,"Nigella sativa Oil-loaded Ethanolic Vesicular Gel for Imiquimod-induced Plaque Psoriasis: Physicochemical Characterization, Rheological Studies, and In vivo Efficacy.",2025-01-01,Ranjan Lal U,"Ayurvet Limited, Katha, Baddi, Himachal Pradesh 173205, India.",Not available
38956896,Prediction of heart failure events based on physiologic sensor data in HINODE defibrillator patients.,2024-01-01,Schwartz T,"Boston Scientific, St Paul, Minnesota, USA.",Not available
38956447,Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real-life.,2024-01-01,Sidenius K; Janson C; Himmelhaus H; Wustenberg E,"Allergiklinikken i Bagsvaerd, Bagsvaerd, Denmark.; Sorlandet Sykehus, Kristiansand, Norway.; Xcenda GmbH, part of Cencora, Hannover, Germany.",Not available
38956085,Healthcare resource utilization and economic burden of multiple sclerosis in Chinese patients: results from a real-world survey.,2024-07-02,Tang M; Geng M,"Novartis Pharma AG, HEOR & Access Strategy, Value Access, Beijing, China.",Not available
38956067,A chemogenetic approach for dopamine imaging with tunable sensitivity.,2024-07-02,Ford CP; Sych Y; Patriarchi T,"Eli Lilly and Company, Indianapolis, IN, USA.",Not available
38955475,Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment.,2024-10-21,Grishin S,"SFC Medica, LLC, Charlotte, North Carolina, USA.","Rheumatology and Clinical Immunology, HELIOS Fachklinik Vogelsang/Gommern, Vogelsang, Germany Eugen.Feist@helios-gesundheit.de."
38955420,Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma.,2024-07-01,Shizuru J,"Stanford Medicine, Palo Alto, California, USA.",Not available
38955178,"A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR).",2024-07-16,Glenn S,"Independent Consultant to Erimos Pharmaceuticals, Houston, TX, USA.","Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA. Electronic address: manmeeta@baptisthealth.net."
38955117,The effect of high-dose selenium on mortality and postoperative organ dysfunction in post-cardiotomy cardiogenic shock patients supported with mechanical circulatory support - A post-hoc analysis of the SUSTAIN CSX trial.,2024-01-01,Ott S; Lee ZY; Pitts L; O'Brien B; Stoppe C,"Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany; Department of Anaesthesiology, Faculty of Medicine, University of Malaysia, Kuala Lumpur, Malaysia.; Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charite (DHZC), 13353 Berlin, Germany; Deutsches Herzzentrum der Charite, Department of Cardiac Anaesthesiology and Intensive Care Medicine, Berlin, Germany","Outcomes Research Consortium, Department of Anesthesiology, Cleveland Clinic, OH, USA. Electronic address: Sascha.ott@dhzc-charite.de."
38954874,Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression.,2024-01-01,Buyze J; Gorwood P; Ito T,"GHU-Paris Psychiatrie et Neurosciences, Hopital Sainte Anne, CMME, F-75014 Paris, France.; Janssen EMEA, High Wycombe, UK.; Janssen Pharmaceutica NV, Beerse, Belgium.; Universite Paris Cite, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Paris, France","Braxia Scientific, Toronto, Ontario, Canada. Electronic address: roger.mcintyre@bcdf.org."
38954370,Population-Based Analysis of 6534 Seizure Emergency Cases from Emergency Medical Services Data.,2024-01-01,Mockel L; Ma Y; Liou HSC; Strzelczyk A,"UCB Pharma, Monheim am Rhein, Germany.; UCB Pharma, Slough, UK.",Not available
38954317,"A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.",2024-01-01,Suett M,"Global Patient Safety and Pharmacovigilance, Teva Pharmaceutical Industries Ltd. , Netanya, Israel.",Not available
38954226,"Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial.",2024-01-01,Kikuta N,"Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.",Not available
38954182,"Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents.",2024-01-01,Paudyal B; Winkler RE,"Ascentage Pharma Group Inc., Rockville, MD, USA.",Not available
38954176,Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.,2024-01-01,Moran D; Guerrero A; Li R; Pavese J; Matsangou M; Bhattacharya P; Ueno Y; Wang X,"Astellas Pharma Global Development, Inc., Northbrook, IL, USA.; Astellas Pharma Inc., Tokyo, Japan.",Not available
38954006,Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.,2024-07-02,Catalano F; Atzori F; Prati G,"SS Oncologia Medica Genitourinaria, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy.; U. O. Oncologia, Ospedale Di Camposampiero, Camposampiero, Italy.; UOC Oncologia Medica, Istituto Fondazione G. Giglio, Cefalu, Italy.",Not available
38953781,A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas.,2024-09-03,Casadei B; Chiusolo P; Carrabba MG; Bonifazi F; Sora F; Barbui AM; Russo D; Grillo G; Cavallo F,"Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Dipartimento di Medicina Traslazionale, Universita del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli"", Bologna, Italy.; IRCCS Ospedale San Raffaele Milano, Milano, Italy.; SC Ematologia AOU Citta della Salute e della Scienza, Torino, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universita Cattolica del Sacro Cuore, Rome, Italy.; UOC di Oncoematologia e TMO, Dipartimento Oncologico ""La Maddalena"", Palermo, Italy.",Not available
38952994,Medical App Treatment of Non-Specific Low Back Pain in the 12-month Cluster-Randomized Controlled Trial Rise-uP: Where Clinical Superiority Meets Cost Savings.,2024-01-01,Franke S,"StatConsult GmbH Magdeburg, Magdeburg, Germany.",Not available
38952860,Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case series.,2024-01-01,Shahriari M,"Central Connecticut Dermatology, Cromwell, Connecticut.",Not available
38952554,"Large-scale, prospective observational study of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors in a real-world clinical setting.",2024-01-01,Chosa M; Hirano K,"PMS, Bayer Yakuhin Ltd., Osaka, Japan.",Not available
38952162,Review of the Different Outcomes Produced by Genetic Knock Out of the Long Non-coding microRNA-host-gene MIR22HG versus Pharmacologic Antagonism of its Intragenic microRNA product miR-22-3p.,2024-06-28,Thibonnier M,"AptamiR Therapeutics, Inc., USA.",Not available
38952082,Unraveling unmet needs in ketogenic dietary services: An ERN EpiCARE survey.,2024-01-01,Darra F; Dianin A,"Dravet Sindrom Hrvatska, ePAG of European Reference Network EpiCARE, Split, Croatia.",Not available
38952038,Automated Absolute Binding Free Energy Calculation Workflow for Drug Discovery.,2024-07-22,Ries B; Magarkar A,"Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str 65, 88397 Biberach an der Riss, Germany.",Not available
38951507,"Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies.",2024-06-29,Zhu Z; Swaim L; Deng S; Lu DR; Gauthier E; Liu Y,"Pfizer Inc, La Jolla, CA, USA.","The Institute of Cancer Research, Sutton, UK. maggie.cheang@icr.ac.uk."
38951245,Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).,2024-07-01,Haberkorn M; Graeven U,"Practice of Hematology and Oncology, Gutersloh, Germany.; UBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany.","Charite - Universitatsmedizin Berlin, Department of Hematology, Oncology, and Cancer Immunology, Freie Universitat Berlin and Humboldt-Universitat Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. dominik.modest@charite.de."
38950925,Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study.,2024-07-01,Braicu EI; York W; Hartman J,"Charite Universitatsmedizin and Arbeitsgemeinschaft Gynakologische Onkologie (AGO), Berlin, Germany.; GSK, Philadelphia, Pennsylvania, USA.","Medical University of South Carolina, Charleston, South Carolina, USA graybill@musc.edu."
38950881,Long-term physical stability of amorphous solid dispersions: Comparison of detection powers of common evaluation methods for spray-dried and hot-melt extruded formulations.,2025-01-01,Ishitsuka T; Fukiage M; Nishida Y; Tanabe F; Shinoda K,"Nara Machinery Co., Ltd., 2-5-7 Jonan-Jima, Ohta-ku, Tokyo 143-0002, Japan.; Pharmaceutical R&D, Ono Pharmaceutical Co., Ltd., 1-15-26, Kamiji, higashinari-ku, Osaka 537-0003, Japan.; Sumitomo Pharma America, Inc., 84 Waterford Drive, Marlborough, MA 01752, USA.","Graduate School of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan. Electronic address: kawakami.kohsaku@nims.go.jp."
38950872,The new frontier in CHO cell line development: From random to targeted transgene integration technologies.,2024-01-01,Zeh N; Schmidt M; Schulz P,"Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH and Co.KG, Biberach an der Riss, Germany.",Not available
38950154,Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United States.,2024-01-01,Khilfeh I; Muser E; Morrison L; Kinkead F; Lefebvre P; Pilon D,"Analysis Group, Inc., Montreal, QC, Canada.; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA.",Not available
38949964,"Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for In Vivo Mouse Studies.",2024-07-11,Fer M; Amalric C; Arban R; Baron L; Cui Y; Darcq E; Franchet C; Frauli M; Halter C; Heyer M; Hoenke C; Hoerer S; Hucke OT; Joseph C; Kieffer BL; Lebrun L; Omrani A; Recolet M; Schaeffer L; Schann S; Schlecker A; Steinberg E; Viloria M; Wurstle K; Young K; Zinser A; Montel F; Klepp J,"Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany.; Domain Therapeutics, 67400 Illkirch, France.",Not available
38949880,"Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.",2024-07-01,Emberson J; Preiss D,"Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.; Medicine Division, Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.",Not available
38949816,Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.,2024-08-01,Casez O,"CHU de Besancon, Service de Neurologie Besancon, France.",Not available
38949387,Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-based Reporter Assays.,2024-06-14,Grande D; Rajendra E; Mason B; Galbiati A; Boulton SJ; Smith GCM; Robinson HMR,"Artios Pharma Ltd, Cambridge; Artios Pharma Ltd, Cambridge.; The Francis Crick Institute, London.",Not available
38948925,NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker.,2024-01-01,Loeffen JLC,Present address: Acerta-Pharma (AstraZeneca) Oss The Netherlands.,Not available
38948832,Heterogeneity of morphometric similarity networks in health and schizophrenia.,2024-06-18,Gallego AG; Janssen N; Hulshoff Pol HE,"Ciber del Area de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.",Not available
38948774,A model for accurate quantification of CRISPR effects in pooled FACS screens.,2024-06-18,Arce MM,These authors contributed equally.,Not available
38948490,Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis.,2024-01-01,Ma C; Peyrin-Biroulet L,"Alimentiv Inc., London, Ontario, Canada.",Not available
38946793,Sexual dimorphism in peri-articular tissue anatomy - More keys to understanding sex-differences in osteoarthritis?,2024-01-01,Wirth W,"Chondrometrics GmbH, Ainring, Germany.",Not available
38945909,"[Pharmacological and clinical profile of inclisiran sodium, a long-acting LDL cholesterol lowering siRNA, LEQVIO for s.c. injection syringe 300 mg].",2024-01-01,Mikami T; Fujiwara Y; Akahori M; Tomimatsu N; Tamaki Y,"Novartis Pharma K.K., Development Japan.",Not available
38945004,BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.,2024-01-01,Robado de Lope L; Serna-Blasco R; Diz Tain P; Cruz-Bermudez A,"Complejo Asistencial Universitario de Leon, Leon, Spain.; Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.","Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Electronic address: mariano.provencio@salud.madrid.org."
38944553,"Retraction notice to ""Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients"" [Immunobiology 219(5) (2014) 392-401].",2024-01-01,Pieper MP,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.","Unit: ""Ex vivo/In vitro Models to Study the Immunopathology and the Pharmacology of Airway Diseases"", Institute of Biomedicine and Molecular Immunology (IBIM), Italian National Research Council (CNR), Palermo, Italy. Electronic address: profita@ibim.cnr.it."
38944461,"Reply to: ""From NAFLD to MASLD: Promise and pitfalls of a new definition'.",2024-01-01,Narro GEC,"Asociacion Latinoamericana para el Estudio del Higado (ALEH), Santiago, Chile.; Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico; Department of Hepatology and Transplant, Hospital Medica Sur, Mexico City, Mexico",Not available
38944121,"Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis.",2024-01-01,Leimu L; Holm P; Gaciarz A; Prince S,"Department of Life Technologies, University of Turku, Turku, Finland; MediCity Research Laboratory, University of Turku, Turku, Finland.; Mobidiag, A Hologic Company, Espoo, Finland.; Organon R&D Finland, Turku, Finland.; R&D, Orion Pharma, Orion Corporation, Turku, Finland","Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland. Electronic address: laura.leimu@orionpharma.com."
38943828,Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment.,2024-01-01,Surana U,"Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore; SiNOPSEE Therapeutics Pte Ltd, ASTARTCentral, 139955, Singapore.",Not available
38943785,"Increasing prevalence of self-harm, suicidal behavior and suicidal ideation throughout a three-year period in the context of COVID-19 pandemic in Spain.",2024-01-01,Gimenez-Palomo A; Fico G; Borras R; Sague-Vilavella M; Gomez-Ramiro M; Fortea A; Fortea L; Vazquez M; Vieta E,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona. c. Villarroel, 170, Barcelona, 08036, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Psychiatry, Hospital Alvaro Cunqueiro, Servizo Galego de Saude (SERGAS), Vigo, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, Barcelona, 08036, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, Barcelona, 08036, Spain.; Institute of Neurosciences (UBNeuro), Spain; Institute of Neurosciences (UBNeuro), Spain.; Psychiatry and Psychology Service, Hospital Clinic de Barcelona. c. Villarroel, 170, Barcelona, 08036, Spain.; Translational Neuroscience Research Group, Galicia Sur Health Research Institute (IISGS), Spain.",Not available
38943232,Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study.,2024-01-01,Cotter G; Davison B; Mebazaa A; Voors A; Hayrapetyan H; Pagnesi M,"Heart Initiative, Durham, NC, USA.; Universite Paris Cite, INSERM UMR-S 942 (MASCOT), Paris, France.",Not available
38942693,Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer.,2024-01-01,Giranda V; Liu F; Chatterjee M,"Merck & Co., Inc., Rahway, NJ.",Not available
38942592,"Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study.",2024-06-28,Dhatt H,"Janssen Pharmaceutical Companies of Johnson & Johnson, Scottsdale, Arizona, USA.","Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK peter.taylor@kennedy.ox.ac.uk."
38942349,Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-Sensitive Magnetic Resonance Imaging and [(18)F]-DOPA Positron Emission Tomography Study.,2024-10-15,Hopkins SC; Koblan KS,"Sumitomo Pharma America, Inc., Marlborough, Massachusetts.","South London and Maudsley NHS Foundation Trust, London, United Kingdom. Electronic address: luke.vano@kcl.ac.uk."
38942169,Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019.,2024-01-01,Diaz LA; Arab JP,"Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile; Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.; MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA; Observatorio Multicentrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile; The Global NASH Council, Washington, DC, USA.","Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. Electronic address: pojsakorndan@gmail.com."
38942047,"Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.",2024-01-01,Corn TH,"Asclepius Consulting (Izana Bioscience), London, UK.","Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Electronic address: claudia.worth@ndorms.ox.ac.uk."
38942026,Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer.,2024-07-08,Li X; He N; Shen F; Wang Z; He F; Sun X; Mao R; Shi W,"Shanghai Hengrui Pharmaceutical Co., LTD, Shanghai 200433, China.","Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Electronic address: caicunzhou_dr@163.com."
38941950,Shared vulnerability and sex-dependent polygenic burden in psychotic disorders.,2024-01-01,Mitjans M; Papiol S; Fatjo-Vilas M; Acosta-Diez M; Zafrilla-Lopez M; Arango C; Vilella E; Martorell L; Molto MD; Bobes J; Crespo-Facorro B; Gonzalez-Pinto A; Fananas L; Rosa A; Arias B,"BIOARABA Health Research Institute, OSI Araba, University Hospital, University of the Basque Country, Vitoria, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Departament Biologia Evolutiva, Ecologia i Ciencies Ambientals, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Departament Biologia Evolutiva, Ecologia i Ciencies Ambientals, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.; Departament Genetica, Microbiologia i Estadistica, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Maranon, School of Medicine, Universidad Complutense de Madrid, Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM), Madrid, Spain; Department of Genetics, Universitat de Valencia, Valencia, Spain; Department of Psychiatry, Universidad de Oviedo, Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Servicio de Salud del Principado de Asturias (SESPA) Oviedo, Spain; FIDMAG Germanes Hospitalaries Research Foundation, Barcelona, Spain; Hospital Universitari Institut Pere Mata, Institut d'Investigacio Sanitaria Pere Virgili-CERCA, Universitat Rovira i Virgili, Reus, Spain; INCLIVA Biomedical Research Institute, Fundacion Investigacion Hospital Clinico de Valencia; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain; Institut de Recerca Sant Joan de Deu (IRSJD), Esplugues de Llobregat, Spain; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany; Max Planck Institute of Psychiatry, Munich, Germany; University Hospital Virgen del Rocio/IBiS/CSIC-Department of Psychiatry, School of Medicine, University of Sevilla, Sevilla, Spain","Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Electronic address: marina.mitjans@ub.edu."
38941869,Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations.,2024-01-01,Oeser K; Zehaczek M; Jeratsch U,"Novartis Pharma GmbH, Nuernberg, Germany.","Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. Electronic address: anna.kron@uk-koeln.de."
38941599,"Assessment of the Feasibility of Objective Parameters as Primary End Points for Patients Affected by Knee Osteoarthritis: Protocol for a Pilot, Open Noncontrolled Trial (:SMILE:).",2024-06-28,Barattini DF; Guadagna S,"Opera CRO, a TIGERMED company, Timisoara, Romania.",Not available
38941572,Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores.,2024-01-01,Lin TY; Motamedi S; Asseyer S; Chien C; Saidha S; Calabresi PA; Fitzgerald KC; Samadzadeh S; Villoslada P; Llufriu S; Green AJ; Preiningerova JL; Petzold A; Leocani L; Garcia-Martin E; Oreja-Guevara C; Outteryck O; Vermersch P; Balcer LJ; Kenney R; Albrecht P; Aktas O; Costello F; Frederiksen J; Uccelli A; Cellerino M; Frohman EM; Frohman TC; Bellmann-Strobl J; Schmitz-Hubsch T; Ruprecht K; Brandt AU; Zimmermann HG; Paul F,"Clinic of Optic Neuritis and Clinic of Multiple Sclerosis (J.F.), Department of Neurology, Rigshospitalet - Glostrup, Denmark; Department of Epidemiology (K.C.F.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Neurology (A.J.G.), University of California San Francisco; Department of Neurology (C.O.-G.), Hospital Clinico Universitario San Carlos, Madrid, Spain; Department of Neurology (J.L.P.), Charles University in Prague, Czech Republic; Department of Neurology (K.R., F.P.), Charite - Universitatsmedizin Berlin; Department of Neurology (O.O., P. Vermersch); Department of Neurology (P. Villoslada), Hospital Del Mar - Pompeu Fabra University; Department of Neurology (P.A., O.A.), Heinrich-Heine-University, Dusseldorf, Germany; Department of Neurology (S. Saidha, P.A.C., K.C.F.); Department of Neurology (S. Samadzadeh), Slagelse Hospital, Denmark; Department of Neuroradiology (O.O., P. Vermersch), Centre Hospitalier Universitaire de Lille, France; Department of Neurosciences (A.U., M.C.), Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Italy; Department of Psychiatry and Psychotherapy (C.C.), Charite - Universitatsmedizin Berlin, Germany; Department of Regional Health Research and Molecular Medicine (S. Samadzadeh), University of Southern Denmark, Odense; Departments of Clinical Neurosciences and Surgery Cumming School of Medicine (F.C.), University of Calgary, Alberta, Canada; Departments of Neurology (L.J.B., R.K.), Population Health and Ophthalmology, NYU Grossman School of Medicine, NY; Experimental Neurophysiology Unit (L.L.), Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute; Experimental and Clinical Research Center (T.-Y.L., S.M., S.A., C.C., S. Samadzadeh, J.B.-S., T.S.-H., A.U.B., H.G.Z., F.P.), a cooperation between the Max Delbruck Center for Molecular Medicine in the Helmholtz Association and Charite - Universitatsmedizin Berlin; From the Charite - Universitatsmedizin Berlin (T.-Y.L., S.M., S.A., C.C., S. Samadzadeh, J.B.-S., T.S.-H., A.U.B., H.G.Z., F.P.); Laboratory of Neuroimmunology (E.M.F., T.C.F.), Professor Lawrence Steinman, Stanford University School of Medicine, Palo Alto, CA; Max-Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC) (T.-Y.L., S.M., S.A., C.C., S. Samadzadeh, J.B.-S., T.S.-H., A.U.B., H.G.Z., F.P.); Miguel Servet University Hospital (E.G.-M.), Zaragoza; Moorfield's Eye Hospital (A.P.), The National Hospital for Neurology and Neurosurgery, Queen Square Institute of Neurology, University College London, United Kingdom; Neuro-ophthalmology Expert Center (A.P.), Amsterdam UMC, Netherlands; Neuroimmunology and Multiple Sclerosis Unit (S.L.), Hospital Clinic Barcelona and IDIBAPS, Barcelona, Spain; Neuroscience Clinical Research Center (S.M., S.A., C.C., J.B.-S., T.S.-H., H.G.Z., F.P.); Vita-Salute San Raffaele University (L.L.), Milan, Italy; and Einstein Center Digital Future (H.G.Z.), Berlin, Germany.",Not available
38941067,Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19.,2024-01-01,Uehara T,"Drug Development and Regulatory Science Division, Shionogi & Co., Ltd., Osaka, Japan.",Not available
38940995,Short-Term Impact of Seizures and Mitigation Opportunities.,2024-01-01,Penovich P; Rabinowicz AL,"Minnesota Epilepsy Group, Saint Paul, MN, USA.; Neurelis, Inc, San Diego, CA, USA.","Comprehensive Epilepsy Center, Cincinnati Children's Hospital, Cincinnati, OH, USA. tracy.glauser@cchmc.org."
38940435,Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis.,2024-12-01,Sun X; Glotfelty L; Shabbir A; Tilton ST; McCann E,"Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Sanofi, Cambridge, Massachusetts, USA .",Not available
38940379,Preclinical evaluation of ELP-004 in mice.,2024-01-01,Geldenhuys WJ,"ExesaLibero Pharma, Inc., Morgantown, West Virginia, USA.",Not available
38939389,Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.,2024-01-01,Beyer-Westendorf J,"Praxis Dr med. Jens Taggeselle, Markkleeberg, Germany.",Not available
38939121,Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic Dermatitis.,2024-01-01,Gori N; Chiricozzi A; Di Stefani A,"Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, Rome, Italy.",Not available
38938861,Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF.,2024-01-01,Ward JH; Williamson KM,"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
38938844,Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.,2024-01-01,Berger JS; Gong MN; Paul JD; Slutsky AS; Farkouh ME,"Berry Consultants, LLC, Austin, Texas, USA.; Institut du Savoir Montfort, Ottawa, Ontario, Canada.; Instituto Mexicano del Seguro Social, Mexico City, Mexico.",Not available
38938812,Structure-Based High-Efficiency Homogeneous Antibody Platform by Endoglycosidase Sz Provides Insights into Its Transglycosylation Mechanism.,2024-06-24,Hsieh YC; Huang TY; Wang NH; Hu PL; Tsai YC; Hsieh YH,"OBI Pharma, Inc., No. 508, Sec. 7, ZhongXiao E. Rd, Nangang Dist., Taipei City 115, Taiwan.",Not available
38938723,The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia.,2023-01-01,Ali S; Banerjee P; Chan KC; Khilla N; McGinniss J; Pordy R; Zhang Y,"Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.",Not available
38938480,The NCDR's Chest Pain Myocardial Infarction Registry: 15 Years of Myocardial Infarction Quality Improvement.,2023-01-01,Garrett KN; Anderson C,"Division of Cardiology, ChristianaCare, Newark, Delaware, USA.; NCDR, Washington, District of Columbia, USA.",Not available
38938327,Plain language summary of a study looking at the effect of empagliflozin treatment in patients with chronic kidney disease.,2024-01-01,Petrini M; Seide S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.",Not available
38937404,Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.,2024-01-01,Vanhooteghem O; Williams P; Shimizu S; Heidbrede T; Warren RB,"Clinique Sainte-Elisabeth, Place Louise Godin 15, 5000, Namur, Belgium.; UCB Pharma, Brussels, Belgium.; UCB Pharma, Madrid, Spain.; UCB Pharma, Morrisville, NC, USA.","Dermatology Practice Dr. Bernhard Korge, Oberstrasse 75-77, 52349, Duren, Germany. hautarzt@dr-korge.de."
38937372,Stability of Protein Pharmaceuticals: Recent Advances.,2024-01-01,Payne RW; Connolly BD; Liu H; Murphy BM; Henry CS; Crommelin DJA,"Legacy BioDesign LLC, Johnstown, CO, USA.; Samsung Biologics, 201-2, Songdo-Dong, Yeonsu-Gu, Incheon, Korea.; Scholar Rock, Inc., Cambridge, MA, USA.; Spyre Therapeutics, Inc., Waltham, MA, USA.","Legacy BioDesign LLC, Johnstown, CO, USA. manning@legacybiodesign.com."
38937277,Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after two years?,2024-06-27,Fongen C,"UCB Pharma B.V, the Netherlands.",Not available
38937161,[Translated article] Pharmaceutical care in respiratory diseases: Current situation and opportunities for hospital pharmacy in Spain.,2024-01-01,Del Estal J,"Servicio de Farmacia, Consorci Sanitari Parc Tauli, Sabadell, Espana.","Servicio de Farmacia, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025, Espana. Electronic address: ngarin@santpau.cat."
38937025,"Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.",2024-01-01,Boccomini C; Bolis SA,"SC Hematology, AOU Citta della Salute e della Scienza, Turin, Italy.; Struttura Complessa di Ematologia, Fondazione IRCCS San Gerardo dei Tintori-Monza, Monza, Italy.","Hematology, Department of Translational and Precision Medicine, Sapienza University-Polo Pontino, S.M. Goretti Hospital, Latina, Italy. Electronic address: alessandro.pulsoni@uniroma1.it."
38936390,Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations.,2024-01-01,Thariat J,"ARCHADE Research Community Caen, France; Department of Radiation Oncology, Centre Francois Baclesse, Caen, France; Laboratoire de Physique Corpusculaire, UMR 6534, Unicaen-Normandie Universite, Caen, France.","Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: annette.lim@petermac.org."
38936103,"Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3beta inhibitors in children and adolescents with cancer.",2024-01-01,Donoghue M; Weiner S; Knoderer H; Bernardi R; Buenger V; Friend J; Gorbatchevsky I; Liaw D; Ludwinski D; Mazar A; Rosenfeld A; Taylor D,"Actuate Therapeutics Inc., For worth, TX, USA.; AstraZeneca, Waltham, MA, USA.; Celcuity Inc., Minneapolis, MN, USA.; Children's Cancer Cause, Washington, DC, USA.; Coalition Against Childhood Cancer (CAC2), Philadelphia, USA.; Genentech, A Member of the Roche Group, South San Francisco, CA USA.; Kazia Therapeutics, NJ, USA.; Loxo Oncology at Lilly, USA.; Merck Sharp & Dohme, NJ, USA.; PORT (Paediatric Oncology Reference Team), London, UK.; Solving Kids' Cancer, New York, USA.; US Food and Drug Administration, Silver Springs, MD, USA.","ACCELERATE, Europe, Belgium. Electronic address: andy1pearson@btinternet.com."
38935433,Frontal white and gray matter abnormality in gambling disorder: A multimodal MRI study.,2024-06-26,Joutsa J,"4Combinostics Ltd, Tampere, Finland.",Not available
38935148,A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.,2024-01-01,Alroughani R,"Departamento de Medicina InternaFacultad de Medicina, Universidad Nacional de Colombia, Bogota, Colombia.",Not available
38934967,Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial.,2024-01-01,Roessig L; Blaustein RO,"Bayer AG, Wuppertal, Germany.; Merck & Co, Inc, Rahway, New Jersey, USA.",Not available
38934946,[XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (I)].,2024-07-01,Fernandez O; Montalban X; Prieto JM; Romero-Pinel L,"Instituto de Investigacion Biomedica de Malaga. IBIMA, Malaga, Espana.; Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Espana.; Universidad Catolica San Antonio, Murcia, Espana.; Universidad de Malaga, Malaga, Espana.",Not available
38934918,Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary.,2024-01-01,Li Y; Hunsche E; Wagman RB,"Sumitomo Pharma America, Marlborough, MA, USA.; Sumitomo Pharma Switzerland GmbH, Basel, Switzerland.",Not available
38934629,"An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHD.",2024-01-01,Sasagawa Y; Maeda Y,"Meiji Seika Pharma Co., Ltd., Tokyo, Japan.",Not available
38934362,Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.,2024-01-01,Andrews JS; Buracchio T; Jagust W,"Development, Denali Therapeutics, South San Francisco, California, USA.; Global Evidence & Outcomes, Takeda Pharmaceuticals Company Limited, Cambridge, Massachusetts, USA.; Office of Neuroscience, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.",Not available
38934147,Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3.,2024-01-01,Sinclair R; Law EH; Zhang F; Napatalung L; King B,"Pfizer Inc., Groton, Connecticut, USA.; Pfizer Inc., New York, New York, USA.; Sinclair Dermatology, Melbourne, Victoria, Australia.",Not available
38934111,"Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.",2024-07-16,Granger CB; Green J,"Boehringer Ingelheim Pharmaceuticals, Inc, Ingelheim, Germany (J.P., T.G.).",Not available
38933669,"A phase I, randomized study to evaluate the safety, tolerability, and pharmacokinetics of mefunidone in healthy subjects.",2024-01-01,Huo B; Zhang S; Wu B,"Guangzhou Nanxin Pharma Co., Ltd., Guangzhou, China.",Not available
38933492,Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.,2024-06-20,Behbehani GK,"Columbus, OH 43210, USA.; Department of Internal Medicine, Division of Hematology, the Ohio State University",Not available
38932995,Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3.,2024-01-01,Trucco F; Ridout D; Weststrate H; Scoto M; Rohwer A; Coratti G; Main ML; Mayhew AG; Montes J; De Sanctis R; Pane M; Pera MC; Sansone VA; Albamonte E; D'Amico A; Bruno C; Messina SS; Childs AM; Willis T; Ong MT; Servais L; Majumdar A; Hughes I; Marini-Bettolo C; Parasuraman D; Gowda VL; Baranello G; Bertini ES; De Vivo DC; Darras BT; Day JW; Mayer O; Zolkipli-Cunningham Z; Finkel RS; Mercuri E; Muntoni F,"Center of Experimental and Translational Myology (CB), IRCCS Istituto Giannina Gaslini, Genoa and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa; Centro Clinico Nemo (GC, RDS, MP, MCP, EM), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department Paediatric Neuroscience Evelina London Children's Hospital and Department Paediatric Respiratory Medicine (FT), Royal Brompton Hospital, Guy's and St Thomas NHS Trust London, United Kingdom; Department of Clinical and Experimental Medicine and Centro Clinico Nemo Sud (SSM), University of Messina, Italy; Department of Neurology (BTD), Boston Children's Hospital, Harvard Medical School, Boston, MA; Department of Neurology (JWD), Stanford University, Palo Alto, CA; Department of Paediatrics The Children's Hospital of Philadelphia (OM, ZZ-C), Philadelphia, PA; Department of Rehabilitation and Regenerative Medicine (JM), Columbia University Irving Medical Center, New York; Departments of Neurology and Pediatrics (DCDV), Columbia University Irving Medical Center, New York; Dubowitz Neuromuscular Centre (FT, HW, MS, AR, MLM, GB, FM), UCL Institute of Child Health & Great Ormond Street Hospital, London; Evelina London Children's Hospital (VLG), London, UK; Leeds Children Hospital (A-MC); MDUK Oxford Neuromuscular Centre & NIHR Oxford Biomedical Research Centre (LS), University of Oxford, United Kingdom; Nemours Children's Hospital (RSF), University of Central Florida College of Medicine, Orlando; Neuromuscular Reference Center, Department of Paediatrics, University and University Hospital of Liege, Belgium; Neurorehabilitation Unit (VAS, EA), University of Milan, Neuromuscular Omnicentre Clinical Center, Niguarda Hospital; Newcastle University and Newcastle Hospitals NHS Foundation Trust (AGM, CM-B), Newcastle Upon Tyne, United Kingdom; Paediatric Neurology (GC, RDS, MP, MCP, EM), Universita Cattolica del Sacro Cuore; Pediatric Neurology and Muscular Diseases Unit (FT), IRCCS Istituto Giannina Gaslini, Genova and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Italy; Population (DR), Policy and Practice Programme, UCL GOS Institute of Child Health, London; Royal Hospital for Children (AM), Bristol; Royal Manchester Children's Hospital (IH); Sheffield Children's Hospital (MTO, LS); St. Jude Children's Research Hospital (RSF), Memphis, TN; The Robert Jones and Agnes Hunt Orthopaedic Hospital (TW), Oswestry; Unit of Neuromuscular and Neurodegenerative Disorders (ADA, ESB), Bambino Gesu Children's Hospital IRCCS, Rome; University Hospitals Birmingham (DP), United Kingdom; and NIHR Great Ormond Street Hospital Biomedical Research Centre (FM), London, United Kingdom.",Not available
38932723,Overview of preclinical and clinical studies investigating pharmacokinetics and drug-drug interactions of padsevonil.,2024-01-01,Chanteux H; MacPherson M; Kramer H; Otoul C; Okagaki T; Rospo C; De Bruyn S; Watling M; Bani M; Sciberras D,"UCB Pharma, Braine-l'Alleud, Belgium.; UCB Pharma, Brussels, Belgium.; UCB Pharma, Slough, UK.; UCB Pharma, Tokyo, Japan.",Not available
38932304,Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France.,2024-05-24,Burlet N,"Vifor Pharma, 92042 Paris, France.",Not available
38932179,Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico.,2024-05-31,Castrillo-Diez JL; Rivera-Santiago C; Barrera-Barrera SA,"Columbia Biotec, Columbia Laboratories, Tlalpan 14090, Mexico.; Leire Genomic Laboratories, Leon 37000, Mexico.",Not available
38931932,"Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions.",2024-06-14,Lowenthal R; Tanimoto S,"ARS Pharmaceuticals, Inc., San Diego, CA 92130, USA.",Not available
38931910,Targeting S. aureus Extracellular Vesicles: A New Putative Strategy to Counteract Their Pathogenic Potential.,2024-06-11,Magnifico I; Medoro A,"Aileens Pharma S.r.l., 20834 Nova Milanese (MB), Italy.",Not available
38931319,Effects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome.,2024-06-20,Cruchet Munoz S; Verbeke Palma S; Espinosa Pizarro MN,"Escuela de Tecnologia Medica, Facultad de Salud, Universidad Santo Tomas, Campus Santiago, Chile. Av. Ejercito 146, Santiago 8370003, Chile.; Facultad de Medicina, Universidad de los Andes, Monsenor Alvaro del Portillo 12455, Las Condes, Santiago 7620001, Chile.; Instituto de Nutricion y Tecnologia de los Alimentos ""Dr. Fernando Monckeberg"", Area Nutricion Humana, Universidad de Chile, El Libano 5524, Macul, Santiago 7830490, Chile.",Not available
38931217,Exploring the Impact of French Raw-Milk Cheeses on Oxidative Process Using Caenorhabditis elegans and Human Leukocyte Models.,2024-06-13,Priam J; Saunier E,"Domes Pharma, ZAC de Champ Lamet, 3 Rue Andree Citroen, F-63284 Pont-du-Chateau, France.",Not available
38930126,"Counteracting HPV Cervical and Anal Infection through Dietary Supplementation of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid: Clinical Case Reports.",2024-06-19,Incocciati B; Di Fraia L,"Di Fraia Laboratori s.r.l., 00034 Colleferro, Italy.",Not available
38929695,Treatment Patterns in Polyarticular Juvenile Idiopathic Arthritis: A Retrospective Observational Health Claims Data Study.,2024-05-31,Heinrich R; Hagemann C; Kock S; Schonfelder T,"InGef-Institut fur Angewandte Gesundheitsforschung Berlin GmbH, Otto-Ostrowski-Strasse 5, 10249 Berlin, Germany.; Pfizer Pharma GmbH, Friedrichstrasse 110, 10117 Berlin, Germany.",Not available
38928470,The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview.,2024-06-20,Mantle D,"Pharma Nord (UK) Ltd., Morpeth NE61 2DB, UK.",Not available
38927554,HLA Association among Thai Patients with Diffuse and Limited Cutaneous Systemic Sclerosis.,2024-06-18,Okudaira Y; Inoko H,"GenoDive Pharma Inc., Naka-cho Honatugi, Atsugi 243-0003, Japan.",Not available
38927230,Activity of Aztreonam/Avibactam and Recently Approved beta-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients.,2024-06-17,Sader HS; Mendes RE; Kimbrough JH; Hubler CM; Castanheira M,"Element Iowa City (JMI Laboratories), 345 Beaver Kreek Ctr, Ste A, North Liberty, IA 52240, USA.",Not available
38927026,An Assessment of Administration Route on MSC-sEV Therapeutic Efficacy.,2024-05-24,Zhang B; Lai RC; Sim WK; Tan TT; Lim SK,"Paracrine Therapeutics Pte. Ltd., 1 Tai Seng Ave, #02-04 Tai Seng Exchange, Singapore 536464, Singapore.",Not available
38926693,Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.,2024-06-26,Hernandez-Perez JM,"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.","Pneumology Department, Hospital Beatriz Angelo, Av. Carlos Teixeira 3, Loures, 2674-514, Portugal. teresamartinrioja@gmail.com."
38926632,Patient out-of-pocket costs for guideline-recommended treatments for erectile dysfunction: a medicare cost modeling analysis.,2025-01-01,McGovern AM; Rojanasarot S; Bhattacharyya S; Hargens LM; Aworunse O,"Boston Scientific, Marlborough, MA, USA.","Department of Urology, UC San Diego Health, San Diego, CA, USA. Joie.de.vi15@gmail.com."
38926553,Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration.,2024-06-26,Lee JH; Barak Y,"Retina Consultants of Texas, Houston, TX, USA.; SamChunDang Pharm. Co. Ltd., Seoul, Korea.","Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. swkang@skku.edu."
38926199,"Commentary on ""The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method"".",2024-06-26,Kuhl N; Mann J,"Analytical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.","Merck & Co. Inc., Rahway, New Jersey, USA. andreas_abend@merck.com."
38926017,Lung structural and functional impairments in young children with cystic fibrosis diagnosed following newborn screening - A nationwide observational study.,2024-01-01,Blanchon S; Rochat I,"Hopital de l'enfance de Lausanne, Lausanne Switzerland.",Not available
38925881,Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis.,2024-07-10,Wong CCY,"Systematic Reviews, CORE Group, Sydney, New South Wales, Australia.",Not available
38925335,"Prevalence, timing, and impact of early recurrence of atrial tachyarrhythmias after pulsed field ablation: A secondary analysis of the PULSED AF trial.",2024-06-24,Tarakji K; Cerkvenik J; van Bragt KA,"Medtronic Inc, Minneapolis, Minnesota.","St. Antonius Ziekenhuis, Nieuwegein, The Netherlands. Electronic address: l.boersma@antoniusziekenhuis.nl."
38925070,Adherence to istradefylline in patients with Parkinson's disease: A group-based trajectory analysis.,2024-07-15,Ito S,"Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan; Pharmacovigilance Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.",Not available
38924756,Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC.,2024-10-24,Cho BC; Lu S; Felip E; Spira AI; Girard N; Lee JS; Lee SH; Ostapenko Y; Danchaivijitr P; Liu B; Alip A; Korbenfeld E; Mourao Dias J; Besse B; Lee KH; Xiong H; How SH; Cheng Y; Chang GC; Yoshioka H; Yang JC; Thomas M; Nguyen D; Ou SI; Mukhedkar S; Prabhash K; D'Arcangelo M; Alatorre-Alexander J; Vazquez Limon JC; Alves S; Stroyakovskiy D; Peregudova M; Sendur MAN; Yazici O; Califano R; Gutierrez Calderon V; de Marinis F; Passaro A; Kim SW; Gadgeel SM; Xie J; Sun T; Martinez M; Ennis M; Fennema E; Daksh M; Millington D; Leconte I; Iwasawa R; Lorenzini P; Baig M; Shah S; Bauml JM; Shreeve SM; Sethi S; Knoblauch RE; Hayashi H,"British Hospital of Buenos Aires, Central British Hospital, Buenos Aires (E.K.); City of Hope National Medical Center, Duarte (D.N.), Chao Family Comprehensive Cancer Center, University of California, Irvine, School of Medicine, Orange (S.-H.I.O.), and Janssen Research and Development, San Diego (E. Fennema, D.M., S.M.S.) - all in California; From the Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine (B.C.C.), Samsung Medical Center, Sungkyunkwan University School of Medicine (S.-H.L.), and the Lung Cancer Center, Asan Medical Center Cancer Institute (S.-W.K.), Seoul, the Department of Hematology-Oncology, Seoul National University Bundang Hospital, Seongnam (J.-S.L.), and the Medical Department, Chungbuk National University Hospital, Cheongju (K.-H.L.) - all in South Korea; Health Pharma Professional Research, Mexico City (J.A.-A.), Oncologia Medica, Antiguo Hospital Civil de Guadalajara ""Fray Antonio Alcalde,"" Guadalajara, and Universidad de Guadalajara, Guadalajara (J.C.V.L.) - all in Mexico; Institut Curie, Institut du Thorax Curie-Montsouris, Paris (N.G.), and Paris-Saclay University, Universite de Versailles Saint-Quentin-en-Yvelines, Versailles (N.G.), and Paris-Saclay University and Institut Gustave Roussy, Villejuif (B.B.) - all in France; Instituto Portugues de Oncologia do Porto, Porto, Portugal (S.A.); Janssen Research and Development, Raritan, NJ (J.X., T.S., M.M., M. Daksh, M.B.); Janssen Research and Development, Spring House, PA (M.E., R.I., P.L., S. Shah, J.M.B., S. Sethi, R.E.K.); Moscow City Oncology Hospital No. 62 (D.S.) and the Medical Center in Kolomenskoe (M.P.) - both in Moscow; St. John of God Murdoch Hospital, Murdoch, WA, Australia (S.M.); Virginia Cancer Specialists, Fairfax (A.I.S.); and Johnson and Johnson Clinical Innovation, Campus Basel, Allschwil, Switzerland (I.L.).; the Clinical Oncology Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur (A.A.), and the Department of Internal Medicine, Division of Respiratory Medicine, International Islamic University Malaysia Medical Specialist Center, Pahang (S.-H.H.) - both in Malaysia; the Department of Medical Oncology, Ankara Bilkent City Hospital and Ankara Yildirim Beyazit University (M.A.N.S.), and the Department of Medical Oncology, Gazi University Faculty of Medicine (O.Y.) - both in Ankara, Turkey; the Department of Medical Oncology, Barretos Cancer Hospital, Sao Paulo (J.M.D.); the Department of Medical Oncology, Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom (R.C.); the Department of Medical Oncology, Division of Adult Solid Tumor, Tata Memorial Center and Homi Bhabha National Institute, Mumbai, India (K.P.); the Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai (S.L.), Harbin Medical University Cancer Hospital, Harbin (B.L.), the Department of Medical Oncology, Huizhou Municipal Central Hospital of Guangdong Province, Huizhou (H.X.), and Jilin Cancer Hospital, Changchun (Y.C.) - all in China; the Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata (H.Y.), and the Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka (H.H.) - both in Japan; the Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and the National Center for Tumor Diseases Heidelberg, German Center for Lung Research, Heidelberg, Germany (M.T.); the Division of Hematology-Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit (S.M.G.); the Division of Medical Oncology, Department of Medicine, Siriraj Hospital Faculty of Medicine, Mahidol University Bangkok Noi Campus, Bangkok, Thailand (P.D.); the Local Health Unit Authority of Romagna, Ravenna Hospital and Department of Onco-Hematology, Santa Maria delle Croci Hospital of Ravenna, Ravenna (M. D'Arcangelo), and the Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan (F.M., A.P.) - both in Italy; the Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus-Vall d'Hebron University Hospital, Barcelona (E. Felip), and the Medical Oncology Department, Hospital Regional Universitario de Malaga y Virgen de la Victoria, Institute of Biomedical Research of Malaga, Malaga (V.G.C.) - both in Spain; the National Cancer Institute, Kyiv, Ukraine (Y.O.); the School of Medicine and Institute of Medicine, Chung Shan Medical University, and the Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung (G.-C.C.), and the Department of Medical Oncology, National Taiwan University Cancer Center, Taipei (J.C.-H.Y.) - both in Taiwan",Not available
38924724,"Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.",2024-07-23,Goadsby PJ; Friedman DI; Holle-Lee D; Demarquay G; Ashina S; Sakai F; Neel B; Gandhi P; Dabruzzo B; Smith JH; Liu Y; Trugman JM,"AbbVie (B.N.), Irvine, CA; AbbVie (P.G., B.D., J.M.T.), Madison, NJ; BIDMC Comprehensive Headache Center (S.A.), Beth Israel Deaconess Medical Center; Department of Neurology (D.H.-L.), West German Headache and Vertigo Center Essen, University of Essen, Germany; Department of Neurology (G.D.), Hospices Civils de Lyon, Lyon Neuroscience Research Center, France; Department of Neurology (P.J.G.), University of California, Los Angeles; Department of Neurology and Department of Anesthesia, Critical Care and Pain Medicine (S.A.), Harvard Medical School, Boston, MA; From the NIHR King's Clinical Research Facility (P.J.G.), King's College London, United Kingdom; International Headache Society Global Patient Advocacy Coalition Executive Committee (F.S.), Saitama International Headache Center, Saitama Neuropsychiatric Institute, Japan; Key-Whitman Eye Center (D.I.F.), Dallas, TX; and AbbVie (J.H.S., Y.L.), North Chicago, IL.",Not available
38924651,"Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies.",2024-01-01,Kac PR,"Universite de Paris Inserm UMR S11-44 Therapeutic Optimization in Neuropsychopharmacology, Paris, France.",Not available
38924336,Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data-driven cluster analysis: A post-hoc analysis of imeglimin clinical trial data.,2024-01-01,Kochi K,"Data Science, Sumitomo Pharma Co., Ltd, Tokyo, Japan.",Not available
38924052,Chinese hamster ovary cell line engineering strategies for modular production of custom extracellular vesicles.,2024-01-01,Hinchliffe M; Ellis M; Simpson C; Humphreys D; Sweeney B; Bracewell DG,"UCB Pharma, Slough, Berkshire, UK.",Not available
38922613,Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.,2024-06-03,Shah RC,"Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut.",Not available
38922484,Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis.,2024-01-01,Sun L; Pierce E; Elmaraghy H; Dawson Z; Torres T,"Eli Lilly and Company, Indianapolis, USA.; Tigermed, Somerset, NJ, USA.","Northwestern University Feinberg School of Medicine, Chicago, IL, USA. peterlio@gmail.com."
38921964,Exposure of Pharmacists and Pharmacy Technicians to Violence in Community Pharmacies in Southeast Europe: Frequency and Ethical Considerations.,2024-06-04,Popcevic M; Mestrovic A,"Pharma Expert Consultancy and Education, 10000 Zagreb, Croatia.; ZU Ljekarna Marusic, 10000 Zagreb, Croatia.",Not available
38921105,Amitraz Resistance in French Varroa Mite Populations-More Complex Than a Single-Nucleotide Polymorphism.,2024-05-27,Marsky U; Rognon B; Douablin A; Rodriguez Ramos MA; Hammaidi A,"Biomnigene, 18 Rue Alain Savary, 25000 Besancon, France.; Veto-Pharma, 12 Rue de la Croix Martre, 91120 Palaiseau, France.",Not available
38919277,The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients.,2024-01-01,Smith ER,"Calciscon AG, Biel, Switzerland.",Not available
38919146,Comparative analysis of GMO regulatory requirements for AAV vectors in the EU and Japan focusing on the shedding data and containment measures.,2024-01-01,Mizoguchi H; Komuro M; Hirai T; Saito K,"Astellas Pharma Inc., Regulatory Affairs, Chuo-ku, Tokyo, Japan.; GlaxoSmithKline K.K., Akasaka Intercity AIR, Minato-ku, Tokyo, Japan.; Pfizer Pharma, GmbH, Biotransformation and Environmental Sciences, Berlin, Germany.; Sanofi K.K., Regulatory Affairs, Shinjuku-ku, Tokyo, Japan.",Not available
38918871,S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.,2024-06-25,Askelson M; Liu J; Mukherjee S; Wong RL,"Bristol Myers Squibb, Immunology and Fibrosis, Princeton, NJ, USA.; Global Biometric Sciences, Bristol Myers Squibb, Princeton, NJ, USA.; Translational Medicine, Bristol Myers Squibb, Princeton, NJ, USA.","Division of Rheumatology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Hermine.brunner@cchmc.org."
38917802,Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy.,2024-07-16,Goelz S; Cahir-McFarland E,"Abata Therapeutics, Cambridge, MA, USA.; Biogen, Cambridge, MA, USA; Biogen, Cambridge, MA, USA.; Oregon Health & Science University, Portland, OR, USA",Not available
38917793,Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study.,2024-09-13,An D; Bishop KM,"Acadia Pharmaceuticals Inc., San Diego, CA 92130, USA.",Not available
38917772,Points to consider when initiating clinical investigations in autistic paediatric populations-A White Paper.,2024-01-01,Staunton H; Volz D; Chatham C,"F. Hoffmann - La Roche Ltd, Basel, Switzerland.; Roche Products Ltd, Welwyn Garden City, UK.","F. Hoffmann - La Roche Ltd, Basel, Switzerland. Electronic address: lindsay_mark.ham@roche.com."
38917767,"Incidence, healthcare resource utilization and costs of hospitalized patients with tick-borne encephalitis (TBE) in Italy.",2024-01-01,Pilz A; Schley K,"Pfizer Corporation Austria GmbH, Wien, Austria.; Pfizer Pharma GmbH, Berlin, Germany.",Not available
38917723,Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2).,2024-01-01,Bunker MT,"LivaNova PLC, Houston, TX, USA.","Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, USA. Electronic address: has1@columbia.edu."
38917636,Do classic psychedelics increase the risk of seizures? A scoping review.,2024-01-01,Soto-Angona O; Fortea A; Martinez-Ramirez M; Ona G,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain.; Department of Psychiatry and Forensic Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain; Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.; Fundacio Clinic per a la Recerca Biomedica-Institut d'Investigacions Biomediques August Pi I Sunyer, Barcelona, Spain; Fundacio Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, Barcelona, Spain; Fundacio Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.; Parc Sanitari Sant Joan de Deu, Barcelona, Spain; Sociedad Espanola de Medicina Psicodelica (SEMPsi), Barcelona, Spain",Not available
38917349,Simulating the Skin Permeation Process of Ionizable Molecules.,2024-07-08,Lundborg M; Lindahl E,"SciLifeLab, ERCO Pharma AB, 171 65 Solna, Sweden.",Not available
38917011,A metabolic inhibitor blocks cellular fucosylation and enables production of afucosylated antibodies.,2024-07-02,Yeo D,"Catalent Pharma Solutions, Emeryville, CA 94608.",Not available
38916965,Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.,2024-06-25,Soiffer RJ,"Novartis Pharma, Basel, Switzerland.",Not available
38916823,Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis.,2024-01-01,Taieb V; Willems D; Lyris N; Gaffney K,"UCB Pharma, Brussels, Belgium.; UCB Pharma, Colombes, France.; UCB Pharma, Copenhagen, Denmark.; UCB Pharma, Slough, UK.","Department of Medicine, University of Alberta, Edmonton, AB, Canada. walter.maksymowych@ualberta.ca."
38916811,Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma.,2024-01-01,Wu J; Hsu H; Fu C,"Kite, A Gilead Company, Santa Monica, CA, USA.",Not available
38916742,Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis.,2024-01-01,Gunes S,"Novartis Pharma AG, Basel, Switzerland.",Not available
38916740,Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis.,2024-01-01,Gunes S,"Novartis Pharma AG, Basel, Switzerland.",Not available
38916347,Absolute quantification of viral proteins from pseudotyped VSV-GP using UPLC-MRM.,2024-08-06,Basu R; Dambra R; Jiang D; Ashour J; Vigil A; Papov VV Jr,"Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.; Materials and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.",Not available
38916179,Insights into New-onset Arthritis in Patients with Hidradenitis Suppurativa.,2024-06-25,Moreno Martinez-Losa M; Exposito-Serrano V; Ribera M; Calvet J,"Department of Dermatology, Parc Tauli Hospital Universitari, Institut d'Investigacio i Innovacio Parc Tauli (I3PT-CERCA), Tauli de Sabadell, Spain; Department of Reumatology, Parc Tauli Hospital Universitari. Institut d'Investigacio i Innovacio Parc Tauli (I3PT-CERCA), Tauli de Sabadell, Spain; Universitat Autonoma de Barcelona, Sabadell, Spain.","Universitat Autonoma de Barcelona, Sabadell, Spain. pgarbayo@tauli.cat."
38915919,Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study.,2024-01-01,Perez-Sampietro M; Chantada-Abal V,"Ipsen Pharma, S.A.U., Barcelona, Spain.",Not available
38915849,Clinical decision-making before discharge in hospitalized persons with schizophrenia: a Spanish Delphi expert consensus.,2024-01-01,Aguera-Ortiz L; Mane A; Gutierrez-Rojas L,"Centro de Investigacion en Red de Salud Mental, CIBERSAM, Instituto de Salud Carlos III, Madrid, Spain.",Not available
38915726,Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease.,2024-06-10,Mulugeta N,"Computational and Systems Biology Program, MIT, Cambridge, MA, USA.",Not available
38915065,Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial.,2024-06-24,Ridker P,"Labcorp, Morrisville, NC, 27560, USA.","Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, 60 Fenwood Rd, Boston, MA, 02115, USA. kliao@bwh.harvard.edu."
38914876,"Efficacy and Safety of Trazodone and Gabapentin Fixed-Dose Combination in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Dose-Finding Study.",2024-01-01,Palka-Kisielowska I; Quarchioni E; Calisti F; Comandini A; Cattaneo A,"Angelini Pharma S.p.A., Rome, Italy.; Neurosanatio s.r.o., Litomysl, Czech Republic.",Not available
38914866,Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.,2024-01-01,Tewes B; Hils M; Pasternack R; Taavela J; Zimmermann T; Lundin KEA; Schuppan D; Maki M,"Dr. Falk Pharma GmbH, Freiburg, Germany.; Jilab Inc, Tampere, Finland.; Zedira GmbH, Darmstadt, Germany.",Not available
38914857,Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry.,2024-01-01,Schrader A; Li AH; Eckmann T; Zhu B; Malatestinic WN; Birt J; Blauvelt A,"CorEvitas, LLC, Waltham, MA, USA.; Eli Lilly and Company, Indianapolis, IN, USA.","Icahn School of Medicine at Mount Sinai, New York, NY, USA. lebwohl@aol.com."
38914574,Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients.,2024-06-24,Comellas M; Lizan L,"Outcomes'10, Castellon de la Plana, Spain.; Outcomes'10, Universidad Jaume I, Castellon de la Plana, Spain.","Department of Dermatology, Instituto de Investigacion Sanitaria de La Princesa (IIS-IP), Hospital Universitario de La Princesa, Diego de Leon, 62, 28006, Madrid, Spain. estebandauden@gmail.com."
38914547,Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma.,2024-06-24,Oliva M,"Centro de Investigacion Biomedica en Red Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain.","Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908, L'Hospitalet de Llobregat, Barcelona, Spain. llorenzo@idibell.cat."
38914170,An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease.,2024-01-01,Lizama BN; North HA; Pandey K; Williams C; Cho E; Di Caro V; Grundman M; Caggiano AO,"Cognition Therapeutics, Pittsburgh, PA, USA.; Dept. of Neurosciences, University of California, San Diego, USA.; Emtherapro Inc, Systems Biology, Atlanta, GA, USA.; Global R&D Partners, LLC, San Diego, California, USA",Not available
38913539,Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study.,2024-09-01,Houchard A,"Data and Insights Generation and Strategy, Ipsen, Boulogne-Billancourt, France.",Not available
38913390,Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants.,2024-08-01,Brandes A,"Centro Espanol Investigacion Farmacoepidemiologica, Madrid, Spain.",Not available
38913185,"2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody (PART 1A - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis PART 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine).",2024-01-01,Baratta M; Jian W; Hengel S; Kaur S; Cunliffe J; Boer J; Hughes N; Kim YJ; Lassman M; Morgan L; Palandra J; Sarvaiya H; Zeng J; Zheng N; Wang J; Yuan L; Ji A; Kochansky C; Tao L; Huang Y; Maes E; Contrepois K; Fu Y; Johnson J; Jones B; Kansal M; Lu Y; Post N; Shen HH; Xue YY; Zhang YC; Biswas G; Cho SJ; Benson K; Azadeh M; Francis J; Garofolo F; Gupta S; Karnik S; Kassim S; Kavetska O; Keller S; Li W; McCush F; Mendes DN; Abhari MR; Scheibner K; Tabler E; Wan K; Wang YM; Yang L; Zimmer J; Bandukwala A; Du X; Xu J; Maxfield K; Mayer C; Pedras-Vasconcelos J; Abhari MR; Shubow S; Verthelyi D; Wagner L,"AbbVie, South San Francisco, CA, USA.; Abbvie, Chicago, IL, USA.; Abbvie, San Mateo, CA, USA.; Aliri, Colorado Springs, CO, USA.; Alturas Analytics, Moscow, ID, USA.; Amgen, Thousand Oaks, CA, USA.; AstraZeneca, Gaithersburg, MD, USA.; AstraZeneca, South San Francisco, CA, USA.; Austria AGES, Vienna, Austria.; BRI Frontage, Vancouver, BC, Canada.; Biogen, Cambridge, MA, USA.; Biopharma, Toronto, ON, Canada.; Brazil ANVISA, Brasilia, Brazil.; Bristol-Myers Squibb, Lawrenceville, NJ, USA.; Chiesi, Boston, MA, USA.; Crinetics, San Diego, CA, USA.; Exelixis, Alameda, CA, USA.; Genentech, South San Francisco, CA, USA.; Incyte, Wilmington, DE, USA.; Ionis, Carlsbad, CA, USA.; Johnson & Johnson Innovative Medicine, Spring House, PA, USA.; Merck & Co., Inc., Rahway, NJ, USA.; Moderna, Mystic, CT, USA.; Novartis, Cambridge, MA, USA.; Novartis, East Hanover, NJ, USA.; PPD Thermo Fisher Scientific, Richmond, VA, USA.; Pfizer, Andover, MA, USA.; Pfizer, Groton, CT, USA.; Pfizer, San Diego, CA, USA.; Regeneron, Tarrytown, NY, USA.; Sanofi, Framingham, MA, USA.; Seattle Genetics, Bothell, WA, USA.; Takeda, Cambridge, MA, USA.; US FDA, Jefferson, AR, USA.; US FDA, Silver Spring, MD, USA.; Ultragenyx, Cambridge, MA, USA.",Not available
38913096,Treatment of positive catheter tip culture without bloodstream infections in critically ill patients. A case-cohort study from the OUTCOMEREA network.,2024-01-01,Darmon M,"OUTCOMEREA Network, 93700, Drancy, France.","Universite Paris Cite Inserm IAME 1137, 75018, Paris, France. niccolo.buetti@gmail.com."
38912846,"The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?",2024-10-03,Figarella Branger D,"Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, Paris, France.",Not available
38912694,Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.,2024-08-01,Schatz DA,"Mount Sinai South Nassau, Oceanside, NY.",Not available
38911847,Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.,2024-01-01,Fresegna D; Dolcetti E; Buttari F; Centonze D,"Synaptic Immunopathology Lab, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Roma, Rome, Italy.",Not available
38911158,"Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents.",2024-06-19,Al-Faiyz YS,"General Q.C Manager, Alexandria company for pharmaceuticals Alexandria 21521 Egypt.","Department of Chemistry, College of Science, King Faisal University P.O. Box 400 Al-Ahsa 31982 Saudi Arabia mayoup@kfu.edu.sa mohammedsalahayoup@gmail.com."
38910839,Subgroup analyses and patterns of multiple sclerosis health service utilisation: A cluster analysis.,2024-01-01,Schaubert K,"Deutsche Multiple Sklerose Gesellschaft (DMSG), Landesverband Niedersachsen, Hannover, Germany.",Not available
38909926,Labrafac(TM) MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol(R) ALF in ex vivo and in vivo rat studies.,2024-08-15,Caisse P; Dumont C,"Gattefosse SAS, 36, Chemin de Genas, Saint-Priest, France.","UCD School of Veterinary Medicine and UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: fiona.mccartney@ucd.ie."
38909542,Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer's disease patients.,2024-01-01,Marston H; Arango C,"Boehringer Ingelheim Pharma, Biberach, Germany.; Centre of Biomedical Research in Mental Health, CIBERSAM, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Gregorio Maranon University Hospital, IiSGM, Spain; Universidad Complutense de Madrid, Spain.","Amsterdam Neuroscience, Mood, Anxiety, Psychosis, Sleep & Stress and Neurodegeneration programs, Amsterdam, the Netherlands. Electronic address: s.braak@amsterdamumc.nl."
38909436,Cross-sectional studies: Is pressing the pause button worth it in research?,2024-01-01,Vieta E; De Prisco M,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, c. Villarroel, 170, 08036, Barcelona, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Institut de Neurociencies (UBNeuro), Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036, Barcelona, Spain","Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: evieta@clinic.cat."
38909413,Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database.,2024-01-01,Lada O; Rabiega P; Fouad F; Pol S,"Gilead Sciences, 65 quai Georges Gorse, Boulogne-Billancourt 92100, France.; IQVIA, Courbevoie, France.; Universite de Paris et Service d'Hepatologie de Cochin (AP-HP), Paris, France.",Not available
38909402,"Nature-based social prescribing programmes: opportunities, challenges, and facilitators for implementation.",2024-01-01,Straff W,"Umweltbundesamt (German Environment Agency), Worlitzer Pl. 1, 0684 Dessau-Rosslau, Germany.","Exeter HSDR Evidence Synthesis Centre, University of Exeter, 79 Heavitree Rd, Exeter EX2 4TH, United Kingdom. Electronic address: s.c.de-bell@exeter.ac.uk."
38909225,Toxicity assessment of Cucurbita pepo cv Dayangua and its effects on gut microbiota in mice.,2024-06-22,Chen B; Wang X; Jian Z; Wang L,"Heilongjiang Biodi Bio-Pharma Technology Company Lmt., No. 178, Yuexiujie, Harbin, Heilongjiang Province, China.",Not available
38909218,Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers.,2024-06-22,Janelidze S,"Roche Diagnostics GmbH, Penzberg, Germany.","Clinical Memory Research Unit, Department of Clinical Sciences Malmo, Faculty of Medicine, Lund University, Solvegatan 19, BMC B11, Lund, 221 84, Sweden. anna.orduna_dolado@med.lu.se."
38908172,Development and validation of the DBS-PS (Deep Brain Stimulation-Perception Scale): Assessing parkinsonian patients' expectations to prevent post-operative disappointment?,2024-07-15,Spitz E; Rolland AS; Schwan R; Devos D,"CHU Lille, Neurology and Movement Disorders Department, Reference Center for Parkinson's Disease, NS-PARK/FCRIN Network, Lille, France.; Centre Psychotherapique de Nancy, 1 rue du Docteur Archambault, BP11010 Laxou Cedex, France; Universite de Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LICEND, NS-PARK/FCRIN Network, Lille, France; Universite de Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LICEND, NS-PARK/FCRIN Network, Lille, France.; Universite de Lorraine, INSERM, CHU Nancy, U1254 - Imagerie Adaptative Diagnostique et Interventionnelle, Nancy, France.; Universite de Lorraine, UMR 1319 INSPIIRE, Equipe Psychologie de la Sante de Metz (EPSAM), Metz, France.","Service de neurologie, CHRU Nancy, 54000 Nancy, France. Electronic address: my.meyer@chru-nancy.fr."
38907948,Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059.,2024-01-01,Brivio E; Bruno B,"Institut de Recerca Sant Joan de Deu, Barcelona, Spain.; Pfizer Global Pharmacometrics, San Diego, CA, USA.",Not available
38907877,Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis.,2024-01-01,Patel V; Chirikov V,"Bristol Myers Squibb, Princeton, NJ, USA.",Not available
38907288,A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.,2024-06-22,Liu D; Holyoak E; Wu BT; Keygan J,"Alcohol, Tobacco & Other Drug Services, Townsville, Australia.; Drug and Alcohol Services of South Australia, Adelaide, Australia.","National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. r.mcketin@unsw.edu.au."
38907024,Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case report.,2024-01-01,Dharia S,"Sarepta Therapeutics, Inc., Cambridge, MA, USA.","Departments of Pediatrics and Neurology, University of Texas Southwestern Medical Center and Children's Health, Dallas, TX, USA. Susan.Iannaccone@UTSouthwestern.edu."
38906618,Sharing brain imaging data in the Open Science era: how and why?,2024-01-01,Mutsaerts HJ; Barkhof F; Chetelat G,"Amsterdam Neuroscience, Brain Imaging, Amsterdam, Netherlands; Amsterdam Neuroscience, Brain Imaging, Amsterdam, Netherlands.; Normandie universite, UNICAEN, INSERM, U1237, NeuroPresage Team, Cyceron, Caen, France.; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK.; Radiology and Nuclear Medicine, Vrije Universiteit Medical Center, Amsterdam University Medical Center, Amsterdam, Netherlands",Not available
38906375,"Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5-6 years.",2024-01-01,Kawamura A; Sogawa Y; Sakakibara S; Nakatsu T; Kimata M; Oe K,"Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.","Laboratory of Viral Infection, Omura Satoshi Memorial Institute, Kitasato University, 9-1, Shirokane 5-chome, Minato-ku, Tokyo, 108-8641, Japan. Electronic address: tetsuo-n@lisci.kitasato-u.ac.jp."
38906230,Formulation and dermal delivery of a new active pharmaceutical ingredient in an in vitro wound model for the treatment of chronic ulcers.,2024-01-01,Naef R,"Topadur Pharma AG, Schlieren, Switzerland.",Not available
38906210,Impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated pain.,2024-01-01,Zhong Y; Perry J; Hunsche E; Soulban G,"Sumitomo Pharma America, Marlborough, Massachusetts.; Sumitomo Pharma Switzerland GmbH, Basel, Switzerland.","Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan. Electronic address: sassanie@med.umich.edu."
38906161,"Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.",2024-01-01,Hirashima Y; Hagihara S; Nakada T,"Ono Pharmaceutical, Osaka, Japan.",Not available
38906102,Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.,2024-06-20,Derosa L; Silva CAC; Birebent R; Fidelle M; Deutsch E; Barlesi F; Albiges L; Planchard D; Andre F; Besse B; Wojcik J; Zitvogel L,"Data2time Sarl, Froideville, Switzerland.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Department of Radiation Oncology, Gustave Roussy, Villejuif, France; Gustave Roussy Cancer Campus, ClinicObiome, Villejuif, France; INSERM U1030, Radiotherapie Moleculaire et Innovation Therapeutique, Villejuif, France.; Institut National de la Sante et de la Recherche Medicale (INSERM) U1015, Equipe Labellisee-Ligue Nationale contre le Cancer, Villejuif, France; Institut National de la Sante et de la Recherche Medicale (INSERM) U1015, Equipe Labellisee-Ligue Nationale contre le Cancer, Villejuif, France.; Universite Paris-Saclay, Ile-de-France, France","Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: lisa.derosa@gustaveroussy.fr."
38904918,BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer.,2024-06-21,Amin K; Slimane K,"Novartis Pharma AG, Basel, Switzerland.","Fudan University Shanghai Cancer Center, Shanghai, China. zhimingshao@fudan.edu.cn."
38904899,Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen((R)) and Smart B((R)) in Women with Climacteric Syndrome in Perimenopause.,2024-01-01,Burchakov DI,"Medsanchast No 14 LLC, 3 bld. 2 Stolyarny Pereulok, Moscow, 123022, Russia.","Alliance Pharma plc and Alliance Pharmaceuticals Ltd. Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, England. Vera.Kachko@allianceph.com."
38904892,"Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.",2024-01-01,Ntalla I; Stokes M; Taylor A,"Data Analytics, Evidera, Bethesda, MD, USA.; Real-World Evidence, Gilead Sciences Europe Ltd., Stockley Park, UK.","Department of Medical Oncology, Winship Cancer Institute, Emory University, 1365 Clifton Road Northeast, Bldg C, Fl 2, Atlanta, GA, 30322, USA. kevin.michael.kalinsky@emory.edu."
38904749,Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib.,2024-01-01,Durand F; Pierce E; Yu G; Chen YF; Mostaghimi A,"Eli Lilly and Company, Indianapolis, USA.","Yale School of Medicine, New Haven, CT, USA. brittany.craiglow@yale.edu."
38904646,Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.,2024-01-01,Carson PE,"Rehoboth Beach, Delaware, USA.",Not available
38904251,Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy.,2024-07-02,Wandel S; Chen CW; Prescott MF; Lefkowitz M; Gimpelewicz CR; Gou L,Novartis Pharma AG Basel Switzerland.; Novartis Pharmaceuticals Corporation East Hanover NJ USA.,Not available
38904059,Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic review.,2024-01-01,MacDonald J; Zayadi A; Le J; Feagan B; Ma C,"Alimentiv, Alimentiv Inc, London, Canada. RINGGOLD: 590969",Not available
38904054,Retention of endoscopic capsules in diverticula: Literature review of a capsule endoscopy rarity.,2024-01-01,Schostek S,"Ovesco Endoscopy AG, Tubingen, Germany. RINGGOLD: 484040",Not available
38903519,Editorial: New functional separation and analysis technologies utilizing human Fc receptors.,2024-01-01,Reusch D; Wuhrer M,"Pharma Technical Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany.",Not available
38903135,Real-world Implications of Botulinum Neurotoxin A Immunoresistance for Consumers and Aesthetic Practitioners: Insights from ASCEND Multidisciplinary Panel.,2024-01-01,Martin MU,"Retired, Springe, Lower Saxony, Germany.",Not available
38902993,Similar Efficacy of Mesalazine in Adult and Older Adult Ulcerative Colitis Patients: Post Hoc Analysis of a Randomized Noninferiority Trial of 1600 mg vs 400 mg Tablets.,2024-06-21,Safroneeva E; Gerstner O; Laoun R,"Tillotts Pharma AG, Rheinfelden, Switzerland.",Not available
38902929,Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing.,2024-12-17,Sader HS,"JMI Laboratories, North Liberty, Iowa, USA.",Not available
38902532,Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.,2024-01-01,Drilon A; Cocco E,"InnoCare Pharma Limited, Beijing, China.",Not available
38901106,"Dual 5-HT(6)/SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-beta toxicity, memory preservation, and antidepressant-like properties.",2024-09-05,Kolaczkowski M,"Adamed Pharma S.A., Pienkow, 6A Mariana Adamkiewicza St., 05-152, Czosnow, Poland.; Jagiellonian University Medical College, Faculty of Pharmacy, 9 Medyczna St., 30-688, Krakow, Poland","Jagiellonian University Medical College, Faculty of Pharmacy, 9 Medyczna St., 30-688, Krakow, Poland. Electronic address: agat.siwek@uj.edu.pl."
38900490,A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome.,2024-07-16,Christiansen MK; Divakara Menon SM; Amit G,"Member of the European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart).",Not available
38899739,"2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (PART 2 - Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies).",2024-01-01,Wang YM; Hersey S; Block K; Bandukwala A; Szapacs M; Weiner R; Awwad K; Dessy F; Downing S; Du X; Garofolo F; Harris S; Hou V; Jones J; Kar S; Li M; Mathews J; Meissen J; Sumner GO; Pan L; Sanderink G; Scully I; Stanta J; Tanaka Y; Wagner L; Wang K; Eck S; Lin YD; Azadeh M; Decman V; Goihberg P; Alcaide EG; Gonneau C; Hedrick MN; Hopkins G; Kar S; McCausland M; Mendez L; Sehra S; Stevens E; Sun YS; Tangri S; Trampont PC; Cludts I; Kavita U; Sugimoto H; Chilewski S; Grimaldi C; Jiang Y; Liu S; Palackal N; Petit-Frere C; Abhari MR; Scheibner K; Williams L; Xu T; Zhang G,"2seventy Bio, Cambridge, MA, USA.; Abbvie, Ludwigshafen, Germany.; Abbvie, Philadelphia, PA, USA.; Alexion, New Haven, CT, USA.; AstraZeneca, Gaithersburg, MD, USA.; AstraZeneca, South San Francisco, CA, USA.; BRI Frontage, Vancouver, BC, Canada.; Bristol Myers Squibb, Lawrenceville, NJ, USA.; Celerion, Stevenage, UK.; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Frontage, Exton, PA, USA.; Genentech, South San Francisco, CA, USA.; GlaxoSmithKline, Rixensart, Belgium.; HilleVax, Cambridge, MA, USA.; Incyte, Wilmington, DE, USA.; Ionis, Carlsbad, CA, USA.; Labcorp, Meyrin, Switzerland.; Merck, Kenilworth, NJ, USA.; Moderna, Cambridge, MA, USA.; Navigate, a Novartis Subsidiary, San Diego, CA, USA.; Novartis, Cambridge, MA, USA.; Pfizer, Andover, MA, USA.; Pfizer, Groton, CT, USA.; Pfizer, Pearl River, NY, USA.; Q2 Solutions, Atlanta. GA, USA.; Regeneron, Tarrytown, NY, USA.; Sanofi Pasteur, Swiftwater, PA, USA.; Sanofi, Ghent, Belgium.; Spark Therapeutics, Plainsboro, NJ, USA.; Stoke, Cambridge, MA, USA.; Takeda, Cambridge, MA, USA.; US FDA, Silver Spring, MD, USA.; Ultragenyx, Cambridge, MA, USA.",Not available
38899716,Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.,2024-11-07,Long GV; Hauschild A; Santinami M; Kirkwood JM; Atkinson V; Mandala M; Merelli B; Sileni VC; Nyakas M; Haydon A; Dutriaux C; Robert C; Mortier L; Schachter J; Schadendorf D; Lesimple T; Plummer R; Larkin J; Tan M; Adnaik SB; Burgess P; Jandoo T; Dummer R,"Centre Hospitalier Universitaire de Bordeaux and Hopital Saint-Andre, Bordeaux (C.D.), Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Universite de Lille, INSERM Unite 1189, Lille (L.M.), and the Medical Oncology Department, Centre Eugene Marquis, Rennes (T.L.) - all in France; Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan (M.S.), the Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo (B.M., M.M.), and Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua (V.C.S.) - all in Italy; From the Melanoma Institute Australia, the University of Sydney, Royal North Shore Hospital, and Mater Hospital, Sydney (G.V.L.), Princess Alexandra Hospital, the Gallipoli Medical Research Foundation, and the University of Queensland, Woolloongabba (V.A.), and Alfred Hospital, Melbourne, VIC (A.H.) - all in Australia; Northern Centre for Cancer Care, Freeman Hospital, and Newcastle University, Newcastle (R.P.), and the Royal Marsden National Health Services Foundation Trust, London (J.L.) - all in the United Kingdom; Novartis Healthcare, Hyderabad, India (S.B.A., T.J.); Novartis Pharmaceuticals, East Hanover, NJ (M.T.); Oslo University Hospital and the Norwegian Radium Hospital, Oslo (M.N.); and Novartis Pharma, Basel (P.B.), and the University Hospital Zurich Skin Cancer Center, Zurich (R.D.) - both in Switzerland.; the Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel (A.H.), and the German Cancer Consortium, National Center for Tumor Diseases, University Hospital Essen, Campus Essen, and the University Alliance Ruhr, Research Center One Health, University of Duisburg-Essen, Essen (D.S.) - all in Germany; the Ella Lemelbaum Institute for Immuno Oncology and Melanoma, Sheba Medical Center, and the Sackler School of Medicine, Tel-Aviv University, Ramat Gan, Israel (J.S.); the Melanoma Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.)",Not available
38898824,Prevalence and coexistence of type 2 inflammatory diseases.,2024-01-01,Ribo P; Palomo-Jimenez PI; Valero A,"Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalonia, Spain.; RICORS, Instituto de Salud Carlos III, Madrid, Spain.",Not available
38898730,Glutathione-Sensitive Photosensitizer-Drug Conjugates Target the Mitochondria to Overcome Multi-Drug Resistance in Cancer.,2024-01-01,Meng C; Liang Y,"Harway Pharma Co., Ltd., Dongying, 254753, China.; Weifang Synovtech New Material Technology CO., LTD., Weifang, 262700, China.",Not available
38898592,"Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFbeta inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study.",2024-01-01,Schadendorf D; Cantalloube C; Wang R; Lee J; Chen X; Demers B; Amrate A; Abbadessa G; Hodi FS,"START-CIOCC HM Sanchinarro, Madrid, Spain.; Sanofi, Bridgewater, New Jersey, USA.; Sanofi, Cambridge, Massachusetts, USA.; Sanofi, Chilly-Mazarin, France.; Sanofi, Vitry-sur-Seine, France.",Not available
38898234,Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.,2024-01-01,Degenhardt S; Thewes V,"Agena Bioscience GmbH, Hamburg, Germany.; Agena Bioscience, Bowen Hills, QLD, Australia.",Not available
38898145,"Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury.",2024-01-01,Membrilla-Mesa MD; Garcia Marco D; Gomez C; Oliviero A,"Departamento de Estadistica, Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Instituto de Investigacion Biosanitaria ibs.GRANADA, Granada, Spain.; Neurofixpharma SA, Salamanca, Spain.",Not available
38898120,Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial.,2024-01-01,Nersesian R; Shagan SM; Maclennan M; Bhagawati-Prasad V; Diarra C; Assaf ZJ; Archer V; Dziadziuszko R,"Chugai Pharmaceutical Co. Ltd, Tokyo, Japan.; F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK.; Genentech Inc., South San Francisco, CA, USA.","Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. solange.peters@chuv.ch."
38898101,Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants.,2024-01-01,Levin EJ; Adams C; Yang M; Provins L; Hall A; Procter M; Ledecq M; Hillisch A; Wolff C; Gillard M,"UCB Biosciences GmbH, Monheim, Germany.; UCB Pharma, Braine-L'Alleud, Belgium.; UCB Pharma, Cambridge, MA, USA.; UCB Pharma, Slough, UK.",Not available
38897875,"Corrigendum to ""Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology"" [SLAS Discovery, Volume 27 (2022) P140-147/2472-5552].",2024-01-01,Enane FO; Fundel-Clemens K; Giner M; Smith Z; Wijayawardena B; Viollet C,Beckman Coulter Life Sciences.; Boehringer Ingelheim Pharma GmbH & Co. KG.,Boehringer Ingelheim Pharma GmbH & Co. KG. Electronic address: diana.santacruz@boehringer-ingelheim.com.
38897673,"Antiplatelet Therapy, Pretreatment, and Primary PCI: Every Minute Counts.",2024-06-25,Montalescot G; Guedeney P,"Sorbonne Universite, ACTION Study Group, INSERM UMRS1166, ICAN-Institut de Cardiologie, Hopital Pitie-Salpetriere (AP-HP), Paris, France.","Sorbonne Universite, ACTION Study Group, INSERM UMRS1166, ICAN-Institut de Cardiologie, Hopital Pitie-Salpetriere (AP-HP), Paris, France. Electronic address: johanne.silvain@aphp.fr."
38897349,The effect of a selenium-based anti-inflammatory strategy on postoperative functional recovery in high-risk cardiac surgery patients - A nested sub-study of the sustain CSX trial.,2024-08-15,Ott S; Lee ZY; Bekele BM; O'Brien B,"Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany; Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Deutsches Herzzentrum der Charite, Department of Cardiac Anaesthesiology and Intensive Care Medicine, Berlin, Germany","Outcomes Research Consortium, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: Sascha.ott@dhzc-charite.de."
38896997,Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.,2024-01-01,Kabbinavar F,"Cardiff Oncology, San Diego, USA.",Not available
38896983,6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).,2024-01-01,Bergsten-Nordstrom E; Mertz SA; Vorobiof DA,"Belong.Life, New York, USA.; Europa Donna - the European Breast Cancer Coalition, Norrkoping, Sweden.; MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, USA.","Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, and ABC Global Alliance, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt."
38896403,Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies.,2024-01-01,Sharma D,"Treasure Valley Dermatology, Boise, ID, USA.","Section of Dermatology, Baylor Scott & White Health System, Dallas, TX, USA. aaron.farberg@gmail.com."
38896383,Epicensus: The Drive to Elevating the Standard of Care for Patients with Psoriasis.,2024-01-01,Guillevin L,"Assistance Publique-Hopitaux de Paris, Hopital Cochin, Universite Paris Descartes, Paris, France.","Department of Dermatology, Department of Biomedical Sciences, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark. simon.francis.thomsen.02@regionh.dk."
38896381,"Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.",2024-01-01,Zhang W; Amouzadeh H,"Amgen Inc., Thousand Oaks, CA, USA.","Tokyo Medical University, 6 Chome-7-1 Nishishinjuku, Shinjuku, Tokyo, 160-0023, Japan. yukari-o@tokyo-med.ac.jp."
38896380,Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis.,2024-01-01,Chan G; Zhang F; Fostvedt L,"Pfizer Inc., Cambridge, MA, USA.; Pfizer Inc., Groton, CT, USA.",Not available
38896264,Changes in forced vital capacity over </= 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry.,2024-01-01,Batista JL; Wilson KM,"Navitas Data Sciences, Pottstown, PA, USA.; Sanofi, Cambridge, MA, USA.","Division of Pulmonary, Critical Care and Sleep Medicine, NYU Grossman School of Medicine, and the Andre Cournand Pulmonary Physiology Laboratory, Bellevue Hospital, New York, NY, USA. kenneth.berger43@gmail.com."
38896194,Correction to: Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.,2024-01-01,Tormakangas O; Kuokkanen K; Messinger J,"Orion Pharma, Orion Corporation, Tengstrominkatu 8, FI-20360 Turku, and Orionintie 1A, 02200, Espoo, FI, Finland.",Not available
38896006,Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID.,2024-06-19,Numan S; Adamczyk R; Hernandez AF,"American Regent, Shirley, NY, USA.",Not available
38895934,Metabolism of new drug modalities research advances - 2023 year in review.,2024-01-01,Johnson KM,"Drug Metabolism and Pharmacokinetics, Inotiv, Maryland Heights, MO, USA.",Not available
38895069,Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy.,2024-01-01,Tacchetti P; Derudas D,"IRCCS Azienda Ospedaliero-Universitaria di Bologna-Istituto di Ematologia ""Seragnoli"" Bologna Italy.; SC di Ematologia e CTMO - Oncologico Oncologico di Riferimento Regionale ""A. Businco"" - ARNAS ""G. Brotzu"" Cagliari Italy.",Not available
38895066,"Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemia.",2024-01-01,Lombard L; Gilroy K; Rane A,Agios Pharmaceuticals Cambridge Massachusetts USA.,Not available
38895059,QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.,2024-01-01,Woll E,Syndena GmbH Connect to Cure Innsbruck Austria.,Not available
38894953,Arbeitsgemeinschaft Gynakologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.,2024-01-01,Thill M; Heil J; Jackisch C; Kolberg-Liedtke C; Maass N; Reimer T; Schneeweiss A; Untch M; Wockel A,"Brustzentrum Heidelberg, Klinik St. Elisabeth, Heidelberg, Germany.; Evangelische Kliniken Essen-Mitte gGmbH, Essen, Germany.; German Breast Group Forschungs GmbH, Frankfurt, Germany.; Klinik fur Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitatsklinikum des Saarlandes, Homburg, Germany.; Klinik fur Gynakologie und Geburtshilfe, Sana Klinikum Offenbach, Offenbach, Germany.; Klinik fur Gynakologie und Gynakologische Onkologie, Agaplesion Markus Krankenhaus, Frankfurt, Germany.; Kooperatives Brustzentrum Paderborn, Klinik fur Gynakologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn und St. Josefs-Krankenhaus, Salzkotten, St. Vincenz-Krankenhaus GmbH, Paderborn, Germany.; Martin-Luther-Universitat Halle-Wittenberg, Halle (Saale), Germany.; Zentrum Familiarer Brust- und Eierstockkrebs, Universitatsklinikum Koln, Cologne, Germany.",Not available
38894952,Arbeitsgemeinschaft Gynakologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.,2024-01-01,Friedrich M; Heil J; Loibl S; Lux MP; Solomayer EF; Thomssen C; Thill M,"Brustzentrum Heidelberg, Klinik St. Elisabeth und Klinik fur Frauenheilkunde und Geburtshilfe, Sektion Senologie, Universitats-Klinikum Heidelberg, Heidelberg, Germany.; German Breast Group Forschungs GmbH, Frankfurt, Germany.; Klinik fur Frauenheilkunde und Geburtshilfe, Helios Klinikum Krefeld GmbH, Krefeld, Germany.; Klinik fur Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitatsklinikum des Saarlandes, Homburg, Germany.; Klinik fur Gynakologie und Gynakologische Onkologie, Agaplesion Markus Krankenhaus, Frankfurt, Germany.; Kooperatives Brustzentrum Paderborn, Klinik fur Gynakologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn und St. Josefs-Krankenhaus, Salzkotten, St. Vincenz-Krankenhaus GmbH, Paderborn, Germany.; Martin-Luther-Universitat Halle-Wittenberg, Halle (Saale), Germany.",Not available
38894924,Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding.,2024-06-13,Aubert-Nicol S; Haghshenas P; Jakalian A; Larouche-Gauthier R; Leclerc JP; Wang J; Wang S; Wang Q; Yadav A,"Paraza Pharma, 2525 Avenue Marie-Curie, Montreal, Quebec H4S 2E1, Canada.; WuXi AppTec Co., Ltd. 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, 200131, P. R. China.",Not available
38893233,Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion.,2024-05-31,Daou D; Al Qudah Y,"Gulf, Novartis Pharma Services AG, 4056 Basel, Switzerland.; Oncology, Gulf, Novartis Pharma Services AG, 4056 Basel, Switzerland.",Not available
38892540,The Mediterranean Diet in Pregnancy: Implications for Maternal Brain Morphometry in a Secondary Analysis of the IMPACT BCN Randomized Clinical Trial.,2024-05-24,Gomez Y; Casas I; Casas R; Bargallo N; Estruch R,"Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), 28029 Madrid, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.; Institut de Recerca Sant Joan de Deu, 08950 Esplugues de Llobregat, Spain.",Not available
38892521,New Value of Acorus tatarinowii/gramineus Leaves as a Dietary Source for Dementia Prevention.,2024-05-23,Sakai A; Nakata K,"Cerebro Pharma Inc., 4-5-6-3F Minamikyuhojimachi, Chuo-ku, Osaka 541-0058, Japan.",Not available
38890511,"Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial.",2024-01-01,Sakaguchi H; Yamanaka H; Imaoka R; Fukushi A; Ichihashi G; Sanaki T; Uehara T; Mukae H,"Drug Development and Regulatory Science Division, Shionogi & Co., Ltd, Osaka, Japan.",Not available
38890270,Negative emotionality shapes the modulatory effects of ketamine and lamotrigine in subregions of the anterior cingulate cortex.,2024-06-18,Beckmann C; Mennes M,"SBGneuro Ltd., Oxford, UK.","Medical School Berlin, Berlin, Germany. matti.gaertner@medicalschool-berlin.de."
38890097,"Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy.",2024-01-01,Bortolheiro TC; Magalhaes Rego E,"Faculdade de Ciencias Medicas da Santa Casa de Sao Paulo, Irmandade da Santa Casa de Sao Paulo da Santa Casa de Sao Paulo, Sao Paulo, SP, Brazil.; Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.","Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil. Electronic address: lorenafigdo@usp.br."
38889976,[Distribution and influencing factors of lipoprotein (a) levels in non-arteriosclerotic cardiovascular disease population in China].,2024-06-10,Zhang X; Chen T; Li RQ,"Beijing Novartis Pharma Company Limited, Beijing 102200, China.",Not available
38889925,Changes in the epidemiology of kidney replacement therapy across Europe in 2020-the first year of the COVID-19 pandemic: an ERA Registry study.,2024-10-30,Asberg A; Lausevic M,"Andalusian Autonomous Transplant Coordination Information System, Seville, Spain.; Society of Nephrology and Dialysis of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina.",Not available
38889737,"Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.",2024-01-01,Gernhardt D; Liu Y; Ahmadi T; Dinh MH; Hoehn D; Favaro E; Elliott B; Thieblemont C,"AbbVie, North Chicago, IL, USA.; Assistance Publique & Hopitaux de Paris (APHP), Hopital Saint-Louis, Hemato-oncologie, Universite de Paris, Paris, France.; Genmab, Copenhagen, Denmark.; Genmab, Plainsboro, NJ, USA.","The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address: kim.m.linton@manchester.ac.uk."
38889345,End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?,2024-01-01,Degtyarev E; Bolanos N; Buchbinder A; Halabi S; Newsome S; Saxton C; Warwick L; Zuber E,"CONSILIUM Salmonson & Hemmings, Woking, UK.; Lymphoma Coalition, Madrid, Spain.; Lymphoma Coalition, Management, Mississauga ON, Canada.; Novartis Pharma, Basel, Switzerland.; Novartis Pharmaceuticals, East Hanover, NJ, USA.",Not available
38888812,Asciminib in Patients With CML-CP Previously Treated With >/= 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study.,2024-01-01,Aoki M; Dawson MK; Matsumura I,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma K.K., Tokyo, Japan.","Department of Hematology, National Cancer Center Hospital East, Chiba, Kashiwa, 277-8577, Japan. yominami@east.ncc.go.jp."
38888681,Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure.,2024-01-01,Farooqui SA; Alderfer J; Romero W,"Pfizer Inc., Groton, CT, USA.; Pfizer Inc., New York, NY, USA.; Pfizer R & D UK Ltd., Sandwich, Kent, UK.",Not available
38888502,"Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy.",2024-01-01,Fernandez DG; Delgado VM; Boria EV,"Centro Medico Adeslas, Granada, 18002, Spain.; Instituto de Investigacion Sanitaria de Navarra (IDISNA), Navarra, 31008, Spain.; Servicio de Alergia, Centro Medico Adeslas, Cordoba, 14006, Spain.",Not available
38888280,"Complex In Vitro Model Characterization for Context of Use in Toxicologic Pathology: Use Cases by Collaborative Teams of Biologists, Bioengineers, and Pathologists.",2024-01-01,Berridge B; Rudmann D; Kuhnlenz J; Tseng M; Reichelt M; Laing ST; Kiyota T; Chamanza R; Sura R; Tomlinson L,"B2 Pathology Solutions LLC, Cary, North Carolina, USA.; Bayer SAS, CropScience, Pathology & Mechanistic Toxicology, Sophia Antipolis, France.; Charles River Laboratories, Ashland, Ohio, USA.; Genentech, South San Francisco, California, USA.; Gilead Sciences Inc., Foster City, California, USA.; Johnson & Johnson Innovative Medicine, High Wycombe, UK.; Neurosetta LLC, Madison, Wisconsin, USA.",Not available
38887697,Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.,2024-01-01,Szabo GT; Kovacs Z; Balogh E; Kovacs KA; Darida M; Buga V; Rokszin G; Abonyi-Toth Z; Kiss Z; Bogos K,"MSD Pharma Hungary Ltd., Budapest, Hungary.; RxTarget Ltd Szolnok, Szolnok, Hungary.",Not available
38887229,Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program.,2024-01-01,Hong YH,"Merck Ltd., Seoul, Republic of Korea.",Not available
38886831,Amyloid-PET imaging predicts functional decline in clinically normal individuals.,2024-06-17,Scholl M,"Centro de Investigacion Biomedica en Red de Bioingenieria, Biomateriales y Nanomedicina, Madrid, Spain.","Institute of Neuroscience, UCLouvain, Brussels, Belgium. lisa.quenon@uclouvain.be."
38886593,Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines.,2024-01-01,Jenkinson S; Brown A; Delaunois A; Dumotier B; Rao M; Ribeiro LR; Sibony A; Timsit Y; Lagrutta A; Mittlestadt SW; Peri R; Roberts S; Valentin JP,"Armstrong Pharmacology, Macclesfield, UK.; Blueprint Medicines, Cambridge, MA, USA.; GSK, Stevenage, UK.; GSK, Waltham, MA, USA.; Metrion Biosciences, San Diego, CA, USA.; Neurocrine Biosciences, San Diego, CA, USA.; Pfizer, La Jolla, CA, USA.; Sanofi, Frankfurt, Germany.; Takeda Pharmaceuticals, Cambridge, MA, USA.; UCB Biopharma, Braine-l'Alleud, Belgium.; Vertex Pharmaceuticals, Boston, MA, USA.","Sanofi, Cambridge, MA, USA. richbrennan@gmail.com."
38886347,HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial.,2024-06-17,Wu Z; Wang X; Jin Y; Diao L; Sun Y; Zhang Y; Hui AM,"EnCureGen Pharma, Guangzhou, China.; Shanghai Fosun Pharmaceutical Development Co., Ltd., Shanghai, China.; Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., Shanghai, China.",Not available
38886189,"Hypocretin-1 receptor antagonism improves inhibitory control during the Go/No-Go task in highly motivated, impulsive male mice.",2024-01-01,Hoyer D,"Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.",Not available
38886185,Patent review of cannabinoid receptor type 2 (CB(2)R) modulators (2016-present).,2024-01-01,Mach L; Nazare M,"Medicinal Chemistry, Leibniz-Forschungsinstitut fur Molekulare Pharmakologie (FMP) Berlin, Berlin, Germany.",Not available
38886096,"Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837.",2024-01-01,Cooper ME; Norregaard PK; Hogberg T; Andersson G; Receveur JM; Linget JM; Elling CE,"7TM Pharma A/S, Horsholm, Denmark.",Not available
38885975,The response of Canada's clinical health research ecosystem to the COVID-19 pandemic.,2024-06-16,Lamontagne F; Masse MH; Yarnell C; Camirand-Lemyre F; Levesque S; Domingue MP; O'Hearn K; Watpool I; Hoogenes J; Sprague S; Menard J; Lemaire-Paquette S; Hebert-Dufresne L; Cook D; Hebert P; Rowan K; Yada N; Menon K; Fowler R; Fox-Robichaud A; Boutin D; Marshall J; Kho ME,"Bruyere Research Institute (Hebert), Ottawa, Ont.; Centre de recherche du Centre hospitalier universitaire de Sherbrooke (Lamontagne, Masse, Camirand-Lemyre, Levesque, Domingue, Menard, Lemaire-Paquette), Sherbrooke, Que.; Children's Hospital of Eastern Ontario (Menon); Children's Hospital of Eastern Ontario Research Institute (O'Hearn, Menon); Department of Critical Care Medicine and Research Institute (Yarnell), Scarborough Health Network, Toronto, Ont.; Hamilton, Ont.; Intensive Care National Audit and Research Centre (Rowan), London, UK; McMaster University (Sprague, Cook, Fox-Robichaud); McMaster University School of Rehabilitation Science (Hoogenes, Kho); Ottawa Hospital Research Institute (Watpool), Ottawa, Ont.; Patient with lived experience (Boutin), Sherbrooke, Que.; Sunnybrook Hospital (Fowler), Toronto, Ont.; Unity Health Toronto (Yada), Toronto, Ont.; Universite de Sherbrooke (Lamontagne, Camirand-Lemyre, Levesque, Domingue); University of Ottawa (Menon), Ottawa, Ont.; University of Toronto (Yada, Fowler, Marshall); University of Vermont (Hebert-Dufresne), Burlington, Vt.","Patient with lived experience (Boutin), Sherbrooke, Que. francois.lamontagne@usherbrooke.ca."
38885121,Enantioselective Synthesis of Sealutomicin C.,2024-07-03,Frost JR; Hepburn HB; Klauber DJ,"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K.; UCB Pharma, 216 Bath Road, Slough, Berkshire SL1 3WE, U.K.; Vertex Pharmaceuticals, 86-88 Jubilee Avenue Milton Park, Abingdon OX14 4RW, U.K.",Not available
38884900,Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study.,2024-01-01,Aguilar CO; Nishijima S; Nishiyama Y; Sugihara M,"Daiichi Sankyo France SAS, Rueil-Malmaison, France.; Daiichi Sankyo, Co., Ltd, Tokyo, Japan.",Not available
38884180,Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorder.,2024-01-01,Yu J; Kielhorn A,"Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA.",Not available
38884137,"Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.",2024-01-01,Lee T; Modelska K,"FibroGen, Inc., San Francisco, California, USA.",Not available
38884028,Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer.,2024-01-01,Belleville E; Lux MP,"ClinSol GmbH & Co. KG, Wurzburg, Germany.; Klinik fur Gynakologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Krankenhaus GmbH, Paderborn, Germany.",Not available
38883924,"A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.",2024-01-01,Hovanesian JA; Yang R; Ni J,"Cloudbreak Pharma, Irvine, California.; Harvard Eye Associates, Laguna Hills, California.",Not available
38882182,Collective Weakness and Fluidity in Weakness Status Associated With Basic Self-Care Limitations in Older Americans.,2024-01-01,Heimbuch H,"OCHIN Inc. Portland, OR, USA.",Not available
38882038,Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40.,2024-01-01,Situ A; Alulis S; Peterson S; Lee J; Patel BP; Disher T,"CRG-EVERSANA, Value and Evidence Services, Burlington, Ontario, Canada.; Janssen Immunology Global Commercial Strategy Organization, Horsham, Pennsylvania.; Janssen-Cilag A/S, Birkerod, Denmark.",Not available
38881900,Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure.,2024-01-01,Ritter M,"Roche Diagnostics GmbH, Antibody Development Technologies, Penzberg, Germany.",Not available
38881606,Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.,2024-01-01,Chong V; Lesmes L; Levin LA,"Adaptive Sensory Technology, San Diego, California.; Consultant, Belmont, Massachusetts.; LKC Technologies, Inc, Gaithersburg, Maryland.",Not available
38881370,Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program.,2024-01-01,Kohler S,"Serenis GmbH, Munich, Germany.",Not available
38881219,Assurance methods for designing a clinical trial with a delayed treatment effect.,2024-08-30,Hampson LV,"Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland.",Not available
38880932,Effects of the phosphodiesterase 2 inhibitor BI 474121 on central nervous system cyclic guanosine monophosphate concentrations: Translational studies.,2024-01-01,Goeldner RG; Rosenbrock H; Schaible J; Zambori J; Schultheis C,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
38880375,Incidence and Remission of Post-Surgical Cystoid Macular Edema Following Cataract Surgery in Eyes With Intraocular Inflammation.,2024-01-01,Kempen JH,"Department of Ophthalmology and Schepens Eye Research Institute (C.S.F., J.H.K.), Massachusetts Eye and Ear Infirmary; MCM Eye Unit (J.H.K.), MyungSung Christian Medical Center (MCM) General Hospital and Myung Sung Medical School, Addis Ababa, Ethiopia; Sight for Souls (J.H.K.), Bellevue, Washington, USA; and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA","From the Vanderbilt Eye Institute (S.G., S.G.), Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: sapna.gangaputra@vumc.org."
38880349,Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians.,2024-01-01,Leohr J; Bue-Valleskey JM; Juneja R; Chien J; Syring K,"Eli Lilly and Company, Indianapolis, Indiana.",Not available
38880347,Current Practice of Podiatrists in Testing for Diabetic Polyneuropathy and Implementing Foot Care (PROTECT Study Survey 2).,2024-01-01,Reiners K,"Consultant Neurologist, Wegberg, Germany.","Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Dusseldorf, Germany. Electronic address: dan.ziegler@ddz.de."
38879975,Two-dimensional sequential selective comprehensive chiralxreversed-phase liquid chromatography of synthetic phosphorothioate oligonucleotide diastereomers.,2024-08-16,Gao M; Holkenjans W; Hetzel T; Pell R,"Bayer AG, Pharmaceutical Division, Friedrich-Ebert-Strasse 217-333 42117 Wuppertal, Germany.",Not available
38879844,"BrainLossNet: a fast, accurate and robust method to estimate brain volume loss from longitudinal MRI.",2024-01-01,Opfer R; Kruger J; Spies L,"Jung Diagnostics GmbH, Hamburg, Germany.",Not available
38879802,Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.,2024-08-01,Cassady K; DeVeaux M; Chokshi D; Boyapati A; Hazra A; Yancopoulos GD; Sirulnik LA; Rodriguez Lorenc K; Kroog GS; Houvras Y,"Regeneron Pharmaceuticals, Inc, Tarrytown, NY.",Not available
38879691,A deep-learning-based model for assessment of autoimmune hepatitis from histology: AI(H).,2024-01-01,Kordy K; Knuuttila A; Zhou X; Kumar D; Koponen V; Mesenbrink P; Pedrosa MC,"Aiforia Technologies PLC, Helsinki, Finland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Schonbeinstrasse 40 4056, Basel, Switzerland. caner.ercan@unibas.ch."
38879611,Point-of-care BCR::ABL1 transcript monitoring using capillary dried blood in chronic myeloid leukemia patients.,2024-01-01,Welch E; Berthier E,"Tasso, Inc., Seattle, WA, USA.",Not available
38879192,Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study.,2024-08-01,Webster DE; Tummalacherla M; Tediarjo A; Yadav V; Neto EC; MacDuffie W; DePhillips M; Sieg E; Kellen MR; Mangravite LM; Sieberts SK; Omberg L,"D.E. Webster, PhD, M. Tummalacherla, MSE, A. Tediarjo, BS, V. Yadav, MS, E. Chaibub Neto, PhD, W. MacDuffie, MS, M.R. Kellen, PhD, L.M. Mangravite, PhD, S.K. Sieberts, PhD, L. Omberg, PhD, Sage Bionetworks, Seattle, Washington, USA.; M. DePhillips, BS, E. Sieg, BS, SDP Digital, Seattle, Washington, USA.",Not available
38878593,Physical comorbidities of older age bipolar disorder (OABD) patients: A global replication analysis of prevalence and sex differences.,2024-01-01,Jimenez E,"Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain; CIBERSAM, ISCIII, Spain.; Department of Psychiatry, Hospital Universitario de Alava, BIOARABA, UPV/EHU, Vitoria, Spain","Faculdade Santa Casa BH, Belo Horizonte, Brazil. Electronic address: teixeiraa@uthscsa.edu."
38878486,"IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer.",2024-08-20,Qian N; Xu G; Dou X; Yang C; Liu Y; Liu Y; Pan X; Wang J; Bai G; Gao X,"Beijing Immunoah Pharma Tech Co., Ltd., Beijing 100141, China.",Not available
38878207,"Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial.",2024-01-01,Fischer S; Kloft C,"Innomedica Switzerland AG, Bern, Switzerland.; Oncology/Hematology, Kantonsspital Graubunden, Chur, Switzerland.",Not available
38878054,The Neurostimulation Appropriateness Consensus Committee (NACC)(R): Recommendations for the Mitigation of Complications of Neurostimulation.,2024-01-01,Falowski SM,"Neurosurgical Associates of Lancaster, Lancaster, PA, USA.","The Spine and Nerve Center of the Virginias, Charleston, WV, USA. Electronic address: doctdeer@aol.com."
38877972,Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.,2024-11-04,Keating M; Baert F; Dubinsky MC; Goetsch M; Danese S,"Atlanta Gastroenterology Associates, Atlanta, GA, USA.; Pfizer Inc, Cambridge, MA, USA.; Pfizer Inc, New York, NY, USA.",Not available
38877811,The Bispectral Electroencephalography Method Quantifies Postoperative Delirium-Like States in Young and Aged Male Mice After Head-Mount Implantation Surgery.,2024-08-01,Dittrich MN,"Sumitomo Pharma Co. Ltd., Osaka, Osaka, Japan.",Not available
38877144,BrainTACO: an explorable multi-scale multi-modal brain transcriptomic and connectivity data resource.,2024-06-14,Kargl D; Lawless N; Fernandez-Albert F; Haubensak W,"Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma, Biberach an der Riss, Germany.",Not available
38877116,Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment.,2024-01-01,Rajagopalan S; Deshpande A; Zhang M; Andersen L; Liao W; Jensen SO; Therkildsen C; Brand R; Shah RH; Kong E; Malbari MS; Manaa D; Callahan MK,"Weill Cornell Medicine, New York, NY, USA.","New York Genome Center, New York, NY, USA. widmana@mskcc.org."
38876834,Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study.,2024-01-01,Gomollon F; Casas D,"Gastroenterology Department, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain; Gastroenterology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Instituto de Investigacion Sanitaria (ISS) Aragon, Zaragoza, Spain; Instituto de Investigacion Sanitaria (ISS) Aragon, Zaragoza, Spain.","Gastroenterology Department, Hospital Royo Villanova, Zaragoza, Spain. Electronic address: patricia.sanz.segura@gmail.com."
38876509,EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update.,2024-10-21,Rodriguez-Carrio J; Wilhelmer TC; Gossec L,"Envision Pharma Group, Wilmslow, UK.; Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.","Patient Research Partner, EULAR, Amsterdam, The Netherlands martinusdewit@hotmail.com."
38875773,Probing the neurocardiac circuit in trauma and posttraumatic stress.,2024-01-01,Germine LT,"Department of Psychiatry, Harvard Medical School, Boston, MA, USA; Institute for Technology in Psychiatry, McLean Hospital, Belmont, MA, USA; The Many Brains Project, Belmont, MA, USA.","Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: aseligowski@mgh.harvard.edu."
38874848,Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study.,2024-01-01,Torres F,"Fundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.",Not available
38874739,Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials.,2024-01-01,Morte A; Cebrecos J; Sust M; Gimenez-Arnau JM,"ESTEVE Pharmaceuticals S.A., Barcelona, Spain.","The London Clinic, London, W1G 6BW, UK. richard.langford@me.com."
38873723,Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial.,2024-08-06,Monfradini F,"Santa Casa de Misericordia de Barretos, Barretos, Brazil.",Not available
38873632,"Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study.",2024-01-01,Huang X; Soliman AM; Rosmarin D; Harris JE,"AbbVie Inc., North Chicago, IL, USA.",Not available
38873610,Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals.,2024-01-01,Ontiveros-Padilla LA; Gajon-Martinez J; Arriaga-Pizano LA; Peralta-Sanchez G; Sarfati-Mizrahi D; Sun W; Chagoya-Cortes HE; Palese P; Krammer F; Lozano-Dubernard B,"Consultora Mextrategy, S.A.S. de C.V., Ciudad de Mexico, Mexico.; Coordinacion de Investigacion en Salud, Centro Medico Nacional Siglo XXI, IMSS, Ciudad de Mexico, Mexico.; Departamento de Biologia Molecular y Validacion de Tecnicas, Instituto de Diagnostico y Referencia Epidemiologicos (InDRE) ""Dr, Manuel Martinez Baez"", Secretaria de Salud, Ciudad de Mexico, Mexico.; Investigadores por Mexico, Consejo Nacional de Humanidades, Ciencias y Tecnologias (CONAHCYT), Ciudad de Mexico, Mexico.; Laboratorio Avi-Mex S.A. de C.V., Ciudad de Mexico, Mexico.; Posgrado en Inmunologia, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Ciudad de Mexico, Mexico.",Not available
38872830,Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A *02-eligible patients.,2024-06-13,Rafail S; Van Kerckhoven M; Van Rossom S; Schats K; Williams D,"Assay Development Histopathology, CellCarta, Antwerpen, Belgium.; Biomarker Discovery and Platform, Adaptimmune, Philadelphia, PA, USA.; Late Stage Development, Adaptimmune, Philadelphia, PA, USA.",Not available
38872632,Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer's continuum.,2024-01-01,Minguillon C,"Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Spain.",Not available
38872405,Cross-sectional study of therapy-related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan.,2024-01-01,Kawai D; Mitsuda Y; Sakashita N,"Eisai Co., Ltd., Tokyo, Japan.; Medilead, Inc., Tokyo, Japan.",Not available
38872261,Development of a novel dosing paradigm to model diazepam rescue therapy in preclinical seizure and epilepsy models.,2024-01-01,Misra SN; Carrazana E,"Formerly of Neurelis, Inc., San Diego, California, USA.; Neurelis, Inc., San Diego, California, USA.",Not available
38872243,Toward the Establishment of a Harmonized Physicochemical Profiling Platform for Therapeutic Oligonucleotides: A Case Study for Aptamers Where the Higher-Order Structure Influences Physical Properties.,2024-07-01,Takeuchi S,"Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Co., Ltd., 26-1 Muraoka Higashi 2-Chome, Fujisawa, Kanagawa 2518555, Japan.",Not available
38871975,Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.,2024-01-01,Grossman JE; Rosenthal K; Mednick G; Delepine C; Curiel TJ; Stebbing J; Lenz HJ,"Agenus, Inc., Lexington, MA, USA.",Not available
38871954,Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn's disease: a case-control study.,2024-06-14,Carrascosa J,"OSATEK, Galdakao, Spain.","IBD Unit, Gastroenterology Department, Hospital Universitario de Galdakao-Usansolo, Galdakao, Spain. iago.r.lago@gmail.com."
38871878,A precise performance-based reimbursement model for the multi-centre NAPKON cohorts - development and evaluation.,2024-06-13,Miljukov O; Schaller J,"Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt Universitat zu Berlin, Berlin, Germany.; Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, NUM Coordination Office, Chariteplatz 1, 10117, Berlin, Germany.","Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany. appel@med.uni-frankfurt.de."
38871822,Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.,2024-01-01,Arzt ME,"Novartis Pharma Schweiz AG, Rotkreuz, Switzerland.","Department of Neurology and Neurorehabilitation, ZURZACH Care, Quellenstrasse 34, CH-5330, Bad Zurzach, Switzerland. andreas.gantenbein@zurzachcare.ch."
38871738,Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.,2024-06-13,Novelli M; Chakrabarti T; Rabinowitz AH; Swanton C,"Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; Oncology Data Science, Oncology R&D, AstraZeneca, Boston, MA, USA.",Not available
38871557,Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents.,2024-01-01,McBride A; Mohammed H; Idryo D; Broome R; Herriman A; Johnson T; Wilkinson K; Schrag A; Johanson C; Izano M; Makinde A,"Bristol Myers Squibb, Princeton, NJ.; Formerly of Bristol Myers Squibb, Princeton, NJ.; Syapse Inc., San Francisco, CA.",Not available
38871237,Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis.,2024-01-01,Walse B; Duelli A; Caing-Carlsson R; Zibert JR; Alenfall J,"Coegin Pharma AB, Lund, Sweden.; Department of Clinical Sciences Malmo, Lund University, Sweden; SARomics Biostructures AB, Lund, Sweden.",Not available
38871137,Developing an innovative 3D printing platform for production of personalised medicines in a hospital for the OPERA clinical trial.,2024-08-15,Do B; Basit AW; Goyanes A,"Departamento de Farmacologia, Farmacia y Tecnologia Farmaceutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.; Department of Clinical Pharmacy, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant 94800 Villejuif, France; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; FABRX Artificial Intelligence, Carretera de Escairon, 14, Currelos (O Savinao), CP 27543, Spain; FABRX Ltd., Henwood House, Henwood, Ashford TN24 8DH, UK; Institut des Sciences Moleculaires d'Orsay (ISMO), Universite Paris-Saclay, CNRS, 91405 Orsay, France.",Not available
38871093,The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases.,2024-01-01,Gonzalez A; Zhao L,"Bristol-Myers Squibb Company, Lawrenceville, New Jersey, USA.; Centro de investigacion biomedica en red enfermedades cardiovasculares, Madrid, Spain.; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA 31008, Pamplona, Spain","Nordic Bioscience A/S, Herlev, Denmark. Electronic address: fge@nordicbio.com."
38871078,Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.,2024-01-01,Rosell-Diaz M; Gallardo-Nuell L; Fernandez-Real JM,"CIBER Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion (CIBERobn), Madrid, Spain; CIBER Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion (CIBERobn), Madrid, Spain.; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI-CERCA), Girona, Spain and University of Girona, Girona, Spain",Not available
38871022,Sexual dimorphism in articular tissue anatomy - Key to understanding sex differences in osteoarthritis?,2024-01-01,Wirth W,"Chondrometrics GmbH, Freilassing, Germany.; Ludwig Boltzmann Institute for Arthritis and Rehabilitation (LBIAR), Paracelsus Medical University, Salzburg, Austria; Research Program for Musculoskeletal Imaging, Center for Anatomy and Cell Biology, Paracelsus Medical University, Salzburg, Austria","Chondrometrics GmbH, Freilassing, Germany. Electronic address: felix.eckstein@pmu.ac.at."
38870835,Identification and structural elucidation of an oxidation product generated during stability studies of Cabergoline drug product.,2024-09-15,Lechel T; Springer A; Rutkowski A; Matzkow D; Zart J; Hartmann T; Hochhuth D,"CP-Pharma Handelsgesellschaft mbH, Ostlandring 13, Burgdorf 31303, Germany.; Chemisch-pharmazeutisches Labor, Rolf Sachse GmbH, Stieffring 14, Berlin 13627, Germany.; CoreFacility BioSupraMol, Institut fur Chemie und Biochemie, Fachbereich Biologie, Chemie, Pharmazie, Freie Universitat Berlin, Takustrasse 3, Berlin 14195, Germany.",Not available
38870473,"Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy: A Nationwide Study.",2024-07-23,Bolin K; Patric B; Tomson T,"From the Centre for Health Governance (K.B.), Department of Economics, University of Gothenburg; UCB Pharma AB (B.P.), Stockholm; and Department of Clinical Neuroscience (T.T.), Karolinska Institutet, Stockholm, Sweden.",Not available
38869987,Hepatic improvement within 27 days of avenciguat treatment in Child-Pugh A cirrhosis detected by an oral cholate challenge test.,2024-10-01,Ertle J; Schoelch C; Gashaw I; McRae MP; Helmke SM; Everson GT,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.; Custom DX Solutions LLC, Houston, Texas, USA.; HepQuant, LLC, Denver, Colorado, USA.",Not available
38869831,Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.,2024-08-15,Gambarotti M; Hardes J; Kanerva J; Strauss SJ; Nathrath M,"EQ ONCOSARC, CRCT Inserm/UT3, ERL CNRS, Toulouse, France.; Orthopaedics and Trauma, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.; Patient and Parent Advocacy Group, FOSTER, Washington, District of Columbia.; U1015, Universite Paris-Saclay, Villejuif, France.",Not available
38869824,Profound Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: A Cross-sectional Study.,2024-01-01,Bayer H,"Dermatology Outpatient Office Dr. Simone Garcovich, Rome, Italy.",Not available
38869771,"Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status.",2024-01-01,Mata M; Laird AD,"Pfizer Inc., La Jolla, CA, USA.; Pfizer Inc., South San Franciso, CA, USA.","Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. mtelli@stanford.edu."
38869493,Fentanyl-Type Antagonist of the mu-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation.,2024-06-27,Tasaka T,"Affinity Science Corporation, Shinagawa-ku, Tokyo 141-0031, Japan.",Not available
38869019,Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme.,2024-11-04,Redondo I; Moses R; Maier S; Hunter Gibble T; Morris N; Milch C,"Eli Lilly and Company, Indianapolis, USA.",Not available
38867022,An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).,2024-01-01,Govaere O; Daly AK; Friedman SL; Yashiro H; Perfield JW,"Fleur De Lis Holdings 10201 Dakins Dr. Richmond, Richmond, VA, USA.; Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Internal Medicine and Hospital, Pfizer Research and Development, Lake Mary, FL, USA.; Pfizer, Inc.; R&D Diabetes & Portfolio Innovation and Excellence, Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt, Germany.; R&D Diabetes, Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt, Germany.","TVP Lab, WT/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. michele.vacca@uniba.it."
38866793,Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months.,2024-06-12,Gong Y; Khachadourian V; Tracey B; Volfson D; Latzman RD; Cosman J; Edgerton J; Anderson D,"AbbVie Pharmaceuticals, North Chicago, IL, USA.; Biogen Inc., Cambridge, MA, USA.; Takeda Pharmaceuticals, Cambridge, MA, USA.","Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA. jamie_adams@urmc.rochester.edu."
38866592,Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS).,2024-06-12,Akerkar S,"Patient Advocacy, Cyprus League of People with Rheumatism (CYLPER), Nicosia, Cyprus.","Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain mcumbrera@us.es."
38866248,Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study.,2024-01-01,Jara-Palomares L; Sanchez-Lopez V,"Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.; Department of Respiratory Diseases, Hospital Universitario Virgen del Rocio, Seville, Spain; Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocio/Centro de Investigaciones Cientificas/Universidad de Sevilla, Seville, Spain.","Department of Internal Medicine, Tergooi MC, Hilversum, the Netherlands. Electronic address: n.a.guman@amsterdamumc.nl."
38866246,Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor.,2024-01-01,Baker RI; O'Donnell JS,"Hollywood Hospital Haemophilia Treatment Centre, Perth, Australia; Irish Centre for Vascular Biology, School of Pharmacy and Biomedical Sciences, RCSI, Dublin, Ireland; Irish-Australian Blood Collaborative Network, Perth, Australia.; National Coagulation Centre, St. James's Hospital, Dublin, Ireland; Western Australia Centre for Thrombosis and Haemostasis, Perth Blood Institute, Murdoch University, Perth, Australia",Not available
38866070,A meta-analysis and systematic review of photodynamic therapy for diabetic foot ulcers.,2024-01-01,Zhang L; Zhao S,"Novo Nordisk (Shanghai) Pharma Trading Co. Ltd, Beijing, PR China.; Systematic Review Solutions. Ltd, Shanghai, PR China.",Not available
38865905,"Stepped, evidence-based and integrated care service model vs. usual care for mental disorders: A randomized controlled trial (RECOVER).",2024-01-01,Schweiger M,"ARINET GmbH, Service-Provider for vocational rehabilitation, Schauenburgerstr. 6 20095 Hamburg, Germany.",Not available
38865793,Preface: In silico technologies to facilitate drug development.,2024-01-01,Oishi M,"Astellas Pharma Inc, Japan.","School of Pharmacy, Kitasato University, Japan. Electronic address: maedak@pharm.kitasato-u.ac.jp."
38865146,Worst Itch Numeric Rating Scale for Prurigo Nodularis: A Secondary Analysis of 2 Randomized Clinical Trials.,2024-08-01,Rhoten S; Ivanescu C; Haeusler N; Brookes E; Msihid J; Makhija M; Bansal A; Thomas RB; Bahloul D,"IQVIA, Danbury, Connecticut.; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.; Sanofi, Cambridge, Massachusetts.; Sanofi, Gentilly, France.",Not available
38865073,An Ethnographic Study of Patient Life Experience in Early-Stage Parkinson's Disease in the United States and Germany.,2024-01-01,Park R; Bennett E; Kuret E; Klein B; Costa A; Messner S,"Gemic, New York, NY, USA.; Novartis Pharma AG, Basel, Switzerland.","Gemic, New York, NY, USA. Todd.Carmody@gemic.com."
38865039,Exploring the genetics of lithium response in bipolar disorders.,2024-06-12,DePaulo JR; Hasler R; O'Donovan C; Reininghaus E,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.; Laboratorios de Investigacion y Desarrollo, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru.; Universite Paris Cite, Inserm UMR-S 1144, Optimisation Therapeutique en Neuropsychopharmacologie, 75006, Paris, France.",Not available
38864733,"Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double-blind, placebo-controlled, crossover study.",2024-01-01,Segerdahl M; Halldin MM; Popescu T,"AlzeCure Pharma AB, Huddinge, Sweden.",Not available
38864397,"16(th) GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytical industry status.",2024-06-02,Zimmer J; Hays A; Lester T; Diaz M; Thomas E; O'Dell M; Hyer E; Tangri S; Dakappagari N; Karnik S; Liu A; Xu B; Sales K; Gorityala S; Reynolds G; Sangster T; Franckaert D; Love I; Patel V; Lin J; Jerks E; Kernstock R; Dufield D; Ambrose D; Warrino D; Luna M; Sanghvi M; Brown M; Hoffpauir B; Rocha A; Yamashita J,"Accurant Biotech, Cranbury, New Jersey, USA.; Agilex Biolabs, Adelaide, Australia.; Aliri Bioanalysis, Colorado Springs, Colorado, USA.; Alturas Analytics, Moscow, Idaho, USA.; BioAgilytix, Durham, North Carolina, USA.; BioAgilytix, San Diego, California, USA.; CMIC, Hoffman Estates, Illinois, USA.; Celerion, Lincoln, Nebraska, USA.; CellCarta Biosciences, Montreal, Canada.; Charles River Laboratories, Edinburgh, Tranent, UK.; Charles River Laboratories, Reno, Nevada, USA.; Eurofins Pharma Bioanalytics, Lake St. Louis, Missouri, USA.; Eurofins Viracor, BioPharma Services, Lenexa, Kansas, USA.; ICON plc, Whitesboro, New York, USA.; KCAS Bioanalytical & Biomarker Services, Olathe, Kansas, USA.; Labcorp, Indianapolis, Indiana, USA.; Labcorp, Madison, Wisconsin, USA.; Navigate Biopharma, San Diego, California, USA.; Pharmaron, Germantown, Maryland, USA.; Q2 Solutions Durham, North Carolina, USA.; Resolian (Formally Alliance Pharma), Malvern, Pennsylvania, USA.; Smithers, Ewing, New Jersey, USA.; Smithers, Gaithersburg, Maryland, USA.; WuXi AppTec, Plainsboro, NJ, USA.",Not available
38864290,Phase II study of fezolinetant for treatment of vasomotor symptoms associated with menopause in Japan.,2024-01-01,Miki T; Miyazaki K; Hashimoto A; He W; Wang X,"Astellas Pharma Global Development, Northbrook, IL, USA.; Astellas Pharma Inc., Tokyo, Japan.",Not available
38863872,"Corrigendum to ""Development of a highly concentrated collagen ink for the creation of a 3D printed meniscus"".",2024-02-15,Zihlmann C; Stiefel N,"Geistlich Pharma AG (Geistlich), Bahnhofstrasse 40, CH-6110 Wolhusen, Switzerland.",Not available
38862742,Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.,2024-01-01,Kallio R,"Schwerpunktpraxis Oncology/ Hematology, Dusseldorf, Germany.","Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. heikki.joensuu@hus.fi."
38862493,"Performance of newer myeloma staging systems in a contemporary, large patient cohort.",2024-06-11,Parrinello CM,"Pine Mountain Consulting, Larkspur, CA, USA.","Huntsman Cancer Institute, University of Utah, Salt lake, UT, USA. g.mohyuddin@hci.utah.edu."
38861871,Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials.,2024-01-01,Chen X; Li K,"AstraZeneca, Wilmington, DE, USA.; Merck & Co., Inc., Rahway, NJ, USA.",Not available
38861666,Fixed-duration pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL: the phase 1b BRUIN trial.,2024-09-26,Wang C; Liu D; Radtke D; Chapman S,"Eli Lilly and Company, Indianapolis, IN.",Not available
38861400,Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.,2024-11-11,Ferrieres J; Lamparter M; Chhabra R; Soronen J; Rietzschel E,"Daiichi Sankyo Europe GmbH, Zielstattstrasse 48, 81379, Munich, Germany.; Department of Endocrinology, Karolinska University Hospital, C2:94; Halsovagen SE 14186, Stockholm.",Not available
38861305,Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide.,2024-01-01,Lowentritt BH; Du S; Rossi C; Muser E; Khilfeh I; Kinkead F; Korsiak J; Lefebvre P; Pilon D,"Analysis Group, Inc., Montreal, QC, H3B 0G7, Canada.; Chesapeake Urology, Towson, MD 21204, USA.; Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Horsham, PA 19044, USA.",Not available
38861294,Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary.,2024-01-01,Moran D; Park JW; Bhattacharya P,"Astellas Pharma Global Development, Inc., Northbrook, IL, USA.",Not available
38861293,COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.,2024-01-01,Shumway N; Rosales M,"Compass Therapeutics, 80 Guest Street, Boston, MA 02135, USA.; Texas Oncology, San Antonio, TX 78258, USA.",Not available
38861216,Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer.,2024-01-01,Brown B; Fallick M; de Paauw-Holt S,"Myovant Sciences Inc, Brisbane, CA, USA.; Sumitomo Pharma Switzerland GmbH, Aeschengraben 27, 4051, Basel, Switzerland.",Not available
38860153,"Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3).",2024-01-01,Rosenbaum D; Edelstein S; Kozuka K; Williams LA,"Ardelyx, Inc, Waltham, MA, USA.",Not available
38859579,"Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study.",2024-01-01,Dreger M,"Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany.",Not available
38858318,Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria.,2024-01-01,Saffore CD; Parikh B; Ye X,"AbbVie Inc., North Chicago, IL, USA.",Not available
38858106,"A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).",2024-08-05,Guzman Ramirez A; Krishnan V; Molinero L; Feng Y; Kim N; Castro M; Lin YG; Monk BJ,"F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Genentech, Inc, South San Francisco, California, USA.; Instituto de Investigacion en Ciencias Medicas (ICIMED), San Jose, Costa Rica.","Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, California, USA rsalani@mednet.ucla.edu."
38858103,Mirvetuximab soravtansine in folate receptor alpha (FRalpha)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial.,2024-08-05,Esteves B; Method M; Matulonis U,"ImmunoGen Inc, Waltham, Massachusetts, USA.","US Oncology Research, Texas Oncology, The Woodlands, Texas, USA rcoledude@mac.com."
38857646,Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Fexofenadine.,2024-01-01,Abrahamsson B; Parr A,"Bioceutics LCC, Acworth, GA, USA.; Oral Product Development, Pharmaceutical Technology & Development, Operations AstraZeneca, Gothenburg, Sweden.",Not available
38857615,"Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study.",2024-01-01,Brander C,"CIBERINFEC, Madrid, Spain; Department of Infectious Diseases and Immunity, University of Vic-Central University of Catalonia, Vic, Spain; Institucion Catalana de Investigacion y Estudios Avanzados (ICREA), Barcelona, Spain.; IrsiCaixa, Badalona, Barcelona, Spain",Not available
38856863,"Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody.",2024-06-10,Roider HG; Hoff S; Tseng SY; Berndt S; Trautwein M; Filarsky K; Gritzan U; Camps J; Grudzinska-Goebel J; Ellinger P; Pesch T; Soon CF; Geyer M; Gluske K; Stelte-Ludwig B; Gorjanacz M,"Bayer AG, Pharmaceuticals, Berlin, Germany.; Bayer AG, Pharmaceuticals, San Francisco, USA.; Bayer AG, Pharmaceuticals, Wuppertal, Germany.; Current address: Roche Diagnostics GmbH, Penzberg, Germany.",Not available
38855053,Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.,2024-01-01,Chinot OL,"Service de Neurologie 2, AP-HP, Hopital de la Pitie-Salpetriere, Paris, France.",Not available
38854711,"Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI's ""big data for better outcomes"" program.",2024-01-01,Abbott T; Steinbeisser C; Evans-Axelsson S,"Astellas Pharma, Inc., Northbrook, IL.; Bayer AG, Berlin, Germany.; Collaborate Project Management, Munich.",Not available
38854392,"The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.",2024-01-01,Fustier P; Legenne P; Stavropoulou V; Stojcheva N; Stumpp MT; Soergel M,"Molecular Partners AG, Zurich-Schlieren, Switzerland.",Not available
38853584,Tailoring polishing steps for effective removal of polysorbate-degrading host cell proteins in antibody purification.,2024-01-01,Maier M; Weiss L; Lakatos D; Franzreb M,"Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
38852921,Efficacy of Faricimab versus Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase III YOSEMITE and RHINE Trials.,2024-01-01,Ahmed A; Amador M; Ding A; Holekamp N; Lu XY; Stoilov I; Yang M,"Genentech, Inc., South San Francisco, California.; Pepose Vision Institute, St. Louis, Missouri; Roche Pharma R&D, Basel, Switzerland.",Not available
38852742,Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies.,2024-01-01,Dutronc Y; Yu G; Murage M; Chen YF; Chiasserini C,"Eli Lilly and Company, Indianapolis, Indiana.",Not available
38852688,Bayesian approach enabled objective comparison of multiple human iPSC-derived Cardiomyocytes' Proarrhythmia sensitivities.,2024-01-01,Daily N; Zushida K; Honda Y; Asyama M; Takasuna K,"Axcelead Drug Discovery Partners, Inc., Kanagawa 251-0012, Japan.; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), HEART Team, Tokyo, Japan; Daiichi Sankyo RD Novare Co., Ltd., Tokyo 134-8630, Japan; FUJIFILM Wako Pure Chemical Corporation, Osaka 540-8605, Japan.; InvivoSciences, Inc., Madison, WI 53719, USA.; Mitsubishi Tanabe Pharma Corporation, Kanagawa 251-8555, Japan.; Sumika Chemical Analysis Service, Ltd. (SCAS), Osaka 554-0022, Japan.","InvivoSciences, Inc., Madison, WI 53719, USA. Electronic address: tetsuro@invivosciences.com."
38852615,Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure.,2024-01-01,Rascher J; Cotton D; Haertter S,"Boehringer Ingelheim Pharma, Biberach, Germany.; Boehringer Ingelheim Pharma, Ingelheim, Germany.; Boehringer Ingelheim Pharma, Ridgefield, Connecticut, USA.",Not available
38852398,Large-scale analysis of neural activity and connectivity from high-density electroencephalographic data.,2024-01-01,Cuartas Morales E,"Direccion Academica, Universidad Nacional de Colombia, Sede de La Paz, La Paz, 202017, Colombia.; Movement Control and Neuroplasticity Research Group, KU Leuven, 3001, Leuven, Belgium",Not available
38852256,Destruxin E backbone modification effects on osteoclast Morphology: Synthesis and SAR study of N-Desmethyl and N-Methyl analogs.,2024-06-15,Sato H,"Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aza-Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan; Mitsubishi Tanabe Pharma Corporation, 1-1-1, Marunouchi, Chiyoda-ku, Tokyo 100-8205, Japan.",Not available
38851739,The Hospital Burden of Flu in Italy: a retrospective study on administrative data from season 2014-2015 to 2018-2019.,2024-06-08,Maifredi G; Montedoro M; Azzi MV; Zanetta L; Xoxi E,"SS Epidemiologia, Agenzia di Tutela della Salute di Brescia, Brescia, Italy.; Sanofi SpA, Milan, Italy.; UVARP ASL Foggia, San Severo c/o Ospedale, Italy.; Universita Cattolica del Sacro Cuore, Alta Scuola di Economia e Management dei Sistemi Sanitari (ALTEMS), Rome, Italy.","IQVIA Solutions Italy Srl, Via Fabio Filzi 29, Milan, 20124, Italy. riccardo.cipelli@iqvia.com."
38851404,Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.,2024-01-01,Sairanen U; Vahteristo M,"Orion Corporation, Espoo, Finland.",Not available
38851236,International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe.,2024-06-08,Makri S; Akerkar S,"Cyprus League for People with Rheumatism (CYLPER), Nicosia, Cyprus.; Sanatorio Julio Mendez, Buenos Aires, Argentina.","Universidad de Sevilla, Health & Territory Research (HTR), Sevilla, Spain mcumbrera@us.es."
38851203,"[(177)Lu]Lu-DOTA-TATE plus long-acting octreotide versus highdose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.",2024-06-29,Folitar I; Zhang Y; Aimone P,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corp, East Hanover, NJ, USA.","University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. Electronic address: simron.singh@sunnybrook.ca."
38850589,Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study.,2024-01-01,He X; Tang Z; Gairy K,"Value Evidence and Outcomes, GSK, Brentford, England, UK.; Value Evidence and Outcomes, GSK, Shanghai, China.",Not available
38850469,Clinical Practice Guidelines of the Latin American Federation of Endocrinology for the use of vitamin D in the maintenance of bone health: recommendations for the Latin American context.,2024-06-08,Paez-Talero A; de la Pena-Rodriguez MP; Reza-Albarran AA; Rueda-Plata PN,"Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo (ACE), Bogota, Colombia.; Departamento de Endocrinologia de La Facultad de Medicina de la Universidad Autonoma de Guadalajara (UAG), Presidenta Electa Para La Federacion Latinoamericana de Endocrinologia (FELAEN), Sociedad Mexicana de Nutricion y Endocrinologia, Colegio Jalisciense de Endocrinologia y Nutricion, Servicios Medicos De La Pena, SC, Guadalajara, Mexico.; Departamento de Endocrinologia y Metabolismo del Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Universidad Nacional Autonoma de Mexico, Sede Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Sociedad Mexicana de Nutricion y Endocrinologia y Consejo Mexicano de Endocrinologia, Ciudad de Mexico, Mexico.; Federacion Latinoamericana de Endocrinologia (FELAEN), Universidad Nacional de Colombia, Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo (ACE), Bogota, Colombia.","Department of Psychiatry and Mental Health, Faculty of Medicine, Pontificia Universidad Javeriana, Bogota, Colombia. oscar_gomez@javeriana.edu.co."
38850402,Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study.,2024-01-01,Procaccini M; Falsetto N; Villano V; Camattari G,"Angelini Pharma S.P.A., Rome, Italy.","Department of Experimental and Clinical Medicine, Neurological Clinic, Marche Polytechnic University, Ancona, Italy. alfierelattanzisimona@gmail.com."
38850346,Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.,2024-06-08,Beecker J,"Dr. Isabelle Delorme Inc, Drummondville, QC, Canada.","Alliance Clinical Trials and Probity Medical Research, Waterloo, ON, Canada. kapapp@probitymedical.com."
38850335,Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.,2024-06-08,Fordellone M,"Universitiy of Campania ""Luigi Vanvitelli"", 81100, Naples, Italy.",Not available
38849969,"Insight into the avidity-affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn.",2024-01-01,Reusch J,"Dynamic Biosensors GmbH, Munich, Germany.",Not available
38849943,"Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study.",2024-06-07,Bulbek H,"Brainstrust-the brain cancer people, Isle of Wight, Cowes, UK.","Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. matthias.preusser@meduniwien.ac.at."
38849462,"Associations between obesity, a composite risk score for probable long COVID, and sleep problems in SARS-CoV-2 vaccinated individuals.",2024-01-01,Inoue Y; Benedict C,"Faculdade de Ciencias Humanas, Universidade Catolica Portuguesa, Lisbon, Portugal.; IRCCS Fondazione Santa Lucia, Roma, Italy.","Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. pei.xue@uu.se."
38849413,Genome-wide determinants of mortality and motor progression in Parkinson's disease.,2024-06-07,Bresner C,"Data Tecnica, Washington DC, USA.","Department of Neurology, Oslo University Hospital, Oslo, Norway. manuela.tan@medisin.uio.no."
38849283,"Nivolumab, Pomalidomide, and Elotuzumab Combination Regimens for Treatment of Relapsed and Refractory Multiple Myeloma: Results from the Phase 3 CheckMate 602 Study.",2024-01-01,Mariz J; Cavo M; Wang Y; Perumal D,"Bristol Myers Squibb, Princeton, NJ.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia ""Seragnoli"", and Dipartimento di Scienze Mediche e Chirurgiche, Universita di Bologna, Bologna, Italy.; Instituto Portugues de Oncologia, Porto, Portugal.","Institut Catala d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain. Electronic address: aoriol@iconcologia.net."
38849048,20-Week intramuscular toxicity study of rotigotine behenate extended-release microspheres for injection via intramuscular injection in cynomolgus monkeys.,2024-01-01,Song T,"Luye Pharmaceutical Co., Ltd. (Luye Pharma), Yantai, Shandong, 264003, PR China.",Not available
38848686,Human iPSC-derived CD4(+) Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model.,2024-06-06,Koga K; Sato T; Shinohara T; Matsuda A; Nakazono K; Shioiri M; Kassai Y,"T-CiRA Discovery, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa, Japan.; Takeda-CiRA joint research program (T-CiRA), Fujisawa, Kanagawa, Japan",Not available
38848180,Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.,2024-01-01,Jaros M; Harrison J,"Scottish Brain Sciences, Edinburgh, UK.; Summit Analytical, Denver, CA, USA.",Not available
38847994,Regional Differences in Diagnosis Journey and Healthcare Utilization: Results from the International Map of Axial Spondyloarthritis (IMAS).,2024-01-01,Makri S; Akerkar S,"Cyprus League for People with Rheumatism (CYLPER), Nicosia, Cyprus.; Sanatorio Julio Mendez, Buenos Aires, Argentina.","Universidad de Sevilla, Health & Territory Research (HTR), Seville, Spain. mcumbrera@us.es."
38847896,Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.,2024-01-01,Abreu F; Chang DS; G Csaky K; Peto T; Stoilov I; Willis JR; Westenskow PD,"Apellis Pharmaceuticals, Waltham, MA, USA.; F. Hoffmann-La Roche Ltd., Basel, Switzerland.; F. Hoffmann-La Roche Ltd., Mississauga, ON, Canada.; Genentech, Inc., South San Francisco, CA, USA.",Not available
38846952,"Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries.",2024-01-01,Marina D; Rubant S; Albuquerque T,"AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.; AbbVie Portugal, Amadora, Portugal.; AbbVie SRL Romania, Bucharest, Romania.",Not available
38846692,"Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel.",2024-01-01,Warren RB,IQVIA Ltd Athens Greece.,Not available
38845817,ICH S1 prospective evaluation study and weight of evidence assessments: commentary from industry representatives.,2024-01-01,Hisada S; Nolte T; Tsubota K,"Astellas Pharma Inc., Ibaraki, Japan.; Development NCE, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Formerly ASKA Pharmaceutical Co., Ltd., Fujisawa-shi, Kanagawa, Japan.",Not available
38845371,REVEALS-a longitudinal cohort study of multifaceted respiratory assessment in ALS.,2024-01-01,Meyjes M; Wood C,"Neurology 1, Azienda Ospedale Universita Citta della Salute e della Scienza, Turin, Italy.",Not available
38844871,Large-scale data mining of four billion human antibody variable regions reveals convergence between therapeutic and natural antibodies that constrains search space for biologics drug discovery.,2024-01-01,Demharter S; Spreafico R; Schulte L; Martin K; Comeau SR,"Biotherapeutics Discovery, Boehringer Ingelheim, Ridgefield, CT, USA.; Discovery Data Science, Genmab, Copenhagen, Denmark.; Discovery Data Science, Genmab, Utrecht, The Netherlands.; Global Computational Biology & Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
38844820,Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.,2024-06-06,Vorholt D; Breitenbucher F,"Janssen-Cilag GmbH, Johnson&Johnson Platz 1, 41470, Neuss, Germany.","Institute of Pathology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Str. 62, 50924, Cologne, Germany. michaela.ihle@uk-koeln.de."
38844797,Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial.,2024-01-01,Rossiter G; Jansson J; Floisand Y,"Takeda, Cambridge, MA, USA.","Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA. ychen6@mgb.org."
38844736,Amniotic fluid stem cell-derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model.,2024-01-01,Mazza T; Cruciani G,"TES Pharma Srl, I, Corciano, Perugia, Italy.",Not available
38844721,Accelerated Predictive Stability Study of a Pediatric Drug Product for a Supplemental New Drug Application.,2024-06-06,Wang J,"Pharma Technical Regulatory, Genentech Inc., South San Francisco, California, USA.",Not available
38844682,Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study.,2024-01-01,Chakravarty SD; Rampakakis E,"Arizona Arthritis & Rheumatology Associates, P.C., Phoenix, AZ, USA.; Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Horsham, PA, USA.","University of Rochester Medical Center, Rochester, NY, USA. christopher_ritchlin@URMC.Rochester.edu."
38844668,Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan.,2024-01-01,Matsui N,"Patient Safety Japan, Bristol-Myers Squibb K.K., Otemachi One Tower, 1-2-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.",Not available
38844408,Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.,2024-06-06,Collins L,"Cancer Immunotherapy Group, Institut de Recerca Biomedica de Bellvitge (IDIBELL) - OncoBell, Barcelona, Spain.","Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK joseph.sacco@nhs.net Takami.Sato@jefferson.edu."
38844309,Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.,2024-01-01,Acosta-Rivera M; Soleymani S; Yao J; Neely J,"Bristol Myers Squibb, Princeton, USA.; Fundacion de Investigacion, San Juan, Puerto Rico.; Informatics and Predictive Sciences, Bristol Myers Squibb, Princeton, USA.; Translational Medicine, Bristol Myers Squibb, Princeton, USA.","Department of Immunology, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain. Electronic address: imelero@unav.es."
38843860,"Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.",2024-06-22,Palmerini E; Tait C; Zarins F; Harrow B; Sharma MG; Ruiz-Soto R; Sherman ML,"Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.","Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: a.j.gelderblom@lumc.nl."
38843469,Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).,2024-09-10,Modest DP; Striefler JK; Jacobasch L; Niedermeier M; Sohm M,"Hematology, Oncology and Tumor Immunology, Charite-Universitatsmedizin Berlin, Berlin, Germany.; Private Practice Oncology/Hematology, Dresden, Germany.; Private Practice Oncology/Hematology, Landshut, Germany.; Private Practice Oncology/Hematology, Memmingen, Germany.",Not available
38842993,Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary Syndrome.,2024-06-24,Manzo-Silberman S; Guedeney P; Procopi N; Kerneis M; Zeitouni M; Arnould MA; Braik N; Barthelemy O; Montalescot G,"Service de Cardiologie, Clinique Saint-Gatien, Saint-Cyr-sur-Loire, France.; Sorbonne Universite, Allies in Cardiovascular Trials Initiatives and Organized Networks (ACTION) Study Group, INSERM UMRS1166, Hopital Pitie-Salpetriere (AP-HP), Paris, France.",Not available
38842957,Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m(2).,2024-01-01,Lefkowitz MP,"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
38842956,Exploration of Theta Burst-Induced Modulation of Transcranial Magnetic Stimulation-Evoked Potentials Over the Motor Cortex.,2025-01-01,Casarotto S; Massimini M,"Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Don Carlo Gnocchi, Organizzazione Non Lucrativa di Utilita Sociale (ONLUS), Milan, Italy.","4Brain, Department of Neurology, Ghent University Hospital, Ghent, Belgium. Electronic address: Sofie.Carrette@ugent.be."
38842383,Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis.,2024-09-03,Faraoni EY,"CONICET, Buenos Aires, Argentina.",Not available
38841854,Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF.,2024-07-23,Desai AS; Lefkowitz MP; Martinez F,"Novartis Pharmaceuticals, East Hanover, NJ (L.-M.C., J.G., M.P.L.).",Not available
38841819,Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis-Results from the MAGNON project.,2024-01-01,Jankovic M; Hoffmann O,"Sauerlandklinik Hachen, Sundern, Germany.; St. Josefs-Krankenhaus Potsdam-Sanssouci, Potsdam, Germany.",Not available
38841799,Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.,2024-01-01,Burgel PR; Price D,"Institut Cochin, Inserm U1016, Universite Paris Cite, Paris, France.; Service de Pneumologie, Hopital Cochin, Assistance Publique Hopitaux de Paris.",Not available
38840229,Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity.,2024-06-05,Berry P,"Janssen Global Services, Montgomery County, Horsham, PA, USA.",Not available
38839950,MYCT1 controls environmental sensing in human haematopoietic stem cells.,2024-01-01,Kardouh M; Nance KJ,"Kite Pharma, Santa Monica, CA, USA.; Pfizer, Cambridge, MA, USA.","Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA. julia.aguade@gmail.com."
38839657,[Brain check-up: a structured approach diagnosing mild cognitive impairment in the primary care setting].,2024-01-01,Bopp AK; Schwientek AK; Langer S; Dogan V; Grimmer T,"Klinik fur Psychiatrie und Psychotherapie, Zentrum fur kognitive Storungen, Klinikum rechts der Isar, Technische Universitat Munchen, Mohlstrasse 26, 81675, Munchen, Deutschland.; Roche Pharma AG, Grenzach-Wyhlen, Deutschland.","Klinik fur Psychiatrie und Psychotherapie, Zentrum fur kognitive Storungen, Klinikum rechts der Isar, Technische Universitat Munchen, Mohlstrasse 26, 81675, Munchen, Deutschland. Lucas.Wolski@tum.de."
38839275,"Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis.",2024-07-15,Manera U; Grassano M,"SC Neurologia 1U, Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Turin, Italy.","""Rita Levi Montalcini"" Department of Neuroscience, ALS Centre, University of Turin, Turin, Italy francesca.palumbo@unito.it."
38838706,A psychometric analysis of the Japanese version of the clinically useful depression outcome scale supplemented with questions for the DSM-5 anxious distress specifier (CUDOS-A).,2024-01-01,Zimmerman M,"South County Psychiatry, Cranston, Rhode Island, USA.",Not available
38838502,"A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer.",2024-01-01,Azaro A; Cavazzina R; Gangl ET; Thompson J; Pouliot G; Kumar R,"BioPharma R&D, AstraZeneca, Boston.; Oncology R&D, AstraZeneca, Cambridge.; Oncology R&D, AstraZeneca, Gaithersburg.; Oncology R&D, AstraZeneca, Waltham.","Hospital Universitario Ramon y Cajal, Madrid, Spain. Electronic address: talonso@salud.madrid.org."
38838446,"Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma.",2024-01-01,Leiby MA; Lin J; Zhao Y; Krepler C; Perini RF; Catherine Pietanza M; Samkari A; Gruber T; Ibrahim N,"Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, NJ 07065, USA.","UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA 15232, USA. Electronic address: lukejj@upmc.edu."
38837892,Cancer-related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition's 2022 Global Patient Survey.,2024-06-24,Kalloger SE; Warwick L,"Lymphoma Coalition, Mississauga, Ontario, Canada.",Not available
38837829,Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries.,2024-01-01,Tromans S; Shankar R,"SUDEP Action, Wantage, UK.; Statsconsultancy Ltd, Bucks, UK.",Not available
38837588,Acetate derived from the intestinal tract has a critical role in maintaining skeletal muscle mass and strength in mice.,2024-01-01,Ida S,"CMIC Pharma Science, Nishiwaki, Japan.",Not available
38837247,Heart Failure and Edema Costs in Patiromer and Sodium Zirconium Cyclosilicate Users.,2024-08-01,Kleinman N,"Kleinman Analytic Solutions, LLC, Paso Robles, California.",Not available
38837167,Time-Resolved Dynamic Optical Coherence Tomography for Retinal Blood Flow Analysis.,2024-06-03,Teussink MM; Spaide RF; Scholl HPN,"Heidelberg Engineering GmbH, Heidelberg, Germany.",Not available
38836790,Isomerization of E-Cinnamamides into Z-Cinnamamides Using a Recycling Photoreactor.,2024-06-21,Kuroda N; Kanemaru K; Oda Y,"IWASAKI Electric Company Limited, 1-1, Ichiriyama-cho, Gyoda-shi, Saitama 361-8505, Japan.; YMC Company Limited, 284 Daigo, Karasuma Nishiiru Gojo-dori, Shimogyo-ku, Kyoto 600-8106, Japan.",Not available
38836560,The role of OX40 ligand/OX40 axis signalling in atopic dermatitis.,2024-09-18,Rynkiewicz N; Lucchesi D; Peakman M; van Krinks C; Valdecantos W; Xing H,"Sanofi, Cambridge, MA, USA.; Sanofi, Cambridge, UK.",Not available
38836098,Human leukocyte antigen (HLA) class I expression on Hodgkin-Reed-Sternberg cells is an EBV-independent major determinant of microenvironment composition in classic Hodgkin lymphoma.,2024-01-01,Borchmann S; Borchmann P; Richter J; Brockelmann PJ,German Hodgkin Study Group (GHSG) Cologne Germany.,Not available
38836097,"Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.",2024-01-01,Illerhaus G; Zucca E,Universita Vita e Salute San Raffaele Milan Italy.,Not available
38835235,"Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease.",2024-11-04,Parra RS,"Alimentiv Inc., London, ON, Canada.",Not available
38834388,Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.,2024-01-01,Bayle A; Bonastre J; Michiels S; Normanno N,"Drug Development Department (DITEP), Gustave Roussy, Villejuif; Faculty of Medicine, Universite Paris-Saclay, Kremlin Bicetre; Oncostat U1018, Inserm, Universite Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) ""Dino Amadori"", Meldola, Italy.; Service de Biostatistique et Epidemiologie, Gustave Roussy, Villejuif.",Not available
38834351,"Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies.",2024-06-04,Vaux T; Fleurinck C; Massow U; Taieb V; Morup MF; Deodhar A,"UCB Pharma, Brussels, Belgium.; UCB Pharma, Colombes, France.; UCB Pharma, Copenhagen, Denmark.; UCB Pharma, Monheim am Rhein, Germany.; UCB Pharma, Slough, UK.","Department of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA mdubreui@bu.edu."
38834319,An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.,2024-06-04,Johansson M; Lindemans C,"PharmaLex, Gothenburg, Sweden.; XNK Therapeutics AB, Huddinge, Sweden.",Not available
38834317,European Autism GEnomics Registry (EAGER): protocol for a multicentre cohort study and registry.,2024-06-04,Leblond CS; Madeira N; Montiel V; Pina Rodrigues A; Tammimies K; O'Neill C,"Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain.; Genetique Humaine et Fonctions Cognitives, UMR3571 CNRS, Institut Pasteur, Paris, France.; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.",Not available
38834087,"Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.",2024-01-01,Borbath I; Blanc JF,"Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium.; Hopital Haut-Leveque, CHU de Bordeaux, Service Hepato-Gastroenterologie et Oncologie Digestive, Bordeaux, France.","Erasme Hospital, Hopital Universitaire de Bruxelles, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: jean-luc.vanlaethem@hubruxelles.be."
38833992,Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.,2024-01-01,Baurain JF; Heitz F; York W; Gupta D,"AGO Study Group; Department for Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; Department of Gynaecology, Charite-Universitatsmedizin Berlin and Humboldt-Universitat zu Berlin, Berlin, Germany; GSK, Philadelphia, PA, USA.; GSK, Waltham, MA, USA.; Universite Catholique de Louvain and Cliniques Universitaires Saint-Luc, Brussels, Belgium.; and Berlin Institute of Health, Berlin, Germany.","AO Ordine Mauriziano Torino and Department of Oncology, University of Torino, Torino, Italy. Electronic address: giorgio.valabrega@unito.it."
38833658,"Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.",2024-08-20,Ananda S; Adelberg D; Heinemann V,"Instituto de Diagnostico e Investigaciones Metabolicas, Buenos Aires, Argentina.; Merck & Co, Inc, Rahway, NJ.",Not available
38833522,Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers.,2024-08-01,Keller PJ; Adams EJ; Wu R; Cote A; Arora S; Cantone N; Meyer R; Mertz JA; Gehling V; Cui J; Stuckey JI; Khanna A; Zhao F; Chen Z; Yu Z; Cummings RT; Taimi M; Rippley R; Levell J; Truong J; Wang J; Sun K; Trojer P,"Constellation Pharmaceuticals, A MorphoSys Company, Boston, Massachusetts.",Not available
38833235,[Living with... psoriasis].,2024-01-01,Quiles Tsimaratos N,"Service de dermatologie, hopital Saint-Joseph, Marseille, France.",Not available
38833140,"Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis.",2024-01-01,Zhang L; Zhang W; Xu Y; Jia Y; Li Z; Chen B,"Keymed Biosciences (Chengdu) Co., Ltd, Chengdu, 610219, Sichuan, China.",Not available
38833044,Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE).,2024-01-01,Haberbosch L,"Instituto Estadual do Cerebro Paulo Niemeyer, Secretaria Estadual de Saude do Rio de Janeiro, Rio de Janeiro, Brazil.","Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and San Raffaele IRCCS Hospital, Via Olgettina 60, Milan, 20132, Italy. giustina.andrea@hsr.it."
38832967,Recommendations for defining giant cell arteritis fast-track clinics. English version.,2024-01-01,Strunk J,"Klinik fur Rheumatologie, Krankenhaus Porz am Rhein gGmbH, Koln, Germany.","Klinik fur Innere Medizin, Abteilung Rheumatologie und Klinische Immunologie, Standort Berlin-Buch, Immanuel Krankenhaus Berlin, Lindenberger Weg 19, 13125, Berlin, Germany. wolfgang.schmidt@immanuelalbertinen.de."
38832950,"Prevalence, incidence and treatment patterns of prurigo nodularis in England: a retrospective database analysis.",2024-09-18,Bahloul D; Hudson R; Balogh O; Diribe O; McDonald R,"Sanofi, Gentilly, France.; Sanofi, Reading, UK.",Not available
38831520,Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi-center clinical trial.,2024-07-30,Krisam J; Carter K; Kuznetsova O; Sverdlov O,"Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.; Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.; Merck & Co., Inc., Rahway, New Jersey, USA.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
38831282,The IMPACT Survey: the economic impact of osteogenesis imperfecta in adults.,2024-06-03,Prince S,"Wickenstones Ltd, Abingdon, Oxfordshire, UK.",Not available
38830991,Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.,2024-01-01,Abramson JS; Fasan O; Lymp J; Vedal M; Nishii R; Avilion A; Papuga J; Nastoupil LJ,"Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Bristol Myers Squibb, Brisbane, CA, USA.; Bristol Myers Squibb, Princeton, NJ, USA.; Bristol Myers Squibb, Seattle, WA, USA.","Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associees, Lille, France. franck.morschhauser@chu-lille.fr."
38830959,CD8(+) CD28(-) regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.,2024-01-01,Seidel-Glatzer A,"Hematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany.",Not available
38830741,Observational study protocol for an arrhythmia notification feature.,2024-06-03,Capodilupo E; Lee V,"WHOOP, Boston, Massachusetts, USA.",Not available
38829139,Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaques.,2024-07-23,Sung J; Schulha S; Jin D; Sharma B; Ng S; Lu S; Wimmer R; Suthram S; Ahmadi-Erber S; Hung M; Carr B; Kuhne M; Schmidt S,"Bioinformatics, Gilead Sciences, Inc., Foster, California, USA.; Discovery Virology, Gilead Sciences, Inc., Foster, California, USA.; Drug Metabolism, Gilead Sciences, Inc., Foster, California, USA.; Oncology, Gilead Sciences, Inc., Foster, California, USA.; Protein Therapeutics, Gilead Sciences, Inc., Foster, California, USA.; Virology, Hookipa Pharma Inc., New York, New York, USA.",Not available
38829053,Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection.,2024-11-01,Bach PB; Carey J; Schonewolf CA; Bognar K; Kotagiri S; Ortendahl JD; Catallini J; Gershman A; Lumbard K; Millberg LK; Nawrocki J; Portwood C; Rangnekar A; Sheridan CC; Trivedi N; Wu T; Zong Y; Cotton L; Ryan A; Cisar C; Leal A; Dracopoli N,"DELFI Diagnostics, Baltimore, Maryland.; Medicus Economics, LLC, Formerly PHAR, San Francisco, California.; Stratevi, Formerly PHAR, San Francisco, California.",Not available
38829005,A Minimal Approach to Demonstrate Concordance of Digital and Conventional Microscopy in Toxicologic Pathology.,2024-01-01,Lempp C; Arms S; Igl BW; Hezler L; Nolte T; Pohlmeyer-Esch G,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
38828563,Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation.,2024-01-01,Rutman H; Mercuri MF; Lanz HJ,"Daiichi Sankyo Pharma Development, Edison, NJ (H.R., M.F.M., H.-J.L.).",Not available
38827168,Safety and Effectiveness of Ustekinumab for Crohn's Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan.,2024-01-01,Nagano K; Tsuchiya H; Asano T; Yamazaki H; Tominaga S,"Janssen Pharmaceutical K.K., Tokyo, Japan.",Not available
38826220,Shared genetics linking sociability with the brain's default mode network.,2024-05-25,Fabbri C,"Global Computational Biology and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.",Not available
38826202,Improving eSource Site Start-Up Practices.,2024-05-24,King LS; Rodrigues GMC; Vattikola A,"Astellas Pharma.; Janssen-Cilag, S.A.; Merck & Co., Inc.",Not available
38825977,Principal component analysis as an efficient method for capturing multivariate brain signatures of complex disorders-ENIGMA study in people with bipolar disorders and obesity.,2024-06-01,Goltermann J; Teutenberg L; Usemann P; Winter NR; Andreassen OA,"CIBERSAM, Instituto de Salud Carlos III, Barcelona, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.",Not available
38825841,Covariate adjustment in randomized controlled trials: General concepts and practical considerations.,2024-01-01,Bretz F,"Novartis Pharma AG, Basel, Switzerland.",Not available
38825839,Response to Harrell's commentary.,2024-01-01,Bretz F,"Novartis Pharma AG, Basel, Switzerland.",Not available
38825627,Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial.,2024-01-01,Egorov A; Hamilton E,"Daiichi Sankyo Co, Ltd., Tokyo, Japan.; Daiichi Sankyo, Inc., Basking Ridge, NJ, USA.","Quironsalud Group, Pangaea Oncology, International Breast Cancer Center, Madrid, Spain. javier.cortes@maj3.health."
38824917,Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies.,2024-06-05,Zinzani PL; Sizelove R; Abhyankar S; Hasanabba S; Tsai DE,"Eli Lilly and Company, Indianapolis, Indiana, USA.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seragnoli, Bologna, Italy.",Not available
38824753,Expediting online liquid chromatography for real-time monitoring of product attributes to advance process analytical technology in downstream processing of biopharmaceuticals.,2024-08-16,Graf T; Naumann L; Bonnington L; Heckel J; Klein S; Brey C; Nachtigall R; Mroz M; McHardy C; Martinez A,"Gene Therapy Technical Development, Roche Diagnostics GmbH, 82377 Penzberg, Germany.; Pharma Technical Development Analytics, Roche Diagnostics GmbH, 82377 Penzberg, Germany.; Pharma Technical Development Bioprocessing, Roche Diagnostics GmbH, 82377 Penzberg, Germany.",Not available
38824634,Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.,2024-01-01,Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D,"Analysis Group, Inc., Montreal, QC, Canada.; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ.",Not available
38824244,Inhibition of lysine acetyltransferase KAT6 in ER(+)HER2(-) metastatic breast cancer: a phase 1 trial.,2024-01-01,Sommerhalder D; Liyanage M; Saul M; Le Corre C; Liu L,"NEXT Oncology, San Antonio, TX, USA.; Pfizer, San Diego, CA, USA.",Not available
38823511,Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial.,2024-01-01,Reyes-Cosmelli F; Homet Moreno B; Markensohn J; Edmondson M; Chen C; Cristescu R; Pena C; Lunceford J; Gunduz S,"Fundacion Arturo Lopez Perez, Santiago, Chile.; Merck & Co. Inc., Rahway, NJ, USA.","Barts Cancer Institute, Queen Mary University of London, London, UK. thomas.powles1@nhs.net."
38823398,Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.,2024-01-01,Cundom JE; Kim H; Wang J; Morgan C; Rokutanda N; Zotkiewicz M,"AstraZeneca, Gaithersburg, MD, USA.; AstraZeneca, New York, NY, USA.; AstraZeneca, Osaka, Japan.; AstraZeneca, Warsaw, Poland.; Instituto de Investigaciones Metabolicas, Buenos Aires, Argentina.","Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea. Electronic address: ohdoyoun@snu.ac.kr."
38822973,The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression.,2024-06-01,Jani MA,"Pharmacy Practice Division, Anand Niketan, Shilaj, Ahmedabad, Gujarat, 380059, India.",Not available
38822758,Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study.,2024-08-01,Ren Y; Zhang X; Yan B,"AnHeart Therapeutics, New York, NY.",Not available
38822554,Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain.,2024-01-01,Hopkins SC; Toongsuwan S; Corriveau TJ; Lew R; Shi L; Zann V; Darpo B; Searle GE; Rabiner EA; Wilding I; Szabo ST; Galluppi GR; Koblan KS,"Clario, Rochester, New York, USA.; Ian Wilding Associates Limited, Nottingham, UK.; Invicro, London, UK.; Quotient Sciences Limited, Nottingham, UK.; Sumitomo Pharma America, Inc., Marlborough, Massachusetts, USA.",Not available
38822167,Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis.,2024-01-01,Kamat S; Tawadrous M; Welte T,"Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III CIBERINFEC, Madrid, Spain.; Pfizer Inc., New York, USA.; Pfizer Ltd., Surrey, UK.",Not available
38821813,Healthcare resource utilization following ustekinumab initiation among bio-naive Canadian patients with moderately-to-severely active Crohn's disease.,2024-01-01,In TSH; Pone E; Eberg M,"IQVIA Solutions Canada Inc., Kirkland, QC, Canada.; Janssen Inc., Toronto, ON, Canada.","Division of Gastroenterology, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada. Electronic address: talat.bessissow@mcgill.ca."
38821718,Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study.,2024-05-31,Lei M,"Global Biostatistics and Data Science, Bristol Myers Squibb Co, Princeton, New Jersey, USA.","Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA moverman@mdanderson.org."
38821716,Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?,2024-05-31,Nauwynck HJ,"Ankyra Therapeutics, Inc, Cambridge, Massachusetts, USA.",Not available
38821188,Varicose vein surgery after acute isolated superficial vein thrombosis in daily practice: INSIGHTS-SVT study.,2024-01-01,Bauersachs R,"Cardioangiologisches Centrum Bethanien CCB, Standort AGAPLESION Bethanien Krankenhaus, Frankfurt am Main, Germany.; Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany","Department for Vascular and Endovascular Surgery, University Hospital Regensburg, Regensburg, Germany. Electronic address: tnoppeney@outlook.de."
38821179,Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD).,2024-01-01,Alvir J; Gupta A; Wajnrajch M,"Pfizer Inc, New York, New York.",Not available
38821100,Production and regulatory issues for theranostics.,2024-01-01,Zimmermann R; Delgado Bolton RC,"Chrysalium Consulting, Lalaye, France; Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja, Logrono, Spain; MEDraysintell, Louvain la Neuve, Belgium; Oncidium Foundation, Auderghem, Belgium.; Servico Cantabro de Salud, Santander, Spain.",Not available
38820854,Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE/BChE selectivity switch and drug-like characterization.,2024-08-05,Cipolloni M; Colliva C; Giacche N,"Tes Pharma s.r.l., via Palmiro Togliatti 20, 06073, Corciano, PG, Italy.",Not available
38820707,Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent beta-thalassemia patients who remained on the same monotherapy over 10 years.,2024-01-01,Barella S; Origa R,"S.C. Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy.; Universita di Cagliari, S.C. Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy.",Not available
38820549,Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial.,2024-08-20,Li W; Lu D; Hu M; Wang ZM; Li B; Xia M,"Akeso Biopharma, Inc, Zhongshan, China.",Not available
38820422,Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis.,2024-09-10,Rose S; Giuseppi AC; Jiang H,"Bristol Myers Squibb, Princeton, NJ.",Not available
38820078,Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.,2024-09-12,Hochhaus A; Wang J; Kim DW; Kim DDH; Mayer J; Goh YT; le Coutre P; Takahashi N; Kim I; Etienne G; Andorsky D; Issa GC; Larson RA; Bombaci F; Kapoor S; McCulloch T; Malek K; Yau L; Ifrah S; Hoch M; Cortes JE; Hughes TP,"CML Patients Group, CML Advocates Network, Turin, Italy (F.B.); From Klinik fur Innere Medizin II, Hematology/Oncology, Universitatsklinikum Jena and Comprehensive Cancer Center Central Germany, Campus Jena, Jena (A.H.), and the Department of Oncology and Hematology, Charite-Universitatsmedizin Berlin, Berlin (P.C.) - both in Germany; Georgia Cancer Center at Augusta University, Augusta (J.E.C.); Novartis Pharma, Basel, Switzerland (T.M., K.M., L.Y., M.H.); Novartis Pharmaceuticals, East Hanover, NJ (S.K.); Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto (D.D.H.K.); Rocky Mountain Cancer Centers, Boulder, CO (D.A.); State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China (J.W.); Uijeongbu Eulji Medical Center, Geumo-dong, Uijeongbu-si (D.-W.K.), and the Department of Internal Medicine, Seoul National University Hospital, Biomedical Research Institute, Cancer Research Institute, Seoul National University College of Medicine, Seoul (I.K.) - both in South Korea; and the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, SA, Australia (T.P.H.).; the Department of Hematology, Akita University, Akita City, Japan (N.T.); the Department of Hematology, Singapore General Hospital, Singapore (Y.-T.G.); the Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, and Masaryk University - both in Brno, Czech Republic (J.M.); the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston (G.C.I.); the Hematology Department, Institut Bergonie, Bordeaux (G.E.), and Novartis Pharma, Paris (S.I.) - both in France; the University of Chicago, Chicago (R.A.L.)",Not available
38819783,Multiyear Clinical Outcomes of Cancers Diagnosed Following Detection by a Blood-Based Multicancer Early Detection Test.,2024-08-01,Choudhry OA; Elias PZ; Rego SP; Sadler JR; Roberta J; Zhang Y; Flake DD 2nd; Beer TM,"Exact Sciences Corporation, Madison, Wisconsin.",Not available
38819367,Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.,2024-01-01,Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA,"Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada.; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, British Columbia, Canada",Not available
38819334,Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.,2024-07-02,Perna E,"Instituto de Cardiologia de Corrientes J. F. Cabral, Corrientes, Argentina.",Not available
38819269,[A biomimetic approach inspired by viruses for the discovery of new drugs].,2024-01-01,Meyniel-Schicklin L; de Chassey B,"ENYO Pharma, Bioserra 1, Batiment B, Lyon, France.",Not available
38818888,Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I).,2024-01-01,He W; Ma X; Miyazaki K; Song N; Wang X,"Astellas (China) Investment Co, Ltd, Beijing.; Astellas Pharma Global Development, Inc., Northbrook, IL.; Astellas Pharma, Inc., Tokyo.",Not available
38818887,Long-term safety of fezolinetant in Chinese women with vasomotor symptoms associated with menopause: the phase 3 open-label MOONLIGHT 3 clinical trial.,2024-01-01,Zhang J; Ma X; Miyazaki K; He W; Wang X,"Astellas (China) Investment Co, Ltd, Beijing, China.; Astellas Pharma Global Development, Inc., Northbrook, IL, USA.; Astellas Pharma, Inc., Tokyo, Japan.",Not available
38817703,Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact.,2024-01-01,Maia T; Belhocine R,"Universita Campus Bio-Medico. ROR: https://ror.org/04gqx4x78; Virology, Hopital Saint-Antoine, Assistance Publique - Hopitaux de Paris. ROR: https://ror.org/01875pg84",Not available
38817598,CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs.,2024-01-01,Lux MP; Thill M; Neubauer H; Hartkopf AD,"ClinSol GmbH & Co KG, Wurzburg, Germany.; Department of Gynecology and Obstetrics, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Germany; Novartis Pharma GmbH, Nuremberg, Germany.; St. Vincenz Kliniken Salzkotten + Paderborn, Paderborn, Germany.",Not available
38817595,Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry.,2024-01-01,Uhrig S; Haberle L,"ClinSol GmbH & Co KG, Wurzburg, Germany.; Department of Gynecology and Obstetrics, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Germany; St. Vincenz Kliniken Salzkotten + Paderborn, Paderborn, Germany.",Not available
38817323,Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification.,2023-01-01,Pereira AC; Vasan RS,"Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.; Psomagen Inc., Rockville, MD, USA.",Not available
38816946,Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data.,2024-01-01,Iwasaki S; Lahav A,"Mitsubishi Tanabe Pharma Holdings America, Inc., 525 Washington Blvd., Jersey City, New Jersey, 07310, USA.",Not available
38816825,"MolScore: a scoring, evaluation and benchmarking framework for generative models in de novo drug design.",2024-05-30,O'Boyle NM; De Graaf C,"Computational Chemistry, Nxera Pharma, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG, UK.","Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK. morganthomas263@gmail.com."
38816422,Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores.,2024-05-30,Simon N,"The Framingham Heart Study, Framingham, MA, USA.",Not available
38815935,A genome-wide meta-analysis of palmoplantar pustulosis implicates T(H)2 responses and cigarette smoking in disease pathogenesis.,2024-01-01,Baum P; Visvanathan S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conn.",Not available
38815641,Manufacturing process of liposomal Formation: A coarse-grained molecular dynamics simulation.,2024-06-25,Mohammadiarani H,"DexCom inc., San Diego, CA 92121, USA.",Not available
38815414,Progressive pulmonary fibrosis (PPF): Estimation of incidence and treatment rates in Japan using a claims database.,2024-01-01,Saito K; Bao H; Sakamoto W,"Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.; Nippon Boehringer Ingelheim Co., Ltd., 2-1-1 Osaki, Shinagawa-ku, Tokyo, 141-6017, Japan.","Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan. Electronic address: yshr.kondoh@gmail.com."
38815205,The potential of three-dimensional printing for pediatric oral solid dosage forms.,2024-06-01,Kreft K; Fanous M; Mockel V,"1Lek Pharmaceuticals d.d., a Sandoz Company, 1000 Ljubljana, Slovenia.; 2Novartis Pharma AG, 4002 Basel Switzerland.",Not available
38814532,Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis.,2024-01-01,L'Italien GJ; Beiner MW; Maclaine GDH; Coric V,"Biohaven Bioscience Ireland Ltd, Dublin, Ireland.; Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, 06510, USA.",Not available
38814395,Sequence-Optimized mRNA Vaccines Against Infectious Disease.,2024-01-01,Rauch S; Lutz J; Muhe J; Kowalczyk A; Schlake T,"Boehringer Ingelheim Pharma & Co. KG, Biberach/Riss, Germany.; CureVac AG, Tubingen, Germany.",Not available
38814388,Introduction to RNA Vaccines Post COVID-19.,2024-01-01,Kramps T,"Novartis Pharma GmbH, Nuremberg, Germany.",Not available
38813200,Current landscape and support for practical initiation of oncological prehabilitation translatable to thyroid cancer: A position paper.,2024-05-30,Joaquim A,"ONCOMOVE(R), Associacao de Investigacao de Cuidados de Suporte em Oncologia (AICSO), 4410-406, Vila Nova de Gaia, Portugal.",Not available
38812841,Telehealth and Mobile Health: Case Study for Understanding and Anticipating Emerging Science and Technology.,2023-01-01,Butte AJ; Sandy L; Smee J,"Qualcomm Technologies, Inc.; San Francisco.; Sulu Coaching.",Not available
38812840,Neurotechnology and Noninvasive Neuromodulation: Case Study for Understanding and Anticipating Emerging Science and Technology.,2023-01-01,Butte AJ; Enriquez J; Persons TM,Excel Venture Management.; PricewaterhouseCoopers.; San Francisco.,Not available
38812809,On the Road to Individualizing Pharmacotherapy for Adolescents and Adults with Schizophrenia - Results from an Expert Consensus Following the Delphi Method.,2024-01-01,Guinart D,"Institut de Salut Mental, Parc de Salut Mar, Barcelona, Spain.",Not available
38812719,Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma.,2024-01-01,Scadding G,"Escuela de Doctorado UAM, Centro de Estudios de Posgrado, Universidad Autonoma de Madrid, Calle Francisco Tomas y Valiente, no 2, Ciudad Universitaria de Cantoblanco, Madrid, Spain.",Not available
38812706,Unmet needs in treatment of symptomatic uncomplicated diverticular disease and prevention of recurrent acute diverticulitis: a scoping review.,2024-01-01,Cuomo R,"UOC of Gastroenterology, AORN Sant'Anna e San Sebastiano, Caserta, Italy.",Not available
38812074,Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension.,2024-01-01,Ait-Oudhia S; Jaworowicz D; Hu Z; Bihorel S; Hu S; Balasubrahmanyam B; Mistry B; de Oliveira Pena J; Wenning L; Gheyas F,"Acceleron Pharma, a subsidiary of Merck & Co., Inc., Rahway, New Jersey, USA.; Cognigen Division of Simulations Plus, Inc., Buffalo, New York, USA.; Merck & Co., Inc., Rahway, New Jersey, USA.",Not available
38811970,Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD.,2024-05-29,Crooks MG; Djukanovic R,"tranScrip Ltd, Wokingham, UK.","Synairgen Research Ltd, Southampton, UK. phillip.monk@synairgen.com."
38811857,A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits.,2024-01-01,Goren EM,"Boehringer Ingelheim Pharma GmbH & Co. KG; CNS Diseases, Biberach an der Riss, Germany.","Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel. jonas.wietek@gmail.com."
38811590,Kinetics of SARS-CoV-2 infection biomarkers in a household transmission study.,2024-05-29,Dodoo C; Alvarado LA; Parkin NT; Robbins EM; Moonsamy P; Toptan T; Ciesek S,"Data First Consulting, Inc., Sebastopol, CA, USA.; EP Statistical Consulting, LLC, El Paso, TX, USA.; Roche Molecular Systems, Pleasanton, CA, USA.",Not available
38811577,Small molecule induced STING degradation facilitated by the HECT ligase HERC4.,2024-05-29,Tran TT,"Monte Rosa Therapeutics, Basel, Switzerland.","Novartis BioMedical Research, Basel, Switzerland. merve.koch@novartis.com."
38811560,"Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant.",2024-05-29,Barnidge D,"The Binding Site Group, part of Thermo Fisher, Rochester, MN, USA.",Not available
38811492,Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy.,2024-01-01,Bourikas D,"UCB Pharma, Agiou Dimitriou 63, 17456, Alimos, Greece.","Mid-Atlantic Epilepsy and Sleep Center, 6410 Rockledge Dr, Bethesda, MD, 20817, USA. kleinp@epilepsydc.com."
38811470,A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis.,2024-01-01,Di Fino S; Palladino C; Patruno C,"AbbVie SrL, Rome, Italy.",Not available
38810843,Tyrosine kinase inhibitors in cancers: Treatment optimization - Part II.,2024-01-01,Combarel D; Paci A,"Service de Pharmacocinetique, Faculte de Pharmacie, Universite Paris-Saclay, Chatenay-Malabry, Chatenay-Malabry 92 296, France.; Service de Pharmacologie, Departement de Biologie et Pathologie medicales, Gustave Roussy, Villejuif 94805, France",Not available
38810600,"Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study.",2024-01-01,Hicks E; Liao S,"Alexion, AstraZeneca Rare Disease, Boston, Massachusetts.",Not available
38810264,Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.,2024-09-10,Abraham I,"Hematology and Oncology, UChicago Medicine, Chicago, IL.",Not available
38810172,Association of Prenatal Exposure to Antiseizure Medications With Creative and Executive Function at Age 4.5 Years.,2024-06-25,Meador KJ; Cohen MJ; Loring DW; Matthews AG; Brown CA; Robalino C; Carmack A; Sumners S; Birnbaum AK; Kalayjian LA; Gedzelman E; Voinescu PE; Gerard EE; Hanna J; Cavitt J; Sam M; Hwang ST; Pack AM; Tsai JJ; Pennell PB,"Brigham and Women's Hospital (P.E.V.), Harvard Medical School, Boston, MA; Columbia University (A.M.P.), New York, NY; Emory University School of Medicine (D.W.L., E.G.), Atlanta, GA; From the Stanford University (K.J.M.), Palo Alto, CA; Minnesota Epilepsy Group (J.H.), Roseville; Northwell Health (S.T.H.), Great Neck; Northwestern University (E.E.G.), Chicago, IL; Pediatric Neuropsychology International (M.J.C.), Augusta; Piedmont University (S.S.), Athens, GA; The Emmes Company (A.G.M., C.A.B., C.R., A.C.), Rockville, MD; University of Cincinnati (J.C.), OH; University of Minnesota (A.K.B.), Minneapolis; University of Southern California (L.A.K.), Los Angeles; University of Washington (J.J.T.), Seattle; Wake Forest University (M.S.), Winston-Salem, NC; and University of Pittsburgh (P.B.P.), PA.",Not available
38810071,Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort.,2024-04-01,Galluzzo M; Moretta G; Campione E,"Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Universita Cattolica del Sacro Cuore, Rome, Italy.",Not available
38809358,Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance.,2024-01-01,Ishikawa Y; Shimono A,"Alexion Pharma GK, 3-1-1 Shibaura, Minato-Ku, Tokyo, 108-0023, Japan.","Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan. marus@med.nagoya-u.ac.jp."
38808617,Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology Platform.,2024-01-01,Brisander M; Liljebris C; Jesson G; Andersson P,"Xspray Pharma AB, Solna, Sweden.",Not available
38808312,Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review.,2024-01-01,Yeowell G; Miller E; Mbada C,"Department of Health Professions, Manchester Metropolitan University, Manchester M15 6BH, UK; iodeyemi@aol.com (I.O.).",clara.fatoye@oldham.ac.uk.
38807439,Graphitic Carbon Nitride as a Photocatalyst for Decarboxylative C(sp(2))-C(sp(3)) Couplings via Nickel Catalysis.,2024-08-12,Allmendinger S; Furegati M; Noel T,"Novartis Pharma AG, Fabrikstrasse, 4002, Basel, Switzerland.",Not available
38806495,"Mice with deficiency in Pcdh15, a gene associated with bipolar disorders, exhibit significantly elevated diurnal amplitudes of locomotion and body temperature.",2024-05-28,Kushima I,"Sumitomo Pharma Co., Ltd., Osaka City, Osaka Pref., Japan.","Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan. d-mori@med.nagoya-u.ac.jp."
38806456,An isoform quantitative trait locus in SBNO2 links genetic susceptibility to Crohn's disease with defective antimicrobial activity.,2024-05-28,Fairfax B,"Translational Bioinformatics, UCB Pharma, Slough, UK.","Translational Gastroenterology Unit, University of Oxford, Oxford, UK. dominik.aschenbrenner@novartis.com."
38806195,"Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.",2024-05-28,Poddubskaya E; Wyrwicz L; Fornaro L; Wang H; Li J; Sheng T,"Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.; BeiGene, Boston, MA, USA.; Narodowy Instytut Onkologii, Warsaw, Poland.; Vitamed, Moscow, Russia.",Not available
38806166,A Nanoplasmonic Assay for Point-of-Care Detection of Mannose-Binding Lectin in Human Serum.,2024-06-12,Garcia Barrientos A; Polito L; Duwe S,"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Mario Negri 2 20156, Milan, Italy.; Midatech Pharma PLC, Oddfellows House, 19 Newport Road, Cardiff CF24 0AA, U.K.",Not available
38806158,This Is What Metabolic Dysfunction-Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol.,2024-01-01,Fischer AM; Lechea N; Coxson HO,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.",Not available
38806089,Quantitative correlation of ENPP1 pathogenic variants with disease phenotype.,2024-01-01,Sabbagh Y,"Inozyme Pharma, 321 Summer St., Suite 400, Boston, MA 02201, USA.",Not available
38805213,"Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases.",2024-06-13,Mammoliti O; Martina S; Claes P; Coti G; Blanque R; Jagerschmidt C; Shoji K; Borgonovi M; De Vos S; Marsais F; Oste L; Quinton E; Lopez-Ramos M; Amantini D; Brys R; Jimenez JM; Galien R; van der Plas S,"Galapagos NV, Generaal De Wittelaan L11, A3, 2800 Mechelen, Belgium.; Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France.",Not available
38805052,Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.,2024-01-01,Lugaresi A; Maimone D; Lus G; Filippi M,"AORN San G. Moscati, Avellino, Italy.; ASST Lariana Ospedale S. Anna, Como, Italy.; Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.; Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.","Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy. emilio.portaccio@unifi.it."
38804962,Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance study.,2024-12-25,Diab R,"Patient Safety & Pharmacovigilance, Sanofi-Aventis (Schweiz) ag 3, Vernier, Switzerland.",Not available
38804813,A plain language summary of the perspectives of women who were interviewed about their experiences with uterine fibroids.,2024-01-01,Hunsche E; Rakov V; Scippa K; McKain L,"Endpoint Outcomes, Long Beach, CA, USA.; Myovant Sciences, Inc., Brisbane, CA, USA.; Sumitomo Pharma Switzerland GmbH, Basel, Switzerland.",Not available
38804596,Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study.,2024-01-01,Cruz AA; Bonini M,"CIBER Epidemiologia y Salud Publica (CIBERESP), Barcelona, Spain.; Ecole Polytechnique de Palaiseau, Palaiseau, France.",Not available
38803455,First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis.,2024-01-01,Ghia P; Allan JN; Szoke A; Abbazio C; Krigsfeld GS,"AbbVie Inc, North Chicago, Illinois, USA (Pharmacyclics LLC, an AbbVie Company) South San Francisco California USA.; Division of Experimental Oncology Universita Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele Milan Italy.; Weill Cornell Medicine New York New York USA.",Not available
38802636,Epidemiology and Treatment Patterns of Patients with Vitiligo: A Real-World Analysis.,2024-01-01,Harbers S,"AbbVie Inc., Toronto, Canada.",Not available
38802635,"Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study.",2024-01-01,Hunter G; Burke LK,"Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.",Not available
38802582,A plasma protein-based risk score to predict hip fractures.,2024-01-01,Gerszten RE,"5 Prime Sciences Inc, Montreal, Quebec, Canada.",Not available
38802435,In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study.,2024-05-27,Schneider T; Treskatsch S,"Division of Gastroenterology, Infectious Diseases, Rheumatology, Charite - Universitatsmedizin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat Zu Berlin, Campus Benjamin Franklin, 10117, Berlin, Germany.","Department of Anesthesiology and Intensive Care Medicine, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat Zu Berlin, Campus Benjamin Franklin, Berlin, Germany. stefan.angermair@charite.de."
38802053,Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial.,2024-01-01,Ward JH; Williamson KM,"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Duke Clinical Research Institute, Durham, NC, USA. Electronic address: marat.fudim@duke.edu."
38801999,Pathophysiology of cutaneous T-cell lymphomas: Perspective from a French referral centre.,2024-01-01,De Masson A; Moins-Teisserenc H; Bagot M; Battistella M; Bensussan A,"INSERM U1160, Institut de Recherche Saint-Louis, Paris, France; INSERM U976, Institut de Recherche Saint-Louis, Paris, France; Laboratoire d'Hematologie Biologique, Hopital Saint-Louis, Assistance Publique-Hopitaux de Paris, France.; Laboratoire de Pathologie, Hopital Saint-Louis, Assistance Publique-Hopitaux de Paris, France.; Mohammed VI Polytechnic University, Benguerir, Morocco.; Service de Dermatologie, Hopital Saint-Louis, Assistance Publique-Hopitaux de Paris, Centre coordinateur national du reseau de cancers rares INCa Lymphomes Cutanes, France; Universite Paris Cite, Paris, France; Universite Paris Cite, Paris, France.","Universite Paris Cite, Paris, France. Electronic address: adele.demasson@aphp.fr."
38801746,"SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.",2024-08-16,Baluch A; Howard DS; Ibrahim U; Auletta JJ,"Adaptive Biotechnologies Corporation, Seattle, Washington, USA.; Division of Hematology and Oncology, Wake Forest Baptist, Winston-Salem, North Carolina, USA.; The Emmes Company, Rockville, Maryland, USA.; The Leukemia and Lymphoma Society, Rye Brook, New York, New York, USA.",Not available
38801606,Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT.,2024-01-01,Deignan C; Amouzadeh H,"Amgen Inc, Thousand Oaks, CA, USA.","Sapporo Skin Clinic, Chuo-ku Minami 3 Jo Nishi 2-1-1 H&B Plaza Building 5F, Sapporo, Japan. masaabe@kojinkai.org."
38800336,In Vitro Wound Healing and Anticancer Effects of Ixora coccinea in Malignant Melanoma Cell Lines.,2024-01-01,Rajendran K,"Bioanalytics and Analytics, Scitus Pharma Services Pvt. Ltd., Chennai, IND.",Not available
38800095,Pathogenic hyperactivation of mTORC1 by cytoplasmic EP300 in Hutchinson-Gilford progeria syndrome.,2024-01-01,Djavaheri-Mergny M,"Faculte de Medecine, Universite de Paris Saclay, Paris, France.",Not available
38799652,Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in pancreatic cancer.,2024-06-20,Kondo J,"TME Therapeutics Inc., Minato-ku, Tokyo 105-0021, Japan.",Not available
38798920,Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction.,2024-01-01,Sarullo FM; Nugara C; Miani D; Driussi M; Carluccio E; Villani A; Degli Esposti L,"Cardiologia e Fisiopatologia Cardiovascolare, Azienda Ospedaliera Universitaria ""Santa Maria della Misericordia"", Perugia, Italy.; CliCon S.r.l., Bologna, Italy.; SOC Cardiologia, Dipartimento Cardiotoracico, Azienda Sanitaria Universitaria Friuli Centrale Ospedale S. Maria della Misericordia, Udine, Italy.; U.O.S.D. di Riabilitazione Cardiovascolare Ospedale Buccheri La Ferla Fatebenefratelli, Palermo, Italy.; UO Cardiologia, Dipartimento di Scienze Cardiovascolari, Neurologiche, Metaboliche, Istituto Auxologico Italiano IRCCS, Milano, Italy.",Not available
38798193,Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study.,2024-01-01,Yergeri MC,"BRYG Pharma Innovations Pvt. Ltd., Mumbai, India.",Not available
38797674,The Out-of-pocket Expenses of People With Tinnitus in Europe.,2024-11-05,Karydou K; Trochidis I; Bernal-Robledano A; Langguth B; Lugo A,"Instituto de Investigacion Biosanitaria ibs.GRANADA.; Sensorineural Pathology Programme, Centro de Investigacion Biomedica en Red en Enfermedades Raras, CIBERER.; ViLabs.",Not available
38797537,Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models.,2024-01-01,Weng J; Omori K; Sato Y; Nakazawa T; Suzuki T; Yamada T; Nakajo I; Kinugasa F; Tureci O; Sahin U; Yoshida T,"Astellas Pharma, Inc., Ibaraki, Japan.; Biontech SE, Mainz, Germany; Formerly of Astellas Pharma, Inc., Ibaraki, Japan.; Formerly of Ganymed Pharmaceuticals AG, Mainz, Germany; Helmholtz Institute for Translational Oncology (HI-TRON) By DKFZ, Johannes Gutenberg University, Mainz, Germany.","Astellas Pharma, Inc., Ibaraki, Japan. Electronic address: toshihide.nishibata@astellas.com."
38797389,"Clinical, sociodemographic and environmental predicting factors for relapse in bipolar disorder: A systematic review.",2024-09-01,Gimenez-Palomo A; Andreu H; Olivier L; Ochandiano I; de Juan O; Fernandez-Plaza T; Salmeron S; Colomer L; Mena JI; Vieta E; Pacchiarotti I,"Bipolar and Depressive Disorders Unit, Hospital Clinic de Barcelona, c. Villarroel, 170, 08036 Barcelona, Spain; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Departament de Medicina, Facultat de Medicina i Ciencies de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain.; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), c. Villarroel, 170, 08036 Barcelona, Spain; Institute of Neurosciences (UBNeuro), Spain; Institute of Neurosciences (UBNeuro), Spain.",Not available
38797087,"Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial.",2024-01-01,Banda N; Yadlapalli SSR; Narala A; Thatikonda R,"Leiutis Pharmaceuticals LLP, Plot No. 23, TIE 1st Phase, Balanagar, Hyderabad, Telangana 500037, India.","Asha Hospital, 443, Venkat Nagar, Banjara Hills, Hyderabad, Telangana 500034, India. Electronic address: prasad40@gmail.com."
38796907,Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan.,2024-01-01,Requena G; Rothnie KJ; Noorduyn SG,"Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main St W, Hamilton, Ontario, L8S 4L8, Canada.; Global Value Evidence and Outcomes, Epidemiology, GSK, 980 Great West Rd, Brentford, Middlesex, TW8 9GS, UK.; Value Evidence and Outcomes, 100 Milverton Drive, Suite 800, Mississauga, Ontario, L5R 4H1, Canada","Department of Respiratory Medicine, Kawasaki Medical School, 577, Matsushima, Kurashiki, Okayama, 701-0192, Japan. Electronic address: ogato@med.kawasaki-m.ac.jp."
38796666,Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial.,2024-01-01,Shimada F; Tajima T; Wroclawska M; Zeiser R,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma K.K., Tokyo, Japan.","Department of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan. teshima@med.hokudai.ac.jp."
38796655,IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.,2024-01-01,Chang AM; Heise M; Velkoska E; Clementi R; Mears J; Tricoci P,"CSL Behring, King of Prussia, PA, USA.; CSL Limited, Melbourne, Victoria, Australia.","Stanford University, Palo Alto, CA, USA. gchertow@stanford.edu."
38796541,Determinants of echocardiographic epicardial adipose tissue in a general middle-aged population - The Cardiovascular Risk in Young Finns Study.,2024-05-25,Pahkala K,"Orion Pharma, Turku, Finland.","Research Center of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. behfor@utu.fi."
38796287,Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial.,2024-01-01,Liu Y; Tecson K,"Oncology Biostatistics, Daiichi Sankyo, Basking Ridge.","Division of Hematology and Oncology, Fred Hutchinson Cancer Center, Seattle, USA. Electronic address: shurvitz@fredhutch.org."
38796193,"Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.",2024-01-01,Thieblemont C,"Service d'hemato-oncologie, Assistance Publique-Hopitaux de Paris, Hopital Saint Louis, Paris, France.; Universite Paris Cite, Paris, France","Service d'Hematologie Lymphoide, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Creteil, France. Electronic address: jehan.dupuis@aphp.fr."
38796134,Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples.,2024-01-01,Mancuso F,"Ingegnerie Toscane - Area R&D, Via Bellatalla, 1, Pisa (PI) 56121, Italy.",Not available
38795793,Framework of the strengths and challenges of clinically integrated trials: An expert panel report.,2024-01-01,Roessig L; Schofield L,"Bayer AG, Wuppertal, Germany.; Novartis Pharmaceuticals Corporation, East Hanover, NJ.",Not available
38795716,"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.",2024-06-08,Rolleri R; Joshi P; Dokhe P; Muller E; Peterson L; Madden C; Bari M,"UCB Pharma, Morrisville, NC, USA.; UCB Pharma, Slough, UK.","Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: clears@bidmc.harvard.edu."
38795690,Deep learning ensembles for detecting brain metastases in longitudinal multi-modal MRI studies.,2024-01-01,Kucharski D; Nalepa J,"Graylight Imaging, Gliwice, Poland","Graylight Imaging, Gliwice, Poland. Electronic address: bmachura@graylight-imaging.com."
38795223,Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.,2024-01-01,Tormakangas O; Kuokkanen K; Messinger J,"Orion Pharma, Orion Corporation, Tengstrominkatu 8, FI-20360 Turku, and Orionintie 1A, Espoo, FI- 02200, Finland.",Not available
38795214,Simultaneous quantification of terpenes and cannabinoids by reversed-phase LC-APCI-MS/MS in Cannabis sativa L. samples combined with a subsequent chemometric analysis.,2024-01-01,Poetzsch M,"Swiss Drug Testing GmbH, Technoparkstrasse 2, CH-8406, Winterthur, Switzerland.",Not available
38794986,Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus.,2024-01-01,Kochi K,"Data Science, Sumitomo Pharma Co., Ltd., Tokyo, Japan.",Not available
38794340,Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets.,2024-05-17,Sandler Topelius N; Bahman M; Hassinen N; Verma S; Hrizanovska L; Lass J; Paaver U; Tahnas J; Kammonen K; Griesser U; Thalmeier A; Khoukh K,"CurifyLabs Oy, Salmisaarenaukio 1, 00180 Helsinki, Finland.; Hietalahden Apteekki, 65130 Vaasa, Finland.; Landeskrankenanstalten-Betriebsgesellschaft-KABEG (Klagenfurt), 9020 Klagenfurt am Worthersee, Austria.; Universitatsklinikum Halle (Saale), 06120 Halle (Saale), Germany.; Universitatsklinikum Magdeburg A.o.R., 39120 Magdeburg, Germany.",Not available
38794266,Characterization of Surfactant Spheroidal Micelle Structure for Pharmaceutical Applications: A Novel Analytical Framework.,2024-04-29,De Caro L; Stoll T; Gozzo F; Giannini C,"Excelsus Structural Solutions (Swiss) AG, Park Innovaare, Parkstrasse 1, 5234 Villigen, Switzerland.; Istituto di Cristallografia, Consiglio Nazionale delle Ricerche, Via Amendola 122/O, 70125 Bari, Italy.",Not available
38794123,Comparative Investigation of pH-Dependent Availability of Pancreatic Enzyme Preparations In Vitro.,2024-04-25,Todd A; Bennett-Huntley E,"Viatris/Mylan Pharma UK Ltd., Sandwich CT13 9ND, UK.",Not available
38792559,"Correction: Colombatti et al. Systematic Literature Review Shows Gaps in Data on Global Prevalence and Birth Prevalence of Sickle Cell Disease and Sickle Cell Trait: Call for Action to Scale Up and Harmonize Data Collection. J. Clin. Med. 2023, 12, 5538.",2024-05-14,Hegemann I,"Novo Nordisk Pharma AG, 8058 Zurich, Switzerland.",Not available
38792492,Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review.,2024-05-17,Levy B,"Service de Medecine Intensive et Reanimation Brabois, CHRU Nancy, Pole Cardio-Medico-Chirurgical, Universite de Lorraine, 54511 Vandoeuvre-les-Nancy, France.",Not available
38792382,Leukocytospermia and/or Bacteriospermia: Impact on Male Infertility.,2024-05-11,Henkel R,"LogixX Pharma Ltd., Merlin House, Brunel Road, Theale, Reading RG7 4AB, UK.",Not available
38792348,Survey on Actual Management of Osteoporosis with the Japanese Medical Data Vision Database in Elderly Patients Undergoing Spinal Fusion.,2024-05-10,Yamamoto K; Tanaka S,"Pharmaceutical R&D Business and Strategy Division, Musculoskeletal Pharmaceutical Brand Strategy, Asahi Kasei Pharma Corporation, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006, Japan.",Not available
38792324,Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naive Patients from the Gaucher Outcome Survey (GOS) Registry.,2024-05-09,Fernandez-Sasso D; Giraldo P,"En el Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Raras, IIS Aragon, C. de San Juan Bosco 13, 50009 Zaragoza, Spain.; Instituto William Osler, Paraguay 2935, Buenos Aires C1425 BRI, Argentina.",Not available
38792289,Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review.,2024-05-07,Zimmerman A; Laitman A,"Salix Pharmaceuticals, Bridgewater, NJ 08807, USA.; West Forsyth Pain Management, Winston Salem, NC 27103, USA.",Not available
38792258,"Opportunities, Challenges, and Scientific Progress in Hemp Crops.",2024-05-20,Hoeng J,"Vectura Fertin Pharma, 4058 Basel, Switzerland.",Not available
38791999,Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database.,2024-05-18,Hedges D,"Aster Insights, Hudson, NY 13610, USA.",Not available
38791981,Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study.,2024-05-16,Kawai D; Mitsuda Y; Sakashita N,"Eisai Co., Ltd., 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan.; Medilead, Inc., 24F Tokyo Opera City Tower, 3-20-2, Nishishinjyuku, Shinjyuku-ku, Tokyo 163-1424, Japan.",Not available
38791952,Heterogeneous Profile of ROR1 Protein Expression across Tumor Types.,2024-05-15,Waldmeier L,"NBE-Therapeutics AG, 4057 Basel, Switzerland.",Not available
38791249,Investigating Distinct Skin Microbial Communities and Skin Metabolome Profiles in Atopic Dermatitis.,2024-05-10,Jung ES; Sim I,"HEM Pharma Inc., Suwon 16229, Gyeonggi, Republic of Korea.",Not available
38790994,The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure.,2024-05-08,Klank D; Hoffmann M; Paschka P; Bergner R,"Medizinische Klinik A, Klinikum der Stadt Ludwigshafen gGmbH, Bremserstrasse 79, 67063 Ludwigshafen, Germany.",Not available
38790705,Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders.,2024-05-14,Nikolic N,"Goodwill Pharma d.o.o, 24000 Subotica, Serbia.",Not available
38790635,"Efficacy and Safety of Coenzyme Q10 Supplementation in Neonates, Infants and Children: An Overview.",2024-04-26,Mantle D,"Pharma Nord (UK) Ltd., Morpeth, Northumberland NE61 2DB, UK.",Not available
38790057,Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells.,2024-05-24,Luo Q; Shi M,"Ascentage Pharma (Suzhou) Co, Ltd, Suzhou, Jiangsu Province, China.",Not available
38789724,A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency.,2024-05-24,Yokoi A; Doi T; Yamamoto N; Mano H,"Eisai Co., Ltd, 5-1-3 Tokodai, Tsukuba-shi, Ibaraki, 300-2635, Japan.; Eisai Inc., 200 Metro Blvd., Nutley, NJ, 07110, USA.","Division of Cellular Signaling, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. skohsaka@ncc.go.jp."
38789635,"Safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 685509, a soluble guanylyl cyclase activator, in healthy volunteers: Results from two randomized controlled trials.",2024-01-01,Bauer V; Giessmann T; Schulze F,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an Der Riss, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.","Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, 06877, USA. diane.wong@boehringer-ingelheim.com."
38787533,Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy.,2024-08-01,Aerts I; Laghouati S; Abbou S,"Pediatric Oncology and Hematology, CHU Jean-Minjoz, Besancon, France.; Pediatric Oncology, CHU Dijon-Bourgogne, Dijon, France.; Service d'oncologie Pediatrique du CHRU de Nancy, Hopital d'enfants, Vandoeuvre, France.",Not available
38787505,"Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey.",2024-01-01,Kim J,"Biostatistics, Astellas Pharma Global Development, Northbrook, Illinois, USA.",Not available
38787476,Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data.,2024-01-01,Soliman AM; Manz KC; Weber V; Mocek A; Hoer A,"Abbvie Inc, North Chicago, USA.; IGES Institut GmbH, Berlin, Germany.","Clinical Research Division, Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt/Main, University of Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. andreas.pinter@kgu.de."
38785922,Fundus Autofluorescence in Posterior and Panuveitis-An Under-Estimated Imaging Technique: A Review and Case Series.,2024-04-25,Wintergerst MWM,"Charite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, 13353 Berlin, Germany.",Not available
38785561,Polyhexamethylene Biguanide Reduces High-Risk Human Papilloma Virus Viral Load in Cervical Cell Samples Derived from ThinPrep Pap Test.,2024-05-17,Di Fraia L; Babalini C; Di Fraia P,"Di Fraia Laboratori s.r.l., 00034 Colleferro, Italy.",Not available
38785465,"New Anticancer Drugs: Reliably Assessing ""Value"" While Addressing High Prices.",2024-04-28,Sehdev S; Ramsay T; Jiang DM,"Life Saving Therapies Network, Ottawa, ON K1H 5E6, Canada.",Not available
38785393,Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study.,2024-05-24,Ecochard L; Snellman J; Wen S; Yin F; Yu S,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
38785352,A Novel image processing technique for weighted particle size distribution assessment.,2024-01-01,Pazhayattil AB; Turner S; Talwar N,"Capcium Inc., Pointe-Claire, Quebec, Canada.; Itaan Pharma Inc., Frederick, MD, USA.",Not available
38784820,Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.,2024-01-01,Llibre-Guerra JJ; Edwards L; Li Y; Rosen HJ,"The Dominantly Inherited Alzheimer Network (DIAN), St Louis, MO 63108, USA.",Not available
38783176,"Effect of degalactosylated bovine glycoprotein formulations MAF and M small es, Cyrillicapsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial.",2024-05-23,Martynenko K; Veklych Z,"Saisei Pharma, Osaka, Japan.",Not available
38783013,Cross-sectional study on exercise-related skin complaints among sports students at two German universities.,2024-05-23,Klenk A,"Dr. Kurt Wolff GmbH & Co. KG, 33611, Bielefeld, Germany.","Institute of Social Medicine and Health Systems Research, University of Magdeburg, Leipziger Str. 44, 39210, Magdeburg, Germany. karl-philipp.drewitz@med.ovgu.de."
38782549,Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.,2024-08-27,Ekoka Omoruyi EV; Rajendran V; Van Hoek P; Van Beneden K,"Galapagos NV, Mechelen, Belgium.","Charite - Universitatsmedizin Berlin, Berlin, Germany gerd.burmester@charite.de."
38782481,"Swallowed topical steroid therapy for eosinophilic oesophagitis in children: practical, evidence-based guidance by the BSPGHAN Eosinophilic Oesophagitis Working Group.",2024-05-23,Cordell A,"Eosinophilic Family Coalition, London, UK.",Not available
38782234,Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach.,2024-01-01,Bernier T; Clemann N; Linker F; Pfister T; Schwind M,"Abbott Laboratories GmbH, 31535, Neustadt Am Rubenberge, Germany.; F. Hoffmann-La Roche Ltd, 4070, Basel, Switzerland.; Grunenthal GmbH, Zieglerstrasse 6, 52078, Aachen, Germany.; Sanofi-Aventis Deutschland GmbH, 65926, Frankfurt, Germany.","Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach, Germany. Electronic address: claudia.sehner@boehringer-ingelheim.com."
38782015,"Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.",2024-01-01,Hansen T; Geist MA; Blaettler T; Bennett R; Dang H; Sundgreen C,"Orphazyme, Copenhagen, Denmark.","Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: mbenatar@miami.edu."
38781544,Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer.,2024-01-01,Nevalaita L; Ikonen T,"Orion Corporation, Orion Pharma, Espoo, Finland.",Not available
38781542,Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma.,2024-01-01,Iwata KK; Moran D; Elsouda D; Guerrero A,"Astellas Pharma, Inc, Northbrook, IL.",Not available
38781315,Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis.,2024-09-10,Wun CC; Munugalavadla V,"AstraZeneca, South San Francisco, CA.",Not available
38780927,Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.,2024-07-01,Awan M,"Astellas Pharma Global Development Inc, Northbrook, Illinois.",Not available
38780469,Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models.,2024-08-01,Ohnstedt E; Parv K; Pang Y; Lofton Tomenius H; Carrasco Lopez M; Choi J; Roos S; Vagesjo E,"Ilya Pharma AB, Uppsala, Sweden.",Not available
38780059,Serum hydroxysteroid (17beta) dehydrogenase 1 concentration in pregnant women correlates with pregnancy-associated plasma protein A but does not serve as an independent marker for preeclampsiadagger.,2024-08-15,Biehl A; Hamalainen E,"Forendo Pharma, Turku, Finland.",Not available
38779376,Putting the Formulation Back in Foam: Optimizing Seborrheic Dermatitis Treatment Across Diverse Hair Types.,2024-01-01,Burnett P; Hanna D,"Drs. Hanna and Burnett are with Arcutis Biotherapeutics, Inc. in Westlake Village, California.",Not available
38779000,Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.,2024-05-30,Ibanez-Prada ED,"Universidad de La Sabana, Chia, Colombia.",Not available
38778549,Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure.,2024-01-01,Wu J; Vranic I,"Pfizer Inc, Groton, Connecticut, USA.; Pfizer Inc, Tadworth, UK.",Not available
38778404,"Progressive Supranuclear palsy (PSP) disease progression, management, and healthcare resource utilization: a retrospective observational study in the US and Canada.",2024-05-23,Fryk H; Klein A; Gasalla T; Scowcroft A,"UCB Pharma, Brussels, Belgium.",Not available
38778353,Combining plasma Abeta and p-tau217 improves detection of brain amyloid in non-demented elderly.,2024-05-23,Iaccarino L; Pontecorvo MJ; Hansson O; Iwatsubo T,"Eli Lilly and Company, Indianapolis, USA.",Not available
38778104,Structural insights into the cross-exon to cross-intron spliceosome switch.,2024-01-01,Stark H,"Vincerx Pharma, Monheim am Rhein, Germany.",Not available
38778101,Selective haematological cancer eradication with preserved haematopoiesis.,2024-01-01,Dell' Aglio A; Jeker LT,"Cimeio Therapeutics, Basel, Switzerland.",Not available
38777937,Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch.,2024-01-01,Sabatino S; Grond S; Koppelhus U; Elrayes M; Chen YF; Liu C,"Eli Lilly and Company, Indianapolis, IN, USA.; TigerMed-BDM Inc, Somerset, New Jersey, USA.",Not available
38777726,Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.,2024-01-01,Maddalena G; Intini R; Murtaza Kasi P; Lonardi S,"Istituto Oncologico Veneto, IRCCS, Padua, Italy.; Weill Cornell Medicine, New York, NY.",Not available
38777513,Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review.,2024-05-28,Fuster V; Fuster JJ; Ibanez B,"CIBER en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain; CIBER en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Mount Sinai Fuster Heart Hospital, New York, New York, USA.","Department of Cardiothoracic Anesthesiology, Rigshospitalet University Hospital Copenhagen, Copenhagen, Denmark. Electronic address: rvn@novo.dk."
38777240,Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment.,2024-01-01,Ether N; Foley CM; Kleiman R; Koshman Y; Leishman D; Martel E; Nichols JV; Popp J; Rajamani S; Riley S; Vargas HM,"AbbVie, North Chicago, IL, USA.; Amgen Inc., Thousand Oaks, CA, USA.; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Clario, Philadelphia, PA, USA.; Eli Lilly and Company, Indianapolis, IN, USA.; Johnson & Johnson Innovative Medicine, CA, USA.; Labcorp, Madison, WI, USA.; Pfizer, Groton, CT, USA.","Pfizer, Groton, CT, USA. Electronic address: todd.a.wisialowski@pfizer.com."
38777187,Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.,2024-01-01,Brown PM; Rubenstein DS; Piscitelli SC; Somerville MC; Tallman AM,"Dermavant Sciences, Inc, Morrisville, North Carolina.","The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia. Electronic address: Jonathanisilverberg@gmail.com."
38777127,Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trial.,2024-01-01,Mattheus M; Hantel S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.","Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA. Electronic address: silvio.inzucchi@yale.edu."
38776926,"The impact of inversions across 33,924 families with rare disease from a national genome sequencing project.",2024-06-06,Calpena E,"Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK; Grupo de Investigacion en Biomedicina Molecular, Celular y Genomica, Unidad CIBERER (CB06/07/1030), Instituto de Investigacion Sanitaria La Fe (IIS La Fe), Valencia, Spain.","Oxford Biomedical Research Centre, Centre for Human Genetics, University of Oxford, Oxford, UK. Electronic address: alistair@well.ox.ac.uk."
38776832,"Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.",2024-08-20,Takada Y; Honda S; Oyamada Y,"AlphaNavi Pharma Inc., Osaka, 564-0053, Japan.; Global Corporate Strategy, Sumitomo Pharma Co., Ltd., Tokyo, 104-8356, Japan.; Pharmacology Research Unit, Research Division, Sumitomo Pharma Co., Ltd., Osaka, 554-0022, Japan; Sumika Chemical Analysis Service, Ltd., Osaka, 554-0022, Japan.","Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Kobe, 650-0047, Japan. Electronic address: tatsuya.kamei@sumitomo-pharma.co.jp."
38776599,Lower arterial cerebral blood flow is associated with worse neuroinflammation and immunomodulation composite proteomic scores.,2024-01-01,Qureshi F; Keshavan A; Leyden K; Jalaleddini K; Ghoreyshi A,"Octave Bioscience, Menlo Park, CA, USA.","Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA. Electronic address: djakimovski@bnac.net."
38776484,Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.,2024-07-20,DiSilvestro PA; Mathews CA; Gill SE; Aghajanian C,"Gynecologic Oncology, SJC Oncology Services-Georgia, LLC, Savannah, GA.; Mersana Therapeutics, Cambridge, MA.; Women & Infants Program in Women's Oncology, Providence, RI.",Not available
38776146,One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.,2024-05-20,Chehab BM; Krucoff MW,"Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.; Segeberger Kliniken GmbH, Herzzentrum, Bad Segeberg, Germany.",Not available
38776083,Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Across Mental Disorders: A Systematic Review and Dose-Response Meta-Analysis.,2024-05-01,Aleman A,"Departamento e Instituto de Psiquiatria da Faculdade de Medicina da Universidade de Sao Paulo, Universidade de Sao Paulo, Brazil.",Not available
38775925,Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.,2024-01-01,Zimmermann L; Valluri U; Siddiqui E,"Astellas Pharma Europe Ltd., 300 Dashwood Lang Road, Bourne Business Park, Addlestone, KT15 2NX, UK.; Astellas Pharma Global Development, Inc., Northbrook, IL, USA.; Astellas Pharma GmbH Deutschland, Munich, Germany.","Astellas Pharma Europe Ltd., 300 Dashwood Lang Road, Bourne Business Park, Addlestone, KT15 2NX, UK. antonia_morga@astellas.com."
38775839,Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study.,2024-10-03,Manghisi B; Monaco MR; Sacco GGA,"Hematology Division, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.",Not available
38775746,Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis.,2024-07-01,Kanazawa Y; Morikawa A,"Pharma Brie, Sendai, Miyagi, Japan.",Not available
38775029,"Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study.",2024-09-18,Frysz M; Patel S; Li MOY,"Boehringer Ingelheim Ltd, Bracknell, UK.",Not available
38774583,An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development.,2024-06-13,Schimek A; Ng JKM; Basbas I; Martin F; Xin D; Saleh D,"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach, Germany.; Boehringer Ingelheim Pharmaceuticals Inc, 900 Ridgebury Road, Ridgefield, CT 06877, USA.; ViraTherapeutics GmbH, Bundesstrasse 27, 6063 Rum, Austria.",Not available
38774565,"Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, Sao Paulo, 2023.",2024-01-01,Resende H; Teich NLS; Dallari AB; Bonilha LAS; Francisco FR; Munhoz RR; Werutsky G; Madi M; Arruda L,"Agencia Nacional de Vigilancia Sanitaria - Anvisa, Brasilia 71205-050, DF, Brazil.; Bristol Myers Squibb, Sao Paulo 04719-002, SP, Brazil.; Comissao Nacional de Etica em Pesquisa (CONEP), Brasilia 70719-040, DF, Brazil.; Independent Lawyer, Sao Paulo 01153-000, SP, Brazil.; Instituto Projeto Cura, Sao Paulo 05507-020, SP, Brazil.; Instituto Teich de Politicas Publicas em Saude, Rio de Janeiro 22640-102, RJ, Brazil.; Latin American Cooperative Oncology Group (LACOG), Porto Alegre 90619-900, RS, Brazil.",Not available
38774416,Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer.,2024-01-01,Nogareda-Seoane Z,"Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.",Not available
38774343,Improving systemic therapy selection for inflammatory skin diseases: A clinical need survey.,2024-01-01,Siegel JJ; Hurton LV; Goldberg MS; Lio PA,"Castle Biosciences, Inc, Friendswood, Texas.",Not available
38774037,Improvement in sleep latency with extended-release once-nightly sodium oxybate for the treatment of adults with narcolepsy: Analysis from the phase 3 REST-ON clinical trial.,2024-01-01,Gudeman J,"Avadel Pharmaceuticals, Chesterfield, MO, USA.",Not available
38773593,Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis.,2024-05-21,Sambevski S,"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.","Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, #6016U, Boston, MA, 02115, USA. jsparks@bwh.harvard.edu."
38773563,"Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study.",2024-05-21,Lafferty KP; Chan D; Chakravarty SD; Krol Y; Gottlieb AB,"Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USA.","University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Alexis.Ogdie@pennmedicine.upenn.edu."
38773354,"A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study.",2024-01-01,Loughrey CM; Hasunuma T; Otani N; Kayley S; Hirano S; Kitai T; Kumagai Y,"AETAS Pharma Co., Ltd., Tokyo, Japan.; Chemical R&D Division, Spera Pharma, Inc., Osaka, Japan.",Not available
38773351,The state of the art in secondary pharmacology and its impact on the safety of new medicines.,2024-01-01,Jenkinson S; Brown A; Delaunois A; Dumotier B; Rao M; Ribeiro LR; Sibony A; Timsit Y; Lagrutta A; Mittlestadt SW; Peri R; Roberts S; Valentin JP,"Armstrong Pharmacology, Macclesfield, UK.; Blueprint Medicines, Cambridge, MA, USA.; GSK, Stevenage, UK.; GSK, Waltham, MA, USA.; Metrion Biosciences, San Diego, CA, USA.; Neurocrine Biosciences, San Diego, CA, USA.; Pfizer, La Jolla, CA, USA.; Sanofi, Frankfurt, Germany.; Takeda Pharmaceuticals, Cambridge, MA, USA.; UCB Biopharma, Braine-l'Alleud, Belgium.; Vertex Pharmaceuticals, Boston, MA, USA.","Sanofi, Cambridge, MA, USA. richbrennan@gmail.com."
38772401,"Multimodal wearable EEG, EMG and accelerometry measurements improve the accuracy of tonic-clonic seizure detection.",2024-06-07,Paesschen WV,"Epilepsy Seizure Detection-Neurology UCB Pharma, Brussels, Belgium.",Not available
38772220,Restless legs symptoms increased during COVID-19 pandemic. International ICOSS-survey.,2024-01-01,Gennaro L,"Department of Psychology, Sapienza University of Rome, Roma, Lazio, Italy; IRCCS Fondazione Santa Lucia, Roma, Italy.","Helsinki Sleep Clinic, Terveystalo Healthcare, Helsinki, Finland. Electronic address: eemil.partinen@helsinki.fi."
38772058,"Enlarged perivascular spaces and their association with motor, cognition, MRI markers and cerebrovascular risk factors in male fragile X premutation carriers.",2024-06-15,Rodriguez-Revenga L,"Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, Barcelona, Spain; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain","Genetics Doctorate Program, Universitat de Barcelona (UB), Barcelona, Spain. Electronic address: aelias@mutuaterrassa.cat."
38771995,Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.,2024-08-10,Bowles J; Alfaro TD; Wu J; Gao M; Slimane K,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ.",Not available
38771475,Safety of Empagliflozin: An Individual Participant-Level Data Meta-Analysis from Four Large Trials.,2024-01-01,Schueler E; Soares AR,"Eli Lilly and Company, Lisbon, Portugal.; Mainanalytics GmbH, Sulzbach, Germany.","University Hospital Wurzburg, Wurzburg, Germany. Wanner_C@ukw.de."
38770047,Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.,2024-01-01,Isaacson SH; Abler V,"Acadia Pharmaceuticals Inc, 12830 El Camino Real, San Diego, CA 92130, USA.; Parkinson's Disease and Movement Disorders of Boca Raton, 951 NW 13th Street, Bldg. 5-E, Boca Raton, FL 33486, USA.",Not available
38769981,Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry.,2024-01-01,D Kou T,"Worldwide Patient Safety, Bristol Myers Squibb, Princeton, NJ.",Not available
38769747,"Safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of olamkicept: Results from randomized, placebo-controlled, first-in-human phase I trials.",2024-01-01,Falahati A,"Global Biometrics, Ferring Pharmaceuticals, Kastrup, Denmark.",Not available
38769334,Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality.,2024-05-20,Badimon L; Padro T; Benczik B; Agg B; Ferdinandy P; Fagherazzi G; Ollert M,"CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.; Cardiovascular Program-ICCC, Institut d'Investigacio Biomedica Sant Pau (IIB SANT PAU); Firalis SA, Huningue, France.; HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; Pharmahungary Group, Szeged, Hungary.","Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg. yvan.devaux@lih.lu."
38769309,Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.,2024-05-20,Gehman VM; Becich M; Katrib A,"Octave Bioscience, Inc, Menlo Park, CA, USA.",Not available
38769296,Production of deoxycholic acid by low-abundant microbial species is associated with impaired glucose metabolism.,2024-05-20,Wu H,"Chan Zuckerberg Biohub, San Francisco, CA, USA.",Not available
38769202,The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.,2024-01-01,Houlden H,", Buffalo, NY, USA.","Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA. mbenatar@miami.edu."
38769156,Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis.,2024-01-01,Nagira Y; Kubota-Ishida N; Chikada T; Tabata Y; Maebashi K,"Meiji Seika Pharma Co., Ltd., Tokyo, Japan.","Meiji Seika Pharma Co., Ltd., Tokyo, Japan. naomi.masuda@meiji.com."
38769083,Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.,2024-01-01,Kirschner U; Kahn M; Papukchieva S; Stosio K; Keis A; Biermann MHC; Hausser-Fruh G; Sturm L; Eberl M; Friedrich B,"Haut- und Venenzentrum Mainz, Dr. med. Uwe Kirschner and Colleagues, Mainz, Germany.; Novartis Pharma GmbH, Nuremberg, Germany.; Temedica GmbH, Munich, Germany.",Not available
38768693,The impact of sinkers on coning issues exhibited by tablets in USP2 dissolution apparatus.,2024-06-25,Terashima H,"Biopharmaceutics, Pharmaceutical R&D, CMC & Production, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan","Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan. Electronic address: h.terashima@ono-pharma.com."
38768668,Effects of induced arterial hypertension for vasospasm on unruptured and unsecured cerebral aneurysms (growth and rupture). A retrospective case-control study.,2024-01-01,Constant Dit Beaufils P; Autrusseau F; Bourcier R,"Institut du Thorax, Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite de Nantes, Nantes F-44093, France; Institut du Thorax, Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite de Nantes, Nantes F-44093, France.; Nantes Universite, CHU Nantes, Pole Hospitalo-Universitaire 11: Sante Publique, Clinique des donnees, INSERM, CIC 1413, F-44000 Nantes, France; Nantes Universite, CHU Nantes, Service de neuroradiologie diagnostique et interventionnelle, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France; Nantes Universite, CHU Nantes, Service de neuroradiologie diagnostique et interventionnelle, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.; Nantes Universite, LTeN, UMR 6607, Ecole Polytechnique de L'Universite de Nantes, Nantes, France.",Not available
38768429,A novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm.,2024-07-23,Zmajkovicova K; Pawar S; Nguyen C; Monticelli H; Maier-Munsa S; Chen K; Sleasman JW,"Formerly X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.; X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.; X4 Pharmaceuticals, Boston, MA.",Not available
38768422,New Generation Nebulizers.,2024-01-01,Knoch M,"PARI Pharma GmbH, Starnberg, Germany (Emeritus); R&D and President.",Not available
38768337,EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.,2024-07-25,Bueno OF; McFadden I; Oprea C; Ross JA; Talpes M; Zhang R,"AbbVie, North Chicago, IL.; Amgen, Thousand Oaks, CA.; Sanofi, Vitry-sur-Seine, France.",Not available
38767967,Evaluation of the Treatment Duration of Japanese Patients With Pancreatic Cancer in a Real-World Setting Using a Large Hospital Claims Database: The SUISEI Study.,2024-07-01,Nii M,"Biometrics, R&D, AstraZeneca K.K., Osaka.",Not available
38766628,Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials.,2024-01-01,Novalbos J,"Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.",Not available
38765989,Renalase Levels are Decreased in Maternal Blood and Placental Tissues in Pregnancies Associated with Preterm Preeclampsia.,2024-05-06,Silva T,"Internal Medicine, New Haven, CT, USA.",Not available
38765567,Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study.,2024-01-01,Rote W; Murphy E; Bedard PW; Roth S; Bieler S; Komers R,"JAMCO Pharma Consulting, Stockholm, Sweden.; Travere Therapeutics Inc., San Diego, California, USA.",Not available
38764525,"Synthetic Marijuana: Assessment of Usage, Motivation and Associated Risks in Adolescent Substance Users.",2024-01-01,Jernigan A,"Gaudenzia, Inc., Harrisburg, PA, USA.",Not available
38763320,Spatially resolved distribution of pancreatic hormones proteoforms by MALDI-imaging mass spectrometry.,2024-01-01,Mohana-Borges R,"Laboratorio de Biotecnologia e Bioengenharia Estrutural (LABGENEST), Instituto de Biofisica Carlos Chagas Filho (IBCCF), Rio de Janeiro, RJ, 21941-902, Brazil","Programa de Pos-Graduacao Em Quimica Biologica, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, RJ, 21941-902, Brazil. Electronic address: Thay.Sisnande@gmail.com."
38763104,Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer.,2024-01-01,Mark M; Bearz A; Moro-Sibilot D; Tiedt R,"Centro di Riferimento Oncologico-IRCCS, Aviano, Italy.; Division of Oncology/Hematology, Kantonsspital Graubuenden, Chur, Switzerland; Novartis Pharma AG, Basel, Switzerland.; Thoracic Oncology, CHU Grenoble-Alpes, Grenoble, France.; Universita della Svizzera Italiana, Lugano, Switzerland.","Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Universitat Autonoma de Barcelona, Spain. Electronic address: efelip@vhio.net."
38762820,"Safety, efficacy, and reliability evaluation ofa novel small-diameter defibrillation lead: Global LEADR pivotal trial results.",2024-01-01,West MB; Carta R; Himes AK; Platner ML; Thompson AE,"Medtronic, Inc, Minneapolis, Minnesota.; Presbyterian Heart Group, Albuquerque, New Mexico.",Not available
38762797,Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial.,2024-08-06,De Salvo MC; Zhang X; Seid LL; Poole L,"FibroGen Inc, San Francisco, California.; Fundacion Respirar-Centro Medico, Buenos Aires, Argentina.",Not available
38762719,Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.,2024-05-18,Connelly MA,"Labcorp, Morrisville, NC, 27560, USA.",Not available
38762535,The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses.,2024-05-18,McIntosh AM; Yusuf S; Pare G,"Bayer AG, Pharmaceuticals, R&D, 42113, Wuppertal, Germany.; Nxera Pharma UK Limited, Cambridge, UK.","Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, ON, Canada. r.walker4@exeter.ac.uk."
38762390,WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography.,2024-01-01,Barr RG,"Department of Radiology, Northeastern Ohio Medical University, Rootstown, Ohio, USA; Southwoods Imaging, Youngstown, Ohio, USA.","Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy. Electronic address: giovanna.ferraioli@unipv.it."
38762217,Tyrosine kinase inhibitors in cancers: Treatment optimization - Part I.,2024-01-01,Combarel D,"Service de Pharmacocinetique, Faculte de Pharmacie, Universite Paris Saclay, Chatenay-Malabry 92 296, France.; Service de Pharmacologie, Departement de Biologie et Pathologie medicales, Gustave Roussy, Villejuif 94805, France",Not available
38762081,Hypothermia in patients with cardiac arrest prior to ECMO-VA: Insight from the HYPO-ECMO trial.,2024-01-01,Levy B; Combes A; Kimmoun A,"INSERM U1116, Faculte de Medecine, Vandoeuvre-les-Nancy, France; Medecine Intensive et Reanimation, CHRU Nancy, Pole Cardio-Medico-Chirurgical, Vandoeuvre-les-Nancy, France; Service de Medecine Intensive-Reanimation, Institut de Cardiologie, APHP Sorbonne Universite Hopital Pitie-Salpetriere, Paris, France.; Sorbonne Universite, INSERM, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, Paris, France; Universite de Lorraine, Nancy, France.","Universite de Lorraine, Nancy, France. Electronic address: blevy5463@gmail.com."
38762057,ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies.,2024-01-01,Farnia S,"Nimitt Consulting, Madison, Wisconsin.","St Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: rebecca.gardner@stjude.org."
38761014,"First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor.",2024-01-01,Lestini G; Liu X; Velinova M; Denney WS; Fu Y; Opipari A; Dean D,"Human Predictions LLC, Cambridge, Massachusetts, USA.; ICON plc, Groningen, The Netherlands.; IFM Therapeutics, Boston, Massachusetts, USA.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
38760098,Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.,2024-01-01,She D; Rees W; Smith M; Cimbora D; Katz E,"Horizon Therapeutics/Amgen, Deerfield, IL, USA.","Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: bruce.cree@ucsf.edu."
38759907,OCT-Guided vs Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy.,2024-07-23,Fabbiocchi F; McGreevy RJ; McNutt RW; Nie H; Phalakornkule K; Buccola J,"Abbott Vascular, Santa Clara, California, USA.; Centro Cardiologico Monzino IRCCS, Milano, Italy.",Not available
38759899,Comprehensive analysis and characterization of glycan pairing in therapeutic antibodies and Fc-containing biotherapeutics: Addressing current limitations and implications for N-glycan impact.,2024-01-01,Meudt M; Baumeister J; Blech M,"Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany; Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Institute of Analytical and Bioanalytical Chemistry, Ulm University, Ulm, Germany.; Institute of Pharmaceutical Biotechnology, Ulm University, Ulm, Germany.",Not available
38759740,A modified Kushner-Moore approach to characterising small-scale blender performance impact on tablet compaction.,2024-06-25,Reynolds G; Meir B; Fathollahi S,"DFE Pharma GmbH & Co. KG, Kleverstrasse 187, 47568 Goch, Germany.; Gericke AG, Althardstrasse 120, CH-8105 Regensdorf, Switzerland.; Oral Product Development, PT&D, Operations, AstraZeneca UK Limited, Charter Way, Macclesfield SK10 2NA, UK.",Not available
38759121,Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.,2024-07-10,Hall WA,"Kaiser Permanente Northern California, Santa Clara, CA.",Not available
38758589,"RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine.",2024-06-19,Bryson N; Alexander R,"Reunion Neuroscience, Inc., Toronto, Ontario M5V 2C3, Canada.",Not available
38758509,Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden.,2024-01-01,Berling P; Charokopou M,"UCB Pharma, Brussels, Belgium.; UCB Pharma, Stockholm, Sweden.","The Swedish Institute for Health Economics (IHE), Lund, Sweden. chiara.malmberg@ihe.se."
38757725,"Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.",2024-01-01,Wright RS,"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.",Not available
38756352,Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.,2024-01-01,Tinterri B; Strange KE; Padron E; Wiseman DH; Jones K; Westers TM; Freeman S; Oelschlaegel U; Valcarcel D,"Hematologie seniors Hopital Saint-Louis, Assistance Publique des Hopitaux de Paris (APHP) Paris France.; INSERM UMR_S1160, Institut de Recherche Saint Louis Universite Paris Cite Paris France.; Institut Carnot OPALE, Institut de Recherche Saint-Louis, Hopital Saint-Louis Paris France.; Laboratoire d'Immunologie et d'Histocompatibilite, Assistance Publique des Hopitaux de Paris (APHP), Hopital Saint-Louis Paris France.; Universidade Catolica Portuguesa Faculdade de Medicina Portugal.; Universidade Catolica Portuguesa, Centro de Investigacao Interdisciplinar em Saude Portugal.; Universite Paris Cite, CNRS, INSERM, Institut Cochin Paris France.",Not available
38755681,NEMO/NF-kappaB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer.,2024-05-16,Chan LK,"Novartis Pharma, 4056, Basel, AG, Switzerland.",Not available
38755461,[Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany].,2024-01-01,Ho H; Leidl Q; Elishar R; Reitz A,"FARCO-PHARMA GmbH, Gereonsmuehlengasse 1-11, 50670, Koln, Deutschland.; Klinikum Bayreuth GmbH, Bayreuth, Deutschland.; Kontinenz Zentrum AG, Klinik Hirslanden, Zurich, Schweiz.",Not available
38755421,Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after >/=1 prior tyrosine kinase inhibitor: 2-year follow-up results.,2024-01-01,Hochhaus A; Damon A; Cacciatore S; Polydoros F; Agrawal N,"Hematology/Oncology, Universitatsklinikum Jena, Jena, Germany.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.","Georgia Cancer Center at Augusta University, Augusta, GA, USA. Jorge.Cortes@Augusta.edu."
38754125,Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies.,2024-09-01,Gossec L; Coarse J; Lambert J; Taieb V; Gladman DD,"Sorbonne Universite, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, Paris, France.; UCB Pharma, Colombes, France.; UCB Pharma, Morrisville, NC, USA.; UCB Pharma, Slough, UK.",Not available
38754046,Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib.,2024-09-05,Byrd JC; Seymour JF; de Bruin G; Rule S; Munugalavadla V,"Acerta Pharma BV, a member of the AstraZeneca group, Oss, The Netherlands.; AstraZeneca, South San Francisco, CA.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Universita Vita-Salute San Raffaele, Milan, Italy.",Not available
38753448,Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial.,2024-10-14,Maheux P; Talloczy Z; Zang X; Schwartz GG; Ray KK,"Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Corp., East Hanover, NJ, USA.",Not available
38753042,2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.,2024-01-01,Noda M,"Non-Profit Organizaition Sasaeau-Kai ""Alpha"", 518-7 Kawado-Cho, Chuo-Ku, Chiba, 260-0802, Japan.",Not available
38753041,Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review.,2024-01-01,Moosmang S; Gashaw I,"Boehringer Ingelheim Pharma GmbH, Ingelheim, Germany.","Boehringer Ingelheim Pharma GmbH, Biberach, Germany. mattia.amoroso@boehringer-ingelheim.com."
38752951,Artificial Intelligence-Enabled Quantitative Coronary Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome.,2024-01-01,Andreini D,"Centro Cardiologico Manzano, Istituti di Ricovero e Cura a Carattere Scientifico, Milan, Italy; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.","Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul National University of College of Medicine, Seoul, South Korea. Electronic address: bkkoo@snu.ac.kr."
38752934,Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis.,2024-01-01,Cainzos-Achirica M; Connelly MA,"Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.; Hospital del Mar and Hospital del Mar Research Institute, Barcelona, Spain; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Labcorp, Morrisville, North Carolina, USA.","Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address: ambarish.pandey@utsouthwestern.edu."
38752712,Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.,2024-01-01,Samineni D; Othman AA; Pithavala YK; Poondru S; Patel C; Vaddady P; Ankrom W; Ramanujan S; Budha N; Wu M; Haddish-Berhane N; Fritsch H; Hussain A; Kanodia J; Li M; Li M; Melhem M; Parikh A; Upreti VV,"AbbVie, South San Francisco, California, USA.; Amgen Inc., South San Francisco, California, USA.; Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.; Bayer, Cambridge, Massachusetts, USA.; BeiGene USA Inc., San Mateo, California, USA.; Blueprint Medicines Inc, Cambridge, Massachusetts, USA.; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany.; Bristol Myers Squibb, Princeton, New Jersey, USA.; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.; Genentech, Inc., South San Francisco, California, USA.; Gilead Sciences, Inc., Foster City, California, USA.; GlaxoSmithKline, Waltham, Massachusetts, USA.; Johnson and Johnson Innovative Medicine, Spring House, Pennsylvania, USA.; Merck & Co. Inc., Lansdale, Pennsylvania, USA.; Pfizer, San Diego, California, USA.; Sanofi, Bridgewater, New Jersey, USA.; Xencor, Pasadena, California, USA.",Not available
38752352,"Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.",2024-06-18,Hackley S; Vogt S; Abreu P; Haughie S; Hassan T; Oudiz RJ,"MEDA Pharma GmbH & Co KG (A Viatris Company), Hessen, Germany (S.V.).; Pfizer Inc, New York, NY (C.B., P.A.).; Viatris Inc, Canonsburg, PA (T.H.).; Viatris/Mylan Pharma UK Ltd, Kent (S. Hackley, S. Haughie).",Not available
38752299,Translating real-world evidence/real-world data.,2024-01-01,Ravenstijn P,"Astellas Pharma, Leiden, The Netherlands.",Not available
38751620,Development and Preclinical Evaluation of a Copper-64-Labeled Antibody Targeting Glycine-Alanine Dipeptides for PET Imaging of C9orf72-Associated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.,2024-05-10,Kaskinoro J; Vehmaan-Kreula P,"Orion Corporation Orion Pharma, 02200 Espoo, Finland.",Not available
38751551,MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.,2024-01-01,Ayuso C; Garcia-Pagan JC,"Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain.",Not available
38750934,Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease.,2024-01-01,Dervieux T,"Prometheus Laboratories, San Diego, CA, USA.","KU Leuven, Leuven, Belgium. Electronic address: severine.vermeire@uzleuven.be."
38750927,Design of greener drugs: aligning parameters in pharmaceutical R&D and drivers for environmental impact.,2024-01-01,Bramke I; Ryan J; Janer G,"AstraZeneca BV, Den Haag, the Netherlands.; EHSS Shared Services, GSK, Stevenage, UK.; Novartis Pharma, Global HSE, Barcelona, Spain.",Not available
38750530,Concepts of lines of therapy in cancer treatment: findings from an expert interview-based study.,2024-05-15,Stehle A,"PIOH Praxis Internistischer Onkologie und Hamatologie, Cologne, Germany.",Not available
38750391,Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing Modifiers.,2024-01-01,Mueller L,"PDMA Neuroscience and Rare Disease, Genentech, Inc., South San Francisco, CA, USA.","The Center for Male Reproductive Health, Reproductive Medicine Associates of New York, New York, NY, USA. nbarchama@rmaofny.com."
38750368,GLP-1-directed NMDA receptor antagonism for obesity treatment.,2024-01-01,DiMarchi RD,"Core Facility Pathology & Tissue Analytics, Helmholtz Munich, Neuherberg, Germany.",Not available
38750115,Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.,2024-01-01,O'Hara RM Jr,"EMD Serono, Inc., Rockland, MA, USA.",Not available
38750034,CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials.,2024-05-15,Moreno V; Rohrberg K; Leutgeb B; Bouseida S; Flinn N; Das Thakur M; Elze MC; Koeppen H; Jamois C; Martin-Facklam M; Lieu CH; Paz-Ares L,"CIBERONC, Instituto de Salud Carlso III, Madrid, Spain.; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.; Genentech, Inc., South San Francisco, CA, USA.; Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; START Madrid-CIOCC, Centro Integral Oncologico Clara Campal, Madrid, Spain.","Weill Cornell Medical College, New York, NY, USA. segaln@mskcc.org."
38749213,Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer.,2024-01-01,Breusa S; Thomas E; Baldinotti N; Zilio S; Guerin H; Mehlen P; Kryza D,"Apoptosis, Cancer and Development Laboratory- Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancerologie de Lyon, INSERM U1052-CNRS, Universite de Lyon1, 69008 Lyon, France; Apoptosis, Cancer and Development Laboratory- Equipe labellisee 'La Ligue', LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancerologie de Lyon, INSERM U1052-CNRS, Universite de Lyon1, 69008 Lyon, France.; Netris Pharma, Lyon, France.; Univ Lyon, Universite Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 boulevard du 11 novembre 1918, F-69100 Villeurbanne, France; Univ Lyon, Universite Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 boulevard du 11 novembre 1918, F-69100 Villeurbanne, France.",Not available
38749110,Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study.,2024-01-01,Manneh R; Cui K; Li C; Jain R; Adelberg D,"AstraZeneca, Gaithersburg, MD, USA.; Merck & Co., Inc., Rahway, NJ, USA.; Sociedad de Oncologia y Hematologia del Cesar, Valledupar, Colombia.",Not available
38748820,"Discovery of Potent, Selective, and Orally Available IRE1alpha Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma Model.",2024-06-13,Beveridge RE; Fu L; Jiang F; Leclerc JP; Lemire A; Wei W; Zhao L,"Paraza Pharma Inc., 2525 Ave. Marie-Curie, Montreal, QC, Canada H4S 2E1.; VIVA Biotech, No. 735, Ziping Road, Pudong New Area, Shanghai 201321, China.; WuXi AppTec Co., Ltd., Shanghai 200131, P. R. China.",Not available
38748747,Chemoenzymatic Synthesis of 2-Aryl Thiazolines from 4-Hydroxybenzaldehydes Using Vanillyl Alcohol Oxidases.,2024-07-22,Gao F; Gallou F; Gao L; Lei X,"Chemical & Analytical Development, Suzhou Novartis Technical Development Co., Ltd., Changshu, 215537, People's Republic of China.; Chemical and Analytical Development, Novartis Pharma AG, Novartis Campus, Basel, 4056, Switzerland.; Current Address: Rezubio Pharmaceuticals Co., Ltd., Zhuhai, 519070, People's Republic of China.",Not available
38747937,Real-world outcomes of ponatinib treatment in 724 patients with CML and Ph+ ALL: a post-marketing surveillance study with a special interest in arterial occlusive events in Japan.,2024-08-14,Masunari A; Nishibayashi S; Kageyama A; Fukuta Y,"Otsuka Pharmaceutical Co., Ltd, Tokyo.",Not available
38747505,Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy.,2024-07-01,Smythe KS,"Adaptive Biotechnologies, Seattle, Washington.",Not available
38747355,Porokeratosis.,2024-11-22,Awad A; Colla TG; Sinclair R,"Sinclair Dermatology, Melbourne, VIC, Australia.",Not available
38747075,Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.,2024-01-01,Sugiura Y; Kamishima M; Tanaka Y; Tsuchiya H; Masuda J,"Janssen Pharmaceutical K.K., Tokyo, Japan.",Not available
38746989,"Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT-7117), an Oral Melanocortin-1 Receptor Agonist.",2024-01-01,Ogasawara A; Ide R; Inoue S; Teng R; Kawaguchi A,"CareCeutics LLC, Berwyn, Pennsylvania, USA.; Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.; Mitsubishi Tanabe Pharma Development America, Inc., Jersey City, NJ, USA.",Not available
38746859,"Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK.",2024-01-01,Hwee J,"GSK, Epidemiology, Mississauga, ON, Canada.",Not available
38746014,Past and future of an IMI-PharmaTrain (IMI-PhT)-initiated multinational pharmaceutical medicine course at the Semmelweis University in Hungary.,2024-01-01,Gottwald M,"Independent Consultant, Berlin, Germany.",Not available
38745783,"Public perception of psychiatry, psychology and mental health professionals: a 15-year analysis.",2024-01-01,Lara-Abelenda FJ,"Departamento Teoria de la Senal y Comunicaciones y Sistemas Telematicos y Computacion, Escuela Tecnica Superior de Ingenieria de Telecomunicacion, Universidad Rey Juan Carlos, Fuenlabrada, Spain.",Not available
38745492,"Association of dietary and nutritional factors with cognitive decline, dementia, and depressive symptomatology in older individuals according to a neurogenesis-centred biological susceptibility to brain ageing.",2024-05-11,Houghton V; Ruigrok SR; Aigner L,"CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, 0828 Barcelona, Spain.",Not available
38745009,"Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial.",2024-01-01,Kuwahara Y; Wada N; Suto F; Arita T; Sugihara M; Tsuchihashi Z; Saito K; Kojima A; Yamaguchi K,"Daiichi Sankyo Co. Ltd, Tokyo, Japan.; Daiichi Sankyo Inc., Basking Ridge, NJ, USA.; Daiichi Sankyo RD Novare Co. Ltd, Tokyo, Japan.","National Cancer Center Hospital East, Kashiwa, Japan. kshitara@east.ncc.go.jp."
38744872,Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advances.,2024-05-14,Dam T,"Neumora Therapeutics, Cambridge, MA, USA.","Division of Neurology, Department of Medicine, University of Ottawa, The Ottawa Hospital Ottawa, Ottawa, ON, Canada. tmestre@toh.ca."
38743951,Hysterectomy Techniques and Outcomes for Benign Large Uteri: A Systematic Review.,2024-07-01,Mamik MM,"Albert Einstein College of Medicine, Bronx, New York; Brown University School of Public Health, Providence, Rhode Island; Florida State University, Tallahassee, Florida; Kaiser Permanente, Roseville, California; Northwestern Medicine, Chicago, Illinois; Ochsner Clinical School, Jefferson, Louisiana; Rutgers New Jersey Medical School, Newark, New Jersey; University Hospitals, Cleveland, Ohio; University of Calgary, Calgary, Alberta, Canada; Waukesha Memorial Hospital, Waukesha, Wisconsin; and Houston Methodist Hospital, Houston, Texas.",Not available
38743766,"Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models.",2024-08-01,Feldsien TM; Lefebvre DR; Reilly EB,"Development Sciences, AbbVie Inc., North Chicago, Illinois.; Discovery Oncology, AbbVie Inc., North Chicago, Illinois.",Not available
38743155,Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study.,2024-01-01,Dubost-Brama A; Bansal A,"Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.; Sanofi, Bridgewater, NJ, USA.","Northwestern University Feinberg School of Medicine, Chicago, IL, USA. apaller@nm.org."
38742994,Supplementation with a Probiotic Formula Having beta-Glucuronidase Activity Modulates Serum Estrogen Levels in Healthy Peri- and Postmenopausal Women.,2024-01-01,Sawashita J,"Pharma & Supplemental Nutrition Solutions Vehicle, Kaneka Corporation, Tokyo, Japan.",Not available
38742863,Care interruptions and mortality among adults in Europe and North America.,2024-08-01,Silverberg MJ,"Kaiser Permanente Northern California, Oakland, CA, USA.",Not available
38742661,Activated factor X stimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R/NADPH oxidases/SGLT1/2.,2024-09-02,Kindo M,"Boehringer Ingelheim Pharma GmbH & Co. KG, Global Cardio-Metabolic Diseases, Birkendorfer Strasse 65, 88397 Biberach, Germany.",Not available
38742491,Influence of Pathophysiologic Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.,2024-08-20,Johnson T,"Abbott Vascular, Santa Clara, CA (N.E.J.W.).",Not available
38741596,T-cell lymphoblastic lymphoma in constitutional mismatch repair deficiency (CMMRD): Exploring treatment opportunities.,2024-01-01,Loeffen JLC,Present address: Acerta-Pharma (AstraZeneca) Oss The Netherlands.,Not available
38740722,Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel.,2024-01-01,Bernlochner I; Xhepa E,"Klinik Und Poliklinik Fur Innere Medizin I, Klinikum Rechts Der Isar, Technische Universitat Munchen, Munich, Germany.",Not available
38740532,"Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.",2024-01-01,Ambrosy AP,"Kaiser Permanente Northern California, Oakland CA, USA.","Department of Internal Medicine, Stadtspital Zurich, Zurich, Switzerland. Electronic address: mattia.arrigo@uzh.ch."
38740373,Impact of linked color imaging on the proximal adenoma miss rate: a multicenter tandem randomized controlled trial (the COCORICO trial).,2024-01-01,Perrod G; Rahmi G,"Gastroenterology and Digestive Endoscopy, Hopital Europeen Georges Pompidou, Paris, France.",Not available
38740030,"Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial.",2024-01-01,Roumiguie M; Lebret T; Li H; Baranwal P; Kapadia E,"Hopital Foch, Universite Paris-Saclay, Universite Versailles Saint-Quentin-en-Yvelines, Suresnes, France.; Institut Universitaire du Cancer Toulouse-Oncopole CHU, Toulouse, France.; Merck & Co, Rahway, NJ, USA.","Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: necchi.andrea@hsr.it."
38739422,"Relative bioavailability, immunogenicity, and safety of two adalimumab-adbm formulations in healthy volunteers: a double-blind, randomized, single-dose, parallel-arm Phase I trial (VOLTAIRE-HCLF).",2024-01-01,McCabe D,"Specialty Medicine, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.",Not available
38739396,Prognostic Value of Cardiovascular Biomarkers in the Population.,2024-06-11,Lorenz T,"Istituto Superiore di Sanita, Rome, Italy.",Not available
38739123,"Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk.",2024-01-01,Davison B; Cohen-Solal A; Gayat E; Cotter G; Mebazaa A,"Department of Anesthesiology and Critical Care and Burn Unit, Saint-Louis and Lariboisiere Hospitals, FHU PROMICE, DMU Parabol, APHP.Nord, Paris, France.; Department of Cardiology, APHP Nord, Lariboisiere University Hospital, Paris, France.; Heart Initiative, Durham, North Carolina, USA.; Momentum Research Inc, Durham, North Carolina, USA; Universite Paris Cite, INSERM UMR-S 942(MASCOT), Paris, France","Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. Electronic address: andrew.p.ambrosy@kp.org."
38739062,"Randomized Placebo-Controlled Trial of 60-Day Percutaneous Peripheral Nerve Stimulation Treatment Indicates Relief of Persistent Postoperative Pain, and Improved Function After Knee Replacement.",2024-01-01,Gilbert JE; Wongsarnpigoon A; Boggs JW,"SPR Therapeutics, Cleveland, OH, USA.","Department of Anesthesiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: JHGoree@uams.edu."
38738770,"Impact of Atopic Dermatitis on Adult Women's Lives: A Survey of 1,009 French Women.",2024-05-13,Hamza M,"Patients experts, LEO Pharma, Voisins-le-Bretonneux, France.",Not available
38738687,"Sun exposure and protection habits: Self-reported attitudes, knowledge and behaviours.",2024-01-01,Saint Aroman M; Ben Hayoun Y,"Dermocosmetics Care & Personal Care, Pierre Fabre, Paris, France.",Not available
38737600,Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.,2024-01-01,Ellerbrock M,"Xcare Praxis fur Strahlentherapie, Saarbrucken, Germany.",Not available
38737345,Prediction of incident chronic kidney disease in community-based electronic health records: a systematic review and meta-analysis.,2024-01-01,Nadarajah R,"NIHR Leeds MedTech and In-Vitro Diagnostic Co-operative, Leeds, UK.",Not available
38736494,MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations.,2024-04-29,Mollerup J,"Pathology Division, Agilent Technologies Denmark ApS, Glostrup, Denmark.",Not available
38735758,Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.,2024-01-01,Delaugerre C; Naudin J; Dalle JH,"INSERM U1131, Institut de Recherche Saint-Louis, Universite Paris Cite, Paris, France.; Novartis Pharma S.A.S., Rueil-Malmaison, France.",Not available
38735684,Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study.,2024-10-17,Ehst B; Sluzevich J; Fazel N; Fan H; Hampele I; Compagno N,"Georgia Dermatology Partners, Snellville, GA, USA.; Newport Dermatology & Laser Associates, Newport Beach, CA, USA.; Novartis Gene Therapies, Bannockburn, IL, USA.; Novartis Pharma Shanghai, Shanghai, China.; Novartis Pharma, Basel, Switzerland.",Not available
38735372,Maternal and fetal outcomes in multiparous women with Cystic Fibrosis.,2024-01-01,Melo Tanner J,"Instituto Nacional del Torax, Santiago, Chile.","Faculty of Medicine, Hebrew University of Jerusalem, Israel. Electronic address: malena@hadassah.org.il."
38735299,"Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK.",2024-06-01,Ealing J,"Northern Care Alliance NHS Trust, Salford, UK.","Division of Psychiatry, University College London, London, UK. Electronic address: r.gould@ucl.ac.uk."
38735133,Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel.,2024-01-01,Gibb EA; Loriot Y,"Departement de Medecine Oncologique, Institut Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; Veracyte, Inc, San Francisco, CA.","Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: tateo.valentina@hsr.it."
38734153,Association between bronchiectasis exacerbations and longitudinal changes in FEV(1) in patients from the US bronchiectasis and NTM research registry.,2024-01-01,Feliciano J; Wu J; Fucile S,"Insmed Incorporated, Bridgewater, NJ, USA.","Mayo Clinic, Rochester, MN, USA. Electronic address: Aksamit.Timothy@mayo.edu."
38733984,Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis.,2024-01-01,Demelo-Rodriguez P,"Universidad Catolica San Antonio, Region de Murcia, Spain.",Not available
38733717,"Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.",2024-01-01,Geraud A; Hueso T; Laparra A; Ouali K; Danlos FX; Hollebecque A; Gazzah A; Goldschmidt V; Baldini C; Bahleda R; Besse B; Barlesi F; Lambotte O; Massard C; Marabelle A; Champiat S; Michot JM,"Gustave Roussy, Departement Interdisciplinaire d'Organisation des Parcours Patients, 94805 Villejuif, France; Gustave Roussy, Departement d'Innovation Therapeutique et d'Essais Precoces, 94805 Villejuif, France; Gustave Roussy, Department d'Hematologie Clinique, 94805 Villejuif, France.; Gustave Roussy, Department de Medecine Oncologique, 94805 Villejuif, France; Hopital Universitaire du Kremlin Bicetre, Service de Medecine Interne, 94270 Le Kremlin-Bicetre, France; Universite Paris-Saclay, Gustave Roussy, 94805 Villejuif, France",Not available
38733494,Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis.,2024-01-01,Kuhne F; Laurenz M; von Eiff C; Warren S,"Pfizer Inc, New York City, New York, USA.; Pfizer Pharma GmbH, Berlin, Germany.",Not available
38733387,JEWELFISH: 24-month results from an open-label study in non-treatment-naive patients with SMA receiving treatment with risdiplam.,2024-01-01,Gorni K; Kletzl H; Martin C; Scalco RS; Fontoura P; Muntoni F,"PDMA Neuroscience and Rare Disease, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Pharma Development, Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Product Development Neuroscience, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Roche Products Ltd, Welwyn Garden City, UK.","Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA. cac3@cumc.columbia.edu."
38733332,"Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis Registry.",2024-08-22,Harrison RW; McLean RR; Dube B; Crabtree MM,"CorEvitas LLC, Waltham, MA, USA.",Not available
38733307,Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.,2024-01-01,Heatta-Speicher T; Michelena N; Kolterer S; Lapthorn J; Kauffman L; Dignass A,"AbbVie Inc., North Chicago, Illinois, USA.; Market Access and HEOR Services, Fortrea, Burlington, North Carolina, USA.",Not available
38733261,The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.,2024-01-01,Kramps T; Melzer N,"Novartis Pharma GmbH, Nurnberg, Germany.",Not available
38732029,Paricalcitol Has a Potent Anti-Inflammatory Effect in Rat Endothelial Denudation-Induced Intimal Hyperplasia.,2024-04-28,Pintor-Chocano A; Sanz A; Sanchez-Nino MD,"RICORS2040, 28049 Madrid, Spain.",Not available
38732014,Fetal Kidney Grafts and Organoids from Microminiature Pigs: Establishing a Protocol for Production and Long-Term Cryopreservation.,2024-04-27,Takasu M,"Sumitomo Pharma, Co., Ltd., Osaka 541-0045, Japan.",Not available
38731962,Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer.,2024-04-26,Pabla S; Nesline M; Conroy JM; DePietro P,"Labcorp Oncology, Buffalo, NY 14203, USA.",Not available
